Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cellular response to zinc ion (GO:0071294),-0.7692821519523766,-2.1020270217881585,0.0,0.05073971829321534,0.04,11/15,16.01%,MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X;GLRA2;P2RX4;MT2A
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.515255468471499,-2.0751904591106825,0.0,0.0462295211115962,0.068,51/87,25.05%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;RPS7;RPS20;RPL32;RPS27;RPL26;RPL27;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;SEC61B;RPL30;RPL29;RPS16;RPL3;RPLP1;RPS17;RPS3;RPL23;RPL17;RPL9;RPL38;RPL36;RPS26;RPS8;RPS12;RPL18A;RPS21;RPS18;RPLP2;RPS6;RPS15A;RPL14;RPS2;RPL10A;RPL39;RPL34;RPL5;RPL22;RPS9;RPS14;RPS25
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.7575011912104264,-2.03108470038654,0.0,0.05900841312618377,0.129,6/14,2.58%,PRKG1;LRP1;SLIT2;TPM1;IGFBP3;IGFBP5
prerank,protein targeting to ER (GO:0045047),-0.4870314635526052,-2.0204054611075803,0.0,0.05186726758862012,0.15,53/99,22.60%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;RPS7;RPS20;RPL32;RPS27;RPL26;RPL27;RPS24;RPLP0;RPS19;RPL31;RPL41;SGTA;RPL13A;RPL30;RPL29;RPS16;RPL3;RPLP1;RPS17;RPS3;SEC62;RPL23;RPL17;RPL9;RPL38;RPL36;RPS26;RPS8;ZFAND2A;RPS12;RPL18A;RPS21;SPCS1;RPS18;RPLP2;RPS6;SGTB;RPS15A;RPL14;RPS2;RPL10A;GET3;RPL39;RPL34;RPL5;RPL22
prerank,dopamine metabolic process (GO:0042417),-0.7039927433528739,-2.0074665633562607,0.0,0.05119073801137725,0.177,8/18,12.75%,SNCAIP;MOXD1;MAOA;COMT;ATP7A;GCH1;MAOB;TGFB2
prerank,blood vessel diameter maintenance (GO:0097746),-0.6010823989203409,-1.9851122937748096,0.0,0.06107558683442588,0.24,17/34,19.17%,ROCK2;ECE1;NOS3;GCLM;NPR1;ACE;BDKRB2;AGTR1;KLF2;EDNRA;EDN1;EDN3;ACE2;NOS1;PER2;GCLC;AGT
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.6828226059602223,-1.9797779405271134,0.0,0.05524991547483448,0.253,7/20,4.89%,IGF1;PDGFRB;LRP1;SLIT2;IGFBP3;IGFBP5;ACE
prerank,regulation of cell morphogenesis (GO:0022604),0.744194389697967,1.9748150015739925,0.0,0.6956999372253609,0.412,5/30,2.67%,NTNG2;NTNG1;EFNA5;FMNL2;CAPZB
prerank,smoothened signaling pathway (GO:0007224),0.7442990683215154,1.973340165437292,0.0,0.3553608991090407,0.417,6/32,5.28%,PTCH1;PTCH2;GLI1;GLI2;STIL;HIPK1
prerank,cellular zinc ion homeostasis (GO:0006882),-0.6172534618395774,-1.9682213103300792,0.0,0.05623652110831366,0.29,12/26,6.86%,SLC30A10;SLC39A10;SLC39A8;MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X;SLC39A14
prerank,response to zinc ion (GO:0010043),-0.6238563444548197,-1.965227232987836,0.0027624309392265192,0.052493683863845,0.3,13/25,17.56%,MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X;GLRA2;P2RX4;MT2A;SLC30A4;D2HGDH
prerank,cellular response to sterol (GO:0036315),0.8651077280553982,1.963677845828608,0.0,0.2838505816749448,0.473,4/13,4.10%,PTCH1;RORA;GPLD1;GRAMD1B
prerank,regulation of smoothened signaling pathway (GO:0008589),0.6790334987779822,1.9563040636549454,0.0013550135501355014,0.24293165824164933,0.516,10/50,7.03%,PTCH1;RORA;GPC3;PTCH2;GLI1;GLIS2;INTU;KIF7;IFT81;PDCL
prerank,dorsal/ventral pattern formation (GO:0009953),0.8071715837243001,1.9511208038970487,0.0,0.2136859726214469,0.546,5/20,4.27%,PTCH1;FBXL15;GLI2;BMPR1B;NBL1
prerank,heart trabecula morphogenesis (GO:0061384),-0.7122857105438503,-1.9486994994937255,0.0,0.06043664223369649,0.359,8/18,2.84%,ENG;TEK;ADGRG6;TGFBR3;RBPJ;FKBP1A;RBP4;TGFBR1
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.4840284752136101,-1.9462826043603907,0.0,0.05740250958424361,0.37,42/91,16.50%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;RPS7;RPS20;RPL32;RPS27;SSR1;RPL26;RPL27;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;RPLP1;RPS17;RPS3;SEC62;RPL23;RPL17;RPL9;RPL38;RPL36;RPS26;RPS8;RPS12;RPL18A;RPS21;RPS18;RPLP2;RPS6;RPS15A
prerank,negative regulation of cell activation (GO:0050866),-0.7359442571423922,-1.9445032203210624,0.0,0.054216328620713426,0.381,6/14,6.95%,PDGFRA;NOS3;THBD;LDLR;APOE;CD200
prerank,smooth muscle contraction (GO:0006939),-0.7185867966807911,-1.9414138482171175,0.0,0.051780533027435134,0.391,8/14,11.69%,ROCK2;MYLK;SLC8A1;BDKRB2;MYH11;PIK3C2A;ACTA2;EDNRA
prerank,regulation of glucose import (GO:0046324),-0.5908005902104845,-1.933784624245226,0.0,0.05492775853329026,0.432,10/30,2.90%,PRKAG2;IGF1;OSBPL8;INSR;PID1;ENPP1;GRB10;PIK3R1;CREBL2;APPL2
prerank,basement membrane organization (GO:0071711),0.8527609021908076,1.9335296794928862,0.0,0.24739127322386317,0.65,5/14,1.47%,NTNG2;NTNG1;PXDN;NID1;LAMB2
prerank,cellular response to copper ion (GO:0071280),-0.7062354232339774,-1.929245559196913,0.0,0.054498215944564624,0.452,8/16,3.81%,MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.6573734935814527,-1.926905113293261,0.0027548209366391185,0.0533471760388389,0.47,9/21,9.68%,RBPMS;BMP6;DAB2;BMP4;TGFBR1;CCN3;JAK2;TGFB3;SLC2A10
prerank,somite development (GO:0061053),0.9053803565265961,1.9152590907197038,0.0,0.28635422517373155,0.741,2/11,0.06%,PTCH1;MEOX2
prerank,zinc ion homeostasis (GO:0055069),-0.5955782053196882,-1.9143603191045655,0.0,0.06029072408958528,0.527,12/28,6.86%,SLC30A10;SLC39A10;SLC39A8;MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X;SLC39A14
prerank,angiogenesis involved in wound healing (GO:0060055),-0.7797024132803749,-1.9143221786910114,0.0,0.05694123941794166,0.527,7/11,9.15%,ADIPOR2;NDNF;PRCP;KDR;CD34;GATA2;MCAM
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.7537467076915213,1.9094661445331267,0.0046801872074883,0.2752051877181969,0.775,6/23,5.67%,PTCH1;GPC3;PTCH2;GPR161;GLIS2;KIF7
prerank,positive regulation of embryonic development (GO:0040019),-0.6696129587807859,-1.9052575981492152,0.0,0.06023487025451879,0.562,5/19,6.20%,PLCB1;OSR1;WNT4;CFL1;ZBED3
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.5984585885431444,-1.9026629739121292,0.0,0.05891445068490003,0.576,15/31,17.55%,OSR1;PDGFRA;HOXA3;TGFBR1;FGFR2;HOXB4;DSCAML1;HOXB9;TBX1;HOXC4;HOXA9;FUZ;MEGF8;HOXD4;HOXD3
prerank,extracellular matrix assembly (GO:0085029),0.7519215858595787,1.8969828913452638,0.00303951367781155,0.2941781111074401,0.829,5/23,1.47%,NTNG2;NTNG1;TNXB;PXDN;LAMB2
prerank,regulation of cholesterol efflux (GO:0010874),0.7067333077345794,1.894983619310104,0.0014792899408284023,0.2755572625852138,0.842,2/30,0.24%,PTCH1;CAV1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.8043845360138816,1.891115663613735,0.001579778830963665,0.26535776037708836,0.857,3/16,1.37%,CLDN1;CLDN11;CLDN19
prerank,hemidesmosome assembly (GO:0031581),0.8812131687384904,1.886782432360581,0.0034129692832764505,0.26288256737260607,0.882,3/11,1.47%,ITGB4;ITGA6;LAMC1
prerank,positive regulation of cholesterol efflux (GO:0010875),0.7476750868064701,1.8829750496329836,0.001557632398753894,0.25732158998587784,0.893,2/21,0.24%,PTCH1;CAV1
prerank,regulation of Golgi organization (GO:1903358),-0.6760075969447276,-1.8829592585909627,0.002403846153846154,0.07372024679003668,0.677,7/17,7.55%,PDE4DIP;MYO5A;STX18;USP6NL;PDCD10;RBSN;MAP2K2
prerank,manganese ion transport (GO:0006828),-0.7174282865405301,-1.8782738705014557,0.0,0.07503328038511844,0.701,7/14,6.86%,SLC30A10;TRPC3;SLC39A8;TRPC1;SLC11A2;ATP2C1;SLC39A14
prerank,embryonic appendage morphogenesis (GO:0035113),0.8374946458462458,1.875782263657701,0.007017543859649123,0.26603447570590005,0.912,1/12,0.01%,PTCH1
prerank,embryonic axis specification (GO:0000578),0.8006235256980979,1.8746144647711884,0.001669449081803005,0.2528054022899895,0.917,3/15,3.46%,PTCH1;COBL;STIL
prerank,regulation of histone modification (GO:0031056),-0.7170854644344647,-1.874414235598651,0.0,0.07554580279212061,0.713,8/13,16.52%,SETD5;IGF2;PARG;UBE2N;CDK9;MTHFR;MYOCD;AKAP8L
prerank,regulation of cell projection organization (GO:0031344),0.8253557245989391,1.8735397638416134,0.005076142131979695,0.2407018507505424,0.919,2/13,0.08%,NTNG2;NTNG1
prerank,erythrocyte differentiation (GO:0030218),-0.5230288651505391,-1.8680634713076025,0.0034482758620689655,0.07775392016228833,0.736,21/44,28.46%,TGFBR3;LYN;MFHAS1;KIT;CEBPG;UBA5;JAK2;RPS19;CASP3;SLC25A38;TAL1;ID2;CDK5RAP3;ABCB10;INHBA;ALAS1;NCKAP1L;RPS14;JAK3;KMT2E;ALAS2
prerank,positive regulation of cholesterol transport (GO:0032376),0.7131064445225794,1.8676362548133632,0.0,0.24659047548711888,0.945,2/27,0.24%,PTCH1;CAV1
prerank,cell-substrate junction assembly (GO:0007044),0.7159937856231442,1.8647034893927037,0.0029585798816568047,0.24316637481966058,0.955,8/33,5.16%,ITGB4;ITGA6;DLC1;SORBS1;LAMC1;PEAK1;SRC;FN1
prerank,skin development (GO:0043588),0.6087046507924347,1.8370216327960696,0.002564102564102564,0.3388319106154059,0.983,12/65,6.65%,ITGB4;CLDN1;ITGA6;WNT10A;JAG1;COL5A3;WNT16;ALOXE3;LSR;WNT5A;TMEM79;COL3A1
prerank,metanephros development (GO:0001656),0.7235176429158751,1.836418838688067,0.0,0.32404970760233914,0.983,3/26,3.23%,PTCH1;FOXD1;NF1
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.45403536885568846,-1.8187245229738693,0.0,0.13309591882958086,0.906,23/91,7.18%,BMP6;SLC30A10;ABCG2;SLC39A10;FTH1;TFRC;SCARA5;SLC39A8;ATP7A;MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X;SLC31A1;FTL;SLC31A2;SLC11A2;SLC39A14;NEDD8
prerank,limb morphogenesis (GO:0035108),0.7361460213986899,1.8150023629199583,0.011326860841423949,0.40952454373011415,0.992,3/20,4.10%,PTCH1;PCSK5;BMPR1B
prerank,inositol phosphate-mediated signaling (GO:0048016),0.7507220987224968,1.8094100973000464,0.00964630225080386,0.421721677074041,0.994,4/19,1.39%,HRH1;NFATC2;PLCE1;NFATC1
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.7471068968372583,1.8088586970312484,0.0112,0.4057127076267595,0.995,4/18,5.19%,CAV1;NEDD4L;CAMK2D;ATP1A2
prerank,regulation of neuron projection arborization (GO:0150011),0.7853114286229909,1.808336742954672,0.006825938566552901,0.39146813269310543,0.995,3/15,4.96%,NTNG2;NTNG1;WNT5A
prerank,synaptic membrane adhesion (GO:0099560),0.7969727106851164,1.807285444673221,0.010084033613445379,0.38091684012290616,0.997,3/14,2.28%,NTNG1;PTPRF;GPC6
prerank,negative regulation of locomotion (GO:0040013),-0.6942639997984537,-1.8071292952825684,0.007556675062972292,0.14649467384143708,0.934,6/12,13.85%,FBLN1;FRMD5;DUSP3;CCDC125;CRK;SPOCK3
prerank,regulation of wound healing (GO:0061041),0.6491383350892279,1.8066877508741297,0.005681818181818182,0.3689744606336935,0.997,10/42,8.22%,CLDN1;CAV1;PRKCE;CLDN19;AJAP1;CASK;TNFAIP3;EPHB2;KANK1;OCLN
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.712100472976766,-1.805154694743742,0.007125890736342043,0.14436807089682752,0.935,7/13,8.02%,RBPMS;BMP6;DAB2;BMP4;TGFBR1;JAK2;TGFB3
prerank,neural tube development (GO:0021915),0.7770693125114829,1.8030568319527815,0.00505902192242833,0.37154764978522425,0.997,3/15,4.94%,PTCH1;STIL;DACT1
prerank,transition metal ion transport (GO:0000041),-0.5358212695758131,-1.8010770617056906,0.0,0.1456149375779894,0.94,11/35,6.32%,SLC30A10;TRPC3;FTH1;TFRC;SLC39A8;ATP7A;TRPC1;SLC31A1;SLC31A2;SLC11A2;ATP2C1
prerank,actin filament-based transport (GO:0099515),-0.6152312855090865,-1.7958180377343513,0.0026041666666666665,0.14844769689156795,0.949,5/21,2.67%,MYO1D;SYNE2;MYO1B;MYO5A;MYO6
prerank,response to cholesterol (GO:0070723),0.7623731273812719,1.7945994490615442,0.004838709677419355,0.39506153173265873,0.998,3/17,4.10%,PTCH1;GPLD1;GRAMD1B
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.7632439526028523,1.790345788863565,0.010256410256410256,0.40031317063574795,0.999,5/16,8.29%,RORA;FOXK1;PDK4;BCKDK;FOXK2
prerank,regulation of neuroinflammatory response (GO:0150077),-0.637315806786708,-1.786411132290054,0.0,0.15793207130969694,0.959,7/19,7.37%,IGF1;NUPR1;IL18;TNFRSF1B;IL33;CD200;DAGLA
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.6331616962622614,1.7825329627441437,0.004005340453938585,0.4226776136826687,1.0,14/46,10.07%,NTNG2;NTNG1;PARVA;PXN;LAMB2;LAMC1;PEAK1;FN1;FER;LAMA5;ITGB7;SRCIN1;NTN4;FERMT2
prerank,mesoderm formation (GO:0001707),0.742566439889121,1.7813460241012216,0.009787928221859706,0.41437318972258014,1.0,1/17,0.03%,ITGB4
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.7294064233148108,1.777613233107248,0.0078125,0.4204360703626612,1.0,6/20,5.61%,SMOC2;SULF1;SPRY1;SPRY4;CREB3L1;APLN
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.7058597744005127,1.7755913411215563,0.008051529790660225,0.41660058809925,1.0,7/21,11.19%,CAV1;FZD2;AXIN1;GSK3B;CSNK1A1;APC;DVL3
prerank,muscle tissue development (GO:0060537),0.774533769381997,1.7725242725452657,0.0017035775127768314,0.4193971043335232,1.0,4/13,4.33%,PTCH1;STRA6;NF1;CSRP3
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.59096147476342,1.7724271809902379,0.0025220680958385876,0.40803129921476633,1.0,18/70,10.51%,NTNG2;NTNG1;PARVA;PXN;LAMB2;LAMC1;SPI1;OPHN1;PEAK1;FN1;FER;POF1B;LAMA5;ITGB7;SRCIN1;NTN4;FERMT2;RELN
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.7127741321204539,1.7708447507487164,0.007656967840735069,0.403503877221127,1.0,6/21,9.62%,CNKSR3;CAV1;PDE4D;NCK2;NLRP2B;RASSF2
prerank,digestive tract development (GO:0048565),0.6679508427124581,1.768393744721119,0.0073964497041420114,0.4018347815552692,1.0,10/33,8.48%,STRA6;PKDCC;GLI1;RARB;COBL;PCSK5;GLI2;CHD8;CCDC39;CLMP
prerank,ventricular septum morphogenesis (GO:0060412),-0.551888013918105,-1.7668465485242661,0.0058997050147492625,0.18950102674383648,0.983,9/27,12.75%,ROBO1;TGFBR3;SLIT2;BMP4;TGFBR1;BMPR2;CITED2;PROX1;TGFB2
prerank,cytoplasmic translation (GO:0002181),-0.440868370796686,-1.7651054251540692,0.0,0.18685605979786177,0.984,47/91,22.60%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;RPS7;RPS20;RPL32;RPS27;RPL26;RPL27;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;RPLP1;RPS17;RPS3;RPL23;RPL17;RPL9;RPL38;RPL36;RPS26;RPS8;RPS12;RPL18A;RPS21;RPS18;RPS6;RPS15A;GSPT2;RPL14;RPS2;RPL10A;RPL39;RPL34;RPL5;RPL22
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.7231362269513176,1.7558337099547143,0.011235955056179775,0.44746862572229956,1.0,3/19,4.67%,THBS4;RIPOR2;RAC2
prerank,embryonic digestive tract development (GO:0048566),0.7252841433927993,1.7549104540067857,0.01192504258943782,0.43989497743586353,1.0,5/18,2.92%,STRA6;PKDCC;RARB;PCSK5;GLI2
prerank,copper ion transport (GO:0006825),-0.728653242862088,-1.7548364830405736,0.004901960784313725,0.20234384628445873,0.991,5/11,6.14%,STEAP3;ATP7A;SLC31A1;SLC31A2;SLC11A2
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.7206073246589496,1.7535792574699494,0.0078125,0.4344838575566348,1.0,4/19,2.50%,LBP;PRKCE;PIK3AP1;TNIP3
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.7220634832166184,-1.7524991163114916,0.0070921985815602835,0.20130071244432488,0.994,4/10,10.33%,ZEB2;RAPGEF2;ATP7A;CTNS
prerank,establishment of skin barrier (GO:0061436),0.7611223670333545,1.750064033768725,0.005084745762711864,0.42897248876533245,1.0,5/15,9.28%,CLDN1;ALOXE3;LSR;TMEM79;SFN
prerank,regulation of water loss via skin (GO:0033561),0.7611223670333545,1.750064033768725,0.005084745762711864,0.42897248876533245,1.0,5/15,9.28%,CLDN1;ALOXE3;LSR;TMEM79;SFN
prerank,pharyngeal system development (GO:0060037),0.7461707816122037,1.7432084145257218,0.01309328968903437,0.451529193792815,1.0,3/15,4.65%,PTCH1;FOLR1;BMP5
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.6698106891823692,1.7411960820627719,0.010479041916167664,0.44975963921102186,1.0,6/27,9.35%,NTNG2;NTNG1;BRSK1;ULK4;FRMD7;GSK3B
prerank,melanocyte differentiation (GO:0030318),-0.7233324692317304,-1.7322813581957441,0.009950248756218905,0.24171435324063154,0.998,4/11,3.98%,ENPP1;LRMDA;KIT;MITF
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5705065874988743,-1.732141049537029,0.005847953216374269,0.23543855704327143,0.998,7/25,10.36%,ANK2;ACTN2;DMD;SLC6A9;ATP1B1;ANK3;ATP1B2
prerank,positive regulation of vasoconstriction (GO:0045907),0.7700415841607577,1.7317995126049472,0.01340033500837521,0.4818470550373283,1.0,3/13,3.83%,CAV1;SMTNL1;SMTNL2
prerank,regulation of glucose metabolic process (GO:0010906),0.6503151047604587,1.7303838671635774,0.008982035928143712,0.47765844132151386,1.0,9/34,9.58%,RORA;OGT;GPLD1;FOXK1;PDK4;BCKDK;SELENOS;FOXK2;SIRT7
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.7127047329451577,-1.728886652652542,0.009828009828009828,0.23681582634028608,0.998,4/11,15.22%,RAPGEF2;LYN;ANXA1;LGALS9
prerank,atrial septum development (GO:0003283),-0.6539489072480845,-1.728103724501077,0.00702576112412178,0.23218613780374853,0.998,6/13,12.75%,NOTCH2;ANK2;NPHP3;BMPR2;DAND5;TGFB2
prerank,muscle tissue morphogenesis (GO:0060415),-0.62007482997587,-1.7249479471425926,0.013020833333333334,0.23337379262839555,0.999,6/16,10.52%,MYLK;TGFBR3;BMP4;TBX1;PROX1;BMP2
prerank,cellular response to amyloid-beta (GO:1904646),-0.5216926420148418,-1.7241876155326739,0.01639344262295082,0.22923077175579284,0.999,8/35,9.43%,IGF1R;IGF1;LRP1;GJA1;EPHA4;VCAM1;GRIN1;LGMN
prerank,integrin-mediated signaling pathway (GO:0007229),0.5750415098481004,1.722960223650394,0.004962779156327543,0.5019738628804116,1.0,20/73,10.55%,ITGB4;TEC;ITGBL1;CEACAM1;ADAMTS1;DOCK1;CDH17;TXK;PLPP3;SRC;FN1;ADAM10;LAMA5;COL3A1;ITGB7;CUL3;PLEK;FERMT2;LAT;ZYX
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.7735907962665297,1.7216450364814035,0.00676818950930626,0.4977360633877014,1.0,3/12,4.74%,DCN;ADAMTS12;ATP2B4
prerank,chordate embryonic development (GO:0043009),0.5925066047663405,1.7206796122741026,0.008064516129032258,0.49211923180743544,1.0,10/55,6.14%,PTCH1;FGFR1;SULF1;KIAA1217;PCSK5;STIL;BMP5;DACT1;WNT5A;ADAM10
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.548438251261446,-1.7204752020769378,0.00554016620498615,0.23114760555798097,1.0,4/24,1.71%,PICALM;NUMB;PID1;DAB2
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.7311260818806039,1.7168555395972818,0.011666666666666667,0.5004157443199965,1.0,3/17,4.67%,THBS4;RIPOR2;RAC2
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.552356846894261,-1.7085023498806564,0.011834319526627219,0.25428921252557446,1.0,8/27,11.17%,FLT1;TEK;PDGFRB;PDGFRA;KIT;EPHA8;TNFAIP8L3;AMBRA1
prerank,regulation of store-operated calcium entry (GO:2001256),0.8125679143147829,1.7077313280628703,0.0108499095840868,0.5336258389656674,1.0,3/10,1.76%,HOMER2;EFHB;SLC8B1
prerank,GPI anchor metabolic process (GO:0006505),0.6561060838817234,1.7035042313873916,0.015220700152207,0.5439827522231626,1.0,5/26,9.37%,PIGU;GPLD1;PGAP3;PIGB;PIGA
prerank,positive regulation of neutrophil migration (GO:1902624),0.7148332621739865,1.7024907392761972,0.011513157894736841,0.5386966896092285,1.0,3/18,4.67%,THBS4;RIPOR2;RAC2
prerank,actin cytoskeleton reorganization (GO:0031532),0.583481086761873,1.7019257746234069,0.007722007722007722,0.5313809462042961,1.0,11/63,5.70%,GAB1;FGF7;CXADR;SIPA1L1;PARVA;CLDN19;PDLIM4;MINK1;TRPV4;THSD7A;FER
prerank,camera-type eye development (GO:0043010),0.6729052085863849,1.6986632921442906,0.020123839009287926,0.5373387958282397,1.0,5/25,6.15%,ALDH1A3;STRA6;EFEMP1;NF1;SHROOM2
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.6342573953552639,-1.697491614877576,0.015228426395939087,0.27811134481542216,1.0,11/15,28.27%,MKNK2;CPEB2;VCP;ZC3H12A;HSF1;DHX36;GSTO1;HNRNPA1;GSTO2;ATF3;DDX3X
prerank,macrophage differentiation (GO:0030225),-0.6518284532004357,-1.6952315399258437,0.021176470588235293,0.27737712666957715,1.0,6/13,19.28%,IL31RA;CDC42;BMP4;CSF1;CASP8;PARP1
prerank,negative regulation of T cell activation (GO:0050868),0.6207305802270462,1.6941913919586025,0.01167883211678832,0.5495553364736386,1.0,6/35,4.23%,RIPOR2;CEACAM1;ARG1;GLMN;IL4I1;PTPN22
prerank,long-term synaptic potentiation (GO:0060291),0.679740193922306,1.6927553227284475,0.028358208955223882,0.5466178496758962,1.0,4/21,2.75%,PLK2;TSHZ3;RGS14;SLC24A1
prerank,response to alcohol (GO:0097305),-0.5367903579974704,-1.6927127797337176,0.011904761904761904,0.2779534296427841,1.0,8/27,12.93%,TGFBR3;SLIT2;TGFBR1;GRIN3A;GRIN2B;GRIN1;PMVK;ABCA2
prerank,limb development (GO:0060173),0.6506982144989817,1.6923902116044247,0.01228878648233487,0.5388445137130116,1.0,5/28,5.13%,PTCH1;LRP4;PCSK5;BMPR1B;INTU
prerank,embryonic organ development (GO:0048568),0.5872761215481221,1.6923458700648162,0.005270092226613966,0.5299820766552448,1.0,10/61,3.53%,ALDH1A3;STRA6;PKDCC;RARB;COBL;PBX1;PCSK5;GLI2;STIL;KMT2A
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.5228252863585668,-1.690526343978332,0.006329113924050633,0.2775732221992128,1.0,7/31,3.93%,ENG;TGFBR3;RBPJ;TPM1;FKBP1A;TGFBR1;FGFR2
prerank,external encapsulating structure organization (GO:0045229),0.503369468553479,1.6899853867194097,0.0,0.5327127454543452,1.0,35/205,7.33%,ITGB4;TGFBI;DCN;VIT;ITGA6;ADAMTS14;SMOC2;F11R;LAMA2;ECM2;PXDN;MMP28;LAMA4;ADAMTS12;NID1;LAMB2;LAMC1;ADAMTSL5;COL6A3;ADAMTS1;MFAP5;ADAM19;ITGAX;MMP15;NF1;COL5A3;SH3PXD2A;ITGA7;ADAMTS19;FN1;NCAN;LAMA5;COL3A1;DAG1;ITGB7
prerank,response to interleukin-6 (GO:0070741),-0.7129694163394926,-1.689373265951391,0.01126126126126126,0.274546258225795,1.0,3/10,0.98%,ST3GAL6;PTGIS;PID1
prerank,actin filament organization (GO:0007015),-0.38037032119072545,-1.689249630916166,0.0,0.26910843183660876,1.0,39/151,11.56%,MYO1D;HIP1;RHOBTB1;EPS8;SVIL;NEDD9;MYO1B;ARHGEF2;RUFY3;MYO5A;TPM1;ELMO1;CDC42;DSTN;MYO6;SHROOM3;RHOBTB3;TRIOBP;TMOD3;PLS3;HIP1R;ERMN;ZBED3;RHOC;MARCKS;ARHGAP17;CAPG;ABI1;FLNA;EVL;RHOH;RHOB;PROX1;TPM3;NEBL;AVIL;LMOD1;TPM2;BAIAP2L1
prerank,cellular response to alcohol (GO:0097306),0.603604846624372,1.687599648993809,0.0196078431372549,0.5356771004002447,1.0,5/42,5.34%,PTCH1;PTGFR;GPLD1;GRAMD1B;ADCY5
prerank,positive regulation of wound healing (GO:0090303),0.6284616233575426,1.6859125434841522,0.014124293785310734,0.535350656931091,1.0,10/36,10.36%,CLDN1;SMOC2;ST3GAL4;PRKCE;PLPP3;RREB1;KANK1;OCLN;FERMT2;ADRA2A
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.6825370649365634,1.682694684023858,0.011146496815286623,0.5425306046031588,1.0,2/21,1.22%,NGF;USP50
prerank,extracellular structure organization (GO:0043062),0.5001763590105908,1.6821549438298322,0.0,0.5369875211313752,1.0,38/204,8.54%,ITGB4;TGFBI;DCN;VIT;ITGA6;ADAMTS14;SMOC2;F11R;LAMA2;ECM2;PXDN;MMP28;LAMA4;ADAMTS12;NID1;LAMB2;LAMC1;ADAMTSL5;COL6A3;ADAMTS1;MFAP5;ADAM19;ITGAX;MMP15;NF1;COL5A3;SH3PXD2A;ITGA7;ADAMTS19;FN1;NCAN;LAMA5;COL3A1;DAG1;ITGB7;ADAMTS2;TEX14;TNR
prerank,nerve growth factor signaling pathway (GO:0038180),0.7951009184800263,1.6796932483596596,0.01818181818181818,0.5399492381056461,1.0,2/10,1.89%,NGF;RAP1A
prerank,vascular process in circulatory system (GO:0003018),-0.6534993204500006,-1.6779124049656533,0.011990407673860911,0.28700639765233404,1.0,6/13,5.71%,ROCK2;NOS3;GCLM;NPR1;ACE;AGTR1
prerank,regulation of tube diameter (GO:0035296),-0.6534993204500006,-1.6779124049656533,0.011990407673860911,0.28700639765233404,1.0,6/13,5.71%,ROCK2;NOS3;GCLM;NPR1;ACE;AGTR1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.695813267664214,-1.6762393285823531,0.017937219730941704,0.2857784743608285,1.0,5/11,2.18%,IGF1R;PLCB1;IGF1;GHR;PIK3R1
prerank,negative regulation of lipid metabolic process (GO:0045833),0.6646469618133123,1.6732950881110045,0.0296875,0.5632344357440997,1.0,4/22,10.36%,APOD;CEACAM1;NCOR1;ADRA2A
prerank,regulation of neuron projection development (GO:0010975),0.5013824545637713,1.6731293285044935,0.0,0.5556967532904086,1.0,29/163,10.75%,ROR2;NTNG2;NTNG1;ITGA6;ROR1;SIPA1L1;NTRK3;LPAR1;RAP1A;PPFIA2;RAB29;RTN4R;TRPV4;LZTS3;WNT5A;BRSK1;ULK4;ABL2;EFNB2;SEMA3A;SRCIN1;KANK1;CDH2;FRMD7;GSK3B;HDAC2;RELN;RTN4RL1;S100A9
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.4651825928818708,-1.6719347336270391,0.011450381679389313,0.2917316965456919,1.0,8/49,6.94%,IGF1;IL31RA;GHR;IL6R;LYN;KIT;IL18;JAK2
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.6825424006752603,1.671127217119235,0.0171875,0.5575071002068518,1.0,3/22,1.89%,NGF;NTRK3;RAP1A
prerank,vasoconstriction (GO:0042310),-0.6893839005481042,-1.670941171888097,0.016355140186915886,0.2889291883187243,1.0,6/11,15.95%,SLC8A1;PIK3C2A;ACTA2;EDNRA;EDN1;EDN3
prerank,smooth muscle tissue development (GO:0048745),0.7867271673577527,1.6681075277758441,0.010526315789473684,0.5637007764550892,1.0,3/10,3.23%,PTCH1;STRA6;NF1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.6321800022979763,-1.6678079927660756,0.017326732673267328,0.2923275951049443,1.0,6/13,12.93%,PLCB1;IGF1;IL33;SLC2A10;GOLGA2;ABCA2
prerank,regulation of multicellular organism growth (GO:0040014),0.7307712805922292,1.667521402615358,0.030694668820678513,0.5582633215178561,1.0,1/15,0.01%,PTCH1
prerank,cardiac conduction system development (GO:0003161),-0.5346807885479861,-1.6656673862217906,0.00911854103343465,0.2933268239754849,1.0,7/24,12.68%,NOTCH2;GJB6;BMP4;GJA1;SMAD5;CACNA1G;GATA6
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.7580330415232465,1.665570414047524,0.030508474576271188,0.551505719467113,1.0,7/12,17.54%,HOMER2;ATP2B4;RCAN1;GSK3B;HOMER3;CHP1;DYRK2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.7580330415232465,1.665570414047524,0.030508474576271188,0.551505719467113,1.0,7/12,17.54%,HOMER2;ATP2B4;RCAN1;GSK3B;HOMER3;CHP1;DYRK2
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.5001254470809706,-1.6649112735097922,0.016025641025641024,0.29028353914019267,1.0,11/34,11.17%,FLT1;TEK;PDGFRB;PDGFRA;PIK3R1;KIT;PIK3R3;EPHA8;TNFAIP8L3;RUBCN;AMBRA1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.4726123042859629,-1.663430349657464,0.003389830508474576,0.28904825095534603,1.0,19/40,25.83%,HIP1;INSR;ANGPT1;DAB2;B2M;HNRNPK;ANXA2;LDLRAP1;HFE;AHI1;EGF;PICK1;CLU;CCL19;C3;NTF3;GREM1;ARRB2;VTN
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.5047738141683997,1.6626395025380707,0.0011086474501108647,0.5569792243251198,1.0,18/159,4.59%,NTNG1;TENM2;CLDN1;CXADR;CDH13;CLDN11;CEACAM1;CLDN19;CDH11;PTPRF;MPZL2;GPC6;CDH5;CDH17;HMCN1;CDH9;TRO;DSCAM
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.5307690377515227,1.6615975210263574,0.008393285371702638,0.5547050544448701,1.0,15/93,11.27%,NGF;CNKSR3;CAV1;NTRK3;EGFR;RAPGEF3;AXIN1;PDE4D;ATP2B4;NCK2;IRGM;NLRP2B;RASSF2;DOCK7;HDAC6
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.7701289688356742,1.6611396395516302,0.02782608695652174,0.5491116103713982,1.0,4/12,5.76%,DCN;CSPG4;UST;NCAN
prerank,catecholamine metabolic process (GO:0006584),-0.6295908060658215,-1.660059336897312,0.008108108108108109,0.29257960165244856,1.0,3/14,3.31%,SNCAIP;COMT;ATP7A
prerank,positive regulation of protein export from nucleus (GO:0046827),0.7206792177929641,1.6576527965886092,0.03471074380165289,0.5580819014861301,1.0,10/15,21.76%,GTSE1;RAPGEF3;BAG3;RBM22;GSK3B;TPR;EMD;YWHAE;TCF7L2;XPO4
prerank,regulation of tissue remodeling (GO:0034103),0.6933309806452574,1.653937612385949,0.025,0.5686115791676303,1.0,3/18,1.54%,THBS4;CEACAM1;LEPR
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.5495298356688905,-1.6529471442461665,0.029154518950437316,0.30642585428000557,1.0,11/22,17.26%,KDM2B;APPL2;NES;GATA2;PROX1;SLC16A2;LRRK2;KDM1A;TOX;ID2;TAFA1
prerank,SNARE complex assembly (GO:0035493),0.7626584794331904,1.6527589268265297,0.039285714285714285,0.5669308115041092,1.0,1/10,0.06%,STXBP6
prerank,negative regulation of developmental growth (GO:0048640),0.6228723408291571,1.6507782367165413,0.028315946348733235,0.5690837133199477,1.0,3/30,4.30%,PTCH1;RTN4R;CDKL3
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.5155163022144935,-1.649805000168044,0.009036144578313253,0.3098129614007215,1.0,7/29,10.52%,ENG;TGFBR3;TPM1;FKBP1A;FGFR2;PROX1;BMP2
prerank,dermatan sulfate metabolic process (GO:0030205),0.756051600725384,1.648230875823567,0.02577319587628866,0.5745861829715532,1.0,4/13,5.76%,DCN;CSPG4;UST;NCAN
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5808968502864064,1.6457743244247764,0.012211668928086838,0.5791877869947861,1.0,10/45,6.40%,GAB1;PLCE1;EFEMP1;EGFR;FAM83A;REPS2;SOX9;SRC;KIF16B;NCK2
prerank,response to ethanol (GO:0045471),-0.6100786703928165,-1.6435970799962714,0.02977667493796526,0.3213700336050426,1.0,5/14,11.73%,ADCY7;GRIN3A;GRIN2B;GRIN1;GLRA2
prerank,vesicle transport along actin filament (GO:0030050),-0.5758641392974191,-1.6419723786448213,0.017632241813602016,0.32051498035828924,1.0,4/19,2.67%,MYO1D;MYO1B;MYO5A;MYO6
prerank,cardiac atrium morphogenesis (GO:0003209),-0.5874293315214048,-1.6402811924336655,0.010050251256281407,0.32031348793427683,1.0,6/16,12.75%,NOTCH2;ENG;BMPR2;PROX1;BMP2;TGFB2
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.38789254971967074,-1.6389210687914002,0.0,0.3191140685572949,1.0,58/110,22.82%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;RPS7;RPS20;RPL32;RPS27;RPL26;RPL27;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;PABPC1;RPLP1;RPS17;RPS3;RPL23;RPL17;PNRC2;RPL9;RPL38;RPL36;RPS26;RPS8;RPS12;RPL18A;RPS21;MAGOH;RPS18;RPLP2;EIF4G1;RPS6;RPS15A;NCBP1;CTIF;MAGOHB;RNPS1;GSPT2;RPL14;RPS2;RPL10A;RPL39;RPL34;RPL5;EIF3E;RPL22;PPP2R1A
prerank,regulation of developmental growth (GO:0048638),-0.5170987335754599,-1.6379291976020194,0.012269938650306749,0.3166331890619007,1.0,7/29,6.29%,PLCB1;IGF1;INSR;GHR;LATS2;MBD5;APOE
prerank,response to copper ion (GO:0046688),-0.5624091179241149,-1.6377204527967129,0.013404825737265416,0.31248491154922614,1.0,8/20,3.81%,MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X
prerank,regulation of coagulation (GO:0050818),0.7488472010271473,1.6374220623184232,0.03411131059245961,0.6124843231284925,1.0,4/11,11.68%,CAV1;EPHB2;PROC;HS3ST5
prerank,cellular response to superoxide (GO:0071451),-0.6978745030971099,-1.637166201563275,0.013953488372093023,0.30943655066578785,1.0,4/10,6.10%,NOS3;ATP7A;SOD3;PRDX2
prerank,negative regulation of signal transduction (GO:0009968),0.4782140575459564,1.6370109453826078,0.0,0.6070619080544599,1.0,39/249,9.70%,PTCH1;DCN;APOD;GPC3;PTCH2;UBASH3B;VGLL4;NTN1;RGS14;ADAMTS12;SULF1;NFATC1;NRARP;LEPROT;EGFR;SOCS5;SPRY1;GLIS2;SPRY4;BMP5;IRAK3;PIP4K2B;DACT1;PTPRC;CREB3L1;KANK2;APLN;KIF7;TNFAIP3;HIC1;EGFL7;SIAH1;KANK1;PALM;PTPRJ;PLEK;NLRP2B;SLC27A4;PTPRT
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5683588118485862,1.63666428462737,0.012836970474967908,0.6016009434026581,1.0,18/55,17.77%,DCN;GPC3;CSPG4;PRELP;GPC6;NCAN;SDC1;HEXA;GPC2;SDC3;CEMIP2;HSPG2;HEXB;HGSNAT;CHP1;GPC5;VCAN;SDC4
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.7394444889450357,1.633556456286393,0.03225806451612903,0.6094899188075799,1.0,2/11,0.82%,CAV1;NEDD4L
prerank,peptide biosynthetic process (GO:0043043),-0.3705249421493111,-1.6332348099639582,0.0,0.315083701636496,1.0,69/153,22.68%,DMD;RPL37A;RRBP1;RPL19;RPL8;RPL37;RPS15;RPS29;FARSB;RPL35A;RPS7;RPS20;RPL32;EEF1A1;RPS27;RPL26;RPL27;RPS24;RPLP0;HARS1;RPS19;HBS1L;RPL31;RPL41;RPL13A;RPL30;RPL29;MRPS6;RPS16;RPL3;RPLP1;RPS17;RPS3;RPL23;RPL17;RPL9;FURIN;RPL38;DHPS;RPL36;RPS26;RPS8;RPS12;RPL18A;RPS21;MRPL32;MRPL18;CARNS1;RPS18;RPLP2;EIF4G1;RPS6;RPS15A;MRPL9;MRPL28;GSPT2;MRPS11;MRPS16;RPL14;MRPS18B;RPS2;MRPL42;RPL10A;RPL39;RPL34;RPL5;MRPS12;RPL22;MRPL55
prerank,aortic valve development (GO:0003176),-0.48676184996401517,-1.6328792572173898,0.006269592476489028,0.31138335976722004,1.0,10/34,5.38%,ROBO1;ROCK2;ELN;SMAD6;SLIT2;NOS3;BMP4;TIE1;BMPR2;TNFRSF1B
prerank,glycolipid biosynthetic process (GO:0009247),0.5915092283399274,1.6314256233528683,0.02145922746781116,0.6125884345090964,1.0,9/38,12.82%,PIGU;ST3GAL4;A4GALT;PGAP3;PIGB;PIGA;ST8SIA5;ST8SIA3;SCCPDH
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.5571486995654803,1.631080665869153,0.013368983957219251,0.6073277966582727,1.0,16/51,14.72%,NGF;EPB41L3;MINK1;KIF20B;GAS7;NBL1;CNTNAP1;TRIO;GPM6A;SLC9A6;PLXNB1;SNX2;SGK1;CTTN;DICER1;CNTNAP2
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.5434336035543685,-1.6307567190162446,0.022408963585434174,0.3127660666982102,1.0,11/22,21.13%,ANK2;AKAP6;VMP1;CALM1;ATP1B1;SLC9A1;CALM3;JPH2;P2RY6;STAC3;GSTO1
prerank,response to amyloid-beta (GO:1904645),-0.4657978043957074,-1.6306243607929822,0.010869565217391304,0.30874205425302015,1.0,9/44,9.43%,IGF1R;IGF1;LRP1;GJA1;EPHA4;VCAM1;MMP2;GRIN1;LGMN
prerank,cell cycle checkpoint signaling (GO:0000075),0.729840916972993,1.6291006682556588,0.030927835051546393,0.6094309258708605,1.0,5/12,14.74%,PLK2;WEE1;CHFR;ZWILCH;ZW10
prerank,regulation of small molecule metabolic process (GO:0062012),0.6201628254531121,1.6269188353443127,0.0206794682422452,0.6126049940795336,1.0,6/28,10.98%,RORA;FOXK1;PDK4;BCKDK;FOXK2;NCOR2
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.5312270505452465,1.6264099611071894,0.01951219512195122,0.6080515510720024,1.0,6/73,2.19%,NGF;CAV1;NTRK3;EGFR;RAPGEF3;AXIN1
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.6308118997144434,-1.62617112592596,0.016317016317016316,0.31591738800278796,1.0,5/12,15.72%,LYN;BST2;IL34;PTK2;CSF1
prerank,iron ion homeostasis (GO:0055072),-0.4335085230675524,-1.6251608918359077,0.0,0.3143082275642737,1.0,22/58,23.51%,PICALM;BMP6;ABCG2;FTH1;TFRC;SCARA5;NEO1;B2M;FTL;SLC11A2;NEDD8;BDH2;FXN;SLC40A1;HFE;SMAD4;CUL1;SKP1;CYBRD1;BOLA2;CCDC115;ISCU
prerank,icosanoid secretion (GO:0032309),-0.6311199435587828,-1.6248723009520798,0.016826923076923076,0.3109140996315492,1.0,4/12,7.39%,ABCC4;ACE;BDKRB2;ANXA1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.5202207607525374,1.6222608887535233,0.007263922518159807,0.6216636223326678,1.0,16/100,5.16%,ROR2;GAB1;DCN;ROR1;NTRK3;FGFR1;HCST;PTPN13;CEACAM1;PIK3AP1;EGFR;WNT16;SOX9;SRC;PIP4K2B;FN1
prerank,positive regulation of neuron differentiation (GO:0045666),0.5848991752902766,1.6219350127437013,0.024251069900142655,0.6163147085145106,1.0,7/40,5.24%,NGF;FGFR1;DLX1;ZC4H2;MMD2;NBL1;HEYL
prerank,monoacylglycerol metabolic process (GO:0046462),0.7148797155281633,1.6214037395836558,0.03372681281618887,0.6125547442575889,1.0,4/13,8.30%,MOGAT2;MOGAT3;AWAT2;ABHD12
prerank,aorta morphogenesis (GO:0035909),-0.5735874110126138,-1.6205525499341267,0.021505376344086023,0.3175780175484091,1.0,8/17,10.38%,ENG;PDGFRB;LRP1;MYLK;RBPJ;ACVRL1;TBX1;PROX1
prerank,tube closure (GO:0060606),0.6088872512906481,1.6202041280560366,0.02556390977443609,0.6117513058132502,1.0,7/31,5.28%,DLC1;PRICKLE1;COBL;FOLR1;STIL;LMO4;MTHFD1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.6906017313273901,1.6189442704884873,0.03559870550161812,0.6113600939938639,1.0,7/16,16.05%,CAV1;LEPROT;BCL3;INPP5F;NF2;PIBF1;SOCS1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.5571496336633158,-1.6171108844280313,0.013227513227513227,0.3222565558616755,1.0,7/20,3.53%,ENG;TGFBR3;RBPJ;BMP4;TBX3;TGFBR1;ACVRL1
prerank,acylglycerol homeostasis (GO:0055090),0.6435204099022958,1.6170144817994268,0.034375,0.6135589147788387,1.0,1/20,0.04%,RORA
prerank,eye morphogenesis (GO:0048592),0.6708145864215567,1.6162701236100507,0.03577235772357724,0.6106889803316349,1.0,5/19,6.15%,ALDH1A3;EFEMP1;MFAP5;NF1;SHROOM2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.5345152960302582,1.6158142860753089,0.017478152309612985,0.6066417613399475,1.0,12/72,5.16%,ROR2;GAB1;DCN;ROR1;NTRK3;FGFR1;HCST;PIK3AP1;WNT16;SOX9;SRC;FN1
prerank,intestinal absorption (GO:0050892),0.7078256333158661,1.6157537174041943,0.03270223752151463,0.6008365057164079,1.0,5/13,14.92%,F11R;TJP2;SLC2A2;ADRA2A;SLC46A1
prerank,regulation of axon guidance (GO:1902667),-0.6840129962128565,-1.6150140117093936,0.01694915254237288,0.32329913433697205,1.0,8/10,30.43%,ZSWIM6;YTHDF1;ZSWIM4;NRP1;TUBB2B;ZSWIM8;MYCBP2;ZSWIM5
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.5508081819453583,-1.6135344416259603,0.013736263736263736,0.323245253776236,1.0,4/20,1.71%,PICALM;NUMB;PID1;DAB2
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.652792812776621,1.61306664102409,0.0224,0.6071836213257563,1.0,5/23,7.89%,THBS4;RIPOR2;MPP1;RAC2;DPP4
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.6865582816942336,1.6129680760703695,0.03727714748784441,0.6016459833117814,1.0,1/15,0.03%,NGF
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.6706929426127485,-1.6101391862189385,0.02247191011235955,0.3276030250307093,1.0,4/10,2.90%,PID1;ENPP1;GRB10;APPL2
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.7500945473755319,1.6086678277220188,0.043936731107205626,0.6154820949756319,1.0,3/11,2.13%,CAV1;LEPROT;BCL3
prerank,negative regulation of cellular component movement (GO:0051271),-0.5913716662758494,-1.6079909648764876,0.0390625,0.32910345059627166,1.0,6/15,7.14%,FBLN1;TGFBR3;FRMD5;SP100;CCDC125;CRK
prerank,maintenance of blood-brain barrier (GO:0035633),0.6241769442253146,1.6067292967307314,0.03138373751783167,0.6180657199468421,1.0,8/30,4.56%,CLDN1;F11R;LAMA2;LAMC1;SLC12A2;CDH5;TJP2;LSR
prerank,spinal cord development (GO:0021510),0.7266124690956297,1.6052706219831674,0.039383561643835614,0.6191010847474571,1.0,6/12,13.44%,VIT;GLI2;NF1;RELN;PKD1;SOX4
prerank,negative regulation of potassium ion transport (GO:0043267),0.7054655495053397,1.599550568751148,0.03782894736842105,0.6402531753111592,1.0,2/13,0.82%,CAV1;NEDD4L
prerank,aortic valve morphogenesis (GO:0003180),-0.4924907195278536,-1.5986245881128094,0.006097560975609756,0.35040334399912665,1.0,8/30,2.87%,ROBO1;ROCK2;ELN;SMAD6;SLIT2;NOS3;BMP4;TIE1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.7517432862853185,1.5985611300217166,0.03185840707964602,0.6389162398053551,1.0,1/10,0.15%,DCN
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.5181681169780247,1.5964835362222447,0.01694915254237288,0.6428952880114643,1.0,4/76,1.21%,GNA14;HRH1;LPAR1;PLCE1
prerank,ganglioside biosynthetic process (GO:0001574),-0.6001344107458527,-1.5958078153063449,0.022004889975550123,0.35388547154314093,1.0,4/15,2.25%,ST3GAL5;ST3GAL1;ST8SIA4;ST6GALNAC3
prerank,activation of phospholipase C activity (GO:0007202),0.5989740599780031,1.5950372454850816,0.04437869822485207,0.6436971753859783,1.0,5/29,4.47%,LPAR1;EGFR;ITK;TXK;GNAQ
prerank,cell-matrix adhesion (GO:0007160),0.513095107859553,1.5924220259480608,0.004866180048661801,0.6498246897212162,1.0,13/95,7.33%,ITGB4;ITGBL1;DLC1;SORBS1;ECM2;ADAMTS12;PPFIA2;ITGA7;PEAK1;SRC;FN1;COL3A1;ITGB7
prerank,electron transport chain (GO:0022900),0.6865795707271019,1.5923954874740596,0.041254125412541254,0.6440793603594674,1.0,2/15,0.66%,PPARGC1A;POR
prerank,regulation of epithelial cell differentiation (GO:0030856),0.6781980340846065,1.592359201189603,0.05228758169934641,0.6385390495064398,1.0,5/17,7.53%,CAV1;CEACAM1;AJAP1;SOX9;MAFG
prerank,regulation of amyloid-beta formation (GO:1902003),-0.4773240912163173,-1.5919881841398063,0.0220125786163522,0.3597833197530161,1.0,12/34,15.46%,IGF1;PICALM;ROCK2;EPHA4;APOE;CASP3;RTN1;GSK3A;SP1;ABCA2;ABCG1;GGA3
prerank,positive regulation of behavior (GO:0048520),0.7604525429486256,1.5907209136553926,0.03804347826086957,0.6406337514769347,1.0,4/10,11.65%,STRA6;NPAS2;SGIP1;CFAP20
prerank,regulation of signal transduction (GO:0009966),0.47764319537930755,1.5898919213190743,0.0010964912280701754,0.6388943710709201,1.0,22/190,6.40%,PTCH1;RORA;IGFBP6;MDFIC;UBASH3B;RGS6;GLI1;PXN;RGS14;PLCE1;SULF1;DTX1;AXIN1;SOCS5;CDC42SE2;OGT;CD55;SRC;NUP62;INTU;IFT81;NCK2
prerank,catecholamine biosynthetic process (GO:0042423),-0.6338998715201867,-1.5874811625369454,0.029953917050691243,0.36760791671375537,1.0,3/11,12.75%,MOXD1;GCH1;TGFB2
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.5992509641358719,-1.58623257398306,0.036585365853658534,0.36667903086563614,1.0,4/14,10.36%,ANK2;ACTN2;ATP1B1;ATP1B2
prerank,negative regulation of anoikis (GO:2000811),0.7068797945654383,1.5860279492585558,0.04873949579831933,0.6512849721301083,1.0,4/14,6.97%,CAV1;SRC;PDK4;MCL1
prerank,amino acid import across plasma membrane (GO:0089718),-0.5254272100053847,-1.585179084311554,0.03389830508474576,0.36567996974575423,1.0,11/24,17.11%,SLC6A6;SLC47A1;SLC6A9;SLC7A5;SLC22A4;SLC7A1;SLC16A2;SLC1A3;SLC1A1;SLC3A2;SLC22A2
prerank,digestive tract morphogenesis (GO:0048546),0.6794407239967968,1.5846005711017421,0.04639175257731959,0.6525447430908393,1.0,2/14,0.56%,STRA6;GLI1
prerank,action potential (GO:0001508),0.5770500039770677,1.58363721812159,0.024291497975708502,0.6516541573102833,1.0,5/44,4.79%,GNA14;SCN10A;SLC4A3;GNAQ;CACNA1H
prerank,melanosome transport (GO:0032402),-0.5680698917724867,-1.583490159988295,0.027918781725888325,0.3620073891258113,1.0,9/18,22.48%,MYO5A;RAB11A;BBS2;MKKS;BLOC1S6;RAB11B;MLPH;BBS5;RAB27A
prerank,pigment granule transport (GO:0051904),-0.5680698917724867,-1.583490159988295,0.027918781725888325,0.3620073891258113,1.0,9/18,22.48%,MYO5A;RAB11A;BBS2;MKKS;BLOC1S6;RAB11B;MLPH;BBS5;RAB27A
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.6186722394957265,1.5825713654636446,0.0425531914893617,0.6510436036652708,1.0,5/24,3.90%,RORA;SULF1;CXCL17;IL1A;EIF2AK3
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.7048397851955575,1.582022819886175,0.045,0.6481917105370488,1.0,5/14,5.61%,SULF1;SPRY1;SPRY4;CREB3L1;APLN
prerank,negative regulation of cell migration (GO:0030336),-0.3561904653239758,-1.5810964295850791,0.0,0.36450248065270874,1.0,36/137,11.61%,ROBO1;PHLDB2;PTPRG;MCC;ENG;AFDN;CLDN5;LIMCH1;LRP1;SLIT2;TPM1;RECK;DACH1;CLIC4;IGFBP3;IGFBP5;GJA1;EPHA4;PTPRK;ACVRL1;CYP1B1;MITF;PODN;SRGAP1;DUSP10;DUSP3;BST2;TMEFF2;CITED2;EVL;RHOB;SINHCAF;ATP1B2;TRIB1;ARID2;FUZ
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.6290969430963729,1.5806527554663907,0.04538341158059468,0.649190551431198,1.0,5/25,4.59%,ITGA6;GLMN;EGFR;SRC;DSCAM
prerank,lymphocyte mediated immunity (GO:0002449),0.7157610505855335,1.5805644635862472,0.030874785591766724,0.644164000580023,1.0,3/12,7.44%,JAG1;CD55;MSH2
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.577654990573307,1.5802070977468918,0.030973451327433628,0.6406094346177605,1.0,5/37,7.33%,TENM2;CXADR;HMCN1;AMIGO2;CRTAM
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.6850657256546195,1.5798694689718513,0.05228758169934641,0.6367129677022045,1.0,4/15,6.93%,RIPOR2;RAPGEF3;CD53;EHD2
prerank,regulation of anoikis (GO:2000209),0.6445030391753596,1.579201737623549,0.054945054945054944,0.6345438649318267,1.0,5/19,6.97%,CAV1;MYBBP1A;SRC;PDK4;MCL1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.6113272032087671,1.578647924870064,0.03636363636363636,0.6320084580566293,1.0,5/26,3.90%,RORA;SULF1;CXCL17;IL1A;EIF2AK3
prerank,negative regulation of lymphocyte migration (GO:2000402),0.7510291032163857,1.5780576784004352,0.041970802919708027,0.6294760630389533,1.0,2/10,1.06%,APOD;RIPOR2
prerank,retinal metabolic process (GO:0042574),0.7211982404180228,1.576539218722906,0.05363321799307959,0.6314248514499613,1.0,3/12,5.82%,ALDH1A3;RDH10;BCO1
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.5626789303567123,-1.5758988960735754,0.03125,0.3748850840710821,1.0,4/18,4.03%,IGF1;IGFBP2;IGF2;IL18
prerank,respiratory tube development (GO:0030323),0.614609320699891,1.5752229537243017,0.04599406528189911,0.6320122736169526,1.0,5/28,2.92%,STRA6;FGF7;FGF1;PCSK5;GLI2
prerank,response to sterol (GO:0036314),0.7291575452073668,1.57378540121653,0.047787610619469026,0.6334853742662525,1.0,1/11,0.04%,RORA
prerank,skeletal muscle organ development (GO:0060538),0.6260178622592997,1.573660642258811,0.0344311377245509,0.6291423215381382,1.0,3/26,4.33%,STRA6;CAV1;CSRP3
prerank,epithelium development (GO:0060429),0.4978994850591795,1.5721381752444203,0.006968641114982578,0.630975938082688,1.0,12/107,7.23%,PTCH1;MEOX2;CDHR2;RIPK4;STIL;SOX9;DACT1;MTHFD1;KANK2;ANXA4;DAG1;TBX2
prerank,positive regulation of lipid transport (GO:0032370),-0.6204976721691536,-1.5721279507597576,0.038202247191011236,0.38129752162078523,1.0,3/12,6.29%,LRP1;DBI;APOE
prerank,amino acid import (GO:0043090),-0.5454980067934572,-1.5716019757386421,0.024390243902439025,0.3784888841379411,1.0,11/21,17.11%,SLC6A6;SLC47A1;SLC7A5;SLC22A4;SLC7A1;SLC25A38;SLC16A2;SLC1A3;SLC6A1;SLC1A1;SLC22A2
prerank,response to axon injury (GO:0048678),0.6525352225825022,1.5713143374119858,0.053712480252764615,0.6297356201561826,1.0,4/18,10.72%,APOD;FOLR1;SARM1;RTN4RL1
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.6152391080442718,-1.5712630216268673,0.04672897196261682,0.3752678042082679,1.0,6/13,14.20%,NOS3;CALM1;GCH1;AKT1;QDPR;MTHFD1L
prerank,sodium-independent organic anion transport (GO:0043252),-0.6692527514836595,-1.5697659351818234,0.03131991051454139,0.3751020640064154,1.0,4/10,10.86%,SLCO3A1;SLCO1C1;SLCO2A1;SLC16A2
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.6897821386005321,1.5684342149121362,0.06563039723661486,0.6377889560687657,1.0,2/13,0.33%,APOD;MDFIC
prerank,embryonic eye morphogenesis (GO:0048048),0.7242103490419557,1.5684160282032633,0.05199306759098787,0.6331206149976983,1.0,5/11,11.09%,ALDH1A3;EFEMP1;MFAP5;TBX2;RARG
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.6135589079225565,1.5682660833899875,0.05417956656346749,0.6289633579549966,1.0,7/26,7.27%,ITPR2;ITPR3;SLC8B1;ERO1A;PTPRC;IBTK;CHERP
prerank,regulation of steroid metabolic process (GO:0019218),0.6090075757251044,1.5675874267137162,0.04504504504504504,0.6271140144891536,1.0,1/23,0.04%,RORA
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.5615295048136226,1.566956101463977,0.043115438108484005,0.6250916678165633,1.0,6/38,8.41%,RORA;PPM1N;TNIP3;PPM1A;TNFAIP3;TNIP1
prerank,mesoderm development (GO:0007498),-0.5511159531791983,-1.5658244656041846,0.03978779840848806,0.38178819142406023,1.0,7/18,13.61%,TBX3;TIE1;TBX1;BMX;JAK2;MEST;MESD
prerank,transepithelial transport (GO:0070633),0.6812948294278026,1.5626024662436484,0.04785478547854786,0.6397517286740065,1.0,5/15,9.80%,CXADR;SLC12A2;GPLD1;ABCC1;BEST1
prerank,response to cadmium ion (GO:0046686),-0.489492317990223,-1.5621185394894124,0.02476780185758514,0.3886521477598369,1.0,9/26,8.19%,MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X;AKT1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5694513917628741,1.5616723360109102,0.0420899854862119,0.6391502503723304,1.0,6/32,4.48%,APOD;DLC1;JAG1;AJAP1;CASK;SRC
prerank,neuron projection morphogenesis (GO:0048812),0.4797832015441983,1.560686626539537,0.012600229095074456,0.6388411126584904,1.0,27/137,13.05%,NGF;NTNG2;NTNG1;LRP4;EPB41L3;PARD6B;MINK1;KIF20B;GAS7;S100A6;NBL1;DIP2A;CNTNAP1;TRIO;BRSK1;EPHB2;RAB3A;S100B;ISL1;GPM6A;POU4F1;DOCK7;SLC9A6;PLXNB1;SGK1;PTEN;CTTN
prerank,protein localization to microtubule organizing center (GO:1905508),0.6791686654173459,1.5604650229280157,0.05591054313099041,0.6351430600984571,1.0,9/15,19.15%,STIL;CEP131;NEDD1;SNX10;C2CD3;HOOK3;PCM1;PIBF1;DCTN2
prerank,negative regulation of hemostasis (GO:1900047),-0.6100932971244355,-1.5600969529269477,0.04295942720763723,0.3905272796744244,1.0,5/12,6.50%,TFPI;THBD;SERPINE2;APOE;CD34
prerank,glucan catabolic process (GO:0009251),-0.579272825758495,-1.5574035168876412,0.026066350710900472,0.39438913008046156,1.0,10/15,35.47%,PGM2L1;CALM1;AGL;PHKG1;PYGB;PYGL;PHKA2;PHKB;STBD1;PYGM
prerank,cell junction maintenance (GO:0034331),0.6841808721218745,1.5572495503919994,0.057724957555178265,0.6443020006106409,1.0,1/14,0.18%,CLDN1
prerank,cellular response to cadmium ion (GO:0071276),-0.4984717880417552,-1.5568902941949228,0.014970059880239521,0.3918860217806854,1.0,9/24,8.19%,MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X;AKT1
prerank,protein localization to centrosome (GO:0071539),0.6594623712815659,1.556079185993901,0.054858934169279,0.6452061201472776,1.0,10/17,19.15%,STIL;CEP131;NEDD1;SNX10;GOLGB1;C2CD3;HOOK3;PCM1;PIBF1;DCTN2
prerank,ERBB signaling pathway (GO:0038127),0.5140241161267209,1.5553287205893256,0.024327784891165175,0.6440688555615705,1.0,11/64,6.40%,GAB1;PLCE1;EFEMP1;EGFR;FAM83A;REPS2;SOX9;PRKCA;SRC;KIF16B;NCK2
prerank,negative regulation of complement activation (GO:0045916),0.7382135381597459,1.5549024982549688,0.04063604240282685,0.6412978503663077,1.0,3/10,8.43%,SERPING1;CD55;SUSD4
prerank,regulation of chondrocyte differentiation (GO:0032330),0.617036100665686,1.5547726925269956,0.03863987635239567,0.6374319514178219,1.0,7/24,4.10%,PKDCC;MBOAT2;ADAMTS12;EFEMP1;PTHLH;SOX9;BMPR1B
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.5707237262300893,1.5521461258228837,0.04291845493562232,0.6442937913453068,1.0,13/37,17.14%,DYNLL1;DYNC2I1;CEP131;IFT81;KIF3C;CLUAP1;DYNLL2;IFT74;TTC21B;TRIP11;PCM1;DYNC2LI1;DYNC2H1
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.7162404113972058,1.5511075395264988,0.04655172413793104,0.6445987850983391,1.0,3/11,4.99%,CEACAM1;IL4I1;PTPRC
prerank,neutral amino acid transport (GO:0015804),-0.47628838621968184,-1.5510854728159662,0.01440922190201729,0.4042715243744317,1.0,14/28,24.62%,SLC6A6;SLC6A9;SLC7A5;CTNS;SLC43A2;SLC1A1;LLGL2;SLC3A2;SLC38A5;SLC1A4;SLC6A17;SLC38A1;SLC7A10;SLC1A5
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.709170560496733,1.5504629805803056,0.05181347150259067,0.6432947034158749,1.0,3/12,2.99%,CAV1;CAMK2D;PDE4D
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.6311141146132317,-1.5504352168655458,0.05301204819277108,0.4022783298080795,1.0,6/11,13.97%,NOS3;CALM1;GCH1;AKT1;QDPR;DHFR
prerank,bicellular tight junction assembly (GO:0070830),0.5507614956354059,1.5479858281798864,0.020380434782608696,0.6497395957484725,1.0,12/46,11.14%,CLDN1;F11R;CLDN11;CLDN19;PARD6B;CDH5;POF1B;OCLN;PDCD6IP;CLDN10;STRN;APC
prerank,cell-cell junction organization (GO:0045216),0.5000289321865052,1.5478569629112222,0.02882205513784461,0.6458649133820111,1.0,11/79,3.53%,CLDN1;CXADR;CDH13;TLN2;CDH11;PARD6B;CDH5;CDH17;CDH9;TRPV4;TJP2
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.6914528575465533,1.5474444921630937,0.05564648117839607,0.6434218713202315,1.0,3/13,9.70%,PIGU;PTPRC;PTPRT
prerank,cellular glucan metabolic process (GO:0006073),-0.6358069813651719,-1.546819554450087,0.032036613272311214,0.40831655219967206,1.0,4/11,12.73%,PRKAG2;GBE1;UGP2;PPP1R3C
prerank,positive regulation of nuclear division (GO:0051785),-0.5018544631728044,-1.5462611990506234,0.05105105105105105,0.40579732845980565,1.0,5/25,3.56%,IGF1;INSR;TGFA;PDGFRB;IGF2
prerank,positive regulation of DNA replication (GO:0045740),0.6697648959225759,1.5444984471163576,0.057233704292527825,0.651980886194738,1.0,4/16,5.80%,GLI1;EGFR;GLI2;STN1
prerank,peripheral nervous system development (GO:0007422),0.6136603076313792,1.5442717607767638,0.05581395348837209,0.6486768486684916,1.0,3/23,6.11%,NGF;NF1;ARTN
prerank,tight junction assembly (GO:0120192),0.5500328001042697,1.544204307806029,0.01891891891891892,0.6447694880641655,1.0,13/49,11.14%,CLDN1;F11R;CLDN11;CLDN19;PARD6B;CDH5;LSR;POF1B;OCLN;PDCD6IP;CLDN10;STRN;APC
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.5174498719433593,1.5438454350350617,0.016602809706257982,0.6422996442770456,1.0,11/75,8.17%,NTNG2;NTNG1;LRP4;PARD6B;MINK1;OPHN1;S100A6;BRSK1;RAB3A;S100B;ISL1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.5587403913425341,1.540012712885765,0.03971631205673759,0.6548231424086315,1.0,5/35,3.26%,CDH13;CDH11;CDH5;CDH17;CDH9
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.6555509403666597,1.5390174531319525,0.06521739130434782,0.6550775241188525,1.0,3/14,8.07%,MEOX2;CARD10;STARD13
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.6114606752228762,-1.537789237584697,0.04047619047619048,0.42733034113826546,1.0,4/12,12.25%,NUPR1;IL18;IL33;TTBK1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.6415341417252185,-1.5377647461890283,0.04555808656036447,0.4233464368832653,1.0,4/10,7.55%,LYN;FAS;NBR1;MAP2K2
prerank,positive regulation of mitochondrial fission (GO:0090141),0.6489966056690705,1.5376619851996922,0.057722308892355696,0.6567013321244023,1.0,10/18,20.63%,DCN;DDHD1;FIS1;MIEF1;BNIP3;RALBP1;PINK1;RALA;PRKN;MUL1
prerank,neurotrophin signaling pathway (GO:0038179),0.6222086746501512,1.5368547747788106,0.054602184087363496,0.6560963123518644,1.0,2/21,1.89%,NGF;RAP1A
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.672547479778189,1.5355825460739658,0.06814310051107325,0.6578342852776952,1.0,1/14,0.10%,GAB1
prerank,primary neural tube formation (GO:0014020),0.5769564624080894,1.5352488124655825,0.04804804804804805,0.6551537417741248,1.0,6/30,5.28%,DLC1;PRICKLE1;COBL;STIL;LMO4;MTHFD1
prerank,extracellular matrix organization (GO:0030198),0.44719678912189353,1.5344102302111495,0.0031413612565445027,0.6546216383378602,1.0,40/276,7.33%,ITGB4;TGFBI;DCN;VIT;ITGA6;ADAMTS14;SMOC2;F11R;LAMA2;ECM2;PXDN;MMP28;LAMA4;ADAMTS12;NID1;LAMB2;LAMC1;ADAMTSL5;KLK2;COL6A3;ADAMTS1;MFAP5;ADAM19;ITGAX;MMP15;NF1;COL5A3;SH3PXD2A;ITGA7;ADAMTS19;SERPINH1;CREB3L1;FN1;NCAN;SH3PXD2B;ADAM10;LAMA5;COL3A1;DAG1;ITGB7
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.5915083578455399,1.5343566624653178,0.04783258594917788,0.6507898719798699,1.0,4/28,7.48%,NGF;SPI1;TRADD;BAG3
prerank,response to organic cyclic compound (GO:0014070),-0.42580727376838967,-1.5324453066721904,0.015873015873015872,0.43510638093620124,1.0,23/52,28.88%,PAQR7;IGFBP5;CYP1B1;IL18;ALPL;ARL6IP5;ANXA1;HLCS;LRRK2;ESR1;FGFR4;ABCA2;SLC1A1;DHFR;TRPM2;TLR3;ABCB4;KYNU;GGT5;STAT3;STRN3;CDKN2D;SFRP1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.4871353905907391,-1.5314582680949749,0.029069767441860465,0.43393787322872573,1.0,9/28,17.34%,STMN2;STMN4;CAMSAP1;GBA2;STMN1;MAP1B;MAPT;SKA2;ARL2
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.6986535833015183,1.5296573457002667,0.07014388489208633,0.6664233377143961,1.0,3/12,10.34%,APOD;PTPRJ;CBLB
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.6809418406758935,1.5294339416551481,0.056856187290969896,0.6632606836194902,1.0,4/15,5.76%,DCN;CSPG4;UST;NCAN
prerank,chondroitin sulfate catabolic process (GO:0030207),0.6964012895191845,1.5293900678718648,0.056105610561056105,0.6594461236096466,1.0,3/13,5.76%,DCN;CSPG4;NCAN
prerank,neural tube closure (GO:0001843),0.5641322305140132,1.5280077778243757,0.04585798816568047,0.6613554204571991,1.0,7/34,5.28%,DLC1;PRICKLE1;COBL;FOLR1;STIL;LMO4;MTHFD1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.6160262709846451,-1.5279227719487238,0.05185185185185185,0.4413729075234509,1.0,3/12,5.50%,IGF1R;INSR;UVRAG
prerank,regulation of cell-cell adhesion (GO:0022407),0.5666388375944879,1.5271838947633314,0.045133991537376586,0.6609171757600739,1.0,7/39,4.48%,MAGI1;EFNA5;CEACAM1;JAG1;MINK1;FLOT2;SRC
prerank,regulation of neuron migration (GO:2001222),0.5968505800638919,1.5261645955302061,0.04608294930875576,0.6610285487432723,1.0,6/26,7.11%,NTNG2;NTNG1;KIF20B;ULK4;COL3A1;SEMA3A
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5713766747046439,1.5256414389673265,0.035868005738880916,0.6592940152900623,1.0,5/36,4.99%,PIGU;CAV1;LEPROT;BCL3;PTPRC
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.6038389431490815,1.5250647597306397,0.06626506024096386,0.6578872337689045,1.0,3/25,1.42%,CAV1;CXADR;CAMK2D
prerank,regulation of urine volume (GO:0035809),-0.6332595774477658,-1.5241153398922593,0.05515587529976019,0.44971631255438205,1.0,5/10,28.03%,NPR3;NPR1;ADM;ADCY6;HAS2
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.5823899581364071,-1.5238856625930295,0.036231884057971016,0.44637626515447437,1.0,3/13,4.50%,ENPP1;ENTPD1;ENPP3
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5656575304867348,1.5233778412703203,0.04454022988505747,0.6610055518802553,1.0,2/33,1.67%,NGF;CEL
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.6291452264999838,1.5230642509365,0.06074766355140187,0.6585523077112097,1.0,2/18,0.33%,APOD;MDFIC
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.44110108088637506,-1.5202371323525319,0.023972602739726026,0.4542601526234828,1.0,15/36,21.65%,SGMS1;TGFBR1;MADD;FAS;MAZ;NR4A2;BCL2L12;RPS3;BDNF;CSNK2A1;DEPTOR;TPD52L1;STYXL1;QARS1;TMBIM6
prerank,retinoid metabolic process (GO:0001523),0.5000630223852526,1.5197701230402298,0.042606516290726815,0.6689260599818703,1.0,16/71,12.13%,ALDH1A3;STRA6;GPC3;RDH10;GPC6;RDH5;AWAT2;CYP2S1;BCO1;OPN1MW;SDC1;SCPEP1;AKR1B10;RDH13;GPC2;SDC3
prerank,GPI anchor biosynthetic process (GO:0006506),0.5719030703242534,1.5177615181003514,0.049253731343283584,0.6736499912681893,1.0,4/30,9.37%,PIGU;PGAP3;PIGB;PIGA
prerank,ear morphogenesis (GO:0042471),-0.5139157300145416,-1.5175367919747942,0.029411764705882353,0.45857027147935686,1.0,6/20,11.87%,OSR1;CHD7;MYO6;FGFR2;TBX1;ZIC1
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.6990570474006315,1.5174282193248372,0.07042253521126761,0.6712520718384158,1.0,2/10,3.18%,HK2;PFKP
prerank,muscle cell development (GO:0055001),-0.4690754884371552,-1.5173570955281044,0.021604938271604937,0.45499108647670256,1.0,11/30,12.01%,MYOF;IGF1;ENG;ANK2;DMD;SLC8A1;DYSF;MYH11;RAMP2;NEBL;KDM1A
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.7149225555643641,1.5171962418444127,0.07023411371237458,0.6647542706367758,1.0,2/10,1.39%,NFATC2;NFATC1
prerank,calcineurin-mediated signaling (GO:0097720),0.7149225555643641,1.5171962418444127,0.07023411371237458,0.6647542706367758,1.0,2/10,1.39%,NFATC2;NFATC1
prerank,negative regulation of proteolysis (GO:0045861),-0.45076190302643576,-1.517126746093769,0.02531645569620253,0.4517417453423049,1.0,9/34,12.01%,TIMP3;PTPN3;DNAJC1;EPHA4;GAS1;SERPINE2;AKT1;LRRK2;CAMK2N1
prerank,heterotypic cell-cell adhesion (GO:0034113),0.6091591448150265,1.5158033523047025,0.06990881458966565,0.6671458131875224,1.0,6/25,9.00%,CXADR;PARVA;ITGAX;ITGA7;ITGB7;CD200R1
prerank,cardiac myofibril assembly (GO:0055003),-0.5647707993521747,-1.5150112236480016,0.050505050505050504,0.4540101749888572,1.0,6/15,11.13%,PDGFRB;PDGFRA;OBSL1;MEF2A;PROX1;NEBL
prerank,Rap protein signal transduction (GO:0032486),0.7366259882614841,1.5149921598359264,0.08680555555555555,0.6671114580235901,1.0,3/10,1.89%,PLK2;RAPGEF3;RAP1A
prerank,phosphate ion homeostasis (GO:0055062),-0.6406557108713191,-1.5148260993129108,0.043795620437956206,0.4507183903329698,1.0,2/10,12.13%,ENPP1;FGFR4
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.3681808253910986,-1.5144563671970137,0.006172839506172839,0.44797437134697465,1.0,34/98,24.32%,INSR;PDGFRB;ECE1;PID1;ANGPT1;PPARD;SLCO1C1;IL10RB;NR1H3;XDH;ANXA2;AGTR1;KLF4;APOE;NR1H2;AKT1;ZC3H12A;ACLY;THBS1;GHITM;CSF1;EIF4G1;AHI1;EGF;ACE2;IFNAR1;AGT;ROMO1;PICK1;INHBA;GRB2;RIPK1;NTF3;GREM1
prerank,epidermis development (GO:0008544),0.5163300071388592,1.5143543305555098,0.033738191632928474,0.6661334290559873,1.0,6/56,4.00%,FGF7;GLI1;WNT10A;EMP1;FLOT2;PTHLH
prerank,regulation of peptide hormone secretion (GO:0090276),0.5021471289546526,1.5129873333851178,0.0299625468164794,0.6681736150216674,1.0,17/67,13.39%,ITPR2;ITPR3;RAPGEF3;SLC8B1;KCNA5;RAP1A;STX1A;TFR2;PRKCA;RAPGEF4;SLC2A2;DPP4;RASL10B;KCNS3;ADRA2A;ENSA;GCK
prerank,presynapse assembly (GO:0099054),0.63311573712181,1.512787089143915,0.08754208754208755,0.6653894335556234,1.0,3/16,4.96%,LRP4;CEL;WNT5A
prerank,negative regulation of cartilage development (GO:0061037),0.6614380138689813,1.5125735047476925,0.08609271523178808,0.662615104794383,1.0,6/13,12.73%,ADAMTS12;EFEMP1;PTHLH;SOX9;CHADL;WNT9A
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.4786328038167776,-1.5119144950991845,0.029154518950437316,0.4518797133872229,1.0,7/29,7.83%,FLT1;TEK;PDGFRB;PDGFRA;KIT;EPHA8;TNFAIP8L3
prerank,regulation of keratinocyte migration (GO:0051547),0.693932927258117,1.5088988851277696,0.07023411371237458,0.6747809808023902,1.0,4/12,12.82%,FGF7;ARF6;PTEN;MAPRE2
prerank,regulation of metal ion transport (GO:0010959),-0.5494265713428489,-1.5079171958024276,0.03209876543209877,0.4615087691704275,1.0,5/16,15.43%,ANK2;SLC30A10;ORAI1;EPB41;SRI
prerank,regulation of monooxygenase activity (GO:0032768),0.6078974196241564,1.5077273845358323,0.06518282988871224,0.675897934310562,1.0,6/23,8.37%,CAV1;POR;EGFR;IL1A;DDAH2;NOS1AP
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.6899110631923644,1.505412931207185,0.0576271186440678,0.6784457717566612,1.0,3/12,7.57%,EFNA5;SPRY4;KANK1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.6899110631923644,1.505412931207185,0.0576271186440678,0.6784457717566612,1.0,3/12,7.57%,EFNA5;SPRY4;KANK1
prerank,type I interferon signaling pathway (GO:0060337),-0.42868933646848195,-1.5042146980197508,0.01910828025477707,0.4653237526118839,1.0,19/41,26.32%,SP100;IFNAR2;ADAR;SAMHD1;IRF2;IFIT2;IFIT3;BST2;IRF1;GBP2;ISG15;IFIT1;IFNAR1;RSAD2;PSMB8;XAF1;IRF5;MYD88;IRF8
prerank,cellular response to type I interferon (GO:0071357),-0.42868933646848195,-1.5042146980197508,0.01910828025477707,0.4653237526118839,1.0,19/41,26.32%,SP100;IFNAR2;ADAR;SAMHD1;IRF2;IFIT2;IFIT3;BST2;IRF1;GBP2;ISG15;IFIT1;IFNAR1;RSAD2;PSMB8;XAF1;IRF5;MYD88;IRF8
prerank,regulation of T cell migration (GO:2000404),0.6353045720953914,1.5038722638616349,0.07631160572337042,0.681095350149105,1.0,2/18,1.06%,APOD;RIPOR2
prerank,epithelial structure maintenance (GO:0010669),0.6875963129810031,1.5033328990103068,0.07432432432432433,0.6799714557977857,1.0,1/11,0.29%,CXADR
prerank,regulation of membrane repolarization (GO:0060306),0.6812214302793088,1.5022547064082798,0.06907894736842106,0.6810025012409913,1.0,2/13,0.82%,CAV1;NEDD4L
prerank,negative regulation of intracellular protein transport (GO:0090317),0.6125090631001789,1.4988461829736193,0.07075471698113207,0.6918613431891353,1.0,4/22,9.04%,APOD;MDFIC;GDI1;SIAH3
prerank,diacylglycerol metabolic process (GO:0046339),0.5937286409685344,1.4970949957901751,0.061764705882352944,0.695675614263909,1.0,4/23,3.58%,DGKA;PLCE1;MOGAT2;DGKZ
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.5992279209065292,1.4956180991115948,0.07053291536050156,0.6984294248541929,1.0,8/21,10.01%,ARHGAP12;LZTR1;SPRY1;MFN2;SPRY4;EPHB2;CGNL1;MAPKAP1
prerank,secondary palate development (GO:0062009),-0.5666653824686709,-1.4926406575861826,0.07213930348258707,0.49920858722945965,1.0,7/14,17.78%,LEF1;TGFBR3;CHD7;TGFB3;TGFB2;SMAD4;WNT11
prerank,vesicle organization (GO:0016050),0.5268390597516409,1.4921139051056542,0.0572987721691678,0.7095036793619408,1.0,10/46,6.95%,CAV1;USP50;HOOK2;PI4K2B;CAV2;PHETA2;DNM1;ZFYVE16;USP8;SNX10
prerank,metanephric mesenchyme development (GO:0072075),-0.620116695573975,-1.4918714605051304,0.04929577464788732,0.4980284400061071,1.0,2/10,3.04%,OSR1;WNT4
prerank,positive regulation of positive chemotaxis (GO:0050927),0.6376704507571503,1.4913470000765712,0.07214765100671142,0.709208115796621,1.0,2/15,0.50%,NTRK3;CDH13
prerank,regulation of cell-matrix adhesion (GO:0001952),0.49536014073299434,1.4910108346312394,0.041720990873533245,0.7069139089626296,1.0,9/64,4.40%,EFNA5;CDH13;UTRN;JAG1;MINK1;AJAP1;CASK;NF1;PEAK1
prerank,apical junction assembly (GO:0043297),0.5129011438626393,1.4896908387487557,0.03795811518324607,0.7092328890161513,1.0,15/53,14.75%,CLDN1;F11R;CLDN11;CLDN19;PARD6B;CDH5;POF1B;OCLN;PDCD6IP;CLDN10;STRN;APC;PATJ;FBF1;CTNNA1
prerank,sprouting angiogenesis (GO:0002040),-0.4050800559880068,-1.488698794622474,0.014705882352941176,0.5048783832964506,1.0,22/51,14.96%,ROBO1;ENG;TEK;CCBE1;RSPO3;ANGPT1;RNF213;SLIT2;RECK;BMP4;PIK3R3;ACVRL1;KDR;AKT1;VEGFC;RAMP2;FLT4;VEGFD;THBS1;ESM1;BMPER;NRP1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.5928805437127376,-1.4886592393894549,0.05596107055961071,0.5009295601737115,1.0,5/12,11.39%,CYP26B1;TRIM16;SNW1;KLF2;CTBP2
prerank,lipid modification (GO:0030258),0.5445707934928035,1.4886025480065919,0.05327868852459016,0.7102452881803097,1.0,5/37,4.15%,DGKA;MBOAT2;PLPP2;DGKZ;PLPP3
prerank,regulation of mitochondrial fusion (GO:0010635),-0.6095641905460609,-1.4864320179642483,0.07159904534606205,0.5044351288307328,1.0,3/11,3.02%,PID1;OMA1;TFRC
prerank,ERBB2 signaling pathway (GO:0038128),0.5487684293123994,1.48622011824421,0.07449856733524356,0.7167305426151693,1.0,4/31,4.48%,GAB1;EGFR;PRKCA;SRC
prerank,regulation of chemotaxis (GO:0050920),-0.4545213395189698,-1.4855981463128298,0.040625,0.5031799710005213,1.0,19/30,32.87%,PDGFRB;PDGFRA;DUSP3;CYRIB;ZSWIM6;YTHDF1;THBS1;ZSWIM4;P2RX4;RARRES2;ZSWIM8;CCL19;MYCBP2;P2RY12;PPM1F;CXCR4;ZSWIM5;AIF1;TREM2
prerank,cellular response to estradiol stimulus (GO:0071392),0.6214214905409458,1.4843911858810375,0.07667731629392971,0.7207784110033197,1.0,9/18,18.67%,EGFR;SSTR1;NRIP1;POU4F1;NCOA3;LCOR;GPER1;CCDC62;RUVBL2
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.6752866838329236,1.4838323908077022,0.07678883071553229,0.7125258942686776,1.0,6/12,18.29%,CUL3;ANAPC5;ANAPC7;ANAPC11;ANAPC4;CDC23
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.6752866838329236,1.4838323908077022,0.07678883071553229,0.7125258942686776,1.0,6/12,18.29%,CUL3;ANAPC5;ANAPC7;ANAPC11;ANAPC4;CDC23
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.6752866838329236,1.4838323908077022,0.07678883071553229,0.7125258942686776,1.0,6/12,18.29%,CUL3;ANAPC5;ANAPC7;ANAPC11;ANAPC4;CDC23
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.4259831175926349,-1.4832800974357128,0.05194805194805195,0.5067100825802661,1.0,10/35,9.39%,IRAG1;KSR1;RAPGEF2;PDE7B;ADGRG6;ADCY1;AKAP6;APOE;ADCY2;PDE2A
prerank,positive regulation of neuron projection development (GO:0010976),0.4800965653402951,1.4830754926693674,0.03217821782178218,0.7121919254676737,1.0,9/85,6.48%,ROR2;ITGA6;ROR1;NTRK3;COBL;RAP1A;BMP5;WNT5A;ABL2
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.6292225036623649,-1.4830592728525234,0.07142857142857142,0.503577500435317,1.0,6/10,27.51%,LYN;KIT;CD40;CD24;BTLA;FGR
prerank,monocyte differentiation (GO:0030224),-0.6361720746071298,-1.4829068809612622,0.06712962962962964,0.5002068878099182,1.0,6/10,18.51%,IL31RA;BMP4;MT1G;PIR;PDE1B;MYH9
prerank,carboxylic acid transport (GO:0046942),-0.3976909280266168,-1.4813838042111451,0.016877637130801686,0.501552862538414,1.0,21/55,23.03%,SLC16A12;SLC13A3;SLC6A6;SLC6A9;SLC7A5;SLC17A5;SLC7A1;SLC7A6;SLC16A6;SLC16A4;SLC15A4;SLC16A2;SLC16A7;SLC1A1;LLGL2;SLC3A2;SLC38A5;SLC25A29;SLC1A4;SLC6A17;SLC38A1
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.6423073377707949,1.4805348034025796,0.08333333333333333,0.7195954521479437,1.0,6/14,12.73%,ADAMTS12;EFEMP1;PTHLH;SOX9;CHADL;WNT9A
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.6657818397462788,1.4799857685458817,0.07441016333938294,0.718427758914528,1.0,2/10,4.23%,LBP;PTPN22
prerank,cholesterol homeostasis (GO:0042632),0.48557589931183837,1.479031967656219,0.05,0.7189729886912462,1.0,4/64,4.10%,RORA;CAV1;CYP7B1;GRAMD1B
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.4011614213324806,-1.479030525244808,0.02575107296137339,0.5053214671837946,1.0,19/47,26.51%,PDGFRB;PID1;XDH;AGTR1;PLCG2;CYBA;GRIN1;ZC3H12A;THBS1;MAPT;ACE2;ADGRB1;AGT;ROMO1;GRB2;RAB27A;RIPK1;ITGB2;ITGAM
prerank,regulation of RNA splicing (GO:0043484),0.4882930802807947,1.4784856971442715,0.036848792884371026,0.7177835103833196,1.0,21/69,15.01%,AHNAK;AHNAK2;CLK1;QKI;SLC38A2;CELF1;ZNF326;SON;CLK4;RBM22;SRPK1;DYRK1A;RPS13;PTBP3;KHDRBS2;SRPK2;PTBP2;ERN1;RBM38;TRA2B;SF1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.6327822676284425,1.478139136399709,0.08803986710963455,0.7157648515513516,1.0,5/14,8.36%,ADAM19;APH1B;NCSTN;ADAM10;DYRK1A
prerank,axon development (GO:0061564),0.48794761118355884,1.476871381039512,0.03783102143757881,0.718272775144813,1.0,13/78,10.91%,NTNG2;NTNG1;FOLR1;PARD6B;S100A6;BRSK1;EPHB2;RAB3A;S100B;ISL1;POU4F1;RTN4RL1;DOCK7
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.5329357131524889,-1.4767766714589132,0.05714285714285714,0.5095251143091956,1.0,10/16,35.47%,PGM2L1;CALM1;AGL;PHKG1;PYGB;PYGL;PHKA2;PHKB;STBD1;PYGM
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.45848690972468403,-1.4766224148411327,0.05014749262536873,0.5061434154320391,1.0,11/28,15.04%,SHANK3;EPHA4;ADCY1;SQSTM1;APOE;LGMN;EIF2AK4;NSG1;YTHDF1;CALB1;ZDHHC2
prerank,regulation of Ras protein signal transduction (GO:0046578),0.4740639275102191,1.475807134318451,0.024721878862793572,0.7193930257604594,1.0,20/86,8.07%,NGF;DLC1;ARHGEF28;PLCE1;OGT;AKAP13;LZTR1;SPRY1;OPHN1;MMD2;MFN2;SPRY4;NUP62;KANK2;LRRC59;EPHB2;RDX;KANK1;ARF6;STARD13
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5866829162137396,1.4752853366180136,0.0794392523364486,0.7181710191915841,1.0,5/23,9.03%,UBASH3B;CAMK2D;ATP1A2;NOS1AP;CASQ2
prerank,mesonephric tubule development (GO:0072164),-0.5553799618906665,-1.474494491048633,0.0728643216080402,0.5093850105788671,1.0,4/15,3.93%,OSR1;SLIT2;BMP4;FGFR2
prerank,regulation of protein export from nucleus (GO:0046825),0.5861804880181036,1.4743610230434394,0.07898894154818326,0.7184608644538168,1.0,9/23,12.95%,GTSE1;RAPGEF3;PTPN14;BAG3;RBM22;GSK3B;SIRT7;TPR;EMD
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.585343073605352,1.4728987387108998,0.06487341772151899,0.7210493276505766,1.0,8/23,12.70%,CAV1;SOCS5;PTPRC;TSG101;SRCIN1;CBLB;SOCS4;MVP
prerank,sterol metabolic process (GO:0016125),-0.3755570071101093,-1.4728414062470592,0.028,0.5109124836766507,1.0,17/60,14.97%,PRKAG2;CYP26B1;PPARD;INSIG2;CYP1B1;ARV1;APOE;SCAP;OSBPL1A;LDLRAP1;OSBPL5;GBA2;NSDHL;PMVK;ABCG1;FDXR;LIPA
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.657972693772436,1.472817064507437,0.08561643835616438,0.7180414781693951,1.0,3/14,3.49%,CAV1;SPRED1;SPRY1
prerank,modulation of chemical synaptic transmission (GO:0050804),0.46475007946863417,1.4706070369887405,0.03143189755529686,0.7242033992703037,1.0,13/107,8.59%,NGF;CLSTN2;CEL;SLC12A2;DGKZ;OPHN1;CLSTN3;NPTX2;ATP1A2;RIMS2;CPLX1;CDH2;GRID1
prerank,negative regulation of cell motility (GO:2000146),-0.3461468644723772,-1.4684065334703011,0.0,0.5214298219735048,1.0,31/108,11.61%,ROBO1;ENG;AFDN;CLDN5;FBLN1;LIMCH1;SLIT2;FRMD5;TPM1;RECK;DACH1;CLIC4;IGFBP5;EPHA4;PTPRK;ACVRL1;CYP1B1;MITF;PODN;SRGAP1;DUSP10;DUSP3;CCDC125;CRK;BST2;TMEFF2;CITED2;RHOB;SINHCAF;ARID2;FUZ
prerank,regulation of filopodium assembly (GO:0051489),0.5313221768009375,1.4680415121397037,0.06346967559943582,0.7317730758936596,1.0,8/38,9.19%,TENM2;RIPOR2;ARAP1;CAPZB;FXR2;ARF6;PALM;GPM6A
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.6134594958544276,-1.4675300146392807,0.0752212389380531,0.5207398495944433,1.0,9/10,34.40%,ACER2;CYP1B1;NEXMIF;WNK1;PDE3B;JAM3;SNAI2;HRG;SERPINE1
prerank,protein kinase B signaling (GO:0043491),-0.4836996566466527,-1.466483952123458,0.03943661971830986,0.5206276354559318,1.0,4/23,8.19%,IGF1;PIK3R3;KDR;AKT1
prerank,embryonic limb morphogenesis (GO:0030326),0.5459163436625175,1.4664613757676037,0.06983655274888559,0.734772209225262,1.0,2/34,1.15%,PTCH1;AFF3
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.4662868740679108,1.4658685874677582,0.03026634382566586,0.7339758097377781,1.0,23/95,12.13%,DCN;GPC3;CSPG4;ST3GAL4;PRELP;UST;XYLT2;GPC6;GLCE;B4GAT1;CHST7;NCAN;NDST1;SDC1;SLC35D2;GCNT2;CHST2;HEXA;CHST12;HS3ST6;HS3ST5;GPC2;SDC3
prerank,sodium ion homeostasis (GO:0055078),0.578633410814763,1.4652776039361848,0.07827476038338659,0.7330421765143914,1.0,5/21,9.39%,NEDD4L;SLC12A2;SLC12A3;ATP1A2;ATP1B3
prerank,positive regulation of ruffle assembly (GO:1900029),-0.5823012761034663,-1.4644449921417657,0.07852193995381063,0.5233761672327469,1.0,10/13,38.40%,EPS8;EPS8L2;PFN1;HRAS;P2RY12;DEF8;PLEKHM1;FAM98A;CARMIL2;NLGN1
prerank,cardiac cell development (GO:0055006),0.6820679663332894,1.4638665950334426,0.08247422680412371,0.7355721515945522,1.0,2/11,2.29%,CXADR;JAG1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.617295993696206,1.463792153532313,0.08552631578947369,0.7292769819833639,1.0,3/16,4.48%,APOD;DLC1;SRC
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.617295993696206,1.463792153532313,0.08552631578947369,0.7292769819833639,1.0,3/16,4.48%,APOD;DLC1;SRC
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.4868021521826846,-1.4627505806132526,0.059782608695652176,0.5254619620691704,1.0,9/22,14.27%,PICALM;ROCK2;LYN;EPHA4;CASP3;GSK3A;SP1;ABCA2;ABCG1
prerank,sulfur compound catabolic process (GO:0044273),0.5440990017801016,1.4622215413939574,0.07909604519774012,0.7327329973115813,1.0,9/38,15.29%,DCN;CSPG4;PRELP;NCAN;ACAT1;HEXA;HEXB;TXN2;GGT1
prerank,positive regulation of filopodium assembly (GO:0051491),0.5709543102406335,1.4622129750477222,0.07606973058637084,0.7295198958375667,1.0,3/24,2.02%,TENM2;RIPOR2;ARAP1
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.41073817509945615,-1.4619988667745512,0.02631578947368421,0.524437470171158,1.0,18/47,18.82%,SOX13;TMEM64;PPARD;CREBL2;NAPEPLD;AKT1;CMKLR1;CREB1;ASXL2;ZC3H12A;BMP2;NOCT;ID2;CEBPB;ZFP36;LRP5;RARRES2;PIM1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.44640323119701375,1.4613925126931515,0.026018099547511313,0.7296769713815277,1.0,20/142,9.48%,CAV1;LPAR1;ACKR3;PLCE1;ITPR3;PTGFR;SLC8B1;CD55;TRPV4;FKBP1B;CAV2;ATP2B4;FIS1;WNT5A;ATP1A2;ADCY5;ABL2;PTGER4;HCRTR2;HMGB1
prerank,negative regulation of cellular senescence (GO:2000773),-0.5612472679848205,-1.461171707501928,0.05527638190954774,0.5231986429880358,1.0,5/13,7.77%,SLC30A10;AKT3;ZKSCAN3;RBL1;CDK6
prerank,regulation of cholesterol esterification (GO:0010872),-0.6106089282241557,-1.461051627884669,0.06651376146788991,0.5199803198607331,1.0,5/10,19.17%,AGTR1;APOE;ABCA2;ABCG1;AGT
prerank,response to histamine (GO:0034776),0.6943101934152196,1.4609288404848622,0.08957952468007313,0.7284367231058781,1.0,3/10,12.25%,HRH1;GABRG2;GABRB3
prerank,regulation of protein autophosphorylation (GO:0031952),-0.4293926332209153,-1.4604781690293251,0.052980132450331126,0.5183460754006357,1.0,5/36,1.08%,PDGFD;ENG;EPHA7;ERRFI1;ENPP1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.6772378782403048,1.4602862995353243,0.10695187165775401,0.7278919821256993,1.0,2/10,8.21%,APOD;PTPRJ
prerank,amide biosynthetic process (GO:0043604),0.5106743074021064,1.459851604749146,0.06284153005464481,0.7264212757664514,1.0,7/47,5.63%,SGMS2;CERS6;ARG1;ASS1;PCSK5;ALOXE3;CLN8
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.43304070478373524,-1.4596128988524901,0.04220779220779221,0.5176146330542118,1.0,11/32,13.12%,CHKA;GPAT4;CHPT1;LPIN2;PCYT1A;SLC44A5;ABHD3;CEPT1;LPIN3;CSNK2A1;MFSD2A
prerank,lipid translocation (GO:0034204),0.5922203467873547,1.4584741681555715,0.06987577639751552,0.7286334165608623,1.0,12/21,15.78%,ATP8B3;ATP8B1;ABCC1;RFT1;ATP9B;ATP11C;ATP9A;ATP8B2;ABCA1;ATP10B;TMEM30A;ATP8B4
prerank,negative regulation of synaptic transmission (GO:0050805),0.5870691701327201,1.4579222807936372,0.07774390243902439,0.727953232514149,1.0,2/23,2.75%,PLK2;SLC24A1
prerank,B cell receptor signaling pathway (GO:0050853),0.5406194181409495,1.4579125457287663,0.06332842415316642,0.7248732938743135,1.0,4/32,4.99%,TEC;NFATC2;ITK;PTPRC
prerank,protein processing (GO:0016485),0.46281089719055657,1.4573914525938358,0.03629976580796253,0.7237736448551859,1.0,10/102,6.14%,PTCH1;KLK2;PCSK5;ADAM19;OGT;APH1B;CD5L;CPE;NCSTN;ADAM10
prerank,protein localization to cell-cell junction (GO:0150105),0.6342898719001169,1.4572006767021763,0.08471760797342193,0.721400903120619,1.0,5/15,7.93%,F11R;CDH5;TJP2;LSR;CGNL1
prerank,negative regulation of lipid storage (GO:0010888),-0.5052307654272403,-1.4571842933154697,0.03950617283950617,0.5221243574027465,1.0,5/19,8.19%,OSBPL8;PPARD;NR1H3;ABHD5;NR1H2
prerank,sulfation (GO:0051923),0.6751726482473501,1.4566034090810267,0.10139860139860139,0.7206634376833376,1.0,3/11,11.68%,UST;SULT1A1;HS3ST5
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.6060613123564025,1.4559218677885182,0.06549520766773163,0.7202728812490541,1.0,2/19,0.38%,DCN;SMOC2
prerank,positive regulation of growth (GO:0045927),-0.3814096256216227,-1.4558967795369666,0.010752688172043012,0.5229009857439691,1.0,23/64,17.05%,PLCB1;INSR;ADNP2;CDC42;TGFBR1;CXCL16;RFTN1;AKAP6;AKT1;SLC25A33;TGFB2;CSNK2A1;MFSD2A;SPHK1;CDKN2AIP;FXN;LGI1;PABIR1;ZPR1;HDGFL2;EIF4G1;NCBP1;DERL2
prerank,regulation of nuclear division (GO:0051783),0.5949288091860346,1.455152633749213,0.06430868167202572,0.720386598489133,1.0,5/20,7.62%,FBXO43;KIF20B;CAV2;CDK13;FBXO5
prerank,mitotic chromosome condensation (GO:0007076),-0.4624132521056478,-1.4549685663771297,0.05307262569832402,0.5222823471204837,1.0,13/26,30.75%,PHF8;SMC4;NCAPD3;MCPH1;CSNK2A1;AKAP8L;CSNK2B;NCAPG2;NCAPD2;NUSAP1;NCAPH;TTN;NCAPG
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.5213319192370802,-1.4547822487044182,0.061696658097686374,0.5194093414258657,1.0,7/16,13.97%,NPR3;HIF1A;APOE;GCH1;AKT1;S100A1;DHFR
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.5212979963413183,-1.4539917501443558,0.07692307692307693,0.5187548152388466,1.0,7/18,17.04%,SMAD3;HIF1A;CD34;CD200;TGFB2;LGALS9;SMAD4
prerank,aminoglycan biosynthetic process (GO:0006023),0.5109287782615733,1.4539764854781165,0.06934812760055478,0.7223024588369462,1.0,19/49,17.77%,GPC3;XYLT2;GPC6;B3GALT1;B4GAT1;NDST1;SDC1;SLC35D2;GCNT2;HEXA;HS3ST6;HS3ST5;GPC2;SDC3;HSPG2;EXT1;EXT2;GPC5;SDC4
prerank,acylglycerol biosynthetic process (GO:0046463),0.5778172864715122,1.4537365230287616,0.08875739644970414,0.7202669390572057,1.0,6/23,3.75%,PLCE1;MOGAT2;MOGAT3;GPAT3;AWAT2;AGMO
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.685404366599058,1.4536265263570025,0.10488245931283906,0.7177379734379697,1.0,3/10,13.05%,CAV1;KCNAB1;KCNRG
prerank,long-chain fatty acid transport (GO:0015909),-0.44054182153443106,-1.4532632248786148,0.05345911949685535,0.5177454149524802,1.0,12/30,14.68%,PRKAG2;ACSL1;ACSL3;APOE;RPS6KB1;ABCD4;CPT2;PRKAB2;ABCD2;MFSD2A;CPT1A;MID1IP1
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.5128318242422332,-1.4528036995026075,0.06870229007633588,0.5157985306234047,1.0,6/16,22.64%,LRP1;APOE;HDAC1;MYOCD;CLU;SRF
prerank,regulation of muscle contraction (GO:0006937),0.563895102991034,1.4526074706584302,0.0784313725490196,0.719051327027836,1.0,4/26,5.19%,CAV1;MYBPH;PLCE1;ATP1A2
prerank,positive regulation of synaptic transmission (GO:0050806),0.48153772160827335,1.4524671549652037,0.056372549019607844,0.7166215877592037,1.0,8/72,6.57%,CLSTN2;PLK2;TSHZ3;RGS14;SLC24A1;CLSTN3;EPHB2;RIMS2
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.6007608601203904,-1.4512748972467209,0.09389671361502347,0.5173986916173673,1.0,5/11,15.22%,CD34;CD200;GATA6;THBS1;LGALS9
prerank,positive regulation of phospholipase C activity (GO:0010863),0.5139056158157951,1.4512313441340317,0.06995884773662552,0.718675227181184,1.0,8/40,6.48%,NTRK3;FGFR1;LPAR1;EGFR;ITK;TXK;GNAQ;ABL2
prerank,superoxide anion generation (GO:0042554),-0.5626427259269543,-1.450170677110175,0.07180851063829788,0.5176251462182123,1.0,4/13,11.33%,NOX4;CYBA;NOX1;NCF2
prerank,negative regulation of cell differentiation (GO:0045596),0.43484935717398954,1.4499625287916147,0.010905125408942203,0.7207925764550377,1.0,33/181,13.49%,PTCH1;RORA;CAV1;TRIB2;ADAMTS12;EFEMP1;EGFR;DTX1;JAG1;SPRED1;SPRY1;PTHLH;SOX9;BMP5;LEO1;WNT5A;TRIO;ANKRD2;PAF1;LDLRAD4;NELFB;RORB;ABCA1;SDHAF2;FERMT2;MEN1;CHADL;SEMA4D;HOPX;WNT9A;PTEN;ZFP36L2;SPRED2
prerank,regulation of insulin secretion (GO:0050796),0.45563322831833847,1.4496514272224639,0.03055229142185664,0.7192288429723429,1.0,17/101,10.36%,EFNA5;INHBB;ITPR2;ITPR3;RAPGEF3;SLC8B1;KCNA5;RAP1A;STX1A;PRKCA;ADCY5;RAPGEF4;SLC2A2;DPP4;ISL1;KCNS3;ADRA2A
prerank,sterol homeostasis (GO:0055092),0.47708184382891344,1.4491592687534394,0.062087186261558784,0.7183201535127292,1.0,4/65,4.10%,RORA;CAV1;CYP7B1;GRAMD1B
prerank,protein maturation (GO:0051604),0.4677845579656788,1.448758159014079,0.03985507246376811,0.7171272893470336,1.0,16/95,12.31%,PTCH1;PCSK5;ADAM19;OGT;APH1B;CPE;NCSTN;ADAM10;NAA35;PCSK7;LMF1;MME;TASP1;XPNPEP3;TSPAN14;MMP16
prerank,negative regulation of MAPK cascade (GO:0043409),0.4654455688744863,1.4481422533589037,0.047503045066991476,0.7165359823673721,1.0,15/87,8.41%,CNKSR3;CAV1;RGS14;STK38;SPRED1;NF1;SPRY1;SPRY4;IRAK3;PTPRC;EPHB2;DAG1;PIK3R2;PTPRJ;TNIP1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.5287319497319847,1.4475474955976684,0.08831521739130435,0.7161522009669496,1.0,12/35,10.01%,DLC1;RIPOR2;SCAI;LZTR1;SPRY1;MFN2;SPRY4;EPHB2;ABL2;KANK1;CUL3;MAPKAP1
prerank,regulation of embryonic development (GO:0045995),-0.4343499940134695,-1.446303129578565,0.03728813559322034,0.5263414566709735,1.0,8/34,9.26%,PLCB1;PHLDB2;INSR;NPHP3;CFL1;ZBED3;SOX17;WDPCP
prerank,positive regulation of cell projection organization (GO:0031346),0.45480243310362317,1.445510029357834,0.031363088057901084,0.7216365866585092,1.0,10/115,4.96%,NGF;ROR2;ITGA6;ROR1;NTRK3;TIAM2;RAP1A;CDKL3;PLXNA3;WNT5A
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.6256885267058775,1.444990394737065,0.08576051779935275,0.72099344275105,1.0,7/15,15.80%,MGAT3;CHST7;EXTL2;CHST2;NAGK;GNPDA2;OGA
prerank,triglyceride metabolic process (GO:0006641),0.5050119292833016,1.4447721755194292,0.06420765027322405,0.7190862435435733,1.0,5/48,3.75%,CAV1;MOGAT2;MOGAT3;GPAT3;AGMO
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.5075674867663595,-1.4443171268531412,0.07084468664850137,0.5293161666874108,1.0,8/18,14.27%,PICALM;ROCK2;EPHA4;CASP3;GSK3A;SP1;ABCA2;ABCG1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.5230816927329145,-1.4440987862675907,0.07197943444730077,0.5265797937299259,1.0,7/16,21.07%,SNCAIP;MCTP2;SYN1;CAMK2A;CPLX2;FLOT1;RIMS1
prerank,miRNA metabolic process (GO:0010586),0.592686233143767,1.4435697248130683,0.08695652173913043,0.7212415365018614,1.0,8/20,17.19%,DDX17;DIS3L2;LIN28B;DGCR8;DICER1;RAN;PRKRA;XPO5
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.5946703398060393,-1.4435108017079499,0.08577878103837472,0.5251755859735358,1.0,4/10,21.42%,ADGRV1;PDZD7;TSKU;PLS1
prerank,regulation of ion transmembrane transport (GO:0034765),0.5431477662736977,1.442942267505536,0.07747489239598278,0.7210014638778055,1.0,11/33,16.76%,NEDD4L;KCNJ4;SCN10A;KCNJ16;ANO6;KCNJ13;CASQ2;NEDD4;CHRM3;WWP2;YWHAE
prerank,regulation of stem cell proliferation (GO:0072091),-0.5072830188460685,-1.4420049424793613,0.07360406091370558,0.5265302850385534,1.0,5/17,12.01%,FBLN1;GJA1;ACE;AGO3;KDM1A
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.5968621436641901,-1.4413157569222423,0.06666666666666667,0.5255220125999023,1.0,9/10,35.84%,PARD3;PLPP1;GAP43;PRKD3;PICK1;HTR2B;F2R;CHRM1;DGKH
prerank,cyclooxygenase pathway (GO:0019371),-0.5978023816268141,-1.440390823244728,0.0896551724137931,0.5253753300311075,1.0,5/10,17.60%,PTGIS;PTGS1;PTGDS;TBXAS1;HPGDS
prerank,positive regulation of keratinocyte migration (GO:0051549),0.6926019563471055,1.4403105287348095,0.09515570934256055,0.7285455883608111,1.0,3/10,12.82%,FGF7;ARF6;MAPRE2
prerank,regulation of activated T cell proliferation (GO:0046006),-0.4496456682143114,-1.4400610006850174,0.05421686746987952,0.5232658828318992,1.0,9/30,18.94%,IGF1;IGFBP2;IGF2;IL18;RPS3;LGALS9;RC3H1;CD24;ICOSLG
prerank,fatty acid elongation (GO:0030497),0.6419197900159428,1.4396657540489497,0.10378912685337727,0.7282059000447252,1.0,7/13,13.29%,ELOVL5;HACD4;ELOVL1;ELOVL2;HACD2;ABCD1;ELOVL6
prerank,triglyceride homeostasis (GO:0070328),0.5602201228341706,1.4396451187960535,0.08936825885978428,0.725499845091007,1.0,1/26,0.04%,RORA
prerank,"wound healing, spreading of cells (GO:0044319)",-0.47990035216374416,-1.4386870926066408,0.06199460916442048,0.5244204271725329,1.0,10/24,10.23%,ARHGAP24;COL5A1;DDR1;ACVRL1;PDCD10;ARHGAP35;RHOC;TMEFF2;FLNA;CCN1
prerank,clathrin coat assembly (GO:0048268),-0.5365844079702952,-1.4381615874751952,0.0759493670886076,0.5228685259915257,1.0,6/15,10.53%,PICALM;HIP1;HIP1R;EPS15;PIK3C2A;NSG1
prerank,sympathetic nervous system development (GO:0048485),0.6247073021291725,1.4381162380827266,0.10260586319218241,0.7286871319728887,1.0,5/15,14.90%,NRP2;NF1;SEMA3A;SOX4;FZD3
prerank,regulation of calcium ion import (GO:0090279),-0.48616846658129825,-1.4380113936960284,0.08035714285714286,0.5201602258602593,1.0,9/21,31.99%,PDGFRB;CXCL12;EGF;PLPP4;PLN;TRIM27;PSEN2;STC1;CCL2
prerank,regulation of hydrolase activity (GO:0051336),0.4747434834101054,1.4374136373192885,0.0410783055198973,0.7287119211665748,1.0,16/71,8.85%,CAV1;EFNA5;SIPA1L1;ARHGAP12;ARHGAP9;CFAP73;TDG;NF1;VAV2;PLXNA3;ARHGEF5;RAB3GAP2;RDX;PAFAH1B1;RAPGEF6;OCRL
prerank,actin nucleation (GO:0045010),-0.4788655327740785,-1.4373978109041123,0.06267806267806268,0.5191520531315529,1.0,14/21,38.92%,JMY;ARPC3;IQGAP2;ACTR2;LMOD1;ARPC1A;ARPC5;TRIM27;WASHC1;ARPC5L;ARPC1B;SPIRE2;SPIRE1;SCIN
prerank,regulation of platelet aggregation (GO:0090330),0.601119581065403,1.4344280215927687,0.1060126582278481,0.7375532304845327,1.0,4/17,4.28%,F11R;CEACAM1;CD9;PRKCA
prerank,superoxide metabolic process (GO:0006801),-0.444118231935444,-1.4337971393876112,0.045307443365695796,0.5272098348371232,1.0,9/29,11.33%,NOS3;ATP7A;SOD3;PRDX2;NOX4;NRROS;CYBA;NOX1;NCF2
prerank,acylglycerol metabolic process (GO:0006639),0.5243162624969495,1.4320872204146147,0.07898448519040903,0.7443740636242446,1.0,6/37,10.45%,CAV1;DGKA;AWAT2;DGKZ;ABHD12;LMF1
prerank,regulation of endothelial cell proliferation (GO:0001936),0.46071683810361297,1.4301462992094036,0.03743961352657005,0.7493938087062323,1.0,13/88,6.83%,THBS4;CAV1;CDH13;NR2F2;SULF1;NRARP;NRP2;NF1;CAV2;PRKCA;WNT5A;NRAS;EGFL7
prerank,aminoglycan catabolic process (GO:0006026),0.5575319912806623,1.430047062698676,0.08771929824561403,0.7469961784561843,1.0,9/28,17.77%,GPC3;GPC6;SDC1;GPC2;SDC3;HSPG2;HGSNAT;GPC5;SDC4
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.5603011298701288,1.4280988698245198,0.08320493066255778,0.7519220863040117,1.0,7/23,16.14%,PLK2;WEE1;CHFR;CHMP4C;ZWILCH;ZW10;INTS3
prerank,regulation of establishment of planar polarity (GO:0090175),0.4534108050896401,1.4278985715633414,0.054187192118226604,0.7500235891377104,1.0,28/88,18.75%,ROR2;PRICKLE1;PRICKLE2;FZD2;SPEF1;SAPCD2;PSME3;DACT1;WNT5A;PSMB5;DVL3;VANGL1;PSMB2;FZD7;PSMA2;PSMA6;FZD3;PSMD13;PSMA7;AP2A2;CELSR1;PSME4;CELSR2;PSMC4;PSMB6;PSMD12;RHOA;PSMD14
prerank,regulation of axonogenesis (GO:0050770),0.4996520198681372,1.427754344795378,0.07620320855614973,0.7478580046656749,1.0,8/51,5.94%,NGF;SIPA1L1;LRP4;TIAM2;RTN4R;PLXNA3;BRSK1;GDI1
prerank,regulation of centrosome duplication (GO:0010824),0.5429243266816678,1.4276213101187019,0.10128388017118402,0.7456280069241134,1.0,9/30,12.90%,PLK2;STIL;CEP131;CHMP5;PDCD6IP;CHMP4B;CENPJ;CHMP4C;GEN1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.5056883303026587,-1.4270761218852521,0.07238605898123325,0.5455203585176146,1.0,8/18,13.39%,AKT3;HDAC7;HDAC9;KDR;ANXA1;PIK3C2A;GATA2;SRPX2
prerank,regulation of Rho protein signal transduction (GO:0035023),0.46689731671306883,1.4261524176655234,0.06327543424317618,0.748786021263297,1.0,15/72,8.07%,DLC1;ARHGEF28;F11R;LPAR1;RIPOR2;SCAI;RTN4R;AKAP13;OPHN1;KANK2;ABL2;COL3A1;KANK1;CUL3;STARD13
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.558469375794695,1.4252338958649442,0.10635155096011817,0.7500915922365026,1.0,5/27,4.74%,UTRN;SLMAP;NEDD4L;CAMK2D;ATP2B4
prerank,embryonic digit morphogenesis (GO:0042733),-0.5051113509758609,-1.4248477458310493,0.07788944723618091,0.5498129343681157,1.0,7/18,9.26%,ECE1;OSR1;MAP3K20;GLI3;TBX3;HDAC1;WDPCP
prerank,regulation of centriole replication (GO:0046599),0.5852642860946209,1.4246318456640228,0.11986863711001643,0.7498423827037358,1.0,3/18,4.94%,PLK2;STIL;NUP62
prerank,negative regulation of response to external stimulus (GO:0032102),0.4486951886304004,1.423664579377806,0.03272727272727273,0.7510861462072521,1.0,22/105,11.15%,RORA;CLDN19;CDH5;CXCL17;AJAP1;CASK;RTN4R;PCBP2;FNDC4;IRAK3;TNFAIP3;TRIM21;SELENOS;MAPK7;PTGER4;ISL1;ACOD1;INPP5F;TRAFD1;SHARPIN;RTN4RL1;PROC
prerank,canonical Wnt signaling pathway (GO:0060070),0.47025965175902473,1.4234125984078014,0.05674653215636822,0.7493494407707907,1.0,25/68,19.41%,CAV1;WNT10A;FZD2;AXIN1;WNT2B;WNT16;PLPP3;WNT5A;GSK3B;CSNK1A1;RARG;APC;DVL3;WNT9A;PTEN;BCL9;FZD7;FZD9;FZD3;PPP1CA;WNT6;CDH3;RAB5A;TCF7L1;SCYL2
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.5840040671918514,1.4233357213838138,0.11690363349131122,0.7469024164256849,1.0,2/19,2.89%,CHRNB3;RIC3
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.44427155650066813,1.4231685068596314,0.03508771929824561,0.7449033600951531,1.0,16/113,7.31%,THBS4;CLDN1;FGF7;CDH13;LAMC1;NRARP;EGFR;FGF1;NRP2;SOX9;PRKCA;BMP5;WNT5A;NRAS;EGFL7;RREB1
prerank,myofibril assembly (GO:0030239),-0.4023496284896366,-1.4229587875497738,0.030303030303030304,0.5528420352358363,1.0,10/42,11.29%,PGM5;PDGFRB;ACTN2;PDGFRA;TPM1;OBSL1;TMOD3;CFLAR;CSRP2;LMOD1
prerank,toxin transport (GO:1901998),0.663687444715628,1.4228633868716252,0.1111111111111111,0.7433950262151554,1.0,5/10,12.50%,RAB29;SLC29A4;SLC22A3;ADAM10;RAB40B
prerank,transition metal ion homeostasis (GO:0055076),-0.4409331513230277,-1.4213906921570978,0.045317220543806644,0.5546559205517644,1.0,7/28,7.56%,PICALM;NEO1;COMMD1;B2M;FTL;SLC39A14;BDH2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.5525669230900381,1.4209997407898198,0.09502262443438914,0.7480290238378631,1.0,5/27,5.76%,DCN;CSPG4;XYLT2;CHST7;NCAN
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.5585284628746051,1.4207041029790548,0.10876132930513595,0.7465270523198846,1.0,5/24,7.16%,PPARGC1A;LEPR;SDHAF4;LYRM7;COX15
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.6442112776409687,1.4201523361143344,0.1079734219269103,0.7459814441593278,1.0,3/13,2.99%,CAV1;CAMK2D;PDE4D
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.4767662875190823,1.4195976521720506,0.055198973042362,0.7455772100527527,1.0,6/67,2.16%,VIT;CDH13;UTRN;DOCK5;ECM2;DOCK1
prerank,gland development (GO:0048732),0.4864270011161307,1.4188428351848823,0.053315994798439535,0.7460044610479583,1.0,10/59,6.09%,STRA6;CAV1;COBL;WNT10A;GLI2;NF1;SOX9;LSR;IGSF3;GFER
prerank,phospholipid translocation (GO:0045332),0.5370201002039363,1.4179570795819694,0.09668109668109669,0.7468082235948756,1.0,11/28,9.87%,ATP8B3;ATP8B1;ANO6;ABCC1;ATP9B;ATP11C;PLSCR1;ATP9A;ATP8B2;ABCA1;ATP10B
prerank,endocrine system development (GO:0035270),0.5845856980856584,1.41778623297035,0.0796875,0.7447830718073614,1.0,3/21,3.23%,STRA6;GLI2;NF1
prerank,heart development (GO:0007507),0.42889940313707126,1.4174817828035517,0.03518728717366629,0.7434201316421564,1.0,39/150,15.69%,STRA6;CXADR;GPC3;DLC1;NTRK3;PLCE1;SGCD;PCSK5;PDLIM4;GLI2;NF1;AKAP13;SMYD4;SGCG;SOX9;CSRP3;BMP5;FN1;MTHFD1;APLN;SH3PXD2B;COL3A1;TBX2;ISL1;POU4F1;LEFTY1;TAB2;POPDC3;NDUFV2;PTEN;KDM6B;PKD1;SOX4;FLRT2;ERBB4;FOXF1;TNNI3;POU6F1;FOXC2
prerank,protein localization to cell surface (GO:0034394),0.5638736243023802,1.4173130569579317,0.0891238670694864,0.741516613253158,1.0,3/26,2.89%,PIGU;FGF7;RIC3
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4463512877812533,-1.4170693867198647,0.08928571428571429,0.5659776052853223,1.0,9/28,12.47%,PID1;ENPP1;GRB10;APPL2;RPS6KB1;PIP4K2A;PRKCZ;GSK3A;PIP4K2C
prerank,positive regulation of tissue remodeling (GO:0034105),-0.5925740029358295,-1.415617942539951,0.09237875288683603,0.5673387403028101,1.0,2/10,4.03%,ROCK2;IL18
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6232663758181642,1.4152563486305598,0.1265164644714038,0.7470880954377832,1.0,7/13,17.73%,CDH13;CD9;ABCA1;CD81;SYK;PPARG;LPL
prerank,negative regulation of secretion by cell (GO:1903531),0.5155040330835949,1.4146970623569526,0.09863013698630137,0.7465034000339296,1.0,1/38,0.06%,STXBP6
prerank,positive regulation of sodium ion transport (GO:0010765),0.6581839897269254,1.413202994959443,0.116751269035533,0.749635850880864,1.0,1/12,0.20%,CNKSR3
prerank,cellular modified amino acid catabolic process (GO:0042219),0.6122846144009348,1.412305943485211,0.10191082802547771,0.7506154947990947,1.0,3/15,8.30%,PRODH;HOGA1;ABHD12
prerank,muscle cell migration (GO:0014812),0.6579445210219932,1.4121310386572161,0.10720562390158173,0.7487458838559047,1.0,1/10,0.16%,THBS4
prerank,positive regulation of ERAD pathway (GO:1904294),0.6293357692075054,1.411986051870391,0.11398963730569948,0.7467536159944346,1.0,6/13,18.42%,CAV1;USP13;NFE2L2;RNF185;UBQLN1;TMEM259
prerank,morphogenesis of an epithelium (GO:0002009),0.5451546029379403,1.4117245596008994,0.10676691729323308,0.7451479680915952,1.0,7/25,9.10%,RIPK4;WNT10A;ARHGAP12;SOX9;LAMA5;DAG1;TBX18
prerank,myelin assembly (GO:0032288),0.6655469124211912,1.411455519634565,0.10088495575221239,0.7436846574399486,1.0,5/10,14.63%,EPB41L3;CD9;CNTNAP1;NCMAP;DICER1
prerank,negative regulation of chemokine production (GO:0032682),0.6117099978923743,1.4104181848306923,0.10101010101010101,0.7450989949839475,1.0,1/14,0.19%,APOD
prerank,regulation of interleukin-13 production (GO:0032656),-0.5505731503965374,-1.4098499934059725,0.09732360097323602,0.5828592249194725,1.0,5/13,15.22%,LEF1;IL18;TNFRSF21;PRKCZ;LGALS9
prerank,negative regulation of neuron differentiation (GO:0045665),0.5757054699301142,1.4089078285751497,0.101620029455081,0.7484865021459668,1.0,4/22,9.35%,DLX1;DTX1;SOX9;GSK3B
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.4030700582456194,-1.4083892977581962,0.05434782608695652,0.5849866688221952,1.0,13/43,8.53%,IGF1;PDGFRB;IL6R;FOXP1;MEF2D;IGFBP5;BMP4;GJA1;IL18;AKT1;MMP2;LDLRAP1;NOX1
prerank,protein lipidation (GO:0006497),0.4722279001709816,1.4083317950378775,0.078125,0.748232044860799,1.0,15/59,14.86%,PIGU;GPLD1;PGAP3;ZDHHC1;ATG5;ZDHHC7;PIGB;ZDHHC23;PIGA;ZDHHC13;ATG7;ZDHHC20;GLUL;ZDHHC8;PIK3C3
prerank,regulation of DNA replication (GO:0006275),0.5003101597961658,1.4074931867270872,0.06882591093117409,0.7491046762007434,1.0,20/49,20.50%,GLI1;EGFR;GLI2;CDAN1;SMC3;STN1;ORC5;FBXO5;ORC3;OBI1;FAF1;CDC6;NUCKS1;BRPF3;GMNN;USP37;DSCC1;DHX9;PPP2CA;ATR
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.5584956517986074,1.4068339431168708,0.13291139240506328,0.7492153170119272,1.0,6/24,7.27%,ITPR2;ITPR3;ERO1A;PTPRC;IBTK;CHERP
prerank,regulation of cellular respiration (GO:0043457),-0.5071224100767222,-1.406679827532289,0.08108108108108109,0.5878035513310189,1.0,6/17,17.33%,CBFA2T3;IL10RB;PRDM16;VCP;NOA1;IFNAR1
prerank,aspartate family amino acid metabolic process (GO:0009066),0.5877499375043831,1.4048915663639525,0.11345218800648298,0.7542801710631934,1.0,8/18,14.33%,ASS1;NAALAD2;SLC25A12;NIT2;MTHFD1;SLC25A13;GOT1;SMS
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.40148432036442727,-1.404805602549602,0.02952029520295203,0.5910322017368129,1.0,10/40,13.07%,SLC7A11;SLC13A3;SLC7A5;SLC5A6;SLC38A11;SLC7A6;SLC25A30;SLC25A11;SLC16A7;SLC38A7
prerank,myeloid leukocyte differentiation (GO:0002573),-0.36979888513593107,-1.4046206939381114,0.0430622009569378,0.5883539625106019,1.0,21/65,19.28%,LEF1;IL31RA;FOXP1;CDC42;BMP4;KIT;CBFA2T3;EP300;MT1G;DEK;CAMK4;TNFRSF11A;CDK4;PIR;LGALS9;PDE1B;CSF1;CASP8;SBNO2;MYH9;PARP1
prerank,postsynaptic membrane organization (GO:0001941),0.6008074525066942,1.4044781747241692,0.11423841059602649,0.7533025150236965,1.0,3/17,1.81%,LRP4;CEL;MUSK
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.6627553820561627,1.4041409525458057,0.1335676625659051,0.7522221845362176,1.0,2/10,3.53%,RAPGEF3;KMT2A
prerank,regulation of smooth muscle contraction (GO:0006940),0.5682844866769208,1.4039202588857378,0.11919504643962849,0.7505272427857119,1.0,2/20,1.21%,CAV1;PLCE1
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.6088701384615848,1.4037354902897505,0.11053540587219343,0.748772221689741,1.0,5/15,8.91%,GLI1;FAM83D;PAF1;CUL3;DDRGK1
prerank,diterpenoid metabolic process (GO:0016101),0.48265707810519076,1.403439887221387,0.0955585464333782,0.747470384556975,1.0,13/55,13.33%,STRA6;GPC3;RDH10;GPC6;RDH5;AWAT2;BCO1;OPN1MW;SDC1;AKR1B10;GPC2;SDC3;HSPG2
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.5284803927951174,-1.4027420293017685,0.07571801566579635,0.5913494921377919,1.0,5/15,19.17%,PRKCH;IL18;AGTR1;CSF1;AGT
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5091459907905805,1.4018248502712747,0.10398860398860399,0.7514347354085975,1.0,6/33,9.48%,MEOX2;ATP2B4;CARD10;STARD13;MECP2;HMGB1
prerank,negative regulation of leukocyte activation (GO:0002695),-0.5176763492441746,-1.4014412161504977,0.0855106888361045,0.5922623986851887,1.0,11/15,34.98%,IL31RA;NR1H3;CD200;ZC3H12A;GRN;FCGR2B;MILR1;CD300LF;CD300A;LRFN5;CD84
prerank,negative regulation of response to wounding (GO:1903035),0.5720128687386574,1.4011378555450331,0.11605723370429252,0.7515440736486663,1.0,6/19,10.72%,CLDN19;AJAP1;CASK;RTN4R;INPP5F;RTN4RL1
prerank,positive regulation of GTPase activity (GO:0043547),0.4169406271021025,1.400361745240543,0.02467811158798283,0.7521725929850461,1.0,31/188,11.43%,ARHGAP42;ITGA6;SIPA1L1;DOCK9;NTRK3;F11R;RGS6;TIAM2;GRTP1;RAPGEF3;RAP1A;ARAP1;SGSM2;NF1;RTN4R;CAV2;ARHGEF5;ZC3H15;RAPGEF6;PKP4;TBC1D16;GSK3B;FOXJ1;SLC27A4;TBC1D2;FERMT2;TBC1D8;DOCK7;RIC1;DVL3;PLXNB1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.5315074852423173,1.4002392688528251,0.10846953937592868,0.7502578244103668,1.0,4/34,5.05%,RORA;TRIB2;WNT5A;TRIO
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.523784979639643,1.3996638268011246,0.0937062937062937,0.7501936825539288,1.0,9/33,8.91%,GLI1;EGFR;CCND3;ADAMTS1;UBE2E2;FAM83D;RDX;PAF1;DDRGK1
prerank,negative regulation of interleukin-10 production (GO:0032693),0.5986766573391609,1.3989995254757563,0.1412151067323481,0.7502995561722889,1.0,1/16,0.38%,TRIB2
prerank,cellular response to exogenous dsRNA (GO:0071360),0.6256284084678371,1.3988895130530425,0.12321428571428572,0.7482704129744027,1.0,1/12,0.24%,CAV1
prerank,protein neddylation (GO:0045116),-0.5393802987400778,-1.3988762430228332,0.0975609756097561,0.5977684003611072,1.0,7/13,25.21%,RBX1;UBA3;NEDD8;NAE1;DCUN1D4;UBE2F;DCUN1D3
prerank,negative regulation of coagulation (GO:0050819),-0.520610434608161,-1.3985559387609432,0.11219512195121951,0.5956541015517061,1.0,5/14,6.50%,TFPI;THBD;SERPINE2;APOE;CD34
prerank,platelet degranulation (GO:0002576),-0.3236810300193352,-1.398507486014519,0.02158273381294964,0.5925823066029248,1.0,29/118,14.24%,IGF1;TIMP3;VWF;ACTN2;ABCC4;PECAM1;PCDH7;CLEC3B;SPARC;LYN;CDC37L1;IGF2;NHLRC2;CALM1;PROS1;TGFB3;VEGFC;CYRIB;QSOX1;SYTL4;PHACTR2;FLNA;MANF;TGFB2;VEGFD;THBS1;TMSB4X;F5;LGALS3BP
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.5055276500009069,-1.3981751943588239,0.06824146981627296,0.5905554671835204,1.0,9/16,33.89%,AGTR1;PDCD10;GATA2;THBS1;APLNR;DLL4;PPP1R16B;HMOX1;JCAD
prerank,negative regulation of cell aging (GO:0090344),-0.5053784996415809,-1.3974549162217602,0.09433962264150944,0.5897022194037166,1.0,5/16,7.77%,SLC30A10;AKT3;ZKSCAN3;RBL1;CDK6
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.45213581063975145,-1.3960611466058908,0.0728862973760933,0.5912277596915798,1.0,11/26,14.68%,PRKAG2;LPGAT1;ADIPOR2;NR1H3;ERLIN1;WDTC1;NR1H2;PRKAB2;SLC45A3;ERLIN2;MID1IP1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.5741971270732549,-1.395856350331242,0.10738255033557047,0.5887546626777168,1.0,4/11,1.89%,RSPO3;NKD1;DAB2;WNT5B
prerank,regulation of cellular senescence (GO:2000772),-0.4418234555025635,-1.3948875858170546,0.09385113268608414,0.5889446502278572,1.0,11/28,19.72%,SLC30A10;AKT3;B2M;ZKSCAN3;RBL1;CDK6;YPEL3;NUAK1;EEF1E1;VASH1;CGAS
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.5335773376360112,1.3948320573748685,0.09687034277198212,0.7619291316542035,1.0,1/31,0.01%,PTCH1
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6625607272870162,1.3942268570198928,0.13804713804713806,0.7619065098753856,1.0,2/10,4.48%,DCN;SRC
prerank,protein localization to cell periphery (GO:1990778),0.43149610397901117,1.3941667373735496,0.05411764705882353,0.7597132775902395,1.0,18/133,9.39%,PTCH1;CAV1;F11R;SLMAP;EPB41L3;RAP1A;RAB8B;RAB29;KCNIP4;FLOT2;RABEP1;RDX;EHD2;RAB3A;EFR3A;RAPGEF6;ZDHHC23;ATP1B3
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.6363111942855434,1.3936953792214453,0.1276595744680851,0.7591613388636549,1.0,3/11,8.37%,CAMK2D;SESTD1;NOS1AP
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.44800541100372193,1.3927408065055515,0.057007125890736345,0.7606213542649045,1.0,9/86,5.32%,THBS4;EFNA5;FGF7;TEC;CSPG4;EGFR;SRC;PTPRC;BANK1
prerank,amino acid transport (GO:0006865),-0.3820081181315569,-1.39256122006796,0.061855670103092786,0.5936843763804984,1.0,18/49,24.62%,SLC7A11;SLC6A6;SLC7A5;SLC7A1;SLC38A11;SLC7A6;SLC43A2;SLC38A7;SLC25A47;SLC3A2;SLC38A5;SLC25A29;SLC1A4;SLC6A17;SLC38A1;SLC38A9;SLC7A10;SLC1A5
prerank,negative regulation of transport (GO:0051051),-0.3821141319102237,-1.3924975021260113,0.04580152671755725,0.5907472798003217,1.0,19/51,23.77%,EPHA3;CTTNBP2NL;DYSF;NR1H3;SIRPA;PIP4P2;ARL6IP5;BST2;NR1H2;SCAMP5;RUBCN;CRYAB;PXK;EGF;YRDC;RACK1;RAB7A;PRKD1;ERBB3
prerank,negative regulation of growth (GO:0045926),-0.3249360867640432,-1.3923623154046831,0.007352941176470588,0.5881167926474595,1.0,23/121,7.81%,NOTCH2;SMAD3;ENPP1;SLIT2;SMARCA2;GJA1;ACVRL1;MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X;BMPR2;CCN3;NPR1;DNAJB2;APBB2;SOX17;JADE1;BST2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.3932175131823571,-1.391998339000408,0.05776173285198556,0.5862788958158601,1.0,11/39,9.43%,ITGA1;TGFA;ERRFI1;PTPN3;RNF115;CDC42;ZFYVE28;DUSP3;SH3KBP1;EPS15;LGMN
prerank,regulation of neuron differentiation (GO:0045664),0.4587286054706898,1.3918923507150032,0.07481296758104738,0.7615331245570225,1.0,7/76,5.24%,NGF;FGFR1;DTX1;ZC4H2;MMD2;NBL1;HEYL
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.3102888087078676,-1.391826949946586,0.0,0.5838380506288736,1.0,50/182,15.24%,IGF1;ROBO1;SLC24A3;PICALM;NOTCH2;ENG;ROCK2;CLDN5;FOXP1;BMP4;SLC7A5;WNT4;ACVRL1;ANKRD13A;LDLR;HIF1A;RBL1;XDH;KLF4;PDCD10;KDR;MYADM;APOE;CD34;HDAC1;HINFP;RBMS3;SUB1;MAP2K2;CRKL;CITED2;GATA2;LGMN;SLC2A10;AGO3;ZC3H12A;BMP2;ESR1;TTBK1;NOCT;TGFB2;MOV10;ID2;MAPT;AGO4;SH3GL2;PARP10;TLE5;LGALS9;RBL2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.5229668524925637,-1.3916651726769937,0.08602150537634409,0.5814280220555763,1.0,10/15,35.07%,JMY;ARPC3;IQGAP2;ACTR2;ARPC1A;ARPC5;TRIM27;WASHC1;ARPC5L;ARPC1B
prerank,positive regulation of cell aging (GO:0090343),-0.5655857758917782,-1.3916584570122208,0.09839816933638444,0.578473058160348,1.0,5/11,19.72%,B2M;YPEL3;LMNA;EEF1E1;CGAS
prerank,respiratory system development (GO:0060541),0.5273743544822027,1.3915852757080995,0.11174785100286533,0.7604699031173221,1.0,4/32,2.92%,STRA6;FGF7;FGF1;GLI2
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.5809736563572017,-1.3908416469312042,0.12,0.5782095681237676,1.0,6/10,31.99%,KDR;IL33;JAK2;NOD2;NAMPT;CCL2
prerank,regulation of cellular localization (GO:0060341),0.4868690482326847,1.3898496430931937,0.10040705563093623,0.7648316952304566,1.0,10/46,11.19%,EFNA5;CAMK2D;PARD6B;ADCY5;GOSR1;BRSK1;FER;TRIM46;WWC1;DVL3
prerank,negative regulation of centrosome duplication (GO:0010826),-0.561910527659954,-1.3896786439983166,0.11086474501108648,0.5788883640155457,1.0,8/11,32.76%,NPM1;TRIM37;KAT2B;KAT2A;CCNF;BRCA1;CDK5RAP2;MDM1
prerank,vascular transport (GO:0010232),-0.3474388751948194,-1.3896006347693113,0.027472527472527472,0.5762116864130133,1.0,27/81,13.71%,SLC24A3;SLC16A12;SLC13A3;SLC22A8;SLC6A6;INSR;SLCO3A1;ABCC4;LRP1;SLC6A9;ABCG2;SLC7A5;SLCO1C1;TFRC;ABCC9;SLC5A6;SLC7A1;SLC15A2;SLC2A10;ATP1B2;SLC16A2;SLC16A7;SLC1A3;ABCA2;SLC6A1;MFSD2A;SLC1A1
prerank,cellular iron ion homeostasis (GO:0006879),-0.37489549931841465,-1.3894663351131489,0.03829787234042553,0.573759096713202,1.0,19/55,23.51%,BMP6;ABCG2;FTH1;TFRC;SCARA5;FTL;SLC11A2;SLC39A14;NEDD8;FXN;SLC40A1;HFE;SMAD4;CUL1;SKP1;CYBRD1;BOLA2;CCDC115;ISCU
prerank,regulation of mitochondrial fission (GO:0090140),0.5595524370591363,1.3885372019714304,0.12,0.7673207670482703,1.0,11/24,20.63%,DCN;DDHD1;FIS1;MIEF1;STAT2;BNIP3;RALBP1;PINK1;RALA;PRKN;MUL1
prerank,regulation of leukocyte activation (GO:0002694),-0.5173178957151365,-1.3882488706193745,0.10268948655256724,0.5748706303208536,1.0,6/14,13.76%,LYN;MFHAS1;CD200;GPR137B;MYO18A;PJA2
prerank,negative regulation of TOR signaling (GO:0032007),-0.409688909258597,-1.3882190837228825,0.05592105263157895,0.5720861373105992,1.0,15/36,27.53%,UBR1;FNIP1;DEPDC5;RNF152;TMEM127;GSK3A;SPAAR;DEPTOR;TNFAIP8L1;CASTOR2;CASTOR1;FLCN;PRKAA1;ATM;TSC1
prerank,transport across blood-brain barrier (GO:0150104),-0.3436036603612148,-1.3882112649139384,0.027624309392265192,0.5692846422888043,1.0,27/83,13.71%,SLC24A3;SLC16A12;SLC13A3;SLC22A8;SLC6A6;INSR;SLCO3A1;ABCC4;LRP1;SLC6A9;ABCG2;SLC7A5;SLCO1C1;TFRC;ABCC9;SLC5A6;SLC7A1;SLC15A2;SLC2A10;ATP1B2;SLC16A2;SLC16A7;SLC1A3;ABCA2;SLC6A1;MFSD2A;SLC1A1
prerank,organic hydroxy compound transport (GO:0015850),0.5105461886434565,1.388184310730948,0.10364145658263306,0.7663781441741708,1.0,3/36,1.94%,STRA6;CEACAM1;ATP8B1
prerank,glycine transport (GO:0015816),-0.5814773638141728,-1.3868641032177225,0.11058823529411765,0.5707776131792449,1.0,4/10,22.36%,SLC6A9;SLC25A38;SLC38A5;SLC6A17
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.5437048674471701,1.38581804288398,0.11161387631975868,0.7733313520023757,1.0,9/23,15.79%,TPTE;MTMR7;MTMR6;OCRL;INPP5F;MTMR3;PTEN;MTMR12;MTMR1
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.48417858517052104,1.3821052412834887,0.10828877005347594,0.7857148349077456,1.0,10/46,11.27%,DGKA;DDHD1;GPAT3;ACP6;DGKZ;SLC27A1;AGPAT4;LCLAT1;PLD1;AGPAT5
prerank,regulation of B cell apoptotic process (GO:0002902),-0.5485825922402467,-1.3819410052055328,0.11246943765281174,0.5841420381457288,1.0,4/12,13.33%,FOXP1;LYN;FNIP1;NOC2L
prerank,linoleic acid metabolic process (GO:0043651),0.5734380729515886,1.3816061918316165,0.1331168831168831,0.7852283741912344,1.0,6/17,12.76%,ELOVL5;ALOXE3;ELOVL1;ELOVL2;ABCD1;PNPLA8
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6661017022559548,1.3813506518105938,0.12093862815884476,0.783863817155521,1.0,4/10,5.19%,NEDD4L;PRKCE;CAMK2D;ATP1A2
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5942888843477053,1.3807501033790124,0.13,0.7838986513553573,1.0,10/16,25.37%,LEPROT;CHMP5;CHMP4A;CHMP4B;CHMP4C;LEPROTL1;VPS36;SNF8;TMEM50B;STAM
prerank,Golgi to endosome transport (GO:0006895),-0.491504787604039,-1.3800163117586837,0.10224438902743142,0.5873765533421278,1.0,11/16,27.01%,AP2A1;VPS13C;WIPI1;DOP1B;EPS15;SORT1;MON2;SYS1;AP1AR;CORO7;KLHL20
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.5034171581745941,-1.3797072654297964,0.10498687664041995,0.5855085689036733,1.0,7/17,23.52%,LYN;PDCD10;ARL6IP5;TAOK2;TGFB2;NOD2;STK25
prerank,detection of mechanical stimulus (GO:0050982),0.5811116093026545,1.3786515818931264,0.12353923205342238,0.7898421008511842,1.0,5/19,13.09%,PIEZO2;CSRP3;CDH2;PIEZO1;PKD1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.6118591707752524,1.378464501517878,0.11694915254237288,0.7881439201942818,1.0,3/13,4.81%,TDG;UPP2;NTHL1
prerank,retinoic acid metabolic process (GO:0042573),0.6114572769055426,1.3780609237605737,0.13725490196078433,0.7873150256201737,1.0,3/14,8.33%,ALDH1A3;CYP2S1;SCPEP1
prerank,presynaptic endocytosis (GO:0140238),0.5501836408960595,1.3770964409363229,0.13692307692307693,0.7885708857831961,1.0,11/24,22.12%,CEL;STX1A;OPHN1;STON1;STON2;SNCG;PACSIN1;AMPH;VAMP2;NLGN3;NLGN2
prerank,circulatory system development (GO:0072359),0.42716232417517797,1.3766323989439762,0.056009334889148193,0.7879556073137728,1.0,34/118,17.01%,STRA6;CXADR;NTRK3;PLCE1;PCSK5;PDLIM4;CDH5;GLI2;NF1;AKAP13;SMYD4;SOX9;FN1;MTHFD1;SH3PXD2B;COL3A1;ISL1;POU4F1;TAB2;POPDC3;PTEN;NXN;KDM6B;PKD1;HSPG2;SOX4;ERBB4;FOXF1;TNNI3;POU6F1;FOXC2;FGF12;FBXW7;PDLIM2
prerank,dicarboxylic acid metabolic process (GO:0043648),0.4796485890453138,1.3761194103453294,0.08379120879120878,0.7876239984884196,1.0,22/52,18.95%,ASS1;FOLR2;MDH1B;AADAT;NIT2;MTHFD1;HOGA1;ALDH18A1;OGDH;ALDH5A1;MDH1;DLST;ACOT8;L2HGDH;GOT1;SLC46A1;GGT1;PHYH;ME2;ALDH1L2;SLC19A1;GPT2
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.4562493696898638,1.3761080070973977,0.08181818181818182,0.7853038719493934,1.0,9/69,4.09%,NGF;FGFR1;PLCD3;PLCE1;PLCB3;OGT;NF1;PLCL1;TPTE
prerank,glycogen catabolic process (GO:0005980),-0.5193144842913991,-1.3756765038044454,0.085,0.5961374808445395,1.0,10/15,35.47%,PGM2L1;CALM1;AGL;PHKG1;PYGB;PYGL;PHKA2;PHKB;STBD1;PYGM
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5957806883169833,1.3753635269728681,0.13953488372093023,0.785946353237952,1.0,4/15,5.70%,CDH13;CEACAM1;EGFR;FER
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5229540373045207,1.3750067681698008,0.12982998454404945,0.7851360618521691,1.0,3/26,4.23%,CAV1;LBP;PTPN22
prerank,central nervous system neuron development (GO:0021954),-0.5022735058507948,-1.3745573148235763,0.12532637075718014,0.5972234784751661,1.0,5/15,14.30%,RAPGEF2;ATP7A;ARHGAP35;GBA2;MAPT
prerank,cellular response to chemical stress (GO:0062197),0.4343386606678744,1.3740558531939342,0.06912991656734208,0.7864793680161902,1.0,19/96,13.78%,CAV1;PPARGC1A;LRRC8D;GPX8;MGAT3;ETV5;TRPV4;ERO1A;FOXO3;KEAP1;FANCC;SELENOS;SLC4A11;LONP1;STX2;NFE2L2;ATG7;BRF2;HTRA2
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.6318099086296624,1.3737873958216957,0.1245674740484429,0.7850956114713569,1.0,1/12,0.24%,CAV1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.5085326563351206,-1.37373488420783,0.10411622276029056,0.5971071525875017,1.0,8/15,29.80%,IGF1;AKT1;FXN;GHITM;OPA1;CLU;PSMD10;TRIAP1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.4996637724890169,1.3733749925509078,0.11063829787234042,0.7842978067194083,1.0,9/41,7.27%,ITPR2;ITPR3;SLC24A1;TRPV4;ERO1A;ATP2B4;PTPRC;IBTK;CHERP
prerank,regulation of synapse assembly (GO:0051963),0.4823711398485036,1.3719840077291399,0.11621621621621622,0.7872795606483483,1.0,5/46,6.38%,CLSTN2;MUSK;GPC6;CLSTN3;EPHB2
prerank,sterol biosynthetic process (GO:0016126),-0.4085738437120119,-1.3719022235236662,0.08571428571428572,0.6001768552867406,1.0,11/33,19.79%,PRKAG2;INSIG2;ARV1;HMGCS1;ACAA2;ACLY;NSDHL;PMVK;MVK;ACAT2;DHCR7
prerank,mesenchyme development (GO:0060485),-0.5137980694943273,-1.371568296946531,0.13043478260869565,0.5984680630510973,1.0,5/15,10.52%,BMP4;TGFBR1;BMPR2;FGFR2;BMP2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5301181541752421,1.3711216379845972,0.1253731343283582,0.7882859624505302,1.0,10/30,16.05%,CAV1;PTPRC;SRCIN1;INPP5F;SEMA4D;NF2;MVP;PTPN6;PIBF1;SOCS1
prerank,regulation of NMDA receptor activity (GO:2000310),-0.41637543041504715,-1.37109658588465,0.07666666666666666,0.5971246972847877,1.0,8/32,9.11%,DAPK1;ACTN2;SLC6A9;GRIA2;NEFL;GRIN2B;CAMK2A;GRIN1
prerank,2-oxoglutarate metabolic process (GO:0006103),0.6048378779340123,1.371068495502461,0.13969335604770017,0.7861752623869781,1.0,8/13,22.41%,AADAT;OGDH;DLST;L2HGDH;GOT1;PHYH;GPT2;IDH2
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.573113265096207,-1.3709585537704359,0.11085450346420324,0.5947295641066128,1.0,4/11,12.75%,TGFBR3;TGFBR1;BMP2;TGFB2
prerank,mononuclear cell differentiation (GO:1903131),-0.4401996274689864,-1.3706993599329267,0.10541310541310542,0.5928234642012163,1.0,8/24,18.51%,IL31RA;LYN;BMP4;MT1G;PIR;PDE1B;TRPM2;MYH9
prerank,positive regulation of integrin activation (GO:0033625),0.6318291348720427,1.3697665463912565,0.1369150779896014,0.7889030078693391,1.0,5/11,10.07%,CDH17;SRC;PIEZO1;PLEK;FERMT2
prerank,endothelial tube morphogenesis (GO:0061154),-0.5754642331887786,-1.3695888114867003,0.10690423162583519,0.5937330060650226,1.0,5/10,16.69%,RBPJ;BMP4;ACVRL1;RHOB;CSNK2B
prerank,positive regulation of glucose import (GO:0046326),-0.46165034409252803,-1.3693986244818872,0.08401084010840108,0.591641223145968,1.0,5/21,2.55%,IGF1;OSBPL8;INSR;PIK3R1;CREBL2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.6416494038444642,1.3685495510012544,0.13167259786476868,0.7912918562211284,1.0,3/10,4.10%,PKDCC;SOX9;BMPR1B
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.4685376522312451,1.368163412877757,0.09286675639300135,0.7903998886652974,1.0,9/54,11.37%,CAV1;NEDD4L;KCNJ4;KCNJ16;KCNIP4;GABBR2;NOS1AP;KCNAB1;NEDD4
prerank,negative regulation of cytokine production (GO:0001818),0.4101262421351256,1.3670279644776575,0.04851157662624035,0.7925337922441957,1.0,26/163,10.18%,APOD;TRIB2;INHBB;HOMER2;CEACAM1;UBE2L6;BCL3;PCBP2;PTPN22;IRAK3;PTPRC;FN1;CHID1;TNFAIP3;ANXA4;N4BP1;SELENOS;RARA;PTGER4;ACOD1;CD200R1;FOXJ1;HMGB1;NPLOC4;AXL;TAX1BP1
prerank,response to progesterone (GO:0032570),0.5734698624778397,1.366839949967067,0.12390924956369982,0.7909351711960086,1.0,4/18,8.58%,CAV1;SRC;CATSPERD;ACOD1
prerank,negative regulation of nuclear division (GO:0051784),0.6294984543292907,1.366200688628829,0.14922813036020582,0.7912721987249757,1.0,4/11,9.46%,FBXO43;TOM1L1;FBXO5;TOM1L2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.6179995667227545,1.366182420101454,0.13926174496644295,0.7890604795481139,1.0,2/15,0.70%,SMOC2;FGFR1
prerank,androgen metabolic process (GO:0008209),0.5752031217502376,1.3659881597473884,0.12841091492776885,0.7875635670927346,1.0,2/18,7.97%,HSD17B3;HSD17B4
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.44025320029862725,-1.365711660647347,0.08430232558139535,0.6006786120267649,1.0,8/27,19.17%,PRKCH;IL18;NR1H3;AGTR1;NR1H2;ABCG1;CSF1;AGT
prerank,RNA splicing (GO:0008380),0.44210182525675373,1.3653408383603083,0.06601466992665037,0.7876900584795321,1.0,24/95,17.58%,DHX8;PPARGC1A;HNRNPC;SF3B2;SF3B1;RBM8A;RNPC3;SRSF4;ZRSR2;SNRPF;PRPF3;SRPK1;SRPK2;DBR1;TCERG1;SNRPA1;SFPQ;PPIG;DHX16;TRA2B;PDCD7;SYNCRIP;YJU2;SLU7
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.6340857617130523,1.3651802202227732,0.15570934256055363,0.7860450898055109,1.0,1/11,0.50%,CDH13
prerank,skeletal system morphogenesis (GO:0048705),-0.40439202482428954,-1.364139767131067,0.07342657342657342,0.6031925353992832,1.0,20/42,19.28%,PDGFRA;CYP26B1;HOXA3;TGFBR1;FGFR2;HOXB4;DSCAML1;HOXB9;LRP6;HOXC4;SPEF2;HOXA9;FUZ;MEGF8;HOXD4;ANKRD11;HOXD3;LRP5;WWOX;RFLNB
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.5329151566747764,-1.363438715934682,0.1218274111675127,0.599978673947607,1.0,4/12,8.51%,IGF1;CAMTA1;AKAP6;SLC9A1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.5329151566747764,-1.363438715934682,0.1218274111675127,0.599978673947607,1.0,4/12,8.51%,IGF1;CAMTA1;AKAP6;SLC9A1
prerank,positive regulation of calcium ion import (GO:0090280),-0.5351071779244311,-1.3629228367517587,0.09004739336492891,0.5988912054881075,1.0,2/12,6.46%,PDGFRB;CXCL12
prerank,histone H2A monoubiquitination (GO:0035518),-0.49341184957937645,-1.3626181687765189,0.1172069825436409,0.5971612306510823,1.0,12/17,29.65%,PCGF5;KDM2B;PCGF2;BMI1;RYBP;TRIM37;SKP1;RNF2;PCGF6;RING1;DDB1;BCOR
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.5428486077847332,1.3624215370061872,0.13574660633484162,0.7943022378608164,1.0,6/25,4.10%,SULF1;ZNF423;FOXD1;FBXL15;CDH5;BMPR1B
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.534549411715653,1.3623004062955475,0.12888198757763975,0.792488277060008,1.0,10/25,17.84%,HK2;PFKP;FOXK1;ALDOB;FOXK2;ADPGK;ENO3;GCK;PGK1;ENO2
prerank,regulation of blood coagulation (GO:0030193),0.5231722101238184,1.3619505950054982,0.14947683109118087,0.7916817785612631,1.0,3/27,1.69%,CAV1;ST3GAL4;FAP
prerank,histone H3-K4 trimethylation (GO:0080182),0.6348610613095209,1.3616871395441534,0.16225749559082892,0.7904619620898262,1.0,3/11,3.72%,OGT;KMT2A;BEND3
prerank,dendritic spine organization (GO:0097061),-0.43865849864298456,-1.3616779105853232,0.10541310541310542,0.597480317711457,1.0,6/26,9.43%,IGF1R;INSR;SHANK3;CDC42;ITGA3;LGMN
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.27980172579545415,-1.3609501889470734,0.0,0.5972403107900066,1.0,122/306,25.06%,RPL37A;RRBP1;CREBL2;WRN;RPL19;RPL8;RPL37;RPS15;RPS29;FARSB;RPL35A;TOP3A;RPS7;RPS20;RPL32;EEF1A1;RPS27;RPL26;RPL27;RBMS1;BLM;RPS24;APOE;RPLP0;ATRIP;MEF2A;HARS1;PTMA;MCM6;RPS19;HBS1L;RPL31;RPL41;RPL13A;RPL30;ORC2;RPL29;MRPS6;RPS16;RPL3;NR4A2;RPLP1;RRAGC;RPS17;EEF1D;RPS3;RPL23;RPL17;RPL9;RPL38;DHPS;RPL36;RPS26;POLR3A;RPS8;POLA1;RPS12;MMS19;RPL18A;RPS21;MRPL32;CLSPN;CDC7;MRPL18;TOPBP1;RAD1;GCNT1;EEF1B2;BARD1;RPS18;RPLP2;EIF4G1;TIPIN;RPS6;RPS15A;MRPL9;MRPL28;PWP1;RNPS1;HOXD3;RAD17;POLR2F;GSPT2;RFC2;MRPS11;POLR2A;POLR2J;RAD9B;GAL3ST2;POLR2D;MRPS16;POLR2K;RPL14;MRPS18B;TIMELESS;RPS2;TOP1MT;MRPL42;RPL10A;THAP1;INHBA;THRB;ALAS1;RPL39;RPL34;RPL5;MRPS12;FUT9;RPL22;MRPL55;POLD2;EEF2;RPS9;RMI2;CDC45;MRPL36;RPS14;POLA2;CDK2;BRCA1;RPS25;PCLAF
prerank,response to gamma radiation (GO:0010332),-0.4438895882858348,-1.3609280764208045,0.12312312312312312,0.5946724918901883,1.0,13/24,27.27%,MAP3K20;WRN;RPL26;KDM1A;CRYAB;HSF1;TRIM13;HRAS;FANCD2;LIG4;DCUN1D3;PRKAA1;ATM
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.48353374520889025,1.3608801669250434,0.1206896551724138,0.7913799085764659,1.0,7/44,12.99%,NGF;SRC;SFN;RPS6KA3;USP47;DHCR24;AQP1
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.5574035240923968,1.360848351341769,0.14626391096979333,0.7893156910345112,1.0,4/21,5.76%,DCN;CSPG4;CHST7;NCAN
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.44721765803512403,-1.3608224964302016,0.08849557522123894,0.5897725715881074,1.0,8/23,17.04%,ZEB2;DAB2;EP300;CITED2;SNW1;SLC2A10;THBS1;SMAD4
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.44721765803512403,-1.3608224964302016,0.08849557522123894,0.5897725715881074,1.0,8/23,17.04%,ZEB2;DAB2;EP300;CITED2;SNW1;SLC2A10;THBS1;SMAD4
prerank,negative regulation of defense response (GO:0031348),0.44805039336302543,1.360722623991614,0.07881136950904392,0.7875777092258784,1.0,16/77,11.15%,RORA;CDH5;CXCL17;PCBP2;FNDC4;IRAK3;TNFAIP3;TRIM21;SELENOS;MAPK7;PTGER4;ISL1;ACOD1;TRAFD1;SHARPIN;PROC
prerank,response to ATP (GO:0033198),-0.479994619698913,-1.360514262609657,0.13165266106442577,0.5880686574121184,1.0,7/18,27.70%,TRPC3;ABCC9;P2RX7;P2RX4;CIB2;P2RY12;P2RY1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.5394925396523198,-1.3594698653844812,0.12149532710280374,0.5888748754957513,1.0,4/12,6.29%,PICALM;ROCK2;FKBP1A;APOE
prerank,response to interferon-gamma (GO:0034341),-0.3498114302724412,-1.357957431587115,0.0594059405940594,0.5911970370598995,1.0,25/67,28.12%,DAPK1;SP100;CXCL16;SIRPA;GBP3;GBP4;GCH1;BST2;RPL13A;GAPDH;GBP6;CCL13;GBP7;LGALS9;GBP2;CD40;PDE12;DAPK3;SHFL;CCL19;AQP4;KYNU;IRF8;CASP1;CIITA
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.5003051976673879,1.3573405589567062,0.11347517730496454,0.7984548014776198,1.0,5/39,1.42%,UTRN;SLMAP;NEDD4L;PRKCE;CAMK2D
prerank,iron ion transmembrane transport (GO:0034755),-0.5754945960379242,-1.356113141058831,0.13176470588235295,0.5945052261284464,1.0,5/10,15.49%,SCARA5;SLC39A8;SLC11A2;SLC39A14;SLC40A1
prerank,cellular sodium ion homeostasis (GO:0006883),0.5789351095010031,1.3559074399785505,0.12776831345826234,0.8016588244255753,1.0,4/15,9.39%,NEDD4L;SLC12A2;ATP1A2;ATP1B3
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.49249255766507877,1.355405283051864,0.11390532544378698,0.8013575072894636,1.0,10/34,15.19%,UBASH3B;PTPN13;PTPRF;PTPN22;PTPRJ;PTPRT;PTPN18;DUSP8;PTPRO;PTPN6
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.43325531893984776,1.3551253485540835,0.0906832298136646,0.800222730710793,1.0,25/85,18.75%,ROR2;PRICKLE1;PRICKLE2;FZD2;PSME3;WNT5A;PSMB5;DVL3;VANGL1;PSMB2;FZD7;PSMA2;PSMA6;FZD3;PSMD13;PSMA7;AP2A2;CELSR1;PSME4;CELSR2;PSMC4;PSMB6;PSMD12;RHOA;PSMD14
prerank,lipoprotein catabolic process (GO:0042159),-0.5438574577644237,-1.355005780687665,0.1383495145631068,0.5954815274598697,1.0,6/11,14.11%,APOE;LYPLA1;NOTUM;CTSD;ABHD17B;LYPLAL1
prerank,arachidonic acid secretion (GO:0050482),-0.5618792906655351,-1.3543862872303423,0.13625866050808313,0.5923856113130256,1.0,3/10,7.39%,ACE;BDKRB2;ANXA1
prerank,arachidonate transport (GO:1903963),-0.5618792906655351,-1.3543862872303423,0.13625866050808313,0.5923856113130256,1.0,3/10,7.39%,ACE;BDKRB2;ANXA1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.37443336756910817,-1.3540931357991495,0.07272727272727272,0.5907116092595629,1.0,8/57,6.94%,IGF1;IL31RA;GHR;IL6R;LYN;KIT;IL18;JAK2
prerank,cellular response to gamma radiation (GO:0071480),-0.49021237654271727,-1.3537290640611677,0.09348441926345609,0.5894037956110237,1.0,6/17,14.74%,MAP3K20;WRN;RPL26;KDM1A;CRYAB;HSF1
prerank,regulation of protein kinase activity (GO:0045859),0.42218411406611733,1.3536618667347444,0.08158508158508158,0.8036385262076609,1.0,19/106,11.08%,TRIB2;UBASH3B;PLCE1;CEACAM1;RAP1A;SPRED1;NF1;PRKAG1;MMD2;GNAQ;PTPRC;LCP2;SFN;RASSF2;LAT;CEP85;RELN;RTRAF;TAB2
prerank,phosphatidic acid metabolic process (GO:0046473),0.4743836414990563,1.3530585059779519,0.11466666666666667,0.8037856317480165,1.0,10/48,11.27%,DGKA;DDHD1;GPAT3;ACP6;DGKZ;SLC27A1;AGPAT4;LCLAT1;PLD1;AGPAT5
prerank,regulation of protein neddylation (GO:2000434),-0.5714807305729974,-1.352588317643456,0.13414634146341464,0.5905752626776232,1.0,9/10,40.78%,HIF1A;EPAS1;DCUN1D4;RPL5;DCUN1D3;RPL11;DCUN1D5;COPS9;DCUN1D1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.5352669996256301,1.3525879852335148,0.13707165109034267,0.8034046227539887,1.0,4/21,2.40%,SULF1;EXTL3;XYLT2;GLCE
prerank,positive regulation of glucose metabolic process (GO:0010907),0.5993060492208888,1.352532374456723,0.1452991452991453,0.8014044840025173,1.0,2/14,2.89%,PPARGC1A;GPLD1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.5626578445301417,1.3524586406824946,0.14715719063545152,0.7995150157242684,1.0,6/17,16.37%,CEACAM1;DGKZ;PTPN22;PTPRJ;SH2D1A;EZR
prerank,cell-cell junction assembly (GO:0007043),0.4536073296306772,1.3522604002124752,0.10165184243964422,0.798189441267406,1.0,11/63,4.42%,CLDN11;TLN2;CDH11;EPB41L3;PARD6B;CDH5;CDH9;TRPV4;CD9;PRKCA;CNTNAP1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.38522853473793156,1.3502950934036102,0.014242115971515769,0.8036593856979417,1.0,43/390,7.09%,NGF;ROR2;GAB1;ROR1;EFNA5;FGF7;SIPA1L1;NTRK3;ARHGEF28;UBASH3B;SORBS1;FGFR1;PXN;SH2D2A;RGS14;SULF1;EGFR;MUSK;EFNB1;CYFIP2;FGF1;NRP2;DOCK1;GPLD1;RBFOX2;SPRED1;GIGYF2;APH1B;CAV2;EIF2AK3;VAV2;SRC;DNM1;ATP6V0D2;KIF16B;PDK4;FER;NCSTN;EPHB2;NCK2;SHB;LCP2;EFNB2
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.5353138925422299,1.3498095129698475,0.1348148148148148,0.8033041664917965,1.0,3/27,2.99%,CAV1;CAMK2D;PDE4D
prerank,regulation of glycogen metabolic process (GO:0070873),-0.5323619328694864,-1.3486627196998198,0.12871287128712872,0.6002949786468631,1.0,9/12,40.86%,AKT1;PPP1R3B;PPP1R3C;RUBCNL;KHK;PPP1R3E;PPP1R3F;PPP1R3D;GCGR
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.4815081353159981,-1.3485693413448898,0.13989637305699482,0.5980568444047624,1.0,4/17,6.63%,ITGA1;PDGFRB;PPP1R12A;CALM1
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.40690177437257874,-1.348235115662031,0.09411764705882353,0.5966747582637472,1.0,9/33,15.53%,IGF1;OMA1;TFRC;AKT1;ACAA2;FXN;MAPT;GHITM;OPA1
prerank,regulation of execution phase of apoptosis (GO:1900117),0.6140748388211257,1.3481501569766223,0.1559792027729636,0.8076578469590101,1.0,2/11,1.69%,DLC1;FAP
prerank,regulation of acrosome reaction (GO:0060046),-0.5620938439793438,-1.347397501693587,0.13769751693002258,0.5967577942402871,1.0,1/10,0.08%,PLCB1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.49693459644267146,1.3467834499858717,0.12831858407079647,0.8108422998278286,1.0,10/35,15.72%,NR3C2;RBFOX2;PGR;SRC;UBR5;DDX17;TMF1;NEDD4;GPER1;YAP1
prerank,regulation of MAPK cascade (GO:0043408),0.40375268789541924,1.346567504782666,0.05856353591160221,0.8095016093438048,1.0,25/157,9.48%,ROR2;CAV1;ROR1;NTRK3;FGFR1;LPAR1;CEACAM1;EGFR;PELI2;MINK1;SPRED1;NF1;CAV2;FAM83D;PTPRC;FN1;STYX;ULK4;ARHGEF5;DAG1;PHLPP1;PIK3R2;PTPRJ;STK3;HMGB1
prerank,regulation of membrane depolarization (GO:0003254),0.5707038798601598,1.3462729076076672,0.15798045602605862,0.8085471493252536,1.0,6/18,13.19%,NEDD4L;CAMK2D;SCN10A;SCN2B;ABCD1;FHL1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.4395828210216356,1.3460870579767976,0.08271604938271605,0.8070394672599054,1.0,10/75,6.83%,THBS4;CDH13;FGFR1;NRARP;NRP2;PRKCA;WNT5A;APLN;NRAS;EGFL7
prerank,lung development (GO:0030324),0.5007657504054731,1.3459924743037586,0.14325452016689846,0.8052027118222289,1.0,4/33,2.92%,STRA6;FGF7;FGF1;GLI2
prerank,phospholipid dephosphorylation (GO:0046839),0.4894986319622496,1.3458165282536925,0.14542936288088643,0.8037243510650874,1.0,12/37,15.79%,PLPP2;TPTE;PLPP3;MTMR7;MTMR6;OCRL;INPP5F;MTMR3;PTEN;MTMR12;PLPPR1;MTMR1
prerank,xenobiotic transport (GO:0042908),-0.4887442611142179,-1.345786941464946,0.09973045822102426,0.5994014933407381,1.0,7/17,10.04%,SLC47A1;ABCG2;SLC7A5;GJA1;SLC22A4;SLC15A2;SLC22A18
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.4826481514663761,1.3446663332916728,0.12236286919831224,0.8060241802105877,1.0,11/39,15.21%,EFNA5;JAG1;AJAP1;CASK;SPRY4;KANK1;GCNT2;NF2;FZD7;PTPRO;PLG
prerank,autonomic nervous system development (GO:0048483),0.5690671975375082,1.3446548114414996,0.15196078431372548,0.8039420572908154,1.0,5/17,13.44%,NF1;FN1;SEMA3A;KIF26A;SOX4
prerank,carboxylic acid catabolic process (GO:0046395),0.6161087817511336,1.3442830408323543,0.14922813036020582,0.8033434306021439,1.0,5/12,14.45%,IL4I1;BCKDK;NAGK;ACOT8;GNPDA2
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.43560873901906016,-1.343737925869471,0.0935672514619883,0.6034791704323842,1.0,6/26,3.66%,IGF1;OSBPL8;INSR;PIK3R1;CREBL2;C2CD5
prerank,inositol lipid-mediated signaling (GO:0048017),0.4629194957735066,1.3435873330351078,0.10899182561307902,0.804073694541445,1.0,7/50,3.86%,NGF;FGFR1;PLCD3;PLCE1;PLCB3;OGT;PLCL1
prerank,negative regulation of viral life cycle (GO:1903901),-0.505953137589022,-1.3432099382929763,0.10991957104557641,0.602695808482957,1.0,3/15,7.81%,LY6E;MID2;BST2
prerank,copper ion homeostasis (GO:0055070),-0.48311810853265524,-1.3431964694479503,0.10846560846560846,0.6003099949937404,1.0,4/17,5.15%,ATP7A;COMMD1;SLC31A1;SLC31A2
prerank,positive regulation of response to wounding (GO:1903036),0.5383351202335249,1.342902934657534,0.14434523809523808,0.804689535674671,1.0,5/24,10.36%,CLDN1;PRKCE;KANK1;OCLN;ADRA2A
prerank,purine-containing compound salvage (GO:0043101),-0.5385380219959248,-1.3427678484529921,0.1414141414141414,0.5992627781577644,1.0,2/12,3.33%,ADK;HPRT1
prerank,neurotransmitter uptake (GO:0001504),0.616667976415346,1.3420250361099544,0.14956521739130435,0.8059223519898319,1.0,5/12,6.69%,SLC1A7;SLC29A4;SLC22A3;ATP1A2;SLC1A6
prerank,small GTPase mediated signal transduction (GO:0007264),0.4220181898573931,1.3420094002543033,0.0881316098707403,0.8038920548667783,1.0,21/103,11.24%,PLK2;NTN1;TIAM2;ARHGAP31;PLCE1;USP50;ARHGAP18;ARHGAP32;RGL1;MRAS;NF1;NUCB1;USP8;NRAS;KRAS;RREB1;RAPGEF6;KSR2;LAT;ADRA2A;PLD1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.5511030683797657,-1.3415441847477736,0.14651162790697675,0.6006927939874203,1.0,6/10,21.91%,EPHA4;ANXA2;RGP1;FURIN;CDK5RAP3;NELL1
prerank,translation (GO:0006412),-0.2926486179050938,-1.3405337395699306,0.0,0.6013913223888486,1.0,85/208,25.05%,RPL37A;RRBP1;RPL19;RPL8;RPL37;RPS15;RPS29;FARSB;RPL35A;RPS7;RPS20;RPL32;EEF1A1;RPS27;RPL26;RPL27;RPS24;RPLP0;HARS1;RPS19;HBS1L;RPL31;QRSL1;RPL41;RPL13A;RPL30;RPL29;MRPS6;RPS16;RPL3;RPLP1;YARS1;RPS17;EEF1D;RPS3;RPL23;RPL17;RPL9;RPL38;DHPS;RPL36;RPS26;RPS8;RPS12;RPL18A;ABCE1;RPS21;MRPL32;MRPL18;APEH;RARS1;NOA1;EEF1B2;RPS18;RPLP2;EIF4G1;RPS6;RPS15A;MRPL9;MRPL28;PPA1;EEF1E1;GSPT2;MRPS11;MRPS16;RPL14;MRPS18B;QARS1;RPS2;MRPL42;GATC;RPL10A;RPL39;RPL34;RPL5;MRPS12;RPL22;MRPL55;EEF2;MRPS34;RPS9;MRPL36;RPS14;TRMT112;RPS25
prerank,cellular response to increased oxygen levels (GO:0036295),0.6157493064444457,1.3404604790633508,0.15846994535519127,0.8076445036004953,1.0,1/11,0.24%,CAV1
prerank,myeloid cell differentiation (GO:0030099),-0.37785305086188803,-1.3402929167415976,0.07364341085271318,0.5996216949019016,1.0,22/47,32.34%,LYN;SNRK;MFHAS1;KIT;UBA5;JAK2;RPS19;CASP3;SLC25A38;TAL1;TET2;INHBA;RPS14;JAK3;RASGRP4;KMT2E;ALAS2;CEBPA;KAT6A;UFL1;EPO;CDKN2B
prerank,striated muscle tissue development (GO:0014706),0.5122490682592128,1.3394704666079207,0.14138438880706922,0.8094535633438107,1.0,8/29,12.65%,CAV1;SGCD;SGCG;CSRP3;BMP5;TBX2;POPDC3;NDUFV2
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.5686062563646086,-1.33928739550912,0.13062098501070663,0.6004132614606453,1.0,3/10,6.46%,RAPGEF2;LYN;CXCL12
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.34552359160068535,-1.3390444635358758,0.09009009009009009,0.598853959114986,1.0,23/66,19.52%,FLT1;PDGFD;ROBO1;SASH1;PDGFRB;KIT;PDCD10;TRAF6;PIK3R6;MAP3K10;IL34;RPS3;LRRK2;TNFRSF11A;EDN1;EDN3;DVL2;EGF;CD40;DIRAS2;TPD52L1;CD24;MST1R
prerank,regulation of dopamine secretion (GO:0014059),-0.4339334644144651,-1.3390148051104027,0.09722222222222222,0.5965849951836971,1.0,18/25,43.50%,SYT9;SYT7;DTNBP1;SYT13;SYT6;KCNA2;CHRNA4;SYT15;SYT1;SYT5;SYT17;CHRNB2;SNCA;SYT4;SYT3;DRD3;FGF20;SYT8
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.5815286757766627,1.3384880106681634,0.146218487394958,0.8110543410275025,1.0,2/15,2.06%,SMOC2;FGF1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.2945864814489857,-1.3384845086149884,0.0,0.5957766275077986,1.0,72/168,22.82%,CNOT6L;RPL37A;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;RPS7;RPS20;RPL32;RPS27;RPL26;RPL27;RPS24;RPLP0;TENT2;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;PABPC1;RPLP1;RPS17;ZC3H12A;RPS3;RPL23;RPL17;PNRC2;RPL9;RPL38;RPL36;RPS26;NBAS;RPS8;RPS12;RPL18A;RPS21;CNOT11;MAGOH;TUT7;MTPAP;RPS18;RPLP2;EIF4G1;RPS6;RPS15A;NCBP1;CTIF;MAGOHB;RNPS1;ZFP36;CNOT9;RC3H1;GSPT2;PDE12;POLR2D;RPL14;RPS2;RPL10A;NBDY;DCP2;RPL39;RPL34;RPL5;EIF3E;RPL22;PPP2R1A
prerank,cognition (GO:0050890),0.48683368731339105,1.3377569072855775,0.11901504787961696,0.8115991118336608,1.0,4/42,3.23%,STRA6;ST3GAL4;MGAT3;NF1
prerank,cellular response to nitrogen compound (GO:1901699),-0.45162769136234193,-1.3372562914,0.11488250652741515,0.5972031679896875,1.0,10/20,21.44%,ROCK2;BLM;EPG5;HSF1;DDI2;NSMCE3;PDE12;TIMELESS;NR1H4;RIOK3
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.6409423591790359,1.3370654686076606,0.15272727272727274,0.8121483223758704,1.0,1/10,0.21%,ETV4
prerank,positive regulation of protein catabolic process (GO:0045732),0.43131639181498743,1.3357663310731194,0.08364083640836409,0.8150587336805,1.0,22/84,17.80%,PLK2;GPC3;VGLL4;NEDD4L;AXIN1;GPLD1;DACT1;WNT5A;TNFAIP3;RDX;GSK3B;ADRA2A;APC;NEDD4;FAF1;ATG7;WWP2;FZR1;EZR;ITCH;VPS11;STX5
prerank,positive regulation of cell junction assembly (GO:1901890),0.4585051501955095,1.3356765190669089,0.12919896640826872,0.8132863395293116,1.0,6/56,8.21%,CLSTN2;CAV1;CLDN19;CLSTN3;EPHB2;PTPRJ
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.41046298158002925,-1.3352998489263979,0.08206686930091185,0.6009881789401856,1.0,6/30,6.22%,FLT1;BMP4;KIT;HOXB4;ACE;KDR
prerank,negative regulation of cell junction assembly (GO:1901889),0.5155077155719006,1.3342097913402384,0.12669683257918551,0.8167945309421882,1.0,3/25,4.48%,APOD;DLC1;SRC
prerank,organophosphate ester transport (GO:0015748),-0.4479921525488914,-1.3341862903224764,0.10277777777777777,0.6021376478542192,1.0,10/24,14.15%,OSBPL8;PLTP;PITPNB;LDLR;TNFAIP8L3;OSBPL5;SCP2;EPG5;PRELID2;PRELID3A
prerank,response to iron ion (GO:0010039),-0.5345289795838609,-1.3334539910904302,0.1405152224824356,0.602124434784474,1.0,6/12,16.13%,BMP6;B2M;HIF1A;SLC11A2;FXN;HFE
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.4448337549881845,1.3328409035821607,0.1251596424010217,0.8198906884509601,1.0,8/62,6.65%,NGF;F11R;LPAR1;RTN4R;AKAP13;MMD2;LRRC59;COL3A1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.584809229614653,1.3317330719539626,0.1678082191780822,0.822129962398388,1.0,4/15,3.43%,TEC;EGFR;ITK;TXK
prerank,regulation of gastrulation (GO:0010470),-0.5044309066916945,-1.3309929619520706,0.12077294685990338,0.6073311368936084,1.0,2/14,1.09%,PHLDB2;OSR1
prerank,positive regulation of cell communication (GO:0010647),0.5148551436543053,1.3305098264848763,0.13323572474377746,0.8247239372677404,1.0,3/28,6.57%,CLSTN2;CLSTN3;RIMS2
prerank,regulation of cell motility (GO:2000145),0.4084704132566388,1.3304650850110118,0.07867730900798175,0.8227954079066677,1.0,20/121,8.85%,FGF7;NTN1;CEACAM1;ARHGAP18;LDB2;EGFR;KIF2A;FGF1;PARD6B;AMOTL1;MGAT3;MINK1;LMO4;PLXNA3;CAVIN1;AMOT;ABL2;SRCIN1;FGF18;INPP5F
prerank,glycogen metabolic process (GO:0005977),-0.43095370178922493,-1.3295641826528726,0.09649122807017543,0.6095574858238861,1.0,10/27,17.91%,PRKAG2;PGM2L1;CALM1;GBE1;UGP2;AGL;PPP1R3C;PHKG1;PYGB;PER2
prerank,cell junction organization (GO:0034330),0.4448935827745949,1.3291160650337404,0.10375,0.8260131623956803,1.0,7/71,3.66%,CLDN1;CXADR;LRP4;RAB8B;PPFIA2;TJP2;OPHN1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.5186173086609183,1.3288945706658057,0.15664556962025317,0.8247799013680533,1.0,8/25,15.23%,LEO1;CDK13;ELL;NELFB;SUPT4H1;HEXIM1;TCERG1;RECQL5
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.5479109181388349,-1.3284948883090237,0.14352941176470588,0.6106219448647279,1.0,3/10,6.94%,GHR;LYN;JAK2
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.5470972610010383,-1.328192568497874,0.14213197969543148,0.6092510347426308,1.0,4/10,21.89%,UBE2J1;OS9;DERL2;SVIP
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.5054851062458091,-1.3273679381485652,0.16350710900473933,0.6095711555864759,1.0,6/13,9.57%,ATG10;UBA5;UBA3;UBA2;NAE1;UBA7
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.5086414352983493,1.3261896863084208,0.14964028776978416,0.833136788237706,1.0,6/29,13.03%,DHX34;DND1;TENT5C;AXIN2;TENT5D;TAF15
prerank,regulation of catabolic process (GO:0009894),0.5566291225756824,1.3258709237915238,0.16129032258064516,0.8323002912963512,1.0,5/18,12.13%,NEDD4L;FAP;FAM83D;ZDHHC7;FAF1
prerank,collagen fibril organization (GO:0030199),0.4290578105772702,1.3258613565082225,0.10416666666666667,0.8302621904726514,1.0,8/88,4.90%,ITGB4;ITGA6;ADAMTS14;PXDN;COL6A3;NF1;COL5A3;SERPINH1
prerank,lipid oxidation (GO:0034440),0.6086121131572242,1.3257391859621215,0.1636060100166945,0.8286896496800368,1.0,1/12,0.58%,PPARGC1A
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.4831583875325686,1.3245061375063716,0.14326647564469913,0.8313160309146037,1.0,12/33,16.95%,GLI1;FAM83D;PSME3;ATP2B4;PAF1;DDRGK1;INO80;PTEN;PKD1;PTPN6;FBXW7;E2F1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5445727036578839,1.3244788065487727,0.16559485530546625,0.8293443032478488,1.0,3/18,4.23%,ASS1;IL4I1;PTPN22
prerank,aorta development (GO:0035904),-0.5014431166189559,-1.3241874031465164,0.16052631578947368,0.6171709404719026,1.0,5/14,9.39%,ROBO1;PDGFRB;LRP1;TBX1;PDE2A
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.5659359314994518,1.323912505444941,0.14720812182741116,0.8294501365827673,1.0,7/16,19.32%,CDK13;DDX17;CELF4;HNRNPM;SFPQ;SLU7;DHX9
prerank,regulation of RNA metabolic process (GO:0051252),0.44048437376159694,1.3237437700691272,0.11913814955640051,0.8279899005582663,1.0,13/59,14.85%,AHNAK;AHNAK2;CLK1;PCBP2;CELF1;ZNF326;SON;CLK4;IGF2BP2;PTBP3;PTBP2;RBM38;TRA2B
prerank,ion homeostasis (GO:0050801),0.5014537687978883,1.3236039984993937,0.1326530612244898,0.8264768634230424,1.0,5/30,7.04%,NEDD4L;CAMK2D;SLC4A3;SLC4A4;SLC4A11
prerank,negative regulation of heart contraction (GO:0045822),0.6098858204930364,1.322806553262917,0.15397631133671744,0.8273667329179885,1.0,3/11,5.19%,PDE4D;FKBP1B;ATP1A2
prerank,amyloid-beta metabolic process (GO:0050435),0.5626287305708266,1.322776624938018,0.16666666666666666,0.8254517206533141,1.0,6/16,10.88%,MGAT3;APH1B;NCSTN;DYRK1A;BACE2;MME
prerank,cGMP-mediated signaling (GO:0019934),-0.5126704860612752,-1.3226930956287992,0.1388888888888889,0.6194713279923875,1.0,3/13,9.39%,IRAG1;APOE;PDE2A
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.3272058336449281,-1.3226560306640238,0.01639344262295082,0.6172738945343618,1.0,37/84,20.31%,SASH1;TEK;ETS1;ANXA3;ROCK2;ANGPT1;NOS3;SPARC;FOXP1;BMP4;AKT3;BMPR2;HIF1A;KDR;AKT1;GATA2;LGMN;AAMP;ZC3H12A;RHOB;PROX1;SP1;FLT4;THBS1;MAP2K3;TMSB4X;EDN1;NRP1;P2RX4;RIN2;EGF;HSPB1;CD40;AGT;BCAR1;MET;GFUS
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.5008223958134802,-1.322600129192549,0.11832946635730858,0.6151435976248788,1.0,4/14,9.96%,DMD;ATP1B1;SLC9A1;ANK3
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.5504743997623771,1.3220548912935166,0.15074626865671642,0.8261702957499395,1.0,6/18,7.68%,DLC1;RIPOR2;SCAI;ABL2;KANK1;CUL3
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.4913587407343803,-1.322053638607257,0.1362530413625304,0.6145606460040014,1.0,7/15,35.58%,PLTP;APOE;ABCG1;SCARB1;LCAT;APOC1;LIPC
prerank,modulation by symbiont of entry into host (GO:0052372),0.5728732954692012,1.3217942169232344,0.16693944353518822,0.8251858205148014,1.0,4/16,15.71%,CAV1;TRIM21;HS3ST5;TRIM5
prerank,regulation of chromatin organization (GO:1902275),-0.5008564759301536,-1.3217156542356576,0.1483375959079284,0.6133029840388349,1.0,5/14,7.05%,SETD5;IGF2;PARG;SETD1A;CDK9
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.46610692321367403,-1.3213256061424965,0.1260053619302949,0.6123260851408224,1.0,5/17,8.19%,ROBO1;SLIT2;PIK3R3;KDR;AKT1
prerank,iron ion transport (GO:0006826),-0.3706303277954886,-1.3207881854138697,0.10344827586206896,0.6118099119660393,1.0,16/47,19.98%,STEAP3;FTH1;TFRC;SCARA5;ATP6V0A4;SLC11A2;ARHGAP1;SLC39A14;ATP6V0C;ATP6V1C1;SLC40A1;HFE;ATP6V1D;TTYH1;RAB11B;ATP6V1F
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.5050831435550204,1.3204178803806395,0.1548872180451128,0.8282965733878942,1.0,8/32,9.82%,MYBBP1A;PPP1R13B;BCL3;FHIT;PHLDA3;HIPK1;MSH2;POU4F1
prerank,myotube differentiation (GO:0014902),-0.4808596548070726,-1.3200092611973266,0.13730569948186527,0.611890326642699,1.0,8/17,21.03%,IGF1;ADAMTS5;KCNH1;ADAMTS15;SORT1;MYEF2;NOS1;ADAM12
prerank,BMP signaling pathway (GO:0030509),-0.3534805737041544,-1.319870613899739,0.08196721311475409,0.6100661220719782,1.0,15/62,13.16%,ENG;SMAD3;BMP6;SMAD6;TGFBR3;BMP4;SMAD9;ACVRL1;BMPR2;SMAD5;TGFB3;SLC33A1;BMP2;TGFB2;MEGF8
prerank,regulation of endocytosis (GO:0030100),0.44156495891159103,1.3191194759723879,0.11709286675639301,0.8312876910161922,1.0,13/61,10.09%,GPC3;CDH13;NEDD4L;OPHN1;TFR2;SRC;LRSAM1;ZFYVE16;STON1;ABL2;PACSIN2;STON2;CALY
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.37442478143214175,-1.318671171288423,0.09124087591240876,0.6116419958927155,1.0,15/45,17.04%,ENG;RBPMS;BMP6;DAB2;BMP4;TGFBR1;ACVRL1;BMPR2;TGFB3;BMP2;TGFB2;HFE;CSNK2B;TWSG1;SMAD4
prerank,endosome organization (GO:0007032),0.4745184413057482,1.3179186261256712,0.12464985994397759,0.8337903900588041,1.0,14/41,17.51%,USP50;HOOK2;PI4K2B;PHETA2;DNM1;USP8;SNX10;HOOK3;LAPTM4B;PI4K2A;ANXA8;ANXA8L1;ALS2;VPS11
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.40615017996641284,1.3179062493451135,0.09744779582366589,0.8318242408295753,1.0,37/119,20.74%,PIGU;PTPN13;SOCS5;PI4K2B;SLC27A1;PIP4K2B;PIK3R4;PGAP3;SOCS6;PLEKHA4;MTMR7;PIK3R2;EFR3A;PIGB;MTMR6;OCRL;INPP5F;MTMR3;PIGA;SOCS4;SOCS7;PTEN;PLEKHA1;PIK3C3;MTMR12;PI4K2A;MTMR1;SOCS1;PITPNM2;SOCS2;RAB5A;PITPNM3;ITPKA;FIG4;VAC14;PIK3C2B;CISH
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.444563994291989,-1.3176633302083376,0.11143695014662756,0.6125052781601594,1.0,4/21,8.56%,ROCK2;ENPP1;NOS3;ASPN
prerank,muscle organ development (GO:0007517),0.45285890549520624,1.3175023843769635,0.1387434554973822,0.8312871281598051,1.0,10/54,5.73%,UTRN;LAMA2;SGCD;COL6A3;MRAS;ITGA7;SGCG;CHD2;CACNA1H;ANKRD2
prerank,regulation of protein import into nucleus (GO:0042306),0.48157292186512896,1.317493476244103,0.1457142857142857,0.8293364119290354,1.0,6/36,8.04%,APOD;MDFIC;UBR5;BAG3;RBM22;PIK3R2
prerank,neuron migration (GO:0001764),-0.3734444639838927,-1.3170266241097335,0.0673758865248227,0.6122878646695369,1.0,17/48,14.96%,NAV1;RAPGEF2;MARK1;ADGRL3;CEP85L;NDNF;SPOCK1;ELP3;DCX;NR4A2;CDKL5;DCDC2;TUBB2A;MDGA1;MAP1B;CDK5R1;NRP1
prerank,regulation of myoblast fusion (GO:1901739),0.6141887749285115,1.3166925564890666,0.18772563176895307,0.8303419015209084,1.0,3/11,6.93%,RIPOR2;CD53;EHD2
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.4463335722310833,-1.3166166096645235,0.12968299711815562,0.6112334824862352,1.0,8/22,17.34%,AEBP1;HSPA8;APOE;CAMSAP1;GBA2;MAP1B;MAPT;ARL2
prerank,positive regulation of immune system process (GO:0002684),-0.486198623001305,-1.3161264113701017,0.15403422982885084,0.6105679434616912,1.0,5/16,22.17%,ANXA1;TGFB2;LGALS9;RSAD2;NCKAP1L
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.36267897787905595,-1.3160433613329425,0.07851239669421488,0.6086866739383545,1.0,20/48,18.00%,ETS1;ANGPT1;NOS3;AKT3;HIF1A;HDAC7;HDAC9;KDR;ANXA1;AKT1;PIK3C2A;GATA2;SP1;THBS1;MAP2K3;SRPX2;TMSB4X;P2RX4;HSPB1;CD40
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.49961794464698595,-1.3159723574221798,0.15443037974683543,0.6067181680102377,1.0,4/14,6.95%,IGF1;LDLR;TNFRSF1B;CD200
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.3856710810180098,-1.315694928070019,0.1125,0.6053374790255341,1.0,7/35,8.47%,PICALM;HIP1;TNK2;B2M;HNRNPK;HIP1R;LDLRAP1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.41713302959690846,1.3155432090880361,0.1234718826405868,0.8327452892802192,1.0,5/90,2.59%,EBF2;CAV1;PPARGC1A;LEPR;OGT
prerank,negative regulation of angiogenesis (GO:0016525),0.42548156308709945,1.3152750920305898,0.10638297872340426,0.8318422586598322,1.0,9/84,5.10%,DCN;THBS4;SULF1;SLC12A2;ADAMTS1;SPRED1;ATP2B4;AMOT;CREB3L1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.5874104860658512,1.3151820694204366,0.17558528428093645,0.8302298903705293,1.0,6/13,13.29%,ELOVL5;HACD4;ELOVL1;ELOVL2;HACD2;ELOVL6
prerank,cellular glucose homeostasis (GO:0001678),0.4777033334395297,1.3143648001604706,0.14486638537271448,0.8312949256618726,1.0,15/41,15.57%,PPARGC1A;LRRC8D;HK2;ZBTB20;FOXK1;PIK3R2;FOXK2;ERN1;GCK;SOX4;NUCKS1;UNC13B;TRA2B;GPER1;ADCY8
prerank,histone deubiquitination (GO:0016578),0.5427962796426572,1.3137500995246614,0.1632,0.8317068190295756,1.0,5/18,13.24%,BRCC3;TAF10;UIMC1;TRRAP;USP15
prerank,glycosaminoglycan metabolic process (GO:0030203),0.4526466337355124,1.313186639781681,0.13066666666666665,0.8318244809351905,1.0,18/54,17.77%,GPC3;XYLT2;GPC6;NDST1;SDC1;SLC35D2;GCNT2;HEXA;HS3ST6;HS3ST5;GPC2;SDC3;HSPG2;EXT1;HGSNAT;EXT2;GPC5;SDC4
prerank,negative regulation of response to stimulus (GO:0048585),-0.3474040899702465,-1.313147155508571,0.075,0.6110477516725018,1.0,17/60,8.46%,SLIT2;SLC30A10;LYN;IGFBP3;APPL2;DDAH1;BRAP;AKT3;NR1H3;ZKSCAN3;RBL1;KLF4;CD34;VPS13C;CDK6;NR1H2;AQP11
prerank,positive regulation of cytokinesis (GO:0032467),0.4929411893689338,1.3127857205023898,0.1489971346704871,0.8314047785169508,1.0,10/32,13.54%,PRKCE;KIF20B;RACGAP1;SPAST;OPN1MW;CSPP1;CUL3;PKP4;CDC6;CIT
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.46055602392044226,-1.312536399559868,0.13333333333333333,0.610741259342787,1.0,7/18,23.74%,PRKAG2;C2CD5;CLIP3;SLC2A1;NR4A3;C3;PRKCB
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.4676350798797358,-1.3118719976465933,0.1293800539083558,0.610659259073643,1.0,6/16,20.14%,NUPR1;ATP7A;VCP;SLC25A33;PDE12;COX7A2
prerank,negative regulation of MAP kinase activity (GO:0043407),0.46247046136709713,1.3115984123092854,0.13487738419618528,0.8340086092410823,1.0,9/44,10.68%,RGS14;STK38;NF1;SPRY1;PTPN22;SPRY4;IRAK3;PTPRJ;MAPK8IP1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.5348271734937118,1.310762444286188,0.17107309486780714,0.8352787951994359,1.0,4/20,9.65%,LBP;PRKCE;PTPN22;TICAM1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.38985168012892846,1.3105747491993343,0.0582010582010582,0.8339545825126262,1.0,26/190,9.13%,RORA;CAV1;VGLL4;PPM1N;ARHGAP12;TNIP3;PDE4D;SPRED1;NF1;PHLDA3;SPI1;SRC;ATP2B4;PPM1A;UACA;BANK1;TNFAIP3;NDUFS3;MCL1;DAG1;CGNL1;PHLPP1;PIK3R2;PTPRJ;TNIP1;PLEK
prerank,cellular metal ion homeostasis (GO:0006875),0.4203927876801628,1.3100226079563586,0.11019929660023446,0.8341203460144881,1.0,12/102,5.19%,CAV1;STC2;NEDD4L;CTRC;SLC12A2;SLC8B1;CDH5;SLC24A1;TRPV4;CSRP3;ATP2B4;ATP1A2
prerank,megakaryocyte differentiation (GO:0030219),-0.5379759570221272,-1.3097632118528963,0.14460784313725492,0.6149337352072322,1.0,3/11,13.79%,KIT;UBA5;TAL1
prerank,positive regulation of cell migration (GO:0030335),0.3818477673016562,1.3097279056127604,0.07157894736842105,0.8332853367304888,1.0,32/253,7.62%,ROR2;GAB1;CLDN1;ITGA6;CAV1;NTRK3;CDH13;DOCK5;PRKCE;EGFR;GTSE1;FGF1;DOCK1;SEMA4B;SH3RF2;CDH5;KIF20B;ITGAX;SOX9;PRKCA;SRC;PTPRC;FN1;FER;TRADD;ADAM10;EPHB2;RDX;RIPOR1;SEMA3A;RREB1;FBXO5
prerank,female gonad development (GO:0008585),0.5579636730803307,1.3095902466532445,0.1645367412140575,0.8318921894187874,1.0,2/19,0.77%,INHBB;NR2F2
prerank,sensory organ development (GO:0007423),0.4498417150525516,1.3094542478111806,0.14134742404227213,0.8303990000823943,1.0,9/51,8.68%,STRA6;WNT10A;PBX1;BMPR1B;HIPK1;SH3PXD2B;SHROOM2;FREM2;ABCB5
prerank,positive regulation of cellular component organization (GO:0051130),-0.31372928375402914,-1.308894614087221,0.029197080291970802,0.6153659416872425,1.0,33/107,12.75%,ASAP1;IGF1R;TRABD2B;INSR;ATP10A;SHANK3;LRP1;DAB2;TGFBR1;TFRC;BCL2L11;FNIP1;TMED9;FNIP2;APOE;FRMPD4;RHOC;SLF2;TGFB3;SH3GLB1;NOX1;SURF4;VCP;SLF1;RPS3;AR;AJUBA;CLIP3;BID;MMP1;MPP7;NRXN1;TGFB2
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.4169627941688817,-1.3081798293874565,0.10294117647058823,0.6154729793338616,1.0,7/26,8.78%,ROCK2;SHANK3;SYNPO2;CDC42;ASAP3;SLC9A1;ACTG1
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.3065478062500364,-1.307341252814709,0.04487179487179487,0.6160490858699089,1.0,26/110,12.41%,TRABD2B;CDC42;TFRC;BCL2L11;EP300;PREB;NAPA;FNIP1;HSPA8;FNIP2;APOE;RHOC;SLF2;SH3GLB1;VCP;SLF1;RPS3;ANKRA2;GFAP;AJUBA;PRKCZ;BID;MMP1;MPP7;CRYAB;SAR1B
prerank,regulation of astrocyte differentiation (GO:0048710),-0.5252940335556493,-1.3064672856228259,0.16152019002375298,0.6163441951289811,1.0,6/12,25.08%,EPHA4;SERPINE2;BMP2;ID2;CLCF1;NOTCH1
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.43652281864650455,-1.3060538109091409,0.14647887323943662,0.6154086292298946,1.0,6/23,14.17%,TGFBR3;TPM1;FKBP1A;FGFR2;PROX1;ID2
prerank,regulation of cell-substrate adhesion (GO:0010810),0.4648960132991665,1.3057619514037893,0.14623955431754876,0.8423820784344456,1.0,5/42,4.67%,VIT;ECM2;MINK1;NF1;RAC2
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.4717215233620331,-1.3055972960383306,0.13810741687979539,0.6148165957036547,1.0,6/17,10.36%,GJC1;GJD3;GJA1;SLC8A1;ATP1B1;ATP1B2
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.5034492583411921,1.3052510256512115,0.16012084592145015,0.8424140231306452,1.0,4/27,3.58%,AHNAK;CAMK2D;PDE4D;FKBP1B
prerank,positive regulation of developmental growth (GO:0048639),0.4544835696156163,1.3051135889684238,0.14112903225806453,0.841010542569598,1.0,3/49,0.85%,NGF;NEDD4L;NTN1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.440792478619504,-1.3044849345475822,0.1436950146627566,0.616058954071505,1.0,10/22,25.47%,PAXIP1;MED17;SUB1;MED24;ESR1;DHX36;MED14;MED30;SRF;PSMC5
prerank,negative regulation of neuron projection development (GO:0010977),0.4369129560652781,1.3043165832661812,0.1293800539083558,0.8421006343744548,1.0,16/56,17.04%,LRP4;LPAR1;RAB29;RTN4R;TRPV4;GDI1;EFNB2;SEMA3A;KANK1;HDAC2;RTN4RL1;PTEN;RTN4;PTPRO;EFNB3;MINAR1
prerank,glucose catabolic process to pyruvate (GO:0061718),0.5170125519004816,1.3029618808889265,0.16587677725118483,0.8435885296155943,1.0,11/24,22.50%,HK2;PFKP;FOXK1;ALDOB;FOXK2;ENO3;GCK;PGK1;ENO2;ENO1;PKM
prerank,canonical glycolysis (GO:0061621),0.5170125519004816,1.3029618808889265,0.16587677725118483,0.8435885296155943,1.0,11/24,22.50%,HK2;PFKP;FOXK1;ALDOB;FOXK2;ENO3;GCK;PGK1;ENO2;ENO1;PKM
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.5056654523100887,-1.3029022604232805,0.16541353383458646,0.618643582357278,1.0,6/13,9.87%,NUPR1;USP19;NR1H3;NR1H2;AQP11;MANF
prerank,heart morphogenesis (GO:0003007),-0.3576175810954717,-1.3025340167108854,0.08741258741258741,0.617563351335223,1.0,15/50,14.53%,ENG;INSR;TGFBR3;NOS3;CHD7;FKBP1A;TBX3;TGFBR1;ACVRL1;TBX1;SOX17;BMP2;TGFB2;MEGF8;PTK2
prerank,negative regulation of macrophage activation (GO:0043031),-0.48224616645729224,-1.302276588088653,0.14138817480719795,0.6161770234312048,1.0,5/16,10.20%,IL31RA;NR1H3;LDLR;CD200;ZC3H12A
prerank,epithelial cell-cell adhesion (GO:0090136),0.60700679419384,1.301595229679365,0.17747440273037543,0.8467034308348433,1.0,1/11,0.16%,THBS4
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.41326438879955313,-1.3014807492255498,0.14411764705882352,0.6165637630257693,1.0,8/27,12.47%,PID1;ENPP1;GRB10;RPS6KB1;PIP4K2A;PRKCZ;GSK3A;PIP4K2C
prerank,RNA processing (GO:0006396),0.3907387600623026,1.3014305458696662,0.08278867102396514,0.8453680300877744,1.0,37/176,14.99%,DHX8;PPARGC1A;HNRNPC;NUFIP1;SF3B2;SF3B1;PIWIL2;RBM8A;RNPC3;CELF1;SRSF4;HNRNPA0;TSEN54;ZRSR2;SNRPF;SON;PABPC4;HNRNPR;TUT1;FASTKD2;PRPF3;DDX17;CSTF3;SRPK1;RBM5;LIN28B;CELF2;SUPT4H1;SRPK2;TSEN34;TCERG1;SNRPA1;SFPQ;PPIG;DICER1;DHX16;PDCD7
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.3469633659044032,-1.3012977422559366,0.09689922480620156,0.6150306848648842,1.0,17/56,17.04%,ENG;RBPMS;BMP6;SMAD6;DAB2;BMP4;TGFBR1;ACVRL1;BMPR2;TGFB3;BMP2;TGFB2;BMPER;HFE;CSNK2B;TWSG1;SMAD4
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.43219396717205455,-1.3007545095815423,0.15053763440860216,0.6145219334405436,1.0,4/21,6.47%,ERRFI1;ROCK2;BMP4;CTSL
prerank,membrane lipid biosynthetic process (GO:0046467),0.44915736136410517,1.3001138963316818,0.13844086021505375,0.8485137354391469,1.0,14/58,13.29%,SGMS2;ST3GAL4;CERS6;ACER3;ELOVL5;PLPP2;PLPP3;HACD4;ELOVL1;ELOVL2;CERT1;HACD2;SCCPDH;ELOVL6
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.5304095576368253,-1.2997361732488255,0.16826923076923078,0.6155664939334606,1.0,6/11,35.88%,AGTR1;ABCG1;AGT;PLA2G7;LIPC;PLA2G5
prerank,muscle cell differentiation (GO:0042692),0.4895609979354969,1.299463630576506,0.17236467236467237,0.8490558900097827,1.0,2/32,1.68%,RORA;GLMN
prerank,inner dynein arm assembly (GO:0036159),0.6118625091309988,1.2993454915379938,0.18327402135231316,0.8476161361276164,1.0,3/11,15.14%,CFAP73;CCDC39;CCDC40
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.5201849899270752,-1.2991557113219059,0.17123287671232876,0.6152923750094372,1.0,7/12,26.38%,DMD;ATP1B1;ANK3;ATP1B2;NOS1;WNK1;WNK2
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.491752392988531,1.2986349019232701,0.17533432392273401,0.848377784812268,1.0,5/30,6.65%,F11R;LPAR1;RTN4R;AKAP13;COL3A1
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.47782404286093894,-1.2974268232376525,0.15966386554621848,0.618485137600688,1.0,4/16,6.29%,NOS3;NDNF;DDAH1;APOE
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.6313866451882957,1.2963439585176637,0.1846435100548446,0.8552396962910248,1.0,3/10,1.42%,NEDD4L;PRKCE;CAMK2D
prerank,cellular response to mechanical stimulus (GO:0071260),0.4585137628744267,1.296087489178682,0.1477900552486188,0.854391499856558,1.0,12/46,16.94%,F11R;PIEZO2;MAP3K1;SOX9;TLR7;PTGER4;PIEZO1;TMEM150C;AQP1;KCNK4;BAD;BNIP3
prerank,regulation of kinase activity (GO:0043549),0.4154591895733418,1.2960829718038018,0.1125,0.8525116150575069,1.0,8/89,1.81%,ROR2;ROR1;NTRK3;FGFR1;PLCE1;LDB2;EGFR;MUSK
prerank,positive regulation of chemotaxis (GO:0050921),0.46165577875503977,1.2960368318532396,0.1591549295774648,0.8507910118300301,1.0,4/43,4.59%,SMOC2;NTRK3;CDH13;DSCAM
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.558957847116232,1.2950155061130435,0.16830065359477125,0.8527248051608195,1.0,2/16,4.99%,CEACAM1;PTPRC
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.4199507503085953,-1.2948044013402757,0.1005586592178771,0.6243225514228542,1.0,9/23,19.40%,IGF1;INSR;HIF1A;PFKFB3;P2RX7;PFKFB1;EGF;ENTPD5;GAPDHS
prerank,primary alcohol metabolic process (GO:0034308),-0.42855101912886046,-1.2947964235464284,0.11781609195402298,0.622295572519342,1.0,5/25,4.13%,IGF1;GPD2;RBP4;CYP1B1;NAPEPLD
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.518198209863747,-1.294412598636968,0.18313253012048192,0.6215059134358646,1.0,7/12,28.69%,NOTCH2;DOCK11;LFNG;MFNG;FCGR2B;DLL1;DOCK10
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.4729635555293656,1.294065826617944,0.15135135135135136,0.8543912940263753,1.0,5/41,8.27%,MAGI1;ADAM19;PLPP3;PIEZO1;GCNT2
prerank,membrane depolarization (GO:0051899),0.48686667916872356,1.293974572988939,0.1588921282798834,0.8528361807555037,1.0,3/32,4.79%,CAV1;SCN10A;CACNA1H
prerank,regulation of sodium ion transport (GO:0002028),0.4821290888950413,1.2935417514447152,0.17647058823529413,0.8525279998183326,1.0,3/34,4.74%,CNKSR3;SLMAP;ATP2B4
prerank,regulation of muscle cell differentiation (GO:0051147),-0.3994803561314849,-1.2922353898543815,0.11290322580645161,0.6258342215448848,1.0,8/31,7.87%,CDC42;IGF2;FGFR2;HDAC9;MEF2A;MAPK12;CDK9;CDON
prerank,negative regulation of B cell proliferation (GO:0030889),-0.5332486373099834,-1.292091166828389,0.18493150684931506,0.6241943398486419,1.0,6/11,32.83%,LYN;TNFRSF21;RC3H1;ATM;FCGR2B;CD300A
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.4449243529889837,-1.2918852241028547,0.14516129032258066,0.6227597997681934,1.0,6/21,10.67%,PRKCH;FOXP1;LYN;SLC39A10;ELF2;LPXN
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.5238871107370756,1.2914250120725328,0.1875,0.8585383197221937,1.0,1/22,0.14%,AHNAK
prerank,focal adhesion assembly (GO:0048041),0.5332348933468583,1.2912400181861157,0.18284789644012944,0.8573607218321792,1.0,4/21,4.48%,DLC1;SORBS1;PEAK1;SRC
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.3209277640291524,-1.2911194187053117,0.0797872340425532,0.622970985711144,1.0,29/88,16.41%,EXOC6B;MYO1B;CLINT1;MYO5A;ARFGEF2;AP1S2;FTH1;DNAJC6;NAPA;COMMD1;AP2A1;FTL;HSPA8;VPS35L;VPS13C;EXOC6;DOP1B;EPS15;EXOC4;OSBPL5;AP4E1;SORCS1;TXNDC5;VAMP7;SH3GL2;DTNBP1;SORT1;MON2;SCFD1
prerank,positive regulation of DNA binding (GO:0043388),0.47601867090531674,1.2910648478018325,0.15517241379310345,0.8561325872506366,1.0,1/31,0.03%,NGF
prerank,response to purine-containing compound (GO:0014074),-0.4633350734402551,-1.2907900982031038,0.12921348314606743,0.6219583807613871,1.0,6/17,19.05%,TRPC3;ABCC9;P2RX7;P2RX4;TRPM2;P2RY6
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5126075771525129,-1.2903100966992602,0.1746031746031746,0.621501534371326,1.0,4/12,8.19%,PLCB1;SLIT2;CCN3;AKT1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.39319744693752234,-1.289648146743195,0.12698412698412698,0.6214826931524183,1.0,20/33,34.40%,ACER2;LYN;CYP1B1;EPHA8;RET;NEXMIF;TGFB2;PTK2;NCKAP1L;FERMT3;CIB1;RAC3;PLAU;PDE3B;P2RY12;JAM3;ADA;SNAI2;HRG;SERPINE1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.4485173523871356,1.289328131583548,0.1407035175879397,0.8610062935005159,1.0,18/57,20.63%,DCN;PPARGC1A;DDHD1;CIDEB;FIS1;MIEF1;GSK3B;HTRA2;HTT;GPER1;BAD;BNIP3;RALBP1;PINK1;BAX;RALA;PRKN;MUL1
prerank,regulation of synapse organization (GO:0050807),-0.4104235260750923,-1.2890084641948711,0.12609970674486803,0.6213013454083329,1.0,8/26,13.93%,EPHA4;SETD5;ARHGAP22;PDLIM5;CDKL5;MDGA1;ABHD17B;YWHAZ
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.577126246008102,1.2886543171894658,0.19591141396933562,0.8617786082663229,1.0,6/13,15.80%,MGAT3;CHST7;EXTL2;CHST2;NAGK;OGA
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.623916360267823,1.288352364205354,0.2045060658578856,0.8611208016724898,1.0,2/10,4.99%,CEACAM1;PTPRC
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.5798742573842601,1.2881246168236509,0.1847649918962723,0.8601692695839754,1.0,5/14,12.75%,EHHADH;DECR2;HSD17B4;ACOT8;ABCD1
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.36783396374433075,-1.2878953609835744,0.1099290780141844,0.6224468373965067,1.0,7/41,3.93%,ENG;TGFBR3;RBPJ;TPM1;FKBP1A;BMP4;FGFR2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.5781589672741416,1.2874639962926735,0.1830065359477124,0.8608220293494182,1.0,2/14,4.46%,HNRNPC;HNRNPA0
prerank,macrophage chemotaxis (GO:0048246),0.6159589731263674,1.286374412495968,0.19680851063829788,0.8631725067960468,1.0,1/10,2.64%,CXCL17
prerank,cellular response to dsRNA (GO:0071359),0.5383040480931299,1.2862517486899305,0.2063758389261745,0.8617471828766308,1.0,1/15,0.24%,CAV1
prerank,positive regulation of T cell proliferation (GO:0042102),-0.35222144417373863,-1.2858383231649455,0.08943089430894309,0.6269856357501965,1.0,10/55,11.02%,IGF1;IGFBP2;TFRC;IGF2;IL18;SLC7A1;VCAM1;ANXA1;RPS3;CD80
prerank,intracellular lipid transport (GO:0032365),-0.4307254207892405,-1.2856335726038668,0.15934065934065933,0.625589405741584,1.0,8/21,14.68%,PRKAG2;ARV1;ABCD4;CPT2;PRKAB2;ABCD2;CPT1A;MID1IP1
prerank,positive regulation of catabolic process (GO:0009896),0.42960289691873216,1.285573455772829,0.13607188703465983,0.8624409720133481,1.0,13/65,15.38%,PLK2;GPC3;NEDD4L;AXIN1;DACT1;WNT5A;TNFAIP3;GSK3B;APC;NEDD4;ATG7;WWP2;FZR1
prerank,regulation of cell migration (GO:0030334),0.3686270136376948,1.285295232912456,0.04485219164118247,0.8615959958286955,1.0,48/382,7.57%,ROR2;NTNG2;NTNG1;CLDN1;ITGA6;CAV1;FGF7;DLC1;NTRK3;CDH13;CEACAM1;SULF1;CLDN19;LDB2;EGFR;GTSE1;KIF2A;FGF1;PARD6B;JAG1;AMOTL1;SEMA4B;SCAI;MGAT3;SH3RF2;CDH5;MINK1;ITGAX;NF1;ARPIN;FOXO3;PRKCA;LMO4;SRC;PLXNA3;AMOT;FER;ULK4;TRADD;ADAM10;EPHB2;RDX;DAG1;RIPOR1;SEMA3A;LDLRAD4;SRCIN1;KANK1
prerank,negative regulation of stem cell differentiation (GO:2000737),0.5715136751522044,1.2850344761356576,0.2037037037037037,0.860607262034559,1.0,4/12,13.31%,JAG1;N4BP2L2;NELFB;ZFP36L2
prerank,sulfur compound biosynthetic process (GO:0044272),0.40622515014851124,1.2850098204191247,0.10216346153846154,0.8588491136562231,1.0,20/104,11.71%,DCN;CSPG4;ST3GAL4;PRELP;UST;GLCE;SLC35B2;B4GAT1;MGST2;CHST7;NCAN;SLC35D2;CHST2;GSTZ1;GSTA4;TPK1;GGTA1;CHST12;GSTA3;GSTK1
prerank,negative regulation of kinase activity (GO:0033673),0.42601289471844833,1.2848284958377485,0.13914174252275682,0.8576795063077323,1.0,21/62,21.81%,TRIB2;UBASH3B;CEACAM1;SPRED1;NF1;GNAQ;PTPRC;SFN;CEP85;RTRAF;CDKN1C;YWHAG;DBNDD1;WARS1;CHP1;IRS2;PDPK1;PPM1E;CEP43;TSC2;GSKIP
prerank,regulation of transmembrane transport (GO:0034762),0.48979441007266095,1.284763511550585,0.1585014409221902,0.8560855866171888,1.0,6/31,8.22%,NEDD4L;KCNJ4;SCN10A;KCNJ16;KCNJ13;OCLN
prerank,negative regulation of platelet activation (GO:0010544),-0.4814002324519931,-1.2837220816037929,0.17493472584856398,0.6294579623536942,1.0,6/16,6.29%,PRKG1;PDGFRA;NOS3;THBD;SERPINE2;APOE
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.435452421315585,-1.283569293135236,0.15211267605633802,0.6280093881620614,1.0,10/21,25.16%,PAXIP1;MITF;MED17;SUB1;MED24;DHX36;MED14;MED30;SRF;BCLAF1
prerank,cellular response to growth factor stimulus (GO:0071363),-0.29156475346338695,-1.2827848055062607,0.03,0.6284988138606283,1.0,51/151,19.62%,FLT1;SOX5;RAPGEF2;SMAD3;BMP6;PDE8A;CLEC3B;BMP4;SMAD9;NDNF;TGFBR1;APPL2;WNT4;ACVRL1;GAS1;MT1G;STMN2;BMPR2;DSTYK;SEMA6A;EEF1A1;KLF4;DUSP3;KDR;TBX1;RPS6KB1;ANXA1;CRKL;AKT1;PDE2A;RAMP2;LGMN;BMP2;SOX6;FLT4;MAPKAPK2;MAP2K3;SPHK1;PLK5;MAPT;NRP1;ZPR1;SMAD4;ZFP36;NOS1;HSPB1;WWOX;HAS1;LIMS1;RACK1;BCAR1
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.4658467973667591,-1.2824170463710165,0.15649867374005305,0.6276490781640223,1.0,8/17,22.43%,CDK9;CCNT1;ZC3H3;HSF1;NCBP1;CPSF7;CPEB1;CPSF6
prerank,calcium import into the mitochondrion (GO:0036444),-0.5421286814049936,-1.2823158292413501,0.18763796909492272,0.625969562118611,1.0,5/10,20.54%,SMDT1;SLC25A23;MICU1;MICU2;MAIP1
prerank,cAMP-mediated signaling (GO:0019933),-0.4083344430342751,-1.2822633071589076,0.1529745042492918,0.6241810814502933,1.0,8/24,9.39%,KSR1;RAPGEF2;PDE7B;ADGRG6;ADCY1;AKAP6;ADCY2;PDE2A
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.4833431161666552,-1.2821220319830147,0.18341708542713567,0.622652330475486,1.0,4/15,6.34%,PDGFRA;TGFBR1;FGFR2;TBX1
prerank,neuropeptide signaling pathway (GO:0007218),0.44049535876691714,1.2816248474751748,0.15159235668789808,0.8662232827667918,1.0,4/58,4.70%,SORCS2;SSTR1;KISS1R;CPE
prerank,fibrinolysis (GO:0042730),0.5878008493419596,1.2809455855072354,0.20882852292020374,0.8669131959602094,1.0,1/13,0.68%,SERPINB2
prerank,peptidyl-lysine trimethylation (GO:0018023),0.5065212052578332,1.280777551634649,0.19699248120300752,0.8657503538161226,1.0,12/26,22.64%,OGT;KMT2A;BEND3;KMT5C;SUV39H1;ATPSCKMT;KMT2D;SETD2;SUV39H2;ETFBKMT;VCPKMT;EEF2KMT
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.39764417147681635,-1.2805196805515793,0.1540880503144654,0.6255385166918567,1.0,6/30,5.61%,ENG;SMAD3;TGFBR3;LATS2;FKBP1A;ITGA3
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.4949372180300042,1.2801384227522916,0.165402124430956,0.8663468459337134,1.0,7/26,17.53%,EFNA5;GPLD1;ADCY5;ADRA2A;ADCY8;STX4;KLF7
prerank,genitalia development (GO:0048806),0.5846898658220013,1.2793328525476646,0.18803418803418803,0.8676156880763786,1.0,2/12,4.96%,STRA6;WNT5A
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.4093484684418843,1.2793268808813263,0.12841854934601665,0.8658130054609614,1.0,45/95,25.61%,DYNLL1;MKS1;SFI1;CEP89;CEP131;CEP78;NEDD1;TUBG1;CKAP5;CEP162;PAFAH1B1;CCP110;TCTN2;C2CD3;CENPJ;NDE1;CEP290;SSNA1;CETN2;RPGRIP1L;FBF1;PCM1;NPHP4;YWHAG;B9D2;YWHAE;CEP57;OFD1;CEP250;DCTN2;ALMS1;TCTN1;HAUS8;CEP43;CC2D2A;HAUS3;SCLT1;HAUS7;TMEM67;CEP83;DYNC1I2;NPHP1;TTBK2;CSNK1D;RAB3IP
prerank,positive regulation of cell division (GO:0051781),0.46415465295739505,1.279228895774623,0.16963064295485636,0.8643282331112746,1.0,11/38,13.54%,PRKCE;FGF1;KIF20B;RACGAP1;SPAST;OPN1MW;CSPP1;CUL3;PKP4;CDC6;CIT
prerank,alpha-amino acid catabolic process (GO:1901606),0.49015559961991717,1.2788300762734712,0.19004524886877827,0.8639936960676496,1.0,7/29,10.43%,PRODH;IL4I1;AADAT;HOGA1;ACAT1;BLMH;GSTZ1
prerank,activation of GTPase activity (GO:0090630),0.40792343036437106,1.2784645362593017,0.1263408820023838,0.863587735587005,1.0,13/89,10.91%,ARHGAP42;SIPA1L1;NTRK3;TIAM2;GRTP1;SGSM2;ARHGEF5;TBC1D16;FOXJ1;SLC27A4;TBC1D2;TBC1D8;DOCK7
prerank,establishment of melanosome localization (GO:0032401),-0.4523301850593237,-1.278250309003555,0.15025906735751296,0.6301712927858121,1.0,9/19,22.48%,MYO5A;RAB11A;BBS2;MKKS;BLOC1S6;RAB11B;MLPH;BBS5;RAB27A
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.5537165803162567,1.277968947587382,0.19292604501607716,0.8636214803543673,1.0,7/15,20.83%,ATL2;REEP3;LNPK;RTN4;ZFYVE27;RAB18;REEP4
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.5222777683408486,1.2770794053302892,0.20722135007849293,0.8651231653684665,1.0,5/19,8.21%,PTGFR;FKBP1B;FIS1;PTPRC;PTPRJ
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.40776841435238165,-1.276378831506886,0.138328530259366,0.6338353568451749,1.0,10/28,12.13%,PRKAG2;ADIPOR2;MITF;SIRPA;TNFRSF1B;JAK2;PRKAB2;CTNS;AVIL;FGFR4
prerank,positive regulation of macroautophagy (GO:0016239),0.44816431351522673,1.2759013172461169,0.17647058823529413,0.8676278746471221,1.0,17/48,22.24%,DCN;LRSAM1;PIP4K2B;SCOC;RAB3GAP2;BAG3;SESN1;IRGM;PAFAH1B2;HTT;TBK1;BNIP3;PINK1;ADRB2;TSC2;GNAI3;RAB3GAP1
prerank,positive regulation of protein acetylation (GO:1901985),0.5711522766261927,1.2756512815900036,0.22727272727272727,0.8667863636641514,1.0,2/12,4.33%,RAPGEF3;DIP2A
prerank,mesenchymal cell differentiation (GO:0048762),-0.3438174325818246,-1.2754677746310927,0.09689922480620156,0.6347099498479655,1.0,15/51,12.75%,RANBP3L;ENG;LEF1;ROCK2;TGFBR3;RBPJ;TGFBR1;WNT4;FGFR2;HIF1A;LRP6;TRIM28;BMP2;LOXL3;TGFB2
prerank,regulation of establishment of protein localization (GO:0070201),-0.481682471148941,-1.2751765124748498,0.15555555555555556,0.633603396268883,1.0,7/14,17.38%,DNAJA1;CORO2B;CEP135;CTSD;CEP120;SCFD1;GAPVD1
prerank,regulation of lymphocyte proliferation (GO:0050670),0.5478841047899857,1.2750765439138942,0.2066115702479339,0.8671910761854351,1.0,2/16,4.23%,TNFSF8;PTPN22
prerank,positive regulation of synapse assembly (GO:0051965),0.4913666119791012,1.2747539826438783,0.20943952802359883,0.866618313937176,1.0,3/27,6.38%,CLSTN2;CLSTN3;EPHB2
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.5225815298536756,1.274329372396507,0.19106317411402157,0.8663757457617106,1.0,9/21,20.81%,GLI1;KIF7;PDCL;SMO;RAB34;TEDC1;ARMC9;TUBD1;STK36
prerank,neuromuscular junction development (GO:0007528),0.5046149679035755,1.2739772143490884,0.18440779610194902,0.8659599552527748,1.0,4/24,2.68%,LRP4;PDZRN3;MUSK;ZC4H2
prerank,negative regulation of cell population proliferation (GO:0008285),0.36705113636320774,1.2732366993954252,0.061791967044284246,0.8668189476258464,1.0,66/351,15.21%,NGF;ROR2;ZBTB7C;APOD;IGFBP6;DLC1;CDH13;VGLL4;CLDN19;GLMN;FAP;ADAMTS1;SSTR1;GPLD1;GNRH1;NF1;IL1A;PTPN14;PTHLH;SOX9;TPTE;BMPR1B;CELF1;MFN2;BMP5;MORC3;KLF10;NUP62;WNT5A;ACVR1C;PDS5B;KANK2;TNFAIP3;NCK2;CTCF;PEX2;CHERP;DIS3L2;RBM5;PTPRJ;CNOT7;DLG3;PBRM1;MTSS1;STRN;AXIN2;RARG;APC;PLXNB1;ZBTB49;MEN1;NF2;WNT9A;PTEN;CDC6;EMD;SOX4;CDKN1C;CTNNBIP1;DNAJA3;CLMN;PTPRU;ERBB4;GPER1;PTPN6;PLG
prerank,positive regulation of B cell proliferation (GO:0030890),0.4739158429642854,1.2731142365019446,0.18475073313782991,0.8654246033030193,1.0,7/29,13.15%,NFATC2;PTPRC;EPHB2;CD320;GPR183;CD81;IL7
prerank,regulation of GTPase activity (GO:0043087),0.38010472833797554,1.2726491557011748,0.08775731310942579,0.86541926219127,1.0,30/177,11.43%,ITGA6;EFNA5;SIPA1L1;DOCK9;F11R;RGS6;ARHGAP12;RAPGEF3;RAP1A;ARHGAP9;ARAP1;SGSM2;NF1;RTN4R;CAV2;VAV2;PLXNA3;ARHGEF5;ZC3H15;RAB3GAP2;RDX;RAPGEF6;PKP4;OCRL;GSK3B;TBC1D2;FERMT2;RIC1;DVL3;PLXNB1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.5814772375874608,1.2720869019979895,0.21328671328671328,0.8657345782499399,1.0,4/11,7.57%,ARPIN;SRC;RREB1;KANK1
prerank,heterochromatin organization (GO:0070828),-0.48400628840957216,-1.272067041262577,0.18872549019607843,0.6411733440012913,1.0,3/14,9.20%,MECOM;PRDM16;BAHD1
prerank,regulation of receptor internalization (GO:0002090),-0.3794885063413387,-1.2709582068600687,0.11612903225806452,0.642631127149106,1.0,13/35,25.49%,INSR;ANGPT1;ANKRD13A;AHI1;EGF;FLOT1;PICK1;MKLN1;NTF3;GREM1;ANKRD13D;RIN3;ARRB2
prerank,lipid phosphorylation (GO:0046834),0.5904237954449195,1.270916681979832,0.22203672787979967,0.868455170749041,1.0,2/10,3.58%,DGKA;DGKZ
prerank,establishment of epithelial cell polarity (GO:0090162),-0.4495381894381366,-1.2707358718003054,0.1525,0.6413773737546153,1.0,4/19,2.84%,PARD3;MSN;CDC42;CYTH3
prerank,regulation of monocyte differentiation (GO:0045655),-0.48137347175660594,-1.2701962238933424,0.16876574307304787,0.6410918270311008,1.0,5/14,19.92%,FOXP1;CDK6;IL34;CSF1;FES
prerank,C4-dicarboxylate transport (GO:0015740),0.5614892019582217,1.270139875031894,0.20439189189189189,0.869587156542571,1.0,5/14,12.99%,LRRC8D;SLC25A12;SLC1A6;SLC25A13;SLC25A22
prerank,protein-containing complex subunit organization (GO:0043933),0.4025069976067785,1.269811245970304,0.1347517730496454,0.869102056959546,1.0,14/109,8.38%,MAGI1;PPARGC1A;WIPF1;LAMC1;REPS2;PARD6B;CD3G;KMT2A;SOX9;CARD10;FANCC;TAPBP;OCLN;DARS1
prerank,response to interleukin-4 (GO:0070670),-0.5258230959017064,-1.2695411744699976,0.18620689655172415,0.641113661422145,1.0,1/10,0.70%,LEF1
prerank,negative regulation of histone methylation (GO:0031061),-0.5377533383640525,-1.2688297666206985,0.19457013574660634,0.6412132434558684,1.0,7/10,29.65%,JARID2;KDM1A;DNMT3B;BRCA1;AASS;WDR5;BCOR
prerank,response to estradiol (GO:0032355),0.4817531991233481,1.2687382481924383,0.20086705202312138,0.8711879530238126,1.0,12/31,20.44%,EGFR;SSTR1;NRIP1;POU4F1;NCOA3;LCOR;GPER1;CCDC62;GGT1;SOCS2;RUVBL2;STAT5B
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.5519074555197371,1.2683068808874973,0.20678513731825526,0.8710284696520357,1.0,2/15,2.92%,EDA;GLI2
prerank,regulation of proteolysis (GO:0030162),0.45586049619314595,1.2680778791653982,0.17142857142857143,0.8701412980033261,1.0,10/48,11.47%,CAV1;CYFIP2;OGT;CLN8;LTBP4;PERP;HDAC2;IST1;HDAC6;SPOPL
prerank,protein localization to cilium (GO:0061512),0.4863625394052772,1.2671168735125171,0.17126269956458637,0.8719834445655884,1.0,14/32,23.17%,ZNF423;RAB29;RABEP1;SNX10;TCTN2;TTC21B;NPHP4;INVS;EHD1;BBS1;TCTN1;TULP2;IFT140;ARL3
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.5250487421679735,-1.2670048646154528,0.22025316455696203,0.6449514451793491,1.0,6/11,19.16%,EP300;SIK1;C1QTNF3;PGP;CLK2;CRY1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.37430896391397667,-1.266317112374743,0.12457912457912458,0.6450961955420196,1.0,9/37,8.47%,IGF1;PRKG1;TPM1;MEF2D;IGFBP5;GJA1;TGFB3;MMP2;LDLRAP1
prerank,positive regulation of cation channel activity (GO:2001259),-0.36718174839226647,-1.266243158449013,0.12087912087912088,0.6433843260800347,1.0,13/40,23.25%,ANK2;ACTN2;SHANK3;AKAP6;CALM1;ANK3;TMSB4X;CALM3;JPH2;P2RY6;STAC3;GSTO1;LRRC38
prerank,cellular response to interleukin-4 (GO:0071353),-0.5301889105190237,-1.2660579500377867,0.1623529411764706,0.6419971253797471,1.0,1/10,0.70%,LEF1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.4252176689358201,-1.2659918747290697,0.1440443213296399,0.6403112260588186,1.0,6/21,8.47%,IGF1;MEF2D;IGFBP5;GJA1;MMP2;LDLRAP1
prerank,hemopoiesis (GO:0030097),-0.3067132887935625,-1.2659769889875818,0.052083333333333336,0.6384456851119426,1.0,21/87,13.79%,FLT1;MECOM;NOTCH2;TEK;TGFBR3;BMP4;SNRK;KIT;FGFR2;MEIS1;FLT3LG;KDR;CD34;MKNK2;PGM3;KIRREL3;BMI1;TOX;FLT4;TGFB2;TAL1
prerank,regulation of cholesterol transport (GO:0032374),-0.4323772959205853,-1.2657887850316631,0.15775401069518716,0.6371051477611884,1.0,11/20,32.70%,LRP1;NR1H3;ARV1;NR1H2;ABCA2;NAXE;ABCB4;TSPO;ABCA13;NUS1;APOC1
prerank,regulation of exocytosis (GO:0017157),0.445192998447094,1.2656448727941054,0.18019257221458046,0.8756959106873042,1.0,5/46,7.28%,STXBP6;RAB8B;RIMS2;RAB3A;CPLX1
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.5044142545543182,1.2654476150915406,0.2141732283464567,0.8747142179360496,1.0,6/22,16.87%,NFATC2;IL4I1;CBFB;SOCS1;LAG3;MDK
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.4189558268327075,-1.265121163121438,0.16071428571428573,0.6373431059823371,1.0,7/23,6.84%,ACSL1;ACSL3;FAR2;ACOT7;ELOVL7;ACSL6;HSD17B12
prerank,positive regulation of nervous system development (GO:0051962),0.4502787022196908,1.2650211236313567,0.176158940397351,0.8744664801238252,1.0,4/42,6.38%,CLSTN2;RGS14;CLSTN3;EPHB2
prerank,indolalkylamine catabolic process (GO:0046218),0.597319102751876,1.2648671443487256,0.2293103448275862,0.8732527009614433,1.0,2/10,3.76%,IL4I1;AADAT
prerank,protein K63-linked deubiquitination (GO:0070536),0.4674079230280665,1.2647963032840168,0.19432624113475178,0.8717589215573325,1.0,11/31,18.75%,USP50;BRCC3;TNFAIP3;USP8;OTUB2;UIMC1;USP13;OTUD7B;STAMBPL1;STAMBP;PSMD14
prerank,positive regulation of signaling (GO:0023056),0.46671123241969115,1.2646567771773114,0.17588652482269504,0.8705235774339675,1.0,5/37,8.85%,CLSTN2;RAB29;CLSTN3;RIMS2;INPP5F
prerank,regulation of cellular protein catabolic process (GO:1903362),0.5291705089032367,1.2636075025433144,0.19329073482428116,0.8723822580316386,1.0,8/18,17.55%,VGLL4;DACT1;RDX;RIC1;FAF1;EZR;VPS11;WDR91
prerank,regulation of angiogenesis (GO:0045765),0.37558886419069787,1.2635079350589313,0.10075839653304441,0.8710108670399581,1.0,21/192,5.86%,GAB1;DCN;THBS4;SMOC2;CEACAM1;SULF1;RAPGEF3;HK2;ADAMTS1;FGF1;CDH5;SPRED1;ITGAX;NF1;IL1A;PRKCA;ATP2B4;WNT5A;AMOT;HIPK1;TNFAIP3
prerank,lysine catabolic process (GO:0006554),0.5735286459382775,1.2634952736837293,0.22487223168654175,0.8676071011476123,1.0,5/12,14.06%,AADAT;OGDH;GCDH;DLST;HYKK
prerank,lysine metabolic process (GO:0006553),0.5735286459382775,1.2634952736837293,0.22487223168654175,0.8676071011476123,1.0,5/12,14.06%,AADAT;OGDH;GCDH;DLST;HYKK
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.5806899828889077,1.2634313448943248,0.19864176570458403,0.8661569493701976,1.0,4/13,7.22%,CYFIP2;CIDEB;NLRC4;PERP
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.32559998113991095,-1.2630562208259841,0.11822660098522167,0.6417634739678904,1.0,21/69,17.43%,UBXN4;USP19;TRIM25;ERLIN1;DNAJB2;UBE4A;STT3B;SGTA;SEC61B;SYVN1;VCP;UBE2J1;FBXO17;ERLIN2;UBE4B;OS9;RNF103-CHMP3;ANKZF1;SGTB;DERL2;FBXO44
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.3975528300773093,1.2629606735207242,0.14893617021276595,0.8661485287502905,1.0,29/109,18.75%,TEC;NFATC2;NFATC1;ITK;MAP3K1;MAPK10;VAV2;PSME3;FER;LCP2;PIK3R2;PSMB5;GAB2;LAT;TAB2;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;SYK;BTK;PSME4;NFATC3;PSMC4;PSMB6;PSMD12;PDPK1;PSMD14
prerank,regulation of dendrite extension (GO:1903859),0.5133301866117483,1.262795837899201,0.20327868852459016,0.865092447572423,1.0,3/18,9.00%,NEDD4L;RIMS2;CPNE9
prerank,dendrite self-avoidance (GO:0070593),-0.45249196124876134,-1.262638567356816,0.17777777777777778,0.6411153248831168,1.0,6/16,13.46%,BSG;DSCAML1;NEXN;PALLD;ROBO4;CNTN2
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.42613416779873364,-1.261140234330102,0.1763157894736842,0.6439355359826816,1.0,4/20,11.66%,IGF1;EP300;TRAF6;H1-0
prerank,regulation of cytokinesis (GO:0032465),0.41057865945131705,1.2610018955554447,0.1527777777777778,0.8700271613144106,1.0,20/78,13.54%,PLK2;PRKCE;KIF20B;RACGAP1;PIK3R4;SPAST;OPN1MW;CSPP1;KIF13A;CUL3;CCP110;PKP4;KLHL21;ZFYVE26;CHMP4C;MAP9;CETN2;AHCTF1;CDC6;CIT
prerank,cellular response to alkaloid (GO:0071312),-0.4553747908986527,-1.2605204854388783,0.1937046004842615,0.6438241111584779,1.0,4/17,7.29%,TGM2;SLC8A1;BLM;CASP3
prerank,negative regulation of T cell proliferation (GO:0042130),0.474604932951028,1.2599913499059427,0.18541033434650456,0.8720781920662571,1.0,4/28,7.33%,ARG1;GLMN;IL4I1;CRTAM
prerank,regulation of protein acetylation (GO:1901983),0.5742003748548131,1.2593227815948915,0.21805792163543442,0.8728156000140417,1.0,3/12,14.15%,RAPGEF3;GSK3B;FAM161A
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.4962004554467237,1.259097030181861,0.2064,0.871946922766413,1.0,8/23,19.61%,OTOP1;ARG1;TXK;IRGM;SOCS1;PPARG;JAK1;SUMO1
prerank,regulation of heart contraction (GO:0008016),0.4092322336555351,1.2589692984513847,0.16728624535315986,0.8707437067770856,1.0,16/90,10.60%,CORIN;ITPR2;ITPR3;CAMK2D;SCN10A;PDE4D;FKBP1B;ATP2B4;CACNA1H;ATP1A2;APLN;TBX2;CASQ2;CELF2;ATP1B3;FXYD6
prerank,negative regulation of protein ubiquitination (GO:0031397),0.4502160011498994,1.2584201214063324,0.1816958277254374,0.8710911025636666,1.0,15/50,17.13%,CAV1;SH3RF2;OGT;TNFAIP3;N4BP1;FBXO5;SIRT7;SPOPL;NXN;USP4;SOX4;GNL3L;BAG2;MINAR1;CHP1
prerank,negative regulation of protein transport (GO:0051224),0.4999739497063372,1.2582456020223487,0.1880597014925373,0.8699760866445397,1.0,1/25,0.23%,PKDCC
prerank,negative regulation of myoblast differentiation (GO:0045662),0.5758461112646417,1.258187935521623,0.2010221465076661,0.8684912903996043,1.0,3/13,5.73%,PRICKLE1;SOX9;ANKRD2
prerank,anterior/posterior pattern specification (GO:0009952),-0.3390647290240346,-1.2580695788738463,0.11788617886178862,0.6493999590803139,1.0,17/53,17.57%,WLS;HOXA3;TGFBR1;BMPR2;HOXB4;HOXA5;HOXB9;TBX1;HOXC4;BMP2;HOXA9;HOXA6;HOXB7;HOXD4;HHEX;HOXD3;LRP5
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.4578075694528653,1.2577427146818734,0.18424753867791843,0.8683770268293015,1.0,5/35,3.59%,CAV1;NR2F2;SULF1;NF1;CAV2
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5358272797716709,-1.2577301084890091,0.18160919540229886,0.6485163136241833,1.0,4/10,10.51%,GLI3;BMP4;IRF1;ZC3H8
prerank,endothelial cell migration (GO:0043542),0.46462276642815603,1.2571620427973127,0.1957142857142857,0.8688257997718826,1.0,6/37,8.07%,CDH13;PXN;FAP;CDH5;DPP4;STARD13
prerank,positive regulation of phosphorylation (GO:0042327),0.3717484338907568,1.2565927388558495,0.07340425531914893,0.8692746521768229,1.0,26/240,6.42%,ROR2;ITGA6;ROR1;EFNA5;FGF7;NTRK3;FGFR1;CLDN19;LEPR;GLMN;EGFR;CCND3;MUSK;ZBTB20;PELI2;FGF1;AXIN1;FXR2;SOX9;LMO4;DSCAM;LIMK2;SLC4A4;NBN;EPHB2;KRAS
prerank,C-terminal protein amino acid modification (GO:0018410),0.573957603521788,1.2565534194043808,0.21114864864864866,0.8677233117893106,1.0,7/11,18.81%,GPLD1;AGBL4;ATG5;ATG7;LCMT1;AGBL1;ICMT
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.3806047655411517,-1.2561610739942233,0.1523809523809524,0.6514804864303011,1.0,5/34,3.56%,IGF1;INSR;TGFA;PDGFRB;IGF2
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.44117563198350734,1.2560722412953877,0.1673525377229081,0.8677894558775978,1.0,7/50,12.99%,NGF;SRC;SFN;RPS6KA3;USP47;DHCR24;AQP1
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.5212303256000509,1.2554209146869606,0.21360759493670886,0.8684674950408962,1.0,3/17,7.44%,JAG1;CD55;MSH2
prerank,positive regulation of metabolic process (GO:0009893),0.39856313637114976,1.2552269461250545,0.1411192214111922,0.8675339730848376,1.0,17/103,13.51%,EBF2;CAV1;PPARGC1A;LEPR;OGT;BEND3;MFN2;ACACA;TSHR;PIGA;KSR2;APC;PRLR;KDM6B;TRPV2;ELOVL6;HCRT
prerank,cellular amino acid catabolic process (GO:0009063),0.4078391798196417,1.254939306233667,0.15173237753882915,0.8668758315541941,1.0,22/87,14.06%,PRODH;ARG1;IL4I1;ACAD8;AADAT;HMGCLL1;BCKDK;HOGA1;OGDH;GCDH;ACAT1;ALDH5A1;ABAT;BLMH;DLST;GSTZ1;GLDC;BCKDHB;BCAT2;GOT1;GLUL;HYKK
prerank,motor neuron axon guidance (GO:0008045),0.548594619113931,1.2547921593405036,0.20603015075376885,0.8657721783101248,1.0,5/15,7.26%,NTN1;RAC2;NTN5;SEMA3A;NTN3
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.4904470734675429,-1.2540239572344944,0.1953727506426735,0.6561496891184775,1.0,3/13,2.60%,NFIB;PPARD;BMP4
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3807865582581543,1.2537746625960662,0.13038674033149172,0.8677422897001005,1.0,28/150,12.80%,CNKSR3;CAV1;TRIB2;NTRK3;UBASH3B;PTPN13;CEACAM1;PDE4D;SPRED1;NF1;PLPP3;GNAQ;PTPRC;IBTK;EPHB2;NCK2;LDLRAD4;OCLN;SFN;NLRP2B;RASSF2;CEP85;SNX25;RTRAF;MEN1;SEMA4D;MVP;PTEN
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.43888054337436394,-1.2536602395364307,0.19518716577540107,0.6554121897246472,1.0,4/19,8.44%,IGF1;PICALM;APOE;RTN1
prerank,cardiac ventricle development (GO:0003231),0.5127757313316028,1.2532468628101063,0.20186335403726707,0.8678734379760868,1.0,2/20,5.24%,STRA6;HEYL
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.32918091930726584,-1.253025042015954,0.08641975308641975,0.6555655125653451,1.0,26/57,28.24%,TGS1;RPS15;RPL35A;RPS7;RPL26;NPM1;HEATR3;RPS24;RPS19;RPS16;RPS17;WDR12;RPL38;RIOK1;NOC2L;RPS6;DHX37;RPL14;RPL5;MRPL36;RPS25;PAK1IP1;RPF2;RPL7;RPL11;NOP16
prerank,negative chemotaxis (GO:0050919),-0.378138902187409,-1.2528948269887272,0.12225705329153605,0.6541035186714822,1.0,7/33,5.19%,ROBO1;EPHA7;SEMA6D;SLIT2;SEMA7A;SEMA3C;SEMA6A
prerank,protein K11-linked ubiquitination (GO:0070979),0.48732336741305887,1.2526441123073362,0.20820668693009117,0.8684903841215409,1.0,11/27,20.40%,UBE2E2;ANAPC5;ANAPC7;ANAPC11;ANAPC2;UBE2D3;ANAPC4;FZR1;CDC23;UBE2W;PRKN
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.528330041602301,-1.252542433834058,0.1891891891891892,0.6533525299696215,1.0,6/10,36.69%,NOC2L;BRCA1;THAP7;CTBP1;SNCA;KLF15
prerank,mRNA metabolic process (GO:0016071),0.4074584974175432,1.252013977231219,0.16997518610421836,0.86911208795182,1.0,19/90,13.67%,PPARGC1A;SF3B2;PCBP2;CNOT10;CELF1;SRSF4;HNRNPA0;SNRPF;SON;DXO;HNRNPR;PRPF3;CSTF3;DIS3L2;SUPT4H1;ZFP36L2;ERN1;TCERG1;SFPQ
prerank,negative regulation of chemotaxis (GO:0050922),-0.3898449195850178,-1.2518916691498108,0.17391304347826086,0.6534402980270823,1.0,7/31,6.12%,ROBO1;SEMA6D;SLIT2;SEMA7A;SEMA3C;SEMA6A;DUSP3
prerank,positive regulation of dendrite extension (GO:1903861),0.5186238422405174,1.2516499991651038,0.205,0.8688067287145659,1.0,3/17,9.00%,NEDD4L;RIMS2;CPNE9
prerank,negative regulation of bone remodeling (GO:0046851),0.5780575436972764,1.2511818404666513,0.21441124780316345,0.8689137126524641,1.0,2/11,5.86%,UBASH3B;TNFAIP3
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.5585509563860833,1.251158606769734,0.23275862068965517,0.867368031358516,1.0,8/13,27.06%,NELFB;SUPT4H1;HEXIM1;TCERG1;RECQL5;EAPP;HNRNPU;NELFA
prerank,gene expression (GO:0010467),-0.2564361557787111,-1.2500415439800339,0.0,0.6572723057554367,1.0,122/348,22.68%,RBPMS;RPL37A;RRBP1;CREBL2;ADAR;NUP107;RPL19;RPL8;RPL37;SNRNP40;RPS15;RPS29;FARSB;RPL35A;RPS7;HNRNPK;RPS20;RPL32;AAAS;EEF1A1;RPS27;RPL26;SEH1L;RPL27;RBMS1;NUP133;RPS24;NOX4;RPLP0;FYTTD1;MEF2A;HARS1;PTMA;RPS19;HBS1L;THOC2;RBMS2;RPL31;RPL41;GLE1;TSPAN17;RPL13A;RPL30;RPL29;MRPS6;RPS16;RPL3;HNRNPH3;NR4A2;RPLP1;RRAGC;RPS17;RPS3;RPL23;RPL17;RPL9;RPL38;DHPS;RPL36;RPS26;POLR3A;RPS8;ZC3H11A;RPS12;MMS19;RPL18A;RPS21;MRPL32;MAGOH;MRPL18;LMF2;NUP88;CDC40;RPS18;RPLP2;EIF4G1;RPS6;NOL9;ANGPT2;HHEX;RPS15A;NCBP1;MRPL9;DNAJB11;MRPL28;CPSF1;PWP1;DDX20;MAGOHB;RNPS1;HOXD3;POLR2F;GSPT2;CLP1;MRPS11;POLR2A;POLR2J;TSPAN5;POLR2D;MRPS16;POLR2K;RPL14;MRPS18B;U2AF2;NOVA1;HNRNPH1;RPS2;SRRM1;THOC7;MRPL42;NUP54;RPL10A;DUSP11;THAP1;THRB;RPL39;RPL34;RPL5;MRPS12;RPL22;SRSF1;MRPL55
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.40291841665057193,-1.2494299044650174,0.15492957746478872,0.6573960792273085,1.0,4/25,6.00%,ANK2;TRPC1;CACNB2;AKAP6
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.48204055835394555,-1.2492763406665426,0.22195704057279236,0.6559210081882039,1.0,5/13,10.42%,ANK2;GJC1;GJA1;CACNB2;KCNN2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3713844287520198,1.2489072930299614,0.1162280701754386,0.8739016861460261,1.0,45/161,18.75%,CAV1;IGFBP6;LRP4;GLI1;PRICKLE1;DKKL1;AXIN1;MLLT3;SOX9;CHD8;PSME3;DACT1;WNT5A;ZNRF3;CUL3;AMFR;PSMB5;TBX18;STK3;GSK3B;CSNK1A1;SDHAF2;AXIN2;APC;DVL3;KREMEN1;EMD;PSMB2;PSMA2;PTPRU;PTPRO;PSMA6;BICC1;TMEM170B;PSMD13;NPHP4;PSMA7;MDK;INVS;PSME4;PSMC4;PSMB6;PSMD12;RUVBL2;PSMD14
prerank,potassium ion import across plasma membrane (GO:1990573),0.443346544635094,1.2485065183225403,0.20303867403314918,0.8737669013690923,1.0,7/41,5.58%,KCNJ4;SLC12A2;KCNJ16;SLC12A4;SLC12A3;ATP1A2;KCNJ13
prerank,sphingolipid biosynthetic process (GO:0030148),0.413453521294583,1.2480456806148377,0.18451612903225806,0.8738603296334266,1.0,16/71,11.60%,SGMS2;CERS6;ACER3;ELOVL5;A4GALT;PLPP2;PLPP3;ALOXE3;CLN8;HACD4;ELOVL1;ELOVL2;CERT1;ST8SIA5;ST8SIA3;HACD2
prerank,regulation of inclusion body assembly (GO:0090083),-0.5182263868396227,-1.247937632631564,0.2210796915167095,0.6581108390319013,1.0,7/11,32.18%,SNCAIP;DNAJB2;DNAJA4;HSPA1A;DNAJB1;HSPA1B;HSPA2
prerank,potassium ion export across plasma membrane (GO:0097623),0.5591379524592754,1.247475466531538,0.24046434494195687,0.8742453851185856,1.0,2/13,8.16%,KCNA5;KCNK5
prerank,secretion (GO:0046903),-0.4567523667155599,-1.2463078486105754,0.21654501216545013,0.661337499410356,1.0,4/14,5.70%,SLC22A6;SLC22A4;NPR1;FBLN5
prerank,vitamin transport (GO:0051180),0.4758558759977892,1.2460596993580104,0.2116788321167883,0.8776550206671568,1.0,11/29,14.92%,FOLR1;FOLR2;SLC27A1;SLC2A2;SLC52A1;TTPA;CD320;CUBN;GC;AMN;SLC46A1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3758834304257934,1.24551372700351,0.1425287356321839,0.8780821212748489,1.0,28/140,8.85%,DLC1;TIAM2;ARHGAP31;PLCE1;ARHGAP18;ARHGAP12;ARHGAP32;ARHGAP9;ARAP1;DEPDC1B;AKAP13;OPHN1;RACGAP1;VAV2;SRC;RAC2;NUP62;TRIO;ARHGEF5;ARHGAP26;RHOJ;ARHGEF1;CGNL1;PIK3R2;STARD13;KALRN;OBSCN;OCRL
prerank,cellular response to interleukin-12 (GO:0071349),-0.34453045030648244,-1.245464462864802,0.13653136531365315,0.6620624933665525,1.0,9/48,9.17%,PLCB1;MSN;CDC42;SIRPA;CFL1;ANXA2;RPLP0;JAK2;CNN2
prerank,regulation of cellular component biogenesis (GO:0044087),-0.36722885549722023,-1.245071562426937,0.11913357400722022,0.6614310362622985,1.0,9/39,10.77%,SNCAIP;RAPGEF2;ROCK2;MSN;TIE1;HSPA8;APOE;ANKRA2;GFAP
prerank,regulation of osteoblast proliferation (GO:0033688),-0.4392518519372155,-1.2450311265144502,0.1711229946524064,0.6597440436712236,1.0,5/17,10.52%,NPR3;FGFR2;MN1;CCN1;BMP2
prerank,Fc receptor signaling pathway (GO:0038093),0.3904219986964602,1.244819288669683,0.16686114352392065,0.8790466188372048,1.0,29/110,18.75%,TEC;NFATC2;NFATC1;ITK;MAP3K1;MAPK10;VAV2;PSME3;FER;LCP2;PIK3R2;PSMB5;GAB2;LAT;TAB2;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;SYK;BTK;PSME4;NFATC3;PSMC4;PSMB6;PSMD12;PDPK1;PSMD14
prerank,positive regulation of cellular senescence (GO:2000774),-0.5233517740381561,-1.2439832870885361,0.19863013698630136,0.6611818608004605,1.0,4/10,19.72%,B2M;YPEL3;EEF1E1;CGAS
prerank,ephrin receptor signaling pathway (GO:0048013),0.39855522512857383,1.2436024502538718,0.1806615776081425,0.8818262788762679,1.0,13/82,8.45%,EFNA5;SIPA1L1;ARHGEF28;EFNB1;APH1B;VAV2;SRC;DNM1;NCSTN;EPHB2;NCK2;EFNB2;KALRN
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.4284771128670879,-1.2435958808020242,0.16666666666666666,0.6605301483671411,1.0,8/21,14.37%,RAD51B;NPM1;CDC25B;CDC25A;RAB11A;CDK4;CDC7;RAD51C
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.41393947417628324,1.2435372762126335,0.172544080604534,0.8804331435870607,1.0,12/72,14.18%,FGF7;FGFR1;FGF1;RBFOX2;SPRED1;KIF16B;FGF18;HNRNPM;GTF2F2;SPRED2;FLRT2;TIAL1
prerank,cardiolipin metabolic process (GO:0032048),0.5525792228119121,1.2433487039147402,0.2508591065292096,0.8794860436204134,1.0,5/13,12.76%,SLC27A1;HADHB;PTPMT1;LCLAT1;PNPLA8
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.4301962157942708,-1.2432970267808274,0.16957605985037408,0.6596039811071923,1.0,4/18,7.84%,UNC13C;NAPA;GRIA2;GRIK2
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3771922769390315,1.2428513295712158,0.12219730941704036,0.8796469742413435,1.0,11/152,5.34%,GNA14;LPAR1;ADGRG5;ADGRG2;PTGFR;AKAP12;GPR161;MC5R;PTHLH;GNAQ;ADCY5
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.4467967161432784,-1.2426718424807373,0.18579234972677597,0.6597888590154678,1.0,11/17,29.92%,ATP5PD;VPS9D1;DMAC2L;ATP5MC3;ATP5PF;ATP5ME;ATP5PO;ATP5MC2;ATP5MF;ATP5MC1;ATP5F1E
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.46033471032491935,-1.2419112311281504,0.19466666666666665,0.6603076146277833,1.0,2/16,0.63%,IGF1R;INSR
prerank,protein localization to membrane (GO:0072657),0.37058660505986574,1.2407278078964723,0.12192393736017897,0.8857609325928897,1.0,23/187,10.07%,PTCH1;CAV1;F11R;SLMAP;EPB41L3;RAP1A;RAB8B;RAB29;KCNIP4;FLOT2;CPE;SH3PXD2B;RABEP1;RDX;EHD2;RAB3A;ITGB7;EFR3A;RAPGEF6;ZDHHC23;ATP1B3;DLG3;FERMT2
prerank,positive regulation of coagulation (GO:0050820),0.5879603894016805,1.240517204559418,0.22972972972972974,0.8832397703502005,1.0,1/10,0.79%,ST3GAL4
prerank,positive regulation of hemostasis (GO:1900048),0.5879603894016805,1.240517204559418,0.22972972972972974,0.8832397703502005,1.0,1/10,0.79%,ST3GAL4
prerank,regulation of mRNA processing (GO:0050684),0.4604350387328091,1.239856136406835,0.2006220839813375,0.8840865466046427,1.0,18/32,26.67%,QKI;SON;SRPK1;SLTM;KHDRBS2;SRPK2;SF1;CWC22;SRSF3;DHX9;TIA1;SRSF10;YTHDC1;JMJD6;IWS1;PABPN1;SAFB2;RBM39
prerank,skeletal muscle tissue development (GO:0007519),0.47825154242725465,1.2395034522800155,0.21067415730337077,0.8837878652107155,1.0,3/32,4.33%,CAV1;CAV2;CSRP3
prerank,negative regulation of multicellular organismal process (GO:0051241),0.36940987191289515,1.239233658677526,0.11664899257688228,0.8831522780586116,1.0,30/199,11.88%,PTCH1;LRP4;DLX1;IL18R1;LAMA4;ZNF423;EGFR;SPRED1;SPRY1;SPI1;PLCL1;SOX9;PCTP;BMP5;ATP2B4;ACVR1C;ACOT13;N4BP1;HOXC10;LDLRAD4;PTGER4;LNPEP;TBX18;GSK3B;SDHAF2;DOCK7;WWC1;PROC;HS3ST5;RAB11FIP5
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3576727182403674,1.2389888652824743,0.09224318658280922,0.8824389131526751,1.0,70/248,18.75%,CAV1;IGFBP6;GPC3;LRP4;GLI1;PRICKLE1;PPM1N;DKKL1;NRARP;FOLR1;EGFR;AXIN1;MLLT3;SOX9;CHD8;GNAQ;PSME3;DACT1;WNT5A;PPM1A;USP8;UBR5;PLEKHA4;FAM53B;KANK1;ZNRF3;CUL3;AMFR;CSNK1G3;PSMB5;RNF220;STK3;GSK3B;USP47;CSNK1A1;SDHAF2;AXIN2;APC;DVL3;COL1A1;KREMEN1;EMD;SOX4;PSMB2;FZD7;CAPRIN2;PSMA2;PTPRU;PTPRO;PSMA6;FZD9;BICC1;TMEM170B;PSMD13;NPHP4;PSMA7;MDK;PPP1CA;INVS;GPC5;PSME4;CSNK1G1;FGF10;PSMC4;CDH3;PSMB6;PSMD12;ATP6AP2;RUVBL2;PSMD14
prerank,negative regulation of viral release from host cell (GO:1902187),-0.4791836991473288,-1.2389137123036968,0.18932038834951456,0.667653190534209,1.0,7/13,20.68%,MID2;TRIM35;TRIM28;CHMP3;TRIM8;TRIM13;TRIM11
prerank,regulation of protein localization to membrane (GO:1905475),0.47857823093075136,1.238317677160361,0.21091445427728614,0.8831772526446989,1.0,10/28,17.60%,GPC3;GPC6;ZDHHC7;VAMP8;SLC5A3;GPC2;CRIPT;MMP14;GPC5;SPTBN1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3876474326515642,1.2383151424084233,0.143698468786808,0.8815886759338771,1.0,23/118,12.28%,EFNA5;SIPA1L1;FMNL2;NEDD4L;CEACAM1;PPFIA2;CAPZB;NF1;LZTS3;BRSK1;TNFAIP3;DAG1;SRCIN1;CDH2;GSK3B;SARM1;ZMYM6;PHLDB1;FERMT2;NEDD4;HTATIP2;SEMA4D;STAT2
prerank,peptide catabolic process (GO:0043171),-0.4045846162007415,-1.2380691622325186,0.191044776119403,0.6683311632602937,1.0,5/23,8.79%,ECE1;CPQ;CTSH;ACE;TPP1
prerank,muscle filament sliding (GO:0030049),-0.3671003953208105,-1.2378951820208741,0.14285714285714285,0.6652510450723936,1.0,8/38,14.51%,ACTN2;DMD;TPM1;MYL6;TPM3;TPM2;DES;VIM
prerank,actin-myosin filament sliding (GO:0033275),-0.3671003953208105,-1.2378951820208741,0.14285714285714285,0.6652510450723936,1.0,8/38,14.51%,ACTN2;DMD;TPM1;MYL6;TPM3;TPM2;DES;VIM
prerank,regulation of protein localization to centrosome (GO:1904779),0.5705160277111894,1.2374345388882002,0.24555160142348753,0.8832562774539648,1.0,6/10,26.74%,NUP62;GSK3B;APC;CEP250;NSFL1C;MARK4
prerank,glutamate receptor signaling pathway (GO:0007215),-0.36472551729031244,-1.2374097899716423,0.1388888888888889,0.6650267558018464,1.0,10/37,9.11%,PLCB1;KCNB1;GRM3;GRIA2;CPEB4;GRIN3A;GRIN2B;DAGLA;GRIK2;GRIN1
prerank,L-glutamate transmembrane transport (GO:0015813),0.5754638181732934,1.2366190302585718,0.24551971326164876,0.8846641219473017,1.0,5/10,12.99%,SLC25A12;PRAF2;SLC1A6;SLC25A13;SLC25A22
prerank,sodium ion transport (GO:0006814),0.39795567117540975,1.2361743762395918,0.1670792079207921,0.8846974407786685,1.0,12/85,7.04%,NEDD4L;SCN10A;NALCN;SLC12A2;ANO6;SLC24A1;SLC12A3;KCNK1;ATP1A2;SLC6A13;SLC4A4;SLC4A11
prerank,alanine transport (GO:0032328),-0.5265683984144665,-1.2360538522925473,0.22747747747747749,0.6672371200469616,1.0,4/10,23.93%,SLC6A6;SLC1A4;SLC6A17;SLC7A10
prerank,cilium organization (GO:0044782),0.3670315549974208,1.2359755582132625,0.11087420042643924,0.8838120005835952,1.0,58/210,18.88%,DYNLL1;PARVA;UBXN10;RAB8B;ABLIM3;MKS1;PTPDC1;DZIP1;DYNC2I1;CYS1;EXOC3;CNGB1;INTU;CEP89;CEP131;IFT81;CEP78;CNGA4;EHD2;SNX10;CEP162;CLUAP1;CCP110;ARMC2;OCRL;UNC119B;TCTN2;TMEM237;FOXJ1;DYNLL2;IFT74;CENPJ;HDAC6;CFAP20;EXOC5;CEP290;FAM161B;PKD1;FBF1;PCM1;PDE6D;IQCG;FAM161A;DNAH5;CFAP298;CFAP70;PIBF1;CFAP61;CFAP410;B9D2;CDC14A;DYNC2H1;EHD1;OFD1;ARMC9;BBS1;CEP250;SNAP29
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.4757912165068401,-1.2352757023170986,0.2,0.667681028627863,1.0,6/13,15.04%,SHANK3;ADCY1;SQSTM1;LGMN;EIF2AK4;ZDHHC2
prerank,histone H4-K16 acetylation (GO:0043984),0.5093566701954597,1.2349945106987994,0.23452768729641693,0.8857799840677232,1.0,4/19,7.53%,OGT;KMT2A;KANSL2;MSL3
prerank,protein K48-linked deubiquitination (GO:0071108),0.4855900142204402,1.2347362568731122,0.21085271317829457,0.8851913753717929,1.0,6/23,11.05%,USP50;TNFAIP3;USP8;OTUB2;MINDY2;OTUD7B
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.45472674850266015,-1.2345524713476668,0.20286396181384247,0.6680473997433061,1.0,4/15,13.37%,OSBPL8;OSBPL11;ABHD5;PLIN3
prerank,prostaglandin biosynthetic process (GO:0001516),-0.44152197774488045,-1.2341457983179511,0.19023136246786632,0.6674671996611871,1.0,7/18,19.84%,PTGIS;PTGS1;PTGDS;TBXAS1;EDN1;HPGDS;MIF
prerank,outflow tract septum morphogenesis (GO:0003148),-0.4178232361894931,-1.2340370145054835,0.15294117647058825,0.6660167502578637,1.0,8/24,6.34%,ROBO1;ENG;SMAD6;BMP4;SEMA3C;BMPR2;FGFR2;TBX1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.3440283644924522,-1.2325295036809356,0.16967509025270758,0.6686814761946966,1.0,10/43,7.71%,ITGA1;TGFA;ERRFI1;PTPN3;RNF115;CDC42;ZFYVE28;DUSP3;SH3KBP1;EPS15
prerank,inner mitochondrial membrane organization (GO:0007007),-0.3415309340253366,-1.2324957986476162,0.13962264150943396,0.6670063970460619,1.0,18/47,21.72%,IMMT;ATP5PD;DMAC2L;ATP5MC3;MICOS13;SAMM50;GHITM;ATP5PF;OPA1;MTX2;ATP5ME;ATP5PO;TIMM10B;TIMM8B;ROMO1;MAIP1;TIMM29;ATP5MC2
prerank,regulation of feeding behavior (GO:0060259),0.5616098331450259,1.2324023608604744,0.2593856655290102,0.8919799990402874,1.0,4/11,16.33%,LEPR;SGIP1;CFAP20;AGRP
prerank,cellular response to interferon-gamma (GO:0071346),-0.3005216301363277,-1.2322090100008662,0.07514450867052024,0.6661234841402801,1.0,24/88,19.76%,DAPK1;SP100;IRF2;TRIM25;SIRPA;B2M;VCAM1;GBP3;JAK2;GBP4;RPL13A;CAMK2A;IRF1;GAPDH;GBP6;CCL13;GBP7;LGALS9;GBP2;MT2A;TRIM8;PDE12;DAPK3;ICAM1
prerank,ganglion development (GO:0061548),0.5664388383877075,1.2309438094077272,0.25084745762711863,0.895527841426986,1.0,3/11,14.90%,NRP2;SEMA3A;FZD3
prerank,regulation of interleukin-2 production (GO:0032663),0.4334258865301361,1.2308176111930713,0.19804741980474197,0.894370397060468,1.0,6/43,5.86%,HOMER2;GLMN;PDE4D;IL1A;PTPRC;TNFAIP3
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.31890629863478814,-1.2307543687261573,0.1645021645021645,0.6686308132810985,1.0,21/54,18.40%,ETS1;ANGPT1;NOS3;AKT3;ACVRL1;PRCP;HIF1A;KDR;APOE;AKT1;GATA2;SP1;THBS1;MAP2K3;TMSB4X;P2RX4;ANGPT2;CSNK2B;HSPB1;CD40;VASH1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.4351251870624406,-1.230433786811375,0.19109947643979058,0.6678574834473234,1.0,7/17,36.15%,LPGAT1;PLA2G4F;CRLS1;LPCAT1;PLA2G4B;PLA2G5;LPCAT4
prerank,cellular response to chemokine (GO:1990869),0.4351902351796031,1.2302935659347185,0.21109607577807848,0.8946562147117612,1.0,3/46,1.71%,ACKR3;RIPOR2;SLC12A2
prerank,regulation of defense response to virus (GO:0050688),0.5375121560060151,1.2298537793676163,0.22759856630824374,0.8946829970551298,1.0,6/14,20.96%,PCBP2;TNFAIP3;ZMPSTE24;ITCH;DHX9;TRAF3
prerank,positive regulation of catalytic activity (GO:0043085),0.4470934195747743,1.2287888600709669,0.20998531571218795,0.8969048038826128,1.0,6/37,7.44%,CAV1;MSH6;NCSTN;AZIN2;ABL2;MSH2
prerank,negative regulation of protein processing (GO:0010955),-0.484708200389925,-1.2286897737420168,0.24278846153846154,0.6712804378337152,1.0,4/12,13.19%,GAS1;SERPINE2;LRRK2;THBS1
prerank,ceramide metabolic process (GO:0006672),0.42122186802955525,1.2273585845912227,0.19678714859437751,0.9003976748672192,1.0,8/49,6.25%,SGMS2;CERS6;ACER3;PLPP2;PLPP3;ALOXE3;CLN8;CERK
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.5021309742520812,1.227337477263706,0.24363057324840764,0.8988908085081768,1.0,6/20,11.37%,NEDD4L;PRKCE;CAMK2D;CASQ2;ADRA2A;NEDD4
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.4815640762508871,1.227225194651631,0.23787878787878788,0.897736364082669,1.0,7/26,13.78%,FGFR1;EYA1;IL1A;MCL1;MAPK7;PPP2R1B;HTRA2
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3610862976147039,1.2269138150470318,0.12133891213389121,0.8973251903015321,1.0,70/260,18.88%,DYNLL1;CDH13;PARVA;NTN1;UBXN10;RAP1A;RAB8B;ABLIM3;EMP1;MKS1;MINK1;SPEF1;ANO6;PTPDC1;DZIP1;OPHN1;DYNC2I1;CYS1;EXOC3;CNGB1;INTU;CEP89;CEP131;IFT81;ABLIM2;CNGA4;EHD2;SNX10;ARF6;CEP162;CLUAP1;RAPGEF6;OCRL;UNC119B;TCTN2;TMEM237;FOXJ1;DYNLL2;IFT74;MTSS1;CENPJ;HDAC6;CFAP20;EXOC5;CEP290;ARHGEF6;PKD1;FBF1;PCM1;PDE6D;FAM161A;DNAH5;PTPRO;VSTM5;CFAP298;CFAP70;PIBF1;CFAP410;EZR;B9D2;CDC14A;ARHGEF7;DYNC2H1;S1PR2;EHD1;OFD1;ARMC9;BBS1;CEP250;SNAP29
prerank,positive regulation of cilium assembly (GO:0045724),-0.43886710006859964,-1.2263739179399604,0.20157068062827224,0.6763299070551432,1.0,6/18,14.45%,ARHGAP35;ENTR1;CEP135;FUZ;CEP120;CROCC
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.4009464263832804,1.2263376420389471,0.1880559085133418,0.897748908979092,1.0,7/75,5.06%,DCN;THBS4;SULF1;ADAMTS1;SPRED1;ATP2B4;AMOT
prerank,ether lipid metabolic process (GO:0046485),0.5545189146767152,1.2260864518538914,0.25326797385620914,0.8970612752959065,1.0,4/14,12.01%,AGMO;NCEH1;PAFAH1B1;LIPE
prerank,eye development (GO:0001654),0.4184680219761866,1.2258612280114625,0.20639147802929428,0.8963432184328706,1.0,9/54,8.68%,STRA6;EFEMP1;PBX1;BMPR1B;HIPK1;SH3PXD2B;SHROOM2;FREM2;ABCB5
prerank,regulation of intracellular protein transport (GO:0033157),0.4568466993544893,1.2255128925500507,0.20389805097451275,0.8960192718007329,1.0,10/32,13.86%,RAB29;KIF20B;PTPN14;CEP131;RIPOR1;SIRT7;GCC2;TPR;CEP290;PCM1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.3733571310730772,-1.2253722080339287,0.19003115264797507,0.6775311924611268,1.0,6/31,6.38%,PARD3;MSN;CDC42;LIN7A;ERBIN;SYNJ2BP
prerank,regulation of protein catabolic process (GO:0042176),0.3908815088226703,1.2250949238714273,0.1654501216545012,0.8959630657646366,1.0,11/99,6.07%,PLK2;GPC3;NEDD4L;EGFR;AXIN1;FAM83D;IRAK3;DACT1;WNT5A;TNFAIP3;AZIN2
prerank,gastrulation (GO:0007369),0.5135018041899749,1.2248875923122273,0.226890756302521,0.8951755559098898,1.0,1/15,0.41%,GPC3
prerank,retina homeostasis (GO:0001895),-0.3988900865935386,-1.2246424690445243,0.18873239436619718,0.6778966577357453,1.0,8/23,21.96%,B2M;ACTB;POTEF;ACTG1;ATP1B2;POC1B;HSPB1;TULP1
prerank,positive regulation of cellular respiration (GO:1901857),-0.5081624153825268,-1.224352468443979,0.22966507177033493,0.6769928339301305,1.0,5/11,23.51%,NUPR1;IL10RB;VCP;IFNAR1;ISCU
prerank,regulation of vasoconstriction (GO:0019229),0.47330663570243214,1.2231782943088192,0.24060150375939848,0.8996637535884333,1.0,3/27,3.83%,CAV1;SMTNL1;SMTNL2
prerank,maintenance of protein localization in organelle (GO:0072595),0.5122418788870345,1.2229742148437543,0.233387358184765,0.8989213742731096,1.0,3/19,4.76%,HK2;BCL3;MORC3
prerank,positive regulation of protein phosphorylation (GO:0001934),0.35245439879571694,1.2229270051854078,0.09683995922528033,0.8975058398934603,1.0,31/348,5.38%,NGF;THBS4;CAV1;EFNA5;FGF7;TEC;NTRK3;INHBB;CSPG4;CLDN19;LEPR;EGFR;RAPGEF3;CCND3;MUSK;RAP1A;PELI2;FGF1;AXIN1;FXR2;PRKAG1;MMD2;SOX9;SRC;BMP5;ATP2B4;LIMK2;PTPRC;BANK1;TOM1L1;BMP15
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.5489447600493947,1.2226781864505463,0.24027072758037224,0.8968362346560631,1.0,5/12,24.20%,SOX9;SMO;PAX2;LHX1;SIX1
prerank,glycoprotein biosynthetic process (GO:0009101),-0.3076757996641329,-1.2214031784906758,0.115,0.6840562593951867,1.0,20/79,14.84%,IGF1;ST3GAL6;ST3GAL5;ST8SIA4;CSGALNACT1;CHST11;ATP7A;COG7;BMPR2;CSGALNACT2;ST6GALNAC2;ALG5;FAM20B;B4GALT7;ALG1;GOLGA2;B3GALT2;ST8SIA2;CHST9;GCNT1
prerank,protein localization to plasma membrane (GO:0072659),0.3777151143100391,1.2212733750513467,0.1707891637220259,0.9001494078183097,1.0,15/129,9.39%,PTCH1;F11R;SLMAP;EPB41L3;RAP1A;RAB8B;KCNIP4;FLOT2;RDX;EHD2;RAB3A;EFR3A;RAPGEF6;ZDHHC23;ATP1B3
prerank,prostanoid biosynthetic process (GO:0046457),-0.4614979070932377,-1.2207986647337574,0.22488038277511962,0.6841905355661484,1.0,6/15,19.84%,PTGIS;PTGS1;PTGDS;TBXAS1;EDN1;MIF
prerank,endodermal cell fate commitment (GO:0001711),0.5771470493527278,1.2205736587890617,0.25925925925925924,0.9010644193812191,1.0,4/10,20.09%,LEO1;PAF1;RTF1;CDC73
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.5651035533346742,1.220203244140455,0.25402504472271914,0.9007889917194019,1.0,6/10,21.04%,SESTD1;FKBP1B;ATP1A2;ADRA2A;YWHAE;CBARP
prerank,glucose metabolic process (GO:0006006),0.4134849832887812,1.2199283593692796,0.19509043927648578,0.9002004798800114,1.0,14/58,17.84%,APOD;PPARGC1A;SLC25A12;ALDOB;PGM1;ADPGK;MDH1;SLC25A13;ENO3;GOT1;HECTD4;PGK1;IRS2;ENO2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.5024477031196277,1.2198536768163442,0.2358490566037736,0.8989178719970649,1.0,7/18,17.51%,VGLL4;DACT1;RDX;FAF1;CD81;EZR;VPS11
prerank,renal system development (GO:0072001),0.4260549060120356,1.2197891746588527,0.21635883905013192,0.8976139707034742,1.0,5/52,2.92%,STRA6;LRP4;SULF1;PCSK5;GLI2
prerank,protein autophosphorylation (GO:0046777),-0.272772481098481,-1.2197822636866456,0.058823529411764705,0.6855875565826229,1.0,39/157,13.56%,FLT1;IGF1R;DAPK1;INSR;TEK;PDGFRB;PDGFRA;GRK5;LYN;DDR1;EPHA4;KIT;FGFR2;STK17B;SIK1;KDR;BMX;EPHA8;CDK12;JAK2;MAP2K2;STK10;MKNK2;AKT1;ULK2;CAMK2A;MAP3K10;CDKL5;EIF2AK4;MKNK1;CAMK4;OXSR1;LRRK2;FGFR4;TAOK2;FLT4;MAPKAPK2;PIM3;MAPKAPK3
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.48199486575339634,-1.2195420489311586,0.23728813559322035,0.6845983315358188,1.0,6/12,21.63%,LDLR;APOE;VBP1;CRYAB;PFDN4;CLU
prerank,regulation of sequestering of calcium ion (GO:0051282),0.5505732057279016,1.2194151595938614,0.261101243339254,0.8974456452100387,1.0,3/12,9.03%,UBASH3B;FKBP1B;CASQ2
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.3008231749359961,-1.2187055444088026,0.09090909090909091,0.6852824662885773,1.0,18/85,9.50%,IGF1;MCC;TGFA;OSR1;ANGPT1;BMP6;TGFBR3;NUPR1;BMP4;TIE1;ACVRL1;FGFR2;B2M;DUSP10;TBX1;CDK6;AQP11;LAMB1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.3534821511314959,-1.2186599482746165,0.13804713804713806,0.6836821991091412,1.0,9/41,7.30%,PRKAG2;NUP107;EP300;LACC1;HIF1A;AAAS;SEH1L;NUP133;PGAM1
prerank,regulation of establishment of cell polarity (GO:2000114),0.5221222336944149,1.2185174857464336,0.2568659127625202,0.8991908133455516,1.0,4/16,7.57%,RIPOR2;CDH5;KIF20B;KANK1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.4808556473110675,-1.2185024483237084,0.22274881516587677,0.6824105767404773,1.0,5/12,21.80%,PIK3R1;BCL2L11;BOK;XBP1;ATF6
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.5535123646067941,1.2181525732799614,0.26567656765676567,0.8989102055949967,1.0,2/13,0.91%,PPARGC1A;GUCA1A
prerank,positive regulation of glycolytic process (GO:0045821),-0.414851936761324,-1.2177574967666103,0.17647058823529413,0.6811849891064742,1.0,8/20,19.40%,IGF1;INSR;HIF1A;PFKFB3;P2RX7;PFKFB1;ENTPD5;GAPDHS
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.414851936761324,-1.2177574967666103,0.17647058823529413,0.6811849891064742,1.0,8/20,19.40%,IGF1;INSR;HIF1A;PFKFB3;P2RX7;PFKFB1;ENTPD5;GAPDHS
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.3698278823350571,-1.217434332109284,0.19756838905775076,0.6805001412604427,1.0,16/30,33.79%,INSIG2;ARV1;HMGCS1;ACAA2;ACLY;NSDHL;PMVK;MVK;ACAT2;DHCR7;TM7SF2;MVD;PLPP6;SQLE;EBP;LBR
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.39243901762442857,1.2158602181099352,0.20280612244897958,0.9056090849915286,1.0,12/80,11.88%,TENM2;RIPOR2;PLCE1;ARAP1;CDC42EP4;RAC2;PALM;CCP110;OCLN;GPM6A;APC;AKIRIN1
prerank,hexose transmembrane transport (GO:0008645),-0.4110442953896484,-1.2157424980489033,0.20891364902506965,0.6839974665461048,1.0,10/21,27.12%,PPARD;SLC2A12;SLC2A10;SLC45A3;SLC2A8;SLC2A9;SLC2A1;SLC45A1;SLC2A3;SLC2A4
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.3715846607072724,1.2156150898813693,0.17155756207674944,0.9049605077895245,1.0,12/140,7.88%,CAV1;LPAR1;ACKR3;PLCE1;ITPR3;PTGFR;CD55;TRPV4;FIS1;ADCY5;ABL2;PTGER4
prerank,regulation of peptidase activity (GO:0052547),0.5010203520591697,1.2156044479887698,0.2463295269168026,0.903467398286478,1.0,1/19,0.24%,CAV1
prerank,epithelial cell migration (GO:0010631),0.44041298641226745,1.2154765965642416,0.23055162659123055,0.9024281492315985,1.0,7/37,8.07%,CDH13;PXN;FAP;KANK2;KANK1;DPP4;STARD13
prerank,establishment of endothelial barrier (GO:0061028),0.46814687136530647,1.2147887965161195,0.23401162790697674,0.9033587997680675,1.0,7/29,8.67%,F11R;RAPGEF3;RAP1A;PDE4D;TJP2;RDX;RAPGEF6
prerank,sterol transport (GO:0015918),0.5126040073366661,1.2147362867863378,0.248,0.9020181801717798,1.0,1/19,0.24%,CAV1
prerank,positive regulation of axonogenesis (GO:0050772),0.437527016898003,1.214627995060507,0.2143864598025388,0.90085090500336,1.0,3/43,1.05%,NGF;NTN1;TIAM2
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5218835032159201,1.2145786688757632,0.250814332247557,0.8995520728676597,1.0,5/16,7.77%,DIP2A;SCD5;ACACA;GCDH;ACAT1
prerank,T cell mediated immunity (GO:0002456),0.5469138545124337,1.2144828333132367,0.24108658743633277,0.8983771125979343,1.0,3/13,7.33%,JAG1;CD55;CRTAM
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.5221363481495869,1.2137923838097682,0.24570446735395188,0.8992989060313783,1.0,2/16,2.06%,FOXD1;FGF1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.41801638604836727,-1.2134681251210762,0.19946091644204852,0.689031527325254,1.0,4/19,6.38%,PARD3;CLIC4;ERBIN;SYNJ2BP
prerank,axonogenesis (GO:0007409),0.3561205204563181,1.2127084535366557,0.1325556733828208,0.9016455135272702,1.0,36/237,11.17%,NTNG2;NTNG1;GAB1;EFNA5;LAMA2;EFNB1;NRP2;PARD6B;SEMA4B;GLI2;OPHN1;S100A6;PRKCA;SRC;DSCAM;WNT5A;BRSK1;ARTN;LAMA5;EPHB2;RAB3A;DAG1;EFNB2;SEMA3A;NTN3;SIAH1;MAPK7;S100B;ISL1;TNR;NTN4;GAB2;POU4F1;RELN;DOCK7;SLC9A6
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.283530660933725,-1.212533690846621,0.11363636363636363,0.6903110485059563,1.0,27/124,14.92%,FRY;PTPRM;RAPGEF2;TPM1;LYN;FRYL;STMN2;RASGRF1;GPRIN3;APOE;EPHA8;TBC1D24;STMN4;CAMSAP1;WDPCP;RAB13;LAMB1;MANF;ATP1B2;RAB11A;STMN1;LGI1;MAPT;SH3GL2;DTNBP1;MICALL1;CDK5R1
prerank,proteolysis (GO:0006508),0.3543854513021042,1.2120024664025115,0.13897596656217345,0.9026620622753787,1.0,52/252,17.65%,PTCH1;CTRC;ADAMTS12;TINAGL1;FAP;NAALAD2;PCSK5;ADAM19;OGT;SENP6;MMP15;APH1B;CPE;CAPN6;CPA2;RNPEP;NCSTN;ADAM10;LVRN;DPP4;FBXO3;PSMB5;LNPEP;UFSP2;PCSK7;BACE2;LONP1;MMP12;MME;PROC;CELA1;TASP1;XPNPEP3;MMP16;CAPN2;MIPEP;ATG4C;HTRA2;PSMA6;PLG;GGT1;FAM111A;TYSND1;NLN;ZMPSTE24;BACE1;MBTPS1;PM20D2;MMP14;TMPRSS7;BMP1;CTSB
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3715486776583194,1.2115802781177576,0.17680826636050517,0.9026004527536319,1.0,46/129,21.95%,CAV1;GPC3;PPM1N;NRARP;EGFR;AXIN1;PSME3;DACT1;PPM1A;USP8;UBR5;PLEKHA4;FAM53B;KANK1;CSNK1G3;PSMB5;RNF220;USP47;AXIN2;COL1A1;SOX4;PSMB2;CAPRIN2;PSMA2;PSMA6;FZD9;PSMD13;PSMA7;GPC5;PSME4;CSNK1G1;FGF10;PSMC4;CDH3;PSMB6;PSMD12;ATP6AP2;PSMD14;PIN1;TRPM4;RNF146;USP34;CCAR2;PSMB3;GSKIP;GID8
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.4033565096434749,-1.2106468814724967,0.2096317280453258,0.6943397947917338,1.0,3/21,2.21%,OSBPL8;OSBPL10;PLA1A
prerank,response to nutrient levels (GO:0031667),-0.4354787160758153,-1.2099438561515226,0.2075,0.6947751199458765,1.0,8/17,32.24%,KCNB1;RPS6KB1;EIF4G1;ATF4;FAM107A;PRKAA1;MEAK7;ULK1
prerank,regulation of cilium assembly (GO:1902017),-0.3136815542786978,-1.2097613166704708,0.1559633027522936,0.6935939026837491,1.0,18/62,14.45%,TBC1D1;RABGAP1;TBC1D30;USP6NL;TBC1D2B;ARHGAP35;ENTR1;TBC1D24;SGSM3;CDKL5;DCDC2;EVI5L;FUZ;CEP97;TBC1D22B;CEP120;TCHP;CROCC
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.5343869329342766,1.209685726122613,0.26424870466321243,0.907744921252898,1.0,1/15,0.21%,ETV4
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.47409099931508863,-1.2095220115251557,0.2702702702702703,0.6926278553020168,1.0,6/12,22.77%,LRRK2;TMEM9;CLN5;GRN;CLN6;CCDC115
prerank,regulation of integrin activation (GO:0033623),0.5273219990860942,1.2093410154878537,0.2634228187919463,0.907427525025431,1.0,5/15,10.07%,SRC;PTGER4;PIEZO1;PLEK;FERMT2
prerank,positive regulation of epithelial cell migration (GO:0010634),0.3864332757949049,1.2089854094248884,0.1855421686746988,0.9071749107702303,1.0,12/92,4.96%,FGF7;SMOC2;DOCK5;PRKCE;FGF1;NRP2;DOCK1;GPLD1;SOX9;PRKCA;SRC;WNT5A
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.384581121175128,-1.208958338187191,0.21406727828746178,0.6925825383226341,1.0,5/24,6.94%,GHR;KIT;IL10RB;CYP1B1;JAK2
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.3564116073818805,1.2086021243635365,0.13900862068965517,0.9070581421309937,1.0,19/214,6.38%,ROR2;CNKSR3;ROR1;NTRK3;ACKR3;RGS14;CEACAM1;EGFR;RAP1A;SPRED1;SPRY1;PTPN22;PRKCA;FAM83D;PTPRC;FN1;STYX;ARHGEF5;EPHB2
prerank,negative regulation of cell communication (GO:0010648),0.4993983337859853,1.207886622090065,0.2544,0.9080665393000463,1.0,2/21,2.26%,UBASH3B;SOCS5
prerank,peptidyl-tyrosine modification (GO:0018212),0.407833420164844,1.2068500497462344,0.19553805774278216,0.9102703311931462,1.0,9/56,6.48%,PKDCC;TEC;FGFR1;EFEMP1;EGFR;SRC;FER;EPHB2;ABL2
prerank,regulation of glycolytic process (GO:0006110),-0.3178789960461699,-1.206646896627402,0.13656387665198239,0.6978613657601228,1.0,12/68,7.30%,PRKAG2;IGF1;INSR;NUPR1;NUP107;CBFA2T3;EP300;HIF1A;AAAS;SEH1L;NUP133;PGAM1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.39919121325491136,-1.2065359090514183,0.22188449848024316,0.6964847064192855,1.0,4/23,3.95%,GHR;KIT;IL10RB;CYP1B1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4032441552818587,1.206440265698371,0.20075757575757575,0.9101783871351985,1.0,6/63,5.89%,ITGA6;CAV1;FGFR1;SRC;PSME3;TRADD
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.508091046413547,1.2057446234143898,0.26148969889064977,0.911135068660677,1.0,6/19,17.58%,HNRNPC;SRC;STN1;EXOSC10;GNL3L;TERF2
prerank,neuromuscular process (GO:0050905),0.5357156464136503,1.2055968988892198,0.24342105263157895,0.9101246898956301,1.0,1/16,0.21%,STRA6
prerank,regulation of histone acetylation (GO:0035065),0.4527696717677341,1.205198805210635,0.24475524475524477,0.9100257526165878,1.0,4/33,3.65%,PPARGC1A;RAPGEF3;KMT2A;SPI1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.42509744675385364,-1.2050882452906702,0.22885572139303484,0.6991358351752514,1.0,7/18,12.46%,FRS2;CCN3;HDAC1;BMP2;GSK3A;SOX6;BDNF
prerank,carnitine shuttle (GO:0006853),-0.5050111362108249,-1.2049505946806665,0.2152777777777778,0.6979309591016177,1.0,5/11,14.68%,PRKAG2;CPT2;PRKAB2;CPT1A;MID1IP1
prerank,chondroitin sulfate metabolic process (GO:0030204),0.460285380771152,1.2048968478128144,0.251453488372093,0.9096463992255419,1.0,4/30,5.76%,DCN;CSPG4;CHST7;NCAN
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.4474635002140395,-1.2046983734437406,0.22857142857142856,0.6969464698503959,1.0,2/15,5.90%,MOXD1;SAT1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.4884933467054401,1.2045029573433064,0.2544,0.9095531597673223,1.0,2/19,0.56%,VGLL4;GLI1
prerank,early endosome to Golgi transport (GO:0034498),-0.4979587963583604,-1.2043228708306966,0.26097560975609757,0.6964139502187687,1.0,4/11,8.88%,TRAPPC10;TMED9;RBSN;SURF4
prerank,rRNA transcription (GO:0009303),0.5138131002273666,1.204096894030635,0.24745762711864408,0.9095886682718521,1.0,6/17,13.76%,CAVIN1;GTF3C6;POLR1E;SIRT7;SPIN1;GTF3C5
prerank,energy reserve metabolic process (GO:0006112),-0.43236423450143063,-1.2039469833106191,0.2222222222222222,0.6959113833352418,1.0,4/19,7.21%,PRKAG2;PID1;GBE1;UGP2
prerank,dopaminergic neuron differentiation (GO:0071542),-0.41065307778934323,-1.203383098577404,0.22074468085106383,0.6959299774684072,1.0,11/19,47.90%,LRP6;NR4A2;MANF;LMX1B;LMX1A;WNT2;SHH;FOXA1;EN1;FOXA2;CDNF
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.4195050857176129,-1.203333330943155,0.19733333333333333,0.6944314649691893,1.0,9/19,36.26%,ADK;HPRT1;CDA;POLD2;APRT;ADA;POLL;TYMS;GMPR
prerank,cellular response to lipid (GO:0071396),0.3529643788070633,1.2028541108689512,0.16216216216216217,0.9125124109965121,1.0,43/191,16.17%,RORA;LBP;EGFR;SSTR1;TNIP3;GPLD1;IL1A;SOX9;WNT5A;ATP1A2;PDK4;ADCY5;TNFAIP3;NRIP1;ABL2;SELENOS;PAF1;BRINP1;DEFA6;ACOD1;IRGM;CHMP5;HMGB1;RORB;TICAM1;POU4F1;AXL;NCOA3;NFKBIB;WNT9A;AQP1;HTRA2;KCNK4;FZD7;LCOR;GPER1;CCR5;CCDC62;ADCY8;ADCY3;TICAM2;PLAA;TESC
prerank,positive regulation of protein secretion (GO:0050714),-0.3003874789318453,-1.2023118544187466,0.14479638009049775,0.6957902927973881,1.0,14/69,14.27%,IGF1;MYRIP;BMP6;WLS;RBP4;C1QTNF3;TGFB3;MYH10;NNAT;SYTL4;LRRC8A;TGFB2;MYO18A;ABCG1
prerank,kidney development (GO:0001822),0.4055022384012216,1.202233843483717,0.20387096774193547,0.9132471499684555,1.0,7/65,5.45%,STRA6;LRP4;SULF1;PCSK5;GLI2;NF1;KANK2
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.47587750580680854,-1.2021524281356237,0.24504950495049505,0.6945784973344588,1.0,2/12,4.03%,LY6E;MID2
prerank,bone development (GO:0060348),-0.34791853777039305,-1.2014757641911373,0.17288135593220338,0.6949489196896275,1.0,9/39,7.80%,RANBP3L;GNAS;CYP26B1;TGM2;GJA1;FGFR2;PLS3;NOTUM;LRP6
prerank,DNA dealkylation (GO:0035510),0.5774667142767251,1.2011062353377633,0.2904929577464789,0.9142856374028073,1.0,9/10,32.35%,MGMT;ALKBH1;ASCC2;ASCC1;ALKBH2;ALKBH3;FTO;MPG;ALKBH5
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.5774667142767251,1.2011062353377633,0.2904929577464789,0.9142856374028073,1.0,9/10,32.35%,MGMT;ALKBH1;ASCC2;ASCC1;ALKBH2;ALKBH3;FTO;MPG;ALKBH5
prerank,artery morphogenesis (GO:0048844),0.4524409048938293,1.2010422386071158,0.2309941520467836,0.913027012381049,1.0,4/30,3.23%,STRA6;FOLR1;JAG1;NF1
prerank,positive regulation of signal transduction (GO:0009967),-0.25288214648749324,-1.2006652234742186,0.04838709677419355,0.6956979152647524,1.0,62/238,14.96%,IGF1;ROBO1;SASH1;VWF;TEK;PTGIS;CCBE1;RSPO3;SHANK3;BMP6;WLS;RBPJ;GRB10;NOS3;PIK3R1;TGFBR1;IGF2;EP300;MBD5;FGFR2;MN1;CCN3;F3;HIF1A;FAS;DSTYK;RSPO2;PDCD10;CUX2;SLC39A14;JAK2;JAG2;CITED2;GRIN1;TRIM16;ATP6V0C;ASXL2;FLNA;SNW1;TXNDC15;DCDC2;TM2D3;RPS3;MACF1;BMP2;KLF2;CD80;LRRK2;PRKCZ;CTBP2;TTC23;NRXN1;LOXL3;BDNF;TGFB2;CSNK2A1;CDKN2AIP;MAML3;ILK;RWDD3;ESM1;NRP1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.4287773266135874,1.200611434889662,0.23226703755215578,0.9131186605874385,1.0,7/46,8.41%,CNKSR3;RGS14;SPRED1;SPRY1;PTPRC;EPHB2;TNIP1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.3833934186133662,-1.2000790112050594,0.2085889570552147,0.6958486139772647,1.0,6/25,7.06%,SLC7A5;KIT;LACC1;B2M;TRAF6;PLCG2
prerank,regulation of Wnt signaling pathway (GO:0030111),0.3731148792675796,1.1996799753135097,0.20685579196217493,0.9149169058467845,1.0,22/108,14.10%,MDFIC;GPC3;VGLL4;SULF1;NFATC1;FOLR1;AXIN1;DEPDC1B;GNAQ;DACT1;TNFAIP3;HIC1;FAM53B;KANK1;TMEM237;KREMEN1;SPIN1;NXN;EMD;CTNNBIP1;CBFB;FZD7
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.5763060434926437,1.1992696099561033,0.2597173144876325,0.9149176739310241,1.0,3/10,9.58%,OGT;SELENOS;SIRT7
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.4269394396341772,1.198160928579509,0.24592391304347827,0.9173221181493625,1.0,11/41,12.76%,EPHX1;ELOVL5;ALOXE3;DECR2;ELOVL1;SCD5;ELOVL2;HSD17B4;ACOT8;ABCD1;PNPLA8
prerank,positive regulation of cell motility (GO:2000147),0.35506233804127446,1.1979236773596678,0.17096774193548386,0.916705155137792,1.0,23/205,7.11%,ROR2;CLDN1;ITGA6;CAV1;NTRK3;CDH13;NTN1;EGFR;GTSE1;FGF1;SEMA4B;SH3RF2;CDH5;ITGAX;PRKCA;CAVIN1;FER;TRADD;ADAM10;EPHB2;RDX;RIPOR1;SEMA3A
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.35254547767235284,1.1973504678299303,0.15852334419109662,0.9172092950518167,1.0,41/186,15.71%,CAV1;IGFBP6;LRP4;VGLL4;GLI1;PRICKLE1;DKKL1;NFATC1;AXIN1;MLLT3;SOX9;CHD8;PSME3;DACT1;WNT5A;HIC1;ZNRF3;CUL3;AMFR;PSMB5;STK3;GSK3B;CSNK1A1;SDHAF2;AXIN2;APC;DVL3;KREMEN1;NXN;EMD;CTNNBIP1;PSMB2;PSMA2;PTPRU;PTPRO;PSMA6;BICC1;TMEM170B;PSMD13;NPHP4;PSMA7
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.5695850085966618,1.1973264685358338,0.2715827338129496,0.9158370912439812,1.0,2/10,4.65%,ARHGAP12;BMP5
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.4940026577262584,-1.1967874200035318,0.25389755011135856,0.7044391069453192,1.0,6/10,14.68%,LPGAT1;NR1H3;NR1H2;SLC45A3;ABCD2;MID1IP1
prerank,response to reactive oxygen species (GO:0000302),0.4114224632096658,1.1966743431970963,0.23505434782608695,0.9166988847985871,1.0,5/54,5.70%,APOD;PXN;EGFR;MPV17;FER
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.42062404381676316,1.1964957790164492,0.21957671957671956,0.9158805325104799,1.0,15/54,17.13%,CAV1;SH3RF2;OGT;TNFAIP3;TRIM21;N4BP1;SIRT7;SPOPL;NXN;USP4;SOX4;GNL3L;BAG2;MINAR1;CHP1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.4023599041194718,1.1964537003312194,0.2244355909694555,0.914564750158845,1.0,8/59,11.07%,ALDH1A3;CYP7B1;OSBPL6;HOGA1;ACACA;HSD17B4;ACOT8;GAMT
prerank,amyloid fibril formation (GO:1990000),0.4181275786751749,1.1964158958389393,0.23128342245989306,0.9132501643660662,1.0,6/51,7.41%,TGFBI;UBE2L6;APH1B;NCSTN;ADAM10;SIAH1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3942789961683542,1.1963762287589208,0.21401752190237797,0.9119263541276093,1.0,11/79,5.61%,DLX1;ADAMTS12;SULF1;CASK;SPRY1;BMPR1B;NBL1;SPRY4;ATP2B4;CREB3L1;APLN
prerank,membrane fusion (GO:0061025),-0.3704184100421227,-1.1961516985218497,0.1875,0.7047183096279908,1.0,4/33,3.74%,MYOF;DNM3;DYSF;NAPA
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3875615319544705,1.195824533515175,0.22982885085574573,0.912469610306528,1.0,5/85,2.95%,ROR1;HOMER2;PIEZO2;RIPOR2;EYA1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.2733482730688274,-1.1957995621710678,0.09032258064516129,0.7040209390922073,1.0,29/113,16.24%,ASAP1;TRABD2B;TFRC;BCL2L11;FNIP1;RASIP1;RBX1;FNIP2;RHOC;SLF2;SH3GLB1;MED25;CAPG;VCP;SLF1;RPS3;AJUBA;BID;MMP1;ESR1;MPP7;TTBK1;DHX33;ERCC2;TAL1;XPA;ISG15;EIF4G1;SKAP1
prerank,neuron differentiation (GO:0030182),0.35680977822780185,1.1935929680763036,0.18161434977578475,0.91881046643448,1.0,13/165,5.56%,TENM2;WNT10A;PBX1;FZD2;BHLHE22;NEUROD6;RUNX2;GLI2;WNT2B;OPHN1;WNT16;WNT5A;BRSK1
prerank,hexose metabolic process (GO:0019318),0.430637215125319,1.1934973621472749,0.22206303724928367,0.9177299731304811,1.0,10/39,19.40%,APOD;ALDOB;PGM1;ADPGK;GALK1;GALK2;PMM1;HECTD4;IRS2;SLC37A4
prerank,regulation of cell cycle process (GO:0010564),0.37315862336862127,1.1933762926692077,0.19189511323003575,0.9166913247252558,1.0,20/104,12.39%,PLK2;FBXO43;KIF20B;CAV2;RACGAP1;SOX9;PIK3R4;RPRD1B;CDK13;KIF13A;FBXO5;CCP110;E4F1;CEP85;APC;KLHL21;ZFYVE26;MAP9;CETN2;AHCTF1
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.39372337550236836,-1.1932194254993322,0.2096317280453258,0.7101774608265463,1.0,7/23,16.28%,SASH1;TRAF6;MAP3K10;RPS3;TNFRSF11A;EDN1;DVL2
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.4402568479855025,-1.1928046299179034,0.24808184143222506,0.7097577103704249,1.0,9/14,37.06%,FLNA;SLC2A10;LOXL3;LIMS2;LIMS1;PRKD1;TIMP1;BST1;PHACTR4
prerank,positive regulation of dendrite development (GO:1900006),0.5644674853845857,1.1923986102664446,0.24822695035460993,0.9187471155562453,1.0,2/10,4.65%,COBL;BMP5
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.46150507991320294,-1.1917687616095325,0.22760290556900725,0.711215646626688,1.0,7/14,16.78%,SEMA7A;KIT;PLCG2;BCL10;CAMK4;LAPTM5;GPRC5B
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.32874059458276816,-1.1916376565645936,0.18439716312056736,0.7099775595105479,1.0,12/41,19.17%,TGFA;NEDD9;EPHA4;ACE;DOCK3;NOX4;LRP8;IL34;BDNF;GPRC5B;EGF;AGT
prerank,positive regulation of lipid metabolic process (GO:0045834),0.4807674426151295,1.1914807454299448,0.2752,0.9204191365951699,1.0,2/22,1.88%,SORBS1;ZBTB20
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.36401418123111223,1.1914716585187697,0.18742857142857142,0.9190059049174987,1.0,8/138,1.81%,NGF;ROR2;ROR1;NTRK3;FGFR1;EGFR;PTPRF;MUSK
prerank,response to exogenous dsRNA (GO:0043330),0.49855991579515674,1.1913280357288427,0.28595317725752506,0.9180511022754726,1.0,3/18,9.65%,CAV1;IRAK3;TICAM1
prerank,T cell activation (GO:0042110),0.3982213707777611,1.1911272925972887,0.21875,0.9172401133385094,1.0,10/69,7.89%,CXADR;LEPR;ITK;CD3G;RAB29;PTPN22;PTPRC;NCK2;CRTAM;DPP4
prerank,hydrogen peroxide catabolic process (GO:0042744),0.5460037950426305,1.1911095421819184,0.28066914498141265,0.915873607885142,1.0,1/11,0.87%,PXDN
prerank,cardiac muscle cell differentiation (GO:0055007),0.4832771203583728,1.1904614317687403,0.26582278481012656,0.9168278146579211,1.0,2/21,3.33%,CXADR;AKAP13
prerank,acidic amino acid transport (GO:0015800),0.49192709150661096,1.190209717210069,0.28685897435897434,0.9163306002874743,1.0,7/17,12.99%,LRRC8D;SLC25A12;PRAF2;SLC6A13;SLC1A6;SLC25A13;SLC25A22
prerank,T-helper cell differentiation (GO:0042093),-0.4516210420069916,-1.190122059668046,0.23658536585365852,0.7128118426266223,1.0,3/14,3.31%,LEF1;FOXP1;ATP7A
prerank,natural killer cell activation (GO:0030101),0.47795124100109176,1.190069515376392,0.26186830015313933,0.9153888227761193,1.0,6/23,18.48%,PBX1;PTPRC;IL21R;AXL;ULBP1;RABL3
prerank,actomyosin structure organization (GO:0031032),0.38716445422437057,1.1900353451172978,0.228643216080402,0.9140802414070329,1.0,12/75,8.78%,F11R;SORBS1;EPB41L4A;EPB41L2;EPB41L3;TMOD2;CSRP3;SRC;KRT19;CUL3;TMOD1;OBSCN
prerank,triglyceride biosynthetic process (GO:0019432),0.5006690462070252,1.1898563330342005,0.265139116202946,0.9132596780637194,1.0,4/18,3.75%,MOGAT2;MOGAT3;GPAT3;AGMO
prerank,response to metal ion (GO:0010038),0.3969694500847665,1.1887711026319097,0.23918575063613232,0.915574591527812,1.0,6/67,4.18%,CAV1;NEDD4L;ITPR3;SLC25A12;IL1A;TFR2
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.4438093767754399,1.188533981799613,0.24617524339360222,0.9149788291951969,1.0,4/33,5.61%,KLF5;SPI1;FOXO3;APLN
prerank,regulation of interleukin-4 production (GO:0032673),-0.4001815567966963,-1.188521194514394,0.2140921409214092,0.7160438573404796,1.0,5/21,15.22%,LEF1;SLC7A5;PRKCZ;CEBPB;LGALS9
prerank,regulation of focal adhesion assembly (GO:0051893),0.4125676709030623,1.1881081547390133,0.22523744911804613,0.9151197935362095,1.0,5/54,4.48%,APOD;EFNA5;DLC1;PEAK1;SRC
prerank,lung epithelium development (GO:0060428),0.5558658799482857,1.1867935744430458,0.304270462633452,0.918256029881067,1.0,1/10,0.21%,STRA6
prerank,nuclear transport (GO:0051169),0.4987456263875608,1.1863628975043468,0.26721311475409837,0.9182949002554514,1.0,2/16,5.19%,RGS14;RBM15B
prerank,mismatch repair (GO:0006298),0.45172106473928675,1.1860497865196233,0.26635514018691586,0.917949177000902,1.0,8/27,21.53%,TDG;MSH6;MSH2;ERCC1;SETD2;MLH3;MLH1;RPA3
prerank,positive regulation of cell adhesion (GO:0045785),0.3898931446514587,1.1857683110777373,0.22194199243379573,0.9175326239315084,1.0,3/74,0.80%,MAGI1;VIT;ECM2
prerank,regulation of mononuclear cell migration (GO:0071675),-0.3929834787609241,-1.1857618895718487,0.22318840579710145,0.7226776204333542,1.0,10/23,18.74%,MSN;SLIT2;LYN;STK10;CMKLR1;IL34;THBS1;PTK2;CSF1;RARRES2
prerank,regulation of DNA binding (GO:0051101),0.4201873049509377,1.1856433122470655,0.25103448275862067,0.9165876174018615,1.0,18/44,23.02%,NGF;BCL3;HJURP;HMGB1;SMO;TXN;E2F1;PPARG;SUMO1;NME1;PRKN;HABP4;MAPK8;RSF1;FOXC1;JUN;SIRT2;ZBTB7A
prerank,negative regulation of axonogenesis (GO:0050771),0.4601263398732834,1.1855204560855586,0.2595307917888563,0.9155838608899874,1.0,9/27,18.51%,LRP4;RTN4R;CDKL3;GDI1;TRIM46;PTEN;RTN4;EFNB3;RHOA
prerank,endothelial cell differentiation (GO:0045446),-0.4792209148782655,-1.18529091921965,0.2727272727272727,0.7224208335658459,1.0,6/12,10.38%,TIE1;ACVRL1;BMPR2;KDR;SCUBE1;PROX1
prerank,negative regulation of lymphocyte activation (GO:0051250),0.48298796406603545,1.1851415895984714,0.25434439178515006,0.9155234621220729,1.0,5/21,9.40%,IL4I1;PTPN22;BANK1;TNFAIP3;FOXJ1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.39081572454473945,-1.1849611404661362,0.23876404494382023,0.7217283456343062,1.0,5/22,11.15%,TIMP3;PTPN3;TNFRSF1B;APOE;FURIN
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.380328364032548,-1.1848305290551602,0.2120253164556962,0.7204544084752025,1.0,7/24,10.57%,TEK;ANGPT1;NDNF;KDR;GATA2;RAMP2;SCG2
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.39814178007551065,-1.18465693153084,0.25190839694656486,0.7193009333099003,1.0,11/20,25.08%,RBPJ;SMAD9;EP300;SMAD5;HIF1A;BMP2;SMAD4;ATF4;XBP1;SMAD1;NOTCH1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.34022407671687926,1.1846484908915544,0.1504149377593361,0.9157904928564323,1.0,39/308,11.50%,EBF2;ETV4;CAV1;INHBB;PPARGC1A;LBP;SMTNL1;FOXD1;LEPR;GLMN;ITK;OGT;ITGAX;TXK;IL1A;SMTNL2;SOX9;BMPR1B;MFN2;KMT5C;SLC27A1;WNT5A;RREB1;CRTAM;FBXO5;PTGER4;GCNT2;TSHR;FOXJ1;ABCA1;KSR2;FERMT2;HILPDA;ADRA2A;AXIN2;APC;COL1A1;VAMP8;PRLR
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.46637266871880423,-1.1845207099549757,0.25862068965517243,0.718054048184011,1.0,6/12,23.71%,PLCG2;CYBA;GRIN1;ADGRB1;RAB27A;ZNF205
prerank,mitochondrion distribution (GO:0048311),-0.45438428617591897,-1.1840566371065757,0.2531328320802005,0.7177512242424626,1.0,3/12,14.30%,MEF2A;LRRK2;MAPT
prerank,heterocycle biosynthetic process (GO:0018130),-0.4533735604233865,-1.1835387062661986,0.24031007751937986,0.7176489208138256,1.0,9/14,40.89%,GCH1;NFS1;PYCR2;MOCS3;PYCR3;PYCR1;ALOX5;GPHN;NOXRED1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.43584798562393046,1.183474481503957,0.2556179775280899,0.9185251598497118,1.0,5/36,8.91%,OGT;FHIT;OPHN1;N4BP1;DDRGK1
prerank,melanosome localization (GO:0032400),-0.4027389035554886,-1.1825895121115295,0.21951219512195122,0.7188371877617551,1.0,9/21,22.48%,MYO5A;RAB11A;BBS2;MKKS;BLOC1S6;RAB11B;MLPH;BBS5;RAB27A
prerank,myeloid cell development (GO:0061515),-0.4068201339394928,-1.1817760051227117,0.23705722070844687,0.7196596249488341,1.0,7/18,22.17%,FOXP1;KIT;ANXA2;NRROS;ABCB10;ALAS1;NCKAP1L
prerank,substrate-dependent cell migration (GO:0006929),0.5152329616467177,1.1816319371727886,0.2707275803722504,0.9235395688204686,1.0,3/14,4.99%,NTN1;OPHN1;PTPRC
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.43165151921749534,-1.1816154529757554,0.2525,0.7184877669689135,1.0,9/16,32.04%,WRN;BLM;MCM6;SSBP1;MCMDC2;TWNK;RAD51;MCM7;MCM2
prerank,positive regulation of cyclase activity (GO:0031281),0.5177021231662027,1.1811923433913851,0.3023255813953488,0.9236794381853355,1.0,2/14,3.23%,GUCA1A;NF1
prerank,positive regulation by host of viral transcription (GO:0043923),-0.42804622763712297,-1.1809519294590374,0.22691292875989447,0.7188921167936358,1.0,5/15,12.55%,LEF1;EP300;CCNT1;SNW1;SP1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.44157995842299835,1.1809365876938858,0.26666666666666666,0.9232280093285078,1.0,3/38,1.84%,CAV1;CAMK2D;KCNA5
prerank,endocardial cushion development (GO:0003197),-0.3990727514042329,-1.1806845514274715,0.23655913978494625,0.7180469138841022,1.0,5/21,3.88%,ENG;NOS3;BMP4;ACVRL1;BMPR2
prerank,negative regulation of protein kinase activity (GO:0006469),0.37681413284882,1.1805526217270956,0.2094175960346964,0.9231055547553593,1.0,13/88,10.77%,CAV1;TRIB2;UBASH3B;CEACAM1;SPRED1;NF1;GNAQ;PTPRC;SRCIN1;SFN;PTPRT;CEP85;RTRAF
prerank,microglial cell activation (GO:0001774),-0.3997686213393955,-1.1804537263445372,0.22629969418960244,0.7171009437454,1.0,12/21,36.28%,JAK2;MAPT;C1QA;CLU;GRN;ITGB2;ITGAM;AGER;AIF1;TREM2;IFNGR1;SNCA
prerank,thymus development (GO:0048538),-0.45368451723540754,-1.1800723973723615,0.22546419098143236,0.7165919382127839,1.0,4/13,16.72%,TGFBR1;TBX1;ZBTB1;EPHB3
prerank,vasodilation (GO:0042311),-0.4487782161105891,-1.1800684784648985,0.27040816326530615,0.7149881505077588,1.0,4/13,17.43%,NOS3;KCNMA1;KLF2;NOS1
prerank,Notch signaling pathway (GO:0007219),0.39833015491373674,1.1800009285162534,0.2371392722710163,0.9235159186474831,1.0,15/59,13.11%,ZNF423;NRARP;PBX1;DTX1;JAG1;MAML2;APH1B;HEYL;NCSTN;ADAM10;POFUT1;DTX4;WWC1;GMDS;CREBBP
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.44645710241605807,1.1797802303015708,0.25188536953242835,0.9228773056344718,1.0,3/31,3.06%,ARG1;GLMN;IL4I1
prerank,axonal fasciculation (GO:0007413),-0.4712150895043942,-1.179232572302369,0.27294685990338163,0.7158645778313293,1.0,6/12,16.72%,EPHA3;EPHA4;ARHGAP35;MEGF8;CDK5R1;EPHB3
prerank,organic substance transport (GO:0071702),-0.2815062851885629,-1.178979016097497,0.1111111111111111,0.7150406947695552,1.0,31/121,19.21%,SLC47A1;PLTP;CHKA;TXNIP;ABCG2;TOM1;CALCRL;SLC22A6;SLC22A4;ABCA4;SPNS2;TCN2;ARL6IP5;TAP2;ABCA9;SLCO2A1;RAMP2;SCAMP5;SLC22A18;ABCD2;SLC35F3;ABCA2;MFSD2A;ARRDC4;ABCG1;CHMP3;ARRDC2;SLC22A2;CHMP2B;MYH9;RCN3
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5546677379349477,1.1787216847056372,0.3014705882352941,0.9251701585214896,1.0,2/10,2.89%,PRKCE;GPLD1
prerank,regulation of T cell proliferation (GO:0042129),0.39541058241339205,1.1786534836296343,0.22791293213828426,0.9240051578985071,1.0,6/61,6.40%,TNFSF8;ARG1;GLMN;IL4I1;PTPRC;NCK2
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.4267739368499127,-1.1782689345834538,0.26184538653366585,0.7154640814365465,1.0,3/16,2.56%,PLCB1;RANBP3L;IGFBP3
prerank,purine nucleotide metabolic process (GO:0006163),0.4671202876380965,1.178222140935384,0.27886056971514245,0.9241414537387201,1.0,8/24,11.62%,FHIT;MTHFD1;PPAT;NT5E;PRPSAP2;NT5C2;PRPS1L1;PRPS1
prerank,mRNA stabilization (GO:0048255),0.4354082800189515,1.1782147613624674,0.24929971988795518,0.9227776852875674,1.0,11/40,19.34%,HNRNPC;DND1;HNRNPA0;TENT5C;AXIN2;TENT5D;TAF15;SYNCRIP;E2F1;DHX9;YBX3
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.38019173177880883,1.1781530820709538,0.24290998766954378,0.9216299054014685,1.0,35/84,24.13%,FXR2;RBFOX2;QKI;RBM8A;CELF1;SRSF4;RBM15B;SON;DDX17;SRPK1;RBM5;CELF2;CELF4;KHDRBS2;SRPK2;SFSWAP;RBMXL1;NSRP1;FXR1;TRA2B;SF1;CWC22;SRSF3;PRDX6;MBNL2;SAP18;SRSF12;TIA1;SRSF10;YTHDC1;JMJD6;ZBTB7A;RBMX;REST;PUF60
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.38897985147983466,1.1777582716498702,0.23284313725490197,0.9216500262095213,1.0,13/78,12.27%,CAV1;TRIB2;PRICKLE1;SOCS5;SH3RF2;KEAP1;CDC20;DDRGK1;GSK3B;CSNK1A1;RCHY1;ZYG11B;NFE2L2
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.4517501815671316,1.1772750307029372,0.27232796486090777,0.9219205446751597,1.0,5/30,8.91%,OGT;FHIT;STYX;N4BP1;DDRGK1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.5419591604215682,1.176171335258387,0.29780033840947545,0.9244773475394387,1.0,6/12,18.88%,STX1A;STX2;STX19;STX4;SNAP23;SNAP29
prerank,lipoprotein transport (GO:0042953),-0.49541108439638604,-1.1760692074592092,0.26590909090909093,0.7203454381439914,1.0,3/10,6.59%,LRP1;ZDHHC17;VMP1
prerank,negative regulation of cell adhesion (GO:0007162),0.38710173735596143,1.1758043304105004,0.2534504391468005,0.924380148918312,1.0,18/72,15.38%,TGFBI;CDH13;RIPOR2;JAG1;DSCAM;PLXNA3;PTPRC;ADAM10;EPHB2;GCNT2;PLXNB1;SEMA4D;NF2;FZD7;PTPRO;SIPA1;PLG;CDH1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.4925065191870873,1.1756109479159338,0.2712680577849117,0.9236703289617884,1.0,4/18,9.02%,POR;SIRT3;ABL2;PDP2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.4428058489407266,1.1752178766750678,0.24818577648766327,0.9235829593979836,1.0,4/30,5.56%,NGF;MMD2;SRC;LRRC59
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.4740523915853498,1.1746635152342177,0.2806451612903226,0.9241555546823279,1.0,6/22,16.37%,CEACAM1;DGKZ;PTPN22;PTPRJ;SH2D1A;EZR
prerank,cytoskeleton organization (GO:0007010),-0.2739903353935756,-1.1742589077761145,0.15492957746478872,0.7239820749844498,1.0,31/114,12.85%,RHOBTB1;NEDD9;MARK1;TPM1;FGD5;MAST4;OBSL1;PLD2;DST;RHOBTB3;CFL1;SYNE3;ARAP3;SEMA6A;WASF3;PRPF40A;APOE;RHOC;SH3KBP1;CAMSAP1;CNN2;WDPCP;DIAPH1;PALLD;RHOH;RHOB;AJUBA;PAK5;DES;CECR2;CCL13
prerank,nitric oxide metabolic process (GO:0046209),-0.4437986064042275,-1.1741180737108345,0.24815724815724816,0.7227816493403755,1.0,4/14,8.19%,NOS3;CYP1B1;GCH1;AKT1
prerank,Ras protein signal transduction (GO:0007265),0.35916833542036053,1.1740201143771558,0.21387940841865757,0.9249760831211767,1.0,23/137,10.36%,PLK2;CDH13;NTN1;PLCE1;USP50;RAPGEF3;RAP1A;CDC42EP4;MRAS;NF1;RAC2;USP8;GDI1;NRAS;KRAS;RIPOR1;ARHGEF1;RREB1;RAPGEF6;CTNNAL1;KSR2;LAT;ADRA2A
prerank,camera-type eye morphogenesis (GO:0048593),0.5500460030646427,1.1737551592048219,0.3062730627306273,0.9244800552370042,1.0,3/10,7.23%,NF1;SHROOM2;TBX2
prerank,homeostasis of number of cells (GO:0048872),-0.4634529508031938,-1.1737514175995096,0.2708860759493671,0.7222315752916505,1.0,3/12,4.37%,NOS3;NAPEPLD;CCN3
prerank,inhibitory synapse assembly (GO:1904862),0.5349470271255813,1.173523197136077,0.28214285714285714,0.9238956116613521,1.0,4/11,12.25%,WNT5A;GABRG2;PLXNB1;GABRB3
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.4781004518279565,1.1730778726145892,0.2677165354330709,0.9240239402001922,1.0,6/20,14.09%,FKBP5;FKBP1B;PPIE;PPIL6;PPIC;PPIG
prerank,tryptophan catabolic process (GO:0006569),0.5458293538065808,1.1729629663886434,0.30244755244755245,0.92304758654663,1.0,2/11,3.76%,IL4I1;AADAT
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3567081635051525,1.1729257064260652,0.1947608200455581,0.9218276781092719,1.0,17/136,10.18%,PTCH1;SPI1;GLIS2;HDAC4;IRAK3;KEAP1;HEYL;BHLHE40;TNFAIP3;ANXA4;TRIM21;ZNF431;ACOD1;FOXJ1;NLRP2B;HDAC2;TAX1BP1
prerank,cilium assembly (GO:0060271),0.3402126897249316,1.172571040646763,0.15902140672782875,0.9216821718299778,1.0,104/297,24.50%,DYNLL1;PARVA;UBXN10;RAB8B;ABLIM3;MKS1;PTPDC1;DZIP1;GORAB;DYNC2I1;CYS1;EXOC3;SFI1;CNGB1;INTU;CEP89;CEP131;IFT81;CEP78;CNGA4;NEDD1;KIF3C;EHD2;SNX10;TUBG1;CCDC39;CKAP5;BBOF1;CEP162;PAFAH1B1;CLUAP1;CCP110;OCRL;UNC119B;TCTN2;TMEM237;FOXJ1;DYNLL2;IFT74;C2CD3;CENPJ;HDAC6;CFAP20;NDE1;EXOC5;CEP290;SSNA1;CETN2;RPGRIP1L;TTC21B;PKD1;TRIP11;FBF1;PCM1;PDE6D;FAM161A;DNAH5;CCDC40;NPHP4;CFAP298;CFAP70;PIBF1;YWHAG;DYNC2LI1;CFAP410;B9D2;YWHAE;CDC14A;CEP57;DYNC2H1;EHD1;OFD1;ARMC9;BBS1;CEP250;SNAP29;TMEM80;DCTN2;ALMS1;TCTN1;HAUS8;STK36;IFT57;CEP43;CPLANE2;IFT140;WDR90;RILPL1;CC2D2A;HAUS3;CEP19;SCLT1;ARL3;HAUS7;TMEM67;FHDC1;CEP83;CFAP52;ARF4;SPATA6;MAK;DYNC1I2;TRAPPC14;NPHP1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.3632097482840609,1.1719703335102112,0.22988505747126436,0.922381247121541,1.0,42/125,23.10%,PLK2;DYNLL1;KIF2A;STIL;TUBG1;DSN1;CKAP5;PAFAH1B1;EML1;CDC20;NUP160;MECP2;DYNLL2;NUP37;RANBP2;BUB3;MAP4;WDR62;NDE1;AHCTF1;PTPA;TUBG2;ZWILCH;ZW10;CENPU;RAN;TBCE;CENPH;B9D2;CENPK;SETD2;MAD1L1;DCTN2;DYNC1LI2;CENPL;DYNC1I1;NUP43;GPSM2;MIS12;DCTN6;SEC13;SBDS
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5431857097959817,1.1719564775751594,0.2821869488536155,0.9210799352108489,1.0,4/11,13.07%,PRODH;MAP3K5;STK24;DIABLO
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.32539413111098137,-1.1716266520190854,0.19858156028368795,0.7273141979416556,1.0,8/46,9.17%,PLCB1;MSN;CDC42;CFL1;ANXA2;RPLP0;JAK2;CNN2
prerank,anterior/posterior axis specification (GO:0009948),-0.4301222778114498,-1.170907841584888,0.2545454545454545,0.7279189431433727,1.0,2/15,2.75%,WLS;TBX3
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.3794774411049596,-1.1707749157651948,0.2215568862275449,0.7267278731871917,1.0,8/25,15.98%,INSR;SMAD3;DDAH1;KLF4;AKT1;KLF2;EDN1;P2RX4
prerank,cellular response to lipopolysaccharide (GO:0071222),0.3634181126537817,1.1705927207318692,0.23894862604540024,0.9244055810638732,1.0,16/101,9.88%,LBP;PRKCE;TNIP3;IL1A;PTPN22;WNT5A;TNFAIP3;SELENOS;PAF1;DEFA6;ACOD1;IRGM;CHMP5;HMGB1;TICAM1;AXL
prerank,cellular response to interleukin-7 (GO:0098761),0.5008784740088881,1.170221617956048,0.28642384105960267,0.9230625173360195,1.0,9/17,20.74%,IL7;IL2RG;SOCS1;BRWD1;IRS2;JAK1;SOCS2;STAT5B;CISH
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.5008784740088881,1.170221617956048,0.28642384105960267,0.9230625173360195,1.0,9/17,20.74%,IL7;IL2RG;SOCS1;BRWD1;IRS2;JAK1;SOCS2;STAT5B;CISH
prerank,monocyte chemotaxis (GO:0002548),-0.3576913431491188,-1.1697765279546577,0.19801980198019803,0.7281762912330495,1.0,6/32,13.48%,FLT1;IL6R;RPS19;ANXA1;CCL13;TNFRSF11A
prerank,cellular response to insulin stimulus (GO:0032869),0.36079712450211204,1.1696270986113233,0.21672555948174324,0.9237272630946294,1.0,19/124,9.63%,GAB1;INHBB;SORBS1;OTOP1;CEACAM1;RAB8B;GPLD1;CAV2;ATP6V0D2;SLC27A1;PDK4;FER;SELENOS;ZDHHC7;SYAP1;PIK3R2;ATP6V0A1;GSK3B;SLC27A4
prerank,protein autoprocessing (GO:0016540),-0.4152918902850293,-1.1693792669911873,0.25675675675675674,0.7277737254840307,1.0,5/17,17.68%,OMA1;CTSL;SPRTN;FXN;CASP4
prerank,regulation of phosphate metabolic process (GO:0019220),-0.43230937217296317,-1.1688982612827115,0.26555023923444976,0.727750416132594,1.0,7/16,18.52%,IGBP1;PGAM1;SRPX2;IKBKB;BARD1;RAD17;CD24
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.3556864595859938,-1.168819241865079,0.23765432098765432,0.7263879360431719,1.0,5/33,8.57%,IGF1R;IGF1;PIK3R1;AKT1;PIK3C2A
prerank,nitric oxide biosynthetic process (GO:0006809),-0.44988587260539104,-1.168663760937776,0.2631578947368421,0.7252598503865416,1.0,4/13,8.19%,NOS3;CYP1B1;GCH1;AKT1
prerank,lipoprotein biosynthetic process (GO:0042158),-0.4711137841762829,-1.1684135190198177,0.2635294117647059,0.7244504222975745,1.0,6/11,24.50%,ATG10;APOE;WIPI1;WIPI2;WDR45B;WDR45
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.4437480778653782,1.1683693580275543,0.2844175491679274,0.9265957375493374,1.0,5/29,4.69%,SORBS1;ZBTB20;ELOVL5;GPLD1;SLC27A1
prerank,T cell proliferation (GO:0042098),-0.44300507480046786,-1.1680907205948343,0.2544987146529563,0.7239013229118514,1.0,2/13,1.74%,MSN;CTPS1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5546893143024729,1.1676360812937774,0.28091872791519434,0.9276610581008317,1.0,3/10,6.72%,CEACAM1;CD9;RDX
prerank,positive regulation of leukocyte activation (GO:0002696),0.48632319321863593,1.167427520493054,0.2797527047913447,0.9270612892399585,1.0,3/18,10.36%,LBP;WNT5A;KARS1
prerank,positive regulation of organelle assembly (GO:1902117),-0.32776948588941324,-1.167131594397851,0.17537313432835822,0.725089855014882,1.0,13/44,14.45%,ASAP1;CNOT6L;G3BP2;STX18;ARHGAP35;ENTR1;SH3GLB1;CAPG;PIP4K2A;FUZ;PIP4K2C;CEP120;CROCC
prerank,cellular response to acid chemical (GO:0071229),-0.3700182855804653,-1.167107770538862,0.23170731707317074,0.7236065868097608,1.0,15/27,31.64%,CPEB4;LAMTOR3;RRAGC;KLF2;GLRA2;SPAAR;RRAGD;CPEB1;XBP1;LAMTOR2;SLC38A9;NSMF;LAMTOR4;SH3BP4;GLRA1
prerank,positive regulation of cell differentiation (GO:0045597),-0.25551728383129313,-1.167103852010422,0.07017543859649122,0.7220543800448394,1.0,47/237,10.52%,TCF4;PLCB1;IGF1;RANBP3L;SOX5;SLC6A6;RAPGEF2;SMAD3;LEF1;PRKCH;BMP6;ARHGEF2;DAB2;IL6R;CCN2;TMEM64;PPARD;CDC42;CREBL2;IGFBP3;BMP4;GJA1;TGFBR1;WNT4;ACVRL1;BMPR2;IL18;HOXB4;HOXA5;BRINP3;AGTR1;KDR;CD34;MEF2A;MAPK12;GLIPR2;CDON;TGFB3;AKT1;CMKLR1;CREB1;ASXL2;LRRC8A;ZC3H12A;CCN1;AR;BMP2
prerank,steroid metabolic process (GO:0008202),0.38978599392817875,1.166939325778723,0.23447401774397972,0.927431922905541,1.0,13/72,15.04%,HSD17B3;CYP7B1;SULT1A1;RDH5;DHRS4;HSD17B4;CUBN;GC;PRLR;MSMO1;DHCR24;STARD3;LSS
prerank,negative regulation of signaling (GO:0023057),0.4598348910166178,1.1668338029250658,0.2971342383107089,0.9264297154936816,1.0,2/25,2.26%,UBASH3B;SOCS5
prerank,metal ion export (GO:0070839),0.4385743843759461,1.1668272808802962,0.27662721893491127,0.9251210390593264,1.0,6/31,9.39%,KCNA5;ATP2B4;ATP1A2;SLC4A4;KCNK5;ATP1B3
prerank,negative regulation of innate immune response (GO:0045824),0.43009729619121645,1.1660237926047272,0.2714078374455733,0.9264694996776455,1.0,10/34,13.24%,SERPING1;IRAK3;TNFAIP3;TRIM21;SUSD4;ACOD1;TRAFD1;CNOT7;STAT2;USP15
prerank,positive regulation of cartilage development (GO:0061036),0.49098449403806144,1.1653535253860892,0.2782462057335582,0.9274153758632501,1.0,3/17,4.10%,PKDCC;SOX9;BMPR1B
prerank,heart process (GO:0003015),0.514345675646686,1.1652637722086379,0.2838709677419355,0.9264377665961734,1.0,2/14,3.80%,SGCD;SGCG
prerank,negative regulation of stress fiber assembly (GO:0051497),0.4544748981968274,1.164291098355827,0.2677165354330709,0.9282338861134788,1.0,3/24,2.02%,DLC1;F11R;ARAP1
prerank,ERAD pathway (GO:0036503),-0.2919596775722406,-1.163943060562105,0.17204301075268819,0.7298759955200868,1.0,25/83,20.74%,UBXN4;USP19;TRIM25;ERLIN1;DNAJB2;UBE4A;STT3B;SGTA;SEC61B;SYVN1;VCP;UBE2J1;FBXO17;UBXN6;ERLIN2;UBE4B;OS9;RNF103-CHMP3;ANKZF1;SGTB;DERL2;FBXO44;RCN3;TRIM13;RNF121
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.3466393561345721,-1.163922359637058,0.2277580071174377,0.7283847466630857,1.0,8/33,10.57%,TEK;ANGPT1;NUPR1;NDNF;KDR;GATA2;RAMP2;SCG2
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.3853457204559272,1.1639074883065423,0.2509457755359395,0.9282289567295514,1.0,11/67,6.48%,PKDCC;TEC;FGFR1;EFEMP1;EGFR;ITK;TXK;SRC;FER;EPHB2;ABL2
prerank,rRNA metabolic process (GO:0016072),-0.25851464440733307,-1.1638779378529762,0.07920792079207921,0.727010949123649,1.0,62/160,25.05%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPL35A;RPS7;RPL32;RPS27;RPL26;RPL27;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;DIS3L;RPLP1;RPS17;WDR12;RPL23;RPL17;RPL9;RPL38;RPL36;RRP7A;ESF1;RPL18A;MAPT;EXOSC3;IMP4;HEATR1;TEX10;LAS1L;RPLP2;POP5;RPS6;NOL9;HELQ;DIS3;DHX37;EXOSC1;FBL;RPL14;TBL3;RPS2;RPL10A;UTP4;RPL39;RPL34;RPL5;RPL22;PWP2;RPS9;WDR3;RPS14;RPS25
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.4746066100787147,1.1638499006859986,0.28593508500772796,0.9271083842940326,1.0,6/20,13.51%,NR2F2;APC;HEXIM1;MEN1;PTEN;CDKN1C
prerank,respiratory electron transport chain (GO:0022904),0.5074860088042689,1.1635535697062172,0.2927241962774958,0.926841601202291,1.0,2/14,1.98%,PPARGC1A;SLC25A12
prerank,cellular copper ion homeostasis (GO:0006878),-0.4487396239403648,-1.1629709817966631,0.25495049504950495,0.7282281942958538,1.0,3/14,5.15%,ATP7A;SLC31A1;SLC31A2
prerank,thyroid hormone generation (GO:0006590),-0.4936271668454471,-1.1629169308695997,0.296127562642369,0.7268509723433352,1.0,5/10,34.12%,CPQ;DIO2;FOXE1;TG;CTSK
prerank,endothelial cell proliferation (GO:0001935),-0.4175040655519143,-1.1627303861052416,0.27648578811369506,0.7259210344637089,1.0,5/17,6.50%,TEK;BMP4;ACVRL1;BMPR2;CD34
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.32902476905526984,-1.1624669900264617,0.22262773722627738,0.7251506519555488,1.0,9/47,7.55%,IGF1R;TGFBR3;FOXO1;FAS;PDCD10;ARL6IP5;IGBP1;NBR1;MAP2K2
prerank,glucose transmembrane transport (GO:1904659),-0.41166785569847497,-1.1621072644278794,0.2591623036649215,0.724710809740793,1.0,10/18,28.08%,PPARD;SLC2A10;SORT1;SLC2A8;SLC2A9;SLC2A1;SLC45A1;SLC2A3;SLC2A4;RAB4B
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.535261591650358,1.1617257009600097,0.2847457627118644,0.9317560357358784,1.0,3/12,15.48%,SORBS1;C1QTNF12;SNX5
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.4795320147630328,-1.1613368846470842,0.26303317535545023,0.7254456692972182,1.0,5/11,25.27%,ARHGEF2;NUPR1;CASP8;RIPK1;BIRC3
prerank,mammary gland development (GO:0030879),0.47542470706188744,1.1606057935520382,0.2850609756097561,0.9343053421768482,1.0,3/21,5.61%,CAV1;GLI2;APLN
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.4647979357150853,1.1606001950789178,0.2680577849117175,0.9329947353502606,1.0,8/19,17.31%,EXTL3;XYLT2;GLCE;NDST1;HS3ST5;HS6ST3;EXT1;EXT2
prerank,odontogenesis (GO:0042476),0.4305697301428767,1.1604687579639972,0.28304597701149425,0.9320801437867131,1.0,4/35,3.17%,EDA;WNT10A;GLI2;TUFT1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.4705843959628232,-1.1601371545071666,0.29782082324455206,0.7274453264387446,1.0,5/11,30.46%,TIMM10B;TIMM8B;ROMO1;TIMM29;TIMM10
prerank,cellular calcium ion homeostasis (GO:0006874),0.3590126328812109,1.160037728462882,0.24017957351290684,0.9322251940442617,1.0,12/133,4.74%,CAV1;STC2;CTRC;CAMK2D;SLC8B1;CDH5;SLC24A1;TRPV4;FKBP1B;CAV2;CSRP3;ATP2B4
prerank,diol metabolic process (GO:0034311),-0.40584345524276877,-1.1596341023854844,0.25815217391304346,0.7274449558473706,1.0,7/19,13.41%,NOS3;PLPP1;DEGS2;CALM1;GCH1;AKT1;SPHK1
prerank,synaptic vesicle recycling (GO:0036465),0.44022680511784895,1.158914790165432,0.27934621099554235,0.9347063916765397,1.0,13/31,22.12%,CEL;STX1A;OPHN1;STON1;RAB3A;STON2;SNCG;RAB5A;PACSIN1;AMPH;VAMP2;NLGN3;NLGN2
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.4303950722141097,1.1588844125955626,0.2928679817905918,0.9334807418178183,1.0,8/33,16.37%,CEACAM1;RAB29;DGKZ;PTPN22;PTPRJ;CD81;SH2D1A;EZR
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.37306349625843577,-1.158867097958863,0.24012158054711247,0.7282144471513522,1.0,8/26,15.98%,INSR;SMAD3;DDAH1;KLF4;AKT1;KLF2;EDN1;P2RX4
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.349151535744983,1.1586687504785498,0.21581920903954802,0.9328972380554846,1.0,51/152,21.95%,CAV1;GPC3;PPM1N;SULF1;NRARP;EGFR;AXIN1;DEPDC1B;PSME3;DACT1;PPM1A;TNFAIP3;USP8;UBR5;PLEKHA4;FAM53B;KANK1;CSNK1G3;PSMB5;RNF220;USP47;AXIN2;COL1A1;SPIN1;SOX4;PSMB2;CAPRIN2;PSMA2;PSMA6;FZD9;PSMD13;PSMA7;GPC5;PSME4;CSNK1G1;FGF10;PSMC4;CDH3;PSMB6;PSMD12;ATP6AP2;PSMD14;PIN1;CDC73;TRPM4;RNF146;USP34;CCAR2;PSMB3;GSKIP;GID8
prerank,positive regulation of interleukin-2 production (GO:0032743),0.4477683299303323,1.1585357476042428,0.2640117994100295,0.9320710855446226,1.0,4/25,4.99%,GLMN;PDE4D;IL1A;PTPRC
prerank,cellular response to oxidative stress (GO:0034599),0.35797823592767025,1.1585283177248813,0.2425629290617849,0.930779139163319,1.0,16/118,7.04%,PPARGC1A;PXN;EGFR;GPX8;MGAT3;ETV5;ERO1A;MPV17;FOXO3;WNT16;KEAP1;FANCC;FER;ANKRD2;SELENOS;SLC4A11
prerank,"phagocytosis, engulfment (GO:0006911)",0.42654353103707005,1.158355244182235,0.27461858529819694,0.9300899530411225,1.0,6/36,8.29%,ARHGAP12;XKR7;DOCK1;XKR4;RAC2;XKR8
prerank,maturation of 5.8S rRNA (GO:0000460),0.49086706474404834,1.1582374860038271,0.3240418118466899,0.9292120312844688,1.0,5/17,11.37%,RRP15;C1D;PES1;EXOSC10;RPF1
prerank,positive regulation of kinase activity (GO:0033674),0.3641549896797315,1.1580299044068578,0.2397590361445783,0.9286254471951766,1.0,14/107,6.99%,ROR2;ROR1;NTRK3;FGFR1;EGFR;MUSK;RAP1A;PRKAG1;MMD2;LMO4;PTPRC;NBN;EPHB2;LCP2
prerank,defense response to protozoan (GO:0042832),-0.4552912836650117,-1.1579577113013655,0.2840909090909091,0.7294180215518579,1.0,8/12,33.93%,GBP4;GBP6;GBP7;GBP2;CD40;MYD88;SLC11A1;BATF2
prerank,regulation of nervous system process (GO:0031644),-0.40174006378401733,-1.1577860312740849,0.2773333333333333,0.728359102595662,1.0,3/18,2.30%,ROCK2;NOS3;SLC8A3
prerank,negative regulation of interleukin-2 production (GO:0032703),0.4835964419333634,1.1575880967036136,0.2922297297297297,0.9288075921013101,1.0,3/18,5.86%,HOMER2;PTPRC;TNFAIP3
prerank,actin filament bundle assembly (GO:0051017),-0.35407074849950965,-1.1574021434475197,0.20477815699658702,0.7279990247251793,1.0,5/33,5.73%,EPS8;NEDD9;MYO1B;PAWR;PLS3
prerank,response to cytokine (GO:0034097),-0.2639244420204528,-1.1571691260603272,0.13793103448275862,0.7271565406065461,1.0,24/141,8.47%,TIMP3;ALDH1A2;IL1R1;SMAD3;LEF1;PID1;OSMR;IL6R;SP100;IFNAR2;YTHDC2;ADAR;CXCL16;LIFR;AKAP6;TRAF6;JAK2;CDK9;IGBP1;CASP3;ANXA1;GCH1;BST2;LDLRAP1
prerank,glutamine family amino acid catabolic process (GO:0009065),0.5211478410301602,1.1569973659635713,0.3101160862354892,0.9294933621682875,1.0,2/13,1.44%,PRODH;ARG1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.5092622340505764,1.156859906609597,0.3065953654188948,0.9286839276830513,1.0,5/12,21.61%,PPARGC1A;ABCD1;IRS2;AKT2;TWIST1
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.5197606289690727,1.1566388502112759,0.30282861896838603,0.9281235399320947,1.0,6/12,12.75%,ELOVL5;ELOVL1;ELOVL2;HSD17B4;ACOT8;ABCD1
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.4152002011775709,-1.1564030469279387,0.2699228791773779,0.7280217764587995,1.0,3/17,8.44%,IGF1;APOE;RTN1
prerank,positive regulation of ATPase activity (GO:0032781),0.4157863865751437,1.1563098926380149,0.26900584795321636,0.9279363433956308,1.0,13/41,19.79%,DYNLL1;MSH6;ALDOB;MSH2;PLSCR1;DNAJC9;ATP1B3;DYNLL2;AHSA1;FGF10;DNAJC24;DHX9;PFN2
prerank,positive regulation of dephosphorylation (GO:0035306),0.4453943984335831,1.1559606596534322,0.2867756315007429,0.9278994159561961,1.0,3/27,4.48%,DLC1;CDH5;SRC
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.29602377679521485,-1.1558852941320208,0.225,0.7280529656895316,1.0,15/70,13.12%,CHKA;ENPP2;GPAT4;CHPT1;NR1H3;LPIN2;DBI;PCYT1A;SLC44A5;NR1H2;ABHD3;CEPT1;LPIN3;CSNK2A1;MFSD2A
prerank,spliceosomal complex assembly (GO:0000245),0.40765770807332596,1.155665118905952,0.27624309392265195,0.9276207222021334,1.0,10/46,11.35%,SF3B1;CELF1;ZRSR2;SMN1;SRPK1;RBM5;CELF2;CELF4;SRPK2;LUC7L2
prerank,cobalamin metabolic process (GO:0009235),0.48364055480700135,1.1554233180886675,0.29505582137161085,0.9271311324295985,1.0,6/17,12.75%,CTRC;ABCC1;CD320;CUBN;MMAB;AMN
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.45734195492497964,-1.1553284798010495,0.29330254041570436,0.728100367066447,1.0,11/12,54.30%,ZBTB1;CCR2;SLC11A1;PRKCQ;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A;IL1B
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.4189781369434761,-1.155140323878839,0.2696078431372549,0.7271271870505086,1.0,4/16,11.10%,ANK2;SEC16A;SEC16B;LRRK2
prerank,negative regulation of catalytic activity (GO:0043086),-0.37835919125658307,-1.1549784655563249,0.2865671641791045,0.7260580518599918,1.0,11/24,33.72%,PPP1R12A;NES;CAMK2A;IFIT1;NOS1;PLN;OXA1L;NOTCH1;NOSIP;TIMP1;APBA3
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.5257852297076299,1.1547794668950735,0.31369150779896016,0.9280006202927767,1.0,7/12,27.06%,NELFB;HEXIM1;TCERG1;RECQL5;EAPP;HNRNPU;NELFA
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.42121788338904975,-1.1543780288717347,0.3,0.7263343112438064,1.0,8/17,25.08%,TNFRSF1B;SERPINE2;IL34;BMP2;ID2;PTN;CLCF1;NOTCH1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.38509134480986024,-1.1542560331586573,0.2740112994350282,0.7251971053525397,1.0,6/23,16.54%,IGF1;AKAP6;PROX1;EDN1;MYOCD;ATP11A
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.4609406707817155,1.1533232976542453,0.2953125,0.9315392698470206,1.0,8/20,17.79%,PSMG2;PFDN6;PSMG1;LONP1;CCT2;HOPX;PSMG3;HSPA4
prerank,epithelial to mesenchymal transition (GO:0001837),-0.3214957228672547,-1.15330278183673,0.2188679245283019,0.7266338937815039,1.0,9/47,4.81%,ENG;LEF1;ROCK2;TGFBR3;RBPJ;TBX3;TGFBR1;WNT4;HIF1A
prerank,lamellipodium organization (GO:0097581),0.44828407807279336,1.1530625768343703,0.29508196721311475,0.9311510552713844,1.0,10/29,16.88%,CDH13;ABLIM3;SPEF1;ABLIM2;SNX2;ARHGEF6;CTTN;PTPRO;SNX1;ARHGEF7
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.46346629742411605,1.1529474205661807,0.3018575851393189,0.930225384268002,1.0,5/21,9.33%,ADAM19;NCSTN;ADAM10;DAG1;BACE2
prerank,cation transport (GO:0006812),0.3485742749584727,1.1527602276066982,0.22797356828193832,0.9295472901070583,1.0,21/167,8.16%,PIEZO2;NEDD4L;KCNJ4;TRPM3;SLC12A2;SLC8B1;KCNA5;KCNJ16;ANO6;SLC29A4;KCNS2;SLC12A3;KCNK1;SLC22A3;CNGB1;ATP1A2;KCNJ13;SLC4A4;SLC4A11;PIEZO1;KCNK5
prerank,cellular response to ionizing radiation (GO:0071479),-0.32263681884232437,-1.152256050181195,0.2074074074074074,0.7281201456178951,1.0,17/47,24.88%,MAP3K20;WRN;RPL26;BLM;EEF1D;RHOB;NET1;KDM1A;CRYAB;RAD1;HSF1;RAD9B;KDM4D;HRAS;GRB2;RAD51;LIG4
prerank,protein N-linked glycosylation (GO:0006487),-0.29797362183829457,-1.1519943427559505,0.18085106382978725,0.7273429314084394,1.0,18/66,17.65%,MGAT4C;ST3GAL1;MGAT4A;SLC39A8;DPM1;ALG5;STT3B;GAL3ST1;PGM3;UBE2J1;B4GALT1;B4GALT7;ALG1;RPN2;FUT8;OST4;ENTPD5;ASGR1
prerank,ceramide catabolic process (GO:0046514),0.5064764953812279,1.1519338052660666,0.3219761499148211,0.9310759110552269,1.0,6/14,18.22%,ACER3;NAGA;NEU1;HEXA;HEXB;ASAH1
prerank,ion transport (GO:0006811),0.35865690984171594,1.1511997657601911,0.24878048780487805,0.9321399136724251,1.0,20/111,12.99%,VDAC2;PIEZO2;TRPM3;SLC12A2;SLC8B1;SLC26A9;ANO6;SLC24A1;SLC1A7;SLC12A4;SLC12A3;CNGB1;SLC1A6;PIEZO1;SLC9A7;SLC9A6;PANX2;SLC25A26;ANO10;SLC25A22
prerank,response to amino acid (GO:0043200),-0.35022101488770074,-1.1508222926377125,0.2082018927444795,0.729274082776185,1.0,17/31,31.64%,CPEB4;LAMTOR3;GRIN1;RRAGC;GLRA2;SPAAR;RRAGD;CPEB1;XBP1;LAMTOR2;TMBIM6;SLC38A9;NSMF;LAMTOR4;SH3BP4;MEAK7;GLRA1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.5182393626867118,1.1507970472124047,0.3062605752961083,0.932245442224786,1.0,4/13,11.54%,KPNA7;KPNA2;CBLB;RANBP2
prerank,regulation of phosphorylation (GO:0042325),0.35796768032048243,1.1506064060860388,0.25908558030480655,0.9316144676074498,1.0,23/120,14.10%,ITGA6;DYNLL1;LDB2;GLMN;EGFR;CDH5;OGT;PRKAG1;DSCAM;NUP62;FN1;FER;NUP160;NUP37;TPR;NUP50;RANBP2;STAT2;NUP210;NUP153;GCK;CDKN1C;FZD7
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.4458824850258177,1.1504878781566044,0.29780564263322884,0.930713673469078,1.0,6/26,9.32%,PCBP2;IRAK3;TNFAIP3;TRIM21;ACOD1;TRAFD1
prerank,response to chemokine (GO:1990868),0.5152661550323634,1.1500288289159875,0.32105263157894737,0.9309537411917376,1.0,2/13,1.71%,RIPOR2;SLC12A2
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.36083702946021756,1.1497147482997205,0.2413793103448276,0.9307499085800771,1.0,15/102,8.76%,CAV1;INHBB;SORBS1;OTOP1;CEACAM1;RAB8B;GPLD1;SRC;ADCY5;FER;SELENOS;SYAP1;PRKAR2A;PIK3R2;TSHR
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.4995093060620371,-1.1492573553544538,0.3069544364508393,0.7326022370206534,1.0,2/10,4.81%,GRB10;HIF1A
prerank,intestinal lipid absorption (GO:0098856),0.5279259121308594,1.1490117025257953,0.31802120141342755,0.9318413979411736,1.0,1/11,1.67%,CEL
prerank,regulation of protein polymerization (GO:0032271),-0.3490972552891239,-1.1488304896207098,0.2408026755852843,0.7324633410733365,1.0,13/35,23.90%,ARHGAP28;ESAM;FCHSD2;CAMSAP1;HAX1;GBA2;TTBK1;DBN1;MAPT;ARL2;PFN1;DBNL;TPPP3
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.5409638708473288,1.148769876787179,0.30666666666666664,0.9314063376578632,1.0,3/10,11.94%,FAP;DPP4;CHADL
prerank,synaptic vesicle membrane organization (GO:0048499),0.49563510326657656,1.147824961777239,0.31735537190082647,0.9332738238231381,1.0,7/17,18.88%,STX1A;SYNGR2;STX2;STX19;STX4;SNAP23;SNAP29
prerank,cellular component maintenance (GO:0043954),0.5139602072217495,1.1462599663786757,0.31643356643356646,0.9372541045348929,1.0,1/12,0.18%,CLDN1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.49200732490163895,1.1459358680719705,0.3176470588235294,0.9371344843207763,1.0,4/15,7.63%,GPC3;SPEF1;DACT1;ZNRF3
prerank,signal transduction by p53 class mediator (GO:0072331),0.4312253560248499,1.1458752806275365,0.29473684210526313,0.9360712525519429,1.0,6/30,9.82%,MYBBP1A;PPP1R13B;BCL3;FHIT;NBN;POU4F1
prerank,vesicle transport along microtubule (GO:0047496),0.4584900065710265,1.145263695575863,0.3073463268365817,0.9369139256306206,1.0,8/23,22.14%,KIF13A;PAFAH1B1;NDE1;KIF5A;KIF5B;HTT;DYNC1I1;FBXW11
prerank,response to lipid (GO:0033993),-0.27035019721570636,-1.1452452417305252,0.17880794701986755,0.7417060349964818,1.0,26/105,15.22%,CTSH;ACER2;SMAD6;NOS3;FOXP1;PAQR7;PPARD;RBP4;FOXO1;ERBIN;ALPL;JAK2;ANXA1;GCH1;TRIM16;TRIB1;ESR1;FGFR4;NOCT;GATA6;MAPKAPK2;ABCA2;TNFRSF11A;MAPKAPK3;ABCG1;LGALS9
prerank,negative regulation of protein metabolic process (GO:0051248),0.4028095461049077,1.1451650952352739,0.2718707940780619,0.9359953776426443,1.0,5/48,6.07%,INHBB;EGFR;FLOT2;IRAK3;AZIN2
prerank,cellular respiration (GO:0045333),0.4072530858003779,1.1450660331837261,0.2894736842105263,0.9350351317716766,1.0,5/41,7.16%,PPARGC1A;SDHAF4;LYRM7;SIRT3;COX15
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.4076147460088958,-1.1450263969331775,0.2751322751322751,0.7408431667508686,1.0,7/18,14.37%,RAD51B;CDC25B;CDC25A;RAB11A;CDK4;CDC7;RAD51C
prerank,regulation of postsynapse organization (GO:0099175),0.4390651093165354,1.1449423781563959,0.29243937232524964,0.9341745009312716,1.0,5/28,7.43%,SIPA1L1;PPFIA2;LZTS3;WNT5A;SRCIN1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.4061497355153823,1.1447065345572787,0.29499323410013534,0.9337428204145454,1.0,22/52,23.03%,LEPROT;PPP1R13B;ABLIM3;RAC2;SFN;HTRA2;UBE2J2;UBE2D3;BAD;NMT1;YWHAG;FBXW7;YWHAE;E2F1;VPS11;CSNK2A2;PINK1;UBL5;MAPK8;TFDP1;YWHAB;SAE1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.4351249266127295,-1.1446910869258917,0.2840095465393795,0.740317950688553,1.0,3/14,4.18%,TFRC;PAXIP1;SHLD2
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.5259523021865128,1.1446506398499596,0.31514084507042256,0.9326801005485215,1.0,3/11,8.67%,F11R;TJP2;RAPGEF6
prerank,mRNA catabolic process (GO:0006402),0.3988142084884255,1.144508384187769,0.2975206611570248,0.9319101661875971,1.0,8/44,13.34%,DHX34;CNOT10;DXO;DIS3L2;AGO1;EXOSC10;ZFP36L2;ERN1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3187083580915741,1.1443660195373975,0.034,0.9311322597815799,1.0,268/1667,15.36%,PTCH1;EBF2;RORA;MEOX2;TENM2;ZBTB7C;DCN;KLF5;ETV4;ITGA6;CAV1;CDH13;NFATC2;ETV1;GLI1;PPARGC1A;PAX9;FOXD2;NR2F2;TSHZ3;NEDD4L;NR3C2;DLX1;POU4F3;RARB;FOXP2;FOXD1;NFATC1;CAMK2D;ZBTB32;KLF12;LDB2;PBX1;ZSCAN25;EGFR;BHLHE22;ZBTB20;NPAS3;NEUROD6;FGF1;JAG1;TNIP3;ETV5;OGT;RUNX2;NUFIP1;NFIA;ZSCAN18;HIVEP2;HOXB6;GLI2;TEF;IL4I1;ZKSCAN7;IRF2BP1;CHD3;CRTC1;MAML2;TXK;LMO1;LMO7;KLF3;KMT2A;SPI1;FOXK1;BEND3;PHF21A;ZNF418;FOXO3;SOX9;UBE2I;BMPR1B;PGR;FOXP4;NPAS2;TFR2;ZBTB8A;GLIS2;CHD8;CSRP3;ZNF585B;ZNF585A;SLC30A9;KAT6B;HDAC4;REL;CHD2;SATB1;BMP5;ZBTB3;ATP2B4;CHD1;KLF10;DACT1;WNT5A;POU5F2;CREB3L1;N4BP2L2;PPM1A;HEYL;ZFP3;ATAD2;ZFP1;SP3;KANK2;BHLHE40;MED18;ZFP90;RPRD1B;TARBP1;CDK13;ANKRD2;ARID3A;ONECUT1;ANXA4;NRIP1;ZFP14;RCOR3;MED12L;NCK2;SIN3B;TEAD3;CDK7;CTCF;NRF1;NFE2L1;HIC1;PEX2;PAF1;ZNF431;NCOR1;PAX3;NCOA5;HOXC10;ZFP62;TBX2;DDX17;ONECUT3;RREB1;DBX2;PIAS2;MAPK7;RARA;SUV39H1;MAFG;USF2;RPAP2;LHX6;KCTD1;PIK3R2;MYPOP;ISL1;PKNOX2;E4F1;FOXK2;TNIP1;MED7;ZNF462;AATF;ZBTB6;AGO1;DDRGK1;TCF20;PLSCR1;TBX18;MED13;TET1;SLTM;MECP2;FOXJ1;RPS6KA3;HMGB1;SIRT7;SMARCD2;RORB;SUPT4H1;POU4F1;RPRD1A;HDAC2;BAZ2B;LEFTY1;DBP;TLX3;TMF1;CTDSP1;TFEB;TPR;FHOD1;ZHX1;PAXBP1;RTRAF;SIX5;MMP12;WWC1;NCOR2;OTUD7B;RARG;FBXL19;EN2;DVL3;PHF20L1;EGR1;MZF1;MED23;ZBTB49;HEXIM1;ZNF148;HTATIP2;JMJD1C;ERF;AKIRIN1;MEN1;INO80;SEMA4D;NCOA3;NFE2L2;STAT2;CD81;HOPX;PEG3;PTEN;TTC21B;KDM6B;CRLF3;PKD1;CREBBP;NCOA2;NFATC4;BCL9;GTF2H1;ARID4A;SOX4;GMEB1;NUCKS1;DPF3;TCERG1;SFPQ;ZFP57;CBFB;DNAJA3;KAT8;TIAL1;UBE2D3;UBE2D1;CAMTA2;CAPRIN2;RAI1;PPIL4;RIPPLY2;EPC2;DICER1;FOXJ2;ZNF182;FOXF1;ZNF260;BRD8;WWP2;COPS5;NR5A1;LCOR;GPER1;MED8;CCDC62;TADA2A;MED12;ZMYM5;POU6F1;TOX4
prerank,toll-like receptor signaling pathway (GO:0002224),0.36965669507550897,1.144305078796432,0.2850182704019488,0.9301098189080149,1.0,20/84,17.65%,LBP;PIK3AP1;SCARA3;TNIP3;MAP3K1;IRAK3;PIK3R4;TLR7;TNIP1;RPS6KA3;HMGB1;TICAM1;S100A9;TAB2;UBE2D3;UBE2D1;PIK3C3;TICAM2;BTK;CTSB
prerank,cellular response to amino acid stimulus (GO:0071230),-0.34379430053424287,-1.1442687484259368,0.2425249169435216,0.7401033928481687,1.0,14/33,24.16%,UBR1;CPEB4;LAMTOR3;RRAGC;GLRA2;SPAAR;RRAGD;CPEB1;CASTOR2;CASTOR1;XBP1;LAMTOR2;SLC38A9;NSMF
prerank,receptor internalization (GO:0031623),0.41679145858935573,1.1440147197616208,0.2948539638386648,0.9298226916704094,1.0,5/44,4.57%,CAV1;ACKR3;CEACAM1;CD9;DNM1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.44103361744961,1.1439862977519233,0.3032544378698225,0.928683607735129,1.0,7/29,13.49%,SPRED1;SPRY1;BMP5;LDLRAD4;SDHAF2;PTEN;SPRED2
prerank,positive regulation of calcium ion transport (GO:0051928),-0.34318462678818906,-1.14395167285125,0.23487544483985764,0.7395772432666495,1.0,9/36,9.11%,PDGFRB;ANK2;MYLK;TRPC3;CACNB2;ORAI1;CXCL12;CAMK2A;GRIN1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.3751159021262168,-1.1437607021552274,0.2478386167146974,0.7386735867062428,1.0,13/25,24.04%,HIP1;RBPJ;AFAP1L2;HIP1R;AKT1;BCAR3;SHKBP1;CNOT9;AGT;NEU3;PLAUR;PDE6H;DOK1
prerank,regulation of microtubule polymerization (GO:0031113),-0.3303043084923749,-1.143391219571456,0.24149659863945577,0.7383057480395085,1.0,14/40,20.23%,CLIP1;STMN2;EML2;CAMSAP1;RPS3;CLIP3;GBA2;STMN1;MAPT;CDK5R1;TUBB4A;ARL2;FES;MET
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.41876965558509965,-1.143390306281374,0.2712765957446808,0.736836585066557,1.0,10/16,29.92%,ATP5PD;DMAC2L;ATP5MC3;ATP5PF;ATP5ME;ATP5PO;ATP5MC2;ATP5MF;ATP5MC1;ATP5F1E
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.2923709940768695,-1.1433418680250675,0.19574468085106383,0.7355327494360749,1.0,29/72,21.63%,SHANK3;PLEKHH2;ARHGEF2;SLIT2;KANK3;STMN2;LDLR;HSPA8;HIP1R;TWF1;MYADM;APOE;EML2;CYRIB;CAMSAP1;VBP1;CLIP3;STMN1;APC2;CRYAB;MID1IP1;TUBB4A;SMAD4;PFN1;SSH2;SSH3;KATNB1;PFDN4;CLU
prerank,nucleotide metabolic process (GO:0009117),0.45372906334777646,1.1427897703568246,0.3113964686998395,0.9314077485939548,1.0,9/23,20.00%,AK5;RNASEH2B;FHIT;NMNAT3;REXO2;CTPS2;DCK;AK7;NUDT5
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.36370380113937034,-1.1426813610702071,0.27741935483870966,0.7360408668937782,1.0,8/28,14.16%,ARHGAP28;ESAM;ARHGAP35;CXCL12;FCHSD2;HAX1;GBA2;DBN1
prerank,regulation of myoblast differentiation (GO:0045661),-0.35398310972869085,-1.1426247856381104,0.26198083067092653,0.7347504956230578,1.0,5/32,2.75%,PLCB1;RANBP3L;IGFBP3;BMP4;TBX3
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.38408620123152715,-1.142511530283697,0.25,0.7336438564041671,1.0,9/22,23.51%,CIAPIN1;NFS1;MMS19;NFU1;CIAO3;FXN;ISCA2;GLRX5;ISCU
prerank,regulation of plasminogen activation (GO:0010755),-0.45157260429745083,-1.1424886226801567,0.29397590361445786,0.7322808733332513,1.0,3/12,13.19%,CLEC3B;SERPINE2;THBS1
prerank,regulation of complement activation (GO:0030449),0.4170290026684152,1.142135002778121,0.3062937062937063,0.9323129255724844,1.0,6/40,13.19%,C2;SERPING1;CD55;SUSD4;CD81;CFH
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.3731719062203108,-1.142130849088543,0.25443786982248523,0.7318929148361782,1.0,12/24,25.67%,B2M;ACE;TAP2;SEC23A;SAR1B;HFE;TAPBPL;ERAP1;SEC31A;PDIA3;MFSD6;TAP1
prerank,engulfment of apoptotic cell (GO:0043652),0.49839092482126834,1.1420465196930232,0.3377049180327869,0.9313553815486614,1.0,4/15,8.29%,XKR7;XKR4;RAC2;XKR8
prerank,microtubule polymerization (GO:0046785),0.4400633800265084,1.141885459839952,0.30043541364296084,0.9306301197414731,1.0,15/29,26.65%,TRPV4;TUBG1;CKAP5;TUBGCP5;CENPJ;NDE1;TUBG2;SLAIN2;TUBGCP6;PIN1;MAP7D3;FGF13;CSNK1D;CLASP2;CCDC57
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.40691058315533246,1.1416489636154736,0.3032440056417489,0.9301821087201348,1.0,12/40,15.14%,FXR2;WDR76;NPAS2;UBE2V2;MCL1;FBXO5;SIRT7;ARMT1;RFWD3;ETAA1;FXR1;NEK4
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.35233030448942115,1.1413189559783319,0.25737898465171194,0.9300957152698358,1.0,29/124,18.75%,ROR2;PRICKLE1;PRICKLE2;NFATC1;PLCB3;FZD2;PSME3;WNT5A;PSMB5;AGO1;DVL3;VANGL1;PSMB2;FZD7;PSMA2;PSMA6;FZD9;FZD3;PSMD13;PSMA7;AP2A2;CELSR1;PSME4;CELSR2;PSMC4;PSMB6;PSMD12;RHOA;PSMD14
prerank,pulmonary valve morphogenesis (GO:0003184),0.4900321692766038,1.1408337696838078,0.30112721417069244,0.9304870229833707,1.0,4/17,5.24%,STRA6;NFATC1;JAG1;HEYL
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.3372243234806015,-1.140733093786494,0.24262295081967214,0.7345872680300818,1.0,7/35,8.04%,ITGA1;PDGFRB;FKBP1A;PPP4R4;PPP1R12A;CALM1;PPP1R11
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.45675823643616364,1.1406104125320453,0.2998522895125554,0.9300323212589242,1.0,1/23,1.14%,MBOAT2
prerank,actin filament depolymerization (GO:0030042),-0.4666230931189348,-1.1404660220511984,0.2956730769230769,0.7339016778355795,1.0,3/11,6.07%,DSTN;CFL1;TWF1
prerank,positive regulation of translational initiation (GO:0045948),-0.3984717828110045,-1.1403771381211822,0.2777777777777778,0.7326771103920867,1.0,8/18,28.27%,RPS6KB1;YTHDF1;YTHDF2;POLR2D;KHDRBS1;YTHDF3;RPS6KB2;DDX3X
prerank,glutamate metabolic process (GO:0006536),0.46668284158496764,1.1398999728885097,0.3062200956937799,0.9312098017525755,1.0,7/19,15.29%,PRODH;AADAT;ALDH18A1;ALDH5A1;GOT1;GLUL;GGT1
prerank,response to fatty acid (GO:0070542),0.46522045018199987,1.1398671495344739,0.3129139072847682,0.9300998634752048,1.0,7/17,17.73%,FOXO3;SOX9;PDK4;GLDC;KCNK4;SCD;LPL
prerank,endoderm development (GO:0007492),0.5136599216034095,1.1397971294323102,0.33217391304347826,0.9290937350459894,1.0,2/13,5.23%,LAMC1;KIF16B
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.44397313121847015,-1.139497540130512,0.32790697674418606,0.7337962834339482,1.0,3/12,6.47%,CTSH;LMO2;CTSL
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.41366144431733165,-1.1388298019226137,0.2548076923076923,0.7343605235267181,1.0,6/16,8.51%,IGF1;ROCK2;TRPC3;AKAP6;MEF2A;SLC9A1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.4589479796706191,1.1386986423401746,0.30652503793626706,0.9315261962310883,1.0,2/22,3.14%,FGF7;CASK
prerank,response to insulin (GO:0032868),0.36747548551467984,1.138636971583049,0.26666666666666666,0.930525742820632,1.0,12/80,8.04%,INHBB;SORBS1;OTOP1;CEACAM1;RAB8B;OGT;GPLD1;SLC27A1;FER;SELENOS;SYAP1;PIK3R2
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.4435200092596888,-1.138377395999566,0.2873303167420814,0.7341554786598745,1.0,7/13,23.14%,PDE8A;GPR37;LRRK2;GPR37L1;RACK1;MET;NR4A3
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.4526588056573031,1.1383116991372746,0.31259968102073366,0.9303969044520305,1.0,6/23,17.56%,GUCA1A;CNGB1;FNTA;FNTB;NMT1;CAMKMT
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.49783937322529626,1.1380957625065151,0.3020833333333333,0.929884042165248,1.0,2/16,5.65%,APOD;CHID1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.4309713797635582,1.137954364067722,0.28634361233480177,0.9291598035585144,1.0,4/32,8.07%,MEOX2;CARD10;RHOJ;STARD13
prerank,tetrapyrrole metabolic process (GO:0033013),0.4710768758808218,1.1378191737851704,0.3212025316455696,0.9284154724727127,1.0,6/18,12.75%,CTRC;ABCC1;CD320;CUBN;MMAB;AMN
prerank,mitotic recombination (GO:0006312),0.49159349085506293,1.1377092922820735,0.29173989455184535,0.9275450474900372,1.0,4/15,12.90%,SMC5;ERCC1;TEP1;GEN1
prerank,regulation of isotype switching (GO:0045191),-0.4348511450452517,-1.1376881540418537,0.270935960591133,0.7346817256317534,1.0,4/14,8.41%,TFRC;PAXIP1;SHLD2;SLC15A4
prerank,positive regulation of macrophage activation (GO:0043032),0.48470241942694514,1.1374811585660283,0.3365695792880259,0.927081165264254,1.0,3/17,10.36%,LBP;WNT5A;KARS1
prerank,positive regulation of hydrolase activity (GO:0051345),0.3502775554813386,1.1371622639642867,0.25280898876404495,0.9269675193027308,1.0,22/137,12.06%,ITGA6;DOCK9;F11R;RGS6;RAPGEF3;RAP1A;ARAP1;SGSM2;NF1;RTN4R;CAV2;ZC3H15;RAPGEF6;PKP4;GSK3B;TBC1D2;FERMT2;FNTA;RIC1;DVL3;PLXNB1;SEMA4D
prerank,fatty acid transmembrane transport (GO:1902001),-0.3930640598859941,-1.136852434181603,0.2930591259640103,0.7357204417113533,1.0,7/19,14.68%,PRKAG2;ABCD4;CPT2;PRKAB2;ABCD2;CPT1A;MID1IP1
prerank,response to tumor necrosis factor (GO:0034612),-0.2742522073533793,-1.1368482822950043,0.1893491124260355,0.7343055527671009,1.0,26/91,18.62%,PID1;ARHGEF2;YTHDC2;CXCL16;GSDME;ERBIN;TNFRSF21;ZFAND6;GBP3;JAK2;IGBP1;CASP3;GCH1;AKT1;ZC3H12A;RPS3;BAG4;CCL13;SPHK1;TNFRSF11A;IKBKB;GBP2;ZFP36;CASP8;CD40;CACTIN
prerank,response to retinoic acid (GO:0032526),-0.3079771227296928,-1.1368299107801911,0.2,0.7329637466198425,1.0,14/59,12.68%,EPHA3;CTSH;ACER2;WNT5B;LYN;ADNP2;RBP4;BRINP3;TBX1;CREB1;TRIM16;SNW1;RET;GATA6
prerank,positive regulation of intracellular protein transport (GO:0090316),0.34760057438015657,1.136781941781556,0.24634420697412823,0.9269926289058854,1.0,55/144,23.11%,LEPROT;GTSE1;RAPGEF3;PPP1R13B;ABLIM3;RAB29;KIF20B;RAC2;FIS1;CEP131;UBR5;RIPOR1;BAG3;RBM22;PIK3R2;MIEF1;SFN;GSK3B;TPR;CEP290;CD81;EMD;HTRA2;TMEM30A;PCM1;UBE2J2;UBE2D3;RAN;BAD;CDH1;NMT1;ERBB2;YWHAG;FBXW7;YWHAE;E2F1;CHP1;VPS11;CSNK2A2;PINK1;TM9SF4;HDAC3;UBL5;CEMIP;AKT2;MAPK8;VAMP2;TCF7L2;TENM1;XPO4;TFDP1;YWHAB;OAZ2;SAE1;PRNP
prerank,carbohydrate biosynthetic process (GO:0016051),0.4592000206196791,1.1361570411052553,0.3270440251572327,0.9278473694369893,1.0,2/21,2.69%,ST3GAL4;B3GALT1
prerank,aspartate family amino acid catabolic process (GO:0009068),0.4717455061510242,1.1356853900331487,0.30218068535825543,0.9281535445644872,1.0,6/19,14.06%,AADAT;OGDH;GCDH;DLST;GOT1;HYKK
prerank,endomembrane system organization (GO:0010256),0.3363800049279334,1.1355185894027873,0.23951434878587197,0.9274946568041565,1.0,50/178,18.40%,ATP8B3;USP50;HOOK2;ATP8B1;RAB29;PI4K2B;A4GALT;CAV2;LMAN2;PHETA2;EIF2AK3;DNM1;RAB30;USP8;SNX10;ATL2;GOLGB1;SYNGR2;ATP8B2;NPLOC4;LYSMD3;TMED4;SUN1;CSNK1A1;REEP3;LNPK;HOOK3;TRIP11;OTOF;HTT;LAPTM4B;ZW10;FBXW8;NUP93;TMED2;SEC23IP;TICAM2;PI4K2A;ATP8B4;ANXA8;ANXA8L1;OSBPL2;TBC1D20;ARHGEF7;DYNC2H1;ALS2;VPS11;SPTBN1;LEMD2;COG3
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.35315747202539827,1.1355119126812874,0.25344036697247707,0.926315469852986,1.0,5/121,0.71%,THBS4;EFNA5;FGF7;TEC;CSPG4
prerank,ovarian follicle development (GO:0001541),0.5151599385750961,1.13537601925495,0.32558139534883723,0.9255713375465638,1.0,1/13,0.54%,INHBB
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.3948642842882509,1.1351965048339907,0.2837653478854025,0.924990615189342,1.0,23/52,25.63%,FXR2;RBFOX2;RBM8A;CELF1;RBM15B;DDX17;RBM5;CELF2;CELF4;KHDRBS2;NSRP1;FXR1;TRA2B;MBNL2;SAP18;SRSF12;YTHDC1;ZBTB7A;RBMX;REST;PUF60;FMR1;THRAP3
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.36736656023742054,1.1344561321980775,0.2826086956521739,0.9261699506867511,1.0,25/83,21.10%,DYNLL1;GTSE1;SFI1;CEP131;CEP78;NEDD1;TUBG1;CKAP5;PAFAH1B1;CCP110;CENPJ;NDE1;CEP290;SSNA1;CETN2;PCM1;YWHAG;YWHAE;CEP57;OFD1;CEP250;DCTN2;ALMS1;HAUS8;CEP43
prerank,actin crosslink formation (GO:0051764),-0.462310899691451,-1.1341517142378428,0.30303030303030304,0.7391934558454059,1.0,3/12,11.56%,EPS8;FLNA;BAIAP2L1
prerank,negative regulation of organelle assembly (GO:1902116),-0.3425759271619021,-1.1331234775465369,0.26198083067092653,0.740745573531069,1.0,16/35,21.64%,NUPR1;TBC1D30;EVI5L;LRRK2;CEP97;TCHP;TRIM37;FEZ2;SCFD1;SMAD4;KAT2B;KAT2A;TESK1;STYXL1;SEC22B;NBDY
prerank,regulation of viral release from host cell (GO:1902186),-0.3802966399970295,-1.1330771541227171,0.27011494252873564,0.7394576697466063,1.0,10/21,20.68%,MID2;TRIM25;VPS4A;TRIM35;TRIM28;CHMP3;CHMP2B;TRIM8;TRIM13;TRIM11
prerank,amyloid precursor protein metabolic process (GO:0042982),0.45789370833436704,1.1328804903645149,0.3140495867768595,0.9299368639453155,1.0,4/18,6.14%,ADAM19;APH1B;NCSTN;ADAM10
prerank,mitotic DNA replication (GO:1902969),-0.47446696053286364,-1.1328587554366825,0.30612244897959184,0.7386897900310021,1.0,7/10,32.04%,MCM6;POLA1;MCMDC2;CDC45;GINS1;MCM3;MCM2
prerank,embryonic organ morphogenesis (GO:0048562),0.4097644161772596,1.132788884779917,0.3137254901960784,0.9290430330614506,1.0,4/42,3.74%,ALDH1A3;EFEMP1;MFAP5;DYNC2I1
prerank,positive regulation of autophagy (GO:0010508),0.36995522855983565,1.1327245130846677,0.2880098887515451,0.9280711480509714,1.0,13/81,11.10%,DCN;PLK2;TPCN1;FOXO3;SCOC;TRIM21;SESN1;IRGM;GSK3B;HMGB1;TICAM1;TFEB;PAFAH1B2
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.4826836154783057,1.132511482355274,0.3386327503974563,0.9275831508306234,1.0,2/17,1.76%,EGFR;CCND3
prerank,positive regulation of vasculature development (GO:1904018),0.360832530692794,1.1324695881055862,0.2828162291169451,0.9265330771280684,1.0,11/94,5.28%,GAB1;SMOC2;RAPGEF3;HK2;FGF1;CDH5;ITGAX;IL1A;PRKCA;WNT5A;HIPK1
prerank,regulation of lipid metabolic process (GO:0019216),0.35741395892531735,1.1324107932389245,0.27864897466827504,0.925552566607294,1.0,7/88,7.01%,RORA;CAV1;CHD9;SC5D;SIN3B;NCOR1;ACACA
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3336138697899131,1.1320164104024055,0.24946236559139784,0.9255837993152766,1.0,25/208,11.08%,RORA;ROR1;PLK2;LPAR1;PPM1N;PELI2;TNIP3;AKAP13;SLC35B2;REL;NUP62;WNT5A;PPM1A;TNFAIP3;TRADD;TRIM21;S100B;TNIP1;TFG;TICAM1;TMED4;CANT1;SHARPIN;OTUD7B;TAB2
prerank,cardiac muscle cell development (GO:0055013),-0.3851376508838129,-1.131712195824631,0.26525198938992045,0.7405687610759472,1.0,7/20,8.74%,SORBS2;PDGFRB;PDGFRA;SLC8A1;OBSL1;MYH11;PDLIM5
prerank,receptor clustering (GO:0043113),0.4431403889121889,1.1314831264990548,0.3063063063063063,0.9260605568142348,1.0,4/27,9.99%,LRP4;MUSK;ITGB7;DLG3
prerank,anion transport (GO:0006820),0.41805865080132204,1.1313305150257351,0.3037593984962406,0.9253556807307514,1.0,4/33,4.89%,VDAC2;LRRC8D;SLC26A9;SLC22A3
prerank,regulation of cation transmembrane transport (GO:1904062),0.44208099423584535,1.1310807030702765,0.3243647234678625,0.92495326405121,1.0,8/29,21.40%,SLMAP;KCNIP4;ATP2B4;KCNAB1;FGF12;KCNIP1;SNTA1;CD63
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.36341752820233425,-1.1310102515617566,0.2740963855421687,0.7411685504260953,1.0,14/27,36.21%,ETS1;SIRPA;TRAF6;CYRIB;SKAP1;NR4A3;ITGB2;PYCARD;HAS2;CCR2;HSPD1;CCL2;PRKCQ;THY1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.3918406871812955,-1.130927417016612,0.29048843187660667,0.7399908059071421,1.0,8/19,17.70%,CUX1;OBSL1;CUX2;LRP8;CDKL5;DBN1;PTPRD;DHX36
prerank,regulation of cation channel activity (GO:2001257),0.3659822085331508,1.1306311352166363,0.3022113022113022,0.9251560152429584,1.0,8/89,4.22%,AHNAK;SLMAP;CAMK2D;MINK1;PDE4D;GRIA3;FKBP1B;KCNS2
prerank,positive chemotaxis (GO:0050918),0.48194916144662225,1.1306132469278833,0.3108974358974359,0.924036491888856,1.0,1/17,0.26%,FGF7
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.3170289760340135,-1.1306069575477355,0.2210144927536232,0.7395413272959778,1.0,9/48,7.30%,PRKAG2;NUP107;EP300;HIF1A;AAAS;SEH1L;NUP133;PRDM16;PGAM1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.35662298128207887,-1.1305830057008237,0.26646706586826346,0.7381825150473141,1.0,14/27,20.33%,SLC47A1;SLC6A9;SLC7A5;SLC7A1;ARL6IP5;SLC25A38;SLC1A3;SLC1A1;SLC3A2;SLC22A2;SLC38A5;SLC25A18;SLC25A29;SLC1A4
prerank,response to organophosphorus (GO:0046683),-0.41512795187167806,-1.1303968394539545,0.31451612903225806,0.7373059819587503,1.0,5/16,15.98%,TRPC3;ABCC9;TRIM16;P2RX7;P2RX4
prerank,negative regulation of metabolic process (GO:0009892),0.3832345558889562,1.1298016717697477,0.2892670157068063,0.9254605324091001,1.0,10/54,8.81%,IL18R1;LAMA4;ZNF423;PLCL1;PCTP;FIS1;ACOT13;HOXC10;ZDHHC7;LNPEP
prerank,regulation of platelet activation (GO:0010543),0.4598920061740322,1.1295014867960969,0.3359872611464968,0.9253236975968457,1.0,3/21,4.28%,TEC;TXK;PRKCA
prerank,purine nucleotide biosynthetic process (GO:0006164),0.5081316469260931,1.129477831373332,0.34121621621621623,0.9242459787832387,1.0,7/12,20.45%,MTHFD1;PPAT;PRPSAP2;PRPS1L1;PRPS1;GART;ADSL
prerank,response to peptide hormone (GO:0043434),0.40687959177655486,1.1293966139468703,0.3071625344352617,0.9233337360860757,1.0,5/43,4.69%,CAV1;OGT;EIF2B3;SRC;SLC27A1
prerank,regulation of programmed cell death (GO:0043067),-0.25069737014821447,-1.128671514651765,0.06481481481481481,0.7409515082930154,1.0,28/161,11.35%,MECOM;DAPK1;HIP1;ACTN2;OMA1;TPT1;ACER2;STEAP3;TGM2;IGFBP3;BCL2L11;WRN;GAS1;MADD;FAS;PRDX2;USP42;LRP8;JAK2;AKT1;HS1BP3;NAE1;VCP;HAX1;RPS3;LRRK2;USP36;BID
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.367056979142666,-1.1283178438187065,0.2605042016806723,0.740531321464269,1.0,8/23,20.72%,BCL2L11;SAMM50;TIMM10B;TIMM8B;COX18;ROMO1;MAIP1;TIMM29
prerank,regulation of protein secretion (GO:0050708),0.35551449115555794,1.1282872281117613,0.25844004656577413,0.9256656396575981,1.0,15/119,7.89%,ITPR2;ITPR3;SLC12A2;RAPGEF3;SLC8B1;KCNA5;RAP1A;STX1A;IL1A;PRKCA;FRMD4A;RAPGEF4;SLC2A2;ARF6;DPP4
prerank,epiboly involved in wound healing (GO:0090505),-0.42210569968085915,-1.128211468137286,0.2969543147208122,0.7394234259599498,1.0,7/16,10.23%,DDR1;PDCD10;ARHGAP35;RHOC;TMEFF2;FLNA;CCN1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.4099941230306734,-1.1275638001197517,0.30851063829787234,0.7399972248706558,1.0,9/17,32.36%,ANK2;SCN4B;SCN1B;KCNE4;KCNH2;SCN5A;GJA5;KCNQ1;CACNA2D1
prerank,cellular response to fluid shear stress (GO:0071498),0.5188877640268666,1.127445883714867,0.3188908145580589,0.9272340172741079,1.0,4/12,12.27%,ASS1;MAPK7;MTSS1;NFE2L2
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.35978465971259055,-1.1273110275373222,0.26345609065155806,0.739309911226302,1.0,6/25,24.76%,IGF1;TRAF6;H1-0;PER2;MAD2L2;TRIM6
prerank,oligosaccharide biosynthetic process (GO:0009312),0.46025240543344026,1.1272866368367251,0.32755905511811023,0.9265693959554706,1.0,2/20,2.69%,ST3GAL4;B3GALT1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.42700940232957313,1.127169458398619,0.30952380952380953,0.9257726477406636,1.0,7/33,12.80%,APOD;MFN2;APLN;TNFAIP3;TAFA5;EFEMP2;PTEN
prerank,lipid transport (GO:0006869),-0.2742457372623065,-1.126942128783154,0.2138728323699422,0.7389869232044676,1.0,24/97,14.27%,OSBPL8;SLCO3A1;ACSL1;PLTP;CHKA;ABCC4;PITPNB;PPARD;SLCO1C1;LDLR;ABCA4;SPNS2;APOE;TNFAIP8L3;ABCA9;SLCO2A1;OSBPL5;SCP2;ABCD2;ABCA2;MFSD2A;PRELID2;PRELID3A;ABCG1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.4023226092111451,1.1265843909153517,0.3067047075606277,0.9264957813866904,1.0,15/39,20.74%,SOCS5;PI4K2B;PIP4K2B;SOCS6;PIK3R2;EFR3A;SOCS4;SOCS7;PIK3C3;PI4K2A;SOCS1;SOCS2;ITPKA;PIK3C2B;CISH
prerank,MAPK cascade (GO:0000165),-0.240572668236952,-1.1265614491081377,0.1388888888888889,0.7387179327639605,1.0,43/295,8.53%,IGF1;KSR1;RAPGEF2;TEK;TGFA;PDGFRB;PTPN3;ACTN2;SHANK3;PDGFRA;MAP3K20;ANGPT1;IL31RA;CTSH;NRK;PIK3R1;RASGRP3;KL;PSMA1;KIT;BRAP;FRS2;FGFR2;NEFL;IL18;RBX1;LAMTOR3;FLT3LG;RASGRF1;GRIN2B;KDR;LYPLA1;PSMD11;CALM1;MEF2A;MAPK12;JAK2;RASGRF2;MAP2K2;PSMD7;RGL2;CAMK2A;PSMD4
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.2771032146879795,-1.1264677216304781,0.17791411042944785,0.737602705247058,1.0,20/95,10.51%,ENG;ZEB2;SMAD3;SMAD6;DAB2;TGFBR3;LATS2;FKBP1A;SKIL;TGFBR1;EP300;ITGA3;PRDM16;LEMD3;VASN;ASPN;CITED2;SNW1;SLC2A10;HTRA3
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.3716148953969006,-1.126137090633388,0.2747875354107649,0.7372321191611557,1.0,8/24,12.73%,IGF1;INSR;ENPP1;IGF2;AKT1;PPP1R3B;GSK3A;PPP1R3C
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3459354611643392,1.1260590493588956,0.27387802071346373,0.9269993696445222,1.0,20/132,10.53%,DCN;PLK2;VGLL4;ZBTB20;TPCN1;GPLD1;FOXO3;DACT1;DXO;SLC4A4;TRIM21;RDX;IRGM;LIN28B;GSK3B;HMGB1;TICAM1;CNOT7;ADRA2A;TFEB
prerank,negative regulation of peptidase activity (GO:0010466),-0.3131275090417546,-1.1253394940955015,0.2536231884057971,0.7381836367605074,1.0,10/47,10.66%,TIMP3;SPOCK2;LRP1;SERPIND1;SERPINI1;SPOCK1;SERPINE2;AKT1;SERPINB9;GAPDH
prerank,positive regulation of developmental process (GO:0051094),0.33877584568878444,1.1252751594277972,0.2785793562708102,0.9283598952579275,1.0,24/164,9.71%,DCN;FGFR1;DLX1;COBL;FOXD1;RAPGEF3;DDHD1;SOX9;BMPR1B;SRC;KMT5C;BMP5;FIS1;WNT5A;TMEM79;LLPH;DAG1;RREB1;FBXO5;ISL1;CDC20;MIEF1;RPS6KA3;PHLDB1
prerank,regulation of macrophage activation (GO:0043030),-0.3451320622763825,-1.1250271742753466,0.2693409742120344,0.7377462823906005,1.0,11/30,13.76%,IL31RA;MFHAS1;NR1H3;IL33;CD200;ZC3H12A;GPR137B;THBS1;SPHK1;MYO18A;PJA2
prerank,mitochondrion localization (GO:0051646),-0.39058073271088056,-1.1248487548300556,0.298050139275766,0.7368252235164373,1.0,4/19,11.10%,MARK1;ZBED3;MEF2A;LRRK2
prerank,iron-sulfur cluster assembly (GO:0016226),-0.36886322795142784,-1.1241841412548401,0.26628895184135976,0.7374422958457386,1.0,10/24,23.51%,CIAPIN1;NFS1;MMS19;NFU1;CIAO3;FXN;ISCA2;GLRX5;BOLA2;ISCU
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.3896942394560091,-1.1241240881108998,0.27154046997389036,0.736262595369121,1.0,7/18,15.04%,STX8;ACTB;LDLRAP1;VPS4A;AR;ABCA2;ZDHHC2
prerank,positive regulation of blood coagulation (GO:0030194),0.48395436489333926,1.1236662531874833,0.315625,0.9323818286733971,1.0,2/17,2.66%,ST3GAL4;ANO6
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3441352371897541,1.1235601907935444,0.2873303167420814,0.9315454873981811,1.0,22/138,13.35%,RORA;PPARGC1A;NR3C2;RARB;MAML2;PGR;TAF10;TAF4B;TEAD3;CDK7;NCOR1;RARA;MED7;RORB;NRBF2;NCOR2;RARG;MED23;GTF2F2;TAF15;CREBBP;GTF2H1
prerank,PERK-mediated unfolded protein response (GO:0036499),0.5393452171375287,1.123237826594716,0.32532347504621073,0.9314625474304332,1.0,5/10,24.32%,EIF2AK3;NFE2L2;QRICH1;DDIT3;HSPA5
prerank,regulation of endothelial cell migration (GO:0010594),0.36654546937246596,1.123064206016181,0.28343558282208586,0.9308725692568413,1.0,10/85,4.96%,DCN;SMOC2;NR2F2;CEACAM1;FGF1;NRP2;GPLD1;NF1;PRKCA;WNT5A
prerank,blood circulation (GO:0008015),0.3840298339221765,1.1230030507208848,0.29906542056074764,0.9299006035502946,1.0,4/49,3.80%,MEOX2;SGCD;SERPING1;SGCG
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.31654057201840036,-1.1228597917473337,0.23684210526315788,0.738786109003542,1.0,6/43,3.88%,IGF1;BMP6;IL6R;BMP4;WNT4;BMPR2
prerank,negative regulation of vascular permeability (GO:0043116),-0.4478134176138944,-1.1226816801982664,0.3136792452830189,0.737938445222624,1.0,6/12,9.42%,ANGPT1;CLDN5;SLIT2;DDAH1;PDE2A;RAMP2
prerank,regulation of neutrophil migration (GO:1902622),0.5344996882372463,1.1224175235118483,0.351493848857645,0.9306532627368106,1.0,2/10,4.67%,MPP1;RAC2
prerank,actin polymerization or depolymerization (GO:0008154),-0.3069146757614874,-1.1223254624716192,0.2490118577075099,0.7376058549776006,1.0,12/50,11.27%,SVIL;DSTN;ARHGAP6;CFL1;WASF3;TWF1;JAK2;CAPG;DIAPH1;ABI1;EVL;AVIL
prerank,fat cell differentiation (GO:0045444),-0.29718622554449287,-1.121994341898141,0.2616033755274262,0.7372600029627099,1.0,16/57,12.87%,OSBPL8;PID1;SMAD6;WNT5B;FOXO1;EP300;KLF4;OSBPL11;PRDM16;ATF5;C1QTNF3;NR4A2;CLIP3;CTBP2;TMEM120A;BBS2
prerank,modulation by host of symbiont process (GO:0051851),-0.3382199950961839,-1.1216706863386556,0.3023255813953488,0.7368039019406358,1.0,7/31,12.55%,LEF1;EP300;NAPEPLD;HDAC1;CCNT1;SNW1;SP1
prerank,negative regulation of blood coagulation (GO:0030195),-0.32887103419450325,-1.1215604795027045,0.26621160409556316,0.7357661112502702,1.0,8/38,6.50%,PDGFRA;TFPI;NOS3;THBD;F3;SERPINE2;APOE;CD34
prerank,regulation of histone deacetylation (GO:0031063),0.4978596313063483,1.1212838627888564,0.3422818791946309,0.9332655688106987,1.0,3/13,15.58%,CAMK2D;PRMT6;SAP30BP
prerank,mRNA processing (GO:0006397),0.32450603498204605,1.121259340712713,0.23711340206185566,0.9321981616660088,1.0,81/287,22.77%,DHX8;PPARGC1A;HNRNPC;CSTF1;SF3B2;SF3B1;PCBP2;RBM8A;RBM10;RNPC3;CELF1;SRSF4;HNRNPA0;ZRSR2;SNRPF;RBM15B;SON;RPRD1B;HNRNPR;SF3B5;PPIE;CDK7;PRPF3;CSTF3;CHERP;DDX46;RBM22;RBM5;ELAVL2;DNAJC8;SNU13;SUPT4H1;RPRD1A;HNRNPM;DBR1;UPF3B;SRRM2;GTF2F2;ERN1;GTF2H1;TCERG1;SNRPA1;SFPQ;THOC3;DDX42;DHX16;TRA2B;PDCD7;SF1;SUGP1;CTNNBL1;SRRT;CMTR1;PSPC1;THOC5;SYNCRIP;PRMT9;CWC22;SLU7;SYMPK;GTF2H3;PLRG1;SRSF3;LSM3;MTREX;DHX38;DHX9;HNRNPD;UBL5;NUDT21;SRSF12;SRSF11;SRSF10;ELAVL1;CWC25;YTHDC1;HNRNPA3;PCF11;LSM2;CPSF2;RBM6
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.4714090807150255,-1.1206323253838635,0.3284671532846715,0.7370839125782047,1.0,6/10,29.40%,BMP6;NEXMIF;MAD2L2;NOTCH4;NOTCH1;PPM1F
prerank,negative regulation of endothelial cell migration (GO:0010596),0.4102519227274587,1.120611823120691,0.3211781206171108,0.9330562095597676,1.0,5/36,9.48%,DCN;NR2F2;ATP2B4;MECP2;HMGB1
prerank,acute inflammatory response (GO:0002526),0.4360025587694585,1.1203524879594262,0.315625,0.9327711873279567,1.0,4/23,13.60%,LBP;ANO6;PLSCR1;CTNNBIP1
prerank,protein-containing complex disassembly (GO:0032984),0.38162616627133505,1.1203342629885649,0.32887700534759357,0.931696787480314,1.0,16/54,19.50%,CAV1;FZD2;AXIN1;TSG101;GSK3B;CSNK1A1;APC;DVL3;VAMP8;LIX1;PYM1;UBQLN1;PPP1CA;SNAP29;MAP1LC3B;LAMP2
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.323859911674941,-1.1203246304883188,0.24584717607973422,0.7365484717048276,1.0,8/41,7.30%,PRKAG2;NUP107;EP300;HIF1A;AAAS;SEH1L;NUP133;PGAM1
prerank,negative regulation of programmed cell death (GO:0043069),-0.22873476939333348,-1.1202213662415192,0.0,0.7355332068265896,1.0,68/355,14.08%,IGF1R;IGF1;MECOM;NOTCH2;TEK;LEF1;OSR1;ANGPT1;GRK5;IL31RA;CTSH;TPT1;SMAD6;DAB2;PIK3R1;DNAJC3;NUPR1;BMP4;TBX3;FOXO1;TFRC;SQSTM1;CFL1;HNRNPK;CAT;FAS;DSTYK;GPX4;ZFAND6;AREL1;NPM1;NAA15;PDCD10;PRDX2;KDR;RPS6KB1;DNAJA1;HDAC1;IFIT3;TRAF6;PTMA;RNF144B;CASP3;ANXA1;ATF5;AKT1;UFM1;CFLAR;CITED2;SERPINB9;ARHGDIA;FLNA;CIAPIN1;UBE2O;HAX1;BID;BABAM2;TXNDC5;BAG4;CRYAB;FLT4;GATA6;THBS1;SPHK1;MYO18A;PIM3;YWHAZ;FXN
prerank,response to thyroid hormone (GO:0097066),-0.426475061205678,-1.1200506062699884,0.354916067146283,0.734642362888797,1.0,3/13,6.47%,CTSH;LMO2;CTSL
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.3747272358913352,1.1200016037749978,0.2950191570881226,0.9315788662904242,1.0,2/69,0.58%,NGF;PPARGC1A
prerank,muscle contraction (GO:0006936),-0.2600513201132568,-1.119866764541536,0.18110236220472442,0.7338425811024137,1.0,28/126,15.16%,MYOF;ITGA1;ROCK2;ACTN2;MYLK;DMD;TPM1;GJC1;SLC8A1;DYSF;SNTB1;TMOD3;BDKRB2;CALM1;MYL9;MYL6;MYH11;TPM3;LMOD1;ACTA2;TPM2;EDNRA;CRYAB;DES;ITGB5;SLC6A8;VIM;TLN1
prerank,brain development (GO:0007420),0.34256885193101344,1.1197651322729099,0.282560706401766,0.9312150118304389,1.0,12/136,9.40%,PTCH1;APOD;PBX1;NF1;CHD8;SHROOM2;AMIGO2;PAFAH1B1;CDH2;EML1;COL4A1;FOXJ1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.46349283364959093,-1.1195468695853406,0.28935185185185186,0.7334738751127895,1.0,7/11,40.83%,SP100;MAD2L2;RPS27L;KAT5;TFAP4;MUC1;FOXM1
prerank,regulation of immune effector process (GO:0002697),0.40652356360812564,1.1193302199152686,0.32554945054945056,0.9314840878239969,1.0,6/41,13.19%,C2;SERPING1;CD55;SUSD4;CD81;CFH
prerank,autophagosome maturation (GO:0097352),-0.34112234167822814,-1.1191868070450777,0.29430379746835444,0.7331085354792569,1.0,14/32,21.76%,UVRAG;GABARAPL1;VMP1;CALM1;VCP;GABARAP;STX17;TECPR1;EPG5;VAMP7;CHMP3;MAP1LC3A;WIPI2;VTI1B
prerank,response to calcium ion (GO:0051592),0.3567884522292331,1.1191170438894118,0.2917166866746699,0.9310638509334298,1.0,8/102,4.96%,CAV1;GUCA1A;ITPR3;CAMK2D;SLC25A12;GPLD1;ADD1;WNT5A
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.3755419675675197,-1.118895117752036,0.2813299232736573,0.7326510578487482,1.0,5/21,7.59%,ADCY1;ADCY7;NPR1;ADCY4;ADCY2
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.40863733252564804,1.1185407879490394,0.31645569620253167,0.9317623382529057,1.0,5/37,9.65%,APOD;IL17RA;CHID1;PLD3;TICAM1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.4089114788170425,-1.1182833541341333,0.33070866141732286,0.7331138945816918,1.0,13/17,34.80%,ANK2;SLC8A1;KCNJ2;CACNB2;CACNA1G;SCN4B;SCN1B;HCN2;CACNA1D;SCN5A;CACNA2D1;CACNA1C;HCN4
prerank,epidermal cell differentiation (GO:0009913),0.3964774773917696,1.1177421922709987,0.32959326788218796,0.9331793011036464,1.0,4/41,4.96%,GLI1;JAG1;WNT16;WNT5A
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.4872905822417043,1.1176517380041722,0.34797297297297297,0.9323388468694392,1.0,3/17,3.82%,F11R;CDH5;ADD1
prerank,positive regulation of lyase activity (GO:0051349),0.4876063561601381,1.1172932440992713,0.33387888707037644,0.9323650625947049,1.0,2/14,3.23%,GUCA1A;NF1
prerank,lipoprotein localization (GO:0044872),-0.4561664934046104,-1.1169017326985862,0.32009345794392524,0.7357147814614524,1.0,3/11,6.59%,LRP1;ZDHHC17;VMP1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.3562419671071022,-1.1168838280636009,0.2852852852852853,0.7344629792128626,1.0,7/26,12.18%,SHANK3;SLC8A3;CUX2;GRIN1;LRRK2;PRKCZ;NRXN1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.4287364990375194,1.1168416902399099,0.3328313253012048,0.9326627215165879,1.0,8/26,23.61%,ST3GAL4;TNIP1;SCCPDH;GK;GBGT1;TKT;GOLPH3;RRM2B
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.5079184185839973,1.116801017985412,0.33157894736842103,0.9316561833767923,1.0,2/12,4.76%,B3GALT1;B4GAT1
prerank,protein-DNA complex disassembly (GO:0032986),-0.4107702378349819,-1.116751180585679,0.30904522613065327,0.7335303206039513,1.0,4/16,10.95%,SMARCE1;SMARCD1;RPL23;ARID2
prerank,positive regulation of stem cell proliferation (GO:2000648),0.4662426382551086,1.1162514248385993,0.3333333333333333,0.932388703501797,1.0,5/17,15.34%,PTPRC;N4BP2L2;LTBP3;FERMT2;PDCD2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.4404799663493902,1.116165826926231,0.32644017725258495,0.9315054182958646,1.0,10/26,17.54%,HOMER2;EFHB;ATP2B4;CHERP;RCAN1;GSK3B;HOMER3;STIMATE;CHP1;DYRK2
prerank,regulated exocytosis (GO:0045055),-0.24735118375143467,-1.1159875722170451,0.12745098039215685,0.7343869504633292,1.0,54/173,23.83%,IGF1;TIMP3;VWF;ACTN2;ABCC4;PECAM1;PCDH7;CLEC3B;SPARC;LYN;CDC37L1;IGF2;NHLRC2;SYT9;SYT7;CALM1;PROS1;TGFB3;VEGFC;CYRIB;ARHGAP17;QSOX1;SYTL4;PHACTR2;FLNA;MANF;TGFB2;VEGFD;THBS1;VAMP7;TMSB4X;F5;LGALS3BP;TLN1;DNAJC5;CPLX2;EGF;RAB11FIP1;FAM3C;RAB11B;MYH9;RARRES2;SYT13;TUBA4A;SYT6;RIMS1;CLU;VTI1B;SNAP25;RAB10;A2M;RIMS3;TAGLN2;PCYOX1L
prerank,protein heterotetramerization (GO:0051290),-0.4368349078398315,-1.115576650859424,0.3260340632603406,0.7342556794056534,1.0,6/13,26.97%,FARSB;GRIN2B;GRIN1;CPSF7;CPSF6;HSD17B8
prerank,positive regulation of leukocyte migration (GO:0002687),-0.3528168303868769,-1.1152450316856795,0.31470588235294117,0.7339703892134033,1.0,10/27,31.48%,IL6R;CSF1;EDN3;PTN;ICAM1;NCKAP1L;ADAM8;JAM3;ADAM17;AIF1
prerank,female gamete generation (GO:0007292),0.4234629305273823,1.1145838741894538,0.3252496433666191,0.9352856780085161,1.0,7/29,18.81%,PIWIL2;DIAPH2;BMP15;MEI4;KMT2D;MDK;USP9X
prerank,activin receptor signaling pathway (GO:0032924),0.4893223885030533,1.114315070081557,0.3322314049586777,0.9350269384549437,1.0,2/15,5.04%,INHBB;ACVR1C
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.3962283351964474,1.1140482418520403,0.33109919571045576,0.9347676905935246,1.0,6/47,7.57%,EFNA5;DOCK5;DOCK1;SPRY4;RREB1;KANK1
prerank,positive regulation of transferase activity (GO:0051347),0.339117204686696,1.1139459878849929,0.3017142857142857,0.9339808137296933,1.0,13/142,6.38%,ROR2;ROR1;NTRK3;FGFR1;EGFR;MUSK;AXIN1;UBE2I;LMO4;NEK7;RFC3;NBN;EPHB2
prerank,B cell activation involved in immune response (GO:0002312),0.4920658675059696,1.1138752234619744,0.3486394557823129,0.9330862397797721,1.0,4/13,16.40%,MSH6;MSH2;GPR183;BATF
prerank,regulation of cardiac conduction (GO:1903779),0.3871125490091584,1.113732203331595,0.32793522267206476,0.9324307897161841,1.0,9/54,10.60%,CORIN;ITPR2;ITPR3;FKBP1B;ATP2B4;ATP1A2;CASQ2;ATP1B3;FXYD6
prerank,phospholipid catabolic process (GO:0009395),-0.37118722151493194,-1.1135905597037923,0.2882882882882883,0.7372229722646154,1.0,3/24,8.38%,GPCPD1;ENPP2;PNPLA6
prerank,regulation of cellular component organization (GO:0051128),0.3438252665608532,1.1135585860945576,0.2888631090487239,0.9318693347759033,1.0,21/135,9.44%,PTCH2;CDH13;PLCE1;CEACAM1;CAMK2D;RAP1A;MLLT3;OPHN1;IRAK3;WNT5A;ZFYVE16;STON1;HJURP;ANGPTL7;ABL2;PACSIN2;LTBP4;STK38L;EBAG9;IRGM;STON2
prerank,regulation of macrophage cytokine production (GO:0010935),-0.43157832749271424,-1.1129103214609815,0.34951456310679613,0.7378550641870941,1.0,7/13,16.78%,SEMA7A;PLCG2;TGFB3;CUEDC2;TGFB2;LAPTM5;GPRC5B
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.31089398924730977,1.1128615418042562,0.162,0.9329257874303195,1.0,125/834,13.67%,RORA;MEOX2;DCN;KLF5;ETV4;ITGA6;CDH13;ETV1;GLI1;PPARGC1A;FOXD2;NR2F2;DLX1;POU4F3;RARB;NFATC1;LDB2;PBX1;EGFR;FGF1;JAG1;TNIP3;ETV5;OGT;RUNX2;NUFIP1;NFIA;GLI2;IL4I1;CRTC1;MAML2;TXK;LMO1;LMO7;KMT2A;SPI1;FOXO3;SOX9;BMPR1B;PGR;NPAS2;TFR2;GLIS2;CHD8;CSRP3;SLC30A9;KAT6B;HDAC4;REL;BMP5;KLF10;LEO1;WNT5A;HEYL;ATAD2;SP3;RPRD1B;APLN;CDK13;ONECUT1;NRIP1;NCK2;CDK7;NRF1;PAX3;HOXC10;DDX17;RREB1;MAPK7;RARA;USF2;PIK3R2;ISL1;E4F1;FOXK2;ELL;TNIP1;ZNF462;AATF;AGO1;DDRGK1;TCF20;PLSCR1;MED13;TET1;FOXJ1;RPS6KA3;HMGB1;SIRT7;SMARCD2;RORB;SUPT4H1;POU4F1;HDAC2;DBP;TMF1;TFEB;FHOD1;PAXBP1;RTRAF;MMP12;WWC1;RARG;DVL3;EGR1;MZF1;ZBTB49;HTATIP2;AKIRIN1;MEN1;INO80;NCOA3;NFE2L2;CD81;PEG3;KDM6B;CRLF3;PKD1;CREBBP;NCOA2;BCL9;SOX4;DPF3;TCERG1;SFPQ
prerank,carbohydrate homeostasis (GO:0033500),-0.2849600265645761,-1.1122031704595066,0.2028985507246377,0.7385447884901345,1.0,7/67,3.87%,IGF1R;INSR;KCNB1;ADIPOR2;RBP4;APPL2;MBD5
prerank,inorganic anion transport (GO:0015698),-0.30095907635869906,-1.1118155881489795,0.27350427350427353,0.7383794411552959,1.0,10/53,9.30%,SLC26A7;ENPP1;SLC4A10;ANO1;CLIC4;ANO4;ENPP3;CLIC5;SLC25A30;SLC25A11
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.4026926970831855,-1.1116130874671746,0.3075060532687651,0.737729453020794,1.0,3/16,1.14%,PDGFD;PDGFRB;PDGFRA
prerank,leukotriene metabolic process (GO:0006691),0.45192151126339397,1.1109284687379546,0.3495440729483283,0.9380826116623923,1.0,5/19,15.29%,MGST2;ABCC1;ABCC10;LTA4H;GGT1
prerank,in utero embryonic development (GO:0001701),-0.3581149561608327,-1.1105760344934092,0.30140845070422534,0.7395492602216042,1.0,7/25,10.52%,CHD7;TGFBR1;IGF2;FGFR2;HINFP;TGFB3;BMP2
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3864521515317523,1.110526626041429,0.32309746328437916,0.9382598672980069,1.0,8/49,7.60%,CAV1;EIF2AK3;SRC;FIS1;NDUFS3;MCL1;SIAH1;PTPMT1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.4156133642944477,1.1102094333224504,0.32994186046511625,0.9381461780278975,1.0,6/36,8.37%,CAV1;EGFR;IL1A;ATP2B4;DDAH2;NOS1AP
prerank,secondary alcohol metabolic process (GO:1902652),-0.30728413787491443,-1.1101637375196318,0.2975778546712803,0.7393929275031981,1.0,21/42,35.52%,PPARD;APOE;SCAP;OSBPL1A;LDLRAP1;OSBPL5;GBA2;NSDHL;ABCG1;TSKU;CLN6;PIP4P1;CH25H;LCAT;IDH3G;SOAT2;RXRA;SQLE;EBP;IDH3A;SULT2B1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.4026185742678948,1.1097337408054524,0.31540697674418605,0.938526841290189,1.0,6/42,11.55%,CDH13;UTRN;PTPRJ;GSK3B;FERMT2;EFEMP2
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.3033782859274601,-1.1096373454738482,0.27169811320754716,0.739492325529606,1.0,26/50,28.00%,CCNT2;BLM;MNAT1;ACTB;CNPPD1;CDC25A;CCNT1;CAMK2N1;TTBK1;SERTAD1;CDK5R1;CCNE2;CCNH;CCNJL;CDK5RAP3;BCCIP;CDC37;STOX1;CCND2;CCNF;CDKN2C;CDKN1B;CCNK;CDKN2D;CCND1;CCNB2
prerank,regulation of aerobic respiration (GO:1903715),-0.4164757216058197,-1.1093175006466365,0.32,0.739111525176266,1.0,4/15,11.79%,ATP7A;CBFA2T3;VCP;SLC25A33
prerank,positive regulation of innate immune response (GO:0045089),0.4163646860368105,1.1092650711800534,0.33480176211453744,0.9388461695019741,1.0,6/30,12.74%,LBP;SPI1;WNT5A;POLR3G;PLSCR1;POLR3D
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.37316454373429453,-1.1089806658981678,0.30793650793650795,0.7387162863724773,1.0,10/23,18.07%,PREB;TMED9;SEC61B;SURF4;SYVN1;SEC16A;VCP;OS9;DERL2;TECPR2
prerank,carboxylic acid metabolic process (GO:0019752),-0.3314516409091893,-1.1089130016016773,0.2847682119205298,0.7376140191764757,1.0,12/33,25.68%,PTGIS;ST3GAL1;DDO;CSGALNACT1;TBXAS1;SLC2A1;AGXT;MIF;GSTO1;CYB5A;GSTO2;SLC2A3
prerank,regulation of cell adhesion (GO:0030155),0.3433902448866656,1.1085889912449245,0.29906542056074764,0.9399001826862615,1.0,13/129,6.48%,TGFBI;EFNA5;CDH13;RIPOR2;MINK1;PRKCA;SRC;DSCAM;RAC2;PLXNA3;ADAM10;EPHB2;ABL2
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.3647217211019859,-1.107738129133197,0.3153409090909091,0.7396880527582974,1.0,10/23,19.16%,NUPR1;CBFA2T3;EP300;SIK1;C1QTNF3;GSK3A;PGP;CLK2;PFKFB1;CRY1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.38241584815138835,1.107665303442209,0.33200531208499334,0.9416884928260557,1.0,12/53,14.11%,EGFR;FXR2;BRCC3;EYA1;SPRED1;NPAS2;HIC1;UIMC1;WRAP53;ERCC6;SPRED2;FXR1
prerank,calcium ion homeostasis (GO:0055074),0.35988219852496883,1.10757766481305,0.3151010701545779,0.940853318895454,1.0,9/95,4.74%,CAV1;STC2;CTRC;SLC8B1;CDH5;SLC24A1;TRPV4;CSRP3;ATP2B4
prerank,ceramide transport (GO:0035627),-0.4428528744692931,-1.1072013165616432,0.332541567695962,0.7398547066281003,1.0,8/12,33.90%,PLTP;ABCA2;PLEKHA3;ABCB4;PLEKHA8;ABCA13;PSAP;CPTP
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.434716634024495,1.1068942917055318,0.34156976744186046,0.9419167922688547,1.0,5/26,6.72%,EGFR;CCND3;ADAMTS1;UBE2E2;RDX
prerank,Wnt signaling pathway (GO:0016055),0.3517673791717101,1.1067215876560745,0.3115151515151515,0.9413692139432458,1.0,23/92,14.90%,WNT10A;FZD2;AXIN1;WNT2B;WNT16;PLPP3;CPE;WNT5A;CSNK1G3;GSK3B;CSNK1A1;FERMT2;STRN;RARG;APC;DVL3;WNT9A;PTEN;NXN;BCL9;FZD7;FZD9;FZD3
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.3353771781326945,1.1063957728542289,0.30211817168338906,0.941318475300268,1.0,9/151,4.99%,ROR2;ROR1;NTRK3;ACKR3;EGFR;RAP1A;PTPN22;PRKCA;PTPRC
prerank,regulation of DNA repair (GO:0006282),0.3916214133705162,1.106286941893434,0.33964817320703655,0.9405931158057096,1.0,11/44,10.79%,EGFR;BRCC3;EYA1;NPAS2;UBR5;UBE2V2;UIMC1;WRAP53;SIRT7;ERCC6;AXIN2
prerank,atrial septum morphogenesis (GO:0060413),-0.45254583459118414,-1.1062020382485285,0.3395348837209302,0.7414791572293908,1.0,3/10,12.75%,NOTCH2;BMPR2;TGFB2
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.2808537805555963,-1.106192473006645,0.25555555555555554,0.7402292728794566,1.0,17/78,11.25%,PICALM;NUMB;PID1;EPHA3;PRKCH;LRP1;DAB2;PIK3R1;SQSTM1;STX8;ITGA3;ACTB;AKT1;LDLRAP1;VPS4A;AR;CLIP3
prerank,synapse organization (GO:0050808),0.34447325242591026,1.1052853900747737,0.3003452243958573,0.9426882849422248,1.0,9/125,2.70%,NTNG1;LRP4;PDZRN3;PTPRF;MUSK;GPC6;PPFIA2;ZC4H2;RAB29
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.3914881783583328,1.1048706958608352,0.3238482384823848,0.9429218159377349,1.0,11/48,13.78%,BCL3;MSH6;PHLDA3;CIDEB;HIPK1;HIC1;MCL1;MSH2;SFN;CDIP1;HTRA2
prerank,actin filament bundle organization (GO:0061572),-0.340152194001158,-1.1044420932854282,0.2828282828282828,0.7438489520441233,1.0,5/33,5.73%,EPS8;NEDD9;MYO1B;PAWR;PLS3
prerank,regulation of biosynthetic process (GO:0009889),-0.4434400502197112,-1.1038646242480363,0.3382352941176471,0.7441747453347203,1.0,11/11,55.69%,SLC25A33;MID1IP1;SNCA;ALOX5;SPHK2;THRSP;GSTP1;CCN6;PIKFYVE;UCP1;PCK1
prerank,adherens junction organization (GO:0034332),0.381135981406497,1.1037937805178153,0.3152909336941813,0.9451751840240755,1.0,5/48,3.26%,CDH13;CDH11;CDH5;CDH17;CDH9
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.506527368896868,1.103736553020988,0.36589698046181174,0.9442388364471238,1.0,4/10,21.15%,HMGB1;CBFB;SOCS1;RUNX1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3571075945215057,1.1037211944767582,0.3272946859903382,0.9431756091247487,1.0,13/87,14.18%,FGF7;FGFR1;FGF1;RBFOX2;SPRED1;KIF16B;FGF18;HNRNPM;GTF2F2;ZFP36L2;SPRED2;FLRT2;TIAL1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.33438545662490987,1.1033055662039681,0.3113101903695409,0.9433600876559599,1.0,12/149,6.98%,EDA;CAV1;ROR1;IL18R1;RIPK4;FLOT2;IRAK3;WNT5A;FER;TRADD;TRIM21;NLRC4
prerank,acute-phase response (GO:0006953),0.4872218832680629,1.1032626273600665,0.36614853195164077,0.9423950405285109,1.0,2/12,8.99%,LBP;PLSCR1
prerank,protein heterooligomerization (GO:0051291),-0.40737259370411105,-1.10297470309817,0.30708661417322836,0.745413118939557,1.0,7/17,26.97%,FARSB;GRIN2B;GRIN1;TMEM120A;CPSF7;CPSF6;HSD17B8
prerank,positive regulation of protein modification process (GO:0031401),0.32883577720666185,1.1025100768372758,0.28844114528101805,0.9437200529907811,1.0,23/203,8.83%,EFNA5;FGF7;DLC1;NTRK3;CLDN19;LEPR;EGFR;RAPGEF3;CCND3;MUSK;PELI2;FGF1;AXIN1;CDH5;FXR2;SOX9;LIMK2;KRAS;RAB3GAP2;DYRK1A;NOS1AP;FGF18;IRGM
prerank,regulation of gluconeogenesis (GO:0006111),0.43473812004465623,1.1021373242651733,0.3538011695906433,0.9437802614560175,1.0,6/27,13.39%,PPARGC1A;OGT;SELENOS;SIRT7;C1QTNF12;GCK
prerank,aggrephagy (GO:0035973),0.43103881753866474,1.1021284807291023,0.3358547655068079,0.9427128122276639,1.0,5/27,11.27%,DYNLL1;WDR81;ATG5;DYNLL2;HDAC6
prerank,regulation of lymphocyte differentiation (GO:0045619),0.45103256921376433,1.1020026594292573,0.35313531353135313,0.9419984226472815,1.0,4/18,19.16%,IL4I1;CRTAM;ZFP36L2;XRCC6
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.47283671209272,1.1018836436671027,0.33495934959349594,0.9412736615630857,1.0,2/15,2.99%,HSPH1;CD55
prerank,ribosome biogenesis (GO:0042254),-0.23573599958343439,-1.1017898991189128,0.18181818181818182,0.7475748863757083,1.0,69/187,25.28%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPL35A;RPS7;RPL32;RPS27;RPL26;RPL27;NPM1;HEATR3;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;RPLP1;RPS17;WDR12;RPL23;RPL17;EIF2A;RPL9;RPL38;RPL36;RRP7A;ESF1;RPL18A;ABCE1;RIOK1;NOC2L;EXOSC3;IMP4;HEATR1;TEX10;LAS1L;RPLP2;POP5;RPS6;NOL9;HELQ;DIS3;DHX37;EXOSC1;FBL;RPL14;TBL3;RPS2;DHX29;RPL10A;UTP4;RPL39;RPL34;RPL5;RPL22;PWP2;RPS9;MRPL36;WDR3;RPS14;RPS25;PAK1IP1
prerank,positive regulation of cell death (GO:0010942),0.3744904361389227,1.1013186553729128,0.31016731016731014,0.9419550619842988,1.0,15/59,12.13%,PRODH;CIDEB;CELF1;WNT5A;SLC6A13;EFNB2;MAP3K5;GSK3B;SARM1;AXIN2;RARG;APC;EGR1;HTATIP2;FAF1
prerank,mitotic spindle organization (GO:0007052),0.33610253437644483,1.1012727909680953,0.31625835189309576,0.9410016870524169,1.0,49/153,23.10%,PLK2;DYNLL1;KIF2A;STIL;SMC3;SPAST;TUBG1;DSN1;CKAP5;PAFAH1B1;EML1;CDC20;NUP160;MECP2;DYNLL2;NUP37;RANBP2;BUB3;MAP4;WDR62;NDE1;MAP9;AHCTF1;PTPA;TUBG2;ZWILCH;ZW10;CENPU;ARHGEF10;RAN;PIBF1;TBCE;CENPH;B9D2;CENPK;MAD1L1;OFD1;RHOA;DCTN2;DYNC1LI2;CENPL;DYNC1I1;NUP43;GPSM2;PRC1;MIS12;DCTN6;SEC13;SBDS
prerank,organelle fusion (GO:0048284),0.4379279042496786,1.1010093752694485,0.3558282208588957,0.9407494968544312,1.0,9/22,22.20%,MFN2;FIS1;MIEF1;MIGA1;STX4;VPS11;BAX;CHCHD3;THG1L
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.3650172291885334,-1.1006528351576117,0.30563002680965146,0.7494696174880512,1.0,3/24,4.81%,GRB10;TMEM204;HIF1A
prerank,body fluid secretion (GO:0007589),-0.40390179270612425,-1.100542693320372,0.35561497326203206,0.7484451741559612,1.0,3/15,4.51%,GPAT4;SLC22A4;NPR1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.3990547229828318,-1.1004859649018197,0.31151832460732987,0.7473103258208497,1.0,5/17,10.52%,NOTCH2;RBPJ;BMP4;GALNT11;BMP2
prerank,neuromuscular synaptic transmission (GO:0007274),-0.39227675428938774,-1.1002735298917832,0.3471502590673575,0.7466265221578818,1.0,3/18,8.30%,KIF1B;TBC1D24;FCHSD2
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.4561488151930216,1.1001255953973155,0.35062893081761004,0.9424431530760609,1.0,9/21,18.05%,FBXO5;CDC20;TEX14;TPR;APC;BUB3;KLHL22;ZW10;MAD1L1
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.37503200322732344,-1.100103557148395,0.3179190751445087,0.7458430725813807,1.0,11/22,38.21%,SLC7A5;RFTN1;IL18;SPHK1;NR1H4;NOD2;MYD88;PRKCQ;TGFB1;LY9;SLAMF6
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.36909415748295515,1.0999800650849274,0.32378580323785805,0.9418210755485144,1.0,11/67,8.04%,PXN;SH2D2A;SULF1;CYFIP2;NRP2;DOCK1;VAV2;SRC;NCK2;SHB;PIK3R2
prerank,cytosolic calcium ion transport (GO:0060401),-0.342966590209996,-1.0998688645266113,0.3103448275862069,0.74522172435185,1.0,10/28,15.71%,SLC8A1;SLC35G1;JPH1;SMDT1;SLC25A23;MICU1;MICU2;ATP2B3;JPH2;JPH4
prerank,regulation of vesicle-mediated transport (GO:0060627),0.3557510176761064,1.0997554071731837,0.3402692778457772,0.9414101616243008,1.0,37/91,23.04%,CDH13;RAB8B;OPHN1;SRC;PTPRC;ZFYVE16;STON1;ABL2;PACSIN2;RIMS2;RAB3A;CPLX1;RINT1;INPP5F;ATP9A;STON2;PLD1;RUFY2;MBTPS1;SYK;RAB33B;RAB21;STX4;SNX12;DENND10;RAB5A;PACSIN3;NSF;SNX17;PACSIN1;RALA;CPLANE2;VAMP2;TSC2;HCK;AP2S1;MAPK1
prerank,nuclear pore complex assembly (GO:0051292),0.5212617880782785,1.0993249520549928,0.36988847583643125,0.9415808838905991,1.0,5/10,15.45%,TPR;AHCTF1;NUP153;RTN4;NUP93
prerank,negative regulation of interleukin-6 production (GO:0032715),0.42929633012128576,1.0987470723329453,0.34880239520958084,0.9422238974588824,1.0,6/27,9.40%,PTPN22;IRAK3;TNFAIP3;SELENOS;CD200R1;FOXJ1
prerank,cellular defense response (GO:0006968),0.3939725464414041,1.0985672135796267,0.3424283765347885,0.941747884428357,1.0,3/40,3.98%,LBP;ITK;CD5L
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.35298673589475277,1.0985287960189667,0.296875,0.9407797388952608,1.0,21/94,17.01%,PRODH;MYBBP1A;PPP1R13B;MSH6;FHIT;ERO1A;CIDEB;HIC1;MCL1;CUL3;MAP3K5;STK24;SFN;POU4F1;DIABLO;ERN1;HTRA2;BAD;BNIP3;E2F1;QRICH1
prerank,oligodendrocyte development (GO:0014003),0.4754672808001659,1.0984571661894644,0.3647260273972603,0.9399531929540174,1.0,4/15,13.09%,EIF2B3;CNTNAP1;EIF2B4;NSUN5
prerank,insulin receptor signaling pathway (GO:0008286),0.3610484450978563,1.0984212383687844,0.3256113256113256,0.9389936525333219,1.0,10/69,9.35%,GAB1;SORBS1;GPLD1;CAV2;ATP6V0D2;PDK4;FER;PIK3R2;ATP6V0A1;GSK3B
prerank,organelle disassembly (GO:1903008),-0.3398110923018244,-1.0984115404520127,0.2926829268292683,0.7482555191566818,1.0,9/33,13.99%,UBA5;KLC1;ULK2;UFM1;VCP;EIF2D;GOLGA2;MTIF2;PLK5
prerank,regulation of cell communication (GO:0010646),0.40834133993443855,1.0981128146703036,0.3465491923641703,0.9388814028927467,1.0,6/35,9.10%,CXADR;CAMK2D;CDC42SE2;NUP62;CASQ2;TBX18
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.4175649963578729,1.0976736551719892,0.3465045592705167,0.9391171788462904,1.0,3/27,2.02%,DLC1;F11R;ARAP1
prerank,B cell homeostasis (GO:0001782),-0.4589612615161544,-1.097195188996207,0.3225806451612903,0.7504539296899869,1.0,2/10,2.16%,DOCK11;LYN
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.31907296269303237,-1.0970544793864834,0.2893772893772894,0.7495584606755882,1.0,10/41,10.42%,ANK2;ACTN2;KCNJ6;KCNMA1;KCNJ2;AKAP6;KCNJ10;FLNA;ANK3;KCNN2
prerank,neuron maturation (GO:0042551),-0.39034639666820414,-1.0970495828677291,0.3253968253968254,0.748307343049502,1.0,10/18,31.84%,EPHA8;LGI4;CLN5;C1QA;PICK1;C3;SCARF1;ACTL6B;RND1;MTCH1
prerank,histone H2A ubiquitination (GO:0033522),-0.3897839890530424,-1.0970350082509968,0.3484042553191489,0.7471004496978342,1.0,9/17,29.65%,KDM2B;RYBP;RNF8;TRIM37;SKP1;RNF2;RING1;DDB1;BCOR
prerank,glycerolipid metabolic process (GO:0046486),0.5098730807154466,1.0963222942372468,0.379073756432247,0.9422174087555969,1.0,2/11,3.58%,DGKA;DGKZ
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.40332445636795444,-1.0960822943333164,0.33076923076923076,0.7486166748607233,1.0,4/17,2.58%,IGF1;DOCK4;PDGFRB;IGFBP5
prerank,regulation of actomyosin structure organization (GO:0110020),-0.4296611574934863,-1.095925867073579,0.3049645390070922,0.7478005635143662,1.0,5/13,8.78%,ROCK2;CDC42;ASAP3;SLC9A1;ACTG1
prerank,nucleoside catabolic process (GO:0009164),0.4903401669642674,1.0952192297685832,0.36428571428571427,0.9445467754982184,1.0,5/11,15.07%,DPYS;UPP2;NT5E;DERA;NT5C3A
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.4225890557989524,-1.0951166224509787,0.3374384236453202,0.7477089643071492,1.0,2/13,7.60%,PLCB1;IL15RA
prerank,cellular response to interleukin-15 (GO:0071350),-0.4225890557989524,-1.0951166224509787,0.3374384236453202,0.7477089643071492,1.0,2/13,7.60%,PLCB1;IL15RA
prerank,B cell differentiation (GO:0030183),-0.3065673789974515,-1.0951117065937879,0.2550335570469799,0.7464697413268487,1.0,10/46,9.82%,KLF6;KIT;CEBPG;FNIP1;VCAM1;HDAC9;PLCG2;NHEJ1;SYVN1;DCAF1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.5108631358759503,1.0944164284717377,0.37435008665511266,0.9458858130889055,1.0,6/11,17.25%,THTPA;TPK1;CTPS2;NT5C3A;SLC25A19;DCK
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3318747679278502,1.0942611463759648,0.30700778642936594,0.945266893797913,1.0,27/166,13.35%,RORA;PPARGC1A;NR3C2;RARB;MAML2;PGR;TAF10;CAVIN1;TAF4B;TEAD3;CDK7;POLR1E;NCOR1;RARA;MED7;RORB;NRBF2;TFB2M;NCOR2;RARG;MED23;NAT14;GTF2F2;TAF15;CREBBP;BRF2;GTF2H1
prerank,granulocyte differentiation (GO:0030851),-0.38923814113156957,-1.0942168221729953,0.33066666666666666,0.7477179111024158,1.0,6/18,13.79%,LEF1;CBFA2T3;EP300;DEK;CDK4;TAL1
prerank,negative regulation of gene expression (GO:0010629),-0.22810714343799685,-1.0941981543448807,0.13333333333333333,0.7465242233202194,1.0,88/302,21.78%,IGF1;ROBO1;SLC24A3;DAPK1;PICALM;NOTCH2;ENG;ROCK2;CLDN5;LGR4;FOXP1;IGFBP5;BMP4;SLC7A5;WNT4;ACVRL1;RPS6KA5;HIF1A;RBL1;XDH;KLF4;PDCD10;HDAC9;KDR;MYADM;APOE;CD34;HDAC1;HINFP;RBMS3;MAP2K2;CRKL;PPP1R11;PAIP2;RPL13A;JARID2;CITED2;GATA2;LGMN;SLC2A10;AGO3;ZC3H12A;RPS3;BMP2;GAPDH;BMI1;ESR1;RPS26;TTBK1;NOCT;NUDT12;TGFB2;NCL;DHFR;MOV10;ID2;MAPT;AGO4;SH3GL2;PARP10;TLE5;LGALS9;RBL2;SUZ12;DNMT3B;TWSG1;ASB1;ZFP36;CNOT9;TNRC6C;DHX36;KAT2B;METTL16;YTHDF2;ANXA7;EED;RACK1;DAPK3;MIF;ZC3H10;TASOR;DNMT3A;HRAS;CILP;RIDA;TMBIM6;DCP2;APLNR
prerank,regulation of organelle organization (GO:0033043),-0.2750007928111086,-1.093957974953342,0.2641509433962264,0.7459227193797329,1.0,17/80,9.39%,ZEB2;PDE4DIP;MSN;MYO5A;CLIC4;EP300;PREB;SQSTM1;TMED9;STX18;USP6NL;PDCD10;RBSN;NEXN;SURF4;DIAPH1;PDE2A
prerank,regulation of MAP kinase activity (GO:0043405),0.34664339617330076,1.0934634864242707,0.3200962695547533,0.9466909116741401,1.0,11/92,5.45%,TRIB2;FGFR1;RGS14;EGFR;FGF1;STK38;NF1;SPRY1;SPRY4;IRAK3;TSG101
prerank,phosphorylation (GO:0016310),0.3109060320512918,1.092889756517602,0.27540650406504064,0.9473417726250544,1.0,52/385,9.93%,TEC;PLK2;FAM20C;TRIB2;CDK15;FGFR1;HCST;DGKA;PRKCE;CAMK2D;MINK1;STK38;MAP3K1;TXK;MAPK10;DGKZ;PRKAG1;EIF2AK3;BMPR1B;PRKCA;CDKL3;PEAK1;MORC3;LIMK2;IRAK3;ACVR1C;PDK4;HIPK1;PIK3R4;BRSK1;NEK7;FER;CDK13;BCKDK;COQ8A;ADAM10;CERK;EPHB2;GMFB;CDK7;BMP2K;STK38L;RARA;MAP3K5;SRPK1;DYRK1A;NRBP2;STK24;STK3;GSK3B;CSNK1A1;TYK2
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.36519444787915534,1.0926585081542415,0.33748443337484435,0.946972178304532,1.0,20/67,19.62%,CAV1;ATP8B1;CAPZB;FXR2;FER;ATG5;RDX;ARF6;TBC1D16;TBC1D2;TBC1D8;PLD1;EVI5;FXR1;DYNC2LI1;TBC1D20;TBC1D5;RAB5A;ATG3;TBC1D10A
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.4641007002606224,-1.0921629613582284,0.34513274336283184,0.7494656943945458,1.0,4/10,24.99%,JARID2;KDM1A;DNMT3B;BRCA1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.32797918662664716,1.0911873034547157,0.3196099674972914,0.9504901171242607,1.0,57/185,19.15%,DYNLL1;PSME3;SFI1;CEP131;CEP78;NEDD1;TUBG1;CKAP5;FBXO5;CUL3;PAFAH1B1;CCP110;CDC20;PSMB5;ANAPC5;ANAPC7;CENPJ;ANAPC11;BUB3;NDE1;CEP290;INO80;SSNA1;CETN2;CDC6;PKD1;ZFP36L2;ANAPC2;PCM1;PSMB2;UBE2D1;PSMA2;PSMA6;ZW10;ANAPC4;PTPN6;FZR1;PSMD13;PSMA7;YWHAG;NEK11;YWHAE;CDC14A;RGCC;E2F1;CEP57;PSME4;ANAPC16;KLHL18;OFD1;PSMC4;CDC23;PSMB6;PSMD12;PSMD14;CEP250;DCTN2
prerank,protein modification process (GO:0036211),0.35603584142322675,1.0909288008042186,0.32802937576499386,0.9502136996621104,1.0,17/76,14.88%,SLC35A1;UBE2L6;DUSP12;STK38;MMP15;ERO1A;UBE2I;CDKL3;CPE;ABL2;CSNK1G3;MANBA;FBXO11;LCMT1;UBE2D3;CHRM3;WWP2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.484729918735022,1.0907823876464542,0.3583916083916084,0.9496206956624715,1.0,2/13,4.76%,B3GALT1;B4GAT1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.4370015367270515,1.0906577828737127,0.3574730354391371,0.9489375937071851,1.0,6/22,13.51%,NR2F2;APC;HEXIM1;MEN1;PTEN;CDKN1C
prerank,chondrocyte differentiation (GO:0002062),0.40670268484535366,1.0905702828564119,0.3373493975903614,0.9480935411389664,1.0,7/32,4.10%,SULF1;RUNX2;GPLD1;WNT2B;EIF2AK3;SOX9;BMPR1B
prerank,cellular response to organic substance (GO:0071310),-0.26060575054977414,-1.090481112255424,0.2198581560283688,0.7527683920604067,1.0,22/116,11.10%,SMAD3;LEF1;PID1;GHR;CLEC3B;SLIT2;IGFBP5;TGFBR1;ACVRL1;BMPR2;CYP1B1;IL18;KLF4;AKAP6;RPS6KB1;TRAF6;ARL6IP5;CDK9;LDLRAP1;RAMP2;HAX1;LRRK2
prerank,tyrosine metabolic process (GO:0006570),0.48877192003132924,1.0903874863612637,0.3701754385964912,0.9475707166668625,1.0,2/11,10.43%,IL4I1;GSTZ1
prerank,sodium ion transmembrane transport (GO:0035725),0.35339645941863984,1.0903482187823124,0.3370646766169154,0.9466230856388924,1.0,14/84,11.17%,SCN10A;NALCN;SLC12A2;ANO6;SLC24A1;SLC12A3;KCNK1;ATP1A2;SLC6A13;SLC4A4;ATP1B3;SCN2B;SLC9A7;SLC9A6
prerank,T cell homeostasis (GO:0043029),-0.4564062529145212,-1.0901141759177984,0.35664335664335667,0.752535375269933,1.0,5/10,25.44%,FAS;AKT1;ZC3H8;NCKAP1L;JAK3
prerank,peptidyl-proline modification (GO:0018208),0.4228419960461558,1.0900277457877756,0.3393124065769806,0.9465423644632295,1.0,6/25,14.09%,FKBP5;FKBP1B;PPIE;PPIL6;PPIC;PPIG
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.5075761753202757,1.0895851471067355,0.3633217993079585,0.94686676405318,1.0,5/10,19.36%,INPP5F;NF2;PIBF1;SOCS1;PPP2CA
prerank,positive regulation of DNA metabolic process (GO:0051054),0.3679086601204888,1.0893669067116414,0.35723771580345287,0.9464184301523713,1.0,11/61,10.73%,SMOC2;EGFR;BRCC3;EYA1;NPAS2;NBN;UIMC1;WRAP53;MECP2;HMGB1;ERCC6
prerank,regulation of JNK cascade (GO:0046328),-0.2575578264873521,-1.0892654387793739,0.2360248447204969,0.7536640297872923,1.0,13/101,6.74%,IGF1R;PLCB1;MECOM;TNFRSF19;TGFBR3;CCN2;MFHAS1;SIRPA;SH3RF3;DUSP10;DUSP3;ANKRD6;TRAF6
prerank,regulation of amyloid fibril formation (GO:1905906),-0.4074852942243469,-1.0888174192177886,0.3342036553524804,0.7537601809656462,1.0,6/15,21.63%,LDLR;APOE;VBP1;CRYAB;PFDN4;CLU
prerank,endothelial cell development (GO:0001885),-0.35051655820577887,-1.088612804255099,0.31486880466472306,0.7531564132703552,1.0,8/25,9.92%,RAPGEF2;COL22A1;MSN;PECAM1;COL15A1;MYADM;PDE2A;ROBO4
prerank,regulation of protein processing (GO:0070613),-0.3672988846253884,-1.0885173376825807,0.3333333333333333,0.7522035528544035,1.0,5/21,14.64%,CCBE1;GAS1;SERPINE2;LRRK2;NKD2
prerank,regulation of JUN kinase activity (GO:0043506),-0.3263602991369794,-1.0884494906382345,0.3087248322147651,0.7511369919700661,1.0,9/33,16.28%,SASH1;DUSP10;DNAJA1;TRAF6;MAP3K10;RPS3;TNFRSF11A;EDN1;DVL2
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.42227832147263933,1.0881344283264758,0.34393939393939393,0.9491927865715482,1.0,9/26,16.76%,NEDD4L;KCNS2;CASQ2;ATP1B3;KCNAB1;NEDD4;FHL1;WWP2;YWHAE
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.3876124018326781,1.0881011464344437,0.3412587412587413,0.948244437945359,1.0,13/45,17.36%,PLK2;WEE1;TOM1L1;CHFR;BRINP1;TOM1L2;ZFP36L2;CDKN1C;ZWILCH;ZW10;FZD3;RGCC;SCRIB
prerank,regulation of protein transport (GO:0051223),-0.3379769734841142,-1.0879833381060868,0.33630952380952384,0.7512070374741628,1.0,7/27,17.38%,DNAJC1;HSPA8;DNAJA1;RHBDF2;LLGL2;SCFD1;GAPVD1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.3762889483681638,1.0871710959198504,0.34805194805194806,0.9500106130673676,1.0,3/53,3.10%,HRH1;SSTR1;MC5R
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.2705283369226357,-1.0871052521121405,0.2640449438202247,0.752432129238292,1.0,22/87,13.39%,ENG;PARD3;SMAD3;CLDN5;SMAD6;TGFBR3;FKBP1A;SMAD9;TGFBR1;APPL2;PTPRK;ACVRL1;SMAD5;NRROS;TGFB3;LPXN;ZFYVE9;FURIN;PRKCZ;TGFB2;FMOD;ITGB5
prerank,intracellular protein transmembrane transport (GO:0065002),-0.30793585346603647,-1.0868811029091123,0.31645569620253167,0.7518483938429544,1.0,20/42,33.28%,C2CD5;SEC61B;TIMM44;SEC62;PAM16;PEX26;TIMM17B;PEX6;PEX1;PEX10;ROMO1;GRPEL1;DNLZ;AIFM1;TIMM50;HSPD1;PEX5;TIMM23;TIMM21;RTN2
prerank,sulfate transport (GO:0008272),-0.4073587622545042,-1.0867476621001335,0.3573200992555831,0.7509865211565862,1.0,4/14,9.30%,SLC26A7;SLC26A2;SLC25A30;SLC25A11
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.4914321706904258,1.0865016892709338,0.37436762225969644,0.9509780028790179,1.0,3/12,6.73%,ATIC;PFAS;PPAT
prerank,positive regulation of DNA recombination (GO:0045911),-0.3479850806287125,-1.0864855091742613,0.3333333333333333,0.7505266092246642,1.0,10/27,20.58%,TFRC;PAXIP1;SHLD2;ACTR2;ARID2;MMS19;ERCC2;PARP1;TIMELESS;MAD2L2
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.32917207678368327,1.086025295925996,0.32079646017699115,0.9513687767484846,1.0,23/151,11.71%,SGMS2;ST3GAL4;CERS6;ARG1;ASS1;PCSK5;ACER3;ELOVL5;PLPP2;PLPP3;PCTP;SLC27A1;MGST2;HACD4;ELOVL1;ELOVL2;TNIP1;CERT1;GSTZ1;GSTA4;GSTA3;HACD2;GSTK1
prerank,activation of protein kinase B activity (GO:0032148),0.4076123886125539,1.0858157676228586,0.35119047619047616,0.9509708688882479,1.0,6/29,10.36%,NTRK3;PRR5;FGF1;WNT5A;MAPKAP1;ADRA2A
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.30394312289509484,1.085662657274253,0.2296890672016048,0.9503642808419747,1.0,105/807,12.06%,PTCH1;TENM2;CAV1;MDFIC;VGLL4;PRICKLE1;PAX9;NR2F2;TSHZ3;NEDD4L;PHC2;DLX1;RARB;FOXP2;ZNF423;FOXD1;ZBTB32;KLF12;LDB2;ATP8B1;MYBBP1A;BCL3;ETV5;RUNX2;RBFOX2;GLI2;IRF2BP1;CHD3;SFMBT2;CIART;SPI1;L3MBTL3;FOXK1;BEND3;PHF21A;FOXO3;SOX9;UBE2I;FOXP4;GLIS2;CHD8;KAT6B;HDAC4;LANCL2;SATB1;KLF10;DACT1;WNT5A;CREB3L1;N4BP2L2;PPM1A;RBM15B;HEYL;SP3;KANK2;BHLHE40;ZFP90;ANKRD2;NRIP1;RCOR3;SIN3B;CTCF;HIC1;PEX2;PAF1;ZNF431;NCOR1;NCOA5;TBX2;RREB1;RARA;SUV39H1;KCTD1;MYPOP;ISL1;E4F1;FOXK2;UIMC1;TSC22D4;MECP2;FOXJ1;HMGB1;SIRT7;RORB;USP47;SUPT4H1;POU4F1;HDAC2;CNOT7;LEFTY1;TPR;ZHX1;WWC1;NCOR2;ILF3;OTUD7B;RARG;HDAC6;MZF1;HEXIM1;ZNF148;ERF;MEN1;KDM8;SEMA4D
prerank,pulmonary valve development (GO:0003177),0.4602694437302775,1.0850990410839638,0.3763955342902711,0.9510443605853156,1.0,4/18,5.24%,STRA6;NFATC1;JAG1;HEYL
prerank,non-motile cilium assembly (GO:1905515),0.4043319623218145,1.0850393058912775,0.34080717488789236,0.950170346082695,1.0,11/30,20.83%,GORAB;CEP89;C2CD3;CEP290;RPGRIP1L;PCM1;PIBF1;BBS1;CEP250;TMEM80;IFT57
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.32394775707957313,-1.0848323488910674,0.30303030303030304,0.7539613623255141,1.0,14/35,26.38%,ETS1;LYN;HOXA5;HIF1A;CDK6;TAL1;ZFP36;ABCB10;INHBA;NCKAP1L;HSPA1A;ACVR1B;FAM210B;STAT3
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.46369480232597293,-1.0847440253716278,0.3638344226579521,0.7529737526443387,1.0,6/10,23.66%,PDE8A;GPR37;LRRK2;GPR37L1;RIPK1;STK26
prerank,negative regulation of cyclase activity (GO:0031280),-0.41507518380946956,-1.0844111288897413,0.3583959899749373,0.7525842415676582,1.0,2/14,2.36%,ADGRV1;GRM3
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3477429333066542,1.084053070711823,0.3491879350348028,0.9521430722508373,1.0,14/100,11.56%,TRIB2;PRICKLE1;GLMN;SOCS5;SH3RF2;OGT;FHIT;KEAP1;N4BP1;DDRGK1;GSK3B;CSNK1A1;RCHY1;ZYG11B
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.42293683798969806,1.0837796116088347,0.35572519083969467,0.9519488925109734,1.0,11/30,19.95%,LEPROT;ABLIM3;RAC2;HTRA2;UBE2J2;UBE2D3;FBXW7;VPS11;CSNK2A2;PINK1;UBL5
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.36070322512463765,1.0834679913331287,0.34581772784019976,0.9518499682582079,1.0,8/66,4.05%,CAV1;NR2F2;CEACAM1;SULF1;CASK;NF1;CAV2;SOX9
prerank,cell junction assembly (GO:0034329),0.3410975683706439,1.0834287070592032,0.35611510791366907,0.9509144024684375,1.0,16/100,10.07%,ITGA6;TLN2;CDH11;PARD6B;CDH5;RAB29;CDH9;TRPV4;OPHN1;DSCAM;FN1;CDH2;PKP4;GPM6A;POU4F1;FERMT2
prerank,estrogen metabolic process (GO:0008210),0.46587553003024806,1.0832137317461676,0.3768595041322314,0.9504903711465313,1.0,3/15,11.25%,SULT1A1;HSD17B4;HSD17B2
prerank,positive regulation of viral transcription (GO:0050434),0.43118233045455306,1.083113323651752,0.3889763779527559,0.9497577844061013,1.0,4/25,12.46%,MDFIC;NELFB;SUPT4H1;GTF2F2
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.2623069732166979,-1.082759733210781,0.24157303370786518,0.7560245437746511,1.0,19/88,11.84%,TRABD2B;SMAD3;SYNPO2;TFRC;BCL2L11;FNIP1;STX18;FNIP2;RHOC;SLF2;SH3GLB1;VCP;VPS4A;SLF1;RPS3;AJUBA;BID;MMP1;MPP7
prerank,negative regulation of cellular process (GO:0048523),0.3087443421801225,1.0825728818415734,0.28225806451612906,0.9504138489725057,1.0,87/521,15.21%,NGF;ROR2;ZBTB7C;TGFBI;IGFBP6;DLC1;CDH13;VGLL4;RIPOR2;CLDN19;GLMN;ADAMTS1;DCBLD2;PPP1R13B;SSTR1;SPEF1;GPLD1;GNRH1;CASK;PIWIL2;IL1A;PTPN14;WNT16;EIF2AK3;PTHLH;CD9;TPTE;CELF1;NPAS2;DSCAM;BMP5;PLXNA3;KLF10;NUP62;PDS5B;KANK2;ADAM10;EPHB2;NCK2;ATG5;NDUFS3;CTCF;CHERP;FBXO5;BRINP1;DIS3L2;RBM5;PTPRJ;PLSCR1;NLRP2B;SIRT7;CNOT7;DLG3;PBRM1;FERMT2;CHMP4B;STRN;AXIN2;RARG;APC;VAMP8;PLXNB1;ZBTB49;MEN1;SEMA4D;TEX15;NF2;HOPX;WNT9A;PTEN;CDC6;CRLF3;FHL1;SOX4;HTRA2;NAIF1;DNAJA3;CLMN;RTN4;CAPRIN2;PTPRU;ERBB4;SIPA1;NDRG3;GPER1;PTPN6;PLG
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3854088486846544,1.082394664028115,0.36235955056179775,0.9499036907311048,1.0,17/42,21.52%,HNRNPC;CHD3;CHD8;SMARCAD1;ACTR8;SMARCD2;HDAC2;PBRM1;ERCC6;INO80;INO80B;ACTR6;SPTY2D1;ZNHIT1;RBBP4;ARID1B;ARID1A
prerank,receptor signaling pathway via STAT (GO:0097696),-0.34429233177980884,-1.0823477056783826,0.3424242424242424,0.7558959111427225,1.0,4/25,6.94%,IL31RA;GHR;IFNAR2;JAK2
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.322081489506163,-1.0820026134880916,0.29491525423728815,0.7555910022322958,1.0,16/36,30.27%,PCGF2;PHC3;BMI1;RYBP;CDC7;SUZ12;EED;EHMT2;RAD51;L3MBTL2;BRCA1;RNF2;PCGF6;RING1;MAX;E2F6
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.4757124339412152,1.081524002053274,0.37666666666666665,0.9515860355757925,1.0,3/13,9.48%,FGFR1;APLN;HMGB1
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.4233364510399981,-1.081513231946588,0.34963325183374083,0.755743552500849,1.0,6/12,20.31%,CSGALNACT1;PARG;UGP2;FUT8;SLC35A3;GFUS
prerank,early endosome to late endosome transport (GO:0045022),0.4483721632696999,1.0813694354738141,0.3622291021671827,0.950997126552634,1.0,9/20,21.65%,HOOK2;WDR81;KIF16B;HOOK3;PIK3C3;LMTK2;WDR91;RAB5A;AKTIP
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.37774984986178073,-1.0806642710219594,0.31607629427792916,0.7568996932038975,1.0,6/18,12.65%,TNFRSF21;OPALIN;TNFRSF1B;IL34;SLC45A3;DAAM2
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.4012817630971109,-1.0805818295899283,0.3605769230769231,0.7559275379975885,1.0,5/16,6.00%,IGF1;TGFBR3;RBPJ;FGFR2;AKAP6
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.3119614737582095,-1.0805675770551042,0.3485915492957746,0.7547557981834581,1.0,4/39,2.67%,MYO1D;MYO1B;MYO5A;MYO6
prerank,regulation of humoral immune response (GO:0002920),0.3891204707590854,1.0797477076160562,0.3650137741046832,0.9549313578289029,1.0,6/44,13.19%,C2;SERPING1;CD55;SUSD4;CD81;CFH
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.3159339863932848,-1.0794664174830975,0.315018315018315,0.756654242077549,1.0,13/39,20.66%,ENG;SLIT2;BMP4;TIE1;RASIP1;KDR;LRP6;BMP2;NRP1;SALL1;LRP5;MET;NOTCH4
prerank,ncRNA processing (GO:0034470),-0.2322251348859106,-1.0793420953341162,0.16853932584269662,0.755744876461957,1.0,73/200,25.42%,SMAD3;RPL37A;INTS9;SSB;ADAR;RPL19;RPL8;RPL37;RPS15;RPL35A;RPS7;RPL32;RPS27;RPL26;RPL27;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;AGO3;RPLP1;RPS17;WDR12;RPL23;RPL17;RPL9;RPL38;RPL36;RRP7A;ESF1;RPL18A;PUS10;INTS1;AGO4;TUT7;EXOSC3;IMP4;HEATR1;TEX10;LAS1L;RPLP2;POP5;RPS6;NOL9;HELQ;DIS3;DHX37;EXOSC1;FBL;RPL14;TBL3;RPS2;RPL10A;UTP4;RPL39;RPL34;RPL5;RPL22;SMAD1;PWP2;RPS9;MRPL44;WDR3;RPS14;RPS25;TRPT1;INTS5
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.31240266185819,1.0792174871954519,0.3452631578947368,0.9554790871621084,1.0,74/264,22.77%,DHX8;HNRNPC;CSTF1;SF3B2;SF3B1;PCBP2;RBM8A;RBM10;RNPC3;SRSF4;HNRNPA0;ZRSR2;SNRPF;RBM15B;HNRNPR;CDK13;SF3B5;PPIE;PRPF3;DDX17;CSTF3;CHERP;SMN1;DDX46;RBM22;SRPK1;RBM5;ELAVL2;DNAJC8;SNU13;CELF4;HNRNPM;SRPK2;DBR1;UPF3B;SRRM2;GTF2F2;SNRPA1;SFPQ;DDX42;DHX16;TRA2B;PDCD7;SF1;SUGP1;CTNNBL1;SRRT;PSPC1;SYNCRIP;CWC22;SLU7;SYMPK;STRAP;PLRG1;SRSF3;LSM3;MTREX;DHX38;DHX9;HNRNPD;UBL5;NUDT21;SRSF12;SRSF11;SRSF10;ELAVL1;CWC25;YTHDC1;DCPS;HNRNPA3;PCF11;LSM2;CPSF2;RBM6
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.4874708639152103,1.0791660940442402,0.3762541806020067,0.9545714533504596,1.0,3/13,5.70%,PIK3AP1;PIK3R4;TLR7
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.409831188540335,-1.0791608509035102,0.35475578406169667,0.7550131322726998,1.0,8/16,25.40%,SHLD2;POLQ;UBQLN4;CGAS;MAD2L2;RMI2;SMCHD1;PARPBP
prerank,negative regulation of apoptotic process (GO:0043066),-0.22032369350371334,-1.0788784977732981,0.06666666666666667,0.7546146138549464,1.0,85/444,13.49%,IGF1R;IGF1;NOTCH2;TEK;LEF1;OSR1;PRKCH;ANGPT1;GRK5;IL31RA;RNF213;CTSH;TPT1;SMAD6;DAB2;SLC30A10;PIK3R1;DNAJC3;NUPR1;BMP4;TBX3;NDNF;KDM2B;FOXO1;TFRC;FNIP1;CPEB4;SQSTM1;CFL1;HNRNPK;CAT;FAS;DSTYK;ZFAND6;AREL1;NPM1;NAA15;KLF4;PDCD10;PRDX2;KDR;APOE;TBX1;RPS6KB1;DNAJA1;HDAC1;MAZ;IFIT3;TRAF6;PTMA;IGBP1;RNF144B;CASP3;ANXA1;ATF5;UNC5B;TGFB3;AKT1;UFM1;CFLAR;CITED2;SERPINB9;MERTK;ARHGDIA;LGMN;NR4A2;FLNA;CIAPIN1;UBE2O;ZC3H12A;HAX1;BID;FOXQ1;BABAM2;TXNDC5;BAG4;CRYAB;BDNF;FLT4;GATA6;CSNK2A1;THBS1;SPHK1;MYO18A;PIM3
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.4579390164039143,1.0787687941383597,0.38499184339314846,0.9547117399781323,1.0,6/17,16.66%,MAPK7;NFE2L2;SFPQ;HTRA2;P4HB;UBQLN1
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.5057310310714153,1.0786443376603887,0.38859180035650626,0.9540845842815541,1.0,4/10,17.11%,RARB;RARA;RARG;PPARG
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.43139346981987553,1.0786035175233042,0.3522906793048973,0.9531650199921404,1.0,4/20,9.39%,NEDD4L;SLC12A2;ATP1A2;ATP1B3
prerank,regulation of cell junction assembly (GO:1901888),0.4199505514883894,1.0784387642670727,0.37821482602118,0.9525932557855006,1.0,3/27,1.89%,F11R;CLDN19;RAP1A
prerank,epithelial tube morphogenesis (GO:0060562),-0.32501075076566033,-1.0782867098581372,0.3258785942492013,0.7551061176315575,1.0,8/32,13.16%,SLIT2;BMP4;ACVRL1;RASIP1;SOX17;PODXL;RHOB;MEGF8
prerank,positive regulation of isotype switching (GO:0045830),-0.40917316206482823,-1.078122069000908,0.35786802030456855,0.7543717085682407,1.0,8/15,26.08%,TFRC;PAXIP1;SHLD2;CD40;MAD2L2;CLCF1;TNFSF13;HMCES
prerank,negative regulation of bone mineralization (GO:0030502),-0.41745363901717314,-1.07781129347746,0.38235294117647056,0.7540119012058298,1.0,6/13,34.96%,ENPP1;RFLNB;GREM1;RFLNA;BCOR;AHSG
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.34367976337255923,1.0775532110231647,0.33983926521239954,0.9542838088417259,1.0,11/107,4.74%,CAV1;STC2;CTRC;SLC8B1;SLC39A13;CDH5;SLC24A1;TRPV4;CSRP3;SLC30A9;ATP2B4
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.3920114827629604,1.0772825977584026,0.3527777777777778,0.9540642744615933,1.0,10/39,16.76%,UTRN;NEDD4L;FXYD6;SCN2B;NEDD4;FHL1;CHRM3;WWP2;FGF12;YWHAE
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.3537037913083568,1.0771964564612175,0.3577639751552795,0.9532786258460438,1.0,17/80,16.76%,NGF;SRC;FIS1;ACVR1C;UACA;MAP3K5;SFN;RPS6KA3;HMGB1;USP47;DHCR24;AQP1;HTRA2;GPER1;BAD;SYK;YWHAE
prerank,mitochondrial fusion (GO:0008053),0.44906449740400034,1.0765030227137138,0.3621533442088091,0.9543948952257445,1.0,8/18,22.20%,MFN2;FIS1;MIEF1;MIGA1;BAX;CHCHD3;STOML2;THG1L
prerank,keratan sulfate biosynthetic process (GO:0018146),0.42178706039853636,1.07601897378581,0.38221528861154447,0.9548229573223432,1.0,5/26,9.26%,ST3GAL4;PRELP;B4GAT1;SLC35D2;CHST2
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.3840069450292031,-1.0758433760548414,0.38242894056847543,0.7584010924054085,1.0,3/18,2.16%,SLIT2;IL6R;LYN
prerank,positive regulation of vasculogenesis (GO:2001214),0.5118391632910098,1.075250601781279,0.39492753623188404,0.9561818203798714,1.0,2/10,1.89%,CEACAM1;RAP1A
prerank,regulation of actin filament-based process (GO:0032970),0.3539579389247945,1.0752169665001836,0.34307496823379924,0.9552363932081839,1.0,6/70,5.91%,EFNA5;DLC1;F11R;ARHGAP18;RAC2;ARHGEF5
prerank,positive regulation of rRNA processing (GO:2000234),0.5172723412322499,1.0750858358888764,0.3621621621621622,0.9546174982227216,1.0,3/10,9.58%,BUD23;UTP15;SIRT7
prerank,cellular response to interleukin-6 (GO:0071354),-0.3472450519870718,-1.0746998768797558,0.3467741935483871,0.7603714310217518,1.0,4/26,1.80%,ST3GAL6;PTGIS;PID1;IL6R
prerank,ribosome assembly (GO:0042255),-0.30104415245564364,-1.074387302002107,0.3218390804597701,0.7600644141422437,1.0,25/47,29.48%,RPS15;RPS27;NPM1;RPLP0;RPS19;RPL3;EIF2A;RRP7A;MRPL20;DHX37;MRPS11;DHX29;NLE1;PPAN;RPS27L;RPL5;C1QBP;PWP2;RPS14;ERAL1;RPF2;RPL11;DDX3X;MRPS2;RPL24
prerank,DNA replication checkpoint signaling (GO:0000076),-0.3901658888210847,-1.0743008211190432,0.36246786632390743,0.7590896614562481,1.0,8/16,24.13%,NAE1;CLSPN;TOPBP1;TIPIN;RAD17;RAD9B;TIMELESS;CDC45
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.4209301783106534,-1.0741203228357024,0.35853658536585364,0.7584375991301655,1.0,2/13,2.36%,ADGRV1;GRM3
prerank,cholesterol metabolic process (GO:0008203),-0.26836217015422476,-1.0737087163626036,0.32142857142857145,0.7583868194872575,1.0,25/68,26.08%,PPARD;INSIG2;ARV1;APOE;HMGCS1;SCAP;OSBPL1A;LDLRAP1;OSBPL5;ACAA2;GBA2;ACLY;NSDHL;PMVK;ABCG1;MVK;ACAT2;DHCR7;TSKU;CLN6;PIP4P1;TM7SF2;SCARF1;CH25H;LCAT
prerank,positive regulation of programmed cell death (GO:0043068),0.3105515056478477,1.0735305349906497,0.33852544132917967,0.9582959674767584,1.0,60/272,17.01%,NGF;ITGA6;DKKL1;TIAM2;ANO6;TNFAIP8;GPLD1;TFPT;NF1;AKAP13;PHLDA3;RNF122;APH1B;FOXO3;VAV2;ACVR1C;TRIO;TRADD;ARHGEF5;NCSTN;PHLDA1;NLRC4;ARHGEF1;SIAH1;MAP3K5;RBM5;KALRN;OBSCN;STK3;HMGB1;NLRP2B;RASSF2;SLC27A4;RARG;APC;HDAC6;HTATIP2;ARHGEF6;FAF1;PTPA;ADAMTSL4;DIABLO;ATG7;SOX4;HTRA2;HTT;UNC13B;FZD9;GPER1;BAD;PDCD2;AIFM2;CTNNBL1;PLEKHG2;ARHGEF11;SYK;ARHGEF7;BNIP3;E2F1;QRICH1
prerank,chromosome condensation (GO:0030261),-0.31506804344845085,-1.073234733154112,0.32075471698113206,0.7585149786797055,1.0,16/36,28.61%,PHF8;SMC4;NCAPD3;MCPH1;H1-0;CSNK2A1;AKAP8L;CSNK2B;NCAPG2;NCAPD2;NUSAP1;TOP2A;AIFM1;BANF1;NCAPH;TTN
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.31151168882407626,1.0729788807838077,0.3500522466039707,0.9588910617426823,1.0,66/241,22.77%,DHX8;HNRNPC;CSTF1;SF3B2;SF3B1;PCBP2;RBM8A;RBM10;RNPC3;SRSF4;HNRNPA0;ZRSR2;SNRPF;RBM15B;HNRNPR;SF3B5;PPIE;PRPF3;CSTF3;CHERP;DDX46;RBM22;RBM5;ELAVL2;DNAJC8;SNU13;HNRNPM;DBR1;UPF3B;SRRM2;GTF2F2;SNRPA1;SFPQ;DDX42;DHX16;TRA2B;PDCD7;SF1;SUGP1;CTNNBL1;SRRT;PSPC1;SYNCRIP;CWC22;SLU7;SYMPK;PLRG1;SRSF3;LSM3;MTREX;DHX38;DHX9;HNRNPD;UBL5;NUDT21;SRSF12;SRSF11;SRSF10;ELAVL1;CWC25;YTHDC1;HNRNPA3;PCF11;LSM2;CPSF2;RBM6
prerank,response to interferon-alpha (GO:0035455),-0.3922506154287408,-1.0728536059137532,0.3523573200992556,0.7584430291123326,1.0,5/16,18.78%,IFNAR2;ADAR;BST2;IFNAR1;PDE12
prerank,proteoglycan biosynthetic process (GO:0030166),-0.3263821092830026,-1.072730060081883,0.3356164383561644,0.7576248988676179,1.0,10/31,11.44%,IGF1;CSGALNACT1;NDST3;CHST11;BMPR2;CSGALNACT2;PXYLP1;FAM20B;B4GALT7;HS3ST3B1
prerank,negative regulation of transmembrane transport (GO:0034763),-0.45262921499137376,-1.0727157937333893,0.3813953488372093,0.756486916653263,1.0,3/10,13.19%,CTTNBP2NL;AKT1;THBS1
prerank,negative regulation of cell division (GO:0051782),-0.44450834899799835,-1.0727021111610924,0.38095238095238093,0.7553454488963919,1.0,3/11,9.79%,TXNIP;BLM;VPS4A
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.4819291981023539,1.0725736058807025,0.3681592039800995,0.9590924935342074,1.0,3/13,15.48%,SORBS1;C1QTNF12;SNX5
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.36269202750440355,-1.072345230881191,0.33787465940054495,0.7551559430632473,1.0,11/22,19.28%,IGF1;ROCK2;MEF2A;SLC9A1;MLIP;EDN1;P2RX4;SMAD4;LMCD1;AGT;PARP1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.3278246591455991,-1.0722689580576352,0.3296398891966759,0.7541586281888656,1.0,16/31,33.15%,TIMM44;PAM16;PEX26;TIMM17B;PEX6;PEX1;PEX10;ROMO1;GRPEL1;DNLZ;AIFM1;TIMM50;HSPD1;PEX5;TIMM23;TIMM21
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.5064349604299709,1.0719071078310642,0.4070175438596491,0.9601087953555202,1.0,3/10,7.45%,IRAK3;PTPRC;MAPK7
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.4461562086447221,-1.071786279813499,0.41545893719806765,0.754337482037574,1.0,6/11,17.04%,FOXO1;LMNA;GSK3A;MLIP;P2RX4;SMAD4
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.4026476601490712,-1.0714773641176223,0.36724565756823824,0.7540000804601711,1.0,3/15,6.01%,DAB2;TNK2;HIP1R
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3073485113072686,1.0714163704842479,0.3213552361396304,0.9605523027763632,1.0,95/366,21.50%,RORA;BNC2;NFATC2;PPARGC1A;ZNF423;EFEMP1;MYBBP1A;NFIA;CHD3;SPI1;FOXO3;KAT6B;SMC3;TOM1L1;SP3;BHLHE40;ONECUT1;ORC5;TGFBRAP1;PPIE;HIC1;ZNF431;LIN54;RREB1;MSL3;FBXO5;ELAVL2;ZNF628;FOXK2;POFUT1;MLF2;ACTR8;RORB;EIF4E;SUPT4H1;ORC3;TRRAP;TFEB;OBI1;USP13;ATXN2;WWC1;SAP30L;EIF2B4;MZF1;MED23;JMJD1C;SPIN1;CREBBP;NCOA2;SOX4;NUCKS1;SFPQ;BAZ2A;FZD7;REXO4;TAF5;KMT2D;SRRT;DMTF1;PSPC1;E2F1;GMNN;ESRRA;HP1BP3;MAGED1;USP37;DSCC1;MTF2;BACH1;CREM;CELSR2;FOXO4;RABL3;ASCC2;SPTY2D1;FADS1;ASCC1;PPP2CA;TCF7L1;TCF3;HNRNPD;ZNF22;HCFC2;HMG20A;GZF1;DDIT3;RNF14;ARNT2;ATXN1L;ZSCAN21;DAXX;CCAR2;SRSF10;FOXC1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.29829691867114866,1.0713641797710973,0.196,0.9596770064450549,1.0,278/1645,16.44%,EBF2;RORA;MEOX2;ZBTB7C;BNC2;KLF5;ETV4;FGF7;MDFIC;CDK15;NFATC2;VGLL4;ETV1;GLI1;PPARGC1A;PRICKLE1;PAX9;FOXD2;NR2F2;TSHZ3;PHC2;NR3C2;DLX1;POU4F3;RGS14;FOXP2;ZNF423;FOXD1;NFATC1;CAMK2D;ZBTB32;EFEMP1;KLF12;PBX1;ZSCAN25;FZD2;EGFR;BHLHE22;ZBTB20;NPAS3;ATP8B1;MYBBP1A;NEUROD6;BCL3;AXIN1;ETV5;OGT;RUNX2;NFIA;ZSCAN18;HIVEP2;RBFOX2;HOXB6;GLI2;TEF;ZKSCAN7;IRF2BP1;CHD3;SFMBT2;MLLT3;KLF3;KMT2A;CIART;SPI1;L3MBTL3;FOXK1;ZNF418;FOXO3;SOX9;UBE2I;PGR;FOXP4;NPAS2;ZBTB8A;GLIS2;CHD8;ZNF585B;ZNF585A;KAT6B;HDAC4;REL;LANCL2;CHD2;SATB1;ZBTB3;ATP2B4;CHD1;KLF10;NUP62;WNT5A;POU5F2;CREB3L1;PPM1A;RBM15B;HEYL;ZFP3;ATAD2;ZFP1;ZNF326;SP3;BHLHE40;MED18;ZFP90;TARBP1;RGMB;ANKRD2;ARID3A;ONECUT1;ANXA4;ZFP14;RCOR3;TGFBRAP1;PPIE;MED12L;TEAD3;CTCF;NRF1;NFE2L1;HIC1;ZNF431;NCOR1;PAX3;LIN54;HOXC10;ZFP62;TBX2;DDX17;ONECUT3;RREB1;DBX2;PIAS2;RARA;SUV39H1;MAFG;MSL3;USF2;FBXO5;MAP3K5;POLR3G;ILF2;LHX6;KCTD1;ELAVL2;MYPOP;ISL1;PKNOX2;ZNF628;E4F1;FOXK2;DYRK1A;MED7;UIMC1;TSC22D4;AATF;ZBTB6;POFUT1;TCF20;MLF2;TBX18;MED13;SLTM;MECP2;FOXJ1;RPS6KA3;ACTR8;HMGB1;SMARCD2;RORB;USP47;SUPT4H1;POU4F1;HDAC2;CNOT7;BAZ2B;DBP;TRRAP;TLX3;KARS1;CTDSP1;TFEB;ZHX1;USP13;ERCC6;SIX5;WWC1;NCOR2;ILF3;SAP30L;FBXL19;EN2;DVL3;HDAC6;COL1A1;TASP1;PHF20L1;EGR1;MZF1;MED23;ZBTB49;HEXIM1;ZNF148;HTATIP2;JMJD1C;ERF;MEN1;BICRA;KDM8;CEP290;NAT14;NFE2L2;STAT2;SPIN1;HOPX;PEG3;TTC21B;CDC6;CRLF3;TAF15;CREBBP;NCOA2;NFATC4;BRF2;GTF2H1;ARID4A;SOX4;GMEB1;CDKN1C;NUCKS1;DPF3;SFPQ;MBD1;ZFP57;BAZ2A;CBFB;FZD7;KAT8;TIAL1;CAMTA2;RAI1;SFMBT1;ERBB4;EPC2;REXO4;FOXJ2;ZNF182;FOXF1;ZNF260;WWP2;NR5A1;LCOR;NEK4;MED8;TADA2A;MED12;SCML2;POU6F1;TOX4;CDH1;PRMT6;SNX5;TAF5;FOXC2;YAP1;SCML4;KMT2D;ERBB2;GBX1;RELB;TESC;PBX4;MED29;PCGF3;SRRT;DMTF1;PCBD2;BATF;ARHGEF11;PSPC1
prerank,signal transduction in response to DNA damage (GO:0042770),-0.2878536112316666,-1.0712628320078892,0.2943396226415094,0.753442053561775,1.0,10/49,14.62%,MAP3K20;ACER2;USP28;MYO6;PAXIP1;ATRIP;HINFP;BID;CLSPN;RAD1
prerank,cellular response to organic cyclic compound (GO:0071407),0.32881484125810345,1.0712564485535383,0.3542600896860987,0.9589519939207718,1.0,23/141,15.58%,RORA;HRH1;FOLR1;EGFR;RAPGEF3;RAP1A;SSTR1;ATP1A2;ADCY5;NRIP1;GABRG2;POU4F1;EGR1;NCOA3;GABRB3;AQP1;CTNNA1;LCOR;GPER1;CCDC62;CDH1;ADCY8;ADCY3
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.4713464167106831,1.0711492350306524,0.3983050847457627,0.9582204712939668,1.0,6/13,22.77%,VDAC2;BAD;BNIP3;BAX;BLOC1S2;RHOT2
prerank,histone H3-K36 demethylation (GO:0070544),-0.44877725358232246,-1.0711128688226628,0.37986270022883295,0.752714963638413,1.0,3/10,12.83%,PHF8;KDM2B;KDM7A
prerank,positive regulation of neurogenesis (GO:0050769),0.35577470085461016,1.0710842060607646,0.3785529715762274,0.9573958259331719,1.0,5/68,4.73%,NGF;RGS14;TIAM2;CDKL3;PLXNA3
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.4914757278722764,1.0706381865706804,0.39019963702359345,0.9576989841028164,1.0,6/11,24.13%,LANCL1;P4HB;UBQLN1;PINK1;PRKN;REST
prerank,skeletal system development (GO:0001501),0.32306162183500686,1.0702379566980296,0.34902411021814006,0.9578507115838676,1.0,17/148,5.78%,PKDCC;FGFR1;SULF1;PRELP;CDH11;KIAA1217;PCSK5;GLI2;AKAP13;EIF2AK3;PTHLH;SOX9;BMPR1B;BMP5;WNT5A;NCAN;SH3PXD2B
prerank,protein-containing complex assembly (GO:0065003),0.3143821484112579,1.070118195141306,0.3632523759239704,0.9571897692238424,1.0,47/259,15.76%,CLDN1;MAGI1;PPARGC1A;WIPF1;LAMC1;FOLR1;REPS2;AXIN1;PARD6B;CD3G;ANO6;KMT2A;SOX9;LEO1;FN1;CARD10;FANCC;SH3PXD2B;TRADD;TAPBP;CNIH1;ADAM10;TRAPPC9;CUL3;OCLN;DARS1;GSK3B;TFG;CSNK1A1;GRIA1;FERMT2;TRRAP;AXIN2;APC;PYGO1;MEN1;CREBBP;BCL9;GSDMD;ZW10;MDN1;BAD;TMED2;SEC23IP;ADCY8;YAP1;KMT2D
prerank,lamellipodium assembly (GO:0030032),0.42222268857027917,1.06947108907518,0.38461538461538464,0.9581271143141332,1.0,4/26,6.46%,CDH13;ABLIM3;SPEF1;ABLIM2
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.37887061745107503,1.0693501238944798,0.3706199460916442,0.9574622777710018,1.0,17/46,21.76%,GTSE1;RAPGEF3;UBR5;BAG3;RBM22;PIK3R2;GSK3B;TPR;NEDD4;EMD;RAN;CDH1;YWHAE;DHX9;HDAC3;TCF7L2;XPO4
prerank,myotube cell development (GO:0014904),-0.45453233142201366,-1.0690973089791473,0.3932853717026379,0.7569127057158951,1.0,2/10,7.43%,IGF1;SELENON
prerank,RNA metabolic process (GO:0016070),0.3322592122007079,1.0688705493530168,0.35722543352601155,0.9579168904215172,1.0,22/127,14.63%,DHX8;HNRNPC;RNASEH2B;NUFIP1;RBFOX2;PCBP2;HNRNPA0;WDR74;PABPC4;HNRNPR;FASTKD2;DDX17;RBM5;SIDT2;AGO1;CELF2;HNRNPM;ATXN2;GTF2F2;ALKBH1;FASTKD1;DICER1
prerank,regulation of BMP signaling pathway (GO:0030510),0.3551551515456628,1.0688027973440513,0.35642317380352645,0.9571077145976833,1.0,8/73,4.27%,DLX1;SULF1;ZNF423;FOXD1;FBXL15;CDH5;BMPR1B;NBL1
prerank,response to hexose (GO:0009746),0.4255286997824743,1.0687050187332936,0.3967310549777117,0.9563751699707123,1.0,8/25,21.69%,GPLD1;EIF2B3;SELENOS;EIF2B4;IRS2;LPL;VAMP2;TCF7L2
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.3244779284204865,-1.0685477904945335,0.34394904458598724,0.7572700986686748,1.0,14/33,24.04%,HIP1;TGFA;AFAP1L2;HIP1R;AKT1;BCAR3;SHKBP1;EGF;CNOT9;AGT;NEU3;PLAUR;PDE6H;DOK1
prerank,DNA packaging (GO:0006323),0.4638095558262527,1.0680621979678344,0.3857374392220421,0.9572036382395758,1.0,3/16,4.87%,HAT1;CDAN1;BANF2
prerank,metal ion homeostasis (GO:0055065),0.38502812253692464,1.068050398944814,0.3573487031700288,0.9562183953706095,1.0,4/40,4.35%,CAV1;SLC12A2;SLC12A4;SLC12A3
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3498852456758684,1.0674442959497663,0.3768472906403941,0.9570144086897263,1.0,10/75,5.58%,KCNJ4;SLC12A2;KCNJ16;SLC24A1;TRPV4;SLC12A4;SLC12A3;ATP2B4;ATP1A2;KCNJ13
prerank,negative regulation of interleukin-8 production (GO:0032717),0.4493794596289657,1.067248047654122,0.37662337662337664,0.9565565822699631,1.0,4/17,11.05%,BCL3;PTPN22;ANXA4;OTUD7B
prerank,protein sumoylation (GO:0016925),0.3736922032148164,1.0669094191847095,0.37916666666666665,0.9565607131217643,1.0,12/49,13.01%,STX1A;EYA1;UBE2I;NUP62;PIAS2;NUP160;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153
prerank,regulation of ossification (GO:0030278),0.3881928590174009,1.066595843997093,0.38248175182481753,0.9565112424486668,1.0,5/36,6.91%,LRP4;SGMS2;SOX9;WNT5A;BMP2K
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.26262429651589986,-1.0665343820474336,0.30857142857142855,0.7617272020036567,1.0,14/94,8.53%,PLCB1;IL1R1;IL1RAP;PSMA1;RPS6KA5;SQSTM1;IRAK4;RBX1;PSMD11;TRAF6;UBE2N;NOD1;PSMD7;PSMD4
prerank,glucose homeostasis (GO:0042593),0.34398448678812954,1.0662586632149027,0.3492063492063492,0.9565233437425104,1.0,20/83,17.87%,PPARGC1A;LRRC8D;LEPR;SLC8B1;HK2;FOXK1;PDK4;PIK3R2;FOXK2;BACE2;ADRA2A;GCK;SOX4;NUCKS1;BAD;ADCY8;HECTD4;PPARG;KLF7;WFS1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.39652802629840794,-1.065890826364554,0.3693467336683417,0.7623081929954395,1.0,4/16,2.58%,IGF1;IGFBP2;IGFBP3;IGFBP5
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.3141540440660575,-1.0658714868789672,0.31746031746031744,0.7611943484930737,1.0,22/38,35.57%,ARHGEF2;SP100;NOS3;MADD;FAS;CFLAR;FEM1B;THBS1;TNFSF10;CASP8;ICAM1;RIPK1;BRCA1;RNF34;DDX3X;SFRP1;TRAF2;RFFL;HMOX1;FAIM2;SERPINE1;PMAIP1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.4565580437810366,1.0657965677100194,0.3996655518394649,0.9569226523416511,1.0,3/16,6.94%,CEACAM1;SOX9;NCOR1
prerank,rRNA processing (GO:0006364),-0.23472571807363501,-1.0657296846665993,0.2777777777777778,0.7604154460331619,1.0,75/172,30.26%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPL35A;RPS7;RPL32;RPS27;RPL26;RPL27;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;RPLP1;RPS17;WDR12;RPL23;RPL17;RPL9;RPL38;RPL36;RRP7A;ESF1;RPL18A;RIOK1;EXOSC3;IMP4;HEATR1;TEX10;LAS1L;RPLP2;POP5;RPS6;NOL9;HELQ;DIS3;DHX37;EXOSC1;FBL;RPL14;TBL3;RPS2;RPL10A;RIOK3;UTP4;RPL39;RPL34;RPL5;RPL22;PWP2;RPS9;WDR3;RPS14;RPS25;NOB1;RPL36A;NHP2;RPL7;NAT10;RPL11;PIH1D2;SART1;RPL24;RRP36;RRP9;WDR46;UTP6
prerank,excitatory postsynaptic potential (GO:0060079),-0.37000233143705763,-1.0656754648014293,0.3469945355191257,0.7593975541291571,1.0,5/19,11.96%,GRIN2B;AKT1;GRIN1;LRRK2;GSK3A
prerank,positive regulation of receptor internalization (GO:0002092),-0.3559867383743502,-1.0653163093937374,0.3867069486404834,0.759176358422083,1.0,8/22,25.49%,INSR;ANGPT1;AHI1;EGF;PICK1;NTF3;GREM1;ARRB2
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.4255248709068463,1.0653004738829994,0.38639876352395675,0.95737157481299,1.0,4/23,5.25%,SLC12A2;SLC12A4;SLC12A3;PDK4
prerank,negative regulation of hippo signaling (GO:0035331),0.47322419817900074,1.0649346268695414,0.39414802065404475,0.9574380759776006,1.0,3/12,13.54%,VGLL4;WWC1;CIT
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.41251695142365524,-1.0643542055377428,0.3867924528301887,0.7606385669095446,1.0,6/13,27.27%,DEPDC5;RNF152;SPAAR;CASTOR2;CASTOR1;ATM
prerank,gluconeogenesis (GO:0006094),0.3882660963489468,1.063713593287548,0.37872340425531914,0.9601196390331448,1.0,13/39,21.46%,PPARGC1A;SLC25A12;ALDOB;PGM1;MDH1;SLC25A13;ENO3;GOT1;PGK1;ENO2;SLC37A4;SLC25A10;ENO1
prerank,cellular response to metal ion (GO:0071248),-0.2549873273859451,-1.0636734165443522,0.28225806451612906,0.7613257464006414,1.0,26/123,11.73%,ADGRV1;BMP6;CLIC4;ADCY1;ADCY7;MT1B;MT1G;MT1A;MT1F;MT1E;MT1M;MT1H;MT1X;B2M;SYT9;SYT7;KCNH1;RASGRP2;MEF2A;PLCG2;SLC41A1;AKT1;LGMN;ANK3;LRRK2;GLRA2
prerank,calcium ion import across plasma membrane (GO:0098703),0.4758591557829368,1.063560999774976,0.39477977161500816,0.9595805431565695,1.0,3/14,4.74%,SLC24A1;TRPV4;ATP2B4
prerank,protein transport (GO:0015031),-0.2165983005103899,-1.062665133258899,0.2,0.7628522151699472,1.0,95/332,22.34%,TBC1D4;STXBP3;VAMP5;TXNIP;LRP1;WLS;STEAP3;ARHGEF2;TBC1D1;MYO6;RABGAP1;TOM1;TFRC;CALCRL;RAB6B;RAB3C;COG7;TBC1D12;PREB;NAPA;TMED9;ATP6V0A4;AP2A1;STX8;TBC1D30;USP6NL;TBC1D2B;NPM1;ZDHHC17;ARHGAP1;APOE;VMP1;ARL6IP5;SGSM3;RAMP2;ATP6V0C;COPZ1;RAB13;SCAMP5;ANK3;COPZ2;EIF2D;STX17;EVI5L;MACF1;SCG2;RAB5C;ATP6V1C1;TMED3;TBC1D22B;SAR1B;RAB24;BBS2;VPS26B;ARRDC4;STX12;HERC2;SVBP;PREPL;ABCG1;CTSA;GGA3;TMED1;CHMP3;RAB3B;STX6;ARF5;HFE;LAPTM5;ARRDC2;SCFD1;ATP6V1D;STX16;SYS1;SEC31A;CHMP2B;RAB11B;MYH9;RCN3;RAB32;SLC10A7;SYNDIG1;ATP6V1F;TMED7;TBC1D17;PICK1;MON1A;ARF3;RAB7A;OPTN;CLU;RAB10;ATP6V1E1;ARL4C;ARL5B
prerank,endocardial cushion morphogenesis (GO:0003203),-0.3826455840436561,-1.0625414112937452,0.339572192513369,0.7620334026438778,1.0,6/18,12.75%,ENG;NOS3;BMP4;ACVRL1;BMP2;TGFB2
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.29749245246465383,-1.0622700817041353,0.3568627450980392,0.7616356313336057,1.0,21/47,29.78%,NR1H3;AGTR1;KLF4;APOE;NR1H2;AKT1;EIF2A;TCOF1;EDN1;CSF1;EIF4G1;AGT;RBM4B;INHBA;GEMIN5;TSC1;MTPN;NANOS3;RBM3;VPS35;GRM5
prerank,cristae formation (GO:0042407),-0.3391898202085353,-1.0621889997872853,0.36875,0.7606795534782924,1.0,13/27,29.92%,IMMT;ATP5PD;DMAC2L;ATP5MC3;MICOS13;SAMM50;ATP5PF;ATP5ME;ATP5PO;ATP5MC2;ATP5MF;ATP5MC1;ATP5F1E
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.4218343783441524,-1.0617511230862893,0.3930232558139535,0.7595600624619547,1.0,5/11,20.66%,AGO3;AGO4;ZFP36;TNRC6C;NOTCH4
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.4218343783441524,-1.0617511230862893,0.3930232558139535,0.7595600624619547,1.0,5/11,20.66%,AGO3;AGO4;ZFP36;TNRC6C;NOTCH4
prerank,ureteric bud morphogenesis (GO:0060675),-0.39087989764523484,-1.0616665071615465,0.38402061855670105,0.7586572792352764,1.0,5/16,24.57%,BMP4;BMP2;SALL1;WNT11;NPNT
prerank,sphingosine metabolic process (GO:0006670),0.4577270870659916,1.0612240869227259,0.3949579831932773,0.9655486364893314,1.0,3/17,4.15%,ACER3;PLPP2;PLPP3
prerank,negative regulation of defense response to virus (GO:0050687),0.4910222854655837,1.0607459780574549,0.3967391304347826,0.9660245455326467,1.0,4/10,21.89%,PCBP2;ITCH;MUL1;TSPAN6
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.4264645394349367,1.0607363561028702,0.3903177004538578,0.9650424946884884,1.0,4/24,9.56%,HNRNPC;SRC;STN1;EXOSC10
prerank,supramolecular fiber organization (GO:0097435),0.30607197822847404,1.0606423781024683,0.3646694214876033,0.9643099819325345,1.0,35/334,9.18%,ITGB4;TGFBI;ITGA6;TNXB;ADAMTS14;PXDN;UBE2L6;ARHGAP12;HOOK2;KIF2A;COL6A3;BFSP1;NCKAP5L;NF1;TRPV4;COL5A3;APH1B;FIGNL2;TMOD2;RAC2;SERPINH1;NCSTN;ADAM10;SHROOM2;POF1B;SPAST;COL3A1;CKAP5;SIAH1;ADAMTS2;CGNL1;TMOD1;LTBP2;LTBP3;COL4A1
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.3161698890729674,-1.060360464530496,0.3717105263157895,0.7611652924750896,1.0,8/32,16.66%,SNCAIP;MCTP2;SYN1;CAMK2A;LRRK2;PREPL;DTNBP1;CPLX2
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.29540696712544945,1.0603457191997159,0.279,0.9642294371916255,1.0,154/1082,13.67%,RORA;MEOX2;DCN;KLF5;ETV4;ITGA6;FGF7;MDFIC;CDH13;NFATC2;ETV1;GLI1;PPARGC1A;FOXD2;NR2F2;DLX1;POU4F3;RARB;ZNF423;NFATC1;LDB2;PBX1;FZD2;EGFR;NPAS3;FGF1;BCL3;AXIN1;JAG1;TNIP3;ETV5;OGT;RUNX2;NUFIP1;NFIA;GLI2;IL4I1;CRTC1;MAML2;MLLT3;TXK;LMO1;LMO7;KMT2A;SPI1;FOXK1;FOXO3;EIF2AK3;SOX9;BMPR1B;PGR;NPAS2;TFR2;GLIS2;CHD8;CSRP3;SLC30A9;KAT6B;HDAC4;REL;BMP5;KLF10;NUP62;WNT5A;PPM1A;HEYL;ATAD2;SP3;ZFP90;RPRD1B;RGMB;ONECUT1;NRIP1;NCK2;CDK7;CTCF;NRF1;UTP15;PAX3;HOXC10;DDX17;RREB1;MAPK7;RARA;USF2;MAP3K5;ILF2;PIK3R2;ISL1;E4F1;FOXK2;ELL;DYRK1A;TNIP1;ZNF462;AATF;AGO1;DDRGK1;TCF20;PLSCR1;MED13;TET1;FOXJ1;RPS6KA3;HMGB1;SIRT7;SMARCD2;RORB;SUPT4H1;POU4F1;HDAC2;DBP;KARS1;TMF1;TFEB;FHOD1;ERCC6;PAXBP1;RTRAF;MMP12;ILF3;RARG;DVL3;COL1A1;TASP1;EGR1;MZF1;ZBTB49;HTATIP2;AKIRIN1;MEN1;BICRA;KDM8;CEP290;INO80;NCOA3;NAT14;NFE2L2;CD81;SPIN1;PEG3;KDM6B;CRLF3;TAF15;PKD1;CREBBP;NCOA2;BCL9;GTF2H1;SOX4;CDKN1C;DPF3;TCERG1;SFPQ
prerank,negative regulation of endocytosis (GO:0045806),0.4159066372314263,1.0598964769828627,0.393026941362916,0.9646028133191492,1.0,3/24,7.64%,CAV1;LRSAM1;ARF6
prerank,regulation of ERAD pathway (GO:1904292),-0.4376518053600527,-1.0598610425376818,0.3804878048780488,0.7613124805691187,1.0,3/11,8.46%,USP19;RNFT1;AQP11
prerank,positive regulation of phosphatase activity (GO:0010922),-0.3603194011384617,-1.0596051293241648,0.3465909090909091,0.7609047503047057,1.0,5/21,14.43%,ITGA1;PDGFRB;CALM1;BMP2;CALM3
prerank,Golgi inheritance (GO:0048313),-0.44210080226011456,-1.0593992671095804,0.3977272727272727,0.7603648928938734,1.0,8/11,37.67%,PDCD10;GOLGA2;YWHAZ;PLK5;STK25;PLK3;VRK1;CDK1
prerank,smooth muscle cell differentiation (GO:0051145),-0.4174563355753522,-1.0592033802906708,0.38345864661654133,0.7597390073088416,1.0,5/12,21.78%,BMP4;TMEM204;GATA6;MYOCD;APLNR
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.39946164969874354,1.0591167637592398,0.3953488372093023,0.9659788914462466,1.0,10/30,13.29%,ELOVL5;HACD4;ELOVL1;PEX2;ELOVL2;SLC27A4;ACOT2;HACD2;ABCD1;ELOVL6
prerank,diol biosynthetic process (GO:0034312),-0.4044737567831508,-1.0589436112854393,0.3946731234866828,0.7593152562571281,1.0,6/15,13.97%,ACER2;GCH1;QDPR;ABCA2;SPHK1;DHFR
prerank,nucleic acid metabolic process (GO:0090304),0.34886634076098955,1.0589095379513884,0.37055837563451777,0.9656083541664372,1.0,14/69,15.26%,HNRNPC;RBFOX2;PCBP2;HNRNPA0;WDR74;DXO;HNRNPR;KPNA2;NT5E;HNRNPM;ATXN2;GTF2F2;RECQL5;RAN
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.3710848924444293,-1.05873879291657,0.3881401617250674,0.7587314497206823,1.0,5/18,6.84%,ACSL1;ACSL3;ELOVL7;ACSL6;HSD17B12
prerank,calcium-mediated signaling (GO:0019722),0.3427121211915813,1.0585835289861856,0.3988165680473373,0.9656137437736048,1.0,13/93,10.16%,ACKR3;PLCE1;PTGFR;EGFR;FKBP1B;EIF2AK3;FIS1;PTPRC;RCAN1;PTPRJ;IRGM;KSR2;LAT
prerank,central nervous system development (GO:0007417),0.3106227523630214,1.058390165745838,0.3739495798319328,0.9652111740277068,1.0,23/250,9.42%,PTCH1;APOD;VIT;PBX1;NF1;SOX9;NPAS2;GLIS2;CHD8;LSR;NCAN;SHROOM2;AMIGO2;TAGLN3;CDH2;ALDH5A1;S100B;EML1;JRKL;PTS;COL4A1;FOXJ1;RPS6KA3
prerank,positive regulation of binding (GO:0051099),0.3393147264902394,1.058181855823841,0.375,0.9648572123698483,1.0,10/84,9.48%,NGF;CAV1;ADD1;DACT1;TRIM21;RARA;AMFR;STK3;GSK3B;HMGB1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.44481072418810685,1.0581630743658912,0.3729641693811075,0.9639050195308779,1.0,4/17,13.17%,COX5A;COX15;COX7C;COX5B
prerank,positive regulation of angiogenesis (GO:0045766),0.33123748196401553,1.0581263886786278,0.4039580908032596,0.9630122023375949,1.0,11/108,5.28%,GAB1;SMOC2;RAPGEF3;HK2;FGF1;CDH5;ITGAX;IL1A;PRKCA;WNT5A;HIPK1
prerank,L-serine metabolic process (GO:0006563),-0.4461218497478096,-1.0576231260991322,0.417910447761194,0.760639385397709,1.0,6/10,34.19%,SERINC3;PSPH;CBS;PHGDH;SHMT2;SHMT1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.41807982713306335,-1.057155691128254,0.3954022988505747,0.7607975518505599,1.0,8/12,45.79%,INSIG2;OS9;TAPT1;GPAA1;ANKRD13C;KDELR1;KDELR2;RER1
prerank,cellular response to UV (GO:0034644),-0.26715071533395024,-1.0567721121798417,0.2916666666666667,0.7606825627128221,1.0,20/76,19.92%,USP28;PTPRK;EP300;RPL26;NPM1;MMP2;CDC25A;EIF2AK4;MFAP4;MMP1;KDM1A;NOC2L;XPA;POLK;ZBTB1;NSMCE3;DHX36;ATF4;PARP1;ERCC4
prerank,glutathione derivative biosynthetic process (GO:1901687),0.4338661985758076,1.0564122355670855,0.3993759750390016,0.9662410128393435,1.0,5/20,11.71%,MGST2;GSTZ1;GSTA4;GSTA3;GSTK1
prerank,glutathione derivative metabolic process (GO:1901685),0.4338661985758076,1.0564122355670855,0.3993759750390016,0.9662410128393435,1.0,5/20,11.71%,MGST2;GSTZ1;GSTA4;GSTA3;GSTK1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.4382284127768816,1.0563697215294987,0.42040185471406494,0.965356308650986,1.0,4/18,7.57%,RIPOR2;CDH5;KIF20B;KANK1
prerank,oogenesis (GO:0048477),0.4539632955703602,1.056349070963046,0.4098360655737705,0.9644259542656074,1.0,4/15,16.87%,PIWIL2;MEI4;KMT2D;MDK
prerank,positive regulation of apoptotic process (GO:0043065),0.3037852991151186,1.0558421100914201,0.3735926305015353,0.9649271114798794,1.0,62/293,17.01%,NGF;ITGA6;DLC1;DKKL1;TIAM2;FAP;MYBBP1A;ANO6;TNFAIP8;GPLD1;TFPT;NF1;AKAP13;PHLDA3;RNF122;APH1B;FOXO3;VAV2;ACVR1C;TRIO;TRADD;ARHGEF5;NCSTN;PHLDA1;NLRC4;ARHGEF1;SIAH1;MAP3K5;RBM5;KALRN;OBSCN;STK3;HMGB1;NLRP2B;RASSF2;SLC27A4;SRPK2;RARG;APC;ARHGEF6;FAF1;PTPA;ADAMTSL4;DIABLO;ATG7;SOX4;HTRA2;HTT;UNC13B;FZD9;GPER1;BAD;PDCD2;AIFM2;CTNNBL1;BACE1;PLEKHG2;ARHGEF11;ARHGEF7;BNIP3;E2F1;QRICH1
prerank,alcohol catabolic process (GO:0046164),0.48258843326460915,1.0556769071932983,0.4131944444444444,0.9643481686749232,1.0,1/10,1.67%,CEL
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.3272028460998705,-1.0554530252057428,0.3601190476190476,0.7631053178091515,1.0,18/29,31.33%,RPS19;RPS16;RPS8;NOP9;RPS21;HEATR1;TSR1;DHX37;MRPS11;KRI1;TBL3;UTP4;PWP2;RPS14;RRP36;WDR46;UTP6;ABT1
prerank,cholesterol transport (GO:0030301),0.37161671686195485,1.0553616469546825,0.38068965517241377,0.9643200209493533,1.0,6/45,14.27%,CAV1;CEL;SOAT1;ABCA1;STARD3;STARD5
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.38615348789146603,1.0553022416639328,0.36768802228412256,0.9634871885282082,1.0,7/38,12.70%,CAV1;PTPRC;NCK2;SRCIN1;DLG3;RELN;MVP
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.3585912994324789,-1.0547619378462487,0.4005681818181818,0.7638762842731409,1.0,4/21,7.55%,IGF1;CTSH;KDR;MAP2K2
prerank,response to estrogen (GO:0043627),0.3968857747642341,1.0539167931798643,0.3858858858858859,0.9666303432419752,1.0,3/31,7.45%,CAV1;KRT19;RARA
prerank,ventricular septum development (GO:0003281),-0.30275576723981934,-1.0538595327309002,0.3717948717948718,0.7652978524961713,1.0,10/37,12.75%,ROBO1;TGFBR3;SLIT2;TGFBR1;BMPR2;CITED2;PDE2A;PROX1;DAND5;TGFB2
prerank,positive regulation of biosynthetic process (GO:0009891),-0.2983465523353884,-1.0538374562186295,0.36200716845878134,0.7642156600592616,1.0,11/40,9.11%,CREBL2;BMP4;WNT4;LARP6;APOE;PLCG2;CYBA;TGFB3;AKT1;CREB1;GRIN1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.30401816319993774,-1.0538047983545429,0.3295880149812734,0.763191455121059,1.0,17/40,29.80%,IGF1;BCL2L11;AKT1;BID;MLLT11;FXN;GHITM;OPA1;TNFSF10;BBC3;PLAUR;CLU;PYCARD;PSMD10;BIK;BMF;TRIAP1
prerank,positive regulation of DNA repair (GO:0045739),0.3713458178657072,1.0533961650372214,0.3880597014925373,0.9671748164978415,1.0,10/46,12.86%,EGFR;FAM168A;BRCC3;EYA1;NPAS2;UIMC1;WRAP53;HMGB1;ERCC6;MGMT
prerank,regulation of cell cycle phase transition (GO:1901987),0.338961985797383,1.0531652992167586,0.3783783783783784,0.9668504922537323,1.0,28/91,18.75%,GTSE1;PSME3;ATP2B4;FBXO5;CDC20;PSMB5;ANAPC5;ANAPC7;ANAPC11;BUB3;ANAPC2;PSMB2;UBE2D1;PSMA2;PSMA6;ANAPC4;FZR1;PSMD13;PSMA7;NEK11;FBXW7;PSME4;ANAPC16;PSMC4;CDC23;PSMB6;PSMD12;PSMD14
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.3892198710115884,1.0520827574278535,0.391008174386921,0.9689532776169945,1.0,12/38,21.59%,PHLDA3;BANK1;DAG1;PHLPP1;PTPRJ;PTEN;PLEKHA1;GPER1;DDIT3;MUL1;TSC2;PPP2R5C
prerank,regulation of transposition (GO:0010528),0.4642100579107177,1.0518691323628488,0.4235294117647059,0.9686181982852049,1.0,3/13,12.29%,PIWIL2;SIRT7;TEX15
prerank,regulation of osteoblast differentiation (GO:0045667),0.3410253766215708,1.0516155697643865,0.3818849449204406,0.9684238182794849,1.0,4/82,4.10%,PTCH1;RUNX2;SOX9;BMPR1B
prerank,regulation of ruffle assembly (GO:1900027),0.42126907694342247,1.0515097664963826,0.40390879478827363,0.9677910586708004,1.0,3/23,7.57%,CAV1;RDX;KANK1
prerank,cortical actin cytoskeleton organization (GO:0030866),0.4251789108209129,1.0510105490712418,0.3993610223642173,0.9683137917140463,1.0,4/20,10.63%,FMNL2;ARF6;PLEK;FHOD1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.3734034944576937,1.0509970532705155,0.39233817701453105,0.9673621475139643,1.0,7/52,7.64%,SORBS1;EPB41L2;PRKCE;EGFR;ATP2B4;EPHB2;ARF6
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.41491006545626774,1.0509022786926532,0.39603960396039606,0.9666569459021671,1.0,4/22,8.58%,LBP;PTPN22;TNFAIP3;ACOD1
prerank,negative regulation of cell projection organization (GO:0031345),0.3566198249442964,1.050083022289076,0.4008207934336525,0.9681591318073124,1.0,11/48,14.47%,LPAR1;RAB29;RTN4R;TRPV4;EFNB2;SEMA3A;KANK1;HDAC2;RTN4RL1;PTEN;PTPRO
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.3931465649093134,1.0498185654332226,0.3922413793103448,0.9679416196415915,1.0,3/35,1.75%,NTRK3;F11R;RAPGEF3
prerank,regulation of intracellular signal transduction (GO:1902531),0.2983276931776436,1.0497329225805563,0.35046248715313466,0.9672056012733014,1.0,59/420,10.01%,DLC1;NTRK3;TIAM2;ARHGAP31;PRR5;PTPN13;CEACAM1;ARHGAP18;ARHGAP12;ARHGAP32;AKAP12;EGFR;ARHGAP9;ARAP1;FGF1;PPP1R13B;BCL3;MINK1;DEPDC1B;SPRED1;GPAT3;CHD3;AKAP13;OPHN1;RACGAP1;PRKAG1;TPTE;PTPN22;FAM83D;VAV2;RAC2;TAF10;PIP4K2B;WNT5A;TRIO;HIPK1;TAF4B;RFC3;ULK4;ARHGEF5;NBN;ARHGAP26;CCNG1;RHOJ;ARHGEF1;PTPMT1;PHLPP1;PRKAR2A;PIK3R2;STARD13;KALRN;OBSCN;OCRL;STK3;DIPK2A;RASSF2;POU4F1;HDAC2;MAPKAP1
prerank,cellular response to peptide (GO:1901653),-0.29140278658441915,-1.0497185200823491,0.3672566371681416,0.7733595311464856,1.0,11/56,10.48%,IGF1R;IGF1;LRP1;ARHGEF2;GJA1;EPHA4;VCAM1;NOD1;GRIN1;LGMN;RPL23
prerank,mitochondrial transcription (GO:0006390),0.4998201442252876,1.0493876661703379,0.391304347826087,0.9672748656511254,1.0,4/10,14.06%,FOXO3;TFB2M;MTERF2;TEFM
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.3835221547132164,-1.049347408750853,0.38596491228070173,0.77328688374047,1.0,6/16,13.12%,NR1H3;LDLR;CTDNEP1;ABHD5;NR1H2;MFSD2A
prerank,keratan sulfate catabolic process (GO:0042340),0.48885230498989396,1.0491780711977838,0.40847457627118644,0.9669116171739535,1.0,3/11,14.23%,PRELP;HEXA;HEXB
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.3969245014746229,-1.048989988678495,0.38071065989847713,0.7731350910685199,1.0,7/13,38.12%,UBE2J1;OS9;DERL2;SVIP;BCAP31;EDEM1;UBAC2
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.4072324978270461,-1.0485750221240981,0.3875968992248062,0.7731488306291969,1.0,6/13,25.46%,KDR;IL33;JAK2;EDN1;NOD2;NAMPT
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.32728392815623314,1.0482320157727445,0.38256658595641646,0.9687999142203537,1.0,14/95,9.88%,LBP;TNIP3;IL1A;WNT5A;TNFAIP3;SELENOS;PAF1;DEFA6;ACOD1;IRGM;CHMP5;HMGB1;TICAM1;AXL
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.4328688339287964,1.0481497083230402,0.4119496855345912,0.968047035703229,1.0,2/20,1.76%,EGFR;CCND3
prerank,Rac protein signal transduction (GO:0016601),0.44524395115305837,1.0478380178917095,0.4161392405063291,0.9679995895038473,1.0,2/18,4.67%,CDH13;RAC2
prerank,negative regulation of blood pressure (GO:0045776),-0.4144869487842858,-1.0476948209863952,0.39344262295081966,0.7744433864521665,1.0,5/13,18.47%,NOS3;BMPR2;PRCP;NOS1;GPR37L1
prerank,tryptophan metabolic process (GO:0006568),0.48992921832577696,1.047558473303248,0.42905982905982903,0.9678519165537824,1.0,2/11,3.76%,IL4I1;AADAT
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.2950667172686719,-1.0472605193694917,0.352059925093633,0.774565461820562,1.0,10/47,10.66%,TIMP3;SPOCK2;RECK;SERPIND1;SERPINI1;SPOCK1;SERPINE2;AKT1;SERPINB9;GAPDH
prerank,regulation of phospholipase C activity (GO:1900274),0.44556238055985486,1.047108030275665,0.3993558776167472,0.9682661589463709,1.0,2/15,0.70%,NTRK3;FGFR1
prerank,glutamine family amino acid metabolic process (GO:0009064),0.39039236127633986,1.0470679765846405,0.3899280575539568,0.9674252273478317,1.0,10/33,15.29%,PRODH;AADAT;NIT2;DDAH2;ALDH18A1;ALDH5A1;CAD;GOT1;GLUL;GGT1
prerank,monocarboxylic acid transport (GO:0015718),-0.28818008110229865,-1.0467257078358079,0.38721804511278196,0.7748285358604852,1.0,11/51,11.94%,SLC16A12;SLCO3A1;ABCC4;ABCG2;SLCO1C1;SLC5A6;SLC16A6;SLC16A4;SLCO2A1;SLC16A2;SLC16A7
prerank,cell projection organization (GO:0030030),0.4052317336566584,1.0466349509902304,0.40294117647058825,0.9676758258534222,1.0,5/30,9.13%,PARVA;RAC2;PACSIN2;RHOJ;PLEK
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.4350851060321952,-1.0465265645593675,0.39622641509433965,0.7742587225047022,1.0,7/10,33.39%,DNAJB2;DNAJA4;HSPA1A;DNAJB1;HSPA1B;HSPA2;SORL1
prerank,protein import into nucleus (GO:0006606),0.34690338127633163,1.0463496043600073,0.4148527528809219,0.9675545222265257,1.0,16/66,16.49%,PRICKLE1;KPNA7;IPO8;NUP62;KPNA2;FAM53B;CBLB;TPR;MMP12;NUP50;RANBP2;CSE1L;NUP153;RAN;NUP93;SYK
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.3398263273759353,-1.046256476442238,0.36694677871148457,0.7738659257206052,1.0,7/26,13.41%,ACER2;NOS3;CYP1B1;GCH1;AKT1;ABCA2;SPHK1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.4531134589219417,1.046227526291209,0.40407470288624786,0.9669776833059723,1.0,4/14,16.49%,CD55;PTPN22;CD81;SYK
prerank,regulation of protein phosphorylation (GO:0001932),0.3062363730948104,1.046211831862196,0.38509316770186336,0.9660605089210591,1.0,24/256,6.42%,EFNA5;FGF7;NTRK3;PLCE1;PTPN13;CLDN19;LEPR;EGFR;CCND3;MUSK;PELI2;FGF1;AXIN1;CDH5;FXR2;EIF2AK3;SOX9;PLPP3;LIMK2;IBTK;FN1;FER;EPHB2;KRAS
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.3427200051172861,1.0460900935757893,0.4074534161490683,0.96548819995423,1.0,9/76,5.89%,NR3C2;EGFR;BCL3;SPI1;PTPN22;PPM1A;UACA;TLR7;TRADD
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.3692083545632501,1.0457695450923443,0.38926174496644295,0.9654474950716402,1.0,5/47,4.74%,CAV1;DKKL1;CEACAM1;SLC27A1;ATP2B4
prerank,autophagosome organization (GO:1905037),-0.2812625382823294,-1.0456538243788513,0.3904382470119522,0.7743612527560692,1.0,16/50,24.50%,ATG16L2;BECN1;GABARAPL1;VMP1;WIPI1;ULK2;GABARAP;AMBRA1;STX12;ATG13;MAP1LC3A;RAB7A;WIPI2;ATG12;WDR45B;WDR45
prerank,positive regulation of protein processing (GO:0010954),-0.3591356272980132,-1.0456330053576932,0.39166666666666666,0.7732994528592199,1.0,2/19,1.69%,CCBE1;CLEC3B
prerank,positive regulation of immune effector process (GO:0002699),0.3945811980912306,1.045128738779766,0.3951734539969834,0.9664226479569923,1.0,4/27,12.38%,LBP;PTPRC;PTPRJ;CD81
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.4141656857362866,1.0450646030483122,0.39006024096385544,0.9656549226851086,1.0,4/26,9.69%,SMOC2;PRKCA;CUL3;EIF4E
prerank,lymphocyte proliferation (GO:0046651),-0.34661646717870565,-1.0450448677245747,0.3681159420289855,0.7738039566161932,1.0,2/22,1.74%,MSN;CTPS1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.428266909585042,-1.04500395890742,0.41330166270783847,0.772790024821814,1.0,6/11,35.96%,UQCRC2;CYC1;UQCRQ;UQCRFS1;UQCR10;UQCR11
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.3664908009906048,1.0449647960992097,0.40052015604681407,0.9649776537942697,1.0,17/51,26.87%,HNRNPC;SRC;NEK7;STN1;NAF1;EXOSC10;CCT2;GNL3L;TERF2;ATR;CCT3;SMG6;MAPK1;TENT4B;TNKS;HNRNPU;SMG5
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.34477734680391325,1.044874373352071,0.4017632241813602,0.96429986379303,1.0,11/74,9.35%,ITGA6;EYA1;IL1A;SRC;PSME3;BMP5;TNFAIP3;TRADD;MCL1;MAPK7;GSK3B
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.3540316535774246,-1.044791845886936,0.40934065934065933,0.7722492382077535,1.0,2/22,1.30%,ALDH1A2;RBP1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.4444688613138443,-1.0445771091957108,0.4073226544622426,0.7717473784049645,1.0,6/10,40.83%,SP100;RPS27L;KAT5;TFAP4;MUC1;FOXM1
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.31436555387899634,-1.044052959751171,0.38127090301003347,0.7720743730773727,1.0,8/35,9.63%,PLXNA2;PLXNA4;SEMA6D;SEMA7A;SEMA3C;SEMA6A;ARHGDIA;FLNA
prerank,regulation of mRNA metabolic process (GO:1903311),0.47053613063236926,1.0437272388197045,0.4159132007233273,0.9665848218407309,1.0,6/11,25.71%,SRPK1;SLTM;SRPK2;DHX9;IWS1;SAFB2
prerank,triglyceride catabolic process (GO:0019433),-0.36240529558916706,-1.0436990458549869,0.38403990024937656,0.7719759770820499,1.0,9/19,43.45%,PNPLA3;FABP7;FABP3;FABP5;LIPH;LIPC;FABP4;PNPLA2;FABP12
prerank,long-chain fatty acid metabolic process (GO:0001676),0.35423342839027794,1.0436972861706917,0.38831168831168833,0.9657154620760585,1.0,14/64,13.29%,AIG1;EPHX1;ELOVL5;ALOXE3;ELOVL1;ELOVL2;HSD17B4;SLC27A4;ACOT8;ACOT2;LTA4H;ABCD1;PNPLA8;ELOVL6
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.2983876604530007,-1.0436474418106458,0.36971830985915494,0.7710317970271773,1.0,11/44,10.42%,ANK2;ACTN2;KCNJ6;KCNMA1;KCNJ2;AKAP6;ATP1B1;KCNJ10;FLNA;ATP1B2;KCNN2
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.33017929962763515,-1.043509391736381,0.37962962962962965,0.770250246972813,1.0,13/29,27.09%,IFNAR2;SAMHD1;UBE2K;USP18;ABCE1;ISG15;YTHDF2;CACTIN;CDC37;YTHDF3;TRIM6;ZBP1;TTLL12
prerank,histone H3-K4 methylation (GO:0051568),0.4089997194799421,1.0434493587778908,0.42128935532233885,0.9655424221942094,1.0,6/26,15.76%,OGT;KMT2A;BEND3;MEN1;DYDC2;KMT2D
prerank,neurotransmitter transport (GO:0006836),0.34941670058492147,1.0433844134786918,0.3903345724907063,0.964801562500273,1.0,12/73,7.28%,PPFIA2;STX1A;CASK;SLC38A2;SLC1A7;SLC29A4;SLC22A3;ATP1A2;BRSK1;SLC1A6;RAB3A;CPLX1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.44853482981652437,1.0429285229721321,0.42122719734660036,0.9651973714089959,1.0,4/14,8.59%,DPYS;UPP2;NT5E;CAD
prerank,chemical homeostasis (GO:0048878),0.3514946232591246,1.0429171515216542,0.4031413612565445,0.9642705471359903,1.0,14/61,18.04%,NEDD4L;SLC4A3;ZBTB20;CLN8;SLC4A4;SLC4A11;USF2;TLCD3A;THADA;PNPLA8;FBXW7;PPARG;IRS2;VGF
prerank,ncRNA transcription (GO:0098781),0.46735404820499893,1.0427610242794627,0.40308747855917665,0.963759734755881,1.0,4/13,12.38%,CAVIN1;RPAP2;SIRT7;SPIN1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.4197715432467244,1.0426286745575168,0.3924646781789639,0.9631794241396499,1.0,1/22,0.41%,DYNLL1
prerank,organic anion transport (GO:0015711),0.34202392925758296,1.0424630179201715,0.39575530586766544,0.9627059164659713,1.0,11/76,7.50%,LRRC8D;SLC35A1;SLC4A3;SLC26A9;SLC35B2;SLC22A3;SLC4A4;SLC35C2;SLC2A2;SLC4A11;SLC52A1
prerank,positive regulation of RNA metabolic process (GO:0051254),0.37368632129670565,1.0424137936382145,0.4125,0.9618870547633406,1.0,9/45,9.58%,EGFR;SLC38A2;BUD23;DXO;UTP15;RBM22;DYRK1A;LIN28B;SIRT7
prerank,macrophage activation involved in immune response (GO:0002281),0.46447797801211044,1.0420763129584147,0.4216666666666667,0.9618939739547366,1.0,1/13,0.73%,LBP
prerank,response to steroid hormone (GO:0048545),0.3822829383336849,1.0416398367117774,0.4068554396423249,0.9621975095317467,1.0,3/31,7.18%,CAV1;ATP1A2;CATSPERD
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.439383512561881,1.0405721963102148,0.4170692431561997,0.964395721084641,1.0,5/19,12.88%,BCL3;PHLDA3;HIPK1;MSH2;CDIP1
prerank,regulation of stress fiber assembly (GO:0051492),0.33880598577175114,1.0404004969014669,0.4068441064638783,0.9639611571832779,1.0,6/74,2.02%,DLC1;F11R;LPAR1;PXN;RAPGEF3;ARAP1
prerank,rRNA pseudouridine synthesis (GO:0031118),0.49022237200114804,1.0400047359217357,0.4194107452339688,0.9640996110518685,1.0,3/10,18.25%,RPUSD2;NAF1;RPUSD4
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.3625074735908952,1.0394133097178784,0.4116059379217274,0.9648701475171626,1.0,9/46,10.91%,IL18R1;LAMA4;ZNF423;PLCL1;PCTP;ACOT13;HOXC10;LNPEP;DOCK7
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.3960237860532618,1.0393831462804186,0.4116788321167883,0.9640216762294521,1.0,1/32,0.24%,CAV1
prerank,cell projection assembly (GO:0030031),0.42893302926592314,1.0392311824882832,0.38972809667673713,0.9635267105582667,1.0,3/22,7.00%,PARVA;RAC2;RHOJ
prerank,fatty acid oxidation (GO:0019395),0.351497282956855,1.0390603651769086,0.3961038961038961,0.963057492024684,1.0,8/57,8.65%,PPARGC1A;EHHADH;HADHB;PEX2;ACAT1;HSD17B4;ADH5;ACADS
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.37193336667846666,1.0388196514128785,0.40625,0.9628083198638024,1.0,5/43,5.61%,KLF5;SPI1;FOXO3;SOX9;APLN
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.49324394845708597,1.0386611580155687,0.4306049822064057,0.962335221944746,1.0,3/10,16.05%,CD55;CD81;SOCS1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.44207637149359674,1.038642546782297,0.43914473684210525,0.9614668190380897,1.0,6/16,15.07%,DPYS;UPP2;NT5E;DPYSL2;DPYSL5;NT5C3A
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.43763148079547765,-1.0381644128317533,0.42342342342342343,0.7839274378133364,1.0,1/10,1.02%,SHANK3
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.3013678723608208,-1.0380717906637882,0.37755102040816324,0.7830942611515773,1.0,21/39,26.20%,RPS15;RPS7;RPS27;NPM1;RPS24;RPS19;RPS16;RPS17;RRP7A;RIOK1;RPS6;MRPS11;RIOK3;UTP4;RPS27L;PWP2;WDR3;RPS14;ERAL1;RPS25;NOB1
prerank,vasculature development (GO:0001944),0.444565442004454,1.0377693622757775,0.4233226837060703,0.9630537754180373,1.0,2/16,2.58%,STRA6;CDH5
prerank,negative regulation of developmental process (GO:0051093),-0.26106675443234045,-1.037401138075949,0.3961352657004831,0.7838043920195208,1.0,20/69,18.40%,NFIB;ROCK2;OMA1;NOS3;BMP4;TFRC;GRIN3A;TBX1;CDK6;WDR77;SINHCAF;BMP2;FUZ;ARHGEF15;DCC;MAPT;SUZ12;RC3H1;WNT11;VASH1
prerank,blood vessel morphogenesis (GO:0048514),0.359949645222418,1.0373757276967868,0.4090909090909091,0.9632065125141965,1.0,9/54,10.33%,STRA6;CAV1;GLMN;NF1;EGFL7;EFNB2;CDH2;COL4A1;AGGF1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.39440730260282664,-1.0367332523699964,0.41362530413625304,0.7845815661324307,1.0,2/14,1.72%,RAPGEF2;PKIG
prerank,regulation of keratinocyte differentiation (GO:0045616),0.4067623181922773,1.0364016312332809,0.4228395061728395,0.9650824886669745,1.0,1/24,0.21%,ETV4
prerank,retinol metabolic process (GO:0042572),0.47357520785328033,1.0363741299128715,0.42978003384094754,0.9642275522392242,1.0,1/14,0.63%,RDH10
prerank,negative regulation of type I interferon production (GO:0032480),0.3653200276436987,1.0355859458060757,0.3997093023255814,0.9655971381592501,1.0,10/40,17.26%,UBE2L6;PCBP2;REL;TNFAIP3;ACOD1;NPLOC4;TAX1BP1;TBK1;RELB;ITCH
prerank,peptidyl-lysine acetylation (GO:0018394),-0.4301488320590996,-1.0354986939173438,0.4271604938271605,0.7869075109714153,1.0,3/10,18.03%,EP300;KAT2B;KAT2A
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.4221114506464349,1.0353235973941879,0.39937106918238996,0.9654684339738088,1.0,9/19,23.74%,CHD8;POLR3G;ELL;BRF2;RPTOR;TENM1;ICE2;POLR3C;MTOR
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.33174718116541146,-1.0350041520302442,0.40514469453376206,0.7871895714447282,1.0,6/26,12.14%,SLC30A10;PLCG2;CYBA;GRIN1;SLC25A33;ABCD2
prerank,high-density lipoprotein particle assembly (GO:0034380),0.4879661234293612,1.0347387322443873,0.4428822495606327,0.9661743248346679,1.0,4/10,17.48%,ABCA1;PRKACB;ZDHHC8;BMP1
prerank,leukotriene biosynthetic process (GO:0019370),0.4571037408457967,1.0344642457733757,0.4317817014446228,0.9660062676224158,1.0,4/14,15.29%,MGST2;GGTA1;LTA4H;GGT1
prerank,long-chain fatty acid import into cell (GO:0044539),-0.4378528112096416,-1.0342001030482737,0.4031890660592255,0.7882721114585395,1.0,3/10,6.35%,ACSL1;ACSL3;RPS6KB1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.3094652615542368,1.033849639745361,0.4264870931537598,0.9668517850816408,1.0,34/163,18.75%,TEC;NFATC2;ITK;CD3G;PDE4D;TXK;EIF2B3;PTPN22;PSME3;PTPRC;LCP2;PIK3R2;PTPRJ;PSMB5;LAT;TAB2;EIF2B4;CD276;PSMB2;PSMA2;PSMA6;PLEKHA1;PSMD13;PSMA7;NFKBIZ;SYK;BTK;PAK3;PSME4;PSMC4;PSMB6;PSMD12;PDPK1;PSMD14
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.39947513913649124,-1.0338204756850198,0.425,0.7882208413007156,1.0,6/13,20.01%,ERLIN1;APOE;SCAP;BMP2;ERLIN2;DKK3
prerank,blood vessel endothelial cell migration (GO:0043534),-0.3481923298365129,-1.033688357135904,0.4227129337539432,0.7874552294964624,1.0,5/22,8.19%,ROBO1;SLIT2;PIK3R3;KDR;AKT1
prerank,cation transmembrane transport (GO:0098655),0.3683247846446678,1.033650350113115,0.41609822646657574,0.966494900129304,1.0,6/44,5.22%,TRPM3;SFXN2;SLC29A4;CACNA1H;ATP1A2;SLC25A20
prerank,regulation of fatty acid metabolic process (GO:0019217),0.42855078690589443,1.033328908786454,0.41887417218543044,0.9665488350508927,1.0,3/17,6.94%,CAV1;PDK4;NCOR1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.29111991424334244,1.0333028262242259,0.4026236125126135,0.9656945525860307,1.0,73/572,12.06%,PTCH1;TENM2;CAV1;NR2F2;NEDD4L;DLX1;RARB;FOXP2;ZBTB32;KLF12;LDB2;ETV5;GLI2;IRF2BP1;CHD3;SPI1;BEND3;PHF21A;FOXO3;SOX9;UBE2I;FOXP4;GLIS2;CHD8;HDAC4;SATB1;KLF10;DACT1;N4BP2L2;PPM1A;KANK2;BHLHE40;ZFP90;ANKRD2;NRIP1;SIN3B;CTCF;HIC1;PEX2;PAF1;ZNF431;NCOR1;NCOA5;TBX2;RREB1;RARA;BAG3;SUV39H1;KCTD1;MYPOP;ISL1;E4F1;MECP2;FOXJ1;HMGB1;SIRT7;SUPT4H1;POU4F1;HDAC2;LEFTY1;TPR;ZHX1;WWC1;NCOR2;OTUD7B;RARG;NEDD4;MZF1;HEXIM1;ZNF148;ERF;MEN1;SEMA4D
prerank,anion transmembrane transport (GO:0098656),0.3423708085452627,1.0329168744131785,0.4105793450881612,0.9658747578589904,1.0,10/67,6.69%,LRRC8D;SLC35A1;SLC25A12;SFXN2;PRAF2;SLC27A1;ABCC1;SLC6A13;SLC35C2;SLC1A6
prerank,negative regulation of receptor binding (GO:1900121),0.48529138333823757,1.032826004884375,0.4475043029259897,0.9652069286343,1.0,1/10,1.78%,PTPRF
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.4584121882678187,1.0327387686404783,0.4231404958677686,0.9645223446855063,1.0,8/12,30.06%,CLCN2;RAN;MBTPS1;MBTPS2;SEC14L2;SREBF2;DGKQ;SREBF1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.3562606893914597,1.032479331480683,0.3981358189081225,0.9633947570468574,1.0,21/51,22.92%,UBE2I;SPAST;NUP160;IST1;NUP37;REEP3;CHMP4A;CHMP4B;CHMP4C;AHCTF1;EMD;RAN;NUP93;LEMD2;PPP2CA;SUMO1;REEP4;CHMP2A;NUP43;SEC13;SIRT2
prerank,mitotic nuclear membrane organization (GO:0101024),0.3562606893914597,1.032479331480683,0.3981358189081225,0.9633947570468574,1.0,21/51,22.92%,UBE2I;SPAST;NUP160;IST1;NUP37;REEP3;CHMP4A;CHMP4B;CHMP4C;AHCTF1;EMD;RAN;NUP93;LEMD2;PPP2CA;SUMO1;REEP4;CHMP2A;NUP43;SEC13;SIRT2
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.39511128500181714,-1.0322158389909444,0.38461538461538464,0.7903133158862191,1.0,2/13,6.74%,ETS1;TRAF6
prerank,protein dephosphorylation (GO:0006470),0.3144383042762283,1.0319847441105672,0.41122565864833904,0.9638856603854473,1.0,30/135,14.47%,UBASH3B;PTPN13;PTPRF;DUSP12;EYA1;PTPN14;TPTE;PTPN22;PTPRC;PPM1A;RPRD1B;PPM1M;MTMR7;RPAP2;PTPRJ;MTMR6;MTMR3;PDP2;PTPRT;RPRD1A;SDHAF2;CTDSP1;PPP2R1B;PTPN18;PTEN;PTPRA;DUSP8;CTDSP2;PTPRU;PTPRO
prerank,regulation of cell differentiation (GO:0045595),0.31053049623724155,1.0313118758926292,0.4258639910813824,0.9648886315302578,1.0,15/148,9.71%,NGF;FGFR1;DLX1;MBOAT2;RUNX2;NF1;FLOT2;PTHLH;BMPR1B;LTBP4;DAG1;DDX17;ISL1;RPS6KA3;PHLDB1
prerank,regulation of B cell differentiation (GO:0045577),0.43641362191966543,1.0307934556403546,0.4227504244482173,0.9654373057691791,1.0,6/17,16.91%,IL4I1;ZFP36L2;PPP2R3C;SYK;BTK;MMP14
prerank,positive regulation of actin nucleation (GO:0051127),-0.4171107324042479,-1.0302990291594356,0.42482100238663484,0.7945580659703204,1.0,2/11,8.30%,WASF3;FCHSD2
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.4158014557852753,1.0300111134977072,0.426517571884984,0.9657951121154045,1.0,10/22,22.42%,ZDHHC1;ZDHHC7;ZDHHC23;ZDHHC20;ZDHHC8;ZDHHC19;GOLGA7B;ZDHHC3;ZDHHC12;GOLGA7
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.4158014557852753,1.0300111134977072,0.426517571884984,0.9657951121154045,1.0,10/22,22.42%,ZDHHC1;ZDHHC7;ZDHHC23;ZDHHC20;ZDHHC8;ZDHHC19;GOLGA7B;ZDHHC3;ZDHHC12;GOLGA7
prerank,calcium ion import into cytosol (GO:1902656),0.4533507700279892,1.0298021965306317,0.43402225755166934,0.965486617783015,1.0,3/15,4.74%,SLC24A1;TRPV4;ATP2B4
prerank,negative regulation of ossification (GO:0030279),0.4125986775326191,1.0295015469174391,0.4253393665158371,0.9654192396664396,1.0,2/23,4.05%,LRP4;SOX9
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.29295251563849706,1.0294847415957558,0.4066265060240964,0.9645578392899452,1.0,60/509,11.43%,ROR2;GAB1;DCN;CAV1;ROR1;FGF7;PLK2;NTRK3;CDH13;FGFR1;LPAR1;NR3C2;HCST;PIK3AP1;EGFR;PELI2;FGF1;AKAP13;CAV2;WNT16;SOX9;SLC35B2;SRC;REL;RAC2;WDR24;NUP62;FIS1;WNT5A;PTPRC;FN1;PPM1A;MIOS;TLR7;TRADD;TRIM21;SIAH1;PIK3R2;S100B;PTPRJ;GCNT2;NOS1AP;FGF18;HMGB1;TFG;TICAM1;TMED4;GAB2;AXL;CANT1;FERMT2;SHARPIN;ADRA2A;RELN;STRN;S100A9;WWC1;TAB2;NEDD4;PLXNB1
prerank,keratan sulfate metabolic process (GO:0042339),0.3925339852899666,1.0294284794667032,0.41853512705530643,0.9637882148623763,1.0,6/31,10.85%,ST3GAL4;PRELP;B4GAT1;SLC35D2;CHST2;HEXA
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.4025537605840199,-1.0291438478507673,0.4325,0.7967231559378228,1.0,5/13,15.11%,RPS15;NPM1;NOP9;ABCE1;NUP88
prerank,protein import into peroxisome membrane (GO:0045046),0.4158805916777002,1.0285335062365681,0.4312796208530806,0.9654122443418083,1.0,7/22,19.83%,RAB8B;FIS1;PEX2;PXMP2;ABCD1;SLC25A17;PEX13
prerank,regulation of T cell activation (GO:0050863),0.37060670897856285,1.028512606550497,0.41225626740947074,0.9645515208759686,1.0,5/42,10.16%,TNFSF8;IL4I1;PTPN22;CRTAM;LAT
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.3826106399220088,1.0281765504358187,0.4081920903954802,0.9645805699469561,1.0,7/31,14.31%,SIPA1L1;PPFIA2;LZTS3;SRCIN1;RELN;PTEN;CAPRIN2
prerank,melanosome organization (GO:0032438),0.4017019485717576,1.0280841036597461,0.4230171073094868,0.963924973981564,1.0,4/26,7.55%,RAB29;HPS1;SHROOM2;KIF13A
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.4398142037922935,1.0280018769261823,0.44982698961937717,0.9632466361065275,1.0,2/15,2.68%,PPARGC1A;ELOVL5
prerank,positive regulation of B cell activation (GO:0050871),0.35693900214433566,1.027969053022943,0.42935528120713307,0.9624249347786428,1.0,13/50,17.63%,NFATC2;KMT5C;PTPRC;EPHB2;CD320;GPR183;CD81;IL7;PPP2R3C;SYK;BTK;MMP14;IRS2
prerank,bone morphogenesis (GO:0060349),-0.3916184303377385,-1.0279356528532946,0.41509433962264153,0.7990851462286401,1.0,4/14,7.80%,CYP26B1;BMPR2;FGFR2;LRP6
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.41924049951325887,1.0278736927730738,0.41455696202531644,0.9608774127248618,1.0,4/21,7.45%,EYA1;IL1A;MCL1;MAPK7
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.41924049951325887,1.0278736927730738,0.41455696202531644,0.9608774127248618,1.0,4/21,7.45%,EYA1;IL1A;MCL1;MAPK7
prerank,mitochondrial genome maintenance (GO:0000002),-0.4291535272477117,-1.0278051962596502,0.43207126948775054,0.7983144029664931,1.0,6/11,19.28%,AKT3;TOP3A;MEF2A;SLC25A33;OPA1;PARP1
prerank,pseudouridine synthesis (GO:0001522),0.461880602216566,1.027771027165196,0.4332784184514003,0.9602726409372753,1.0,3/13,6.98%,RPUSD2;PUS7;PUS3
prerank,regulation of extracellular matrix organization (GO:1903053),-0.3828973207291967,-1.0277398996852918,0.38765432098765434,0.7973497261473952,1.0,6/15,12.13%,AEBP1;LRP1;DDR1;TIE1;SLC2A10;FGFR4
prerank,response to ketone (GO:1901654),0.40251927230337414,1.0274008601966182,0.41091492776886035,0.9604124982570379,1.0,1/24,0.24%,CAV1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.3389695177774282,1.027222332318899,0.41125,0.9599912456776581,1.0,12/73,11.27%,GLMN;MYBBP1A;TDG;SF3B1;SPI1;HDAC4;POLR1E;CTCF;MECP2;PPHLN1;ERCC6;HDAC6
prerank,cellular response to heat (GO:0034605),0.37460668087434623,1.0271769255124976,0.40057636887608067,0.9592381227087278,1.0,12/35,21.74%,FGF1;TRPV4;IL1A;BAG3;TPR;CLPB;HTRA2;YWHAE;SLU7;SUMO1;DAXX;RBBP7
prerank,establishment of protein localization to organelle (GO:0072594),0.33511420095575567,1.0259488049269292,0.42297650130548303,0.9617437952974913,1.0,28/72,26.57%,PRICKLE1;HK2;IPO8;LRSAM1;NUP62;FAM53B;LAMP1;TPR;MMP12;NUP50;CSE1L;NUP153;RAN;NUP93;SYK;PINK1;LAMP2;RPAIN;RALA;TSC2;SEC13;SPRN;IPO13;PTTG1IP;CD68;NUP188;RANBP17;TNPO1
prerank,glial cell differentiation (GO:0010001),-0.3289310550501827,-1.0257637313689658,0.3963963963963964,0.8017396626556992,1.0,3/28,2.30%,NFIB;ADGRG6;SLC8A3
prerank,negative regulation of epithelial cell migration (GO:0010633),0.38518137482727854,1.0256854935232667,0.4291845493562232,0.9615655629458999,1.0,2/33,0.77%,DCN;NR2F2
prerank,nucleotide biosynthetic process (GO:0009165),0.4271128859368658,1.0256744813289864,0.4142857142857143,0.9606925340415321,1.0,6/18,11.62%,MTHFD1;PPAT;NMNAT3;PRPSAP2;PRPS1L1;PRPS1
prerank,mammary gland epithelium development (GO:0061180),-0.3894975232499735,-1.0250573427772545,0.4295942720763723,0.8025091618760274,1.0,4/14,14.17%,WNT4;JAK2;AKT1;ID2
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.35162722523504325,1.0249774458853267,0.42761394101876676,0.9617182125896006,1.0,10/59,9.70%,CDH13;CEACAM1;MPZL2;CDH17;HMCN1;TRO;DSCAM;AMIGO2;CDH2;PTPRT
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.4065501488468345,-1.0248952794127175,0.42042755344418054,0.8018686498274553,1.0,8/12,32.67%,UNC13C;SYT7;UNC13A;RIMS1;RIMS3;SYT1;SYT5;DOC2B
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.33439708618369157,1.0245987045524265,0.4216417910447761,0.9618347234506356,1.0,14/75,13.51%,NR2F2;RGS14;STK38;NF1;SPRY1;SPRY4;IRAK3;PRKAR2A;PTPRJ;APC;HEXIM1;MEN1;PTEN;CDKN1C
prerank,regulation of neuron apoptotic process (GO:0043523),0.32656177550599047,1.0243040159722399,0.42478941034897716,0.9617492041495281,1.0,10/96,10.89%,NGF;PPARGC1A;NF1;FOXO3;EGLN3;MSH2;ISL1;NRBP2;POU4F1;SRPK2
prerank,positive regulation of gene expression (GO:0010628),0.29154059591425624,1.0241398659235046,0.4198782961460446,0.9613333565934826,1.0,61/442,11.59%,NGF;FGF7;NTRK3;PPARGC1A;FOXD1;CLDN19;GLMN;EGFR;MUSK;MYBBP1A;FGF1;BCL3;ITK;ADAM19;SLC26A9;CDH5;FXR2;SF3B1;SLC38A2;ITGAX;PIWIL2;TXK;IL1A;PRKAG1;WNT16;EIF2AK3;SOX9;CELF1;TFR2;PTPN22;WNT5A;FN1;EPHB2;KRAS;RIMS2;UBR5;POLR1E;RDX;CTCF;CRTAM;PTGER4;RBM22;OCLN;DYRK1A;NOS1AP;FGF18;AGO1;DDRGK1;PLSCR1;GSK3B;TICAM1;POU4F1;HILPDA;ADRA2A;METTL5;ERCC6;SRPK2;PLD1;UPF3B;EGR1;MED23
prerank,microtubule polymerization or depolymerization (GO:0031109),0.399735535560053,1.0240266707270642,0.43283582089552236,0.9607799071883782,1.0,5/25,10.90%,KIF2A;NCKAP5L;TRPV4;CKAP5;CENPJ
prerank,positive regulation of cellular protein localization (GO:1903829),0.3440200807469174,1.023870297080545,0.41959798994974873,0.9603324884042019,1.0,19/69,20.40%,GTSE1;RIC3;EIF2AK3;LIMK2;NUP62;CARD10;DDRGK1;GSK3B;FERMT2;APC;SLC5A3;RTN4;YAP1;GNL3L;STX4;TM9SF4;CEP250;LAMTOR5;PRKN
prerank,protein polymerization (GO:0051258),0.3441770475647245,1.023799507502187,0.42802056555269924,0.9596297688827248,1.0,10/56,10.90%,COBL;TRPV4;GAS7;CKAP5;WASHC3;CASQ2;DIAPH3;CHMP4A;CHMP4B;CENPJ
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.4722723175975598,1.0228785731635448,0.4394213381555154,0.9612934264887464,1.0,2/11,1.53%,NEDD4L;LEPROT
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.35930192179201226,1.0225617786991021,0.4350282485875706,0.9612952698062829,1.0,6/43,7.45%,LBP;PTPN22;IRAK3;TNFAIP3;SELENOS;RARA
prerank,cellular component assembly (GO:0022607),0.29819473879431496,1.0224893800887285,0.43685300207039335,0.9605953572576809,1.0,27/253,9.40%,MAGI1;PPARGC1A;PARVA;WIPF1;LAMC1;REPS2;PARD6B;CD3G;SPEF1;KMT2A;OPHN1;ADD1;SOX9;CDAN1;RAC2;WNT5A;CARD10;FANCC;TEX11;TAPBP;SHROOM2;SPAG17;RHOJ;OCLN;DARS1;CALD1;FOXJ1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.4367042064486111,1.0217161269639,0.45410628019323673,0.9620287884539616,1.0,3/15,13.45%,HOMER2;GRM1;HOMER3
prerank,nucleic acid-templated transcription (GO:0097659),-0.29645726295902486,-1.021560019272921,0.4,0.809937372747856,1.0,17/42,21.82%,CREBL2;MEF2A;PTMA;NR4A2;RRAGC;POLR3A;MMS19;PWP1;RNPS1;HOXD3;POLR2F;POLR2A;POLR2J;POLR2D;POLR2K;THAP1;THRB
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3537009250553306,1.0214134282590719,0.42762284196547146,0.9619916595660786,1.0,13/54,19.71%,PLK2;GTSE1;CNOT10;ARID3A;SFN;CNOT7;SOX4;RGCC;TNKS1BP1;E2F1;CNOT8;CNOT1;BAX
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.30451234066974187,-1.0213677672075332,0.38064516129032255,0.809355826483306,1.0,10/33,22.92%,LEF1;TRAF6;IL34;HAX1;ID2;HSF1;CSF1;CASP8;FES;RIPK1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.38882537998347966,1.0207043997489584,0.42584434654919234,0.96306819919996,1.0,11/29,21.15%,AXIN1;KANK2;ISL1;DDRGK1;UFSP2;CBFB;YAP1;KMT2D;VPS11;CNOT1;RUNX1
prerank,isotype switching (GO:0045190),0.4838639781818298,1.02044080640148,0.45119705340699817,0.9629346406661053,1.0,3/10,16.40%,MSH6;MSH2;BATF
prerank,negative regulation of neuron death (GO:1901215),0.33029466558956766,1.020089778216019,0.43239951278928135,0.9630095803133586,1.0,10/93,10.70%,NGF;PPARGC1A;MSH2;ISL1;NRBP2;CD200R1;GSK3B;POU4F1;CHMP4A;CHMP4B
prerank,cellular protein modification process (GO:0006464),0.2850100471203226,1.019957990589466,0.4364364364364364,0.9624992155839498,1.0,209/983,18.41%,PIGU;TEC;PLK2;FAM20C;TRIB2;CDK15;GPC3;STC2;FGFR1;ST3GAL4;HCST;SLC35A1;PRKCE;PTPN13;UBE2L6;CAMK2D;LAMB2;LAMC1;CEL;PTPRF;FBXL15;UST;UBE2E2;SOCS5;CD3G;DUSP12;MINK1;B3GALT1;ASB6;STK38;MAP3K1;MMP15;TXK;LMO7;MAPK10;PTPN14;ERO1A;SCG3;PRKAG1;EIF2AK3;UBE2I;TPTE;BMPR1B;PTPN22;PRKCA;CDKL3;SPSB4;PEAK1;PSME3;NUCB1;CPE;MORC3;LIMK2;IRAK3;PTPRC;ACVR1C;KEAP1;FN1;PPM1A;EGLN3;PDK4;HIPK1;PIK3R4;BMP15;SUMF1;BRSK1;NEK7;FER;CDK13;BCKDK;COQ8A;ADAM10;SOCS6;PTP4A2;SIRT3;ATG5;PPM1M;ABL2;GOLM1;GMFB;COL3A1;CDK7;BMP2K;RAB3A;STK38L;RARA;FBXO31;CUL3;MTMR7;MAP3K5;RCN1;CDH2;SRPK1;PTPRJ;GCNT2;DYRK1A;NRBP2;CSNK1G3;MTMR6;PSMB5;DCAF13;MTMR3;PDP2;STK24;STK3;GSK3B;SIRT7;PTPRT;CSNK1A1;SDHAF2;TYK2;CTDSP1;SRPK2;ST8SIA5;ILF3;MANBA;FBXL19;PROC;PRKCSH;PPP2R1B;ST8SIA3;KLHL21;HS3ST5;FBXL5;PTPN18;MEN1;SGK1;LIPE;HUNK;FBXO11;PARP6;OARD1;DAD1;MAP3K21;PTEN;PTPRA;DUSP8;PRKACB;ATG7;SIK3;ERN1;FBXO21;LCMT1;PSMB2;P4HB;UBE2D3;STT3A;PSMA2;KLHL22;CTDSP2;PTPRU;PTPRO;CHM;FNTB;FEM1C;PSMA6;PARP8;CHRM3;CHGB;PIK3C3;WWP2;COPS5;NEK4;PTPN6;PSMD13;FBXW8;SERP2;CDKL2;PSMA7;MAN2A2;OGA;FBXO41;DDB2;ERBB2;TBK1;NEK11;TBCK;FBXL12;MBTPS1;SYK;FBXW7;BTK;FBXL3;PAK3;MAP3K9;PPP1CA;CUL4B;LMTK2;PP2D1;RNF7;DYRK2;PSME4;VCAN;CALU;FSTL1;BTBD6;WFS1;JAK1;PINK1;VGF;DAPK2;PTAR1;SOCS2;PSMC4;FBN1;ILKAP;COG3;PSMB6;PSMD12
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.4472897064936875,1.019666343465579,0.45634266886326197,0.9624098572113682,1.0,2/15,9.52%,USP50;NLRP2B
prerank,regulation of interleukin-12 production (GO:0032655),-0.2833092068163836,-1.0195159477082196,0.3875968992248062,0.813188865489685,1.0,13/47,25.44%,PLCB1;FOXP1;PLCG2;CMKLR1;THBS1;LGALS9;LAPTM5;CD40;TLR3;C1QBP;CCL19;IRF5;JAK3
prerank,cholesterol biosynthetic process (GO:0006695),-0.30700252791641663,-1.0191565628151087,0.41975308641975306,0.8130820610791429,1.0,10/31,19.79%,INSIG2;ARV1;HMGCS1;ACAA2;ACLY;NSDHL;PMVK;MVK;ACAT2;DHCR7
prerank,nucleotide catabolic process (GO:0009166),-0.3745175742836257,-1.0190706233465519,0.4635416666666667,0.812199874086493,1.0,6/16,18.92%,SAMHD1;XDH;NUDT3;VCP;NT5C;NT5C1A
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.2601001407683626,-1.01902319645613,0.3786407766990291,0.8112014414256083,1.0,13/74,12.75%,PHLDB2;SMAD3;LEF1;EPHA3;DAB2;TGFBR1;MCRIP1;GLIPR2;TGFB3;VASN;BMP2;USF3;TGFB2
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.36168527796013844,1.018852636838424,0.4301994301994302,0.9637648735775408,1.0,6/41,7.45%,LBP;PTPN22;IRAK3;TNFAIP3;SELENOS;RARA
prerank,clathrin-dependent endocytosis (GO:0072583),-0.3261458681087814,-1.0188435094830754,0.3983516483516483,0.8105909777014967,1.0,6/26,16.04%,PICALM;DNAJC6;AP2A1;FCHSD2;LMBRD1;FNBP1L
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.47173856108448603,1.0187807137999605,0.4601449275362319,0.9630892357993396,1.0,3/10,8.53%,DPYS;UPP2;NT5E
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.3189739585748842,-1.0187003618390185,0.42032967032967034,0.8098700683671348,1.0,8/29,9.00%,SHANK3;PLEKHH2;SLIT2;KANK3;HIP1R;TWF1;MYADM;CYRIB
prerank,positive regulation of interferon-gamma production (GO:0032729),0.36366306038161306,1.0180060345905988,0.4306864064602961,0.9643772185699174,1.0,7/48,8.17%,IL18R1;PDE4D;TXK;PTPN22;TLR7;CRTAM;ISL1
prerank,vasculogenesis (GO:0001570),0.3848802997644639,1.0178868700233876,0.42158273381294964,0.9637911416011873,1.0,4/32,6.83%,CAV1;GLMN;SPRED1;EGFL7
prerank,protein homotetramerization (GO:0051289),0.3605526986745831,1.017732000058813,0.4434330299089727,0.9633242536486994,1.0,4/49,7.01%,ALDH1A3;ALDH9A1;ACOT13;ACACA
prerank,membrane assembly (GO:0071709),0.3870262250285021,1.017649941102108,0.4444444444444444,0.9626575289303386,1.0,13/34,22.12%,LRP4;CEL;FLOT2;SPAST;CHMP4B;STX2;PTEN;STX4;SPTBN1;S100A10;CHMP2A;NLGN3;NLGN2
prerank,negative regulation of hormone secretion (GO:0046888),-0.42492287838475173,-1.0176109759997076,0.4467120181405896,0.8118526003359274,1.0,3/10,17.29%,GJA1;RAB11FIP3;RAB11FIP1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.28706715782040765,-1.0174008521324402,0.4068965517241379,0.8113509260520978,1.0,16/42,25.40%,SHLD2;ACTR2;ARID2;KDM1A;MMS19;POLQ;UBQLN4;PPP4R2;PARP1;TIMELESS;CGAS;MAD2L2;RMI2;RAD51;SMCHD1;PARPBP
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.3977937246148927,-1.0173832571942496,0.4117647058823529,0.810287632723338,1.0,6/13,28.03%,MMS19;NFU1;ISCA2;GLRX5;BOLA2;CIAO2B
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.2874247584198389,1.0171590400787989,0.4532520325203252,0.9631873383612601,1.0,57/417,11.93%,MDFIC;VGLL4;PRICKLE1;PAX9;NR2F2;TSHZ3;PHC2;FOXP2;ZNF423;FOXD1;ATP8B1;MYBBP1A;BCL3;RUNX2;RBFOX2;SFMBT2;CIART;SPI1;L3MBTL3;FOXK1;SOX9;UBE2I;GLIS2;CHD8;KAT6B;HDAC4;LANCL2;KLF10;WNT5A;CREB3L1;RBM15B;HEYL;SP3;BHLHE40;RCOR3;CTCF;NCOR1;TBX2;RARA;SUV39H1;KCTD1;FOXK2;UIMC1;TSC22D4;MECP2;RORB;USP47;HDAC2;CNOT7;ZHX1;NCOR2;ILF3;HDAC6;HEXIM1;ZNF148;MEN1;KDM8
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3086474299295241,1.0163564068091488,0.44043715846994536,0.96450888325083,1.0,15/166,5.80%,SMOC2;GLI1;PPARGC1A;SORBS1;ASS1;EGFR;BCL3;ELOVL5;FXR2;GPLD1;GLI2;PIWIL2;SLC27A1;DDAH2;STN1
prerank,response to laminar fluid shear stress (GO:0034616),0.4833286387529258,1.0162617174494417,0.45166959578207383,0.9638995974356236,1.0,4/10,12.27%,ASS1;MAPK7;ABCA1;NFE2L2
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.40902791301773733,-1.0159708287799336,0.4221698113207547,0.8130079580988924,1.0,4/11,13.76%,LYN;MFHAS1;CYBA;PJA2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.31520848071593405,1.0156847685858894,0.44215349369988544,0.9645967414488003,1.0,42/129,22.50%,DYNLL1;FBXL15;WEE1;SFI1;BRSK1;CEP131;CEP78;NEDD1;CDK7;PHLDA1;TUBG1;CKAP5;PAFAH1B1;CCP110;MASTL;CENPJ;FBXL17;KDM8;NDE1;CEP290;SSNA1;CETN2;ENSA;LCMT1;PCM1;YWHAG;FBXL12;PPP1R12B;YWHAE;FBXL3;CEP57;BACH1;OFD1;CEP250;DCTN2;ALMS1;TAF2;HAUS8;CEP43;FBXW11;BORA;HAUS3
prerank,membrane repolarization during action potential (GO:0086011),-0.400624439309341,-1.015629689395891,0.4282238442822384,0.8128563192140342,1.0,6/13,30.78%,KCNJ2;ATP1B1;KCNE4;KCNH2;ATP1A1;KCNQ1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.3508183207143042,1.0155895748597723,0.4418300653594771,0.9640073513160572,1.0,11/56,10.95%,EGFR;CCND3;ADAMTS1;UBE2E2;RDX;FBXO5;CUL3;ANAPC5;ANAPC7;MECP2;ANAPC11
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3393360705729176,1.0154492040378662,0.4247448979591837,0.9635218322943644,1.0,14/66,13.19%,EGFR;CCND3;ADAMTS1;UBE2E2;WEE1;PSME3;DACT1;KANK2;RDX;APC;INO80;PTEN;PKD1;FHL1
prerank,positive regulation of exosomal secretion (GO:1903543),0.4369532420973393,1.01530877200904,0.432520325203252,0.9630192256204295,1.0,7/15,25.37%,TSG101;SDC1;PDCD6IP;SDC4;CHMP2A;SNF8;STAM
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.40334800047712366,-1.0152705441190788,0.42355889724310775,0.8127344429516175,1.0,9/12,32.04%,MCM6;CDC7;MUS81;MCMDC2;CDC45;MCM3;MCM7;MCM5;MCM2
prerank,myelin maintenance (GO:0043217),0.47674679772671047,1.014743768493539,0.4490161001788909,0.9637154868121803,1.0,5/10,22.23%,EPB41L3;ABCD1;PTEN;PRX;MYRF
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.2954205764663784,-1.0146239923471572,0.4387755102040816,0.8134257845157441,1.0,11/39,13.90%,ROBO1;RBPJ;NOS3;EP300;CCN3;PDCD10;JAG2;SNW1;TM2D3;TGFB2;MAML3
prerank,negative regulation of DNA binding (GO:0043392),-0.321545689371644,-1.0146097599987896,0.4174454828660436,0.8123530563024508,1.0,6/28,20.58%,LEF1;SP100;JAK2;KDM1A;PER2;MAD2L2
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.3475598280755081,-1.01451489294935,0.416,0.8115616812663674,1.0,7/19,25.08%,SMAD6;BMPR2;BMP2;TGFB2;SMAD4;OLFM1;NOTCH1
prerank,neuron development (GO:0048666),-0.2348970256023335,-1.0144261286322787,0.4396551724137931,0.8106726114698903,1.0,36/141,14.92%,FRY;PTPRM;RAPGEF2;LYN;PBX3;FRYL;ATP7A;STMN2;RASGRF1;GPRIN3;APOE;EPHA8;TBC1D24;STMN4;THOC2;DCX;VSX1;CAMSAP1;RAB13;LAMB1;MANF;LGI4;RP1;MYT1L;GBA2;RAB11A;STMN1;HS6ST1;TGFB2;LGI1;MAPT;SH3GL2;DTNBP1;CLN5;MICALL1;CDK5R1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.45559634206742805,1.0139741911038394,0.4509466437177281,0.9649512474153426,1.0,7/13,28.83%,WNT5A;AXL;IL7;DHX9;IFIH1;TRIM44;MAVS
prerank,L-amino acid transport (GO:0015807),0.3889799969040062,1.013973878368433,0.43655589123867067,0.9640740190086012,1.0,7/28,12.99%,SLC25A12;SLC38A2;PRAF2;SLC1A6;SLC7A2;SLC25A13;SLC25A22
prerank,response to hydrogen peroxide (GO:0042542),-0.2898223104850296,-1.0139629669113521,0.39705882352941174,0.8107785111070456,1.0,14/45,17.52%,CYP1B1;SIRPA;CAT;PDCD10;ANXA1;OSER1;RHOB;RPS3;NET1;GLRX2;FXN;APTX;ANKZF1;TRPM2
prerank,myeloid cell activation involved in immune response (GO:0002275),0.4365292625851408,1.0137800599736857,0.4427860696517413,0.963723671714515,1.0,3/18,10.36%,LBP;DOCK2;KARS1
prerank,dicarboxylic acid transport (GO:0006835),0.39327023616977613,1.0130958385881024,0.4459665144596651,0.9647592566508948,1.0,6/28,6.69%,FOLR1;FOLR2;SLC25A12;SLC1A7;PRAF2;SLC1A6
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.33228030495897637,1.0129567074089671,0.4481074481074481,0.9642863515218235,1.0,6/73,6.98%,NGF;DLC1;EIF2AK3;EGLN3;TRADD;NLRC4
prerank,regulation of dephosphorylation (GO:0035303),0.4452499643313968,1.0127434122667485,0.44715447154471544,0.9639775842026895,1.0,7/15,26.87%,SRC;MTMR3;SMG7;MTMR1;SMG6;PPP1R16A;SMG5
prerank,zymogen activation (GO:0031638),0.3750732675704436,1.0126909036034066,0.45416666666666666,0.9632632417138548,1.0,6/39,7.22%,KLK2;CYFIP2;CIDEB;CD5L;NLRC4;PERP
prerank,defense response to tumor cell (GO:0002357),0.4782359359093598,1.0126187046319033,0.4352517985611511,0.9625714130973337,1.0,2/10,3.65%,DLEC1;SPI1
prerank,regulation of organelle assembly (GO:1902115),0.33632868687479506,1.0125917739182317,0.42962962962962964,0.9617637941521502,1.0,26/73,21.98%,PLK2;SENP6;STIL;TSG101;ATG5;RDX;MTMR3;PDCD6IP;TBC1D16;TBC1D2;TBC1D8;CENPJ;ATXN2;EVI5;DYNC2LI1;EZR;TBC1D20;VPS11;TBC1D5;RAB5A;ATG3;TBC1D10A;ALMS1;CDKL1;IFT140;HCK
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.4338485786998072,1.0124462633401163,0.435,0.9613067421369785,1.0,3/17,9.48%,CXCL17;ANO6;HMGB1
prerank,positive regulation of cell growth (GO:0030307),0.32178223185259897,1.012314951343655,0.4418052256532066,0.9608081849716066,1.0,12/96,12.06%,NGF;NEDD4L;NTN1;EGFR;ADAM10;RIMS2;CPNE9;RPS6KA3;USP47;S100A9;INO80;SEMA4D
prerank,regulation of macrophage differentiation (GO:0045649),-0.3721560021363398,-1.0122266119618577,0.44,0.8145455941908626,1.0,7/15,22.92%,IL34;ID2;HSF1;CSF1;CASP8;INHBA;RIPK1
prerank,intracellular cholesterol transport (GO:0032367),-0.3780491723439906,-1.0122128638712637,0.43256997455470736,0.8134770943114852,1.0,5/15,14.27%,LDLR;LRP6;LDLRAP1;VPS4A;ABCG1
prerank,regulation of B cell activation (GO:0050864),0.3989163153969833,1.0120137787336547,0.423861852433281,0.960818867236748,1.0,5/25,13.31%,IL4I1;BANK1;TNFAIP3;FOXJ1;ZFP36L2
prerank,stress-activated MAPK cascade (GO:0051403),-0.2692315032249795,-1.0118432957367252,0.4117647058823529,0.8134183396698185,1.0,17/61,19.93%,TNFRSF19;MAP3K20;TRAF6;UBE2N;NOD1;CRKL;MAP3K10;TRIB1;TAOK2;MAP2K3;IKBKB;LGALS9;ZFP36;IRAK2;CUL1;GPS1;SKP1
prerank,negative regulation of lyase activity (GO:0051350),-0.36845756939879615,-1.0116626328349083,0.43609022556390975,0.8127631651834698,1.0,2/16,2.36%,ADGRV1;GRM3
prerank,bile acid and bile salt transport (GO:0015721),0.40143608857696766,1.0114156461377923,0.43670886075949367,0.9616095245167297,1.0,2/24,1.94%,CEACAM1;ATP8B1
prerank,cellular response to retinoic acid (GO:0071300),-0.28223650494565716,-1.0112119715683525,0.4564459930313589,0.8129386625426253,1.0,9/42,11.18%,EPHA3;WNT5B;LYN;ADNP2;BRINP3;TBX1;CREB1;SNW1;RET
prerank,regulation of vasculogenesis (GO:2001212),0.4504697047029108,1.0109527669027971,0.4633333333333333,0.9620373975376146,1.0,2/14,1.89%,CEACAM1;RAP1A
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.3937741378610976,1.0109227431710819,0.4496240601503759,0.9612548572273998,1.0,7/25,14.37%,LEPROT;CHMP5;CHMP4A;CHMP4B;CHMP4C;LEPROTL1;LAPTM4B
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.2957437976091002,1.0108315271926325,0.46743697478991597,0.9606557641380306,1.0,19/234,6.98%,EDA;CAV1;ROR1;PPARGC1A;IL18R1;RIPK4;FZD2;LPAR5;CRTC1;FLOT2;PLPP3;HDAC4;IRAK3;WNT5A;FER;TRADD;ARHGEF5;TRIM21;NLRC4
prerank,plasma membrane repair (GO:0001778),-0.39631252927050675,-1.0106217578044776,0.4466501240694789,0.8135047525795144,1.0,4/13,9.25%,MYOF;DYSF;SYT7;SYTL4
prerank,regulation of dendrite development (GO:0050773),0.3638939237714911,1.0103242437571238,0.4335766423357664,0.9612298549881638,1.0,7/37,12.06%,NEDD4L;COBL;BMP5;GSK3B;SARM1;NEDD4;SEMA4D
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.28885116089159824,-1.0102650897047316,0.4258064516129032,0.8133748558130695,1.0,8/37,17.03%,PRKAG2;PARD3;CALM1;UBE2K;SPHK1;CALM3;EIF4G1;EGF
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.32624427906568926,1.009717590084962,0.44183168316831684,0.9620595068091516,1.0,26/84,18.75%,PSME3;FBXO31;FBXO5;CUL3;CDC20;PSMB5;ANAPC5;ANAPC7;ANAPC11;BUB3;ANAPC2;PSMB2;UBE2D1;PSMA2;PSMA6;ANAPC4;FZR1;PSMD13;PSMA7;PSME4;ANAPC16;PSMC4;CDC23;PSMB6;PSMD12;PSMD14
prerank,nuclear membrane reassembly (GO:0031468),0.3486391570824715,1.0096770107397173,0.44,0.9613083268450233,1.0,21/54,22.92%,UBE2I;SPAST;NUP160;IST1;NUP37;REEP3;CHMP4A;CHMP4B;CHMP4C;AHCTF1;EMD;RAN;NUP93;LEMD2;PPP2CA;SUMO1;REEP4;CHMP2A;NUP43;SEC13;SIRT2
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.31256380289425767,1.009468601221389,0.464,0.9609876147211306,1.0,21/128,10.55%,F11R;INHBB;PXN;CDH5;RUNX2;BMPR1B;SRC;BMP5;ACVR1C;BMP15;ZFYVE16;RGMB;TGFBRAP1;COL3A1;GCNT2;LTBP2;CGN;FERMT2;LEFTY1;FNTA;ZYX
prerank,regulation of exosomal secretion (GO:1903541),0.4192178870642175,1.0091326381020373,0.46129541864139023,0.9610307726038181,1.0,9/19,25.37%,TSG101;SDC1;PDCD6IP;ATP9A;SDC4;PRKN;CHMP2A;SNF8;STAM
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3039308760190163,1.0086371296176475,0.4613686534216336,0.9615189766435863,1.0,63/173,25.28%,DYNLL1;FOLR1;CAPZB;RAB29;CD55;TRAPPC3L;LMAN2;GOSR1;CNIH1;SPAST;ACTR10;ATL2;CUL3;COG6;GOLGB1;NRBP2;TFG;TMED4;GRIA1;DYNLL2;ANK1;PROC;COPE;GOLT1A;COPG1;TRIP11;TEX261;ZW10;COPA;TMED2;TICAM2;TBC1D20;TRAPPC3;ERGIC1;SPTBN1;ARCN1;STX5;COG3;BET1;DCTN2;SEC24B;NSF;DYNC1LI2;CNIH4;SPTB;USO1;COG5;DYNC1I1;TRAPPC8;SPTBN5;PGAP1;DCTN6;SEC13;F8;VAPA;ARF4;VAPB;DYNC1I2;SAR1A;SPTAN1;PEF1;WHAMM;LMAN1
prerank,tricarboxylic acid metabolic process (GO:0072350),0.4567679641991226,1.008244733995495,0.4554294975688817,0.9617667773173204,1.0,1/12,1.60%,ASS1
prerank,sensory perception of sound (GO:0007605),0.3254968900486703,1.0078421708351395,0.4406779661016949,0.962025851188043,1.0,5/88,4.62%,ROR1;HOMER2;RIPOR2;EYA1;TMC2
prerank,DNA modification (GO:0006304),0.3990024050959068,1.0075440172918118,0.453125,0.9620344894621111,1.0,3/22,5.31%,TDG;NTHL1;EXOSC5
prerank,regulation of protein kinase C signaling (GO:0090036),-0.3803150281743328,-1.0074158696371445,0.42857142857142855,0.8202139579134236,1.0,6/14,18.00%,ADGRV1;MYADM;GPD1L;FLT4;WNT11;CD40
prerank,regulation of phospholipase activity (GO:0010517),0.48199288566252263,1.0066189556971594,0.4780316344463972,0.9636719284763392,1.0,1/10,0.70%,FGFR1
prerank,pore complex assembly (GO:0046931),0.42151388475674423,1.0065094560991381,0.4418604651162791,0.963079048321788,1.0,9/19,15.45%,ANO6;ADAM10;TPR;AHCTF1;NUP153;GSDMD;RTN4;BAD;NUP93
prerank,positive regulation of viral process (GO:0048524),0.33770654952484236,1.0064318465219553,0.44954128440366975,0.9624255195466486,1.0,10/60,12.46%,MDFIC;KPNA2;PPIE;SRPK1;NELFB;SUPT4H1;AXL;CNOT7;SRPK2;GTF2F2
prerank,cellular response to ATP (GO:0071318),-0.37597541842540433,-1.006358003524994,0.424390243902439,0.8220789143146187,1.0,5/14,27.70%,P2RX7;P2RX4;CIB2;P2RY12;P2RY1
prerank,regulation of sprouting angiogenesis (GO:1903670),0.38288502641285244,1.0063207698538064,0.4291845493562232,0.961885614560042,1.0,10/33,18.55%,CEACAM1;FGF1;CREB3L1;RHOJ;FGF18;CEMIP2;GLUL;ITGA5;JAK1;PDPK1
prerank,negative regulation of wound healing (GO:0061045),0.3854095809158277,1.006279782774751,0.45795795795795796,0.961168548597545,1.0,4/28,3.14%,CLDN19;SLC12A2;AJAP1;CASK
prerank,sphingolipid metabolic process (GO:0006665),0.31746740561061054,1.0058128395915824,0.4600484261501211,0.9615754008398182,1.0,16/108,8.73%,SGMS2;CERS6;ACER3;ELOVL5;PLPP2;TEX2;PLPP3;ALOXE3;SUMF1;CLN8;HACD4;CERK;ELOVL1;NEU1;ELOVL2;CERT1
prerank,heme biosynthetic process (GO:0006783),-0.33522086627705383,-1.0055601466630237,0.45776566757493187,0.8232093624296561,1.0,11/22,24.33%,ABCG2;SLC25A38;FECH;CPOX;FXN;ABCB10;ALAS1;UROD;HMBS;TSPO;ALAD
prerank,negative regulation of GTPase activity (GO:0034260),0.3979436659751063,1.0054346621501293,0.44952681388012616,0.9617829586103541,1.0,2/22,6.72%,F11R;RDX
prerank,positive regulation of actin filament polymerization (GO:0030838),0.35342069253276176,1.005371665808087,0.4379263301500682,0.9611052408687936,1.0,12/44,21.98%,PRKCE;CDC42EP4;FER;NCK2;ARF6;CTTN;CDC42EP3;BAIAP2;PFN2;NCK1;TENM1;HCK
prerank,protein monoubiquitination (GO:0006513),0.36850381991408493,1.0053596637445104,0.44803370786516855,0.9602960185561694,1.0,15/36,23.22%,LEO1;TRIM21;PAF1;CUL3;UBE3D;OBI1;UBE2D3;KLHL22;FANCL;UBE2R2;UBE2W;CDC73;PRKN;RNF20;DTX3L
prerank,regulation of phospholipid metabolic process (GO:1903725),0.4721586809779906,1.0052540563262058,0.4694589877835951,0.9597310206690124,1.0,3/10,19.30%,MTMR3;MTMR1;DNAJC19
prerank,T cell receptor signaling pathway (GO:0050852),0.30686255234397214,1.0048208439576563,0.46551724137931033,0.9600272327412813,1.0,30/138,18.75%,TEC;ITK;CD3G;PDE4D;TXK;EIF2B3;PTPN22;PSME3;PTPRC;LCP2;PIK3R2;PTPRJ;PSMB5;LAT;TAB2;EIF2B4;CD276;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;NFKBIZ;PAK3;PSME4;PSMC4;PSMB6;PSMD12;PDPK1;PSMD14
prerank,endocytic recycling (GO:0032456),-0.27959366910663624,-1.0044215240343248,0.42971887550200805,0.8253131831299501,1.0,15/50,22.32%,VPS39;VPS35L;ENTR1;EPS15;RAB13;DENND1A;EIPR1;EHD4;MICALL1;STX6;RAB11FIP3;RAB11B;ANKRD27;RAB7A;ARL4C
prerank,negative regulation of inflammatory response (GO:0050728),0.2984940916596122,1.0039995815230642,0.45714285714285713,0.9614247465787482,1.0,19/182,9.00%,RORA;PLK2;CD3G;CDH5;CXCL17;MC5R;FNDC4;PTHLH;SRC;ADCY5;TNFAIP3;SELENOS;MAPK7;PTGER4;PRKAR2A;ISL1;ACOD1;TSHR;CD200R1
prerank,synaptic vesicle endocytosis (GO:0048488),0.37671512040446603,1.0039339592599759,0.45845697329376855,0.9607742946151706,1.0,13/33,22.12%,CEL;STX1A;OPHN1;DNM1;STON1;STON2;SNCG;PACSIN1;AMPH;VAMP2;ITSN1;NLGN3;NLGN2
prerank,regulation of immune response (GO:0050776),0.31088150747879956,1.003925790150753,0.4618937644341801,0.9599540586386942,1.0,22/135,16.49%,CXADR;HCST;CD3G;CD300LG;IL4I1;PTPN22;N4BP1;COL3A1;ITGB7;CRTAM;PLSCR1;CD200R1;COL1A1;LAIR1;CD276;CD81;ULBP1;SH2D1A;IL15;ZMPSTE24;LAG3;SYK
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.28814257809727356,1.00380620308135,0.4850976361767729,0.9594297943189426,1.0,80/327,21.50%,RORA;BNC2;NFATC2;PPARGC1A;ZNF423;EFEMP1;MYBBP1A;NFIA;CHD3;SPI1;KAT6B;SP3;BHLHE40;ONECUT1;TGFBRAP1;PPIE;HIC1;ZNF431;LIN54;RREB1;MSL3;ELAVL2;ZNF628;FOXK2;POFUT1;MLF2;ACTR8;RORB;SUPT4H1;TRRAP;TFEB;USP13;WWC1;SAP30L;MZF1;MED23;JMJD1C;SPIN1;CREBBP;NCOA2;SOX4;SFPQ;BAZ2A;FZD7;REXO4;TAF5;KMT2D;SRRT;DMTF1;PSPC1;E2F1;ESRRA;HP1BP3;MAGED1;MTF2;BACH1;CREM;CELSR2;FOXO4;ASCC2;SPTY2D1;FADS1;ASCC1;PPP2CA;TCF7L1;TCF3;HNRNPD;ZNF22;HCFC2;HMG20A;GZF1;DDIT3;RNF14;ARNT2;ATXN1L;ZSCAN21;DAXX;CCAR2;SRSF10;FOXC1
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.362421721085139,1.0036274996334893,0.4520166898470097,0.9590160811389115,1.0,14/42,20.17%,RARS2;TARS2;VARS1;CARS2;DARS1;KARS1;AIMP1;WARS1;WARS2;DARS2;TARS1;SARS2;HARS2;TARS3
prerank,"base-excision repair, AP site formation (GO:0006285)",0.4213717049603635,1.0035760036715817,0.45662847790507366,0.9583222574448037,1.0,2/17,4.81%,TDG;NTHL1
prerank,regulation of pseudopodium assembly (GO:0031272),0.46373062802814835,1.003505939803135,0.4652777777777778,0.9568511101556143,1.0,3/10,14.97%,CDC42EP4;APC;CDC42EP3
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.46373062802814835,1.003505939803135,0.4652777777777778,0.9568511101556143,1.0,3/10,14.97%,CDC42EP4;APC;CDC42EP3
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.43015919795576996,1.0029204785669201,0.45746388443017655,0.9575968181811217,1.0,2/16,1.84%,PLCB3;KLK2
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.3814973291885712,1.0027922897298163,0.4544159544159544,0.9571233225150859,1.0,1/29,0.24%,CAV1
prerank,regulation of axon regeneration (GO:0048679),0.45259183753426835,1.0024970927057955,0.4576271186440678,0.9570852383221642,1.0,4/12,10.72%,RTN4R;INPP5F;STK24;RTN4RL1
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.3526679283911335,-1.002440848362372,0.46194225721784776,0.8295321298257503,1.0,9/17,25.21%,PID1;NUPR1;CBFA2T3;PFKFB1;PDE12;PARP1;GIT1;TIGAR;FLCN
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.3824234818470889,-1.0024057084125255,0.43779904306220097,0.8285135747828338,1.0,2/13,1.37%,PLXNA2;PLXNA4
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3702519620625211,1.0021293980219779,0.45314685314685316,0.9572446610660563,1.0,13/38,20.40%,LEPROT;ABLIM3;RAC2;SIAH3;HTRA2;UBE2J2;UBE2D3;FBXW7;VPS11;CSNK2A2;PINK1;UBL5;PRKN
prerank,cellular response to osmotic stress (GO:0071470),0.41316285488960147,1.0016341471627872,0.44549763033175355,0.957714032795805,1.0,3/21,7.04%,LRRC8D;TRPV4;SLC4A11
prerank,intermediate filament organization (GO:0045109),-0.36238992972249207,-1.0016316211883403,0.48157894736842105,0.8294773487566638,1.0,5/17,14.51%,NEFL;BFSP2;GFAP;DES;VIM
prerank,regulation of cellular catabolic process (GO:0031329),-0.25634830572686995,-1.0008770796308424,0.43103448275862066,0.8305137226195908,1.0,16/62,14.67%,DAPK1;ITPR1;ACER2;NUPR1;EP300;DEPDC5;DRAM1;PIP4K2A;USP33;RRAGC;GPR137B;LRRK2;PIP4K2C;BOK;MAPT;RRAGD
prerank,regulation of gene expression (GO:0010468),0.2810067070816397,1.0008470130979281,0.4909819639278557,0.9589742441131843,1.0,112/903,11.78%,NGF;RORA;BNC2;AHNAK;FGF7;NTRK3;NFATC2;STC2;PPARGC1A;AFF3;ZNF423;FOXD1;CLDN19;EFEMP1;GLMN;MUSK;AHNAK2;MYBBP1A;FGF1;ADAM19;SLC26A9;CDH5;TDG;NFIA;COQ7;CLK1;SLC38A2;ITGAX;CHD3;SFMBT2;TXK;PCBP2;IL1A;SPI1;PRKAG1;WNT16;EIF2AK3;FLOT2;PTHLH;SOX9;CELF1;PGR;PTPN22;DIP2A;KAT6B;HDAC4;REL;ATP2B4;WNT5A;PTPRC;ATXN7L3B;CREB3L1;FN1;ZNF326;SON;SP3;BHLHE40;APLN;ONECUT1;TAPBP;ADAM10;TGFBRAP1;C1D;PPIE;EPHB2;KRAS;TRIM21;RIMS2;UBR5;RDX;CTCF;HIC1;ZNF431;CLK4;LIN54;RREB1;MSL3;IGF2BP2;ELAVL2;OCLN;ZNF628;GCNT2;FOXK2;NOS1AP;ZNF462;FGF18;AGO1;POFUT1;DDRGK1;MLF2;PLSCR1;MECP2;GSK3B;ACTR8;RORB;TICAM1;SUPT4H1;POU4F1;CNOT7;TRRAP;PTBP3;TFEB;USP13;SRPK2;WWC1;SAP30L;HDAC6;EGR1;MZF1;MED23;ZNF148;JMJD1C
prerank,negative regulation of protein binding (GO:0032091),0.33142390579536396,1.0007822850649761,0.45590062111801244,0.9583169418900344,1.0,5/71,5.27%,CAV1;EFHB;PTPRF;DACT1;STYX
prerank,carbohydrate catabolic process (GO:0016052),0.3602342447557547,1.0007251085612987,0.4643356643356643,0.9576444546914107,1.0,11/38,17.84%,HK2;NAGA;NEU1;ALDOB;PGM1;MANBA;ENO3;DERA;GCK;PGK1;ENO2
prerank,potassium ion homeostasis (GO:0055075),0.38709977004285623,1.0005000448644408,0.4485842026825633,0.9574552124665628,1.0,5/23,9.39%,SLC12A2;SLC12A4;SLC12A3;ATP1A2;ATP1B3
prerank,regulation of G0 to G1 transition (GO:0070316),-0.2920369502583485,-1.000449382249153,0.4429530201342282,0.8306585093578766,1.0,20/38,37.41%,PCGF2;PHC3;BMI1;RYBP;CDC7;SUZ12;EED;EHMT2;RAD51;L3MBTL2;BRCA1;RNF2;PCGF6;RING1;MAX;E2F6;CDKN2B;EHMT1;DAB2IP;PHC1
prerank,protein phosphorylation (GO:0006468),0.2831403518365897,1.0002667153930278,0.48335015136226034,0.9572915634189051,1.0,76/479,13.54%,PKDCC;TEC;PLK2;FAM20C;TRIB2;CDK15;FGFR1;HCST;PRKCE;CAMK2D;EFEMP1;EGFR;MUSK;MINK1;STK38;MAP3K1;TXK;MAPK10;PRKAG1;EIF2AK3;BMPR1B;PRKCA;CDKL3;PEAK1;SRC;MORC3;LIMK2;IRAK3;ACVR1C;PDK4;HIPK1;PIK3R4;BRSK1;NEK7;TLR7;FER;CDK13;BCKDK;COQ8A;ADAM10;EPHB2;ABL2;GMFB;CDK7;BMP2K;STK38L;RARA;MAP3K5;SRPK1;DYRK1A;NRBP2;CSNK1G3;CAD;STK24;STK3;GSK3B;RPS6KA3;MASTL;CSNK1A1;TYK2;RELN;SRPK2;ILF3;TOP1;HTATIP2;SGK1;LIPE;HUNK;MAP3K21;PKD1;USP15;PRKACB;SIK3;ERN1;GTF2H1;CIT
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.47639528138309284,1.000261499717549,0.4808362369337979,0.9564800303415053,1.0,1/10,0.24%,CAV1
prerank,regulation of response to external stimulus (GO:0032101),0.3140464307768755,1.0002411696530793,0.46867749419953597,0.9556902431254193,1.0,12/121,7.09%,CAV1;GUCA1A;ADAMTS12;PIK3AP1;CD55;CELF1;PTPN22;WNT5A;CNGB1;EPHB2;N4BP1;EFNB2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.32604162498395306,-1.0000800578753375,0.4322766570605187,0.8306214835453372,1.0,11/24,24.86%,NR1H3;NR1H2;AQP11;SYVN1;LRRK2;OPA1;RACK1;XBP1;CLU;TMBIM6;HSPA1A
prerank,cAMP biosynthetic process (GO:0006171),-0.4204320157577032,-0.9991599292157974,0.46206896551724136,0.8320475250810521,1.0,4/10,7.59%,ADCY1;ADCY7;ADCY4;ADCY2
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.3009380180563837,-0.9991331722476696,0.48253968253968255,0.8310157941010764,1.0,8/31,24.67%,PLCB1;PLCG2;LGALS9;LAPTM5;CD40;TLR3;CCL19;IRF5
prerank,cellular response to oxygen-containing compound (GO:1901701),0.2893938490869892,0.9990792703626042,0.4781704781704782,0.9579362719416243,1.0,52/291,16.37%,RORA;LBP;PXN;FOLR1;EGFR;RAPGEF3;RAP1A;SSTR1;TNIP3;GPLD1;IL1A;MPV17;SOX9;ATP2B4;WNT5A;PDK4;FER;TNFAIP3;NRIP1;ABL2;SELENOS;PAF1;BRINP1;DEFA6;ACOD1;TSHR;IRGM;CHMP5;HMGB1;RORB;TICAM1;POU4F1;AXL;EGR1;NCOA3;NFKBIB;WNT9A;AQP1;CAPN2;RRAGB;HTRA2;KCNK4;FZD7;LCOR;GPER1;CCR5;CCDC62;CPEB3;TICAM2;PLAA;TESC;EZR
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.21686528802457367,-0.9989213596545614,0.45,0.8305065142691284,1.0,30/170,13.88%,IGF1;ROCK2;PRDM6;FOXP1;ADNP2;SLC8A1;PRDM5;NOVA2;SIRPA;LDLR;HNRNPK;HIF1A;ZNF507;APOE;HINFP;PCBP1;ATP1B1;CDK6;TRIM14;PRDM2;ZC3H12A;PROX1;ANKRA2;BMI1;PCBP4;MEGF8;CDK4;AHR;CIAO3;CAVIN4
prerank,wound healing (GO:0042060),0.33149238285794147,0.998732897252915,0.4607190412782956,0.9580359154733941,1.0,8/62,7.04%,CLDN1;AHNAK2;FGF1;DCBLD2;NF1;WNT5A;COL3A1;RAB3A
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.4184229290625541,0.9987327037696355,0.4520766773162939,0.9555560986084931,1.0,8/20,18.05%,CDC20;TEX14;TPR;APC;BUB3;KLHL22;ZW10;MAD1L1
prerank,spindle assembly checkpoint signaling (GO:0071173),0.4184229290625541,0.9987327037696355,0.4520766773162939,0.9555560986084931,1.0,8/20,18.05%,CDC20;TEX14;TPR;APC;BUB3;KLHL22;ZW10;MAD1L1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.4184229290625541,0.9987327037696355,0.4520766773162939,0.9555560986084931,1.0,8/20,18.05%,CDC20;TEX14;TPR;APC;BUB3;KLHL22;ZW10;MAD1L1
prerank,protein import (GO:0017038),0.31945104000052643,0.9985604501350913,0.4609756097560976,0.9552187732248125,1.0,22/84,19.83%,PRICKLE1;RAB8B;IPO8;NUP62;FIS1;PEX2;FAM53B;PXMP2;TPR;MMP12;NUP50;CSE1L;ABCD1;NUP153;RAN;NUP93;SYK;HSPA4;SLC25A17;LAMP2;RPAIN;PEX13
prerank,regulation of hormone secretion (GO:0046883),-0.379818395482127,-0.9981067201206624,0.46973365617433416,0.8316958715507181,1.0,8/15,40.25%,ANXA1;EDN1;EDN3;SCG5;NMB;IL11;VAMP3;LIF
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.29549204907591725,-0.9980503833801772,0.43686006825938567,0.8307387002317125,1.0,6/36,7.20%,MECOM;FOXO1;SIRPA;DUSP10;DUSP3;IGBP1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3292259341662738,0.9976889405205143,0.47101449275362317,0.9566449303657019,1.0,12/76,12.80%,TRIB2;PRICKLE1;AXIN1;SOCS5;SH3RF2;KEAP1;DDRGK1;GSK3B;CSNK1A1;RCHY1;ZYG11B;PTEN
prerank,regulation of catecholamine secretion (GO:0050433),-0.31158839381963643,-0.9976768569023445,0.4472049689440994,0.8306884739183059,1.0,21/29,43.50%,KCNB1;SYT9;SYT7;DTNBP1;SYT13;SYT6;KCNA2;CHRNA4;SYT15;SYT1;SYT5;SYT17;CHRNB2;SNCA;SYT4;SYT3;DRD3;FGF20;HRH3;CHGA;SYT8
prerank,extracellular transport (GO:0006858),0.4466563920254457,0.9972066697671307,0.4743801652892562,0.9571249186883892,1.0,4/13,15.14%,TSG101;SPAG17;WWP2;CCDC40
prerank,mitotic cell cycle phase transition (GO:0044772),0.29684519820537886,0.997103870967543,0.4925053533190578,0.9565804508973035,1.0,45/204,17.29%,PLK2;DYNLL1;CCND3;FBXL15;WEE1;SFI1;BRSK1;CEP131;CEP78;SPAST;NEDD1;CCNG1;CDK7;PHLDA1;TUBG1;CKAP5;CUL3;PAFAH1B1;CCP110;CCNJ;ANAPC7;MASTL;EIF4E;CHMP4B;CENPJ;FBXL17;KDM8;NDE1;CEP290;SSNA1;CETN2;ENSA;CRLF3;LCMT1;PCM1;POLE;YWHAG;FBXL12;PPP1R12B;YWHAE;FBXL3;E2F1;CEP57;USP37;CUL4B
prerank,regulation of adaptive immune response (GO:0002819),-0.3433444041205922,-0.9970461081228946,0.44986449864498645,0.8313365988848296,1.0,9/18,28.07%,ADCY7;IRF1;EIF2AK4;SAMSN1;AHR;SKAP1;PYCARD;TRIM27;FCGR2B
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.33781234391757076,0.9969447720605492,0.4598155467720685,0.9561716185097345,1.0,15/63,19.71%,PLK2;GTSE1;CNOT10;ARID3A;FBXO31;SFN;CNOT7;RFWD3;SOX4;RGCC;TNKS1BP1;E2F1;CNOT8;CNOT1;BAX
prerank,postreplication repair (GO:0006301),0.3540478579198231,0.9965267879841958,0.47018030513176146,0.9564823452767744,1.0,6/45,7.44%,UBE2L6;USP43;POLI;RFC3;UBE2V2;MSH2
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.3234817028588244,-0.9964076012549069,0.47230320699708456,0.8320794533964432,1.0,12/25,31.32%,ETS1;HIF1A;TAL1;ABCB10;INHBA;NCKAP1L;HSPA1A;ACVR1B;FAM210B;STAT3;HSPA1B;ACVR2A
prerank,eosinophil migration (GO:0072677),-0.3736314558644033,-0.9958252181428214,0.4318766066838046,0.8315217339330009,1.0,11/14,51.71%,SCG2;CCL13;CCL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,eosinophil chemotaxis (GO:0048245),-0.3736314558644033,-0.9958252181428214,0.4318766066838046,0.8315217339330009,1.0,11/14,51.71%,SCG2;CCL13;CCL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,potassium ion transmembrane transport (GO:0071805),0.30617386642278394,0.9955886082334228,0.4840182648401826,0.9581807084661398,1.0,18/135,11.17%,KCNJ4;NALCN;SLC12A2;KCNA5;KCNJ16;SLC24A1;SLC12A4;KCNS2;SLC12A3;KCNK1;ATP1A2;KCNJ13;KCNK5;ATP1B3;KCNS3;KCNAB1;SLC9A7;SLC9A6
prerank,regulation of protein kinase B signaling (GO:0051896),0.2996947054219209,0.9952363089025407,0.4857456140350877,0.9583049477190848,1.0,21/193,10.07%,GAB1;FGF7;NTRK3;FGFR1;PIK3AP1;EGFR;FGF1;PHLDA3;TPTE;SRC;RAC2;BANK1;DAG1;PHLPP1;PIK3R2;PTPRJ;GCNT2;FGF18;GAB2;AXL;FERMT2
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.4101211788876707,0.9950054659626202,0.45652173913043476,0.9580519808257498,1.0,8/18,20.68%,SPI1;SRC;FER;IL6ST;YAP1;JAK1;ST18;IL6
prerank,icosanoid biosynthetic process (GO:0046456),0.46980341116422525,0.9948198275029166,0.4840989399293286,0.9577600930466118,1.0,4/10,22.80%,MGST2;LTA4H;FADS1;PLA2G4A
prerank,endodermal cell differentiation (GO:0035987),0.3816631064452075,0.9946922305981221,0.4599447513812155,0.9572841407578911,1.0,9/31,17.35%,MMP15;ITGA7;LEO1;FN1;PAF1;MMP14;ITGA5;RTF1;SETD2
prerank,aromatic amino acid family catabolic process (GO:0009074),0.4285214517751701,0.9945646605467598,0.4542483660130719,0.9568081996034703,1.0,3/15,10.43%,IL4I1;AADAT;GSTZ1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.2861019839113783,-0.994503767371359,0.44932432432432434,0.834126388591689,1.0,8/40,12.75%,SMAD3;LEF1;DAB2;TGFBR1;GLIPR2;TGFB3;BMP2;TGFB2
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.3924793700767332,-0.9944555867810236,0.48402948402948404,0.8331748058619399,1.0,4/13,8.19%,IGF1;INSR;IGF2;AKT1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.335921418454783,-0.9942535282493266,0.4497354497354497,0.8326104042191975,1.0,8/21,16.18%,SLC8A3;TGM2;RAP1GDS1;SMDT1;SLC25A23;MICU1;MICU2;ANXA6
prerank,protein palmitoylation (GO:0018345),0.37558349634202687,0.9940475898824435,0.44144144144144143,0.9573264104193948,1.0,13/30,22.51%,ZDHHC1;ZDHHC7;ZDHHC23;ZDHHC13;ZDHHC20;GLUL;ZDHHC8;ZDHHC19;GOLGA7B;ZDHHC3;ZDHHC12;GOLGA7;ZDHHC5
prerank,transferrin transport (GO:0033572),-0.3033009876777534,-0.9936168239251123,0.47019867549668876,0.833279537254705,1.0,11/33,22.13%,STEAP3;TFRC;ATP6V0A4;ARHGAP1;ATP6V0C;ATP6V1C1;HFE;ATP6V1D;RAB11B;ATP6V1F;ATP6V1E1
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.36146005246821067,-0.9932872452525277,0.4621212121212121,0.8331045711867733,1.0,4/17,8.02%,BMP4;WNT4;LARP6;TGFB3
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.39573676246982636,-0.9932449480129337,0.4858490566037736,0.8321445934770372,1.0,4/12,8.19%,IGF1;INSR;IGF2;AKT1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.2498020842029161,-0.993056420528578,0.4444444444444444,0.831531682139004,1.0,19/69,19.49%,POU2F1;INTS9;CCNT2;CDK9;RPRD2;PHAX;CCNT1;SNAPC1;ZC3H8;SP1;INTS1;NCBP1;POLR2F;POLR2A;POLR2J;SNAPC5;POLR2D;POLR2K;TAF6
prerank,negative regulation of immune response (GO:0050777),0.3011764630685775,0.993042333673475,0.4764638346727899,0.9592260242184991,1.0,18/154,9.32%,PLK2;CD3G;MC5R;PCBP2;SPI1;PTHLH;SRC;IRAK3;ADCY5;FER;TNFAIP3;TRIM21;COL3A1;PTGER4;PRKAR2A;ACOD1;TSHR;TRAFD1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.4250173979964289,0.9928174105844418,0.4551282051282051,0.9590119519655719,1.0,3/16,6.73%,ATIC;PFAS;PPAT
prerank,mitochondrion organization (GO:0007005),0.30221917665376075,0.9928005953101102,0.48337028824833705,0.9582389194795166,1.0,38/165,20.70%,CXADR;PPARGC1A;PISD;HK2;RAB29;WDR81;CAV2;MPV17;TOMM34;MFN2;DNM1;FIS1;ATPAF1;SIRT3;NRF1;MIEF1;IMMP2L;TFB2M;LONP1;MTX1;NIPSNAP2;TOMM40;DNAJA3;POLG2;BCS1L;AIFM2;BNIP3;ESRRA;MIGA1;TMEM70;PINK1;GABPA;DNAJC19;BAX;CHCHD3;PRKN;MUL1;ATP5F1D
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.31016589755023094,0.9927813412375028,0.4766248574686431,0.9574703950973897,1.0,9/122,3.28%,SMOC2;GLI1;SORBS1;EGFR;BCL3;HSPH1;FXR2;GLI2;PIWIL2
prerank,negative regulation of protein depolymerization (GO:1901880),-0.32973768675391707,-0.9927363335812751,0.43699731903485256,0.831325987654871,1.0,6/24,14.68%,PLEKHH2;ARHGEF2;STMN2;CAMSAP1;APC2;MID1IP1
prerank,microtubule anchoring (GO:0034453),0.4426849954686133,0.9926885126613065,0.4886164623467601,0.9569049890038882,1.0,3/12,13.86%,DAG1;GCC2;PCM1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.31648676050606406,0.9926829172308284,0.4770857814336075,0.9561086157757364,1.0,24/101,16.37%,VGLL4;CYFIP2;BCL3;OGT;FXR2;PIWIL2;DACT1;RDX;PERP;HDAC2;IST1;METTL5;PLD1;UPF3B;FAF1;NSUN5;ATG7;SOX4;FXR1;PYM1;BAD;CPEB3;ERBB2;EZR
prerank,negative regulation of biosynthetic process (GO:0009890),0.42460545040145714,0.9923933367914236,0.47419354838709676,0.9560708978564997,1.0,6/16,20.68%,CEACAM1;ABCD1;ABCB7;GPER1;COA8;IL6
prerank,cellular response to BMP stimulus (GO:0071773),0.3316916499091824,0.9922299748255236,0.46062992125984253,0.9556974798119711,1.0,9/66,5.66%,DLX1;ADAMTS12;RUNX2;SOX9;BMPR1B;BMP5;BMP15;ZFYVE16;RGMB
prerank,ganglioside metabolic process (GO:0001573),-0.3427936613953865,-0.9921483702417392,0.4648648648648649,0.8318827634325722,1.0,8/20,22.45%,ST3GAL5;ST8SIA4;ST6GALNAC3;ABCA2;ST8SIA2;NEU3;ST6GALNAC4;CLN6
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.36328748073064676,-0.991656146992185,0.4634146341463415,0.8321269983404851,1.0,7/16,22.54%,SOX5;HOXB4;SOX6;TGFB2;DHX36;PTN;SP7
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.288956909427361,-0.9915578469778871,0.4631578947368421,0.8313232787025812,1.0,10/36,19.71%,MAP3K20;USP28;ATRIP;HINFP;CLSPN;RAD1;TIPIN;RAD17;RAD9B;TIMELESS
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.31935850339801997,0.9915013070452345,0.48602673147023084,0.9568049389131806,1.0,9/86,5.38%,INHBB;SULF1;ZNF423;FOXD1;FBXL15;CDH5;BMPR1B;BMP5;BMP15
prerank,mRNA splice site selection (GO:0006376),0.3813550196962597,0.9912798158259603,0.46865671641791046,0.9565927752310696,1.0,11/30,24.13%,CELF1;CELF2;CELF4;LUC7L2;SFSWAP;SF1;SLU7;SRSF12;SRSF10;YTHDC1;PUF60
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.44788446391013337,0.9912360725868965,0.4904679376083189,0.9559063784743694,1.0,1/12,0.98%,IL18R1
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.36662547593456596,-0.9909986848296022,0.4491725768321513,0.8318385668196149,1.0,3/16,2.25%,ST3GAL5;ST8SIA4;ST6GALNAC3
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.3048929189564387,-0.9908177905400669,0.48742138364779874,0.8312249758654577,1.0,16/32,37.23%,TRPC1;AKAP6;CALM1;CALM3;JPH2;P2RY6;GSTO1;APLNR;NPSR1;F2R;CASQ1;CXCL10;CAPN3;THY1;SNCA;TRDN
prerank,negative regulation of neurogenesis (GO:0050768),0.36915394542318497,0.9907533809621777,0.47413793103448276,0.9563812437176993,1.0,8/34,14.25%,LRP4;NF1;RTN4R;GDI1;HOOK3;PTEN;PCM1;RTN4
prerank,regulation of epithelial cell migration (GO:0010632),0.3483184932242356,0.990568655424027,0.4525065963060686,0.9560455848248294,1.0,8/51,7.31%,DOCK5;PRKCE;CEACAM1;DOCK1;SOX9;SRC;RHOJ;RREB1
prerank,negative regulation of DNA recombination (GO:0045910),-0.2872659333940488,-0.9905302685334343,0.4791666666666667,0.8309471626430679,1.0,19/43,26.74%,SHLD2;BLM;H1-0;POLQ;UBQLN4;ZRANB3;POLR2F;POLR2A;POLR2J;POLR2D;POLR2K;CGAS;MAD2L2;ACD;RMI2;SMCHD1;PARPBP;POLR2I;PARP3
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.41819472318872697,0.9903857008690811,0.44929797191887677,0.9557152417124467,1.0,1/18,0.54%,INHBB
prerank,regulation of protein metabolic process (GO:0051246),-0.2749654896782083,-0.9902458969295411,0.45849802371541504,0.8306657110404447,1.0,11/44,12.03%,ROCK2;FKBP1A;LDLR;ACE;SPOP;KLF4;APOE;NEDD8;KLF2;FURIN;TMEM9
prerank,cell cycle G2/M phase transition (GO:0044839),0.3069607739160851,0.9901791953372103,0.4891922639362912,0.9554511046574563,1.0,41/130,22.50%,DYNLL1;FBXL15;WEE1;SFI1;BRSK1;CEP131;CEP78;NEDD1;CDK7;PHLDA1;TUBG1;CKAP5;PAFAH1B1;CCP110;MASTL;CENPJ;FBXL17;KDM8;NDE1;CEP290;SSNA1;CETN2;ENSA;LCMT1;PCM1;YWHAG;FBXL12;PPP1R12B;YWHAE;FBXL3;CEP57;OFD1;CEP250;DCTN2;ALMS1;TAF2;HAUS8;CEP43;FBXW11;BORA;HAUS3
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.32612533091117835,-0.9899398487536275,0.4670487106017192,0.8304980277517635,1.0,5/23,5.61%,ENG;SMAD3;TGFBR3;LATS2;ITGA3
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.3273244054563396,0.9897949452369769,0.48717948717948717,0.9556260240648352,1.0,25/73,21.62%,LMO1;KMT2A;SPI1;PSME3;PUS7;PSMB5;PSMB2;CBFB;PSMA2;PSMA6;PDCD2;KITLG;PSMD13;PSMA7;YAP1;ITCH;PSME4;PSMC4;PSMB6;PSMD12;PSMD14;TCF3;RUNX1;FOXC1;PSMB3
prerank,connective tissue development (GO:0061448),0.36469393059670546,0.989783192773057,0.4539969834087481,0.9548554659160052,1.0,7/35,13.69%,SULF1;SLC39A13;SOX9;SH3PXD2B;DDRGK1;PKD1;TRIP11
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.32974214435871,0.9895816792785388,0.4701397712833545,0.9545674704282214,1.0,9/70,8.12%,WIPF1;PRKCE;CYFIP2;DOCK1;CD3G;VAV2;SRC;PIK3R2;MYH2
prerank,mitotic cytokinetic process (GO:1902410),0.40664905628318987,0.9895724474899322,0.4805194805194805,0.9537967301391714,1.0,6/20,11.97%,CHMP5;PDCD6IP;CNTROB;CHMP4A;CHMP4B;CHMP4C
prerank,positive regulation of cellular component movement (GO:0051272),-0.3284334224976558,-0.9895653754983128,0.4450402144772118,0.8304016991255369,1.0,5/24,7.20%,ETS1;SPOCK2;LYN;TGFBR1;RPS19
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.36181792271248125,0.9891955469909616,0.4889543446244477,0.9539448830834358,1.0,14/37,23.97%,RNASEH2B;PABPC4;SIDT2;DFFB;NUDT18;ENTPD2;RNASE3;MTREX;HNRNPD;NUDT5;EXOSC7;NUDT1;RNASEH1;DNASE1L1
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.3140998822000267,-0.9891851811262803,0.47230320699708456,0.8304241547294071,1.0,8/26,13.97%,NPR3;ATP7A;HIF1A;APOE;GCH1;AKT1;S100A1;DHFR
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.3315579900830461,-0.9891348676211383,0.45257452574525747,0.829503800344664,1.0,5/21,10.31%,PRKCH;FOXP1;SLC39A10;BCL10;RPS3
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.36859167884342164,-0.9890323105012019,0.46446700507614214,0.8287357552124677,1.0,4/16,8.02%,BMP4;WNT4;LARP6;TGFB3
prerank,alpha-amino acid metabolic process (GO:1901605),0.35190300741098574,0.9889212758115888,0.4675862068965517,0.9539031256445556,1.0,10/45,13.53%,ASS1;NAALAD2;SLC25A12;AADAT;MTHFD1;DDAH2;ALDH18A1;SLC25A13;GOT1;GLUL
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.404023103314627,0.9887715081264395,0.4796380090497738,0.9526656826766189,1.0,11/23,24.31%,PPP1R13B;SFN;BAD;NMT1;YWHAG;YWHAE;E2F1;MAPK8;TFDP1;YWHAB;YWHAQ
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.404023103314627,0.9887715081264395,0.4796380090497738,0.9526656826766189,1.0,11/23,24.31%,PPP1R13B;SFN;BAD;NMT1;YWHAG;YWHAE;E2F1;MAPK8;TFDP1;YWHAB;YWHAQ
prerank,negative regulation of cellular protein localization (GO:1903828),0.3619999645582248,0.9886208745166205,0.4676056338028169,0.9522530070444394,1.0,4/34,3.65%,NEDD4L;RIPOR2;LEPROT;SPI1
prerank,receptor metabolic process (GO:0043112),0.3467266495945368,0.9885260942740426,0.478494623655914,0.951710034567776,1.0,7/53,5.29%,CAV1;ACKR3;PHETA2;CD9;DNM1;KIF16B;PIK3R4
prerank,organelle organization (GO:0006996),0.2811851562594812,0.9882470096542311,0.516359918200409,0.9516279973750226,1.0,78/388,17.17%,CAV1;CXADR;FMNL2;PPARGC1A;ATP8B3;PLCE1;ATP8B1;CAPZB;RAB29;PI4K2B;WDR81;CAV2;LMAN2;EIF2AK3;CNTNAP1;RAB30;ZFYVE16;TMEM135;TNFAIP3;CEP78;SIRT3;PACSIN2;NRF1;PEX2;ATL2;RANBP10;GOLGB1;MICAL3;ARMC2;CHMP5;PDCD6IP;ATP8B2;NPLOC4;ZMYM6;LYSMD3;TMED4;CSNK1A1;DIAPH3;HILPDA;TFB2M;LNPK;CHMP4A;CHMP4B;ANK1;LONP1;CHMP4C;DPYSL2;MTX1;FAM161B;NIPSNAP2;ABCD1;TRIP11;HTT;DNAJA3;IQCG;POLG2;FAM161A;RAB34;SPRYD3;SIPA1;ZW10;FBXW8;BCS1L;TMED2;SEC23IP;TICAM2;PI4K2A;ATP8B4;CFAP61;CFAP410;TBC1D20;MDK;ARHGEF7;BRWD1;GEM;ESRRA;DYNC2H1;STX4
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.4658373331644907,0.9882052409148031,0.47217235188509876,0.9509329758220137,1.0,2/10,6.14%,WNT5A;ADAM10
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.45031035161441185,0.9881428088408114,0.4662045060658579,0.9502993565599497,1.0,3/11,13.44%,JAG1;ISL1;SOX4
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.35509401622862563,-0.988026040607614,0.4583333333333333,0.8303716542884445,1.0,8/18,24.86%,HIP1R;ACAA2;BID;GSK3A;BOK;CHCHD10;ZNF205;HSPA1A
prerank,positive regulation of potassium ion transport (GO:0043268),-0.2890796606827557,-0.987965819628582,0.4558303886925795,0.8294879672473107,1.0,9/38,10.42%,ANK2;ACTN2;KCNJ6;KCNMA1;KCNJ2;AKAP6;KCNJ10;FLNA;KCNN2
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.24641835460908132,-0.9878986411730231,0.45408163265306123,0.8286295135345955,1.0,27/72,27.84%,UVSSA;EP300;RBX1;MNAT1;ERCC2;XPA;POLK;ISY1;LIG3;COPS6;CCNH;POLR2F;RFC2;POLR2A;POLR2J;GTF2H4;POLR2D;POLR2K;GPS1;ERCC4;ERCC5;POLD2;POLR2I;RFC4;UBB;GTF2H5;DDB1
prerank,sulfur compound transport (GO:0072348),0.3832315494137669,0.9877944897896657,0.46060606060606063,0.9503867723619304,1.0,5/27,5.54%,LRRC8D;RACGAP1;SLC35B2;SLC27A1;SLC6A13
prerank,regulation of protein dephosphorylation (GO:0035304),0.36379380673200745,0.987624571070242,0.4818435754189944,0.9500608478056117,1.0,14/37,24.11%,DLC1;CDH5;ENSA;PTPA;HTT;PPP6R3;SYMPK;PIN1;PPP6R1;CALM2;CDCA2;YWHAB;PPP6R2;PRKCD
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.32750753316184117,0.9876193033177092,0.47361809045226133,0.9492851526649725,1.0,9/71,8.12%,WIPF1;PRKCE;CYFIP2;DOCK1;CD3G;VAV2;SRC;PIK3R2;MYH2
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.32428686512965393,-0.9872786403184001,0.46419098143236076,0.8292522560445109,1.0,7/24,11.66%,DACH1;ACVRL1;BMPR2;BLM;SUB1;RPS3;H1-0
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.3458169084073674,0.9872044787870652,0.48667601683029454,0.9495798371788974,1.0,4/46,5.86%,APOD;CDH13;MFN2;TNFAIP3
prerank,axon guidance (GO:0007411),0.2915864049073427,0.9871576267319777,0.5140388768898488,0.9488899760321248,1.0,25/201,7.45%,GAB1;EFNA5;LAMA2;NTN1;EFNB1;NRP2;SEMA4B;GLI2;OPHN1;PRKCA;SRC;DSCAM;RAC2;PLXNA3;WNT5A;NTN5;ARTN;LAMA5;EPHB2;DAG1;EFNB2;SEMA3A;NTN3;SIAH1;MAPK7
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.3388386475009433,-0.9870659363626301,0.4540682414698163,0.8287988772627194,1.0,10/20,27.93%,ENTPD1;TXNIP;IL18;P2RX7;P2RX4;ENTPD5;C3;SUGT1;PYCARD;CASP1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.34957806436023964,-0.9870391402215122,0.48157894736842105,0.8278186470438204,1.0,1/19,0.12%,IGF1
prerank,plasma membrane tubulation (GO:0097320),0.44502604681865987,0.9865317559358421,0.48771929824561405,0.9497185478575485,1.0,6/13,19.97%,PACSIN2;EHD2;CHMP4A;CAVIN2;PACSIN3;PACSIN1
prerank,positive regulation of reproductive process (GO:2000243),0.3742630259402053,0.9863998785297285,0.4704184704184704,0.9492716265903622,1.0,3/31,6.63%,INHBB;CACNA1H;LHFPL2
prerank,lymphocyte chemotaxis (GO:0048247),0.37002429244784757,0.9861458338267112,0.47889374090247455,0.9491215612068047,1.0,2/34,2.15%,SLC12A2;CYP7B1
prerank,response to acidic pH (GO:0010447),-0.385228023046567,-0.9860252967693859,0.49534883720930234,0.829640482135613,1.0,6/13,25.96%,SLC9A1;GPR4;LGMN;RAB11B;PKD2L1;PKD1L3
prerank,signal release from synapse (GO:0099643),-0.27617397882181594,-0.9854469440052528,0.48031496062992124,0.8301417550494984,1.0,20/43,29.32%,STXBP3;LIN7A;HSPA8;SYN1;GAD1;NRXN1;SYN3;NRXN2;DNAJC5;CPLX2;UNC13A;SYN2;RIMS1;SNAP25;SLC32A1;PPFIA3;PIP5K1C;PTPRN2;GRM4;SYT1
prerank,regulation of cell division (GO:0051302),0.3260060166506201,0.9852862779525,0.4691823899371069,0.9505411806432722,1.0,13/72,12.39%,PLK2;FGF1;MLLT3;PIK3R4;CSPP1;KIF13A;CCP110;SFN;KLHL21;ZFYVE26;NCOA3;CETN2;AHCTF1
prerank,adrenergic receptor signaling pathway (GO:0071875),0.4010378675516228,0.9852415255170567,0.4717868338557994,0.9498626867345273,1.0,5/20,11.98%,PDE4D;AKAP13;GPR101;ADRA2A;ADCY9
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.24614669367153694,-0.9851617705145806,0.4772727272727273,0.8297850511335909,1.0,19/93,13.76%,PLCB1;SASH1;TNFRSF19;CCN2;MFHAS1;SH3RF3;XDH;PDCD10;ANKRD6;TRAF6;ARL6IP5;MAP3K10;ZC3H12A;BMP2;TAOK2;FLT4;TGFB2;SPHK1;PJA2
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.3394047313117989,-0.9850478237474245,0.4742547425474255,0.8290605165867768,1.0,6/19,12.23%,ENPP1;BPNT2;PAPSS1;SLC26A2;TPST1;SLC35B3
prerank,actin filament polymerization (GO:0030041),0.369178631826281,0.9849754360498566,0.47155688622754494,0.9497311117948142,1.0,4/29,9.92%,COBL;GAS7;WASHC3;DIAPH3
prerank,cellular response to hormone stimulus (GO:0032870),0.3269151156464102,0.9849556813244867,0.4815756035578145,0.9489994062924316,1.0,16/69,18.49%,CAV1;SRC;CACNA1H;ATP1A2;RDX;RARA;ADRA2A;NCOA3;NCOA2;GCK;BRD8;GPER1;CTSB;SFR1;SOCS2;LHCGR
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.2726010575425689,-0.9849554096139133,0.47058823529411764,0.8282510748042426,1.0,21/51,25.08%,SMAD6;SKIL;SMAD9;BMPR2;SMAD5;CRIM1;GREM2;LEMD3;HTRA3;BMP2;DAND5;CHRDL1;BMPER;SMAD4;VWC2L;SMURF2;FSTL3;BAMBI;SMAD1;GREM1;NOTCH1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.30529495353028785,-0.9849164594735663,0.4462025316455696,0.8262794700806307,1.0,9/29,19.95%,GPAT4;ACOT7;DBI;ACSL6;MLYCD;ACLY;ACOT6;ACOT11;OXSM
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.30529495353028785,-0.9849164594735663,0.4462025316455696,0.8262794700806307,1.0,9/29,19.95%,GPAT4;ACOT7;DBI;ACSL6;MLYCD;ACLY;ACOT6;ACOT11;OXSM
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.29621702982129516,0.9848761516806431,0.4967105263157895,0.9484484760541866,1.0,36/172,16.38%,DGKA;PTPN13;PISD;DDHD1;PI4K2B;GPAT3;ACP6;DGKZ;PCTP;SLC27A1;PIP4K2B;AGPAT4;PIK3R4;PLEKHA4;MTMR7;PIK3R2;MTMR6;OCRL;INPP5F;MTMR3;PLSCR1;LCLAT1;ETNK2;PLD1;AGPAT5;CDS2;PTEN;PLEKHA1;PIK3C3;MTMR12;GPD1;STARD10;PI4K2A;MTMR1;PITPNM2;HDHD5
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.30054722935306366,-0.9846952795543709,0.4735099337748344,0.8247945285081428,1.0,14/31,27.73%,MNAT1;ERCC2;RAMAC;NCBP1;CCNH;POLR2F;POLR2A;POLR2J;GTF2H4;POLR2D;POLR2K;POLR2I;CMTR2;GTF2H5
prerank,7-methylguanosine RNA capping (GO:0009452),-0.30054722935306366,-0.9846952795543709,0.4735099337748344,0.8247945285081428,1.0,14/31,27.73%,MNAT1;ERCC2;RAMAC;NCBP1;CCNH;POLR2F;POLR2A;POLR2J;GTF2H4;POLR2D;POLR2K;POLR2I;CMTR2;GTF2H5
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.30000009207845507,-0.9846806556582123,0.48986486486486486,0.8238033404760049,1.0,13/33,26.38%,ETS1;HOXA5;HIF1A;TAL1;FES;RAB7B;ABCB10;INHBA;NCKAP1L;HSPA1A;ACVR1B;FAM210B;STAT3
prerank,proton transmembrane transport (GO:1902600),0.36471525054712045,0.9846702696244609,0.473604826546003,0.9481737717365057,1.0,5/36,10.01%,OTOP1;ATP1A2;SLC4A11;COX15;NNT
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.4005599219979325,0.9844968215917114,0.4831288343558282,0.9478091102584348,1.0,1/20,0.23%,PKDCC
prerank,DNA conformation change (GO:0071103),0.4182363901135015,0.9844014932789064,0.47471451876019577,0.947269011119023,1.0,5/17,14.96%,HAT1;TOP3B;HMGB1;TOP1;NAA10
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3170876406293737,0.9840922419881855,0.47911547911547914,0.9472929650659482,1.0,8/87,6.48%,EFNA5;DLC1;F11R;ARHGAP18;RAPGEF3;RAC2;ARHGEF5;ABL2
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.27757070988316074,0.9840503456106383,0.5463709677419355,0.9466069487490906,1.0,67/497,11.93%,MDFIC;VGLL4;PRICKLE1;PAX9;NR2F2;TSHZ3;PHC2;FOXP2;ZNF423;FOXD1;ATP8B1;MYBBP1A;BCL3;RUNX2;FXR2;RBFOX2;SFMBT2;GIGYF2;CIART;SPI1;L3MBTL3;FOXK1;EIF2AK3;SOX9;CNOT10;UBE2I;GLIS2;CHD8;CDAN1;KAT6B;HDAC4;LANCL2;KLF10;SAMD4B;WNT5A;CREB3L1;RBM15B;HEYL;SP3;BHLHE40;PUS7;RCOR3;SELENOS;CTCF;NCOR1;TBX2;RARA;SUV39H1;KCTD1;IGF2BP2;FOXK2;UIMC1;TSC22D4;MECP2;GSK3B;RORB;USP47;HDAC2;CNOT7;ZHX1;NCOR2;ILF3;HDAC6;HEXIM1;ZNF148;MEN1;KDM8
prerank,regulation of T cell differentiation (GO:0045580),0.3644776192010582,0.9836052569915907,0.4670571010248902,0.946966440842214,1.0,5/33,16.87%,NFATC2;CRTAM;IL7;CBFB;MDK
prerank,regulation of ion transport (GO:0043269),0.32160160026275886,0.9835701073225738,0.49137931034482757,0.946278738534872,1.0,5/76,2.41%,NEDD4L;KCNJ4;SCN10A;KCNA5;KCNJ16
prerank,modified amino acid transport (GO:0072337),0.4214776807873066,0.9832765302535185,0.4772727272727273,0.9462626716318856,1.0,3/15,5.54%,FOLR1;FOLR2;SLC6A13
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.4031328138685074,-0.9830811731843957,0.5034965034965035,0.8271413746163018,1.0,7/11,43.23%,GRK3;ADM;ARRB2;DRD3;ADRB3;ARR3;SAG
prerank,regulation of viral life cycle (GO:1903900),0.4001455229590994,0.9829822211800305,0.4737654320987654,0.9462381796915617,1.0,6/21,15.71%,TSG101;KPNA2;TRIM21;AXL;HS3ST5;TRIM5
prerank,regulation of defense response (GO:0031347),-0.25231897077948706,-0.9825407202701543,0.4717948717948718,0.8275831280383925,1.0,21/76,17.72%,IL1R1;FOXP1;SEMA7A;APPL2;SAMHD1;LACC1;AREL1;AGTR1;APOE;LRP8;JAK2;ANXA1;USP18;IRF1;CASP12;TMSB4X;ERAP1;ACE2;CASP8;CASP4;SBNO2
prerank,regulation of interleukin-6 production (GO:0032675),0.312957453487112,0.982452452949623,0.49878934624697335,0.9468317060382996,1.0,13/96,9.48%,LBP;IL1A;PTPN22;IRAK3;WNT5A;IL17RA;TLR7;TNFAIP3;SELENOS;ISL1;CD200R1;FOXJ1;HMGB1
prerank,phospholipid transport (GO:0015914),0.33541849474122826,0.9818904881390204,0.48598130841121495,0.9475009673348015,1.0,11/52,9.87%,ATP8B3;ATP8B1;PITPNC1;PCTP;ABCC1;ATP9B;ATP11C;ATP9A;ATP8B2;ABCA1;ATP10B
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.3458843530564103,-0.981864477461459,0.4789473684210526,0.8283475441709687,1.0,6/18,11.85%,ADCY1;RPS6KA5;CRTC3;LRP8;CD200;CRTC2
prerank,response to hydroxyurea (GO:0072710),-0.40968439853705885,-0.9815761648860675,0.4987714987714988,0.8280457712151577,1.0,4/11,19.71%,BLM;DDI2;NSMCE3;TIMELESS
prerank,regulation of cell population proliferation (GO:0042127),0.27700191696183135,0.9813896673725262,0.5545545545545546,0.948015851663955,1.0,91/691,12.87%,NGF;ROR2;ZBTB7C;FGF7;IGFBP6;DLC1;NTRK3;CDH13;GLI1;FGFR1;CLDN19;PTGFR;GLMN;FOLR2;EGFR;ADAMTS1;FGF1;JAG1;SSTR1;ACER3;KIF20B;GPLD1;RBFOX2;GNRH1;ITGAX;IL1A;PTPN14;PTHLH;SAPCD2;SOX9;TPTE;CELF1;HDAC4;BMP5;KLF10;NUP62;FN1;EGLN3;PDS5B;KANK2;RPRD1B;FER;CDK13;CEP131;ADAM10;NCK2;KRAS;CTCF;EFNB2;HOXC10;TBX2;CHERP;RARA;FBXO5;CUL3;DIS3L2;DPP4;S100B;RBM5;PTPRJ;GCNT2;FGF18;TSHR;DDRGK1;TET1;MECP2;GAB2;HDAC2;TRNP1;CNOT7;DLG3;PBRM1;HILPDA;ADRA2A;TBC1D8;STRN;AXIN2;SRPK2;RARG;APC;IL6ST;PRLR;ZBTB49;MEN1;SGK1;STAT2;CD81;NF2;WNT9A;PTEN;CDC6
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.4008937980883169,-0.9812885597049515,0.4801864801864802,0.8277531748990526,1.0,2/11,1.71%,MSN;DAB2
prerank,protein hydroxylation (GO:0018126),-0.3607466345298531,-0.9812292744039107,0.4745308310991957,0.8268863123908037,1.0,6/15,16.79%,PLOD2;PLOD1;P3H2;JMJD4;P3H3;P3H4
prerank,negative regulation of macroautophagy (GO:0016242),-0.3225617942550904,-0.9808333642289613,0.47368421052631576,0.8268620129909515,1.0,9/26,16.41%,NUPR1;AKT1;QSOX1;RUBCN;LRRK2;USP36;UBQLN4;FEZ2;SCFD1
prerank,positive regulation of cell cycle process (GO:0090068),-0.24206628747457154,-0.9807041832655098,0.5340314136125655,0.8261816689003488,1.0,9/91,3.96%,IGF1;INSR;TGFA;PDGFRB;SVIL;MAP3K20;CDC42;IGF2;USP19
prerank,cortical cytoskeleton organization (GO:0030865),0.35104651546859433,0.980546633820246,0.48945147679324896,0.9493347480039576,1.0,12/41,18.51%,FMNL2;EPB41L3;TRPV4;RAC2;ARF6;PLEK;FHOD1;RND2;PPP2R3C;EZR;LCP1;RHOA
prerank,sodium ion export across plasma membrane (GO:0036376),0.42761672754938285,0.9804717157707782,0.49125874125874125,0.9487469809019387,1.0,3/13,9.39%,ATP1A2;SLC4A4;ATP1B3
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.3410661600685425,0.9803678138202786,0.4771838331160365,0.948241213281419,1.0,10/57,9.48%,USP50;CYFIP2;CIDEB;FIS1;ACVR1C;UACA;NLRC4;PERP;MAP3K5;HMGB1
prerank,protein prenylation (GO:0018342),0.4629323476828803,0.9799079017180891,0.47217235188509876,0.9486766628825172,1.0,4/10,18.12%,FNTA;CHM;FNTB;PTAR1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.43748447455997885,0.9797248186325944,0.4812286689419795,0.9483458085728971,1.0,2/12,1.97%,DOCK5;ADAMTS1
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.4095252577953618,-0.9797204525026215,0.5055432372505543,0.8277273708648457,1.0,4/10,14.20%,MTHFS;MTHFR;DHFR;MTHFD1L
prerank,establishment of spindle localization (GO:0051293),-0.36867373801440956,-0.9796294348172547,0.47680412371134023,0.8269387922263043,1.0,6/14,31.25%,CFL1;ZBED3;LLGL2;NUSAP1;TLE6;DYNC1H1
prerank,mitochondrion transport along microtubule (GO:0047497),-0.38393655584631087,-0.9794999619475784,0.4722222222222222,0.8262343947567443,1.0,7/13,26.99%,NEFL;HIF1A;MAPT;OPA1;RHOT1;LRPPRC;UBB
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.3972646136447483,-0.9788251417955596,0.4976635514018692,0.8270045108050575,1.0,4/11,13.19%,SEMA6A;SYNJ2BP;KLF2;THBS1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.33160617020551736,-0.9785415779439891,0.46153846153846156,0.8267689168368744,1.0,11/24,26.99%,TRAF6;UBE2N;NOD1;AAMP;CASP8;IRAK2;MAP2K6;IKBKG;NOD2;RNF34;UBB
prerank,regulation of protein localization to nucleus (GO:1900180),0.3511302857272779,0.9784041609927376,0.5046854082998661,0.9509472563039923,1.0,11/43,15.72%,GTSE1;EIF2AK3;LIMK2;CARD10;GSK3B;FERMT2;TPR;OTUD7B;GLUL;CTNNA1;YAP1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.32245630246139195,0.9782263019266974,0.48930817610062893,0.9506493890879113,1.0,9/73,8.12%,WIPF1;PRKCE;CYFIP2;DOCK1;CD3G;VAV2;SRC;PIK3R2;MYH2
prerank,regulation of cellular component size (GO:0032535),-0.2989920379823726,-0.9781336929314393,0.45741324921135645,0.8268782778110514,1.0,3/30,1.25%,PICALM;EPS8;MSN
prerank,positive regulation of neuron migration (GO:2001224),-0.4058346860884362,-0.9780967509747911,0.5123595505617977,0.8259624510223103,1.0,3/11,5.19%,RAPGEF2;ARHGEF2;SEMA6A
prerank,microtubule nucleation (GO:0007020),0.4033318711978863,0.9779878213540111,0.47368421052631576,0.9505408443209943,1.0,10/20,26.65%,TUBG1;TUBGCP5;CENPJ;NDE1;TUBG2;SLAIN2;TUBGCP6;CSNK1D;CLASP2;CCDC57
prerank,second-messenger-mediated signaling (GO:0019932),0.32158152265278184,0.9778632178198163,0.5072639225181598,0.9500710804222394,1.0,8/82,10.16%,HRH1;ACKR3;PLCE1;EIF2AK3;DDAH2;RCAN1;KSR2;LAT
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.39094518316738036,-0.977719189996085,0.5119617224880383,0.8259811111247054,1.0,5/12,29.80%,RPL26;KDM1A;MIF;TAF9;TRIAP1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.39602316196518983,-0.9774139246731353,0.46604215456674475,0.825799118505581,1.0,4/11,19.62%,STMN1;NRP1;MST1R;BCAR1
prerank,regulation of lymphocyte migration (GO:2000401),-0.40337077521554204,-0.977200514006167,0.47216035634743875,0.8253191030156609,1.0,3/10,8.19%,MSN;STK10;AKT1
prerank,regulation of inflammatory response (GO:0050727),0.29440614177162244,0.9766358441562258,0.5382932166301969,0.9523761041351851,1.0,24/190,11.15%,RORA;ADAMTS12;PIK3AP1;CDH5;CXCL17;FNDC4;CELF1;MGST2;WNT5A;ABCC1;IL17RA;TLR7;TNFAIP3;TRADD;SELENOS;MAPK7;PTGER4;ISL1;TNIP1;ACOD1;CD200R1;SHARPIN;S100A9;PROC
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.4439683357975357,0.9760222450048602,0.4845360824742268,0.9532318781400017,1.0,1/12,1.60%,ASS1
prerank,oxoacid metabolic process (GO:0043436),-0.3082026755550587,-0.9759544126041211,0.47604790419161674,0.8276198027178158,1.0,8/27,20.44%,ENPP1;DDO;BPNT2;TPST1;PPA1;AGXT;MIF;SULT4A1
prerank,cardiocyte differentiation (GO:0035051),-0.40410147187882706,-0.975821573595018,0.47692307692307695,0.8269747028521187,1.0,6/10,15.43%,SIK1;BMP2;GATA6;TGFB2;EEF1AKMT4-ECE2;MYOCD
prerank,positive regulation of nervous system process (GO:0031646),0.4064514214642689,0.9754743177938028,0.4876441515650741,0.9538593315503872,1.0,7/18,14.63%,ITGAX;RIMS2;NCMAP;ATPSCKMT;HCRT;UNC13B;DICER1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.3921500916167173,-0.9751976329107164,0.5167464114832536,0.8276514710865738,1.0,2/11,1.57%,ITM2A;NECAB1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.3651398610463672,0.9750679388577027,0.45942028985507244,0.9540982424791283,1.0,4/32,5.25%,SORBS1;CEACAM1;ZBTB20;PDK4
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.278206642952535,0.9750147664090099,0.5534079348931842,0.9534683732501125,1.0,41/348,9.82%,NGF;FGF7;NTRK3;PPARGC1A;FOXD1;CLDN19;MUSK;FGF1;ADAM19;SLC26A9;CDH5;RAB29;SLC38A2;ITGAX;IL1A;PRKAG1;WNT16;EIF2AK3;SOX9;CELF1;PTPN22;WNT5A;FN1;EPHB2;KRAS;RIMS2;UBR5;RDX;CTCF;MAPK7;OCLN;NOS1AP;FGF18;AGO1;INPP5F;DDRGK1;PLSCR1;GSK3B;RESF1;TICAM1;POU4F1
prerank,platelet aggregation (GO:0070527),-0.2940523745088737,-0.974788925569984,0.5017064846416383,0.8277284375161874,1.0,11/33,18.51%,STXBP3;GNAS;PDGFRA;ACTB;MYL9;ACTG1;FLNA;ILK;TLN1;HSPB1;MYH9
prerank,histone lysine demethylation (GO:0070076),-0.30949523549173874,-0.9747302455966447,0.4823529411764706,0.8268726878624404,1.0,5/25,12.83%,KDM5C;PHF8;KDM2B;KDM1A;KDM7A
prerank,regulation of p38MAPK cascade (GO:1900744),0.36714269779035325,0.974725526579348,0.49177877428998507,0.9534361543375074,1.0,6/35,8.02%,RELL1;MINK1;SPI1;PTPN22;ULK4;PHLPP1
prerank,snRNA transcription (GO:0009301),-0.24516681042993613,-0.9745791151227077,0.521551724137931,0.8262480966413458,1.0,19/70,19.49%,POU2F1;INTS9;CCNT2;CDK9;RPRD2;PHAX;CCNT1;SNAPC1;ZC3H8;SP1;INTS1;NCBP1;POLR2F;POLR2A;POLR2J;SNAPC5;POLR2D;POLR2K;TAF6
prerank,regulation of blood circulation (GO:1903522),-0.29160416473654005,-0.9744247377632634,0.4966442953020134,0.8256688647882888,1.0,11/34,19.17%,ECE1;TPM1;ACE;BDKRB2;AGTR1;DES;S100A1;SRI;ACE2;PER2;AGT
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.32249279572589046,-0.9744086439470702,0.4813753581661891,0.824702417478692,1.0,10/26,23.42%,ALPK1;TRAF6;UBE2N;NOD1;AAMP;CASP8;IRAK2;MAP2K6;IKBKG;NOD2
prerank,regulation of spindle assembly (GO:0090169),0.383134248147183,0.9742753701209744,0.49851190476190477,0.9537746920169466,1.0,6/25,11.97%,SENP6;CHMP5;PDCD6IP;TPR;CHMP4B;CHMP4C
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.3804520221829857,0.9742497865953532,0.49319213313161875,0.95306269637691,1.0,9/26,18.29%,FBXO5;CUL3;ANAPC5;ANAPC7;ANAPC11;CDC6;LCMT1;ANAPC4;CDC23
prerank,histone deacetylation (GO:0016575),0.3530189247703801,0.9741980193962864,0.5,0.9524228466939226,1.0,18/43,24.13%,HDAC4;SMARCAD1;RCOR3;SIN3B;MSL3;SIRT7;HDAC2;HDAC6;SFPQ;BAZ2A;MORF4L2;MTA3;HDAC3;BRMS1L;SIRT2;SIN3A;SUDS3;REST
prerank,cellular response to interleukin-1 (GO:0071347),-0.22314442963848674,-0.9739238887403096,0.5221238938053098,0.8249875010183305,1.0,18/143,8.53%,PLCB1;IL1R1;PTGIS;IL1RAP;PSMA1;RPS6KA5;SQSTM1;SIRPA;IRAK4;RBX1;HIF1A;PSMD11;GBP3;TRAF6;UBE2N;NOD1;PSMD7;PSMD4
prerank,chromatin remodeling (GO:0006338),0.30542294845387685,0.9738272622349486,0.48182883939038684,0.9525704394518651,1.0,33/100,21.52%,HNRNPC;CHD3;SOX9;CHD8;HDAC4;SATB1;SMARCAD1;GATAD1;ACTR8;SMARCD2;HDAC2;BAZ2B;PBRM1;ERCC6;TOP1;INO80;KDM6B;BAZ2A;TADA2A;INO80B;CHD1L;KDM4B;SUV39H2;RUVBL2;NUDT5;HCFC2;RBBP4;CHRAC1;KDM5B;ARID1B;DAXX;RSF1;ARID1A
prerank,histone H4-K8 acetylation (GO:0043982),0.4266305638035929,0.9737493143644859,0.4878048780487805,0.9512230284585258,1.0,3/15,14.16%,OGT;KANSL2;KAT8
prerank,histone H4-K5 acetylation (GO:0043981),0.4266305638035929,0.9737493143644859,0.4878048780487805,0.9512230284585258,1.0,3/15,14.16%,OGT;KANSL2;KAT8
prerank,regulation of calcium ion transport (GO:0051924),0.33820813093429514,0.9734911790145342,0.5086321381142098,0.9511333119023989,1.0,3/54,1.76%,HOMER2;EFHB;SLC8B1
prerank,macrophage migration (GO:1905517),0.4351217965305645,0.9729290731989327,0.49744463373083475,0.9517952835504748,1.0,1/13,2.64%,CXCL17
prerank,positive regulation of phospholipid transport (GO:2001140),-0.4056372301920673,-0.9729186139297772,0.5081206496519721,0.8266956641560658,1.0,2/10,6.29%,DBI;APOE
prerank,regulation of telomere capping (GO:1904353),0.386079802665338,0.9724130836813951,0.4947526236881559,0.9523118698701211,1.0,8/23,26.70%,NEK7;NBN;TERF2;HNRNPD;SMG6;MAPK1;TNKS;RAD50
prerank,intraciliary retrograde transport (GO:0035721),0.4396846040736463,0.9720733721870084,0.4882943143812709,0.9524115241021576,1.0,6/12,25.86%,DYNC2I1;TTC21B;DYNC2LI1;DYNC2H1;IFT140;DYNC2I2
prerank,regulation of interferon-gamma production (GO:0032649),0.3207874219183023,0.9720413156896351,0.5031210986267166,0.9517297561604905,1.0,10/71,9.88%,IL18R1;PDE4D;TXK;PTPN22;TLR7;CRTAM;RARA;ISL1;HMGB1;AXL
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.28378095695291133,-0.9720210086893781,0.49363057324840764,0.8280738386506605,1.0,12/36,22.08%,AFDN;VAMP5;GORASP2;ANK3;MACF1;BBS2;PREPL;GGA3;SYS1;RAB7A;OPTN;RAB10
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.3989962829799001,0.971857193991246,0.48513302034428796,0.9514495202847303,1.0,8/21,18.94%,CNOT10;SAMD4B;CNOT7;PAN2;TNKS1BP1;CNOT8;PNLDC1;CNOT1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.3178025776237695,0.971575286142937,0.5141104294478528,0.9506612880258487,1.0,22/78,22.89%,DYNLL1;KIF2A;CAPZB;RACGAP1;KIF3C;ACTR10;DYNLL2;KIF26A;KIF5A;LAG3;AP2A2;KLC2;DCTN2;AP1M1;SEC24B;DYNC1LI2;ACTR1B;DYNC1I1;DCTN6;AP2S1;CLTA;SEC13
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.3178025776237695,0.971575286142937,0.5141104294478528,0.9506612880258487,1.0,22/78,22.89%,DYNLL1;KIF2A;CAPZB;RACGAP1;KIF3C;ACTR10;DYNLL2;KIF26A;KIF5A;LAG3;AP2A2;KLC2;DCTN2;AP1M1;SEC24B;DYNC1LI2;ACTR1B;DYNC1I1;DCTN6;AP2S1;CLTA;SEC13
prerank,telomere maintenance via recombination (GO:0000722),0.4484446432509742,0.9713353730611519,0.4830827067669173,0.9505381783402617,1.0,3/11,12.79%,SMC5;ERCC1;TEP1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.4352734571771803,0.9711453563425654,0.5042158516020236,0.9502687537042054,1.0,5/14,14.41%,FOXO3;TFB2M;MTERF2;TEFM;FASTKD1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.39315186606544156,-0.9705104913219763,0.48863636363636365,0.8311032402526559,1.0,7/11,29.36%,SLIT2;CCN3;MIF;DUSP1;GREM1;RIN3;DDT
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.24769242081164963,-0.9703843369744234,0.5560975609756098,0.8304325753405041,1.0,14/74,12.63%,RBPJ;PSMA1;EGLN1;EP300;RBX1;HIF1A;PSMD11;PSMD7;PSMD4;CITED2;EPAS1;CUL2;HIF3A;PSMB4
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.3992325103992312,-0.9701086806947813,0.5077605321507761,0.8301167347013998,1.0,5/11,30.78%,KCNJ2;ATP1B1;KCNH2;ATP1A1;KCNQ1
prerank,positive regulation of dendritic spine development (GO:0060999),-0.3298147781318596,-0.9689705036316001,0.5154639175257731,0.8321245957169421,1.0,4/20,6.87%,SHANK3;APOE;CUX2;LRP8
prerank,regulation of fat cell differentiation (GO:0045598),0.32228303717680157,0.9687369368855333,0.49169859514687103,0.9555911286395421,1.0,4/74,5.05%,RORA;TRIB2;WNT5A;TRIO
prerank,glial cell development (GO:0021782),0.3846239584066839,0.9685141956127425,0.48302469135802467,0.9553994641998175,1.0,7/25,16.87%,NF1;EIF2B3;S100A9;EIF2B4;NSUN5;SOX4;MDK
prerank,regulation of lipase activity (GO:0060191),0.42267192830935196,0.9684767707527577,0.5145797598627787,0.9547293495270085,1.0,4/13,18.51%,PCSK5;LMF1;LPL;RHOA
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.3125774025868954,-0.9682437968046408,0.5233644859813084,0.8330380272186183,1.0,8/25,13.57%,ARHGAP24;SLIT2;TBC1D30;EVL;EVI5L;CEP97;ARHGAP44;TCHP
prerank,membrane lipid metabolic process (GO:0006643),0.39468553672706846,0.9678966977943324,0.4934640522875817,0.9554529502244835,1.0,5/22,6.25%,AGMO;TEX2;ALOXE3;MGST2;CERK
prerank,mRNA methylation (GO:0080009),-0.3627999932748377,-0.9671473565425992,0.4838709677419355,0.8350267316808454,1.0,8/15,36.62%,NSUN2;TRMT61B;METTL16;METTL8;METTL14;TRMT6;TRMT61A;TRMT10C
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.3557038699403177,0.9667723964406695,0.5072674418604651,0.9575349352870649,1.0,1/34,0.10%,GAB1
prerank,regulation of interleukin-17 production (GO:0032660),-0.3019237617048357,-0.9666760508027167,0.4886731391585761,0.8352274086495912,1.0,8/31,25.86%,SLC7A5;RFTN1;IL18;SPHK1;NR1H4;NCKAP1L;NOD2;MYD88
prerank,cellular response to hydroxyurea (GO:0072711),-0.41371218131213894,-0.9664810844267044,0.5106888361045131,0.8347470243023831,1.0,4/10,19.71%,BLM;DDI2;NSMCE3;TIMELESS
prerank,regulation of lipid kinase activity (GO:0043550),-0.39392037659599555,-0.9662119484181059,0.5023809523809524,0.8344984242831758,1.0,5/11,15.24%,PIK3R1;PIK3R3;RBL1;PPP2R5A;RBL2
prerank,phospholipid biosynthetic process (GO:0008654),0.35540111071128383,0.9661353291089111,0.4863013698630137,0.9583637829690119,1.0,9/36,20.41%,SGMS2;AGPAT4;AGPAT5;DHDDS;DPAGT1;HDHD5;FADS1;DOLK;DOLPP1
prerank,regulation of cell development (GO:0060284),-0.28501753276472735,-0.9659916696433363,0.5085324232081911,0.8340348772063504,1.0,5/36,8.19%,NOTCH2;FOXO1;HDAC9;RPS19;AKT1
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.4358004890678083,0.9657229638679826,0.49746192893401014,0.9586219027884171,1.0,2/13,4.12%,NR3C2;PGR
prerank,homocysteine metabolic process (GO:0050667),-0.39409840587195505,-0.965593355960011,0.5184331797235023,0.8340352967784186,1.0,6/11,30.81%,NOX4;MTHFR;MTRR;CBS;CTH;MPST
prerank,monosaccharide transmembrane transport (GO:0015749),-0.3517336505910321,-0.965243472125191,0.5094850948509485,0.8339604558025884,1.0,5/16,17.76%,SLC2A12;SLC2A10;SLC45A3;SLC2A8;SLC2A9
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.4178217059928009,0.9651724685417185,0.4927536231884058,0.9593022525856029,1.0,3/15,9.76%,FGFR1;CELF1;CELF4
prerank,phasic smooth muscle contraction (GO:0014821),-0.40691764912180806,-0.9651555218029765,0.5386416861826698,0.8331837593511092,1.0,3/10,24.11%,EDN1;EDN3;HTR2B
prerank,regulation of actin filament polymerization (GO:0030833),0.32164604206806613,0.9651125483820625,0.5110246433203631,0.9586693404544959,1.0,8/69,7.64%,KANK4;PRKCE;ARHGAP18;CDC42EP4;FER;NCK2;KANK1;ARF6
prerank,stem cell differentiation (GO:0048863),-0.2834804335837865,-0.9650589930024912,0.5291970802919708,0.8324424280902225,1.0,8/39,8.66%,OSR1;KIT;FGFR2;HOXB4;ACE;PSMD11;LRP6;JARID2
prerank,positive regulation of phagocytosis (GO:0050766),0.3466363834360947,0.9645775175901217,0.5181208053691275,0.9592877667328443,1.0,6/47,8.21%,C2;ANO6;LMAN2;PTPRC;DOCK2;PTPRJ
prerank,regulation of pH (GO:0006885),-0.3956402975038389,-0.964424367447559,0.49765258215962443,0.8330660942702428,1.0,3/11,8.51%,ATP6V0A4;LACC1;SLC9A1
prerank,cAMP metabolic process (GO:0046058),0.4240297505161626,0.9636412894601138,0.5066445182724253,0.9608166655536228,1.0,6/13,15.58%,PDE4D;PTHLH;ADCY5;ADCY9;ADCY8;ADCY3
prerank,microtubule depolymerization (GO:0007019),0.4103846465380674,0.9631594870590426,0.5056726094003241,0.9612924814923556,1.0,3/17,7.38%,KIF2A;NCKAP5L;CKAP5
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.3877613535872967,-0.9629877448910563,0.531615925058548,0.8357587983825604,1.0,5/11,25.54%,HIF1A;ATF4;RACK1;NR4A3;FBXO7
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.38914697900599976,0.9628558578266405,0.5055821371610846,0.9612999639865732,1.0,3/22,3.65%,RELL1;MINK1;SPI1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.4006103728222542,0.9628376425910986,0.5158730158730159,0.9605844337105797,1.0,2/20,4.33%,PPARGC1A;DIP2A
prerank,response to X-ray (GO:0010165),0.4157134118840295,0.9626796271695741,0.5132450331125827,0.9602275520227697,1.0,4/14,13.52%,BRCC3;IKBIP;MSH2;NUCKS1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.4503750189467002,0.9620211087434279,0.488245931283906,0.9610986958383454,1.0,2/10,8.65%,GCDH;ACADS
prerank,fatty acid catabolic process (GO:0009062),0.32162998013381383,0.9612404436339769,0.5170670037926675,0.9623195317803174,1.0,11/67,10.28%,EHHADH;CEL;AIG1;PCCB;HADHB;PEX2;ACAT1;HSD17B4;ACADS;SLC27A4;ACOT8
prerank,regulation of cytoplasmic translation (GO:2000765),-0.3694490097591272,-0.9603459571967938,0.49406175771971494,0.8417409322384077,1.0,5/14,18.04%,CPEB4;CPEB2;UNK;DHX36;CPEB1
prerank,regulation of biomineral tissue development (GO:0070167),0.3687355069145951,0.9597413772012654,0.5015337423312883,0.9652746906102754,1.0,5/26,10.71%,SGMS2;SOX9;BMP2K;FBXO5;ANKH
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.3371658308519007,-0.9595175002558111,0.4913151364764268,0.84285310614906,1.0,1/17,1.51%,LPGAT1
prerank,actin filament capping (GO:0051693),0.39593710953951033,0.959513097414339,0.5274193548387097,0.9643525591583565,1.0,4/18,7.67%,ADD3;CAPZB;ADD1;VILL
prerank,barbed-end actin filament capping (GO:0051016),0.39593710953951033,0.959513097414339,0.5274193548387097,0.9643525591583565,1.0,4/18,7.67%,ADD3;CAPZB;ADD1;VILL
prerank,ubiquinone metabolic process (GO:0006743),0.42003226611870753,0.9589610346308906,0.5084175084175084,0.9649626783300945,1.0,5/15,16.94%,COQ7;COQ8A;COQ9;AIFM2;COQ6
prerank,cellular response to inorganic substance (GO:0071241),-0.32520118660392483,-0.9588671472949153,0.5108695652173914,0.8435001690037703,1.0,6/21,19.71%,FOXO1;BLM;MTR;DDI2;NSMCE3;TIMELESS
prerank,maturation of LSU-rRNA (GO:0000470),0.3748642189069631,0.9588393912743284,0.504601226993865,0.964525719358878,1.0,5/26,11.37%,RRP15;RPL35;SNU13;PES1;RPF1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.39124708277315456,-0.9587425820195493,0.5287081339712919,0.8428251267501561,1.0,6/10,39.53%,CALM1;CALM3;GPR35;CRHR1;GNB5;DRD3
prerank,protein K48-linked ubiquitination (GO:0070936),0.3292951543654434,0.9587241777159071,0.5079155672823219,0.96407182616284,1.0,16/54,21.60%,NEDD4L;UBE2E2;TNFAIP3;UBR5;CUL3;AMFR;TTC3;FBXO38;UBE2D3;UBE2D1;UBE2R2;ITCH;KBTBD7;PRKN;RNF146;ZNRF1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.4382664194285628,0.9587031675557913,0.4973730297723292,0.9633677888321714,1.0,5/12,21.83%,DND1;NCOR1;NCOR2;PPARG;ELAVL1
prerank,positive regulation of endocytosis (GO:0045807),0.33596545485646784,0.9586789869116625,0.5219178082191781,0.9626692482013729,1.0,7/45,10.09%,GPC3;NEDD4L;ANO6;TFR2;SGIP1;AXL;CALY
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.33542960307507486,-0.9583240473508471,0.5105820105820106,0.8429095811744758,1.0,4/17,10.45%,SASH1;BMP6;NFKBIL1;TRIB1
prerank,cellular response to decreased oxygen levels (GO:0036294),0.3189115908393721,0.9581850534466465,0.5496083550913838,0.9631252407396325,1.0,14/65,17.99%,RORA;EGLN3;SUV39H1;HILPDA;AQP1;P4HB;BAD;PGK1;UBQLN1;RGCC;BNIP3;HP1BP3;SUV39H2;PINK1
prerank,leukocyte cell-cell adhesion (GO:0007159),0.3780552932138666,0.9581559328983099,0.5007496251874063,0.962444808880877,1.0,6/24,16.49%,F11R;TNIP1;NT5E;SEMA4D;EZR;SYK
prerank,response to muscle stretch (GO:0035994),-0.3539648342857564,-0.9579279041625202,0.49875311720698257,0.8429354006425571,1.0,4/15,14.53%,DMD;SLC8A1;SLC9A1;PTK2
prerank,sphingoid metabolic process (GO:0046519),0.4439116253364107,0.9571828802730833,0.5173611111111112,0.9642412946204876,1.0,2/12,4.15%,PLPP2;PLPP3
prerank,ethanol metabolic process (GO:0006067),-0.3841895385373061,-0.9570818690094641,0.5284360189573459,0.8441643207835748,1.0,1/12,0.05%,ALDH1A1
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.40905820538034776,0.9570791784262858,0.5025641025641026,0.9637327525618623,1.0,2/15,2.89%,PRKCE;GPLD1
prerank,nucleosome disassembly (GO:0006337),-0.36947924774058954,-0.9568359969414921,0.5,0.8428113363630938,1.0,3/14,10.95%,SMARCE1;SMARCD1;ARID2
prerank,chromatin disassembly (GO:0031498),-0.36947924774058954,-0.9568359969414921,0.5,0.8428113363630938,1.0,3/14,10.95%,SMARCE1;SMARCD1;ARID2
prerank,response to muramyl dipeptide (GO:0032495),-0.38381762555754106,-0.9567952160916946,0.5189873417721519,0.8419277080606012,1.0,7/12,24.67%,ARHGEF2;ERBIN;NOD1;VIM;TRIM41;NOD2;IRF5
prerank,cellular potassium ion homeostasis (GO:0030007),0.4263954719949248,0.9567943635100897,0.5053003533568905,0.9636776430052469,1.0,3/13,9.39%,SLC12A2;ATP1A2;ATP1B3
prerank,regulation of cellular protein localization (GO:1903827),0.3444371423851852,0.9565663590003595,0.5527777777777778,0.9634934976148178,1.0,9/45,17.74%,GPC3;GPC6;TRIM46;DVL3;RAB11FIP5;GPC2;SETD2;GPC5;LCP1
prerank,response to glucagon (GO:0033762),-0.33644480562894147,-0.9561392346593669,0.5167958656330749,0.8426305275462711,1.0,8/19,19.16%,ADCY1;ADCY7;ADCY4;ADCY2;CREB1;PRKAR2B;CYSLTR2;CRY1
prerank,regulation of vasculature development (GO:1901342),-0.3140548763666733,-0.9559859448783321,0.49226006191950467,0.8420102943618043,1.0,3/26,2.71%,ETS1;SP100;EGLN1
prerank,Notch signaling involved in heart development (GO:0061314),-0.38875644275299504,-0.9559539655369395,0.5224586288416075,0.8411056713049848,1.0,3/11,7.04%,NOTCH2;RBPJ;GALNT11
prerank,DNA damage checkpoint signaling (GO:0000077),-0.30024843809993107,-0.9553525447307394,0.5132450331125827,0.8417030499318002,1.0,7/28,17.70%,MAP3K20;USP28;ATRIP;HINFP;CLSPN;RAD1;RAD17
prerank,motile cilium assembly (GO:0044458),0.439020593704715,0.9550963553228805,0.506993006993007,0.9664280155580142,1.0,3/12,15.14%,CCDC39;BBOF1;CCDC40
prerank,response to glucose (GO:0009749),0.3406284820587575,0.954581796015751,0.4973045822102426,0.966993697904015,1.0,17/46,21.69%,ZBTB20;GPLD1;EIF2B3;SELENOS;EIF2B4;ERN1;GCK;SOX4;UNC13B;TRA2B;GPER1;ADCY8;IRS2;LPL;PAX2;VAMP2;TCF7L2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.30908924803362897,-0.9545520713942937,0.5201149425287356,0.842670943352725,1.0,11/24,24.33%,ABCG2;SLC25A38;FECH;CPOX;FXN;ABCB10;ALAS1;UROD;HMBS;TSPO;ALAD
prerank,positive regulation of protein localization to membrane (GO:1905477),0.30757143731630865,0.9545513257016444,0.5317647058823529,0.9663059536703869,1.0,33/98,22.51%,SORBS1;PRKCE;EGFR;PPP1R13B;ATP2B4;FIS1;EPHB2;ARF6;MIEF1;SFN;SLC5A3;CD81;KIF5B;ZDHHC8;GPER1;BAD;NMT1;ERBB2;YWHAG;YWHAE;E2F1;CHP1;STX4;SPTBN1;PDPK1;CEMIP;PRKN;AKT2;ITGB1;MAPK8;TFDP1;YWHAB;ZDHHC5
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.3754095387605634,0.9542567302195596,0.5157894736842106,0.9662883353047286,1.0,6/25,17.58%,SF3B1;SRSF4;PRPF3;DBR1;TRA2B;SLU7
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.3663153141469867,-0.9540538326701322,0.531322505800464,0.8430262102204426,1.0,2/13,4.13%,SOX13;NAPEPLD
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.31205763234732026,0.953450436079711,0.5431034482758621,0.9675010078856827,1.0,22/79,22.89%,DYNLL1;KIF2A;CAPZB;RACGAP1;KIF3C;ACTR10;DYNLL2;KIF26A;KIF5A;LAG3;AP2A2;KLC2;DCTN2;AP1M1;SEC24B;DYNC1LI2;ACTR1B;DYNC1I1;DCTN6;AP2S1;CLTA;SEC13
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.31006848454518265,-0.9534427818968585,0.5167173252279635,0.8436218939912054,1.0,9/25,27.68%,EPHA4;RPS7;SGTA;RPL23;CSNK2A1;HFE;RPL5;ALAD;RPL11
prerank,modulation by host of viral genome replication (GO:0044827),-0.36285691374382634,-0.9533665544286392,0.5253807106598984,0.8428306572949769,1.0,7/13,28.83%,YTHDC2;ZC3H12A;EIF2AK4;PPIB;FBXL2;CCNK;IFI27
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.3169381768065676,0.9532637534579907,0.532319391634981,0.9672392440969622,1.0,13/63,18.02%,NFATC2;PTPRC;EPHB2;NCK2;CD320;IL6ST;GPR183;CD276;CD81;IL7;IL15;IRS2;FGF10
prerank,membrane raft organization (GO:0031579),-0.3500538199823648,-0.9530608377160276,0.5195822454308094,0.842639040669969,1.0,5/15,18.34%,RFTN1;ANXA2;MYADM;NAXE;FLOT1
prerank,regulation of transferase activity (GO:0051338),0.41311954932726697,0.9529903735916204,0.5301003344481605,0.9671788632263358,1.0,1/17,1.61%,LDB2
prerank,regulation of cellular metabolic process (GO:0031323),0.33976011645458554,0.952773304780133,0.5289139633286318,0.9669917017820676,1.0,11/45,17.99%,COQ7;MPV17;KIF16B;PDK4;ACACA;TBC1D16;NCOR2;ACACB;PANK2;PM20D2;PINK1
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.36805297632751516,-0.9526295977882817,0.5035460992907801,0.8427784242824901,1.0,6/12,16.52%,LAMA3;ACTB;ACTG1;FUZ;VANGL2;AHI1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.3654589633340445,-0.9525767695855314,0.5089686098654709,0.8419360997499077,1.0,5/12,18.02%,GCLM;BDH2;CNDP2;GGCT;GCLC
prerank,generation of neurons (GO:0048699),0.2831930113760018,0.952466411605309,0.5573770491803278,0.9669786932990486,1.0,26/190,11.16%,FGFR1;WNT10A;FZD2;BHLHE22;NEUROD6;RUNX2;WNT2B;OPHN1;RACGAP1;WNT16;WNT5A;HEYL;BHLHE40;BRSK1;ARTN;SEMA3A;PAFAH1B1;LHX6;EML1;NRBP2;GPM6A;RELN;ERCC6;LRP12;DOCK7;EN2
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.430435764509975,0.952378284524999,0.53184165232358,0.9664322087520273,1.0,3/12,10.46%,TET1;RESF1;PPHLN1
prerank,negative regulation of viral transcription (GO:0032897),-0.36540338940031086,-0.952279666512673,0.53315649867374,0.8417096831562856,1.0,6/13,20.68%,MID2;TRIM14;UBP1;ZFP36;TRIM13;TRIM11
prerank,response to lipopolysaccharide (GO:0032496),0.28820226420926354,0.9520718285602042,0.550561797752809,0.9664319477553728,1.0,21/138,11.08%,LBP;TNIP3;IL1A;PTPN22;HNRNPA0;IRAK3;WNT5A;FER;TNFAIP3;SELENOS;PAF1;DEFA6;ACOD1;IRGM;CHMP5;RPS6KA3;HMGB1;TICAM1;AXL;S100A9;TAB2
prerank,protein glycosylation (GO:0006486),-0.21649704761351293,-0.9520591165351237,0.5912408759124088,0.8413002046487321,1.0,23/125,11.93%,ST3GAL6;MGAT4C;ST3GAL5;ST3GAL1;ST8SIA4;MGAT4A;EOGT;SLC39A8;COG7;DPM1;ST6GALNAC2;ALG5;PLOD2;STT3B;PLOD1;GAL3ST1;AQP11;PGM3;B4GALT1;B4GALT7;ALG1;GOLGA2;RPN2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.3339975455663802,0.9519114069326133,0.5147849462365591,0.9660934350943272,1.0,4/48,3.58%,UBASH3B;CAMK2D;PDE4D;FKBP1B
prerank,regulation of mitochondrial translation (GO:0070129),0.3880755532092276,0.9518975329153402,0.5417322834645669,0.965393618589426,1.0,9/21,23.14%,RMND1;FASTKD2;MPV17L2;ALKBH1;MTG2;RPUSD4;MALSU1;TSFM;MTG1
prerank,regulation of lamellipodium assembly (GO:0010591),0.3557576182879645,0.9518165436580613,0.5094066570188133,0.964852919190864,1.0,6/34,11.88%,PLCE1;CAPZB;RAC2;FER;OCLN;AKIRIN1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.3158390014856552,0.9516131054261305,0.5395408163265306,0.9645697603498178,1.0,6/70,9.35%,NGF;HIPK1;TRADD;MCL1;BAG3;GSK3B
prerank,regulation of viral transcription (GO:0046782),0.345068134092975,0.9508358540739141,0.5294117647058824,0.965771352790809,1.0,6/39,12.46%,MDFIC;TRIM21;NELFB;SUPT4H1;HEXIM1;GTF2F2
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.4197689172975182,0.9508083597694795,0.4983108108108108,0.9650940896640214,1.0,2/13,7.23%,GLI1;TBX2
prerank,negative regulation of DNA replication (GO:0008156),0.42380701127449283,0.9507754690782563,0.5298013245033113,0.9644279366174043,1.0,4/13,20.50%,CDAN1;CDC6;GMNN;ATR
prerank,regulation of neuron death (GO:1901214),0.30848485697597,0.9505681478992497,0.5303210463733651,0.9642070758272473,1.0,19/82,17.13%,PPARGC1A;RAB29;WNT5A;EGLN3;EFNB2;MAP3K5;CD200R1;GSK3B;SARM1;CHMP4A;CHMP4B;EGR1;LANCL1;SNCG;DHCR24;HTRA2;TBK1;GPR75;CHP1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.37957538117490675,0.9505659662466286,0.5200642054574639,0.963475815476047,1.0,7/22,16.57%,LEO1;CDK13;ELL;SUPT4H1;ERCC6;TCERG1;THOC5
prerank,negative regulation of catabolic process (GO:0009895),0.338976501986746,0.9503758177164859,0.5187760778859527,0.9632014684496564,1.0,7/47,10.36%,EGFR;HDAC4;IRAK3;AZIN2;NCOR1;ZDHHC7;ADRA2A
prerank,positive regulation of histone methylation (GO:0031062),0.376166688890259,0.9494523575820438,0.5186915887850467,0.9647665422927357,1.0,6/24,17.36%,OGT;KMT2A;PAF1;TET1;AUTS2;MTF2
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.3242874741461394,-0.9494222083772401,0.5512465373961218,0.847203085642464,1.0,9/21,20.26%,CYP26B1;PPARD;LPIN2;FAH;LPIN3;ACBD5;AGXT;ACOX1;PLA2G15
prerank,neuron projection regeneration (GO:0031102),0.4560053542998844,0.9491554323763965,0.5188356164383562,0.9647711386472102,1.0,2/10,10.72%,FOLR1;RTN4RL1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.3935855230179503,0.9489367602952461,0.5015822784810127,0.9645830849401678,1.0,5/21,9.03%,CAMK2D;PDE4D;FKBP1B;ATP1A2;CASQ2
prerank,cellular protein localization (GO:0034613),0.2747936685821767,0.9488532790316909,0.5714285714285714,0.9640568394204856,1.0,75/285,20.77%,PIGU;FGF7;GRTP1;EPB41L3;EGFR;RAB29;STX1A;RIC3;SGSM2;SIL1;CSRP3;CNTNAP1;MFN2;CPE;ARL11;WNT5A;AMOT;SH3PXD2B;RAB3GAP2;SYNRG;KIF13A;ARF6;OCLN;TBC1D16;ARL4A;FOXJ1;TMED4;TBC1D2;FERMT2;TBC1D8;AXIN2;RIC1;HDAC6;STX2;STX19;RTP3;CTTN;USP4;EVI5;RRAGB;PTPRU;CNTNAP2;ARL5A;COPA;TMED2;SEC23IP;TICAM2;TBCK;AP3B1;SNX1;CELSR1;RAB21;STX4;SLU7;ARCN1;FAM91A1;STX5;SCFD2;FGF10;TBC1D5;EHD1;COG3;RABL3;TM9SF4;TM9SF2;CEP250;RAB5A;NSF;SNX17;TBC1D10A;PACSIN1;PIGK;TBC1D8B;RAB18;USO1
prerank,regulation of axon extension (GO:0030516),0.34643113015566174,0.9488470144233982,0.520949720670391,0.9633333254488633,1.0,8/37,14.25%,NTN1;RTN4R;CDKL3;SEMA3A;GSK3B;TRIM46;CTTN;RTN4
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.2650498722657813,-0.9485483279395697,0.5259259259259259,0.8485496928481567,1.0,18/48,19.45%,NEDD9;CUX1;CDC42;OBSL1;TRIOBP;MYADM;CUX2;CRK;CRKL;FLNA;CDKL5;ILK;NRP1;PTPRD;CARMIL1;LIMS2;TESK1;LIMS1
prerank,regulation of B cell proliferation (GO:0030888),0.33306083591313157,0.9485441351835419,0.5339805825242718,0.963362577373904,1.0,7/44,13.15%,NFATC2;PTPRC;EPHB2;CD320;GPR183;CD81;IL7
prerank,calcium ion transport into cytosol (GO:0060402),0.38267386561381417,0.9481230220826313,0.49770992366412214,0.9636538106165646,1.0,3/21,4.74%,ITPR3;TRPV4;ATP2B4
prerank,primary miRNA processing (GO:0031053),-0.4117761033147176,-0.9480618427555735,0.5330188679245284,0.8488486931525695,1.0,5/10,27.65%,SMAD3;PUS10;SMAD1;MRPL44;SMAD2
prerank,hepaticobiliary system development (GO:0061008),0.3853364368697435,0.9478930011516744,0.536115569823435,0.9634573324932587,1.0,4/20,6.09%,COBL;NF1;LSR;GFER
prerank,carnitine metabolic process (GO:0009437),0.442320614135206,0.9478300579684196,0.5229202037351444,0.9628883151710512,1.0,1/12,1.67%,ALDH9A1
prerank,regulation of osteoclast differentiation (GO:0045670),0.34922745084932855,0.9478167989478685,0.5194805194805194,0.9621841040469045,1.0,1/33,0.50%,UBASH3B
prerank,cellular response to hexose stimulus (GO:0071331),-0.3081618819772314,-0.9474676360527146,0.5205479452054794,0.8493414111508925,1.0,3/23,6.86%,IGF1R;KCNB1;SLC39A14
prerank,response to interleukin-1 (GO:0070555),-0.24366075308492224,-0.9474078760906954,0.6395939086294417,0.8485242120726934,1.0,19/73,18.68%,IL1R1;PTGIS;YTHDC2;SIRPA;HIF1A;GBP3;TRAF6;IGBP1;ANXA1;ZC3H12A;CCL13;TNFRSF11A;TLE5;LGALS9;GBP2;RC3H1;CD40;CACTIN;IRAK2
prerank,regulation of fatty acid oxidation (GO:0046320),0.40254862032192773,0.9471550291176604,0.5348837209302325,0.9630099105577244,1.0,3/16,5.25%,PPARGC1A;SOX9;PDK4
prerank,cilium movement (GO:0003341),0.3310790368730494,0.9471482402479129,0.5257452574525745,0.9622981391541208,1.0,13/48,22.53%,CFAP73;SPEF1;SPAG17;CCDC39;DNAH5;CCDC40;CFAP70;CFAP61;ODAD1;ZBBX;TTC29;DNAI4;CFAP100
prerank,macromolecule catabolic process (GO:0009057),0.36960955065081236,0.9470230192730338,0.5120845921450151,0.9619058496964699,1.0,7/26,11.37%,LRSAM1;KIF16B;PIK3R4;CLN8;SIAH1;SNX25;NEDD4
prerank,negative regulation of protein secretion (GO:0050709),-0.2760709385589482,-0.9469005464038072,0.5054945054945055,0.8487743696660194,1.0,12/38,18.56%,KCNB1;CCN3;NR1H3;MIDN;APOE;CD200;SERGEF;RHBDF2;RAB11FIP3;RAB11FIP1;RSAD2;OPRM1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.3158685763175344,0.9468323670078237,0.5251989389920424,0.9616284937147302,1.0,23/70,21.62%,LMO1;KMT2A;PSME3;N4BP2L2;PUS7;PSMB5;PSMB2;CBFB;PSMA2;PSMA6;PSMD13;PSMA7;YAP1;ITCH;PSME4;PSMC4;PSMB6;PSMD12;PSMD14;TCF3;RUNX1;FOXC1;PSMB3
prerank,positive regulation of intracellular transport (GO:0032388),0.33732394468857824,0.9467309553167881,0.5069060773480663,0.9611613709456402,1.0,15/38,22.66%,RAB29;KIF20B;CEP131;EHD2;RIPOR1;TPR;NEDD4;CEP290;PCM1;TBC1D20;EHD1;VAMP2;TENM1;PGAP1;OAZ2
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.45375016214706765,0.9465269476531867,0.551789077212806,0.9609608713733437,1.0,2/10,8.40%,NUFIP1;NAF1
prerank,neuron projection organization (GO:0106027),-0.34660401235236243,-0.9464339304177172,0.5140664961636828,0.8489374183040432,1.0,5/15,21.42%,INSR;LGMN;ABCD2;PICK1;PLS1
prerank,substantia nigra development (GO:0021762),-0.2724695852133813,-0.9463574421439888,0.5440251572327044,0.8481428380239132,1.0,14/37,15.09%,CDC42;CKB;GNB4;CALM1;ACTB;MAOB;COX6B1;SEC16A;CNP;TTBK1;S100A1;CALM3;RAD1;ATP5PF
prerank,histone H3 deacetylation (GO:0070932),0.4171328839343862,0.9463321410584769,0.5447019867549668,0.9607379999347526,1.0,5/15,13.67%,HDAC4;SMARCAD1;SIRT7;HDAC2;SFPQ
prerank,phosphatidylinositol metabolic process (GO:0046488),0.2949087037453217,0.9457263645863536,0.5390898483080513,0.9614946894708487,1.0,17/109,9.15%,PTPN13;PLCB3;PI4K2B;TPTE;SLC27A1;PIP4K2B;PIK3R4;PGAP3;PLEKHA4;MTMR7;PIK3R2;MTMR6;OCRL;INPP5F;MTMR3;PLEK;LCLAT1
prerank,regulation of exit from mitosis (GO:0007096),0.3531673300716696,0.9455447708777668,0.5211267605633803,0.9611918029844191,1.0,13/38,18.29%,CDC20;ANAPC5;ANAPC7;ANAPC11;BUB3;ANAPC2;UBE2D1;ZW10;ANAPC4;CDC14A;RGCC;ANAPC16;CDC23
prerank,inner ear morphogenesis (GO:0042472),-0.3144209122966199,-0.9454366677914231,0.5229357798165137,0.8495188344577564,1.0,5/22,11.87%,CHD7;MYO6;FGFR2;TBX1;ZIC1
prerank,neuromuscular process controlling balance (GO:0050885),-0.37672562917937974,-0.9448624311338194,0.5384615384615384,0.8500112741439687,1.0,3/12,12.18%,PCDH15;TPP1;NRXN1
prerank,purine ribonucleotide transport (GO:0015868),0.4090520439475025,0.9446654758380265,0.5286738351254481,0.962580463178249,1.0,2/16,4.44%,LRRC8D;SLC35B2
prerank,regulation of chemokine production (GO:0032642),-0.27739548548190346,-0.9445994851855071,0.5905797101449275,0.849777462197364,1.0,5/36,6.53%,IL6R;FOXP1;IL18;HIF1A;IL33
prerank,artery development (GO:0060840),0.38461419862500845,0.9445461690232759,0.5208012326656395,0.9621677164366641,1.0,2/23,3.23%,STRA6;NF1
prerank,negative regulation of interleukin-1 production (GO:0032692),0.3708760075146051,0.94450475224558,0.5226209048361935,0.9615579343011774,1.0,3/23,9.52%,CEACAM1;TNFAIP3;NLRP2B
prerank,branched-chain amino acid metabolic process (GO:0009081),0.38868031479055665,0.9440553502710862,0.533011272141707,0.9612151364864716,1.0,5/20,11.48%,ACAD8;BCKDK;ACAT1;BCKDHB;BCAT2
prerank,branched-chain amino acid catabolic process (GO:0009083),0.38868031479055665,0.9440553502710862,0.533011272141707,0.9612151364864716,1.0,5/20,11.48%,ACAD8;BCKDK;ACAT1;BCKDHB;BCAT2
prerank,post-translational protein modification (GO:0043687),0.2701845413170746,0.9440102279782958,0.6196891191709845,0.9606109629465714,1.0,77/332,19.43%,FAM20C;GPC3;STC2;LAMB2;LAMC1;FBXL15;SOCS5;ASB6;LMO7;SCG3;SPSB4;PSME3;NUCB1;KEAP1;FN1;BMP15;SUMF1;ADAM10;SOCS6;PTP4A2;ATG5;GOLM1;RAB3A;FBXO31;CUL3;RCN1;CDH2;PSMB5;DCAF13;FBXL19;PROC;PRKCSH;KLHL21;FBXL5;MEN1;FBXO11;FBXO21;PSMB2;P4HB;STT3A;PSMA2;KLHL22;CHM;FEM1C;PSMA6;CHGB;COPS5;PSMD13;FBXW8;PSMA7;FBXO41;DDB2;FBXL12;MBTPS1;FBXW7;FBXL3;DSCC1;CUL4B;RNF7;PSME4;VCAN;CALU;FSTL1;BTBD6;WFS1;VGF;SOCS2;PSMC4;FBN1;PSMB6;PSMD12;PSMD14;ICMT;RAB5A;ZBTB16;DDA1;KBTBD7
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.2961595563431491,0.9437106885043347,0.5619834710743802,0.9605939588107291,1.0,15/110,10.36%,LPAR1;ADGRG5;ADGRG2;PTGFR;GPR161;MC5R;PTHLH;GNAQ;ADCY5;PTGER4;TSHR;GNAL;GPR101;ABCA1;ADRA2A
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.3170012052841895,0.943144278372549,0.5317997293640054,0.9612675919233512,1.0,16/61,18.75%,CAV1;PSME3;PDK4;PSMB5;NCOR2;PSMB2;PSMA2;PSMA6;PANK2;PSMD13;PSMA7;PSME4;PSMC4;PSMB6;PSMD12;PSMD14
prerank,adenine nucleotide transport (GO:0051503),0.4016380784848753,0.9430079336032803,0.5247349823321554,0.9608579904650343,1.0,2/17,4.44%,LRRC8D;SLC35B2
prerank,regulation of cytoskeleton organization (GO:0051493),0.29736402612456114,0.9429537341814791,0.5576251455180442,0.9602741492843668,1.0,8/108,5.91%,EFNA5;DLC1;F11R;ARHGAP18;SPEF1;RAC2;CAPN6;ARHGEF5
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.38539610784819084,0.9423695029679379,0.5293185419968305,0.9609717720064223,1.0,3/20,10.78%,CAMK2D;FIS1;THADA
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.32492728997648834,-0.9423460851478154,0.5429292929292929,0.8544845953114829,1.0,4/18,7.43%,FLT1;AKT3;IGF2;COL4A3
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.294321667651257,-0.9421748350070407,0.5481927710843374,0.8539396457324822,1.0,4/31,4.18%,RBP4;TFRC;PAXIP1;SHLD2
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.38651738929345114,0.9418802980650816,0.5249221183800623,0.961472726359169,1.0,5/20,13.39%,DKKL1;BCKDK;NCOR1;C1QTNF12;GCK
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.3037017756789299,-0.9413363013275904,0.5714285714285714,0.8550654764160613,1.0,9/26,20.23%,CLIP1;STMN2;RPS3;MAPT;CDK5R1;ARL2;FES;KATNB1;MET
prerank,N-glycan processing (GO:0006491),-0.3310663430913644,-0.9411819336301224,0.5516304347826086,0.8544891083190904,1.0,5/18,14.84%,ST8SIA4;MGAT4A;GANC;ST8SIA2;FUT8
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.31064321091093705,-0.9411806356198253,0.5508474576271186,0.8535228566073804,1.0,6/23,17.03%,PRKAG2;CALM1;UBE2K;SPHK1;CALM3;EGF
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.3653715915288954,0.9408358728285197,0.5365079365079365,0.9632425044796173,1.0,10/26,22.56%,EGFR;SOX9;SYAP1;ZFP36L2;ERBB2;PDPK1;PTPN12;STAT5B;FOXC1;IQGAP1
prerank,regulation of DNA metabolic process (GO:0051052),0.336248140759492,0.9403537313538629,0.5459533607681756,0.9636934099506357,1.0,8/44,9.58%,MPV17;WDR18;SMARCAD1;TOM1L1;KPNA2;NBN;UBE2V2;SIRT7
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.36533438913953153,-0.9402727234475031,0.5373493975903615,0.8548968939820912,1.0,2/12,5.95%,FOXP1;KLF4
prerank,import into cell (GO:0098657),0.3376745804976362,0.9395741862070415,0.5468531468531469,0.9648607358083187,1.0,8/41,6.69%,LRRC8D;SLC1A7;SLC12A4;SLC27A1;LRSAM1;ATP1A2;SLC6A13;SLC1A6
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.23328730614019774,-0.9390986753540378,0.583756345177665,0.8568979237518025,1.0,20/76,18.68%,PTGIS;G3BP2;COMMD1;CYP1B1;ERBIN;KLF4;CD200;CMKLR1;NFKBIL1;LRRC14;ZC3H12A;COMMD7;TMSB4X;PARP10;NLRC3;RWDD3;TRIM37;CDK5RAP3;CACTIN;IRAK2
prerank,hexose biosynthetic process (GO:0019319),0.3362558199057862,0.9389462043902993,0.5325034578146611,0.9656907642114249,1.0,13/42,21.46%,PPARGC1A;SLC25A12;ALDOB;PGM1;MDH1;SLC25A13;ENO3;GOT1;PGK1;ENO2;SLC37A4;SLC25A10;ENO1
prerank,response to nitric oxide (GO:0071731),-0.37477835693551054,-0.9388527029427175,0.5210280373831776,0.8565106520624836,1.0,5/13,24.97%,EGLN1;FOXO1;MTR;CCL19;CDK2
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.4153533597400154,0.9388083410006909,0.5523648648648649,0.9652907882248779,1.0,4/13,17.17%,LAMP1;GAB2;SYK;STX4
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.390344245583904,0.9387363886373359,0.5292259083728278,0.964747610373418,1.0,4/20,12.77%,RGS14;GPRASP1;PLEK;RPGRIP1L
prerank,glucose import (GO:0046323),0.4194932910540262,0.9384167351883244,0.538971807628524,0.9648162699997102,1.0,3/13,9.63%,SLC27A1;ZDHHC7;SLC27A4
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.3742790051428577,0.9380414812958822,0.5200617283950617,0.965038865881169,1.0,3/20,6.14%,APH1B;NCSTN;ADAM10
prerank,positive regulation of lamellipodium organization (GO:1902745),0.35277836946502905,0.9379486232445644,0.5346820809248555,0.9645514098607456,1.0,8/32,16.88%,PLCE1;SRC;RAC2;RREB1;OCLN;AKIRIN1;AUTS2;ARHGEF7
prerank,positive regulation of phospholipase activity (GO:0010518),0.3756622232595471,0.9378147334401248,0.4984472049689441,0.964157936789066,1.0,2/22,0.70%,NTRK3;FGFR1
prerank,protein kinase A signaling (GO:0010737),0.42605196466401357,0.9375790936149474,0.5588752196836555,0.9640028927728403,1.0,4/12,17.74%,RDX;PRKACB;EZR;LCP1
prerank,brain morphogenesis (GO:0048854),-0.3657329902277073,-0.9374489310477009,0.5521327014218009,0.8590665728272893,1.0,4/12,14.89%,SHANK3;SPEF2;BBS2;MKKS
prerank,microvillus organization (GO:0032528),0.41905003361657917,0.9374205746965628,0.5373134328358209,0.9636562743568423,1.0,3/13,8.67%,RAP1A;MINK1;RAPGEF6
prerank,fatty acid beta-oxidation (GO:0006635),0.3212830303203626,0.9374099414298007,0.540720961281709,0.9629719823778757,1.0,9/51,10.28%,EHHADH;DECR2;HADHB;PEX2;GCDH;ACAT1;HSD17B4;ACADS;ACOT8
prerank,neutrophil chemotaxis (GO:0030593),0.32650760284782576,0.9373450785313192,0.5315436241610738,0.9624122186971366,1.0,1/53,0.29%,CXADR
prerank,regulation of T cell chemotaxis (GO:0010819),0.4352754261808811,0.9368530277176655,0.5195035460992907,0.9628663421724236,1.0,2/11,6.14%,WNT5A;ADAM10
prerank,negative regulation of phosphorylation (GO:0042326),0.30400814469629867,0.9368484253428825,0.5691747572815534,0.9621702904014866,1.0,9/85,8.22%,DYNLL1;NTRK3;PTPN13;PLPP3;HDAC4;IBTK;EPHB2;NCOR1;OCLN
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.2631729616184407,0.9366251835702615,0.669021190716448,0.9619813945137702,1.0,81/476,17.11%,RORA;FGF7;MDFIC;NFATC2;GLI1;PPARGC1A;NR2F2;ZNF423;NFATC1;FZD2;EGFR;NPAS3;BCL3;AXIN1;RUNX2;GLI2;MLLT3;KMT2A;FOXK1;FOXO3;SOX9;NPAS2;GLIS2;CHD8;KAT6B;HDAC4;NUP62;WNT5A;PPM1A;ATAD2;SP3;ZFP90;RGMB;CTCF;PAX3;RREB1;RARA;MAP3K5;ILF2;FOXK2;DYRK1A;MED13;RORB;HDAC2;KARS1;TFEB;ILF3;DVL3;COL1A1;TASP1;EGR1;BICRA;KDM8;CEP290;NAT14;SPIN1;CRLF3;TAF15;CREBBP;GTF2H1;SOX4;CDKN1C;FZD7;KAT8;RAI1;ERBB4;FOXF1;NEK4;MED12;CDH1;SNX5;FOXC2;YAP1;TESC;PBX4;PCBD2;ARHGEF11;TFE3;E2F1;QRICH1;PPARG
prerank,quinone biosynthetic process (GO:1901663),0.4098609423487991,0.9365025200023929,0.5322314049586777,0.9615478553816258,1.0,3/14,8.81%,COQ7;COQ8A;COQ9
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.3977408080080536,0.9362246358444122,0.5508474576271186,0.9614938197968046,1.0,6/17,21.39%,KCNS2;NOS1AP;KCNAB1;KCNRG;SUMO1;VAMP2
prerank,ncRNA metabolic process (GO:0034660),0.34259353342587817,0.9355962602140793,0.547887323943662,0.962272339014915,1.0,12/37,25.77%,PIWIL2;DDX17;DGCR8;DICER1;RAN;PRKRA;XPO5;DTD1;TDRD9;MEPCE;TENT4B;AGO2
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.3973811502124799,-0.9352538422055934,0.5416666666666666,0.8637142010282713,1.0,5/10,21.72%,ATP5PD;VPS9D1;ATP5MC3;ATP5PO;ATP5MC2
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.3537340284452961,0.9352533186007284,0.5344070278184481,0.9624097655053035,1.0,12/29,21.69%,LEO1;TRRAP;AXIN2;PYGO1;MEN1;CREBBP;BCL9;KMT2D;TCF7L1;CDC73;ASH2L;TCF7L2
prerank,inorganic cation transmembrane transport (GO:0098662),0.27407224300982175,0.9351395564834644,0.6184486373165619,0.961953041556565,1.0,38/268,13.98%,KCNJ4;OTOP1;SCN10A;NALCN;TRPM3;SLC12A2;KCNA5;SLC39A13;KCNJ16;ANO6;SLC24A1;TRPV4;KCNS2;SLC12A3;KCNK1;ATP2B4;CACNA1H;ATP1A2;SLC6A13;SLC4A4;SLC30A6;SLC4A11;COX15;KCNK5;ATP1B3;NNT;KCNS3;TRPC4AP;KCNAB1;SCN2B;SLC9A7;SLC9A6;PKD1;TRPV2;ABCB7;KCNK10;KCNK4;SLC6A4
prerank,purine-containing compound catabolic process (GO:0072523),-0.3676274543347703,-0.9350122842872911,0.5560975609756098,0.8632964362096495,1.0,5/13,24.17%,DPYD;XDH;NT5C;NT5C1A;GDA
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.2306711395115169,-0.9349999604479386,0.6179775280898876,0.8623735458125917,1.0,18/80,14.51%,PICALM;ROCK2;EPHA4;LARP6;PRR16;EIF3C;RPL26;NPM1;RPS6KB1;CASP3;ZCCHC4;GSK3A;YTHDF1;SP1;ABCA2;THBS1;ABCG1;VIM
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.3072321037408646,-0.9346831969620301,0.5377906976744186,0.86218246909525,1.0,4/24,6.22%,TEK;PIK3R1;DUSP3;KDR
prerank,gliogenesis (GO:0042063),-0.3494936154729118,-0.9339983351339485,0.5386533665835411,0.8629953528096601,1.0,4/15,12.75%,NFIB;ANXA1;CDK6;TGFB2
prerank,intracellular protein transport (GO:0006886),-0.19032003195064318,-0.9337506111916996,0.75,0.8626750724132896,1.0,74/304,20.64%,RANBP3L;TBC1D4;STXBP3;WLS;ARHGEF2;KIF13B;IPO9;TBC1D1;MYO6;RABGAP1;APPL2;RAB6B;COG7;NUP107;TBC1D12;PREB;C2CD5;NAPA;TMED9;AP2A1;STX8;TBC1D30;USP6NL;TBC1D2B;NPM1;HEATR3;AKAP6;NUP133;RANBP6;RASSF9;AKT1;SURF4;SGSM3;COPZ1;SEC16A;GABARAP;COPZ2;EIF2D;STX17;EVI5L;AP4E1;RAB5C;CLIP3;RANBP3;TMED3;TBC1D22B;SAR1B;RAB24;VPS26B;STX12;HERC2;CTSA;NUP88;GGA3;TMED1;STX6;ARF5;LAPTM5;SCFD1;XPO6;STX16;TECPR2;SEC31A;COX18;RAB32;CDC37;SYNDIG1;E2F3;KATNB1;TMED7;TBC1D17;VPS28;MAIP1;PICK1
prerank,apoptotic cell clearance (GO:0043277),0.3498010509146176,0.9334142013288453,0.5267857142857143,0.9653524062503854,1.0,6/30,9.48%,XKR7;XKR4;RAC2;RARA;XKR8;HMGB1
prerank,regulation of viral entry into host cell (GO:0046596),-0.2858578718690283,-0.9329988081329634,0.5427631578947368,0.8636812951758975,1.0,12/30,32.60%,LY6E;MID2;TRIM25;TRIM14;LGALS9;TRIM11;TRIM6;TRIM27;CIITA;LGALS1;IFITM2;TRIM62
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.2621072522384167,-0.9328825725938009,0.5897435897435898,0.8630279964399743,1.0,12/45,19.76%,SP100;IRF2;TRIM25;B2M;VCAM1;JAK2;CAMK2A;IRF1;GBP2;MT2A;TRIM8;ICAM1
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.3482863978319598,-0.9328636613079788,0.5437158469945356,0.8621002544658142,1.0,5/16,12.91%,ARHGAP24;RASGRF1;ARHGAP17;GABARAP;ARHGAP44
prerank,lipid catabolic process (GO:0016042),0.3845451774726227,0.9322837212502423,0.5414551607445008,0.9673181631228056,1.0,5/18,22.92%,CEL;LIPE;LPL;HSD11B1;SIRT2
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.4148927996240728,0.9322321592552619,0.5430579964850615,0.9667315062609443,1.0,4/13,11.66%,SOCS5;TSG101;CBLB;SOCS4
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.3305058657469159,-0.9320525438124447,0.5641025641025641,0.8631540867389981,1.0,4/17,15.99%,PARD3;CALM1;CALM3;EIF4G1
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.3143745908449226,-0.9320023167549645,0.5327380952380952,0.8623288345499903,1.0,4/20,12.93%,ARV1;APOE;LDLRAP1;ABCA2
prerank,regulation of DNA damage checkpoint (GO:2000001),0.4473340227723624,0.9318235042319458,0.5435168738898757,0.9669745250179386,1.0,5/10,21.37%,WDR76;RFWD3;ETAA1;THOC5;CCAR2
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3799370016798431,0.931712444545029,0.5404580152671755,0.9665223169235483,1.0,4/20,10.48%,ATIC;PFAS;PPAT;NT5C2
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.33196567869358395,0.9314768264855586,0.536986301369863,0.9663674714209592,1.0,7/46,12.67%,TSHZ3;DGKZ;OPHN1;ATP1A2;CDH2;RELN;GRM1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.3522960615679944,-0.9309691864833591,0.5445783132530121,0.8639601629588606,1.0,6/15,13.12%,NR1H3;LDLR;SIK1;CTDNEP1;NR1H2;MFSD2A
prerank,myoblast differentiation (GO:0045445),-0.35211978212998996,-0.9309067467458192,0.5240384615384616,0.8631621888158615,1.0,4/14,10.59%,IGF1;HINFP;MAPK12;EPAS1
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.39192543622866016,-0.9307503984370331,0.5679824561403509,0.862606531798422,1.0,4/10,23.94%,DCLRE1B;DCLRE1C;ACD;TFIP11
prerank,import into nucleus (GO:0051170),0.30441345048642143,0.9306663304833106,0.5604534005037783,0.9676142887109148,1.0,15/73,16.49%,PRICKLE1;IPO8;NUP62;SNRPF;FAM53B;SMN1;TPR;MMP12;NUP50;HTATIP2;CSE1L;NUP153;RAN;NUP93;SYK
prerank,negative regulation of JNK cascade (GO:0046329),0.3525378369208088,0.9306437723387937,0.5510791366906475,0.966963035155447,1.0,14/31,24.58%,SH3RF2;PTPN22;DACT1;NCOR1;MAPK8IP1;MEN1;ITCH;PINK1;HDAC3;PRKN;AIDA;TAOK3;PDCD4;CYLD
prerank,apoptotic mitochondrial changes (GO:0008637),0.3540924645302709,0.9305499119711398,0.547550432276657,0.9664730934424095,1.0,12/32,21.37%,HK2;FIS1;SFN;NAIF1;ERBB4;FZD9;BAD;AIFM2;BNIP3;ATG3;BAX;CCAR2
prerank,negative regulation of insulin secretion (GO:0046676),0.3966965105210689,0.9302827473766551,0.5374800637958532,0.966400912099512,1.0,1/17,0.54%,INHBB
prerank,cartilage development (GO:0051216),0.3197612275730511,0.9299930512307301,0.5674931129476584,0.9663644198316229,1.0,6/49,4.05%,SULF1;RUNX2;GPLD1;WNT2B;TRPV4;SOX9
prerank,positive regulation of MAPK cascade (GO:0043410),0.27033843604314467,0.9295047408829221,0.6123949579831933,0.9667970719734927,1.0,14/245,4.99%,ROR2;ROR1;NTRK3;FGFR1;LPAR1;ACKR3;EGFR;RAP1A;PELI2;FGF1;CAV2;PTPN22;PRKCA;PTPRC
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.3274059404861687,-0.9294723501292813,0.5592783505154639,0.8650230316525983,1.0,5/18,12.18%,SHANK3;CUX2;GRIN1;PRKCZ;NRXN1
prerank,positive regulation of natural killer cell activation (GO:0032816),0.4141396624595832,0.929399972757407,0.5363321799307958,0.9663264434003006,1.0,3/13,9.88%,LAMP1;TICAM1;AXL
prerank,transcription by RNA polymerase II (GO:0006366),0.26753281188319344,0.9292404237702483,0.6427083333333333,0.9660074007995507,1.0,57/305,18.15%,RORA;PPARGC1A;NR3C2;RARB;DTX1;CSTF1;MAML2;MLLT3;PGR;INTS10;TAF10;LEO1;SNRPF;MED18;RPRD1B;TAF4B;CDK13;TEAD3;CDK7;PAF1;NCOR1;CSTF3;RREB1;RARA;RPAP2;ELL;MED7;NELFB;RORB;SUPT4H1;RPRD1A;NRBF2;ERCC6;NCOR2;RARG;MED23;GTF2F2;TAF15;CREBBP;GTF2H1;TRIP11;MBD1;CBFB;NR5A1;TAF5;YAP1;INTS3;SRRT;ELOA;ESRRA;PPARG;RTF1;TCEA1;SETD2;SYMPK;TSC22D1;GTF2H3
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.3096277408669107,-0.9289930595999909,0.5482954545454546,0.8652940798510748,1.0,11/22,20.16%,SLIT2;KANK3;HIP1R;TWF1;MYADM;TMSB10;CYRIB;TMSB4X;PFN1;SSH2;SSH3
prerank,divalent inorganic cation homeostasis (GO:0072507),0.3648771386953766,0.9288842123560183,0.5434782608695652,0.9661616666577024,1.0,1/25,0.24%,CAV1
prerank,myelination (GO:0042552),-0.26124724174027825,-0.9282251529384515,0.5709090909090909,0.8662712751202069,1.0,12/46,13.82%,PARD3;ADGRG6;SLC8A3;TNFRSF21;BCAS1;PLLP;CMTM8;GAL3ST1;LGI4;SBF2;ABCD2;DEGS1
prerank,protein destabilization (GO:0031648),0.3561094930499537,0.9277970100467507,0.5539772727272727,0.9679902586819156,1.0,15/32,23.11%,TRIM21;PEX2;CUL3;IRGM;KDM8;CREBBP;HTT;FBXL3;SENP2;CDC73;PRKN;MUL1;DERL1;FBXW11;PRNP
prerank,regulation of receptor recycling (GO:0001919),0.3941487016899252,0.9272438124779937,0.5508196721311476,0.968581635218847,1.0,4/16,9.11%,RAB29;KIF16B;INPP5F;TBC1D16
prerank,cellular response to glucose starvation (GO:0042149),0.3321169795344903,0.9270894140541405,0.5507868383404864,0.9682414577299342,1.0,8/41,8.96%,MYBBP1A;PRKAG1;FOXO3;EIF2AK3;PIK3R4;BRSK1;SESN1;MTMR3
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.3276278205340616,-0.926934714963608,0.6027397260273972,0.8676099366230373,1.0,9/19,33.50%,POLR2F;POLR2A;POLR2J;POLR2D;POLR2K;ACD;POLR2I;TINF2;POLR2B
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.3276278205340616,-0.926934714963608,0.6027397260273972,0.8676099366230373,1.0,9/19,33.50%,POLR2F;POLR2A;POLR2J;POLR2D;POLR2K;ACD;POLR2I;TINF2;POLR2B
prerank,regulation of TORC1 signaling (GO:1903432),-0.27654212866028816,-0.9269310357274744,0.5866261398176292,0.8666647551178838,1.0,12/33,27.27%,SEH1L;DEPDC5;RNF152;RRAGC;GPR137B;SPAAR;RRAGD;CASTOR2;CASTOR1;PIP4P1;FLCN;ATM
prerank,embryonic skeletal system development (GO:0048706),0.3391746288838309,0.9268903199087668,0.5558739255014327,0.9680045042758739,1.0,5/35,4.96%,SULF1;KIAA1217;PCSK5;DYNC2I1;WNT5A
prerank,negative regulation of cell development (GO:0010721),-0.3070971071762156,-0.9266139230311321,0.5473372781065089,0.8665694953133659,1.0,3/25,4.54%,IGF1;APPL2;B2M
prerank,RNA 3'-end processing (GO:0031123),0.30981895952761085,0.9262659177541185,0.5869565217391305,0.9687251161181695,1.0,24/69,25.75%,CSTF1;RBM8A;SRSF4;RPRD1B;TUT1;CSTF3;LIN28B;RPRD1A;UPF3B;THOC3;THOC5;SLU7;SYMPK;SRSF3;DHX38;NUDT21;SRSF11;PCF11;CPSF2;WDR33;SARNP;PABPN1;TENT4B;PNPT1
prerank,regulation of hippo signaling (GO:0035330),0.3836699779243379,0.9261301522108594,0.5451612903225806,0.9683543230006122,1.0,4/17,13.54%,VGLL4;WWC1;NF2;CIT
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.33017595476731765,-0.9251048952729536,0.5681233933161953,0.8693342977851983,1.0,5/18,19.00%,NUP133;THOC2;ZC3H11A;HHEX;DDX19A
prerank,nervous system development (GO:0007399),0.2638852719280923,0.9250344591054421,0.6755102040816326,0.9702283842676215,1.0,66/429,13.58%,NGF;EFNA5;LPAR1;LDB2;JAG1;ZC4H2;RAB29;RBFOX2;NF1;STIL;OPHN1;TMOD2;NPAS2;GLIS2;NBL1;HDAC4;DSCAM;PCDHB15;DACT1;ACVR1C;INTU;FN1;NTN5;CLN8;NCAN;ARTN;LSAMP;ARHGAP26;EPHB2;GMFB;SCD5;TAGLN3;CHERP;SIAH1;CDH2;ALDH5A1;S100B;IGF2BP2;DYRK1A;JRKL;KALRN;PTS;DOC2A;GPM6A;MPZ;UNC119B;RPS6KA3;BTBD2;POU4F1;AXL;RELN;ERCC6;BPNT1;TMEM223;APC;PRPS1;WDR62;FBXL17;DPYSL2;NDUFV2;PTEN;CHRM2;PKD1;SMO;SDK1;DPF3
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.3419426650966263,0.9250021125966288,0.5297450424929179,0.9696114702780451,1.0,11/35,18.98%,AWAT2;HMGCLL1;SCD5;ACACA;GCDH;ACAT1;GGTA1;GGT1;HPGD;SCD;BDH1
prerank,fatty acid transport (GO:0015908),-0.33121301983022233,-0.9245628223853822,0.5470297029702971,0.8697163565222243,1.0,3/17,6.29%,ACSL1;PPARD;APOE
prerank,histone H3-K9 demethylation (GO:0033169),-0.3815123581612482,-0.9245302139802191,0.5540229885057472,0.8688560322796134,1.0,4/11,20.15%,PHF8;KDM1A;KDM7A;KDM4D
prerank,midbody abscission (GO:0061952),0.3942695488116288,0.92418316146859,0.541038525963149,0.9708514875450449,1.0,5/17,11.97%,CHMP5;PDCD6IP;CHMP4A;CHMP4B;CHMP4C
prerank,covalent chromatin modification (GO:0016569),-0.34793495936760777,-0.924069094479004,0.555,0.869057072301933,1.0,4/14,12.45%,SETD5;HDAC1;HLCS;PARP2
prerank,autophagosome assembly (GO:0000045),-0.24792497220036225,-0.9239222024198933,0.6188524590163934,0.8684713541752149,1.0,17/52,24.50%,ATG16L2;BECN1;GABARAPL1;VMP1;WIPI1;ULK2;GABARAP;STX17;AMBRA1;STX12;ATG13;MAP1LC3A;RAB7A;WIPI2;ATG12;WDR45B;WDR45
prerank,positive regulation of telomere maintenance (GO:0032206),0.3487635977641826,0.9238936846212786,0.5445103857566765,0.9708406032868317,1.0,12/31,26.70%,NEK7;NBN;NAF1;ERCC1;MRE11;HNRNPD;SLX4;MAPK1;ATRX;TNKS;PML;RAD50
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.35460240566002477,0.923759918617837,0.5592203898050975,0.9704432223482574,1.0,9/27,18.67%,KAT6B;MSL3;TRRAP;PHF20L1;CREBBP;KAT8;BRD8;MORF4L2;RUVBL2
prerank,dephosphorylation (GO:0016311),0.28001229948005507,0.9235872422480488,0.5977272727272728,0.9701357010026709,1.0,31/147,15.19%,PTPN13;PTPRF;DUSP12;PLPP2;ACP6;PTPN14;TPTE;PLPP3;PTPN22;PTPRC;THTPA;PPM1A;PPM1M;MTMR7;PTPRJ;MTMR6;MTMR3;PDP2;PTPRT;SDHAF2;CTDSP1;PPP2R1B;PTPN18;PTEN;PTPRA;DUSP8;CTDSP2;PTPRU;PTPRO;PLPPR1;PTPN6
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.31395166068100183,-0.9233569343810389,0.5647668393782384,0.868947778744013,1.0,5/20,11.05%,HOXA5;MEIS1;CDK6;HOXB8;HOXA9
prerank,NAD biosynthetic process (GO:0009435),0.37378958313708827,0.9233140735900967,0.5564784053156147,0.9700604663293108,1.0,4/20,12.57%,NAPRT;NADSYN1;NMNAT3;NAXD
prerank,bile acid biosynthetic process (GO:0006699),0.3616898915141746,0.9229283442277113,0.5419254658385093,0.9702751051215723,1.0,4/24,10.28%,CYP7B1;OSBPL6;HSD17B4;ACOT8
prerank,regulation of interleukin-8 production (GO:0032677),0.3051390296644675,0.9229275276503688,0.5712418300653594,0.9695775673033685,1.0,8/69,11.05%,LBP;BCL3;PTPN22;PTPRC;TLR7;ANXA4;HMGB1;OTUD7B
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.43026902882893914,0.9227703772009154,0.5537340619307832,0.969242549182645,1.0,1/10,5.04%,CNGB1
prerank,tRNA wobble uridine modification (GO:0002098),-0.35081791552424857,-0.9227316724077699,0.5345268542199488,0.8694959457190381,1.0,9/14,37.21%,ELP3;TRMT9B;ELP4;GTPBP3;MOCS3;KTI12;ELP1;CTU2;CTU1
prerank,regulation of cell killing (GO:0031341),0.39300197796265746,0.9227296903335329,0.5536,0.9686323506704029,1.0,5/16,14.10%,CD55;WNT5A;NOXO1;CFH;FZD7
prerank,tRNA wobble base modification (GO:0002097),-0.35174136471719497,-0.9224746671693007,0.5555555555555556,0.8691852376737877,1.0,9/14,37.21%,ELP3;TRMT9B;ELP4;GTPBP3;MOCS3;KTI12;ADAT2;CTU2;CTU1
prerank,regulation of interleukin-1 production (GO:0032652),0.3883779664530257,0.9222695160177496,0.5338842975206611,0.9689975897123602,1.0,2/15,9.48%,CEACAM1;HMGB1
prerank,visual perception (GO:0007601),0.3021402617618082,0.9221322890807552,0.5942928039702233,0.9686327487827472,1.0,9/84,11.96%,RDH10;POU4F3;EFEMP1;SLC24A1;CNGB1;CRYBB3;BEST1;COL1A1;CRYBG3
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.3552057118878201,0.9219746030954545,0.532561505065123,0.9683181985328978,1.0,7/30,17.58%,HNRNPC;SRC;STN1;EXOSC10;MEN1;GNL3L;TERF2
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.28342000360422637,-0.9219136767179741,0.5852090032154341,0.8696162393358784,1.0,4/29,6.94%,IL31RA;GHR;IFNAR2;JAK2
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.3395663430964666,0.9219074818104965,0.5669957686882934,0.967780975043894,1.0,5/38,8.37%,CAV1;ASS1;ATP2B4;DDAH2;NOS1AP
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.2759349071319299,-0.9217460546398143,0.6011904761904762,0.8690466307684288,1.0,7/28,15.19%,SMAD3;PIK3R1;FLNA;ZC3H12A;TRIM28;ZIC1;ZPR1
prerank,axonal transport (GO:0098930),-0.27687742664273635,-0.921697904582097,0.6115107913669064,0.8682276966681606,1.0,9/36,18.22%,KIF1B;DST;NEFL;HIF1A;MAPT;DTNBP1;OPA1;TMEM108;BLOC1S6
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.325133575482091,-0.9214174272217394,0.5384615384615384,0.8679565289494543,1.0,4/17,15.22%,SLC7A5;PRKCZ;CEBPB;LGALS9
prerank,glycolipid metabolic process (GO:0006664),0.32646859478435025,0.9214108614760488,0.5610425240054869,0.9682599463408631,1.0,17/47,24.25%,ST3GAL4;NAGA;SUMF1;PGAP3;CERK;NEU1;HEXA;SCCPDH;HEXB;GBGT1;ASAH1;ST6GALNAC6;SUMF2;PGAP1;ESYT2;ARSA;SMPD2
prerank,chromatin organization (GO:0006325),0.2847949922167825,0.9213432586174647,0.5944380069524913,0.9677228614028657,1.0,44/132,21.52%,SPI1;SOX9;CDAN1;HDAC4;SATB1;CHD1;SMARCAD1;SUV39H1;GATAD1;SMARCD2;SUPT4H1;HDAC2;BAZ2B;PBRM1;TOP1;INO80;KDM6B;NUCKS1;BAZ2A;TADA2A;CHD1L;KDM4B;MCM3AP;BRWD1;HP1BP3;SETD2;MTF2;SUV39H2;HMGN2;RUVBL2;TCF7L1;HDAC3;NUDT5;HCFC2;RBBP4;HMG20A;CHRAC1;LOXL2;KDM5B;DAXX;SETDB1;RSF1;DDX11;ARID1A
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.27848381769990327,0.9212402833133996,0.6153846153846154,0.9672750654099153,1.0,18/158,11.08%,ROR1;PLK2;LPAR1;PELI2;AKAP13;SLC35B2;REL;NUP62;PPM1A;TRADD;TRIM21;S100B;TFG;TICAM1;TMED4;CANT1;SHARPIN;TAB2
prerank,RNA export from nucleus (GO:0006405),0.29360529764765725,0.9210324220447229,0.6227544910179641,0.9670477146291966,1.0,33/100,23.30%,RBM8A;SRSF4;NUP62;RBM15B;NUP160;UPF2;EIF4E;NUP37;TPR;NUP50;UPF3B;RANBP2;NUP210;SMG7;NUP153;THOC3;RAN;NUP93;THOC5;MCM3AP;XPO5;SLU7;SYMPK;SRSF3;DHX38;SRSF11;NUP43;DDX25;YTHDC1;SMG6;CPSF2;SEC13;WDR33
prerank,synapse assembly (GO:0007416),-0.2387807745165073,-0.9209871552459342,0.6401673640167364,0.8680524042467954,1.0,6/67,2.92%,FARP1;SHANK3;DNM3;SPOCK2;ADGRL3;OBSL1
prerank,epithelial cell morphogenesis (GO:0003382),-0.33867060498581814,-0.9207618222221275,0.5714285714285714,0.8676522434798222,1.0,5/17,20.23%,COL22A1;COL15A1;COL18A1;DACT2;MET
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.28779350332094245,0.9203226576918319,0.5770114942528736,0.9679832216368315,1.0,10/108,7.79%,NGF;DLC1;EIF2AK3;FIS1;ACVR1C;EGLN3;UACA;TRADD;NLRC4;MAP3K5
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.38744649528218444,-0.9202927369125298,0.5649038461538461,0.8678093877572556,1.0,5/10,29.40%,DNAJA1;CORO2B;MAPT;NDFIP2;PPM1F
prerank,regulation of cell aging (GO:0090342),-0.3626696833802238,-0.919982341840702,0.5774647887323944,0.867604593919852,1.0,4/11,19.84%,LMNA;NUAK1;VASH1;MIF
prerank,RNA modification (GO:0009451),0.311896040687191,0.9199699779570832,0.5706594885598923,0.9681177191954933,1.0,18/54,23.23%,MRM2;RBM15B;PUS7;PUS3;WDR4;CDKAL1;FTSJ1;NSUN5;ALKBH1;ANKRD16;URM1;TYW5;ADARB1;THG1L;TFB1M;TRMT1;JMJD6;MEPCE
prerank,positive regulation of inflammatory response (GO:0050729),0.2983433905460366,0.919678597023039,0.603448275862069,0.9680901977779214,1.0,14/86,12.38%,LBP;MGST2;WNT5A;ABCC1;IL17RA;TLR7;TRADD;PTGER4;TNIP1;KARS1;S100A9;IL6ST;VAMP8;CD81
prerank,regulation of telomerase activity (GO:0051972),0.32472196990601343,0.9195317618281249,0.5700808625336927,0.9677433005209742,1.0,6/45,12.07%,SRC;NEK7;NAF1;WRAP53;MEN1;CCT2
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.30697666700530846,-0.9191270948184982,0.5736842105263158,0.8687071754970082,1.0,5/22,14.43%,PDGFD;ACE;CALM1;TAOK2;CALM3
prerank,positive regulation of protein metabolic process (GO:0051247),0.28890478811189463,0.9189038727437407,0.6073113207547169,0.9685107153572027,1.0,13/110,11.37%,PLK2;GPC3;NEDD4L;AXIN1;TFR2;DACT1;WNT5A;TNFAIP3;MAPK7;ISL1;GSK3B;APC;NEDD4
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.28379730174929846,-0.9187609638242175,0.6116838487972509,0.8686932325129164,1.0,8/30,17.65%,DPM1;ALG5;STT3B;UBE2J1;RPN2;FUT8;OST4;ASGR1
prerank,glycerolipid catabolic process (GO:0046503),-0.3183502010964156,-0.9187212712904154,0.555256064690027,0.8678464430578867,1.0,3/19,12.51%,GPCPD1;PNPLA6;ABHD2
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.3937928782266501,0.9186930579355204,0.5425709515859767,0.9682994706505608,1.0,4/16,9.03%,CAMK2D;FKBP1B;ATP1A2;CASQ2
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.2811099345385595,-0.9184759651918212,0.5963855421686747,0.8674916664884645,1.0,6/31,9.70%,STXBP3;KCNB1;SYT9;SYT7;CACNA1G;SCAMP5
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.29316091215192547,-0.9182041129725026,0.5882352941176471,0.867261587743687,1.0,6/27,13.59%,IGF1;PDGFRA;CDK6;BMI1;SPHK1;CDK4
prerank,regulation of ATP biosynthetic process (GO:2001169),0.39662246532682705,0.9180162817339628,0.5453100158982512,0.9691574199692184,1.0,1/16,0.58%,PPARGC1A
prerank,protein complex oligomerization (GO:0051259),0.2950167572660313,0.917667684108488,0.5914634146341463,0.9692571946752994,1.0,25/85,24.22%,CLDN1;LRRC8D;BEND3;SPAST;NLRC4;ATL2;PDCD6IP;GSDMD;VSTM5;ADCY8;HGSNAT;GLRA3;ALS2;EHD1;MS4A1;NUDT21;STOML2;CHMP2A;YME1L1;ELAVL1;MPP2;JMJD6;PRMT8;RBMX;DNM1L
prerank,regulation of bone mineralization (GO:0030500),0.31709452653772724,0.9176563422290618,0.572,0.9685944151425832,1.0,4/55,4.10%,PKDCC;SGMS2;ANO6;BMPR1B
prerank,regulation of microtubule-based movement (GO:0060632),0.4249230231861631,0.9172782903677995,0.5706521739130435,0.9687223938461982,1.0,4/11,15.68%,LAMP1;HDAC6;TTC21B;CFAP298
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.34054731980566905,-0.9171006752424746,0.5735294117647058,0.8689848857198951,1.0,4/14,6.94%,GHR;LYN;PIK3R1;JAK2
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.30123977156842224,0.9169846690513231,0.5879396984924623,0.9686979247149224,1.0,8/72,9.98%,PLK2;GTSE1;BCL3;CNOT10;ARID3A;NBN;SFN;CNOT7
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.24206482954952668,-0.9168967258609871,0.59765625,0.8685257614597647,1.0,25/54,31.67%,MADD;UBE2K;CFLAR;RNF31;CLIP3;SPHK1;IKBKB;PELI3;LAPTM5;CASP8;CASP4;RACK1;TRAIP;IKBKG;RIPK1;SPPL2B;HSPA1A;BIRC3;SPATA2;PYCARD;CASP1;HSPA1B;TRAF2;ADAM17;RFFL
prerank,lymphocyte migration (GO:0072676),-0.2760962642109319,-0.916739359095061,0.5792880258899676,0.8679767897789736,1.0,24/32,51.86%,MSN;RET;CCL13;CCL19;ADAM8;CCL2;S1PR1;CCL25;MYO1G;CCL5;CCL11;CCL15;ZAP70;CCL4;GATA3;CCL7;CCL8;MSMP;CCR6;CKLF;CCL1;CCL3;TBX21;XCL1
prerank,regulation of endopeptidase activity (GO:0052548),0.3078173457687762,0.9166935991638997,0.5727513227513228,0.9687312972732506,1.0,6/59,6.00%,SERPINB2;SERPING1;APH1B;PSME3;SERPINH1;NCSTN
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.40911529972579974,0.916131572051228,0.5578583765112263,0.9693011176639802,1.0,2/14,6.14%,WNT5A;ADAM10
prerank,regulation of cellular response to heat (GO:1900034),0.29903322115779346,0.9160622009813709,0.5960591133004927,0.9687693699610959,1.0,27/77,23.74%,CAMK2D;HSPH1;NUP62;BAG3;NUP160;GSK3B;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153;CREBBP;NUP93;CHORDC1;DNAJC7;YWHAE;BAG2;CAMK2G;RPTOR;ATR;CCAR2;NUP43;RPA3;SEC13;MAPK1;MTOR
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.37508549493987786,-0.915927140807103,0.5807174887892377,0.8690295838290648,1.0,5/11,13.12%,NR1H3;LDLR;CTDNEP1;NR1H2;MFSD2A
prerank,mesonephros development (GO:0001823),-0.3691995843950368,-0.9157783180214041,0.5406698564593302,0.8684619126115811,1.0,2/11,2.60%,OSR1;BMP4
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.3533190357929348,-0.9153535710695667,0.5880893300248139,0.8686415227720367,1.0,5/13,14.60%,GREM2;NRROS;BMP2;DAND5;CHRDL1
prerank,regulation of phagocytosis (GO:0050764),-0.24889961882236442,-0.9147488015731653,0.6092436974789915,0.8691740877166981,1.0,9/53,9.19%,TGM2;DYSF;SIRPA;SYT7;PIP4P2;IL15RA;CYBA;GATA2;MERTK
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.3810579857543013,0.9146535486115381,0.5703001579778831,0.9713181995992105,1.0,2/17,3.14%,SULF1;CASK
prerank,protein localization to Golgi apparatus (GO:0034067),-0.28577362394448763,-0.9140534230976192,0.5709969788519638,0.8699247603984048,1.0,4/27,6.91%,VPS13D;OBSL1;COG7;VPS13C
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.422729042663904,0.9136613592259905,0.5756013745704467,0.9729013753598618,1.0,3/11,17.17%,SPI1;TICAM1;STX4
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.29875719350180424,0.9134860384711003,0.6093552465233881,0.9725880328763085,1.0,14/78,13.51%,NR2F2;EGFR;CCND3;CCNG1;CDK7;CCNJ;APC;HEXIM1;MEN1;PTEN;CDC6;PKD1;GTF2H1;CDKN1C
prerank,Rho protein signal transduction (GO:0007266),0.31483966441964406,0.9134836877422439,0.5888738127544098,0.9719072605234601,1.0,13/53,17.24%,CDH13;NTN1;CDC42EP4;RHOJ;RIPOR1;ARHGEF1;CTNNAL1;ADRA2A;CDC42EP3;ARHGEF11;CELSR1;RTKN;ARHGDIB
prerank,gonad development (GO:0008406),0.329101242229169,0.9132228494467812,0.5669515669515669,0.9718258089854754,1.0,5/41,7.44%,NR2F2;WNT2B;SOX9;WNT5A;MSH2
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.28400708686011117,0.9131349105113783,0.6061684460260973,0.9713493686005327,1.0,25/114,22.10%,EDA;TNFSF8;FOXO3;PSME3;TRADD;PSMB5;CDIP1;TNFRSF11B;TXNDC17;PSMB2;PSMA2;PSMA6;TNFRSF14;PSMD13;PSMA7;PSME4;PSMC4;PSMB6;PSMD12;PSMD14;ST18;TRAF3;TRAF5;PSMB3;LTBR
prerank,ceramide biosynthetic process (GO:0046513),0.3232534366863549,0.9129071528950299,0.5785123966942148,0.9711627849845392,1.0,4/40,5.63%,SGMS2;CERS6;ALOXE3;CLN8
prerank,regulation of cholesterol storage (GO:0010885),-0.34459079323469993,-0.9128679761746964,0.6157517899761337,0.8718795985535719,1.0,4/15,14.27%,PPARD;NR1H3;NR1H2;ABCG1
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.3290406494081117,-0.9128330627290936,0.5763546798029556,0.8710366390127571,1.0,2/16,4.13%,SOX13;NAPEPLD
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.2760483048329506,-0.9127420562689487,0.5830388692579506,0.8703179563060347,1.0,10/34,17.43%,ANK2;SLC8A1;CALM1;ATP1B1;SLC9A1;ZC3H12A;CALM3;SRI;P2RX4;NOS1
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.3300652992568993,-0.9126617464545643,0.5628415300546448,0.8695612185340623,1.0,4/19,8.02%,BMP4;WNT4;LARP6;TGFB3
prerank,activation of protein kinase activity (GO:0032147),0.2855630605951831,0.912341877697784,0.6193853427895981,0.9717932707020271,1.0,20/106,15.86%,NTRK3;PRR5;FGF1;AXIN1;MINK1;WNT5A;CARD10;TOM1L1;ADCY5;PRKAR2A;STK3;MAPKAP1;ADRA2A;PRLR;ADCY9;PRKACB;TXN;ADCY8;ADCY3;PIBF1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.38806640974932066,-0.9117998385798436,0.5625,0.8707280753905419,1.0,2/10,2.52%,MSN;CDC42
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.32485436271012547,-0.9116584355682558,0.5770308123249299,0.8701676156351411,1.0,5/20,13.26%,FAS;CASP3;GSK3A;BOK;DCC
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.3602814256724583,-0.9116578595046202,0.5811764705882353,0.8692484375145166,1.0,4/12,14.40%,AP2A1;TMEFF2;AR;EDN1
prerank,hippo signaling (GO:0035329),0.3518816775815926,0.9115197809284687,0.5725190839694656,0.9730004319236696,1.0,9/26,16.76%,AMOTL1;TJP2;AMOT;TEAD3;STK3;WWC1;NPHP4;YAP1;YWHAE
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.2897513922499978,-0.9114209421686557,0.5771428571428572,0.8688842315125507,1.0,12/27,36.82%,MAP3K20;TAOK2;IKBKB;CUL1;SKP1;IKBKG;TNIP2;UBB;MAP3K8;CCDC88C;RPS27A;UBC
prerank,regulation of cell death (GO:0010941),0.2956963990948616,0.910792483186735,0.6090047393364929,0.9739594876553836,1.0,18/94,13.44%,PRODH;ACER3;SPEF1;RAB29;WNT16;CIDEB;CELF1;NPAS2;ATG5;SARM1;FERMT2;CHMP4B;AXIN2;APC;FAF1;SNCG;DHCR24;SOX4
prerank,regulation of autophagy (GO:0010506),0.26947587133435663,0.9106286042406379,0.6518046709129511,0.9736609872616803,1.0,31/216,11.37%,DCN;PLK2;LEPR;TPCN1;FOXK1;PRKAG1;FOXO3;PTPN22;WDR41;ATP6V0D2;WDR24;PIP4K2B;KEAP1;ABL2;TRIM21;MCL1;RMC1;PIK3R2;FOXK2;ATP6V0A1;IRGM;MTMR3;GSK3B;HMGB1;TICAM1;EIF4E;TFEB;USP13;TAB2;HDAC6;NEDD4
prerank,chromatin assembly (GO:0031497),0.32993783243528874,0.9105995689758521,0.5850144092219021,0.9730477566909045,1.0,6/38,7.08%,SOX9;CDAN1;KAT6B;CTCF;PAF1;LIN54
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.39621325698473864,0.9105096946257887,0.5804311774461028,0.9725767409088061,1.0,1/14,0.43%,CORIN
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.40917707652881696,0.9103793441598934,0.5523978685612788,0.972172085282599,1.0,4/12,11.37%,PTPN14;SIRT7;TPR;NEDD4
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.3494406152919452,0.9103701383709156,0.5658682634730539,0.9715112846097087,1.0,6/28,16.91%,NRARP;EGFR;EGFL7;WWP2;FBXW7;MMP14
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.3680071849145018,-0.9103581512707947,0.5751633986928104,0.8704847604865003,1.0,3/12,14.27%,NR1H3;NR1H2;ABCG1
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.23085012494477797,-0.9102159595743508,0.6812227074235808,0.8699007056670686,1.0,17/68,20.44%,ENPP1;GPAT4;HPRT1;ACOT7;BPNT2;DBI;ACSL6;TPST1;MLYCD;LRRK2;ACLY;ACOT6;OPA1;ACOT11;HINT1;OXSM;SULT4A1
prerank,regulation of cellular component movement (GO:0051270),-0.25312000962891573,-0.9102039271312377,0.6111111111111112,0.8690035516878185,1.0,13/49,13.24%,ETS1;ROCK2;TGFBR3;SP100;LYN;TGFBR1;IGBP1;RPS19;CDK6;DIAPH1;ZSWIM6;YTHDF1;ZSWIM4
prerank,prostaglandin metabolic process (GO:0006693),-0.288349357448184,-0.9096250675386025,0.6164772727272727,0.8695534089974664,1.0,8/26,19.84%,PTGIS;PTGS1;PTGDS;TBXAS1;EDN1;HPGDS;ACOX1;MIF
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.3021151768710378,0.9094267839005515,0.6012987012987013,0.9729771425338632,1.0,21/71,20.40%,ADAMTS12;FAP;TNFAIP3;SOCS6;CHFR;PDCD6IP;CHMP4B;LONP1;OTUD7B;HDAC6;ZYG11B;FBXL17;CHMP4C;CAPN2;PSMA6;CUL4B;CTSB;USP9X;HM13;UBE2W;PRKN
prerank,peptidyl-amino acid modification (GO:0018193),-0.3778280334155049,-0.9091079437767459,0.6048192771084338,0.8698823007283272,1.0,1/10,3.31%,ATP7A
prerank,membrane organization (GO:0061024),-0.1995276390120418,-0.9089094187132123,0.7368421052631579,0.8694224024427557,1.0,32/227,9.96%,MYOF;PICALM;HIP1;TGFA;ANK2;DNM3;DAB2;TFRC;DNAJC6;DYSF;NAPA;TRIP10;AP2A1;STX18;LDLR;SYT9;HSPA8;HIP1R;MYADM;ATP2C1;ACTB;SH3KBP1;CTDNEP1;EPS15;SH3GLB1;LEMD3;LDLRAP1;PIK3C2A;ACTG1;ARPC3;VPS4A;ANK3
prerank,cellular protein catabolic process (GO:0044257),0.30354383132711105,0.9088686102029796,0.5690322580645162,0.9735676501483168,1.0,16/59,22.85%,ADAMTS12;FAP;PISD;CPA2;LONP1;CAPN2;HTRA2;PSMA6;AP2A2;BNIP3;CTSB;PRKN;TCIRG1;YME1L1;AP2S1;CLTA
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.3407513477606088,-0.9088143927013929,0.5761904761904761,0.868755983305318,1.0,7/15,19.28%,IGF1;ROCK2;MEF2A;SLC9A1;EDN1;AGT;PARP1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.41721764690136964,0.9081326824115996,0.5719626168224299,0.9745910597050906,1.0,2/10,7.80%,EMC9;EMC7
prerank,protein secretion (GO:0009306),0.30978328570669367,0.9080525490505067,0.582010582010582,0.9740993327677486,1.0,7/56,9.72%,TANGO6;PCSK5;RAB8B;RIMS2;RAB3A;LTBP2;ABCA1
prerank,ubiquinone biosynthetic process (GO:0006744),0.3960152772908946,0.9079808916679319,0.5730897009966778,0.9735762323144378,1.0,3/15,8.81%,COQ7;COQ8A;COQ9
prerank,positive regulation of histone acetylation (GO:0035066),0.3628039405447047,0.907842481058819,0.5734157650695518,0.9731905059977037,1.0,1/23,0.58%,PPARGC1A
prerank,negative regulation of phosphatase activity (GO:0010923),0.3551619399622227,0.907727742185834,0.5834633385335414,0.9727602352669837,1.0,7/25,12.92%,SH3RF2;FKBP1B;BOD1L1;GSK3B;MASTL;SEMA4D;PTPA
prerank,organelle assembly (GO:0070925),0.26298736280438534,0.9075873996963041,0.7247706422018348,0.9724062990520206,1.0,90/385,19.80%,DYNLL1;PARVA;UBXN10;RAB8B;ABLIM3;MKS1;PTPDC1;DZIP1;DYNC2I1;TMOD2;CYS1;EXOC3;NUP62;CNGB1;INTU;HPS1;CEP89;TSG101;NEK7;CEP131;SH3PXD2B;IFT81;ATG5;CNGA4;EHD2;NCOR1;SNX10;CEP162;CLUAP1;TMOD1;IRGM;OCRL;CHMP5;PDCD6IP;UNC119B;TCTN2;TMEM237;FOXJ1;IST1;DYNLL2;IFT74;TUBGCP5;CHMP4A;CHMP4B;CENPJ;ATXN2;HDAC6;CFAP20;CHMP4C;EXOC5;CEP290;INO80;CDS2;CSDE1;UBAP2L;MAPRE2;PKD1;ATG7;DDX6;FLII;FBF1;PCM1;PDE6D;FAM161A;DNAH5;PIK3C3;CFAP298;CFAP70;PIBF1;CFAP410;B9D2;MRPL22;UBQLN1;CDC14A;DYNC2H1;EHD1;OFD1;ATG2B;ARMC9;BBS1;CEP250;SNAP29;MAP1LC3B;G3BP1;LSM3;ATG3;HDAC3;TUBGCP6;TCTN1;RB1CC1
prerank,inorganic anion transmembrane transport (GO:0098661),-0.23879032946256248,-0.9074611858366357,0.634703196347032,0.8709844546793812,1.0,23/63,22.15%,ANO1;SLC12A6;ANO4;SLC5A6;ANO3;GABRA2;SLC26A2;SLC25A30;SLC25A11;LRRC8A;GABRB1;SLC12A5;GLRA2;SLC1A3;SLC6A1;SLC1A1;ANO5;SLC12A7;GABRE;GABRA5;SLC37A1;ANO2;SLC12A9
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.2963969190782168,-0.9071247547621266,0.5614525139664804,0.8708206370493784,1.0,3/22,5.81%,ADGRV1;GRM3;ORAI1
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.41187890290840085,0.906860760628939,0.5609348914858097,0.973305546430912,1.0,2/11,9.56%,EXOSC5;EXOSC10
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.37699491523073486,0.9067961941219046,0.5681063122923588,0.9727880734916038,1.0,8/19,19.16%,AXL;IL7;PPP2R3C;SYK;BTK;MDK;MMP14;XRCC6
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.31959785171551414,-0.9067895141347572,0.5842696629213483,0.8707883556951093,1.0,2/18,6.91%,PLCB1;AGRN
prerank,regulation of cartilage development (GO:0061035),0.38213440421839695,0.9066384614054643,0.5745393634840871,0.9724876293944034,1.0,4/18,4.10%,MBOAT2;PTHLH;SOX9;BMPR1B
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.2999171965487848,0.9065364513329831,0.6140127388535032,0.9720736619155015,1.0,8/76,9.13%,NTRK3;PRKCE;CDC42EP4;NUP62;FER;NCK2;ARF6;PLEK
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.24420334643076327,-0.9060886681742408,0.6330935251798561,0.8714196840442181,1.0,14/51,19.75%,IL6R;CXCL12;CMKLR1;VEGFC;LGMN;IL34;VEGFD;THBS1;PTK2;LGALS9;CSF1;EDN3;RARRES2;PTN
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.39087038002859564,0.9058197714388795,0.583739837398374,0.9730031788461763,1.0,1/17,0.47%,NTRK3
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.3695447321664714,-0.9055439302907085,0.5995525727069351,0.8717512920706955,1.0,4/11,15.43%,FRS2;BMP2;SOX6;MYOCD
prerank,potassium ion transport (GO:0006813),0.28504152500898816,0.9053060522887797,0.6122685185185185,0.9734522224348574,1.0,18/120,13.89%,KCNJ4;NALCN;KCNA5;KCNJ16;SLC24A1;KCNS2;KCNK1;ATP1A2;KCNJ13;KCNK5;ATP1B3;KCNS3;KCNAB1;SLC9A7;SLC9A6;AQP1;KCNK10;KCNK4
prerank,rRNA methylation (GO:0031167),0.36369770490479825,0.9049339988367922,0.5521669341894061,0.9736043655906873,1.0,6/22,16.71%,MRM2;BUD23;TFB2M;METTL5;NSUN5;MRM1
prerank,dendritic cell differentiation (GO:0097028),-0.2977227552654295,-0.9048737902275147,0.6016713091922006,0.8723897205256449,1.0,10/22,35.39%,LYN;CAMK4;LGALS9;TRPM2;CCL19;IRF8;PRTN3;TREM2;BATF2;LILRB1
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.23744594540626707,-0.9043386522806295,0.649402390438247,0.8727667029981367,1.0,14/62,14.33%,LYN;EP300;HOXA5;MEIS1;SETD1A;HDAC1;MYL9;CDK6;AGO3;HOXB8;HOXA9;THBS1;MOV10;AGO4
prerank,peptidyl-proline hydroxylation (GO:0019511),0.4177821053354728,0.9039121431886922,0.593128390596745,0.9752132941669305,1.0,4/11,14.08%,EGLN3;P4HTM;P4HA1;P4HB
prerank,regulation of potassium ion transport (GO:0043266),0.340525492535798,0.9038745325713035,0.5878186968838527,0.974623687619867,1.0,7/31,13.61%,KCNA5;KCNIP4;CASQ2;ADRA2A;KCNAB1;FHL1;KIF5B
prerank,regulation of striated muscle contraction (GO:0006942),0.35084239115648014,0.9038725608075109,0.5924764890282131,0.9739590340110523,1.0,3/27,5.19%,MYBPH;SCN10A;ATP1A2
prerank,cochlea morphogenesis (GO:0090103),0.4304768474782255,0.9035048771280851,0.5830564784053156,0.9740689391902293,1.0,4/10,20.86%,SOX9;TBX18;MYO3B;PAX2
prerank,mitotic nuclear division (GO:0140014),0.29734658069705394,0.9034831246976395,0.5773447015834349,0.9734476720406771,1.0,19/71,18.51%,KIF2A;SMC3;NUP62;SPAST;TUBG1;DSN1;CHMP4B;NDE1;MAP9;INO80;TUBG2;KLHL22;ZW10;ARHGEF10;RAN;PIBF1;CENPK;OFD1;RHOA
prerank,nuclear body organization (GO:0030575),0.41244460669273975,0.9034611147235623,0.568935427574171,0.9728292023640644,1.0,3/12,10.89%,USP50;WRAP53;SRPK2
prerank,regulation of protein localization to cell surface (GO:2000008),0.34252415530278346,0.9033469842174213,0.5796460176991151,0.9724036254106132,1.0,3/33,2.89%,NEDD4L;LEPROT;RIC3
prerank,placenta development (GO:0001890),0.407223788074003,0.9033336006007285,0.587521663778163,0.9717666947087493,1.0,1/12,2.24%,ADAM19
prerank,response to light stimulus (GO:0009416),0.31315497879325566,0.9032707442890233,0.6119791666666666,0.9712391198540843,1.0,8/55,11.91%,MSH6;SLC24A1;MAPK10;BRSK1;OPN1MW;OPN1MW3;ERCC6;MEN1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.29662777387701983,-0.9029218603996801,0.5807365439093485,0.875188713425852,1.0,3/23,2.70%,WNT5B;BMP4;GJA1
prerank,water-soluble vitamin metabolic process (GO:0006767),0.2990540801135731,0.9028902728986291,0.6072772898368883,0.9714020626882751,1.0,16/68,15.44%,CTRC;FOLR2;PCCB;ACP5;THTPA;MTHFD1;ABCC1;SLC52A1;CD320;CUBN;MMAB;TPK1;AMN;SLC46A1;PANK2;SLC25A19
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.2900565581181961,-0.9028817640645539,0.6018808777429467,0.8743733700183494,1.0,5/25,11.96%,GRIN2B;AKT1;GRIN1;LRRK2;GSK3A
prerank,cell chemotaxis (GO:0060326),0.306100567896451,0.9028088243611841,0.600265604249668,0.970912862852723,1.0,3/60,0.78%,PARVA;LPAR1;ACKR3
prerank,phosphate-containing compound metabolic process (GO:0006796),0.2672466842920326,0.9026534242325133,0.6727861771058316,0.970615071958857,1.0,22/198,7.20%,PLCD3;PLCE1;PLCB3;HK2;DUSP12;PFKP;PLPP2;ACP6;TPTE;PLPP3;LIMK2;PIP4K2B;PTPRC;THTPA;PPM1A;CLN8;BCKDK;COQ8A;CERK;EPHB2;PPIP5K2;ALDOB
prerank,translesion synthesis (GO:0019985),0.3244684006710517,0.9025940286224506,0.5853314527503526,0.9700652645954889,1.0,6/42,10.63%,UBE2L6;USP43;POLI;RFC3;NPLOC4;RCHY1
prerank,bicarbonate transport (GO:0015701),0.3604710734373776,0.9025543211347153,0.5720653789004457,0.9694917579140048,1.0,4/25,7.04%,SLC4A3;SLC26A9;SLC4A4;SLC4A11
prerank,regulation of spindle organization (GO:0090224),0.38102699621266256,0.90247730011711,0.5952380952380952,0.9690013484251955,1.0,3/18,12.02%,SENP6;NUP62;MAP9
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.2651668192456692,-0.9023427235006559,0.6512345679012346,0.8747353784118982,1.0,9/36,17.03%,TGFA;SHANK3;HIF1A;HDAC1;JAK2;EDN1;NRP1;HFE;EGF
prerank,protein insertion into membrane (GO:0051205),0.34161677955872577,0.902301893249845,0.5844544095665172,0.9687140352452647,1.0,13/32,24.80%,EGFR;STX1A;TRAM1;RTP3;EMD;OTOF;UBE2J2;SEC61G;STX5;VAMP2;PRNP;VAPA;SERP1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.2790621201272828,0.9021528075729635,0.6188811188811189,0.9683815203677993,1.0,20/117,16.59%,PLK2;CD3G;MC5R;PTHLH;SRC;ADCY5;PTGER4;PRKAR2A;TSHR;KARS1;ADCY9;CD81;PRKACB;GGT1;ADCY8;ADCY3;PTH2R;GPR27;SYK;RXFP1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.2382813903255117,-0.9020091171867594,0.6521739130434783,0.8745926360634395,1.0,8/57,10.70%,DAPK1;ACTN2;GRIA2;NEFL;GRIN2B;CAMK2A;GRIN1;CACNG7
prerank,regulation of fibrinolysis (GO:0051917),0.40347790040423404,0.9019845377910519,0.5730897009966778,0.9681162010653223,1.0,1/13,1.69%,FAP
prerank,mesenchyme morphogenesis (GO:0072132),-0.3283122164405361,-0.9013075430118159,0.5841836734693877,0.8754407474933915,1.0,5/17,12.75%,ENG;NOS3;ACVRL1;BMP2;TGFB2
prerank,membrane protein proteolysis (GO:0033619),0.328140978711722,0.9010639226995758,0.5885634588563459,0.9695782708454561,1.0,6/37,9.33%,ADAM19;APH1B;NCSTN;ADAM10;DAG1;BACE2
prerank,fatty acid biosynthetic process (GO:0006633),0.3019601779831247,0.9006929199987821,0.5994865211810013,0.9697085510439832,1.0,15/63,19.23%,ELOVL5;DECR2;HACD4;ELOVL1;SCD5;ACACA;ELOVL2;HACD2;LTA4H;ABCD1;ELOVL6;HPGD;SCD;LPL;FADS1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.3705714830345859,-0.9006746919611326,0.5859728506787331,0.8750717288233698,1.0,5/10,29.21%,KLF4;MYADM;WNK1;MAP2K5;MBP
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.3705714830345859,-0.9006746919611326,0.5859728506787331,0.8750717288233698,1.0,5/10,29.21%,KLF4;MYADM;WNK1;MAP2K5;MBP
prerank,microvillus assembly (GO:0030033),0.39758062388367665,0.9006600305364234,0.5855263157894737,0.9691156111697299,1.0,3/14,8.67%,RAP1A;MINK1;RAPGEF6
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.2854568811099631,0.9005742952807867,0.6465721040189125,0.9686425179306429,1.0,18/112,10.55%,F11R;PXN;DLX1;WNT10A;CDH5;SOX9;SRC;WNT5A;TGFBRAP1;COL3A1;MAPK7;GCNT2;LTBP2;CGN;FERMT2;LEFTY1;FNTA;ZYX
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.34676189605118246,0.9004470458059903,0.5776487663280117,0.9682692002125678,1.0,9/26,21.18%,FKBP1B;ATP1A2;CASQ2;ADRA2A;THADA;UBQLN1;YWHAE;CBARP;CALM2
prerank,cellular response to estrogen stimulus (GO:0071391),-0.3437686682089899,-0.9002576515998807,0.6,0.8751906900578853,1.0,4/14,13.08%,SERPINB9;AR;NCOA4;ARID5A
prerank,plasma membrane organization (GO:0007009),0.3076118675069045,0.9000879767899149,0.6189189189189189,0.9684064079896919,1.0,21/61,19.97%,EPB41L3;AHNAK2;ANO6;A4GALT;PACSIN2;EHD2;RAB3A;PLSCR1;CHMP4A;STX2;ARL8B;ABCD1;OTOF;OSBPL2;STX4;SPTBN1;CAVIN2;PACSIN3;NSF;FA2H;PACSIN1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.32119393785928535,-0.9000016365625918,0.6028169014084507,0.8748324997057518,1.0,6/17,14.27%,ERLIN1;APOE;SCAP;ABCA2;ERLIN2;ABCG1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.3719571907178121,0.8999586899527153,0.580542264752791,0.9680312040676228,1.0,2/21,4.40%,EFNA5;PEAK1
prerank,negative regulation of RNA splicing (GO:0033119),0.37943209058551775,0.8999581103193782,0.5821371610845295,0.967373765360787,1.0,9/19,24.09%,SRSF4;RPS13;PTBP3;SFSWAP;PTBP2;SAP18;SRSF12;SRSF10;RBMX
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.362355370126423,-0.8995301290705495,0.5952380952380952,0.8750667798316865,1.0,6/11,22.92%,IL34;ID2;HSF1;CSF1;CASP8;RIPK1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.38206035937285376,0.8994667641465035,0.5913461538461539,0.9678110757046104,1.0,5/17,13.11%,PBX1;MAML2;HEYL;WWC1;CREBBP
prerank,determination of heart left/right asymmetry (GO:0061371),-0.2557692017401025,-0.8994620180662087,0.6506849315068494,0.8743173161858265,1.0,11/43,16.59%,ENG;TBX3;NPHP3;SOX17;ZIC3;DAND5;MEGF8;VANGL2;MKKS;AHI1;SOX18
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.2749559402696125,0.8991851937449148,0.6485875706214689,0.9677550946160524,1.0,38/146,19.69%,DYNLL1;PSME3;SFI1;CEP131;CEP78;NEDD1;TUBG1;CKAP5;FBXO5;PAFAH1B1;CCP110;PSMB5;MECP2;USP47;CENPJ;NDE1;CEP290;SSNA1;CETN2;FHL1;PCM1;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;YWHAG;YWHAE;CEP57;PSME4;OFD1;PSMC4;PSMB6;PSMD12;PSMD14;CEP250;DCTN2;ALMS1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.28799567172266904,0.899039262849054,0.6425992779783394,0.9674157461281165,1.0,31/96,23.30%,RBM8A;SRSF4;NUP62;RBM15B;NUP160;UPF2;EIF4E;NUP37;TPR;NUP50;UPF3B;RANBP2;NUP210;SMG7;NUP153;THOC3;NUP93;THOC5;MCM3AP;SLU7;SYMPK;SRSF3;DHX38;SRSF11;NUP43;DDX25;YTHDC1;SMG6;CPSF2;SEC13;WDR33
prerank,modification-dependent protein catabolic process (GO:0019941),0.266592325884665,0.8986681869810683,0.6752411575562701,0.9675733430099236,1.0,46/193,18.75%,NEDD4L;UBE2L6;RNF130;WDR81;UBE3C;UBE2I;SPSB4;KEAP1;CHFR;SIAH1;ZNRF3;CUL3;UBL7;CDC20;AMFR;ANAPC5;ANAPC7;NPLOC4;RCHY1;TRPC4AP;LONP1;ANAPC11;NEDD4;BUB3;TTC3;FBXO11;RNF185;FBXO21;FBXO8;ANAPC2;UBA1;UBE2D1;KLHL15;FEM1C;ANAPC4;FZR1;PSMD13;UBE2R2;UBQLN1;ITCH;RNF7;WDR91;ANAPC16;PINK1;CDC23;PSMD14
prerank,arachidonic acid metabolic process (GO:0019369),-0.26728015043412423,-0.898388275140319,0.6161616161616161,0.8758849423582533,1.0,7/35,10.29%,PTGIS;CYP1B1;GPX4;DAGLA;PTGS1;PTGDS;TBXAS1
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.24505406421374382,-0.8980466976288024,0.6595744680851063,0.8757539514105608,1.0,22/54,29.48%,RPL35A;RPL26;NPM1;HEATR3;RPLP0;RPL3;WDR12;NOC2L;LAS1L;MRPL20;RPL14;NLE1;PPAN;RPL10A;RPL5;PAK1IP1;RPF2;NHP2;RPL7;RPL11;NOP16;RPL24
prerank,negative regulation of cell cycle (GO:0045786),-0.2275009604857674,-0.8974455169150378,0.704225352112676,0.8762600865380458,1.0,13/73,12.01%,SMAD3;PTPN3;LATS2;NUPR1;BMP4;PTPRK;GAS1;BRINP3;CDK6;TRIM35;RHOB;BMP2;CAMK2N1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.39592190810182437,0.8973098234000763,0.5941780821917808,0.9698571694902419,1.0,2/15,4.62%,PIEZO2;TMC2
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.34133771688338554,0.8973087538986068,0.5889212827988338,0.9692037078531872,1.0,7/33,14.04%,KLK2;AXIN1;DDRGK1;UFSP2;HDAC6;NCOA2;CBFB
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.38293774441218187,0.8971670580824906,0.5802861685214626,0.9688941533418283,1.0,1/17,0.82%,NEDD4L
prerank,innate immune response (GO:0045087),-0.18870459457586647,-0.8964864638172718,0.7910447761194029,0.8776180860141052,1.0,47/217,22.41%,SP100;SERINC3;LYN;MFHAS1;ADAR;CXCL16;TNK2;MID2;TRIM25;B2M;IRAK4;ALPK1;PLCG2;GCH1;NRROS;CYBA;BST2;TRIM14;BCL10;TRIM35;TRIM28;PGLYRP1;MFAP4;NCF2;AKAP1;POLR3A;PJA2;CFP;PTK2;IKBKB;TRIM59;ISG15;IFIT1;MASP1;CYBC1;CD40;TRIM8;RARRES2;COLEC12;TLR3;FES;TRIM13;TRIM11;SHFL;RPL39;IKBKG;RNF187
prerank,negative regulation of cell growth (GO:0030308),-0.20841327598534248,-0.8961030846400904,0.7297297297297297,0.8776257945468348,1.0,30/121,17.78%,SMAD3;ENPP1;SLIT2;SMARCA2;GJA1;ACVRL1;BMPR2;CCN3;NPR1;DNAJB2;APBB2;SOX17;RNF6;JADE1;BST2;ULK2;GSK3A;TGFB2;DCC;CDKN2AIP;TCHP;SERTAD3;CCDC85B;CGRRF1;BTG1;MAG;SEMA3G;SMAD4;RERG;WNT11
prerank,RNA catabolic process (GO:0006401),0.3147264811535644,0.8960222022260362,0.585195530726257,0.970824584941299,1.0,15/46,23.67%,RNASEH2B;CNOT10;PABPC4;DXO;DIS3L2;SIDT2;ZFP36L2;ERN1;RNASE3;MTREX;HNRNPD;EXOSC7;LSM2;RNASEH1;RNH1
prerank,striated muscle cell differentiation (GO:0051146),0.387573524654018,0.8959637044185476,0.5875420875420876,0.9702967649481179,1.0,5/16,12.85%,AKAP13;PLD3;SDC1;POPDC3;KDM6B
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.3046043774627304,0.8958237843361638,0.6028097062579821,0.9699363841717187,1.0,12/60,20.68%,SMOC2;NEK7;RFC3;NAF1;WRAP53;CCT2;POLG2;RGCC;DSCC1;ATR;CCT3;HGF
prerank,positive regulation of ossification (GO:0045778),0.32963836031779614,0.8952718335427181,0.5909090909090909,0.9705337279290934,1.0,4/39,4.96%,PKDCC;ANO6;BMPR1B;WNT5A
prerank,protein polyubiquitination (GO:0000209),0.25932824161637,0.8951168546531917,0.7103882476390346,0.9702129247048983,1.0,81/297,21.65%,NEDD4L;UBE2L6;ZNRF2;FBXL15;PELI2;UBE2E2;IRF2BP1;UBE3C;LMO7;PSME3;LRSAM1;TMEM129;TNFAIP3;TRIM21;UBR5;CHFR;UBE2V2;SIAH1;FBXO31;CUL3;AMFR;PSMB5;BLMH;LNPEP;ANAPC5;ANAPC7;UBE3D;SHARPIN;ANAPC11;FBXL19;LONRF1;NEDD4;FBXL5;FBXL17;TTC3;FBXO11;FBXO21;FBXO38;ANAPC2;PSMB2;ANKRD39;CBFB;UBE2J2;UBE2D3;UBE2D1;PSMA2;PSMA6;ANAPC4;WWP2;FZR1;PSMD13;FBXW8;PSMA7;TRIM5;FBXO41;DDB2;UBE2R2;FBXL12;FBXW7;FBXL3;ITCH;PSME4;PSMC4;CDC23;PSMB6;PSMD12;PSMD14;DDA1;KBTBD7;HECTD2;UBE2W;PRKN;MKRN1;RNF146;RNF14;MUL1;TRAF3;TRAF5;ZNRF1;PSMB3;AKTIP
prerank,positive regulation of lipid localization (GO:1905954),-0.36876609847880953,-0.8950175118596191,0.6169724770642202,0.8792062739766774,1.0,2/11,10.20%,LRP1;ZC3H12A
prerank,protein localization to synapse (GO:0035418),-0.3481716024092645,-0.8950040390740578,0.5740318906605922,0.8783412614297317,1.0,3/12,14.93%,BSN;NRXN1;NRXN2
prerank,regulation of acute inflammatory response (GO:0002673),-0.32151331204064715,-0.8949181867740859,0.6363636363636364,0.8776557500256581,1.0,1/18,1.18%,OSMR
prerank,regulation of stem cell differentiation (GO:2000736),0.28485472415839713,0.8948881723727379,0.6072319201995012,0.9700772903281192,1.0,27/89,21.62%,JAG1;LMO1;KMT2A;PSME3;PUS7;SLC4A11;NELFB;PSMB5;ZFP36L2;PSMB2;CBFB;PSMA2;PSMA6;PSMD13;PSMA7;YAP1;ITCH;PSME4;PSMC4;PSMB6;PSMD12;PSMD14;TCF3;OCIAD1;NUDT21;RUNX1;PSMB3
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.3433641004928726,0.8947867229746108,0.5707964601769911,0.9696548047480307,1.0,8/29,13.29%,ELOVL5;ELOVL1;SCD5;ACACA;GCDH;ELOVL2;HACD2;ELOVL6
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.39627154257622355,0.8946159149644137,0.5868372943327239,0.9693415587216646,1.0,1/13,0.88%,NAPRT
prerank,glycerophospholipid catabolic process (GO:0046475),-0.2804255763535968,-0.8942761250508265,0.6231003039513677,0.8782144811197996,1.0,3/27,8.38%,GPCPD1;ENPP2;PNPLA6
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.3094939650432712,-0.8941983074640617,0.6222826086956522,0.8775005545180118,1.0,5/19,12.82%,CCT7;CORO2B;CEP135;CCT8;CEP120
prerank,positive regulation of vacuole organization (GO:0044090),0.4209181559686339,0.8941932707667692,0.5966101694915255,0.9696121317702027,1.0,3/10,6.43%,LRSAM1;PIP4K2B;RAB3GAP2
prerank,sensory perception of light stimulus (GO:0050953),0.2900077726149134,0.8936249275030507,0.6104368932038835,0.9702211658829014,1.0,9/87,11.96%,RDH10;POU4F3;EFEMP1;SLC24A1;CNGB1;CRYBB3;BEST1;COL1A1;CRYBG3
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.27348170236699093,0.8935007528344793,0.6542372881355932,0.9698495308773039,1.0,16/150,10.74%,GAB1;FGF7;FGFR1;PIK3AP1;EGFR;FGF1;SRC;RAC2;PIK3R2;PTPRJ;GCNT2;FGF18;GAB2;AXL;FERMT2;STRN
prerank,peptidyl-asparagine modification (GO:0018196),-0.2770413860185999,-0.8934012714222251,0.6571428571428571,0.8784966672599784,1.0,8/31,17.65%,DPM1;ALG5;STT3B;UBE2J1;RPN2;FUT8;OST4;ASGR1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.3886396547565381,0.8933091937019076,0.5756578947368421,0.9696207999364936,1.0,1/16,0.79%,ST3GAL4
prerank,heart contraction (GO:0060047),0.32063080799691557,0.8929999888507056,0.6148555708390646,0.9696329170125062,1.0,7/41,12.40%,SGCD;SGCG;CSRP3;ATP1A2;CASQ2;SCN2B;TNNI1
prerank,ncRNA 3'-end processing (GO:0043628),-0.3415331953049586,-0.8926321660182153,0.5743589743589743,0.8793643165483483,1.0,2/14,5.87%,SSB;TRNT1
prerank,reticulophagy (GO:0061709),-0.35882814816339476,-0.8921621822862922,0.5746835443037974,0.879589493529781,1.0,3/12,8.62%,UBA5;ULK2;UFM1
prerank,regulation of protein localization (GO:0032880),-0.23904975042203971,-0.8920260024996094,0.6982758620689655,0.8790261896160905,1.0,15/58,19.63%,PICALM;AFDN;FKBP1A;TRIM25;TRIM14;WDPCP;VPS4A;CTSD;KDM1A;MMD;STX6;TESK1;PARP1;RACK1;PLEKHM2
prerank,negative regulation of B cell activation (GO:0050869),-0.3048019614354973,-0.8919872822828178,0.6233766233766234,0.8782119362743901,1.0,11/21,28.88%,LYN;TNFRSF21;SAMSN1;ID2;LAPTM5;RC3H1;INHBA;PARP3;ATM;FCGR2B;SFRP1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.2435586606784762,-0.8917570170774127,0.6862745098039216,0.877852645397323,1.0,13/48,15.30%,ADCY1;ADCY7;NPR1;ACOT7;PAPSS1;SLC26A2;ADCY4;ADCY2;PANK1;SLC35B3;PPCDC;IMPDH1;NUDT2
prerank,epithelial cell development (GO:0002064),0.3715391910512359,0.8915642594319209,0.5917065390749602,0.9722004709913761,1.0,4/20,10.11%,BFSP1;POF1B;TMEM79;LRTOMT
prerank,Golgi organization (GO:0007030),0.27616734640599494,0.8915356823059892,0.6757396449704142,0.9716109253969949,1.0,29/112,18.79%,ATP8B3;ATP8B1;RAB29;PI4K2B;LMAN2;RAB30;ATL2;GOLGB1;ATP8B2;NPLOC4;LYSMD3;TMED4;CSNK1A1;GCC2;TRIP11;HTT;ZW10;FBXW8;TMED2;SEC23IP;TICAM2;PI4K2A;ATP8B4;TBC1D20;ARHGEF7;DYNC2H1;STX5;COG3;BET1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.30563020946642844,-0.890916686889011,0.6010498687664042,0.8789967199927872,1.0,8/20,18.79%,MTHFS;GCLM;PLOD2;PTDSS2;CNDP2;GGCT;GCLC;GATM
prerank,protein import into mitochondrial matrix (GO:0030150),-0.32126750690077466,-0.8906404780180128,0.6408977556109726,0.8787127604749222,1.0,9/18,33.15%,TIMM44;PAM16;TIMM17B;ROMO1;GRPEL1;DNLZ;TIMM50;TIMM23;TIMM21
prerank,calcium ion import (GO:0070509),-0.2798991877027097,-0.8900330797373582,0.6215384615384615,0.8791300997287314,1.0,7/28,12.83%,SLC8A1;CACNB2;CACNA1G;SMDT1;SLC25A23;MICU1;MICU2
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.2790718342988214,-0.8899889893092355,0.6158357771260997,0.8783335389534018,1.0,6/29,15.04%,SLC4A10;APOE;GRIK2;CAMK2A;DBN1;ZDHHC2
prerank,zinc ion transmembrane transport (GO:0071577),-0.2946882784271791,-0.8899152360624858,0.6336088154269972,0.8776160352221513,1.0,4/22,6.86%,SLC30A10;SLC39A10;SLC39A8;SLC39A14
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3285539054977953,0.8892830868670254,0.594059405940594,0.9758949731592309,1.0,4/36,4.96%,NFATC1;PLCB3;FZD2;WNT5A
prerank,cytoplasmic microtubule organization (GO:0031122),0.30957631063741403,0.8890390181946045,0.6035182679296346,0.9757653281189461,1.0,17/54,21.78%,HOOK2;TRPV4;FIGNL2;LIMK2;SPAST;TUBGCP5;HOOK3;PCM1;SLAIN2;CRIPT;EZR;CHP1;RHOA;KATNAL1;TUBGCP6;CLIP4;CCDC88B
prerank,ameboidal-type cell migration (GO:0001667),0.3101386763971599,0.8888991508769842,0.6050870147255689,0.9754243604469244,1.0,6/51,7.33%,GPC3;AMOTL1;SEMA4B;AMOT;SEMA3A;ITGB7
prerank,nuclear membrane organization (GO:0071763),0.380430861327633,0.8888051632140939,0.6048632218844985,0.9749841290419224,1.0,5/19,15.10%,NEMP1;SPAST;CHMP4B;EMD;GPER1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.29019981688693824,0.8885430553786648,0.6242496998799519,0.9749418427001026,1.0,21/85,20.54%,TRIB2;PRICKLE1;SOCS5;SH3RF2;KEAP1;DDRGK1;GSK3B;CSNK1A1;RCHY1;USP13;ZYG11B;RNF185;FBXW7;BAG2;RNF180;TMEM259;DDA1;SUMO1;TMTC3;PRKN;RNF14
prerank,regulation of DNA biosynthetic process (GO:2000278),0.34641577194777473,0.8881345567916521,0.5878877400295421,0.9751877238540962,1.0,2/27,5.33%,SMOC2;TOM1L1
prerank,icosanoid metabolic process (GO:0006690),0.3166669745535375,0.8877283359514191,0.5870786516853933,0.9753932188705704,1.0,15/40,24.58%,EPHX1;CYP2S1;ALOXE3;ABCC1;ABCC10;LTA4H;PNPLA8;GGT1;HPGD;FADS1;FAAH;PON3;PLA2G4A;PTGR1;DAGLB
prerank,amino acid transmembrane transport (GO:0003333),0.31684270701703854,0.8876706774884162,0.5910987482614742,0.9748541023604848,1.0,6/45,6.69%,LRRC8D;SLC25A12;SFXN2;SLC38A2;SLC6A13;SLC1A6
prerank,neuron projection development (GO:0031175),0.2651066250044853,0.8875394471933028,0.6703296703296703,0.9744888501656166,1.0,25/168,13.05%,NGF;EPB41L3;MINK1;KIF20B;GAS7;OPHN1;NBL1;DIP2A;CNTNAP1;TRIO;EPHB2;GPM6A;GSK3B;HMGB1;POU4F1;ERCC6;LRP12;DOCK7;SLC9A6;NEDD4;PLXNB1;MAP4;SGK1;PTEN;CTTN
prerank,regulation of fibroblast proliferation (GO:0048145),-0.25482272042986726,-0.8874608655757914,0.6713286713286714,0.8823351994945445,1.0,11/45,14.52%,IGF1;PDGFRA;FTH1;CDK6;MED25;BMI1;B4GALT7;SPHK1;CDK4;PARP10;NLRC3
prerank,central nervous system neuron differentiation (GO:0021953),-0.27010689280612227,-0.8873695765822203,0.656957928802589,0.8816492076844467,1.0,9/33,14.30%,ATP7A;SPOCK1;LRP6;NR4A2;PROX1;MDGA1;GBA2;TOX;MAPT
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.37438741164156153,0.8872390494131833,0.5803858520900321,0.9744963822863628,1.0,3/17,7.04%,STX1A;CACNA1H;RAB3A
prerank,"phototransduction, visible light (GO:0007603)",0.3869901290322614,0.886983474825161,0.5824742268041238,0.9743659459767877,1.0,2/14,5.04%,GNAQ;CNGB1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.38391918395879665,0.8869186661864362,0.5880503144654088,0.973843916862332,1.0,4/17,14.74%,CTCF;BUB3;ZWILCH;ZW10
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.37551833260252226,-0.8869074661306929,0.5932584269662922,0.8817594459754602,1.0,3/10,15.22%,IL18;PRKCZ;LGALS9
prerank,replicative senescence (GO:0090399),0.39990827610549107,0.8867270050647045,0.584717607973422,0.9736018719218639,1.0,2/12,10.88%,WNT16;MME
prerank,regulation of translational initiation (GO:0006446),-0.23889077289511434,-0.8865936970807093,0.7272727272727273,0.881623307331177,1.0,22/63,23.50%,DNAJC3;NPM1;RPS6KB1;GLE1;PAIP2;EIF2AK4;YTHDF1;MTIF2;CEBPB;EIF4G1;NCBP1;CTIF;HSPB1;YTHDF2;KLHL25;ATF4;DDX1;POLR2D;EIF1B;KHDRBS1;EIF3E;YTHDF3
prerank,lymphocyte differentiation (GO:0030098),0.2911528122927915,0.8864734011223441,0.6261319534282018,0.9734679278187311,1.0,9/68,9.88%,LEPR;PBX1;TPD52;PTPN22;HDAC4;PTPRC;MSH2;PTPRJ;AXL
prerank,rRNA modification (GO:0000154),0.3598075504436533,0.8863481600355841,0.5811437403400309,0.9731156321324942,1.0,4/21,10.56%,MRM2;BUD23;TFB2M;METTL5
prerank,regulation of mitotic spindle assembly (GO:1901673),0.36577917934526927,0.886254717319878,0.5987361769352291,0.972679187190415,1.0,5/19,11.97%,CHMP5;PDCD6IP;TPR;CHMP4B;CHMP4C
prerank,defense response to fungus (GO:0050832),-0.3209471195167336,-0.8858401648040654,0.6069651741293532,0.8825039365213326,1.0,4/17,18.74%,PLCG2;BCL10;GAPDH;RARRES2
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.2981918616688196,0.885424509035392,0.6124523506988564,0.9738393930515834,1.0,8/65,5.70%,CDH13;CEACAM1;EGFR;ARAP1;SPRY1;NUP62;TSG101;FER
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.40800744985615245,0.8849382823083671,0.5855855855855856,0.9742555448726351,1.0,2/12,6.12%,WDR18;NBN
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.36948564041180676,0.8848155601813958,0.6053459119496856,0.9738539848085723,1.0,3/18,9.35%,RAP1A;RIMS2;GSK3B
prerank,aerobic respiration (GO:0009060),-0.2981779470993938,-0.8847226028169755,0.6557377049180327,0.8841367610652626,1.0,8/20,29.17%,SDHB;UQCRC2;MTFR1;ME3;OXA1L;NDUFS8;MTFR2;UQCR10
prerank,neurotransmitter secretion (GO:0007269),-0.24635879672120153,-0.8844901249708833,0.689922480620155,0.8837566259832927,1.0,20/44,29.32%,STXBP3;LIN7A;HSPA8;SYN1;GAD1;NRXN1;SYN3;NRXN2;DNAJC5;CPLX2;UNC13A;SYN2;RIMS1;SNAP25;SLC32A1;PPFIA3;PIP5K1C;PTPRN2;GRM4;SYT1
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.3158064267961501,0.8844039393188727,0.6310013717421125,0.9740585956901038,1.0,9/43,16.05%,SORBS1;OGT;PIP4K2B;KANK1;SLC27A4;C1QTNF12;NUCKS1;SNX5;SOCS1
prerank,positive regulation of peptidase activity (GO:0010952),0.365256519183512,0.884309247037504,0.5829228243021346,0.9736080863290442,1.0,4/20,8.91%,APH1B;PSME3;NCSTN;DDRGK1
prerank,RNA transport (GO:0050658),0.29126822507310707,0.8842306274816618,0.639030612244898,0.9731309042953723,1.0,17/71,19.26%,RBM8A;SRSF4;NUP62;CKAP5;SIDT2;EIF4E;TPR;RTRAF;ATXN2;UPF3B;NUP153;THOC3;THOC5;XPO5;SLU7;SRSF3;DHX38
prerank,myeloid dendritic cell activation (GO:0001773),0.4025042216528239,0.8837662444819043,0.5948717948717949,0.9734798852946972,1.0,3/12,16.40%,DOCK2;HMGB1;BATF
prerank,filopodium assembly (GO:0046847),-0.3133584195847713,-0.8835002832685713,0.6258992805755396,0.8851713892492857,1.0,3/16,5.88%,DNM3;FGD5;ARHGEF4
prerank,positive regulation of T cell cytokine production (GO:0002726),0.3574606801525524,0.883376248577648,0.6033690658499234,0.9736681119520193,1.0,2/20,2.99%,IL18R1;CD55
prerank,regulation of ATP metabolic process (GO:1903578),0.30313084939231844,0.8829328891299012,0.6218375499334221,0.9739872102857833,1.0,14/54,13.39%,OGT;BEND3;PRKAG1;NUP62;FIS1;NUP160;NUP37;TPR;NUP50;RANBP2;NUP210;ABCD1;NUP153;GCK
prerank,base conversion or substitution editing (GO:0016553),-0.36625700467497024,-0.8827528544337323,0.610705596107056,0.8859975362882043,1.0,1/11,3.22%,ADAR
prerank,homotypic cell-cell adhesion (GO:0034109),0.31952605130729,0.882691223418015,0.628808864265928,0.9738707588629002,1.0,4/39,5.16%,UBASH3B;TJP2;PLPP3;FN1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.2901358944069276,0.8825186097863857,0.6477832512315271,0.9736148660691774,1.0,4/75,1.21%,RGS6;GUCA1A;RGS14;PLCE1
prerank,regulation of T cell cytokine production (GO:0002724),-0.32267462844175565,-0.8824401425905093,0.6105263157894737,0.8858196397094305,1.0,3/15,6.74%,B2M;TNFRSF1B;TRAF6
prerank,mitochondrion morphogenesis (GO:0070584),-0.3576271976892485,-0.8821154248743917,0.6173708920187794,0.8856454778369938,1.0,2/11,12.89%,PID1;SLIRP
prerank,response to organonitrogen compound (GO:0010243),-0.2581292283355868,-0.8817297159490421,0.6807692307692308,0.8856112006315981,1.0,12/38,25.13%,HLCS;SYVN1;VCP;RRAGC;GLRA2;UBXN6;DHFR;TRPM2;RCN3;NR1H4;IRF5;KYNU
prerank,regulation of calcium-mediated signaling (GO:0050848),0.3445801733221707,0.8816374876961846,0.6005873715124816,0.9749185315199075,1.0,4/25,13.97%,CDH13;PLEK;TMBIM4;HTT
prerank,sensory perception of taste (GO:0050909),-0.35815588273717897,-0.8815410683438324,0.5986547085201793,0.8851587980189445,1.0,8/10,49.94%,PKD2L1;PKD1L3;CD36;ASIC1;ASIC3;TAS1R1;TAS1R2;GNAT3
prerank,aerobic electron transport chain (GO:0019646),0.290381765390587,0.8814756866938797,0.6377551020408163,0.9746135543466042,1.0,14/68,15.67%,COX5A;NDUFA6;NDUFB10;NDUFS3;COX15;NDUFS6;SDHD;SDHAF2;COX7C;NDUFA3;NDUFV2;COX5B;NDUFV1;NDUFA7
prerank,cytokine-mediated signaling pathway (GO:0019221),0.2499032485780248,0.8814385489905745,0.798183652875883,0.9740636271812806,1.0,35/532,7.15%,RORA;EDA;TEC;SERPINB2;LBP;TNFSF8;ACKR3;IL19;IL18R1;CEACAM1;CAMK2D;LEPR;PELI2;IL17C;SOCS5;STX1A;ITGAX;IL1A;SPI1;FOXO3;SRC;PSME3;SLC27A1;IRAK3;FN1;IL17RA;FER;TRADD;SOCS6;LAMA5;IL21R;ABL2;TRIM21;MCL1;SDC1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.40827929972338856,0.8813127296735782,0.5960502692998204,0.9736949255302348,1.0,1/11,2.26%,SOCS5
prerank,regulation of secretion by cell (GO:1903530),-0.23790159452250947,-0.8801457683339551,0.7253218884120172,0.8873666957416932,1.0,12/54,16.66%,SNCAIP;DNAJC1;RAB3C;MCTP2;ANXA1;SYN1;CAMK2A;RAB13;RHBDF2;LLGL2;RAB3B;CPLX2
prerank,neuron projection extension (GO:1990138),0.33859043694489627,0.8796499528478896,0.6189111747851003,0.9766629149928117,1.0,11/32,22.56%,NRP2;CDKL3;LLPH;SEMA3A;SLC9A6;AUTS2;USP9X;SPG11;NLGN3;IMPACT;IQGAP1
prerank,positive regulation of heart rate (GO:0010460),-0.3234318249608195,-0.879461445805389,0.6312997347480106,0.888001728080938,1.0,5/17,15.95%,TPM1;ADRA1B;EDN1;ADM;EDN3
prerank,granulocyte chemotaxis (GO:0071621),0.30334315087964786,0.8794142907933936,0.6337285902503293,0.9765261716954723,1.0,1/55,0.29%,CXADR
prerank,regulation of sister chromatid cohesion (GO:0007063),0.4027566617801803,0.8793676361883523,0.599290780141844,0.9759961075382022,1.0,2/12,10.79%,CTCF;AXIN2
prerank,cytosolic transport (GO:0016482),-0.209244002571907,-0.8793081467099065,0.7162162162162162,0.8875113111080859,1.0,33/108,21.76%,MYO1D;DENND5A;RAB6B;RHOBTB3;GOSR2;AP2A1;STX8;BECN1;RBSN;VPS13C;DOP1B;EPS15;UBE2O;RGP1;SNX16;VPS26B;BET1L;PREPL;CLN5;SORT1;MON2;STX6;LAPTM5;HEATR5A;STX16;SYS1;YKT6;PLEKHJ1;TBC1D17;ANKRD27;RAB7A;RNF126;VTI1B
prerank,protein targeting to membrane (GO:0006612),0.28375464443387644,0.8791608977403629,0.6460396039603961,0.975794234397054,1.0,23/83,20.36%,RAB8B;SIL1;FIS1;ZDHHC1;PEX2;ZDHHC7;ZDHHC23;PXMP2;TRAM1;CHMP4A;CHMP4B;RTP3;ABCD1;ZDHHC20;CHM;ZDHHC19;GOLGA7B;ICMT;SLC25A17;ATG3;PEX13;ZDHHC3;ZDHHC12
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.2490152002796858,-0.8790756178661846,0.6474820143884892,0.8871976628277105,1.0,8/39,13.19%,TEK;ANGPT1;NDNF;KDR;GATA2;RAMP2;SCG2;THBS1
prerank,axonal transport of mitochondrion (GO:0019896),-0.35483871882247786,-0.8789159022830899,0.606280193236715,0.8866687469704976,1.0,4/11,15.53%,NEFL;HIF1A;MAPT;OPA1
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.28945739493083655,0.878451891975298,0.6509554140127388,0.9766481591216273,1.0,16/64,18.15%,MLLT3;LEO1;CDK13;CDK7;POLR1E;PAF1;ELL;NELFB;SUPT4H1;GTF2F2;GTF2H1;ELOA;RTF1;TCEA1;SETD2;GTF2H3
prerank,plasma membrane invagination (GO:0099024),0.3387766818214896,0.8782967148909168,0.5947136563876652,0.9763393506578669,1.0,2/29,2.16%,ARHGAP12;DOCK1
prerank,transcription preinitiation complex assembly (GO:0070897),0.3947472053959714,0.8780639438631357,0.5966101694915255,0.9761805755037514,1.0,7/12,31.78%,POLR1E;BDP1;TAF1;TBP;GTF2A2;TAF7;TAF1B
prerank,negative regulation of axon extension (GO:0030517),0.3347819388557953,0.8779813264405373,0.5893648449039882,0.9757241688370083,1.0,10/30,18.70%,SEMA4B;RTN4R;CDKL3;SEMA3A;TRIM46;SEMA4D;SEMA6C;RTN4;SEMA4C;SEMA4A
prerank,ketone body metabolic process (GO:1902224),-0.36993633645277124,-0.8779214318554095,0.6100917431192661,0.8880059734381064,1.0,4/10,8.90%,HMGCL;BDH2;HMGCS2;ACSS3
prerank,defense response to symbiont (GO:0140546),-0.21679532977963004,-0.877723068872875,0.7659574468085106,0.887596757873678,1.0,24/92,21.47%,SERINC3;IFNAR2;ABCC9;SAMHD1;IRF2;IFIT2;IFIT3;AGBL5;BST2;FLNA;IRF1;NDUFAF4;ABCE1;MOV10;ISG15;IFIT1;CD40;RSAD2;PDE12;OPRK1;CGAS;TLR3;BNIP3L;SHFL
prerank,histone H2A acetylation (GO:0043968),0.37050081616070546,0.8773173443036927,0.613126079447323,0.9765207917994012,1.0,6/16,18.84%,MSL3;TRRAP;BRD8;MORF4L2;RUVBL2;NAA40
prerank,cellular response to calcium ion (GO:0071277),0.2910950298319981,0.8771920070100667,0.6523929471032746,0.9761394270408117,1.0,5/67,4.96%,GUCA1A;CAMK2D;GPLD1;ADD1;WNT5A
prerank,embryonic hemopoiesis (GO:0035162),-0.3485409620571383,-0.8766811762210972,0.6130653266331658,0.8890307963815913,1.0,5/12,18.58%,KIT;FLT3LG;KDR;TAL1;ATF4
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.27279222996697705,0.8766446835004724,0.6577102803738317,0.9766876392578007,1.0,19/116,16.59%,PLK2;CD3G;MC5R;PTHLH;SRC;ADCY5;SELENOS;PTGER4;PRKAR2A;TSHR;ADCY9;PRKACB;GGT1;ADCY8;ADCY3;PTH2R;GPR27;SYK;RXFP1
prerank,neuron apoptotic process (GO:0051402),-0.3119072238304764,-0.8765539080520873,0.6494565217391305,0.8884330805970662,1.0,5/19,11.35%,TNFRSF21;FAS;NAE1;GAPDH;BID
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.3255251480083685,-0.8765060855407011,0.6393034825870647,0.8876539999034812,1.0,8/15,31.42%,SAMHD1;USP18;ISG15;YTHDF2;CACTIN;YTHDF3;TTLL12;NLRC5
prerank,relaxation of cardiac muscle (GO:0055119),0.3936557382938273,0.8763695998888906,0.6030927835051546,0.9766391775954423,1.0,2/13,5.19%,CAMK2D;ATP1A2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.29904275916610684,-0.8763514545963699,0.6683937823834197,0.8870832844271868,1.0,4/20,10.59%,TGFBR1;HIF1A;DNAJB2;EPAS1
prerank,positive regulation of cell development (GO:0010720),-0.27344407441837537,-0.8762057743383918,0.6557377049180327,0.8865059173113701,1.0,4/31,4.92%,NUMB;TGM2;BMP4;RFX3
prerank,multivesicular body assembly (GO:0036258),0.3370578522143219,0.8760566639850244,0.6032689450222882,0.9766604151412153,1.0,7/30,11.97%,TSG101;CHMP5;PDCD6IP;IST1;CHMP4A;CHMP4B;CHMP4C
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.3848444704021106,0.875993417439394,0.615,0.9761554204138576,1.0,3/13,13.49%,SPRED1;HIC1;SPRED2
prerank,cellular response to glucagon stimulus (GO:0071377),-0.3138040158125224,-0.875837294886318,0.6451612903225806,0.8863813723387238,1.0,6/17,15.96%,ADCY1;ADCY7;ADCY4;ADCY2;PRKAR2B;CYSLTR2
prerank,histone H4 acetylation (GO:0043967),0.3063200891284754,0.8754816561581512,0.6332863187588152,0.9766235009891998,1.0,13/47,19.21%,OGT;KMT2A;BEND3;HAT1;KANSL2;MSL3;TRRAP;KAT8;BRD8;MORF4L2;RUVBL2;NAA40;NAA60
prerank,positive regulation of cell cycle (GO:0045787),0.2984430866241957,0.8754703115622697,0.6192893401015228,0.9760088387950415,1.0,8/62,10.89%,SMOC2;EGFR;CCND3;PRKCA;TRIM21;RARA;EIF4E;SRPK2
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.3594561219762433,0.8754580237929406,0.6115569823434992,0.9754016761815588,1.0,3/20,4.69%,CEACAM1;BMP5;SLC27A1
prerank,protein O-linked mannosylation (GO:0035269),-0.31411969760913927,-0.8751064405184079,0.6301775147928994,0.8870919244254534,1.0,3/18,4.35%,TMTC2;TMTC1;DPM1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.2810072655975428,-0.875098573133483,0.6637931034482759,0.8862338091672208,1.0,10/28,23.42%,LACC1;TRAF6;UBE2N;NOD1;AAMP;CASP8;IRAK2;MAP2K6;IKBKG;NOD2
prerank,ribosomal small subunit assembly (GO:0000028),0.3722245523576156,0.8749726261810762,0.6100840336134454,0.9758084486319344,1.0,1/16,0.72%,RPSA
prerank,histone H4 deacetylation (GO:0070933),0.4136011190819199,0.8745096350277421,0.5846422338568935,0.9761544554894435,1.0,6/10,24.13%,HDAC4;SMARCAD1;HDAC2;HDAC3;SIRT2;REST
prerank,regulation of myotube differentiation (GO:0010830),-0.2918851813653801,-0.8743324049240935,0.6573033707865169,0.8869973311994586,1.0,11/24,29.12%,CCN3;SIK1;HDAC9;HDAC1;BDNF;ATP11A;XBP1;DMPK;NOTCH1;RBM24;FBXO22
prerank,hydrogen peroxide metabolic process (GO:0042743),0.36347851194733016,0.8743035865787124,0.6119402985074627,0.9759679493697799,1.0,1/19,0.87%,PXDN
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.30228368889756707,0.8740448162335192,0.6441558441558441,0.9759062591764649,1.0,10/57,15.58%,LPAR1;AKAP12;ADCY5;GNAL;ADRA2A;ADCY9;CHRM2;CHRM3;ADCY8;ADCY3
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.3401186945188701,0.8738242162758927,0.6009463722397477,0.9757207621608535,1.0,8/26,16.64%,SOCS5;TSG101;NCK2;CBLB;ADRA2A;SOCS4;HBEGF;FBXW7
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.4058663180633802,0.8729485551771355,0.6320422535211268,0.9769101217650308,1.0,3/11,10.61%,RESF1;PPHLN1;TPR
prerank,positive regulation of interleukin-6 production (GO:0032755),0.28854512528974885,0.8728669936244089,0.6517285531370038,0.9764409791187459,1.0,7/68,9.48%,LBP;IL1A;WNT5A;IL17RA;TLR7;ISL1;HMGB1
prerank,protein deacetylation (GO:0006476),0.3168796007474912,0.872725677786907,0.6438746438746439,0.9761160905726851,1.0,16/41,24.08%,HDAC4;RCOR3;SIRT3;SIN3B;MSL3;SIRT7;HDAC2;HDAC6;BAZ2A;MORF4L2;MTA3;HDAC3;BRMS1L;SIRT2;SIN3A;SUDS3
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.28705648642549325,0.8722879404542774,0.6448717948717949,0.9764294446096409,1.0,8/69,9.48%,LBP;IL1A;WNT5A;PTPRC;EPHB2;ISL1;PTPRJ;HMGB1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.3387289307612013,0.8721882588005067,0.6097922848664689,0.9759972337605868,1.0,7/30,13.12%,KLK2;HEYL;NCOR1;PIAS2;NCOR2;HDAC6;NCOA2
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.3015947588860818,0.8721223552544806,0.6350267379679144,0.9754996414641648,1.0,13/53,20.40%,GLMN;OPHN1;PSME3;DDRGK1;TMF1;PKD1;FBXW7;BAG2;RHBDF1;PINK1;PSMD14;TMTC3;PRKN
prerank,mRNA export from nucleus (GO:0006406),0.27634416287237396,0.8715264604780238,0.6925837320574163,0.9761253395257985,1.0,35/102,24.85%,RBM8A;SRSF4;NUP62;RBM15B;NUP160;UPF2;EIF4E;NUP37;TPR;NUP50;UPF3B;RANBP2;NUP210;SMG7;NUP153;THOC3;NUP93;THOC5;MCM3AP;SLU7;SYMPK;SRSF3;DHX38;SRSF11;NUP43;DDX25;YTHDC1;SMG6;CPSF2;SEC13;WDR33;IWS1;SARNP;PABPN1;NXF1
prerank,amino sugar metabolic process (GO:0006040),-0.36798268146436,-0.8715074767254821,0.669833729216152,0.8922905566805196,1.0,2/10,2.65%,ST3GAL1;CSGALNACT1
prerank,chloride transmembrane transport (GO:1902476),0.3040371684547923,0.8707123336828454,0.6500672947510094,0.9771888532543701,1.0,9/48,12.25%,SLC12A2;ANO6;SLC12A4;SLC12A3;CLCN1;GABRR2;GABRG2;GABRG1;GABRB3
prerank,glycerol metabolic process (GO:0006071),-0.3600768965302279,-0.8705010649645883,0.6121495327102804,0.8935922036494391,1.0,3/10,13.52%,TPI1;COQ3;PGP
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.2765911064977436,-0.8704348062708122,0.6589595375722543,0.8928689962617885,1.0,16/27,38.92%,SYT9;SYT7;ARHGAP17;VAMP7;SYT13;SYT6;RIMS1;RIMS3;SYT15;SYT1;SYT5;DOC2B;SYT17;SYT4;SYT3;SCIN
prerank,regulation of lymphocyte activation (GO:0051249),0.3977046559812767,0.8700993843448188,0.6086956521739131,0.9778265470184242,1.0,2/12,10.16%,CRTAM;LAT
prerank,folic acid metabolic process (GO:0046655),0.36174110672808724,0.8697883048057784,0.6142131979695431,0.9778202132271002,1.0,6/18,17.88%,FOLR2;MTHFD1;SLC46A1;ALDH1L2;PM20D2;SLC19A1
prerank,cellular response to purine-containing compound (GO:0071415),-0.36294641816138806,-0.8697111092803358,0.6,0.8936021050859753,1.0,5/10,30.95%,SLC8A1;TRPM2;P2RY6;P2RY1;RYR2
prerank,cellular response to leucine starvation (GO:1990253),0.4111395485422783,0.8696116907142422,0.6014234875444839,0.9775618348302194,1.0,5/10,23.74%,SESN1;RRAGB;GCN1;IMPACT;MTOR
prerank,respiratory chain complex IV assembly (GO:0008535),0.3455011180687837,0.8690645537054952,0.6015625,0.9780443957493188,1.0,7/21,19.28%,COA5;COX15;COX19;COX16;BCS1L;SURF1;COA8
prerank,cellular response to hypoxia (GO:0071456),0.26548739514056985,0.8687418837435668,0.6806039488966318,0.97807768115571,1.0,28/126,18.75%,RORA;PSME3;EGLN3;SUV39H1;PSMB5;HILPDA;AQP1;CREBBP;PSMB2;P4HB;PSMA2;PSMA6;BAD;PSMD13;PSMA7;PGK1;UBQLN1;RGCC;BNIP3;HP1BP3;SUV39H2;PSME4;BACH1;PINK1;PSMC4;PSMB6;PSMD12;PSMD14
prerank,nucleocytoplasmic transport (GO:0006913),0.31469553551252977,0.868472808636279,0.6522346368715084,0.9780116207208833,1.0,6/40,14.54%,RGS14;SNRPF;RBM15B;SMN1;HTATIP2;LSG1
prerank,regulation of type I interferon production (GO:0032479),0.27974506483506545,0.8683727492994039,0.6612090680100756,0.9775974043130877,1.0,27/84,24.58%,UBE2L6;PCBP2;PTPN22;TNFAIP3;TRIM21;POLR3G;ACOD1;DTX4;NPLOC4;NLRP4;TAX1BP1;POLR3D;CREBBP;TBK1;CRCP;ITCH;MRE11;G3BP1;XRCC6;DHX9;PIN1;TRAF3;IFIH1;DHX58;POLR3C;POLR3K;CYLD
prerank,regulation of centrosome cycle (GO:0046605),0.3571973614633017,0.8680906746396816,0.625585023400936,0.9775317359382559,1.0,6/21,12.90%,CEP131;CHMP5;PDCD6IP;CHMP4B;CHMP4C;GEN1
prerank,base-excision repair (GO:0006284),0.3036054441038758,0.8678386105226584,0.6502659574468085,0.9774096874632434,1.0,11/48,17.88%,TDG;NTHL1;RFC3;USP47;APEX2;ERCC6;ADPRS;POLB;PRMT6;POLE;RFC1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.34681833298011344,0.8678329832445484,0.6129032258064516,0.9767955505745949,1.0,4/24,11.88%,PLCE1;RAC2;OCLN;AKIRIN1
prerank,protein O-linked glycosylation (GO:0006493),0.27788253686791253,0.8678176100322202,0.6816037735849056,0.9762073949376288,1.0,12/96,9.86%,ST3GAL4;GALNTL6;OGT;C1GALT1C1;GCNT4;B4GAT1;FKRP;B3GLCT;POFUT1;TET1;ST6GAL1;GALNT18
prerank,relaxation of muscle (GO:0090075),0.39153870708437344,0.8678057304562005,0.6151202749140894,0.9756115970164387,1.0,2/13,5.19%,CAMK2D;ATP1A2
prerank,positive regulation of ATP metabolic process (GO:1903580),0.3278902004707037,0.8676378833636709,0.6290550070521862,0.9753317118431607,1.0,4/32,6.01%,PPARGC1A;ZBTB20;BEND3;SLC4A4
prerank,regulation of cellular response to stress (GO:0080135),0.27013871296279574,0.8675177304883567,0.7095631641086186,0.9749689550837681,1.0,38/115,23.04%,CAMK2D;HSPH1;SLC38A2;NPAS2;NUP62;MCL1;BAG3;AMFR;NUP160;GSK3B;NUP37;TPR;NUP50;RANBP2;NUP210;ARMT1;ABCD1;NUP153;CREBBP;NEK4;NUP93;ADCY8;AIFM2;CHORDC1;DNAJC7;YWHAE;BAG2;CAMK2G;PINK1;RPTOR;PRKN;ATR;CCAR2;NUP43;RPA3;MBTPS2;SEC13;MAPK1
prerank,positive regulation of cellular process (GO:0048522),0.2466093586627119,0.8674823699828301,0.8214643931795386,0.9744247516415564,1.0,88/565,14.63%,CAV1;FGF7;PRODH;NTRK3;GLI1;FGFR1;LBP;DLX1;PTGFR;FOLR2;EGFR;FGF1;SMC5;ACER3;FXR2;KIF20B;ITGAX;FKBP1B;LMAN2;CIDEB;PTHLH;SAPCD2;SOX9;BMPR1B;CELF1;PRKCA;HDAC4;BMP5;WNT5A;FN1;DOCK2;RPRD1B;FER;CDK13;CEP131;ADAM10;KRAS;TRIM21;ACACA;EFNB2;HOXC10;TBX2;RARA;CSPP1;FBXO5;CUL3;DPP4;S100B;ISL1;PTPRJ;GCNT2;FGF18;TSHR;DDRGK1;TET1;NCMAP;MECP2;RPS6KA3;USP47;GAB2;HDAC2;CNOT7;HILPDA;ADRA2A;TBC1D8;S100A9;AXIN2;SRPK2;APC;IL6ST;PRLR;INO80;FAF1;NOXO1;CD81;PTEN;CDC6;IL7;SOX4;HBEGF;P4HB;FZD7;CCKBR;FXR1;IL2RG;KLHL22;ERBB4;DICER1
prerank,negative regulation of hydrolase activity (GO:0051346),0.29741883018877513,0.8672230833739105,0.6359945872801083,0.9743094123307517,1.0,4/49,7.45%,F11R;SH3RF2;RDX;MAPK7
prerank,reverse cholesterol transport (GO:0043691),-0.3373244372385248,-0.8671107927759318,0.6573426573426573,0.8982846090803415,1.0,5/13,26.08%,APOE;ABCG1;CLU;SCARB1;LCAT
prerank,regulation of Notch signaling pathway (GO:0008593),0.2820302694186832,0.867094618062525,0.6770963704630788,0.9739641348585748,1.0,16/76,16.91%,NRARP;EGFR;DTX1;JAG1;MAML2;SRC;EGFL7;BMP2K;POFUT1;IL6ST;TSPAN14;CREBBP;WWP2;YAP1;FBXW7;MMP14
prerank,positive regulation of bone mineralization (GO:0030501),0.3249865134888815,0.8670904913268096,0.6246458923512748,0.9733630793374647,1.0,3/35,4.10%,PKDCC;ANO6;BMPR1B
prerank,regulation of protein ubiquitination (GO:0031396),0.27441523734766127,0.8670568474990029,0.6774566473988439,0.972810537113243,1.0,24/108,17.99%,CAV1;PRICKLE1;AXIN1;SH3RF2;OGT;TNFAIP3;N4BP1;CUL3;SIRT7;RCHY1;SPOPL;NXN;USP4;SOX4;UBE2D1;FBXW7;UBQLN1;GNL3L;BAG2;MINAR1;CHP1;WFS1;PHF23;PINK1
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.34756717353545175,0.866985339886727,0.6293375394321766,0.9723469766543525,1.0,4/21,13.39%,HK2;RPE;DERA;GCK
prerank,sensory perception of chemical stimulus (GO:0007606),-0.32060478454403196,-0.8669700033559989,0.6423357664233577,0.8977382482798938,1.0,1/15,1.05%,GNAS
prerank,positive regulation of interleukin-1 production (GO:0032732),0.2980131933828421,0.8667369712975539,0.6410596026490066,0.9722148434488608,1.0,7/51,13.87%,USP50;WNT5A;NLRC4;ISL1;HMGB1;EGR1;GSDMD
prerank,RNA destabilization (GO:0050779),0.3663668935974126,0.8664580365557994,0.6056572379367721,0.972163301118075,1.0,4/18,9.06%,GIGYF2;CELF1;DXO;LIN28B
prerank,development of primary male sexual characteristics (GO:0046546),0.3233093079449613,0.8663531513612593,0.6226138032305433,0.9717498516008204,1.0,8/34,15.35%,WNT2B;SOX9;WNT5A;LHFPL2;MSH2;CSDE1;NR5A1;KITLG
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.3988178966377779,0.8663499944303268,0.606312292358804,0.9711429651262196,1.0,1/12,1.25%,CEACAM1
prerank,signal peptide processing (GO:0006465),0.4020042427729282,0.8660240408877478,0.6243567753001715,0.9712051727033526,1.0,1/11,2.16%,PCSK5
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.28888108498908716,0.8652398250458476,0.6579925650557621,0.9721847759581078,1.0,14/66,15.72%,GTSE1;EIF2AK3;LIMK2;CARD10;UBR5;BAG3;RBM22;PIK3R2;FERMT2;TPR;CCT2;RAN;CDH1;YAP1
prerank,cellular macromolecule catabolic process (GO:0044265),0.3033261071011786,0.8650961529749969,0.6576819407008087,0.9718471831635265,1.0,16/49,26.00%,RNASEH2B;PABPC4;SIDT2;DFFB;MANBA;HTRA2;OGA;RNASE3;MTREX;HNRNPD;PRKN;EXOSC7;RNASEH1;DNASE1L1;PNPT1;UBE2G1
prerank,cellular response to organonitrogen compound (GO:0071417),0.2780438956939347,0.8650912238356759,0.66785290628707,0.9712441435154642,1.0,16/99,16.37%,HRH1;FOLR1;RAPGEF3;RAP1A;SOX9;TSHR;GABRG2;EGR1;GABRB3;AQP1;CAPN2;RRAGB;CTNNA1;CDH1;CPEB3;EZR
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.28423073184166536,0.8645731062803127,0.6611464968152866,0.9716696960329546,1.0,14/69,15.67%,COX5A;NDUFA6;NDUFB10;NDUFS3;COX15;NDUFS6;SDHD;SDHAF2;COX7C;NDUFA3;NDUFV2;COX5B;NDUFV1;NDUFA7
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.3581255510309617,0.8641126354310269,0.6121794871794872,0.9719785383849174,1.0,1/18,0.80%,TSHZ3
prerank,protein polyglutamylation (GO:0018095),0.39320396124784507,0.8640894865174736,0.6080843585237259,0.9714168367008563,1.0,3/11,16.92%,TTLL1;CFAP20;TTLL9
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.3283413601607376,-0.8640695460640815,0.6588785046728972,0.903169183571076,1.0,1/14,1.18%,OSMR
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.3223590548708707,-0.8638514681994403,0.6558139534883721,0.9027816206701706,1.0,5/14,19.71%,ACTR2;ARID2;MMS19;PARP1;TIMELESS
prerank,positive regulation of proteolysis (GO:0045862),0.299328001095191,0.8635537335117162,0.6610389610389611,0.9718977126413647,1.0,9/55,10.36%,CYFIP2;OGT;GPLD1;NLRC4;PERP;TNIP1;HDAC2;IST1;ADRA2A
prerank,error-prone translesion synthesis (GO:0042276),0.34714883620481374,0.8635358529836181,0.6196513470681458,0.9713332201767358,1.0,10/21,27.69%,POLI;RFC3;REV3L;RFC1;RPA3;POLE2;PRIMPOL;REV1;RPA2;RPA1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.39561989514884394,0.8633697834341361,0.6089965397923875,0.9710798321193824,1.0,2/10,12.33%,NPTX2;DLGAP2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.29268380147087203,-0.8631420868948773,0.6802168021680217,0.9033501575378445,1.0,8/22,22.17%,ROCK2;FKBP1A;PPP4R4;PPP1R11;IKBKB;STYXL1;CRY2;NCKAP1L
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.41208333669673797,0.862573046017605,0.6294964028776978,0.9720634194976645,1.0,5/10,20.60%,LEO1;PAF1;CPEB3;CDC73;NUDT21
prerank,steroid hormone biosynthetic process (GO:0120178),0.3276554696832206,0.8625450523988846,0.6360902255639098,0.9715040212687098,1.0,5/29,19.79%,HSD17B3;HSD17B2;STARD3;STAR;HSD17B11
prerank,positive regulation of ion transport (GO:0043270),0.30640185134054543,0.8624981169115697,0.6353887399463807,0.9709878142219837,1.0,2/48,2.66%,CNKSR3;ANO6
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.36550680645778266,0.8622435234820031,0.6476510067114094,0.9709039454632664,1.0,2/16,7.24%,RBFOX2;DDX17
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.34938441597618997,-0.8622359070104483,0.6731707317073171,0.9044369852629397,1.0,2/11,6.50%,MECOM;CD34
prerank,positive regulation of secretion by cell (GO:1903532),-0.21819671761186926,-0.8619647908816676,0.7365853658536585,0.9041215710421387,1.0,15/70,15.98%,IGF1;BMP6;KCNB1;CADPS;TGFB3;MYH10;SYTL4;BMP2;TGFB2;MYO18A;ABCG1;EDN1;DTNBP1;EDN3;P2RX4
prerank,cellular component disassembly (GO:0022411),0.29988491842406734,0.8619278938619725,0.6644736842105263,0.9709197855207784,1.0,13/53,17.74%,LAMC1;KLK2;MMP15;SH3PXD2B;ADAM10;MMP12;NOXO1;MMP16;CAPN2;PLG;MMP14;BMP1;LCP1
prerank,calcium ion transport (GO:0006816),0.2724621176150349,0.8614149043257637,0.6916859122401847,0.9713331808358281,1.0,8/113,4.79%,CAV1;NALCN;TRPM3;ANO6;SLC24A1;TRPV4;ATP2B4;CACNA1H
prerank,cellular response to interleukin-2 (GO:0071352),0.3988955025284583,0.8613083354888399,0.6127946127946128,0.9703389226720396,1.0,6/11,29.48%,IL2RG;SYK;JAK1;STAT5B;STAT5A;SHC1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.3988955025284583,0.8613083354888399,0.6127946127946128,0.9703389226720396,1.0,6/11,29.48%,IL2RG;SYK;JAK1;STAT5B;STAT5A;SHC1
prerank,oligosaccharide metabolic process (GO:0009311),0.3018921352671189,0.860410097509384,0.654320987654321,0.9715196943680751,1.0,7/46,11.49%,ST3GAL4;B3GALT1;NAGA;NEU1;ST8SIA5;MANBA;ST8SIA3
prerank,"base-excision repair, gap-filling (GO:0006287)",0.31941327787183743,0.8601068836858623,0.6528571428571428,0.9715292242802098,1.0,7/35,17.88%,TDG;NTHL1;RFC3;ADPRS;POLB;POLE;RFC1
prerank,establishment of protein localization to extracellular region (GO:0035592),0.3104903050520718,0.8595371441882953,0.6495726495726496,0.9720431113544599,1.0,5/39,9.72%,TANGO6;RAB8B;RAB3A;LTBP2;ABCA1
prerank,histone H2B ubiquitination (GO:0033523),0.40114429727020656,0.8594706487071943,0.6294326241134752,0.9715816954796753,1.0,5/10,23.22%,LEO1;PAF1;CDC73;RNF20;DTX3L
prerank,positive regulation of stress fiber assembly (GO:0051496),0.30793174124957856,0.85929984138787,0.6534090909090909,0.9713137898162664,1.0,14/44,21.25%,LPAR1;PXN;RAPGEF3;ARHGEF5;FERMT2;FHOD1;NF2;ARHGEF10L;ARHGEF10;RGCC;RHOA;PFN2;PPM1E;S100A10
prerank,regulation of actin nucleation (GO:0051125),0.39089555376345886,0.8588660686882268,0.6073943661971831,0.9715959418382665,1.0,1/12,3.44%,ARPIN
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.28052191593479364,-0.8587744598303845,0.6666666666666666,0.9098710372010287,1.0,2/25,4.69%,PICALM;ANKRD13A
prerank,mRNA transport (GO:0051028),0.2747376175535025,0.8580561816515582,0.7087845968712395,0.9726215722833814,1.0,34/101,24.99%,RBM8A;SRSF4;NUP62;RBM15B;NUP160;UPF2;EIF4E;NUP37;TPR;NUP50;UPF3B;RANBP2;NUP210;SMG7;NUP153;THOC3;NUP93;THOC5;MCM3AP;SLU7;SYMPK;SRSF3;DHX38;SRSF11;NUP43;DDX25;YTHDC1;SMG6;CPSF2;SEC13;WDR33;SARNP;NXF1;FMR1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.33534282872839144,0.8577988936207991,0.64,0.972548433653699,1.0,9/27,23.66%,CSTF3;POP7;ERN1;DICER1;TOE1;PCF11;RPP30;RNASE1;RNASEH1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.3438032304624983,-0.8577604262725831,0.6691176470588235,0.911149422782244,1.0,5/12,29.88%,SEH1L;RMDN1;CENPC;CENPE;NDC80
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.40113300460838547,0.8577198127518113,0.6172413793103448,0.9721185584675754,1.0,3/11,13.60%,SOX9;WNT5A;CTNNBIP1
prerank,regulation of mitotic spindle organization (GO:0060236),0.3171748965876957,0.8576715415713718,0.653954802259887,0.9715991903414255,1.0,7/35,12.02%,NUP62;CHMP5;PDCD6IP;TPR;CHMP4B;CHMP4C;MAP9
prerank,extracellular matrix disassembly (GO:0022617),0.299382109453625,0.8574303880313756,0.673202614379085,0.9714461999673554,1.0,13/53,17.74%,LAMC1;KLK2;MMP15;SH3PXD2B;ADAM10;MMP12;NOXO1;MMP16;CAPN2;PLG;MMP14;BMP1;LCP1
prerank,organonitrogen compound catabolic process (GO:1901565),0.29470240392733216,0.8567420289643596,0.6666666666666666,0.9722240919826808,1.0,12/57,15.15%,IL4I1;LRSAM1;CLN8;BCKDK;LVRN;SIAH1;LNPEP;NAGK;LTA4H;PNPLA8;GNPDA2;TXN2
prerank,COPII-coated vesicle budding (GO:0090114),-0.21963877503173662,-0.8565751762352594,0.7627906976744186,0.9128073683656174,1.0,20/68,21.25%,TGFA;TRAPPC10;PREB;NAPA;GOSR2;SCAP;ANKRD28;SEC16A;SEC16B;SEC23A;GOLGA2;SAR1B;F5;TRAPPC2;SCFD1;CTSC;SEC31A;TRAPPC6B;TRAPPC6A;SEC22B
prerank,response to ionizing radiation (GO:0010212),-0.21840214272590072,-0.8565727814883852,0.7660550458715596,0.9119289378325574,1.0,30/70,27.50%,USP28;PAXIP1;BLM;ANXA1;NHEJ1;EEF1D;RHOB;BABAM2;NET1;TOPBP1;RAD1;CLK2;RNF8;EYA3;ABRAXAS1;RAD9B;KDM4D;TRIM13;XRCC4;FANCD2;GRB2;RAD51;NABP1;LIG4;BRCA1;DCUN1D3;PRKAA1;ATM;SMPD1;BRAT1
prerank,negative regulation of immune effector process (GO:0002698),0.375121078308965,0.8563481030439609,0.6016528925619835,0.9724093387373198,1.0,2/13,5.70%,CD55;FER
prerank,regulation of mitotic nuclear division (GO:0007088),0.29230268696833434,0.856262813431794,0.679144385026738,0.9719645568518859,1.0,9/55,9.46%,FBXO43;KIF20B;CAV2;IL1A;NUP62;TOM1L1;CDK13;FBXO5;TOM1L2
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.31899365659196127,0.8562599156764858,0.6484848484848484,0.9707627224539208,1.0,10/32,15.45%,NUP62;NUP160;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153;RAN;NUP93
prerank,tRNA export from nucleus (GO:0006409),0.31899365659196127,0.8562599156764858,0.6484848484848484,0.9707627224539208,1.0,10/32,15.45%,NUP62;NUP160;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153;RAN;NUP93
prerank,cellular response to cAMP (GO:0071320),0.3321899568031065,0.8560615619300848,0.6358296622613803,0.9705700753955908,1.0,2/30,1.89%,RAPGEF3;RAP1A
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.28607763961968474,-0.8560573980008471,0.6983240223463687,0.9121143888686625,1.0,11/21,28.15%,RPS7;UBE2S;RPL23;GOLGA2;CDC14B;SKP1;MAD2L2;RPL5;MAD2L1;RPL11;GORASP1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.32064542022585796,-0.8553096461771315,0.6734177215189874,0.9127457127899449,1.0,8/16,29.65%,PAXIP1;SNW1;KDM1A;DNMT3B;SMAD4;BRCA1;WDR5;BCOR
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.39866449428600165,0.8552620183849322,0.6068840579710145,0.9715538676043437,1.0,1/11,1.73%,EGFR
prerank,autophagy of mitochondrion (GO:0000422),-0.25457603516144184,-0.8549768358729897,0.7427536231884058,0.9126255693422092,1.0,16/38,26.21%,SQSTM1;BECN1;GABARAPL1;WIPI1;ULK2;GABARAP;AMBRA1;ATG13;USP30;MAP1LC3A;WIPI2;ATG12;WDR45B;WDR45;FBXO7;CISD2
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.28156767613408534,0.8549434128570133,0.6741573033707865,0.9716039699375932,1.0,6/76,8.41%,CAV1;PRICKLE1;AXIN1;HDAC4;CUL3;TNIP1
prerank,renal filtration (GO:0097205),0.4043772229410415,0.8549254119268808,0.6190476190476191,0.9710399126814258,1.0,2/10,11.51%,SULF1;XPNPEP3
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.3372267417965176,0.8548815125190674,0.620253164556962,0.9705241641154871,1.0,9/21,22.92%,AATF;HDAC6;ABCD1;ABCB7;PINK1;COA8;PRKN;PAX2;SIRT2
prerank,positive regulation of defense response (GO:0031349),0.2766300374655155,0.8547307670763116,0.6932367149758454,0.9702034413293177,1.0,18/89,17.73%,NPAS2;MGST2;LRSAM1;WNT5A;ABCC1;IL17RA;TLR7;TRADD;POLR3G;PTGER4;TNIP1;PLSCR1;S100A9;POLR3D;IL15;NFKBIZ;MDK;LPL
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.3521891171843558,-0.8546144580010053,0.6377777777777778,0.9124904495907737,1.0,3/10,13.12%,PCGF5;IGF2;PRMT7
prerank,negative regulation of phagocytosis (GO:0050765),-0.31401367980393935,-0.8541968903504144,0.6666666666666666,0.9124261295926629,1.0,3/17,6.62%,DYSF;SIRPA;PIP4P2
prerank,apoptotic nuclear changes (GO:0030262),0.34518376174403614,0.8540842503056009,0.6327769347496206,0.970938541973349,1.0,6/24,15.10%,ACVR1C;DFFB;HMGB1;EXOG;DICER1;GPER1
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.28894179043590856,-0.853417828511425,0.6890080428954424,0.9131317025173727,1.0,2/20,6.91%,PLCB1;AGRN
prerank,cellular response to reactive oxygen species (GO:0034614),0.29120548746124114,0.8527004003002956,0.6700898587933247,0.9730769777240449,1.0,10/59,12.99%,PXN;EGFR;MPV17;FER;TNFAIP3;MAPK7;MAP3K5;HDAC6;NFE2L2;AQP1
prerank,acetyl-CoA metabolic process (GO:0006084),-0.3186780475674409,-0.8525729526608905,0.6381909547738693,0.9140146380625365,1.0,7/15,16.18%,HMGCS1;HMGCS2;MLYCD;ACLY;PMVK;MVK;ACSS1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.22812855841031482,-0.8524110924885689,0.7269076305220884,0.9134956401534353,1.0,18/52,22.18%,CNOT6L;EDC3;NT5C3B;HBS1L;EDC4;CNOT11;TUT7;EXOSC3;LSM7;ZFP36;DIS3;CNOT9;RC3H1;EXOSC1;PDE12;POLR2D;DCP2;LSM5
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.1907950990108837,-0.8523791470599578,0.8508771929824561,0.9126857502846589,1.0,55/148,27.75%,PRKAG2;CHD4;WRN;EP300;RPL37;RPS15;TOP3A;RPS20;JMY;BLM;ATRIP;HDAC1;AKT1;BRD7;SMYD2;PRKAB2;PIP4K2A;RPL23;RICTOR;CSNK2A1;NOC2L;TOPBP1;RAD1;CDK5R1;BARD1;CSNK2B;BANP;TP53RK;NUAK1;RAD17;RFC2;CDK5RAP3;RAD9B;TAF6;EHMT2;MAP2K6;RPL5;PIP4P1;RMI2;PRDM1;CDK2;BRCA1;PAK1IP1;RNF34;MLST8;L3MBTL1;PRKAA1;RFC4;RPF2;RMI1;ATM;ING5;TPX2;RPL11;TAF11
prerank,positive regulation of cell killing (GO:0031343),0.3860606397797905,0.8523698942545379,0.6245733788395904,0.973166498266871,1.0,6/13,23.34%,WNT5A;NOXO1;FZD7;SYK;MAPK8;RAC1
prerank,nucleosome organization (GO:0034728),0.28939625249140005,0.8522399095038373,0.6722454672245467,0.9728403066930921,1.0,17/55,21.52%,SOX9;KAT6B;CTCF;PAF1;LIN54;SMARCD2;INO80;MCM3AP;SETD2;NAP1L1;ACTR6;SPTY2D1;NAA60;ZNHIT1;DAXX;RSF1;ARID1A
prerank,negative regulation of transposition (GO:0010529),0.3593954024985553,0.8520311767122821,0.61,0.9726504589064223,1.0,3/16,12.29%,PIWIL2;SIRT7;TEX15
prerank,membrane lipid catabolic process (GO:0046466),0.3993177064055652,0.8519890345835655,0.6391752577319587,0.9721284261235379,1.0,2/10,4.81%,NAGA;MGST2
prerank,positive regulation of secretion (GO:0051047),-0.35408839974126594,-0.851965742045224,0.6474654377880185,0.9126669124414366,1.0,2/11,4.51%,ACSL3;NPR1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.29912271540540203,0.8518268640983344,0.6679738562091503,0.9718473856184233,1.0,6/52,7.64%,SORBS1;PRKCE;EGFR;ATP2B4;EPHB2;ARF6
prerank,DNA double-strand break processing (GO:0000729),0.35702129095859925,0.8517571188372436,0.6260032102728732,0.9714050164009089,1.0,3/18,6.89%,SMARCAD1;NBN;UBE2V2
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.3855036706178172,0.8516528141048713,0.6331658291457286,0.9710174340129997,1.0,3/13,18.76%,RIC3;STX4;TM9SF4
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.33498342400774156,-0.851634548514826,0.6699266503667481,0.9124787085085567,1.0,2/13,7.84%,SLC4A10;GRIK2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.2802751178500042,-0.8514259853963511,0.6845070422535211,0.9120127499768732,1.0,10/26,25.80%,LGR4;APPL2;NFKBIL1;LRRC14;IRF1;FLOT1;CACTIN;TLR3;BIRC3;SMPDL3B
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.30356955861190954,-0.8513705219232327,0.6376021798365122,0.9112644480377131,1.0,6/17,16.52%,BMP4;RFX3;VEZF1;BTG1;NKX6-1;AHI1
prerank,regulation of gene silencing by RNA (GO:0060966),0.2966375693712377,0.8513484667790333,0.6489071038251366,0.9704137186272243,1.0,12/50,15.45%,IPO8;NUP62;NUP160;AGO1;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153;PUM2;NUP93
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.2966375693712377,0.8513484667790333,0.6489071038251366,0.9704137186272243,1.0,12/50,15.45%,IPO8;NUP62;NUP160;AGO1;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153;PUM2;NUP93
prerank,actin filament network formation (GO:0051639),0.39964864985906406,0.8500834024001155,0.6461267605633803,0.9723389120400353,1.0,2/11,10.63%,COBL;FHOD1
prerank,regulation of primary metabolic process (GO:0080090),-0.19567874891707604,-0.8495692030906974,0.8135593220338984,0.9141627430610622,1.0,24/126,15.44%,ROCK2;PPARD;PSMA1;TGS1;LDLR;PLPP1;APOE;TBL1XR1;PSMD11;HMGCS1;C1QTNF2;TNFAIP8L3;PSMD7;PSMD4;PRKAB2;NFYB;FGFR4;SP1;PSMB4;PMVK;ID2;CERS2;MVK;NFYC
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.2939546742773861,-0.8494889374525113,0.6657963446475196,0.9134492892987776,1.0,4/20,5.19%,SEMA6D;SEMA7A;SEMA3C;SEMA6A
prerank,response to molecule of bacterial origin (GO:0002237),0.28201782519702595,0.8494730431423653,0.6902106567534076,0.9729135994506176,1.0,10/69,11.08%,LBP;PTPN22;HNRNPA0;IRAK3;FER;TNFAIP3;ACOD1;RPS6KA3;S100A9;TAB2
prerank,snRNA 3'-end processing (GO:0034472),0.3544248343832341,0.8490945693986818,0.6451104100946372,0.9730693498613969,1.0,5/19,21.47%,EXOSC5;TUT1;INTS6L;TOE1;EXOSC7
prerank,glycoprotein catabolic process (GO:0006516),0.3622173761816398,0.8486770470522499,0.6421725239616614,0.9733128743352025,1.0,5/17,18.96%,ADAMTS12;MMP12;MANBA;OGA;EDEM2
prerank,positive regulation of organelle organization (GO:0010638),0.3216135970552866,0.8485018758151537,0.6695652173913044,0.9730734522049287,1.0,7/32,15.89%,PPARGC1A;RAB3GAP2;IRGM;GSK3B;LNPK;HTRA2;SHCBP1L
prerank,negative regulation of transferase activity (GO:0051348),0.32337517840425367,0.8483215148935732,0.6486880466472303,0.9728136506599926,1.0,6/28,17.63%,SRC;FBXO5;GSK3B;MEN1;CDKN1C;IRS2
prerank,contractile actin filament bundle assembly (GO:0030038),0.37887744570019416,0.8479795298012718,0.6356073211314476,0.9722869704051239,1.0,4/15,10.55%,SORBS1;SRC;CUL3;ZYX
prerank,stress fiber assembly (GO:0043149),0.37887744570019416,0.8479795298012718,0.6356073211314476,0.9722869704051239,1.0,4/15,10.55%,SORBS1;SRC;CUL3;ZYX
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.3665185782750352,0.8474258991769802,0.6331569664902998,0.9727990498590493,1.0,2/14,8.64%,AK5;NMNAT3
prerank,Golgi to plasma membrane transport (GO:0006893),0.3003560577545573,0.847405123288074,0.672108843537415,0.9722410331790539,1.0,1/47,0.06%,STXBP6
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.3542457961290625,-0.8470592685153077,0.6912751677852349,0.9175502192027107,1.0,4/10,15.43%,CACNB2;CALM1;CALM3;SRI
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.3513409965316887,-0.8467541754966317,0.6495327102803738,0.9172844177583686,1.0,6/10,35.88%,ENPP2;PLA2G15;PLA2G7;PLA2G6;LIPC;PLA2G5
prerank,determination of bilateral symmetry (GO:0009855),-0.26967577702749385,-0.8466826243710992,0.7217125382262997,0.9165625284842225,1.0,6/25,14.89%,NPHP3;TBX1;GALNT11;CITED2;ZIC3;MKKS
prerank,embryonic heart tube development (GO:0035050),-0.3348502212060302,-0.8466805869862012,0.6707021791767555,0.915694240326679,1.0,4/14,16.59%,SOX17;CITED2;MEGF8;SOX18
prerank,receptor catabolic process (GO:0032801),0.32992000439406327,0.8464566789958693,0.6631736526946108,0.9735585672340021,1.0,6/24,11.37%,KIF16B;PIK3R4;GPRASP1;ZNRF3;SNX25;NEDD4
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.29698173707593717,-0.8464067464032503,0.6766304347826086,0.9153924442035649,1.0,4/18,12.90%,PIK3R1;BCL2L11;RNFT1;BOK
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.25540109890308266,-0.8463319558714238,0.7266881028938906,0.9146754698020944,1.0,10/33,17.52%,CYP1B1;SIRPA;ANXA1;OSER1;RHOB;RPS3;NET1;FXN;ANKZF1;TRPM2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.23272831252625925,-0.8461236359885799,0.7431906614785992,0.9142000981849694,1.0,17/48,22.65%,EP300;ATAD2B;ACTB;TAF1D;DEK;SMARCD1;H1-0;SMARCA5;SERTAD1;POLR2F;KAT2B;KAT2A;TAF1C;POLR2K;POLR1C;ZMIZ2;POLR1F
prerank,aminoglycan metabolic process (GO:0006022),0.3945817548930967,0.8458165276842259,0.6496598639455783,0.9742028141966588,1.0,1/10,2.21%,XYLT2
prerank,chloride transport (GO:0006821),0.27782345207155396,0.8453084813948212,0.6844059405940595,0.9746004101190566,1.0,13/74,12.51%,SLC12A2;SLC26A9;ANO6;SLC12A4;SLC12A3;CLCN2;CLCN1;GABRR2;GABRG2;BEST1;GABRG1;GABRB3;ANO10
prerank,multivesicular body organization (GO:0036257),0.32347865187522523,0.845160421528054,0.6419019316493314,0.9742998009539001,1.0,7/31,11.97%,TSG101;CHMP5;PDCD6IP;IST1;CHMP4A;CHMP4B;CHMP4C
prerank,determination of left/right symmetry (GO:0007368),0.3123513131601656,0.8449704693702088,0.6666666666666666,0.9740709433138873,1.0,8/37,15.14%,ENKUR;STIL;CCDC39;FOXJ1;LEFTY1;SMO;DNAH5;CCDC40
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.2828572162849251,-0.8446886112545587,0.7146892655367232,0.9162527445659978,1.0,3/22,5.38%,SLC7A5;LACC1;TNFRSF1B
prerank,peptidyl-lysine modification (GO:0018205),0.2670608196027601,0.8445310727456773,0.7218934911242604,0.9743651612101134,1.0,32/99,23.44%,STX1A;EYA1;SENP6;UBE2I;HDAC4;NUP62;SIRT3;PIAS2;NUP160;SIRT7;NUP37;TPR;NUP50;HDAC6;RANBP2;NUP210;NUP153;ATPSCKMT;NUP93;SENP3;SUMO1;SENP2;TRPM4;LOXL2;ETFBKMT;NUP43;VIPAS39;VCPKMT;IFIH1;SIRT2;SAE1;BCL11A
prerank,peptidyl-serine phosphorylation (GO:0018105),0.25391912302550895,0.8444876086829822,0.7566079295154186,0.973868457390491,1.0,21/153,13.34%,PLK2;PRKCE;CAMK2D;STK38;EIF2AK3;PRKCA;MORC3;HIPK1;BRSK1;STK38L;DYRK1A;CSNK1G3;GSK3B;RPS6KA3;MASTL;CSNK1A1;SRPK2;TOP1;SGK1;PKD1;ERN1
prerank,receptor-mediated endocytosis (GO:0006898),0.2599276026650101,0.8441721953462157,0.7403189066059226,0.9738853984333334,1.0,24/132,16.60%,CAV1;ACKR3;FOLR1;HSPH1;COLEC11;CAV2;CD9;TFR2;DNM1;SGIP1;INPP5F;CUBN;M6PR;NEDD4;CD81;AMN;CTTN;HSPG2;CLEC9A;CLTB;AP2A2;SNX1;SYK;SCARB2
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.30547087877674933,0.8437330959962775,0.6514285714285715,0.9741615326132481,1.0,4/42,5.75%,UBE2L6;USP43;POLI;RFC3
prerank,phosphatidylserine metabolic process (GO:0006658),0.31555107773010876,0.8437284130786862,0.6551226551226551,0.9735804526828002,1.0,4/32,8.99%,MBOAT2;SLC27A1;ABHD12;PLSCR1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.34690804387672836,0.8436927990519555,0.6365105008077544,0.9730564090703846,1.0,2/19,2.82%,CXCL17;MPP1
prerank,anterograde trans-synaptic signaling (GO:0098916),0.24865204776671054,0.843614922405134,0.7829293993677555,0.9726120447460366,1.0,31/224,14.69%,HRH1;CHRNB3;CEL;MINK1;GRIA3;SLC12A4;NPTX2;SLC1A6;CPLX1;GABBR2;PAFAH1B1;PRKAR2A;GABRR2;GABRG2;HCRTR2;MYCBPAP;DOC2A;MPZ;RPS6KA3;GRIA1;SCN2B;GABRG1;GABRB3;SNCG;GRM1;KIF5A;CHRM2;PRKACB;HCRT;UNC13B;CHRM3
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.28377691497832175,0.8433715843692844,0.6675392670157068,0.9724802266286866,1.0,12/59,16.08%,BCL3;REL;TLR7;TRADD;AZI2;IRAK1BP1;TICAM1;SHARPIN;TAB2;TICAM2;TBK1;RELB
prerank,cardiac muscle contraction (GO:0060048),0.3138381922789234,0.843315011368574,0.6771428571428572,0.9719992620227266,1.0,7/34,15.19%,CAMK2D;CSRP3;ATP1A2;CASQ2;SCN2B;TNNI1;TNNI3
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.3210905346840377,0.8429525427865796,0.6838995568685377,0.9721086505167824,1.0,2/32,2.58%,DLC1;CDH5
prerank,kinetochore organization (GO:0051383),-0.32506680033231733,-0.8427687907381721,0.680628272251309,0.9193192891363928,1.0,9/13,40.07%,CENPT;CENPC;CENPE;NDC80;CENPF;CENPA;DLGAP5;NUF2;CENPW
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.36760383589848866,0.8425601752362804,0.6469622331691297,0.9722655592484359,1.0,1/16,0.78%,ACKR3
prerank,positive regulation of protein ubiquitination (GO:0031398),0.27759442888222957,0.8424028501160333,0.7114673242909988,0.9719862952678754,1.0,4/80,4.37%,CAV1;PRICKLE1;AXIN1;SPSB4
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.359859473227927,-0.8422979960788081,0.6529126213592233,0.9194456458434481,1.0,3/10,7.68%,CSGALNACT1;CSGALNACT2;PXYLP1
prerank,methylguanosine-cap decapping (GO:0110156),-0.350881909124349,-0.8417634073919703,0.6712962962962963,0.9196866465226635,1.0,3/10,10.58%,EDC3;EDC4;PNRC2
prerank,regulation of gene silencing by miRNA (GO:0060964),0.2849241424416713,0.841531753763592,0.6841415465268676,0.9730632567626831,1.0,20/62,22.89%,DND1;IPO8;NUP62;NUP160;AGO1;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153;FXR1;PUM2;NUP93;PPARG;DHX9;NUP43;PUM1;ELAVL1;SEC13
prerank,histone acetylation (GO:0016573),0.2760193899413724,0.841499658877062,0.6914357682619647,0.9725426199121081,1.0,19/69,19.21%,SPI1;BEND3;HAT1;KAT6B;TAF10;MSL3;TRRAP;PHF20L1;CREBBP;KAT8;BRD8;TADA2A;BRPF3;MORF4L2;TAF5;BRD1;RUVBL2;NAA40;NAA60
prerank,positive regulation of endopeptidase activity (GO:0010950),0.32366832498117937,0.8412143887456462,0.6687116564417178,0.9724838379849915,1.0,4/26,6.00%,USP50;APH1B;PSME3;NCSTN
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.39306477798230643,0.8411452126890183,0.6299638989169675,0.9714564474776404,1.0,2/10,18.83%,CNGB1;CEP250
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.39306477798230643,0.8411452126890183,0.6299638989169675,0.9714564474776404,1.0,2/10,18.83%,CNGB1;CEP250
prerank,negative regulation of protein polymerization (GO:0032272),0.3287831688668282,0.8411432653967773,0.6816816816816816,0.9708775859948743,1.0,4/27,8.36%,KANK4;CDH5;KANK1;DYRK1A
prerank,peptide cross-linking (GO:0018149),0.32770229274456464,0.8410860723447207,0.661042944785276,0.9704185432221545,1.0,3/25,6.65%,CD3G;FN1;COL3A1
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.29786370762408776,0.8410478122916318,0.6815114709851552,0.9699081437095534,1.0,12/43,19.01%,BRCC3;BRSK1;NBN;CHFR;RINT1;UIMC1;DONSON;CDC6;FZR1;INTS3;ORC1;MRE11
prerank,steroid biosynthetic process (GO:0006694),0.28524889256197006,0.8403770710717342,0.6781002638522428,0.9706276236920173,1.0,8/56,11.64%,HSD17B3;CYP7B1;OSBPL6;SC5D;HSD17B4;ACOT8;PRLR;MSMO1
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.2773705094933563,-0.8403472584350117,0.7130681818181818,0.9215691002273662,1.0,4/24,7.87%,CDC42;MEF2A;MAPK12;CDON
prerank,cGMP metabolic process (GO:0046068),-0.33453869703060873,-0.840283817117935,0.6589861751152074,0.9208298011355739,1.0,2/12,9.39%,NPR1;PDE2A
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.3221167863246026,0.839829656547172,0.6575757575757576,0.9710763017996704,1.0,10/27,25.11%,SPRED1;HIC1;DYRK1A;SPRED2;YJU2;ATR;KMT5A;TWIST1;PTTG1IP;MDM2
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.29306015763066406,-0.8389420670750893,0.6666666666666666,0.9226153546984867,1.0,6/20,27.36%,AKR1B1;FDXR;TSPO;STARD3NL;HSD17B10;TSPOAP1
prerank,calcium ion transmembrane transport (GO:0070588),0.27337483953933095,0.838862210901856,0.7192546583850932,0.9723777004271396,1.0,7/86,4.74%,NALCN;TRPM3;SLC8B1;ANO6;SLC24A1;TRPV4;ATP2B4
prerank,positive regulation of myelination (GO:0031643),-0.34573265231542016,-0.838461199991192,0.669047619047619,0.9227189447359796,1.0,2/11,5.38%,PARD3;TNFRSF1B
prerank,regulation of cell size (GO:0008361),0.33537435293252416,0.8379303053175867,0.6818181818181818,0.9735739706381392,1.0,12/23,23.74%,VAV2;RDX;PLEK;RARG;PTEN;EZR;RAP1GAP2;RHOA;LAMTOR5;RPTOR;RAC1;MTOR
prerank,pyruvate metabolic process (GO:0006090),0.28776431494270555,0.8378933407623576,0.7068741893644618,0.973065459702767,1.0,12/52,17.84%,HK2;HOGA1;ALDOB;DLAT;PGM1;SLC16A1;ENO3;GCK;ME2;PGK1;LDHB;ENO2
prerank,DNA repair (GO:0006281),0.24220752420898753,0.8378630447962486,0.8091762252346194,0.9725491248315804,1.0,64/284,19.61%,FAAP24;TDG;MSH6;BRCC3;EYA1;POLI;SLC30A9;KMT5C;FANCC;PDS5B;RFC3;KPNA2;FANCF;NBN;UBE2V2;MSH2;UIMC1;ACTR8;USP47;TRRAP;APEX2;ERCC6;ERCC1;TDP1;MEN1;INO80;CETN2;MDC1;MGMT;RFWD3;ADPRS;GTF2H1;NUCKS1;ALKBH1;RAD51AP2;POLB;EME2;REXO4;RECQL5;FAM111A;PRMT6;POLE;DDB2;FANCL;INTS3;CHD1L;KDM4B;USP45;TNKS1BP1;RHNO1;CUL4B;SETD2;PSME4;TDP2;BRIP1;BACH1;GTF2H3;ERCC6L2;ASCC2;MRE11;ASCC1;MLH3;RPAIN;SUMO1
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.25956919811436147,-0.8374458821915712,0.7390029325513197,0.9239477720701299,1.0,14/28,32.99%,CLIP1;RPS3;MAPT;CDK5R1;ARL2;FES;MET;GIT1;HSPA1A;CDK5RAP2;DCTN1;HSPA1B;NAV3;TOGARAM1
prerank,peptide metabolic process (GO:0006518),0.2742207609054466,0.8372914708585137,0.7180124223602484,0.9730795893277011,1.0,17/75,16.37%,PCSK5;MGAT3;CPE;LVRN;LNPEP;BACE2;GSTZ1;GSTA4;MME;GSTA3;GSTK1;LTA4H;MIPEP;ABCB9;GGT1;NLN;BACE1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.21799846971332146,-0.8372594245425413,0.8043478260869565,0.9234512378124576,1.0,18/55,19.53%,NUPR1;TGFBR1;BCL2L11;GSDME;FAS;BECN1;TNFSF12;BCL10;RPS3;BID;BOK;TNFSF10;WWOX;TPD52L1;STYXL1;AGT;RACK1;BBC3
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.3733811671771897,0.8371734718287839,0.6453781512605042,0.9727334435512246,1.0,3/12,17.25%,UPP2;CAD;DCK
prerank,negative regulation of cell death (GO:0060548),0.26915016186954477,0.8369693374275778,0.7101096224116931,0.9725246412724717,1.0,14/88,10.70%,PPARGC1A;SPEF1;WNT16;NPAS2;NUP62;KANK2;AMIGO2;ATG5;CD200R1;GSK3B;POU4F1;FERMT2;CHMP4A;CHMP4B
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.2861205427428414,-0.8365377222517696,0.696236559139785,0.9239912465519852,1.0,2/19,1.31%,AFDN;BMP6
prerank,termination of RNA polymerase II transcription (GO:0006369),0.31030978082534644,0.836247891966128,0.6623931623931624,0.973293653561492,1.0,4/33,7.26%,CSTF1;SNRPF;MED18;CSTF3
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.2821854860898177,-0.8359858472845331,0.7442528735632183,0.9242810852061246,1.0,11/22,27.95%,RPL37;RPS15;RPS7;RPS20;RPL23;EEF1E1;CDK5RAP3;PLA2R1;UBB;ATM;MSX1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.2610155628573312,-0.8359065341931299,0.7270114942528736,0.9235546379399806,1.0,16/30,34.40%,ARHGEF2;NOS3;FAS;CFLAR;TNFSF10;CASP8;ICAM1;RIPK1;BRCA1;RNF34;DDX3X;TRAF2;RFFL;HMOX1;FAIM2;SERPINE1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.30574651381941703,0.8358830733399099,0.6653005464480874,0.9734098661218638,1.0,1/37,0.26%,EFNA5
prerank,regulation of mitotic cell cycle (GO:0007346),0.2535150277534735,0.8357127859538265,0.7633928571428571,0.9731511777348135,1.0,37/171,18.75%,SMOC2;FBXO43;KIF20B;CAV2;PRKCA;PSME3;NEK7;CDK13;FBXO5;BRINP1;CDC20;PSMB5;ANAPC5;ANAPC7;EIF4E;ANAPC11;BUB3;CDKN1C;ANAPC2;PSMB2;UBE2D1;PSMA2;TTC28;PSMA6;ANAPC4;FZR1;PSMD13;PSMA7;NEK11;SCRIB;PSME4;ANAPC16;PSMC4;CDC23;PSMB6;PSMD12;PSMD14
prerank,regulation of receptor binding (GO:1900120),0.3941738980256108,0.8356887921184634,0.6198630136986302,0.9726095144061291,1.0,1/10,1.78%,PTPRF
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.29030830279752884,0.8356118685344365,0.7108433734939759,0.972174804549403,1.0,4/50,5.89%,NR3C2;EGFR;TLR7;TRADD
prerank,mitochondrion disassembly (GO:0061726),-0.25442278094010956,-0.8354102979367284,0.7348993288590604,0.9236704684610002,1.0,15/34,26.21%,SQSTM1;BECN1;GABARAPL1;WIPI1;ULK2;GABARAP;AMBRA1;USP30;MAP1LC3A;WIPI2;ATG12;WDR45B;WDR45;FBXO7;CISD2
prerank,negative regulation of viral process (GO:0048525),-0.22560884307271026,-0.8353517443139699,0.7628458498023716,0.9229217334987618,1.0,18/57,21.47%,MID2;BST2;TRIM14;ZC3HAV1;TRIM35;TRIM28;PROX1;UBP1;PARP10;CHMP3;ISG15;IFIT1;ZFP36;RSAD2;TRIM8;TRIM13;TRIM11;SHFL
prerank,positive regulation of protein maturation (GO:1903319),0.3859706361553463,0.8353049661384403,0.6526315789473685,0.9721723008943519,1.0,4/11,16.90%,TFR2;NLRC4;SOX4;BAG2
prerank,positive regulation of transport (GO:0051050),0.2710116524458571,0.8352056766272069,0.7032569360675512,0.9717702231882278,1.0,7/85,5.49%,GPC3;NEDD4L;GPLD1;KMT2A;LMAN2;TFR2;DOCK2
prerank,tRNA transport (GO:0051031),0.30780310047066506,0.8351782888140499,0.681203007518797,0.9712479842875832,1.0,10/35,15.45%,NUP62;NUP160;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153;RAN;NUP93
prerank,negative regulation of histone modification (GO:0031057),-0.3243278905741148,-0.8351368622425906,0.683698296836983,0.9224825782132755,1.0,8/14,39.98%,JARID2;NOC2L;BRCA1;AASS;THAP7;CTBP1;SNCA;SPHK2
prerank,Golgi localization (GO:0051645),-0.3426508214874938,-0.8349957672910969,0.6932367149758454,0.9218876666049144,1.0,3/11,6.04%,CDC42;UVRAG;PDCD10
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.3736112001097452,0.833789350182665,0.637901861252115,0.9733515080167536,1.0,2/13,4.79%,STX1A;CACNA1H
prerank,organophosphate catabolic process (GO:0046434),-0.3392454566162474,-0.8332705337813586,0.6588785046728972,0.9243468547863616,1.0,1/11,2.72%,ENPP2
prerank,double-strand break repair (GO:0006302),0.25222691540843883,0.8329416448505043,0.7625,0.9744283142198559,1.0,37/158,19.61%,SMC5;BRCC3;EYA1;PAXX;SMARCAD1;KPNA2;NBN;UBE2V2;PALB2;SWI5;UIMC1;ACTR8;HMGB1;ZSWIM7;ERCC1;TDP1;ZFYVE26;INO80;MDC1;GEN1;RFWD3;NUCKS1;SFPQ;RAD51AP2;POLB;EME2;REV3L;RECQL5;KDM4B;TNKS1BP1;TDP2;BRIP1;SFR1;PSMD14;MRE11;XRCC6;SUMO1
prerank,regulation of mitochondrion organization (GO:0010821),0.30003613463929535,0.832737231801466,0.7004103967168263,0.9742142941805788,1.0,15/47,21.23%,PPARGC1A;PISD;FIS1;GSK3B;SIRT7;HDAC6;STAT2;HTRA2;PRMT6;FBXW7;CSNK2A2;PINK1;PRKN;MUL1;GOLPH3
prerank,cellular protein metabolic process (GO:0044267),0.2376009291450034,0.8326470565745526,0.8416751787538305,0.9738094117644752,1.0,44/396,11.23%,FAM20C;IGFBP6;GPC3;STC2;RPSA;SLC35A1;UBE2L6;LAMB2;LAMC1;PCSK5;DUSP12;STK38;MMP15;APH1B;ERO1A;SCG3;MRPL37;MRPL43;UBE2I;CDKL3;NUCB1;CPE;FN1;BMP15;PABPC4;NCSTN;ADAM10;ABL2;GOLM1;RCN1;CDH2;IGFALS;DARS1;TNIP1;CSNK1G3;RPL35;MRPL41;RPS13;MRPS15;MRPS33;MANBA;PROC;MRPL3;PRKCSH
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.32395785127344034,-0.8326398400585816,0.693069306930693,0.9246984571876697,1.0,5/14,10.09%,CHKA;LPIN2;ETNK1;CEPT1;LPIN3
prerank,regulation of microtubule-based process (GO:0032886),0.30708875531207797,0.8322689452972717,0.6839080459770115,0.9739524032211904,1.0,5/36,11.27%,EFNA5;GSK3B;PHLDB1;APC;HDAC6
prerank,defense response to virus (GO:0051607),-0.201889724834645,-0.8319487279434227,0.8742857142857143,0.9251615322374961,1.0,25/100,21.47%,SERINC3;IFNAR2;ABCC9;SAMHD1;IRF2;IFIT2;IFIT3;AGBL5;BST2;FLNA;IRF1;NDUFAF4;AKAP1;ABCE1;MOV10;ISG15;IFIT1;CD40;RSAD2;PDE12;OPRK1;CGAS;TLR3;BNIP3L;SHFL
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.29054185740525523,0.8317819625534691,0.6917808219178082,0.9742755409151249,1.0,4/46,4.96%,HK2;TOMM34;MFN2;FIS1
prerank,keratinocyte differentiation (GO:0030216),0.3100076172264784,0.8316914698317227,0.6848920863309352,0.9738641111876808,1.0,3/29,4.96%,JAG1;WNT16;WNT5A
prerank,neutrophil migration (GO:1990266),0.2841860931806245,0.8314172383847191,0.7043363994743759,0.973801143965148,1.0,1/58,0.29%,CXADR
prerank,neuronal action potential (GO:0019228),0.3382570679633351,0.8313809133009038,0.6691842900302115,0.9732915953340711,1.0,2/22,4.79%,SCN10A;CACNA1H
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.29495141014321236,0.8313240444826675,0.7071823204419889,0.9728242903875984,1.0,11/49,13.63%,SRC;DACT1;PPM1A;LDLRAD4;PTGER4;ISL1;GSK3B;HMGB1;NLRP2B;HDAC6;LCMT1
prerank,cellular response to light stimulus (GO:0071482),-0.2125343836792615,-0.8312196081316543,0.7953488372093023,0.9256331697697355,1.0,16/66,19.92%,USP28;PTPRK;EP300;RPL26;NPM1;CDC25A;EIF2AK4;KDM1A;NOC2L;POLK;ZBTB1;NSMCE3;DHX36;ATF4;PARP1;ERCC4
prerank,tRNA aminoacylation (GO:0043039),0.3092206362172377,0.8310920778686448,0.6595441595441596,0.9726482978272987,1.0,13/37,22.21%,RARS2;VARS1;DARS1;KARS1;AIMP1;WARS1;WARS2;DARS2;TARS1;SARS2;HARS2;GATB;MARS2
prerank,zinc ion transport (GO:0006829),0.34021608573269607,0.8309931347146601,0.6677367576243981,0.9722623357766597,1.0,3/21,6.05%,SLC39A13;SLC30A9;SLC30A6
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.37290268499407786,0.8308598893783115,0.6767676767676768,0.9719477708995996,1.0,3/14,16.83%,ANO6;GPER1;RGCC
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.31953639178308063,0.8306612084011274,0.6851574212893553,0.9717399266488917,1.0,3/29,9.48%,CXCL17;ANO6;HMGB1
prerank,chemical synaptic transmission (GO:0007268),0.24085587578868986,0.8305063578099947,0.8255451713395638,0.9714520588564709,1.0,37/284,13.51%,HRH1;CHRNB3;CEL;PDLIM4;MINK1;STX1A;RIC3;GRIA3;SLC12A4;NPTX2;BRSK1;SLC1A6;RAB3A;CPLX1;GABBR2;PAFAH1B1;PRKAR2A;GABRR2;GRID1;GABRG2;HCRTR2;MYCBPAP;DOC2A;MPZ;RPS6KA3;GRIA1;SCN2B;GABRG1;GABRB3;DLGAP2;SNCG;GRM1;KIF5A;PTEN;CHRM2;PRKACB;HCRT
prerank,mRNA 3'-end processing (GO:0031124),0.27482871058238334,0.8304948699393675,0.7407878017789072,0.970896757027842,1.0,26/78,25.25%,CSTF1;RBM8A;SRSF4;LEO1;RPRD1B;TUT1;PAF1;CSTF3;RPRD1A;UPF3B;THOC3;THOC5;SLU7;SYMPK;PAPOLG;SRSF3;DHX38;CDC73;NUDT21;SRSF11;PCF11;CPSF2;WDR33;SARNP;PABPN1;TENT4B
prerank,apical protein localization (GO:0045176),0.38024898222014736,0.83014010324226,0.647912885662432,0.9709934546805126,1.0,2/10,6.15%,ATP8B1;SHROOM2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.36959573909506904,0.8299423446478478,0.656140350877193,0.9708021342379032,1.0,5/13,22.61%,PRPF3;USP4;SRSF12;SRSF10;LSM2
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.24147226097721336,-0.8299401335663462,0.7935943060498221,0.9273601351579275,1.0,5/38,8.41%,SASH1;BMP6;POLR3B;CYBA;SLC15A4
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.317435138012638,-0.8298582379186151,0.6804878048780488,0.9266427918483975,1.0,3/14,5.82%,ENPP1;ENPP3;CMPK1
prerank,regulation of interleukin-10 production (GO:0032653),0.29778183624660526,0.8296198526861529,0.689041095890411,0.9708954601432869,1.0,1/44,0.38%,TRIB2
prerank,nucleus organization (GO:0006997),-0.2290551338802554,-0.8294507247908227,0.8029739776951673,0.9265740737701361,1.0,9/47,11.18%,PITPNB;SYNE1;SEH1L;NUP133;RPS19;CTDNEP1;LEMD3;VPS4A;USP36
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.30393197324184557,0.8292923258183241,0.6988304093567251,0.9709566632397879,1.0,4/34,6.38%,PTPN22;WNT5A;PTPRC;EPHB2
prerank,mitochondrial gene expression (GO:0140053),0.2946905065268822,0.829172129536889,0.6909340659340659,0.9706079367968985,1.0,13/42,21.17%,FOXO3;FASTKD2;MRPS28;RARS2;PTCD3;TFB2M;MRPS15;TEFM;MRPL16;NDUFA7;MRPL2;GATB;MRPS7
prerank,detection of visible light (GO:0009584),0.3473119700807244,0.8287349472325082,0.690671031096563,0.9708561280301798,1.0,2/16,5.04%,GNAQ;CNGB1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.30405606877224134,-0.8286106232658746,0.6887755102040817,0.9273034247456592,1.0,6/15,27.68%,RPS7;RPL23;MAD2L2;RPL5;MAD2L1;RPL11
prerank,nuclear pore organization (GO:0006999),-0.321326156331474,-0.8285213565044471,0.7088305489260143,0.9266516907220447,1.0,3/14,6.17%,NUP107;SEH1L;NUP133
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.31881376045351617,0.8283870072034895,0.6819526627218935,0.9709359797049865,1.0,2/26,7.45%,CEACAM1;RARA
prerank,ureteric bud development (GO:0001657),0.3507892649605631,0.828319841216351,0.6815181518151815,0.9704986729221045,1.0,1/17,0.41%,GPC3
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.23743301451597115,0.8279888879698429,0.8425357873210634,0.9705456205951738,1.0,82/341,20.54%,NEDD4L;UBE2L6;RNF130;WDR81;UBE3C;RNF122;PCBP2;UBE2I;SPSB4;PSME3;KEAP1;TOM1L1;TSG101;TNFAIP3;CHFR;SIAH1;ZNRF3;CUL3;UBL7;CDC20;AMFR;PSMB5;ANAPC5;ANAPC7;SIAH3;NPLOC4;UBE3D;SHARPIN;RCHY1;TRPC4AP;ANAPC11;OTUD7B;FBXL19;NEDD4;SPOPL;BUB3;FBXL17;TTC3;FAF1;FBXO11;NFE2L2;RNF185;FBXO21;FBXO8;ANAPC2;PSMB2;UBA1;UBE2D3;UBE2D1;PSMA2;KLHL22;KLHL15;FEM1C;PSMA6;ANAPC4;WWP2;FZR1;PSMD13;PSMA7;PLAA;UBE2R2;FBXW7;UBQLN1;ITCH;RNF7;PSME4;WDR91;ANAPC16;PINK1;PSMC4;CDC23;PSMB6;PSMD12;PSMD14;USP9X;KBTBD7;GID4;UBE2W;DDIT3;PRKN;RNF146;RNF14
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.3625804397961977,0.8277900662933146,0.6766169154228856,0.970354909134002,1.0,3/14,6.73%,ATIC;PFAS;PPAT
prerank,positive regulation of protein binding (GO:0032092),0.2801665781438522,0.827592609955345,0.7116644823066841,0.9701479303622685,1.0,21/56,24.26%,CAV1;ADD1;DACT1;TRIM21;AMFR;STK3;GSK3B;MEN1;PKD1;CAPRIN2;RAN;PPP2CA;PIN1;PRKN;AKTIP;TCF7L2;DERL1;NMD3;DTX3L;RIPK2;HIPK2
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.3249916372447216,0.8273583795913821,0.6826347305389222,0.9700560112843686,1.0,6/26,10.98%,HEYL;KANK2;NCOR1;PIAS2;ISL1;NCOR2
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.2226702226449929,-0.8271476356323924,0.8,0.9284811440388746,1.0,12/56,13.56%,LACC1;IRAK4;ALPK1;CTSL;TRAF6;PLCG2;NOD1;BCL10;LGMN;S100A1;MAPKAPK2;MAPKAPK3
prerank,androgen receptor signaling pathway (GO:0030521),0.3774550235814199,0.8267435581905309,0.6660550458715596,0.9706411717391629,1.0,5/11,21.52%,DDX17;TMF1;RNF14;DAXX;ARID1A
prerank,proteoglycan metabolic process (GO:0006029),0.31909939966894163,0.8259920687870398,0.6818851251840943,0.971462148125916,1.0,5/26,11.12%,ADAMTS12;SULF1;BMPR1B;CANT1;CHST12
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.28748623524767664,0.8259683316668763,0.7070151306740028,0.9709407711528352,1.0,16/51,21.67%,LPAR1;PXN;RAPGEF3;ARHGEF5;PLEK;FERMT2;FHOD1;NF2;ARHGEF10L;ARHGEF10;RGCC;RHOA;PFN2;PPM1E;S100A10;CX3CL1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.27103967694901343,0.8257797427636993,0.7209302325581395,0.9707088426913681,1.0,8/73,9.48%,LBP;IL1A;WNT5A;PTPRC;EPHB2;ISL1;PTPRJ;HMGB1
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.2535597951020061,-0.8257253706714671,0.749271137026239,0.930257293598497,1.0,10/30,22.08%,VAMP5;SEC16A;ANK3;MACF1;BBS2;PREPL;GGA3;SYS1;OPTN;RAB10
prerank,bile acid metabolic process (GO:0008206),0.32150290542383336,0.8256446974552019,0.6975683890577508,0.9703933770718963,1.0,4/27,10.28%,CYP7B1;OSBPL6;HSD17B4;ACOT8
prerank,regulation of translation (GO:0006417),0.24881046892020048,0.8255467721245479,0.7804610318331504,0.970047075039277,1.0,47/173,22.09%,BCL3;FXR2;PIWIL2;GIGYF2;FOXO3;EIF2AK3;CNOT10;SAMD4B;PUS7;EIF5B;IGF2BP2;RPS6KA3;EIF4E;CNOT7;EIF1;METTL5;ATXN2;ILF3;PLD1;EIF2B4;UPF3B;ETF1;CSDE1;NSUN5;DDX6;SOX4;ALKBH1;MIF4GD;FXR1;PYM1;MTG2;CPEB3;ERBB2;LTN1;SYNCRIP;CNOT8;CNOT1;DHX9;HNRNPD;LARP4;EIF4G2;IL6;MALSU1;TSFM;ELAVL1;IMPACT;DDX25
prerank,myoblast fusion (GO:0007520),0.376535303826524,0.8254138865369642,0.6643478260869565,0.9697476822377704,1.0,3/12,12.38%,CD9;CACNA1H;CD81
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.3534646059121559,0.8253420301140114,0.6506622516556292,0.9693179514846181,1.0,5/15,24.20%,SOX9;SMO;PAX2;LHX1;SIX1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.32628594343115136,0.8249384471981263,0.6590909090909091,0.9695221005435533,1.0,3/24,3.58%,CAMK2D;PDE4D;FKBP1B
prerank,protein tetramerization (GO:0051262),0.2776515556141352,0.8246922951639385,0.7340686274509803,0.9694059564337995,1.0,4/67,7.01%,ALDH1A3;ALDH9A1;ACOT13;ACACA
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.2678009057705542,0.8245439824550705,0.7541191381495564,0.9691130911630673,1.0,21/80,18.40%,KIF2A;LMAN2;RACGAP1;PLPP3;TAPBP;KIF3C;RINT1;ATP9B;ATP9A;COPE;KIF26A;KIF5A;COPG1;HTT;ZW10;COPA;TMED2;ERGIC1;ARCN1;KLC2;COG3
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.31674638705023334,0.8244042918336977,0.6671597633136095,0.9687971082160559,1.0,1/27,0.73%,LPAR1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.3087558065221601,-0.8243624813858978,0.7015706806282722,0.931939757362894,1.0,4/15,16.13%,TGFB3;CUEDC2;TGFB2;HFE
prerank,stabilization of membrane potential (GO:0030322),-0.3051353426251021,-0.8242893385361237,0.7037974683544304,0.9312300886629679,1.0,1/16,0.21%,KCNK2
prerank,RNA methylation (GO:0001510),0.2752421913285774,0.824140183792916,0.7256176853055917,0.9687295666963814,1.0,18/60,23.23%,MRM2;BUD23;RBM15B;TARBP1;TFB2M;METTL5;THADA;FTSJ1;TRMT5;NSUN5;CMTR1;THUMPD3;METTL2A;METTL2B;ZC3H13;TRMO;TFB1M;MEPCE
prerank,protein autoubiquitination (GO:0051865),0.27923652977428093,0.8238399140156064,0.6889168765743073,0.968731306142853,1.0,14/61,17.26%,SH3RF2;RNF122;LRSAM1;TRIM21;CUL3;AMFR;RNF220;UBE3D;OBI1;RNF185;UBE2D3;WWP2;DDB2;ITCH
prerank,DNA duplex unwinding (GO:0032508),-0.22775253959227193,-0.8236720728271802,0.8087649402390438,0.9315735518148724,1.0,21/50,32.04%,WRN;RBX1;BLM;MCM6;ANXA1;SSBP1;ERCC2;XPA;GTF2H4;DDX1;PARP1;MCMDC2;TWNK;RAD51;UBB;GTF2H5;DDB1;ASCC3;MCM9;MCM7;MCM2
prerank,regulation of dendritic spine development (GO:0060998),0.3512743754983942,0.823637236616462,0.6954397394136808,0.9685587760424872,1.0,3/19,7.64%,PPFIA2;LLPH;ARF6
prerank,protein alkylation (GO:0008213),0.3304577213051103,0.8236338656708138,0.6692546583850931,0.9680038239379666,1.0,9/22,25.76%,ETF1;LCMT1;METTL22;CAMKMT;ETFBKMT;VCPKMT;EEF2KMT;PRMT8;PRMT3
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.31398639126047073,-0.8235887985359458,0.7122641509433962,0.9308479062812384,1.0,3/13,9.35%,ENPP1;BPNT2;TPST1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.3792886620828494,0.8235685155608249,0.6760330578512397,0.9675610256562609,1.0,4/12,10.98%,HEYL;NCOR1;PIAS2;NCOR2
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.28529374178480693,0.823441842992771,0.7439024390243902,0.967252475613887,1.0,7/48,12.28%,OTOP1;ARG1;IRAK3;PTPRC;NLRP2B;CNOT7;STAT2
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.22322153761346966,-0.8230535438783485,0.8271028037383178,0.9293331570775817,1.0,19/61,21.25%,TGFA;TRAPPC10;PREB;NAPA;GOSR2;ANKRD28;SEC16A;SEC16B;SEC23A;GOLGA2;SAR1B;F5;TRAPPC2;SCFD1;CTSC;SEC31A;TRAPPC6B;TRAPPC6A;SEC22B
prerank,COPII vesicle coating (GO:0048208),-0.22322153761346966,-0.8230535438783485,0.8271028037383178,0.9293331570775817,1.0,19/61,21.25%,TGFA;TRAPPC10;PREB;NAPA;GOSR2;ANKRD28;SEC16A;SEC16B;SEC23A;GOLGA2;SAR1B;F5;TRAPPC2;SCFD1;CTSC;SEC31A;TRAPPC6B;TRAPPC6A;SEC22B
prerank,vesicle coating (GO:0006901),-0.22322153761346966,-0.8230535438783485,0.8271028037383178,0.9293331570775817,1.0,19/61,21.25%,TGFA;TRAPPC10;PREB;NAPA;GOSR2;ANKRD28;SEC16A;SEC16B;SEC23A;GOLGA2;SAR1B;F5;TRAPPC2;SCFD1;CTSC;SEC31A;TRAPPC6B;TRAPPC6A;SEC22B
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.2615122603902682,0.8228389432763965,0.7310012062726177,0.9678342497145772,1.0,22/87,19.28%,SDHAF4;LYRM7;NDUFA6;NDUFB10;COA5;NDUFS3;NDUFS6;IMMP2L;SDHAF2;COX19;NDUFA3;NDUFV2;COX16;NDUFV1;NDUFAF5;BCS1L;NDUFA7;DMAC2;NDUFAF6;NDUFS2;SURF1;COA8
prerank,cellular protein-containing complex assembly (GO:0034622),0.2499026220395507,0.8228025648746302,0.7918552036199095,0.9673472478846753,1.0,30/160,15.45%,STXBP6;PXN;AXIN1;SRC;NCK2;CCDC39;SGIP1;PSMG2;CASQ2;IMMP2L;CALY;PFDN6;PSMG1;TPR;CHMP4A;CHMP4B;LONP1;VAMP8;PRLR;CCT2;AHCTF1;VAMP1;HOPX;NUP153;RTN4;CLTB;POMP;CCDC40;PSMD13;NUP93
prerank,liver development (GO:0001889),0.3010886330958641,0.8227768542200675,0.7090643274853801,0.9668325888035788,1.0,5/32,7.30%,COBL;NF1;LSR;GFER;CCDC39
prerank,regulation of monocyte chemotaxis (GO:0090025),0.32260817598863256,0.8222504969758418,0.6990740740740741,0.9672470853807049,1.0,4/24,9.48%,CXCL17;ANO6;NBL1;HMGB1
prerank,peroxisomal membrane transport (GO:0015919),0.32079431916488643,0.822158713429533,0.6920731707317073,0.966856128455209,1.0,5/27,12.75%,RAB8B;FIS1;PEX2;PXMP2;ABCD1
prerank,positive regulation of telomerase activity (GO:0051973),0.30431797404036554,0.822040036729628,0.7148997134670487,0.9665176314718986,1.0,4/33,12.07%,NEK7;NAF1;WRAP53;CCT2
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.26620136490547475,-0.8216618418466538,0.7122507122507122,0.9311946395335805,1.0,7/26,18.58%,PDE8A;AKT1;GPR37;LRRK2;HSPB1;GPR37L1;ATF4
prerank,organophosphate biosynthetic process (GO:0090407),0.29550163157995646,0.8215833459595039,0.7089337175792507,0.9667745733991441,1.0,10/37,20.22%,AGPAT4;PPIP5K2;TPK1;AGPAT5;GK;PPIP5K1;MOCS2;FADS1;ITPKA;TKT
prerank,negative regulation of nervous system development (GO:0051961),-0.2951966655770195,-0.8208835939002125,0.6808510638297872,0.931803436571787,1.0,2/17,4.54%,APPL2;B2M
prerank,sphingolipid catabolic process (GO:0030149),-0.3082565249098089,-0.8207526646843891,0.7064439140811456,0.9311990566762891,1.0,4/15,13.41%,ACER2;ENPP2;PDXDC1;SPHK1
prerank,regulation of actin filament-based movement (GO:1903115),-0.3447105549781696,-0.8202754340497795,0.6876513317191283,0.9311981700206111,1.0,7/10,31.44%,ANK2;SRI;PLN;PDE4B;SCN5A;PDPN;STC1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.3485435624547497,0.8200889560115073,0.7058823529411765,0.9689571126293947,1.0,7/17,25.21%,ALG9;DHDDS;DPAGT1;DOLK;DOLPP1;ALG12;ALG14
prerank,chromosome organization (GO:0051276),0.2605479137237524,0.8200604325963374,0.7673568818514007,0.9684449274473063,1.0,23/99,20.26%,MSH6;CDAN1;SATB1;MSH2;SUV39H1;GATAD1;SUPT4H1;HDAC2;AXIN2;CETN2;RFWD3;NUCKS1;COPS5;DDB2;CENPH;BRWD1;GEM;CUL4B;MTF2;HMGN2;TCF7L1;HDAC3;HMG20A
prerank,defense response to Gram-negative bacterium (GO:0050829),0.2910833604973594,0.820055341491822,0.7183288409703504,0.9678981988340614,1.0,6/42,15.16%,LBP;DEFA6;IRGM;AQP1;GSDMD;TNFRSF14
prerank,UV-damage excision repair (GO:0070914),0.37630623758621173,0.820050662716663,0.6678141135972461,0.9673493983713725,1.0,4/12,17.29%,ERCC1;INO80;DDB2;CUL4B
prerank,prostanoid metabolic process (GO:0006692),0.36510559160783923,0.8198593246730163,0.6737012987012987,0.9671089655905645,1.0,6/13,25.98%,CYP2S1;PLAA;HPGD;PTGR1;PTGR2;GSTM1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.26029223239820126,0.8198447537884631,0.7771295215869312,0.9665774368655365,1.0,7/104,5.18%,CAV1;DLX1;SPRED1;SPRY1;BMPR1B;NBL1;PPM1A
prerank,snRNA processing (GO:0016180),0.36197496786010414,0.8197972840839328,0.7075928917609047,0.96610745607314,1.0,5/16,18.94%,INTS10;TUT1;INTS6L;INTS3;TOE1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.27233872641063417,0.819353003366855,0.7409326424870466,0.9663882455838153,1.0,15/62,18.15%,MLLT3;LEO1;CDK13;CDK7;PAF1;ELL;NELFB;SUPT4H1;GTF2F2;GTF2H1;ELOA;RTF1;TCEA1;SETD2;GTF2H3
prerank,inositol phosphate metabolic process (GO:0043647),0.28534380915146673,0.8191841211330168,0.7142857142857143,0.9661634595467459,1.0,3/46,1.51%,PLCD3;PLCE1;PLCB3
prerank,cellular amide metabolic process (GO:0043603),0.2578043750571076,0.8190796378113658,0.7678355501813785,0.9657951943048357,1.0,22/102,16.69%,FOLR2;PCCB;PLPP2;PLPP3;CPE;PLAAT5;MTHFD1;ACOT13;CLN8;CERK;NIT1;ST6GAL1;ACSF2;ACOT8;MME;ACOT2;MIPEP;ABCB9;SLC46A1;PANK2;NLN;ALDH1L2
prerank,response to unfolded protein (GO:0006986),0.283985970690683,0.8188202070668171,0.72870249017038,0.9657243449567553,1.0,14/48,21.88%,HSPH1;DNAJC4;SERPINH1;BAG3;ERN1;HSPA4;ERP44;DNAJB4;BAX;DDIT3;PRKN;DAXX;HSPA9;DERL1
prerank,regulation of cilium movement (GO:0003352),0.396332415600841,0.8186271008178759,0.671353251318102,0.9655164571144735,1.0,3/10,15.68%,CCDC39;CCDC40;CFAP298
prerank,maturation of SSU-rRNA (GO:0030490),-0.24689135630048917,-0.8181252388920461,0.7707006369426752,0.9343340530501526,1.0,18/34,30.26%,RPS19;RPS16;RPS8;RIOK1;HEATR1;TSR1;DHX37;MRPS11;RIOK3;UTP4;PWP2;WDR3;RPS14;NOB1;NAT10;RRP36;WDR46;UTP6
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.2648813160418381,0.8178605749857468,0.7259439707673568,0.9663745038299881,1.0,14/83,17.82%,PLK2;CDK15;CDK7;FBXO5;CUL3;EIF4E;CDC6;CRLF3;POLE;E2F1;USP37;CUL4B;BACH1;ORC1
prerank,regulation of lamellipodium organization (GO:1902743),0.36020347711833134,0.8177994474774894,0.6772046589018302,0.9659349879764478,1.0,2/14,5.70%,CAPZB;FER
prerank,response to cAMP (GO:0051591),0.3034725701853773,0.8177281839393554,0.6775106082036775,0.9655008059299487,1.0,2/37,1.89%,RAPGEF3;RAP1A
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.2852414565190387,-0.8176153304989119,0.7299465240641712,0.9343467557888814,1.0,11/19,37.82%,TEK;KDR;NRP1;LIMS1;TSC1;SFRP1;PPM1F;MYOC;HRG;THY1;MAP4K4
prerank,neuron projection fasciculation (GO:0106030),-0.34657280911647703,-0.8172737311984535,0.7092198581560284,0.9341407031492869,1.0,7/10,31.99%,EPHA4;ARHGAP35;CDK5R1;EPHB3;AMIGO1;SEMA5A;NRCAM
prerank,positive regulation of biomineral tissue development (GO:0070169),0.299154786455951,0.8171398962292448,0.7240896358543417,0.9660210082645407,1.0,3/40,4.10%,PKDCC;ANO6;BMPR1B
prerank,stem cell development (GO:0048864),0.35390764815009385,0.8165845748707519,0.6950596252129472,0.9665175603101054,1.0,2/16,7.85%,PTPRC;CDH2
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.3365008496827194,0.8164477402527063,0.6742671009771987,0.9662290133916717,1.0,4/19,15.41%,F11R;OCLN;CBFB;NPHP4
prerank,amide transport (GO:0042886),0.3200723095644308,0.8163777705997327,0.7180616740088106,0.9657913697206857,1.0,6/26,14.92%,FOLR1;FOLR2;SLC27A1;CERT1;ABCB9;SLC46A1
prerank,protein localization to nucleus (GO:0034504),0.2566237817045297,0.8159656262413985,0.7608440797186401,0.9659965509424,1.0,18/102,16.76%,PRICKLE1;BCL3;IPO8;NOL8;MORC3;NUP62;PAF1;FAM53B;TPR;MMP12;NUP50;COL1A1;CSE1L;NUP153;RAN;NUP93;SYK;YWHAE
prerank,glycolytic process (GO:0006096),0.3101386510411174,0.8157165816760156,0.7076023391812866,0.9659174310962287,1.0,9/28,22.50%,HK2;ALDOB;PGM1;ENO3;GCK;PGK1;ENO2;ENO1;PKM
prerank,regulation of vacuole organization (GO:0044088),0.33230340903848743,0.8157069336089583,0.6888888888888889,0.9653844734031131,1.0,10/20,27.29%,MTMR3;ENO3;LAPTM4B;SCARB2;ENO2;RAB5A;ENO1;NPRL2;TBC1D14;IFT20
prerank,visual system development (GO:0150063),0.2930840967395333,0.8151230114229885,0.7146814404432132,0.9659325934552119,1.0,6/37,8.68%,PBX1;BMPR1B;HIPK1;SH3PXD2B;FREM2;ABCB5
prerank,lysosome organization (GO:0007040),0.3028629723729733,0.8148201820660947,0.7345505617977528,0.9659503087168368,1.0,6/36,11.69%,HOOK2;HPS1;ABCA1;ATP10B;TFEB;HOOK3
prerank,response to glucocorticoid (GO:0051384),-0.2562015133123277,-0.8141241006184936,0.7349397590361446,0.9391141600169559,1.0,3/26,7.39%,SLIT2;BCL2L11;ANXA1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.31215280603614587,0.8139150843823499,0.6905829596412556,0.9670253626559138,1.0,11/29,21.06%,TRAPPC3L;GOSR1;COG6;COPE;COPG1;COPA;RAB33B;TRAPPC3;COG3;NSF;COG5
prerank,defense response to bacterium (GO:0042742),-0.19368478755188073,-0.8134945267871037,0.8478260869565217,0.9394709977968251,1.0,23/105,22.04%,ANXA3;IL6R;GBP4;RPS19;NOD1;PPP1R11;RPL30;STAB1;PGLYRP1;GBP6;GBP7;CFP;CEBPB;GBP2;ISG15;MR1;RARRES2;ADGRB1;COLEC12;ROMO1;TLR3;OPTN;RPL39
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.36717549972652896,0.8132328666472753,0.6786941580756014,0.9676644358266979,1.0,3/12,10.98%,NCOR1;LIN28B;NCOR2
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.2683120792160574,-0.8129735571194175,0.7647058823529411,0.9395865206266671,1.0,12/23,36.28%,TGM2;SLC9A1;LRRK2;ATF4;PDE4B;ADCY6;NR4A3;APLP1;KCNQ1;RYR2;GNG2;SNCA
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.321346027293017,0.8127484744010884,0.6749611197511665,0.9680170180891361,1.0,9/22,21.62%,PSMB5;NFE2L2;PSMB2;PSMA2;PSMA6;PSMA7;PSME4;PSMB6;PSMB3
prerank,organic acid transport (GO:0015849),0.2590630817172027,0.8126660664666926,0.7683956574185766,0.9676099013395487,1.0,13/94,11.57%,LRRC8D;CEACAM1;FOLR1;FOLR2;ATP8B1;SLC38A2;SLC27A1;SLC6A13;SLC7A14;SLC7A2;SLC27A4;SLC16A1;SLC3A1
prerank,cellular response to fatty acid (GO:0071398),-0.3251178675000514,-0.8125716799016265,0.7013574660633484,0.939460362259254,1.0,4/12,21.15%,PID1;ZC3H12A;NR1H4;DGAT2
prerank,neural crest cell development (GO:0014032),-0.22972015285216735,-0.8121854631115794,0.8211920529801324,0.9393027426847487,1.0,21/44,32.90%,SEMA6D;SEMA7A;SEMA3C;SEMA6A;TBX1;RADIL;TCOF1;ANXA6;SEMA3G;SOX10;HTR2B;TAPT1;SEMA4G;SEMA3F;SEMA3D;SEMA5A;SNAI2;NRTN;SEMA4F;NRG1;SEMA5B
prerank,renal water homeostasis (GO:0003091),0.3210510230969274,0.8118708314172184,0.6712749615975423,0.9685116948351078,1.0,9/23,18.74%,ADCY5;PRKAR2A;ADCY9;AQP1;PRKACB;ADCY8;ADCY3;WFS1;RAB11FIP2
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.37404578637460184,0.8116911397064753,0.6796296296296296,0.9682979613213625,1.0,1/10,4.96%,WNT5A
prerank,fatty acid metabolic process (GO:0006631),-0.1894358412158454,-0.8115726735058191,0.9280575539568345,0.939594794241699,1.0,28/115,20.97%,ACSL1;ACSL3;ADIPOR2;PPARD;ACADSB;LPIN2;ACOT7;GPX4;ACSL6;CPT2;ECHDC3;LPIN3;ACBD5;MLYCD;ACLY;ABCD2;CPT1A;ACOT6;HACL1;ACOT11;PER2;PNPLA3;ACOX1;OXSM;PLA2G15;XBP1;SLC27A2;ADIPOR1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.3235069689926985,-0.8115053507209226,0.7254901960784313,0.9388608085633591,1.0,5/12,25.09%,NAE1;CLSPN;TOPBP1;RAD17;STK33
prerank,histone mRNA catabolic process (GO:0071044),-0.3016579927224696,-0.8114727205410122,0.7176165803108808,0.9380720785451544,1.0,4/15,15.01%,SSB;TENT2;TUT7;MTPAP
prerank,activation of adenylate cyclase activity (GO:0007190),-0.24538514091215752,-0.8111270490372643,0.7882736156351792,0.9378368346860695,1.0,7/35,14.82%,LGR4;ADCY1;ADCY7;ADCY4;ADCY2;EDNRA;LGR5
prerank,synaptonemal complex assembly (GO:0007130),0.35485444652627157,0.810716834063322,0.7058823529411765,0.9689488433400769,1.0,3/15,17.96%,TEX11;REC8;SYCP2
prerank,synaptonemal complex organization (GO:0070193),0.35485444652627157,0.810716834063322,0.7058823529411765,0.9689488433400769,1.0,3/15,17.96%,TEX11;REC8;SYCP2
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.31253327171735196,0.8101286374573714,0.7065527065527065,0.969466871548868,1.0,12/31,22.21%,PPP1R13B;SFN;GSK3B;BAD;NMT1;YWHAG;YWHAE;E2F1;BAX;MAPK8;TFDP1;YWHAB
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.22822286660194188,-0.8097151077063247,0.8222996515679443,0.9395284151085005,1.0,12/44,18.14%,ROCK2;ZC3HAV1;PABPC1;ZC3H12A;YTHDF1;MOV10;ZFP36;TNRC6C;DHX36;RC3H1;METTL16;YTHDF2
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.34154190746472896,-0.8096892688377552,0.7307692307692307,0.9387279992856693,1.0,1/10,0.68%,TGFA
prerank,positive regulation of cytokine production (GO:0001819),0.23489115314037493,0.809621854194445,0.8658280922431866,0.9698451831116338,1.0,44/292,17.73%,RORA;LBP;IL18R1;SULF1;GLMN;ITK;CXCL17;PDE4D;TXK;IL1A;EIF2AK3;PTPN22;WNT5A;PTPRC;IL17RA;TLR7;CRTAM;RARA;POLR3G;PTGER4;ISL1;HMGB1;TICAM1;HILPDA;ADRA2A;IL6ST;EGR1;CD276;POLR3D;CREBBP;IL7;CLEC9A;TNFRSF14;IL15;PIBF1;TBK1;BATF;SYK;CRCP;RGCC;MDK;SCRIB;SPTBN1;LPL
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.23756111381709843,-0.8094075906539184,0.7874015748031497,0.9384440414127622,1.0,18/40,27.92%,COMMD1;RPS7;SGTA;RPL23;CSNK2A1;PTK2;UBQLN4;RAD23A;HFE;LAPTM5;FOXF2;CDK5RAP3;CLU;RPL5;UBE3A;RPL11;CCDC22;SMURF1
prerank,nuclear envelope organization (GO:0006998),0.33031373942038983,0.8091910738203673,0.7056,0.9700914452292255,1.0,7/20,20.83%,NEMP1;SUN1;REEP3;EMD;NUP93;LEMD2;REEP4
prerank,"DNA-templated transcription, termination (GO:0006353)",0.2695631354910023,0.8086976660260813,0.745,0.9704429852405244,1.0,8/68,7.36%,CSTF1;CAVIN1;SNRPF;MED18;CDK7;POLR1E;CSTF3;SMN1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.2961657563997869,0.8082645325670824,0.7112068965517241,0.9706785591670981,1.0,6/37,15.31%,CAV1;FIS1;SIAH1;S100A9;SFPQ;BAD
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.35383330749347663,0.808243659733651,0.6959459459459459,0.9701641517283237,1.0,4/15,13.34%,TSEN54;RTRAF;TSEN34;ERN1
prerank,response to leucine (GO:0043201),-0.33580898630137634,-0.8078556724047234,0.7086247086247086,0.9394868491193265,1.0,1/10,0.83%,UBR1
prerank,cellular response to leucine (GO:0071233),-0.33580898630137634,-0.8078556724047234,0.7086247086247086,0.9394868491193265,1.0,1/10,0.83%,UBR1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.3621695523000679,0.8070106349422365,0.6833631484794276,0.9718526623982198,1.0,6/11,29.24%,PPIP5K2;PPIP5K1;ITPKA;FGF2;IP6K2;ITPKB
prerank,carbohydrate derivative transport (GO:1901264),0.33236248175109956,0.8067816174807838,0.7272727272727273,0.9717239867819523,1.0,1/18,0.73%,LBP
prerank,synaptic vesicle cycle (GO:0099504),0.3053791716771911,0.8067156432915679,0.6921898928024502,0.9712886716672321,1.0,4/30,7.28%,STX1A;BRSK1;RAB3A;CPLX1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.3656940865880695,0.8062514758816604,0.6530973451327433,0.9715638115566255,1.0,5/12,22.14%,RBM15B;LRIF1;PCGF3;CDYL;YTHDC1
prerank,positive regulation of mitochondrial translation (GO:0070131),0.35386541104352864,0.8062296640660792,0.6803953871499177,0.9710545800971987,1.0,4/14,18.25%,RMND1;FASTKD2;MPV17L2;RPUSD4
prerank,regulation of tumor necrosis factor production (GO:0032680),0.24933477579058458,0.8061056502296318,0.7797408716136631,0.9707460509972679,1.0,13/112,9.48%,LBP;IL1A;PTPN22;IRAK3;WNT5A;PTPRC;TNFAIP3;EPHB2;SELENOS;RARA;ISL1;PTPRJ;HMGB1
prerank,polyol metabolic process (GO:0019751),0.2810666359215885,0.8060820938162553,0.7264021887824897,0.9702399627018246,1.0,3/46,1.51%,PLCD3;PLCE1;PLCB3
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.32271640777409316,0.805838645556775,0.7216338880484114,0.9701500759965396,1.0,1/24,0.78%,ACKR3
prerank,proteasome assembly (GO:0043248),0.36914273343423626,0.8055358391132668,0.674061433447099,0.9701783733604904,1.0,4/11,15.39%,PSMG2;PSMG1;POMP;PSMD13
prerank,peptidyl-glutamic acid modification (GO:0018200),0.3189611799258123,0.8055156893138887,0.6871165644171779,0.969672401905619,1.0,5/24,16.92%,TTLL1;AGBL4;CFAP20;NAA10;TTLL9
prerank,positive regulation of protein deacetylation (GO:0090312),0.3556278372342028,0.8053266692834543,0.6921797004991681,0.969460294992934,1.0,3/14,15.58%,DYRK1A;FNTA;SAP30BP
prerank,negative regulation by host of viral process (GO:0044793),-0.34241325290796804,-0.8050375319367168,0.7035294117647058,0.9437536948930892,1.0,2/10,10.26%,ZC3H12A;EIF2AK4
prerank,cellular response to ketone (GO:1901655),0.29767701890982035,0.8049745089723285,0.7094890510948905,0.969525770344976,1.0,8/35,15.58%,PTGFR;SRC;ADCY5;PTGER4;ACOD1;AQP1;ADCY8;ADCY3
prerank,protein deubiquitination (GO:0016579),0.23291350102014402,0.8049039095427467,0.8408376963350785,0.9691204242404443,1.0,55/242,18.83%,USP50;TNIP3;OGT;BRCC3;TFPT;FOXK1;PSME3;TAF10;KEAP1;TNFAIP3;USP8;OTUB2;USP48;CCP110;FOXK2;TNIP1;CDC20;UIMC1;PSMB5;ACTR8;MINDY2;USP47;TRRAP;USP13;OTUD7B;APC;INO80;PTEN;USP15;USP4;PSMB2;POLB;UBE2D1;PSMA2;PSMA6;USP35;COPS5;PSMD13;PSMA7;DDB2;INO80B;STAMBPL1;STAMBP;USP45;USP37;PSME4;NFRKB;PSMC4;FOXO4;PSMB6;PSMD12;RHOA;PSMD14;USP9X;KDM1B
prerank,positive regulation of transmembrane transport (GO:0034764),-0.31154597253927274,-0.8038540797508307,0.7341463414634146,0.9448822608982392,1.0,7/13,23.59%,ACSL1;C2CD5;CLIP3;P2RX7;CA2;NR4A3;C3
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.26185774403945444,-0.8031099135573251,0.7598870056497176,0.9454151959003282,1.0,10/24,26.51%,KCNB1;C2CD5;ANK3;MTCL1;MIEF2;TCAF2;HRAS;ITGB2;CIB1;ITGAM
prerank,regulation of phosphatase activity (GO:0010921),0.31781585798764556,0.802927541748186,0.7013574660633484,0.9721145855636237,1.0,8/24,24.03%,SH3RF2;PTPA;HTT;CHP1;PPP6R3;PPP6R1;PPP6R2;URI1
prerank,positive regulation of vascular permeability (GO:0043117),0.37045249724794604,0.802743997905093,0.7025641025641025,0.9718800459286101,1.0,3/12,8.22%,TRPV4;TJP2;OCLN
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.36280448544899396,0.8024672799101817,0.6925675675675675,0.9718358523138598,1.0,4/12,20.27%,GPLD1;ADCY8;STX4;TRPM4
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.28515953165916236,0.8023819788612655,0.7311827956989247,0.9714364188410742,1.0,6/45,13.87%,USP50;WNT5A;NLRC4;ISL1;EGR1;GSDMD
prerank,eye photoreceptor cell development (GO:0042462),0.3409106523118674,0.8022932863710613,0.7016666666666667,0.9710647059912897,1.0,3/15,12.77%,RORB;CEP290;RPGRIP1L
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.30818548906944954,0.8022268240213213,0.7247838616714697,0.9706299784022208,1.0,3/29,9.55%,SPI1;CRTAM;LAMP1
prerank,cell part morphogenesis (GO:0032990),0.3593670541630688,0.8021600970297387,0.6974358974358974,0.9702182646003151,1.0,2/13,6.56%,FIS1;PACSIN2
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.312476301801082,-0.8019236079122891,0.7233009708737864,0.9465867266317963,1.0,2/13,2.60%,DDO;MTHFS
prerank,striated muscle cell development (GO:0055002),0.35230231212655694,0.8017342920127061,0.6962233169129721,0.9704322227472022,1.0,4/14,13.58%,TMOD2;SDC1;TMOD1;FLII
prerank,macroautophagy (GO:0016236),0.24843708252092336,0.8010564924529316,0.7986111111111112,0.971129505618747,1.0,38/118,22.27%,DYNLL1;PRKAG1;SRC;MFN2;PIP4K2B;PIK3R4;TSG101;ATG5;MTMR3;DYNLL2;CHMP4A;CHMP4B;VAMP8;CHMP4C;ARL8B;TOMM40;LIX1;ATG7;PIK3C3;PLAA;EI24;UBQLN1;MTERF3;CSNK2A2;PINK1;TBC1D5;SNAP29;MAP1LC3B;ATG3;LAMP2;RB1CC1;PRKN;VPS16;CHMP2A;ATG14;TCIRG1;VIPAS39;VPS36
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.3746142992015026,0.8006359873610867,0.6916221033868093,0.9713254572221189,1.0,2/11,6.81%,LEO1;PAF1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.27072522692726675,0.8006132399941053,0.7435897435897436,0.9708306324883984,1.0,7/62,7.45%,ACKR3;SRC;CREB3L1;SELENOS;NDUFS3;MCL1;MAPK7
prerank,polyamine metabolic process (GO:0006595),0.35225595901088225,0.8004428367823132,0.6948853615520282,0.9705975900615728,1.0,4/13,14.33%,SAT2;HDAC6;SMOX;SMS
prerank,carbohydrate derivative catabolic process (GO:1901136),0.33965702382439233,0.8002081832502317,0.7060702875399361,0.9704786404828444,1.0,5/18,15.80%,NAGA;BPGM;MANBA;DERA;OGA
prerank,negative regulation of protein catabolic process (GO:0042177),-0.2295162053957288,-0.8000322614770351,0.8309352517985612,0.9491441456530751,1.0,14/40,26.50%,TIMP3;PTPN3;FLNA;RGP1;CTSA;BANP;TIMP4;CDK5RAP3;ADGRB1;MAD2L2;NELL1;MAD2L1;AGAP2;CST3
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.33340410680492877,0.7996649481727529,0.6976,0.9709051901788492,1.0,4/17,11.98%,AKAP13;GPR101;ADRA2A;ADCY9
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.27166646656010657,0.7991568783888473,0.7442176870748299,0.9712201667504886,1.0,15/58,19.61%,SMC5;BRCC3;PAXX;NBN;UBE2V2;UIMC1;HMGB1;ERCC6;ERCC1;MDC1;POLB;PSMD14;MRE11;XRCC6;SUMO1
prerank,positive regulation of protein import (GO:1904591),0.3011326708059251,0.7987890724549409,0.7119645494830132,0.9713408689072339,1.0,8/30,15.38%,ARHGEF5;UBR5;BAG3;RBM22;PIK3R2;TPR;RAN;CDH1
prerank,negative regulation of cholesterol transport (GO:0032375),-0.32157268569911845,-0.7985116775757242,0.7207207207207207,0.9508790626022469,1.0,3/10,35.75%,ABCA2;APOC1;SHH
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.3338861187033114,-0.798388379003506,0.7289293849658315,0.9502197487096905,1.0,1/10,1.02%,ACTN2
prerank,photoperiodism (GO:0009648),0.30533686236131485,0.7983714294582126,0.7123287671232876,0.971495302976282,1.0,7/28,17.05%,CRTC1;BHLHE40;FBXL17;PER3;FBXL12;FBXL3;PPP1CA
prerank,protein stabilization (GO:0050821),0.24150106701545193,0.7983121344916065,0.824295010845987,0.9710585434056689,1.0,46/168,21.00%,PPARGC1A;PARVA;GTSE1;WDR81;FLOT2;PLPP3;GNAQ;MORC3;CDK7;BAG3;IRGM;STK3;ATP1B3;LAMP1;RASSF2;ZSWIM7;HYPK;USP13;DVL3;CCT2;PTEN;SOX4;RTN4;PER3;TESC;FBXW7;PRKRA;BAG2;RAB21;CHP1;WFS1;PINK1;COG3;RABL3;USP9X;AAK1;COA8;LAMP2;SUMO1;SEL1L;PFN2;PIN1;PRKN;MUL1;CCT3;PDCL3
prerank,organic cation transport (GO:0015695),0.3247479511271876,0.7980929269213105,0.7239819004524887,0.9708975786234224,1.0,6/20,17.33%,SLC29A4;SLC22A3;SEC14L1;SLC25A26;SLC25A19;RALBP1
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.22429767992858168,-0.7980188491535783,0.8090277777777778,0.9500156521028595,1.0,10/44,16.59%,ENG;TBX3;NPHP3;SOX17;ZIC3;MEGF8;VANGL2;MKKS;AHI1;SOX18
prerank,cellular response to cytokine stimulus (GO:0071345),0.22820532848374628,0.7977740919619583,0.9064089521871821,0.9709042797038033,1.0,44/416,12.28%,RORA;TEC;LBP;IL19;IL18R1;RIPOR2;PTPN13;ADAMTS12;LEPR;SLC12A2;SOCS5;STX1A;ITGAX;IL1A;PTPN14;FOXO3;SOX9;IRAK3;WNT5A;FN1;FER;TRADD;SOCS6;LAMA5;ABL2;MCL1;SDC1;PTPRJ;ACOD1;IRGM;GSK3B;PTPRT;GAB2;POU4F1;AXL;TYK2;TPR;MME;IL6ST;EGR1;PRLR;PTPN18;NFE2L2;STAT2
prerank,cell differentiation in spinal cord (GO:0021515),0.37109995521392175,0.797652710940924,0.6845878136200717,0.9705886604543787,1.0,3/10,13.44%,ZC4H2;ISL1;SOX4
prerank,regulation of fibroblast migration (GO:0010762),0.3290017827310659,0.7976187431030101,0.7225609756097561,0.970107647118046,1.0,1/20,1.22%,PRKCE
prerank,Golgi to lysosome transport (GO:0090160),-0.3291663000392796,-0.7975162553742342,0.7482517482517482,0.9500533217976439,1.0,3/11,16.29%,RBSN;SORT1;LAPTM5
prerank,acyl-CoA metabolic process (GO:0006637),0.296913845409582,0.7973979433853363,0.7339971550497866,0.9699626236402604,1.0,10/35,17.59%,ACOT13;ACACA;OGDH;ACSF2;DLST;ACOT8;ACOT2;ACACB;SUCLG2;SUCLA2
prerank,response to UV-A (GO:0070141),0.3581530186433223,0.7968142697420175,0.7040650406504065,0.9704109745359538,1.0,2/14,10.88%,EGFR;MME
prerank,endoplasmic reticulum organization (GO:0007029),0.2642887342292394,0.796694411455218,0.7654476670870114,0.9700781704584873,1.0,26/72,25.92%,STX1A;CAV2;LMAN2;EIF2AK3;ATL2;TRAM1;REEP3;LNPK;EMD;OTOF;UBE2J2;RTN4;SEC61G;STX5;RAB18;REEP4;VAMP2;PRNP;VAPA;VCPIP1;VAPB;DNM1L;SERP1;LMAN1;REEP5;SEC61A1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.24505512727796736,-0.796651229401413,0.7761194029850746,0.9507089660711132,1.0,7/29,16.09%,SMAD3;ADAR;AGO3;PUS10;AGO4;TUT7;ZC3H7A
prerank,axoneme assembly (GO:0035082),0.3022056743071757,0.7964136642055866,0.7180616740088106,0.9700246461623766,1.0,4/31,9.40%,SPEF1;SPAG17;CCDC39;FOXJ1
prerank,regulation of actin filament depolymerization (GO:0030834),-0.31293782668139813,-0.7951270150942154,0.7420091324200914,0.9524478177804598,1.0,1/12,1.04%,PLEKHH2
prerank,tRNA metabolic process (GO:0006399),0.3313695580184489,0.7948792434952957,0.7060702875399361,0.9721494336899023,1.0,8/17,23.14%,KARS1;POP7;ADAT1;DARS2;DTD1;RPP21;THG1L;RPP30
prerank,protein localization to phagophore assembly site (GO:0034497),-0.3264538177126397,-0.7948373022412742,0.7482678983833718,0.9520859726213811,1.0,6/11,24.50%,WIPI1;STX17;ATG13;WIPI2;WDR45B;WDR45
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.30516392782196533,0.7948258912093614,0.7429837518463811,0.9717079902819676,1.0,1/29,1.14%,MBOAT2
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.30615754563746267,0.7946309914673593,0.7263464337700145,0.9715216764839237,1.0,4/27,11.08%,MAP3K1;IRAK3;TNIP1;TAB2
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.32711594185501985,0.7946219439873772,0.6993569131832797,0.9710014040026925,1.0,4/20,9.03%,CAMK2D;FKBP1B;ATP1A2;CASQ2
prerank,apoptotic process (GO:0006915),0.23387554553723897,0.7943514090291216,0.8471474703982778,0.9709325257775547,1.0,16/203,7.41%,EFNA5;DLC1;PRKCE;FAP;HK2;CYFIP2;OGT;MAGI3;IL1A;CIDEB;EGLN3;TRADD;FASTKD2;MAGEH1;PAX3;SIAH1
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.27347872588060024,-0.7942693929583181,0.7604166666666666,0.9521968380475946,1.0,11/18,43.40%,GPR137B;TLR3;FSTL3;TCTA;LILRB1;LILRB3;CARTPT;TMEM178A;LRRC17;TLR4;IL4
prerank,regulation of multicellular organismal development (GO:2000026),-0.2565009510069741,-0.7939120993778354,0.7530864197530864,0.9519800566261616,1.0,8/25,19.75%,INSR;SOX17;SPAAR;TRIP12;DHX36;KAT2A;CD24;PTN
prerank,negative regulation of double-strand break repair (GO:2000780),-0.24737024957560258,-0.7938606859059908,0.8041543026706232,0.9512374035396534,1.0,13/30,25.40%,SHLD2;POLQ;UBQLN4;HSF1;TRIP12;CYREN;CGAS;MAD2L2;NUDT16L1;RMI2;TFIP11;SMCHD1;PARPBP
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.3068707129338442,0.7938529168738917,0.7204301075268817,0.9712326559746793,1.0,7/27,17.05%,CRTC1;BHLHE40;FBXL17;PER3;FBXL12;FBXL3;PPP1CA
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.3076933446516511,-0.7938506860700465,0.7481108312342569,0.9504150995783623,1.0,9/13,51.86%,CYRIB;MR1;IL12A;IL12RB1;IL23A;IL23R;IL12B;PVR;XCL1
prerank,peptidyl-threonine modification (GO:0018210),0.2666814953893159,0.7930917780336139,0.7509529860228716,0.9720333912665723,1.0,23/66,25.70%,CAMK2D;GALNTL6;PRKCA;HIPK1;DYRK1A;CAD;GSK3B;CIT;TBK1;GALNT4;LMTK2;DYRK2;CSNK2A2;PDPK1;CDC42BPG;ACVR1;MAPK8;MAPK1;PRKCD;HIPK2;ROCK1;TNKS;TAF1
prerank,presynapse organization (GO:0099172),0.3716383019103692,0.7925516457524089,0.6961325966850829,0.9723940074259014,1.0,3/10,22.12%,WNT5A;NLGN3;NLGN2
prerank,photoreceptor cell development (GO:0042461),-0.30320135953781613,-0.7921760170352269,0.732824427480916,0.9524585670848691,1.0,7/14,32.16%,DCX;RP1;MFSD2A;AHI1;TULP1;MYO7A;CDHR1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.19934263817449016,-0.7918804799450253,0.8900523560209425,0.952162494913893,1.0,24/80,21.76%,DENND5A;TRAPPC10;RAB6B;TMED9;RHOBTB3;GOSR2;RBSN;SURF4;UBE2O;RGP1;VPS26B;BET1L;PREPL;CLN5;STX6;HEATR5A;STX16;YKT6;PLEKHJ1;TBC1D17;RAB7B;RAB7A;RNF126;VTI1B
prerank,pre-replicative complex assembly (GO:0036388),0.26434912289026563,0.791636678400703,0.761528326745718,0.9734573453165484,1.0,18/64,18.75%,PSME3;ORC5;PSMB5;ORC3;CDC6;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;GMNN;PSME4;ORC1;ORC6;PSMC4;PSMB6;PSMD12;PSMD14
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.34346162164595045,0.7914359384734775,0.7135416666666666,0.9732883166893784,1.0,4/14,13.09%,KEAP1;FAF1;NFKBIB;PKD1
prerank,positive regulation of response to stimulus (GO:0048584),-0.2296032438136343,-0.791266850468363,0.8169934640522876,0.9523594390968266,1.0,11/40,19.72%,B2M;SELENON;YPEL3;ECHDC3;CD80;TGFB2;CDKN2AIP;ILK;EEF1E1;RSAD2;CGAS
prerank,ncRNA catabolic process (GO:0034661),0.30425115506129397,0.7909198124011275,0.7192716236722306,0.9736167326551709,1.0,4/28,9.56%,EXOSC5;DIS3L2;LIN28B;EXOSC10
prerank,cellular response to pH (GO:0071467),0.33769848284113824,0.7907073343926899,0.7287581699346405,0.9734565572354723,1.0,4/17,17.13%,GPLD1;RAB11FIP5;KCNK4;CHP1
prerank,cellular senescence (GO:0090398),0.3072011574005659,0.7906288458482571,0.7236641221374046,0.9730525757406259,1.0,3/27,7.23%,SMC5;SPI1;TBX2
prerank,RNA stabilization (GO:0043489),0.29724509782567166,0.7904153222447714,0.7285714285714285,0.9728928849827101,1.0,8/33,16.95%,DND1;NAF1;TENT5C;AXIN2;TENT5D;TAF15;ZCCHC17;E2F1
prerank,adipose tissue development (GO:0060612),-0.32254308305195334,-0.790406712769534,0.7431818181818182,0.9529494822932928,1.0,5/11,25.46%,ARID5B;LRP5;XBP1;DGAT2;NAMPT
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.29837106945861785,0.789900336296174,0.7380281690140845,0.9732557613411985,1.0,7/32,15.38%,BRCC3;BRSK1;NBN;RINT1;UIMC1;DONSON;FZR1
prerank,activation of protein kinase A activity (GO:0034199),0.335008155391345,0.789636505508237,0.7186963979416809,0.973157800278609,1.0,6/16,15.58%,ADCY5;PRKAR2A;ADCY9;PRKACB;ADCY8;ADCY3
prerank,positive regulation of exocytosis (GO:0045921),0.28776180383860356,0.7895672144884044,0.7510791366906475,0.9727338084796828,1.0,14/35,26.16%,TSG101;RAB3A;SDC1;PDCD6IP;SDC4;RAB2B;RAB27B;RAB5A;CHMP2A;RAB9A;SNF8;STAM;ATP6AP1;CLASP2
prerank,protein modification by small protein removal (GO:0070646),0.22745708732611766,0.7895399744982606,0.8553590010405827,0.9722435484265367,1.0,58/252,19.64%,USP50;TNIP3;OGT;BRCC3;SENP6;TFPT;FOXK1;PSME3;TAF10;KEAP1;TNFAIP3;USP8;OTUB2;USP48;CCP110;FOXK2;TNIP1;CDC20;UIMC1;PSMB5;ACTR8;USP47;TRRAP;USP13;OTUD7B;APC;INO80;PTEN;USP15;USP4;PSMB2;POLB;UBE2D1;PSMA2;PSMA6;USP35;COPS5;PSMD13;PSMA7;DDB2;INO80B;STAMBPL1;STAMBP;USP45;USP37;PSME4;NFRKB;PSMC4;FOXO4;PSMB6;PSMD12;RHOA;PSMD14;USP9X;KDM1B;SENP3;SENP2;ADRB2
prerank,negative regulation of autophagy (GO:0010507),0.2732805520666403,0.7895208974815989,0.7650200267022697,0.9717451024678178,1.0,10/54,14.38%,LEPR;FOXK1;PTPN22;MCL1;FOXK2;NRBP2;EIF4E;TAB2;ATG7;KLHL22
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.2439065116283297,-0.789416659877187,0.7830188679245284,0.9536579066274958,1.0,9/32,15.94%,ARHGEF2;STMN2;EML2;CAMSAP1;CLIP3;STMN1;APC2;MID1IP1;TUBB4A
prerank,regulation of response to biotic stimulus (GO:0002831),-0.2532145436918735,-0.7890599957224244,0.8143322475570033,0.9534294343694198,1.0,8/28,17.39%,FOXP1;APPL2;SAMHD1;LRP8;IRF1;GATA6;ERAP1;CASP8
prerank,regulation of programmed necrotic cell death (GO:0062098),0.32623497824108494,0.788996708491174,0.7214397496087637,0.9720912063952505,1.0,3/20,9.03%,OGT;FLOT2;PDCD6IP
prerank,cellular response to starvation (GO:0009267),0.24112271669186885,0.7883571418647771,0.8246606334841629,0.9726465374590212,1.0,18/147,9.21%,INHBB;MYBBP1A;PRKAG1;FOXO3;EIF2AK3;ATP6V0D2;KLF10;WDR24;PDK4;PIK3R4;MIOS;BRSK1;ATG5;RIPOR1;MAP3K5;SESN1;MTMR3;STK24
prerank,negative regulation of histone acetylation (GO:0035067),0.36427571581242724,0.7880929400263579,0.7026086956521739,0.9725794493384222,1.0,1/11,3.65%,SPI1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.28440089059525164,-0.7874460255251624,0.7678100263852242,0.9552379074858779,1.0,8/17,27.31%,PODXL;RET;TGFB2;SKAP1;NCKAP1L;CIB1;RAC3;P2RY12
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.23992487331470042,-0.7874397632014214,0.825503355704698,0.9544059620951848,1.0,14/32,30.58%,PICALM;PGAM1;EIF2A;TCOF1;NR1H4;RBM4B;TIGAR;GEMIN5;TSC1;MTPN;NANOS3;RBM3;GRM5;TMED10
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.33204355994397355,0.7873801024533842,0.7216981132075472,0.9732757111891972,1.0,4/18,12.95%,NF1;MORC3;PEX2;EMD
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.2699570661494024,-0.7873267666366323,0.776,0.9537678675875964,1.0,10/21,31.38%,ARHGEF2;STMN2;CAMSAP1;APC2;MID1IP1;KATNB1;CIB1;TPX2;CAMSAP3;NAV3
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.30220873597688885,0.7872606914136714,0.7581329561527581,0.9729182512994328,1.0,2/30,1.84%,NEDD4L;KCNA5
prerank,cardiac muscle tissue development (GO:0048738),0.27297892167762466,0.7872105246747352,0.7516425755584757,0.9724706691779401,1.0,9/50,12.85%,SGCD;AKAP13;SGCG;CSRP3;BMP5;TBX2;TBX18;NDUFV2;KDM6B
prerank,negative regulation of signaling receptor activity (GO:2000272),0.3114012087018722,0.7871691163287784,0.740625,0.9720097750117104,1.0,5/25,11.66%,SOCS5;TSG101;EPHB2;CBLB;SOCS4
prerank,cilium-dependent cell motility (GO:0060285),-0.26787805437458145,-0.7871450840213401,0.7515151515151515,0.9532448384209453,1.0,10/22,36.67%,RFX3;EFHC2;DNAH3;CFAP44;DRC1;CFAP54;CCDC65;DNAAF2;TEKT2;DNAH17
prerank,hyaluronan catabolic process (GO:0030214),0.3316339280372776,0.786593474854852,0.7118110236220473,0.972445340747363,1.0,7/18,24.70%,HEXA;CEMIP2;HEXB;CHP1;CEMIP;GUSB;FGF2
prerank,regulation of autophagosome maturation (GO:1901096),-0.3040399721800527,-0.7865571428333336,0.7390243902439024,0.9533345147177653,1.0,3/13,14.56%,UVRAG;RUBCN;UBQLN4
prerank,regulation of regulated secretory pathway (GO:1903305),-0.23487288093006464,-0.7864327644693049,0.8296529968454258,0.9526901375674063,1.0,19/34,37.19%,SYT9;SYT7;SYN1;LRRK2;PREPL;DTNBP1;SYT13;SYT6;RIMS1;RAB27A;RIMS3;RAB15;SYT15;SYT1;SYT5;SYT17;UNC13D;SYT4;SYT3
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.276632645100404,-0.7862144746812724,0.7662337662337663,0.952224767978374,1.0,5/20,12.83%,SLC8A3;SMDT1;SLC25A23;MICU1;MICU2
prerank,positive regulation of cell population proliferation (GO:0008284),0.22438673144667867,0.786017994124032,0.8984771573604061,0.9728957487113407,1.0,48/423,10.49%,FGF7;NTRK3;CDH13;GLI1;FGFR1;LAMC1;PTGFR;FOLR2;EGFR;FGF1;ACER3;KIF20B;ITGAX;PTHLH;SAPCD2;SOX9;S100A6;HDAC4;BMP5;WNT5A;PTPRC;FN1;RPRD1B;FER;CDK13;CEP131;ADAM10;KRAS;EFNB2;HOXC10;TBX2;RARA;FBXO5;CUL3;DPP4;S100B;GCNT2;FGF18;TSHR;DDRGK1;TET1;MECP2;GAB2;HDAC2;CNOT7;HILPDA;ADRA2A;TBC1D8
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.2474212257666529,0.7857000783200643,0.7846153846153846,0.9729155234595673,1.0,14/101,10.36%,FGFR1;EGFR;CCND3;FGF1;SRC;SLC27A1;ATP2B4;WNT5A;SYAP1;FGF18;IRGM;DIPK2A;FERMT2;ADRA2A
prerank,protein mannosylation (GO:0035268),-0.26370778643094084,-0.7856095196771619,0.8025078369905956,0.952384216159809,1.0,3/22,4.35%,TMTC2;TMTC1;DPM1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.2628840486651506,0.7854744898478849,0.7902010050251256,0.9727924833697338,1.0,5/65,7.39%,CAV1;SPRED1;SPRY1;PPM1A;LDLRAD4
prerank,regulation of defense response to virus by host (GO:0050691),0.2946337718329209,0.78481712395254,0.7376093294460642,0.9733607292730123,1.0,3/30,6.12%,PTPN22;TNFAIP3;ZDHHC1
prerank,positive regulation of neuron death (GO:1901216),0.27885315591618853,0.7848154233563204,0.7688172043010753,0.9728371747789999,1.0,9/46,11.42%,NF1;FOXO3;WNT5A;EFNB2;MAP3K5;GSK3B;SARM1;SRPK2;EGR1
prerank,cellular response to amino acid starvation (GO:0034198),-0.20053299435553695,-0.7846390846559445,0.9140271493212669,0.9531698016170262,1.0,22/71,23.20%,FAS;LAMTOR3;SEH1L;DEPDC5;SH3GLB1;ATP6V0C;RNF152;RRAGC;EIF2AK4;ATP6V1C1;ATF2;RRAGD;CEBPB;ATP6V1D;ATF4;CASTOR2;ATP6V1F;CASTOR1;LAMTOR2;ATP6V1E1;PRKD1;SLC38A9
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.31736311478492013,-0.7843213834440094,0.7648456057007126,0.9520248290622138,1.0,5/11,21.13%,FKBP1A;CALM1;CALM3;SRI;GSTO1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.31736311478492013,-0.7843213834440094,0.7648456057007126,0.9520248290622138,1.0,5/11,21.13%,FKBP1A;CALM1;CALM3;SRI;GSTO1
prerank,positive regulation of axon extension (GO:0045773),0.31828821931273876,0.7840343404775745,0.7196850393700788,0.9736165851088484,1.0,2/22,4.59%,NTN1;DSCAM
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.35065913370998114,0.7835953052803338,0.7056737588652482,0.9738155469020688,1.0,11/11,64.96%,NFKBIZ;MALT1;NFKBID;NLRP10;CLEC6A;IL12B;IL23R;IL23A;CARD9;IL12RB1;PRKCQ
prerank,negative regulation of ATPase activity (GO:0032780),-0.2922648251794321,-0.7833057678670191,0.7783505154639175,0.9528057199145794,1.0,6/16,27.53%,PAM16;PXK;IFIT1;PLN;OXA1L;TSC1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.32162003733268985,0.783221575669439,0.7100494233937397,0.9739166429014109,1.0,5/19,17.88%,FOLR2;MTHFD1;SLC46A1;ALDH1L2;SLC19A1
prerank,regulation of protein kinase A signaling (GO:0010738),-0.27374732125071327,-0.7827673676734365,0.7879581151832461,0.9528312558486534,1.0,7/20,19.84%,ADGRV1;AKAP6;LRRK2;PRKAR2B;PJA2;TCIM;MIF
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.31492990794459835,-0.78232677783002,0.7660098522167488,0.9527644218300827,1.0,7/12,29.20%,SERINC3;PSPH;SEPHS1;CBS;SEPHS2;CTH;PHGDH
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.31974481432053303,0.7820772642179945,0.7274167987321711,0.9753189276212925,1.0,6/18,19.28%,COA5;COX19;COX16;BCS1L;SURF1;COA8
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.3263419758554926,-0.7820752938779062,0.7296037296037297,0.9523404996692229,1.0,2/10,6.34%,FGFR2;TBX1
prerank,response to amino acid starvation (GO:1990928),-0.19859399529949154,-0.7818622848149284,0.9321266968325792,0.9518643689712935,1.0,22/72,23.20%,FAS;LAMTOR3;SEH1L;DEPDC5;SH3GLB1;ATP6V0C;RNF152;RRAGC;EIF2AK4;ATP6V1C1;ATF2;RRAGD;CEBPB;ATP6V1D;ATF4;CASTOR2;ATP6V1F;CASTOR1;LAMTOR2;ATP6V1E1;PRKD1;SLC38A9
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.33106229272124543,0.7814340071928054,0.7310924369747899,0.9758824373132035,1.0,3/18,10.98%,EGFR;NCOR1;NCOR2
prerank,protein homooligomerization (GO:0051260),0.2472192129093258,0.7813917280990809,0.8327566320645905,0.9754242124605464,1.0,10/114,9.03%,ALDH1A3;ALDH9A1;BEND3;ACOT13;SPAST;NLRC4;ACACA;CLYBL;ATL2;PDCD6IP
prerank,meiosis I (GO:0007127),-0.2600333253728148,-0.7812492678766917,0.7612732095490716,0.9519797799645238,1.0,3/23,8.93%,BCL2L11;FOXJ3;MYBL1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.29374077537814625,0.7807292361238157,0.7458646616541353,0.9760241031992445,1.0,6/32,17.82%,CDK15;FBXO5;CDC6;E2F1;BACH1;ORC1
prerank,mesenchymal to epithelial transition (GO:0060231),-0.3302844958382323,-0.7803312493863804,0.7572383073496659,0.9526431048322682,1.0,2/10,16.44%,BMP4;SALL1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.26043097279735256,0.7797409531098913,0.7621550591327201,0.9771559279445173,1.0,21/59,23.88%,RUNX2;SOX9;MED7;AGO1;MED13;MECP2;MED23;PTEN;CBFB;MED8;MED12;MED31;BAX;MED15;IL6;MED16;TWIST1;TCF7L2;JUN;MED27;MED20
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.249056155173692,0.7796257896544116,0.7828220858895706,0.9768173972784527,1.0,22/87,18.75%,WEE1;PSME3;DACT1;KANK2;FBXO5;PSMB5;USP47;APC;PTEN;FHL1;ZFP36L2;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;RGCC;PSME4;PSMC4;PSMB6;PSMD12;PSMD14
prerank,glucan biosynthetic process (GO:0009250),0.35623935647556426,0.7792657251312672,0.7427597955706985,0.9763647540841919,1.0,2/12,7.99%,GYS1;PGM1
prerank,glycogen biosynthetic process (GO:0005978),0.35623935647556426,0.7792657251312672,0.7427597955706985,0.9763647540841919,1.0,2/12,7.99%,GYS1;PGM1
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.20189377936158917,-0.7790564516659882,0.918918918918919,0.9538685647775648,1.0,26/72,26.23%,IFNAR2;MADD;LIFR;JAK2;CFLAR;USP18;RNF31;CLIP3;ABCE1;SPHK1;IKBKB;CASP8;CD24;IRAK2;RACK1;CDC37;VRK2;IKBKG;SOCS3;SIGIRR;RIPK1;SPPL2B;BIRC3;SPATA2;PYCARD;ZBP1
prerank,transport along microtubule (GO:0010970),-0.29944660205198637,-0.7780200171792556,0.7456359102244389,0.9547294045248668,1.0,3/13,11.25%,CDC42;BORCS5;CLIP3
prerank,mucosal immune response (GO:0002385),0.34150513280239264,0.777528118721053,0.7302405498281787,0.9787197951410049,1.0,3/15,18.92%,DEFA6;OTUD7B;RNASE3
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.30362733365003575,-0.7772795924578574,0.765,0.9550752550004132,1.0,4/13,12.40%,BMP4;ZC3H8;CAMK4;TOX
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.21793222061004863,-0.7771727863589014,0.852233676975945,0.95442463529295,1.0,6/44,12.71%,PRKAG2;INSIG2;OSBPL1A;OSBPL9;SCP2;PMVK
prerank,regulation of dendrite morphogenesis (GO:0048814),0.2883514177729148,0.7770903161277084,0.7344213649851632,0.9788991466726782,1.0,8/32,15.43%,NEDD4L;CDKL3;GSK3B;SARM1;NEDD4;SEMA4D;CAPRIN2;FBXW8
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.29505752047470424,0.7770632957412013,0.7638691322901849,0.9784210480650292,1.0,5/31,19.00%,HSD17B3;PRLR;LSS;STAR;MOCS2
prerank,response to growth factor (GO:0070848),-0.22587334397399006,-0.7770325258625042,0.8703071672354948,0.9538043766211627,1.0,9/41,13.99%,TGFBR1;ACVRL1;BMPR2;KLF4;RPS6KB1;AKT1;GATA6;SPHK1;PLK5
prerank,mitotic spindle assembly (GO:0090307),0.27615384875468824,0.7770031223739201,0.7489539748953975,0.9780167340711917,1.0,8/42,18.51%,KIF2A;RACGAP1;SMC3;MAP9;ARHGEF10;PIBF1;OFD1;RHOA
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.32436191109361767,-0.7762070172120251,0.7644230769230769,0.9542952118302951,1.0,4/10,26.37%,GALNT3;MGAT5B;GALNT2;GALNT13
prerank,peptidyl-serine modification (GO:0018209),0.2322209870149877,0.7761612790573207,0.8488499452354874,0.9788805013421313,1.0,19/166,11.95%,PLK2;PRKCE;CAMK2D;STK38;EIF2AK3;PRKCA;MORC3;HIPK1;BRSK1;STK38L;DYRK1A;CSNK1G3;GSK3B;RPS6KA3;MASTL;CSNK1A1;SRPK2;TOP1;SGK1
prerank,response to interferon-beta (GO:0035456),-0.26065774583143775,-0.7759530687166898,0.7687861271676301,0.9538794637223954,1.0,4/22,10.09%,IFNAR2;UBE2K;BST2;IRF1
prerank,protein depolymerization (GO:0051261),0.30343669168185294,0.7758130978008718,0.7578947368421053,0.9789230937251058,1.0,4/27,8.50%,KIF2A;NCKAP5L;CKAP5;MICAL3
prerank,negative regulation of protein modification process (GO:0031400),0.25629167537835545,0.7753069139201029,0.7992831541218638,0.9792269690553524,1.0,12/79,12.92%,NTRK3;PTPN13;PLPP3;ATP2B4;IBTK;EPHB2;OCLN;GSK3B;MEN1;ENSA;PTEN;PTPA
prerank,Golgi ribbon formation (GO:0090161),-0.3003674249146839,-0.7749270770828836,0.7936893203883495,0.9545647650098527,1.0,5/13,21.37%,GOLGA2;MYO18A;STX6;STX16;OPTN
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.3642096834899872,0.7746664255643408,0.7481884057971014,0.9797427965696541,1.0,1/10,2.66%,ANO6
prerank,response to endoplasmic reticulum stress (GO:0034976),0.24596351375158512,0.77444817822761,0.8202115158636898,0.9795570703023757,1.0,27/107,21.88%,THBS4;ERO1A;EIF2AK3;CREB3L1;SELENOS;MAP3K5;PIK3R2;DDRGK1;GSK3B;ERN1;RNF185;P4HB;MBTPS1;UBQLN1;QRICH1;WFS1;ERP44;TMEM259;TMTC3;BAX;SEL1L;CREB3L2;DDIT3;PRKN;NCK1;JUN;DERL1
prerank,nitrogen compound transport (GO:0071705),0.23509359634436297,0.7744480726755855,0.8488241881298992,0.9790325642199303,1.0,21/141,13.98%,LRRC8D;SLC12A2;CD3G;SLC38A2;SLC29A4;SLC22A3;ABCC1;SLC6A13;SEC14L1;SLC52A1;SLC7A14;CERT1;CD320;SLC7A2;CUBN;SLC3A1;CEP290;AMN;AQP1;TMEM30A;SLC6A4
prerank,T cell migration (GO:0072678),0.33954911001002563,0.7737226710971181,0.7096774193548387,0.9797374531400945,1.0,2/13,11.77%,SLC12A2;GPR183
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.28832162329678634,-0.7735282881622495,0.7616707616707616,0.9558306273872087,1.0,6/14,18.74%,CMKLR1;IL34;THBS1;PTK2;CSF1;RARRES2
prerank,establishment of apical/basal cell polarity (GO:0035089),0.3427707716627564,0.7732967434857508,0.7538461538461538,0.9799228453048683,1.0,6/14,18.51%,OPHN1;FOXJ1;PATJ;EZR;SCRIB;RHOA
prerank,regulation of innate immune response (GO:0045088),0.2663032601299579,0.7732596185659308,0.7751004016064257,0.9794583252792336,1.0,9/57,9.32%,PTPN22;IRAK3;TNFAIP3;TRIM21;N4BP1;POLR3G;ACOD1;PLSCR1;TRAFD1
prerank,protein localization to lysosome (GO:0061462),0.29387947042263673,0.7725364586902239,0.7574404761904762,0.980114609348674,1.0,9/28,19.59%,ZFYVE16;M6PR;GCC2;NEDD4;CD81;RTN4;AP3M1;SCARB2;LAMTOR5
prerank,negative regulation of RNA metabolic process (GO:0051253),0.32131899723151003,0.7725262752731251,0.75748031496063,0.9796032641987353,1.0,5/18,12.28%,NCOR1;RPS13;PTBP3;NCOR2;PTBP2
prerank,UV protection (GO:0009650),0.35019073537761014,0.7723544247156934,0.724561403508772,0.979362578282048,1.0,1/10,2.10%,SCARA3
prerank,establishment of protein localization to membrane (GO:0090150),-0.2052217870722669,-0.7721586391025904,0.8925619834710744,0.9571243919189563,1.0,16/66,18.51%,PARD3;AFDN;RFTN1;GORASP2;SYNE3;AQP11;RABGEF1;BID;RAB11A;TAOK2;MICALL1;ZDHHC2;VPS37C;ZDHHC14;RAB11B;COX18
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.2805248271957307,-0.7720124842347189,0.7919799498746867,0.9565234326728074,1.0,5/16,21.88%,CEBPG;VAMP7;TUBB4B;PLEKHM2;RAET1E
prerank,positive regulation of protein depolymerization (GO:1901881),0.35277233240530514,0.7718164501916609,0.699288256227758,0.9797378572700708,1.0,3/11,14.21%,TRPV4;PLEK;CFL2
prerank,negative regulation of glycolytic process (GO:0045820),-0.32400571212247165,-0.7717306495262558,0.7522935779816514,0.9553178342752812,1.0,2/10,3.46%,NUPR1;CBFA2T3
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.32400571212247165,-0.7717306495262558,0.7522935779816514,0.9553178342752812,1.0,2/10,3.46%,NUPR1;CBFA2T3
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.26519550720340757,-0.7716245192454599,0.7853107344632768,0.9546716194293139,1.0,4/19,17.03%,SLCO1C1;KLF4;KLF2;EGF
prerank,RNA polyadenylation (GO:0043631),0.3009963038376322,0.7714779351842294,0.7469135802469136,0.9792536038911399,1.0,12/26,25.75%,LEO1;TUT1;PAF1;CSTF3;SYMPK;PAPOLG;CDC73;PCF11;CPSF2;WDR33;TENT4B;PNPT1
prerank,mRNA polyadenylation (GO:0006378),0.3009963038376322,0.7714779351842294,0.7469135802469136,0.9792536038911399,1.0,12/26,25.75%,LEO1;TUT1;PAF1;CSTF3;SYMPK;PAPOLG;CDC73;PCF11;CPSF2;WDR33;TENT4B;PNPT1
prerank,mRNA modification (GO:0016556),0.3177884241406681,0.7712513644871257,0.7570977917981072,0.9790837577224035,1.0,3/22,6.98%,RPUSD2;PUS7;PUS3
prerank,synaptic vesicle transport (GO:0048489),0.36222910399856695,0.7709169073020619,0.7223140495867768,0.9790913506826282,1.0,4/11,19.70%,KIF5A;KIF5B;TMEM230;SPG11
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.30442345555023065,-0.7707612465082219,0.775,0.9551443994115173,1.0,5/13,21.25%,NUPR1;LRRK2;FEZ2;SCFD1;SEC22B
prerank,dendrite morphogenesis (GO:0048813),0.288647680679015,0.7707278852685868,0.7838983050847458,0.9788727268203771,1.0,4/35,6.38%,LRP4;MINK1;DIP2A;EPHB2
prerank,DNA catabolic process (GO:0006308),0.348979067212584,0.7706559235879665,0.7132867132867133,0.9784722648708268,1.0,4/11,25.93%,DFFB;REXO4;DNASE1L1;FBH1
prerank,protein insertion into ER membrane (GO:0045048),0.28183715456140773,0.7705054220968776,0.7748148148148148,0.9781952118864857,1.0,8/37,15.11%,STX1A;EMC9;EMC7;TRAM1;EMD;OTOF;UBE2J2;SEC61G
prerank,regulation of DNA recombination (GO:0000018),0.28540711220874904,0.7699737475878969,0.7609022556390977,0.9785115534834995,1.0,4/32,7.44%,MSH6;SMARCAD1;KPNA2;MSH2
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.3129555723502737,0.7693475343239136,0.7357594936708861,0.979015831206283,1.0,3/22,8.27%,FLOT2;MAPK7;GCNT2
prerank,lytic vacuole organization (GO:0080171),0.29184760135325355,0.7692921250187212,0.7651296829971181,0.9785896908031837,1.0,5/32,11.69%,HOOK2;HPS1;ABCA1;TFEB;HOOK3
prerank,positive regulation of double-strand break repair (GO:2000781),-0.22159319993653628,-0.7691286244317713,0.8645833333333334,0.9567024083298219,1.0,13/39,26.74%,SHLD2;SLF2;SLF1;ACTR2;ARID2;MMS19;PARP1;TIMELESS;KDM4D;MAD2L2;SMCHD1;ZCWPW1;PARP3
prerank,protein acylation (GO:0043543),0.2781641016113366,0.7691128765849642,0.7684659090909091,0.9783570645039992,1.0,10/38,14.96%,ZDHHC1;ZDHHC7;ZDHHC23;ZDHHC13;CREBBP;ZDHHC20;GLUL;NAT9;ZDHHC8;NAA10
prerank,synaptic vesicle exocytosis (GO:0016079),0.27502981086065836,0.7685429258339681,0.7855153203342619,0.9787524243649119,1.0,13/40,21.99%,STX1A;RIMS2;RAB3A;CPLX1;STX2;STX19;OTOF;UNC13B;STX4;SNAP23;SNAP29;VAMP2;SNPH
prerank,regulation of rRNA processing (GO:2000232),0.3294241209866829,0.7675344234723369,0.7157712305025996,0.9798898861818889,1.0,3/16,9.58%,BUD23;UTP15;SIRT7
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.35491386991139584,0.7673689134641143,0.747008547008547,0.9796330328803388,1.0,2/11,9.65%,SCARA3;TICAM1
prerank,positive regulation of macrophage migration (GO:1905523),-0.2616299885702452,-0.7673261209224969,0.8125,0.9585432560621582,1.0,7/19,18.74%,CMKLR1;IL34;THBS1;PTK2;CSF1;P2RX4;RARRES2
prerank,phospholipid metabolic process (GO:0006644),0.2539977715371103,0.767146017915908,0.8278894472361809,0.9794979171645478,1.0,7/71,8.30%,PLPP2;ACP6;PLPP3;PIP4K2B;AGPAT4;CLN8;ABHD12
prerank,erythrocyte development (GO:0048821),-0.3209974792787295,-0.7662255358980611,0.7623762376237624,0.9593998927874973,1.0,4/10,28.46%,ABCB10;ALAS1;NCKAP1L;ALAS2
prerank,regulation of TOR signaling (GO:0032006),-0.1951340335179867,-0.7661211687137437,0.9315068493150684,0.9587481367538618,1.0,12/67,14.67%,UBR1;FNIP1;LAMTOR3;SEH1L;FBXO9;DEPDC5;RRAGC;RICTOR;TMEM127;GSK3A;DEPTOR;RRAGD
prerank,polyol biosynthetic process (GO:0046173),0.32228551126482835,0.7654486437523513,0.7504078303425775,0.9817397143284977,1.0,2/16,6.92%,ACER3;PPIP5K2
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.3124549608473626,-0.7653355793215119,0.7574370709382151,0.9591759765156326,1.0,6/11,36.51%,AKAP6;LRRC38;ALG10B;LRRC55;TREM2;RNF207
prerank,protein ubiquitination (GO:0016567),0.21831161503945767,0.7653082036307752,0.9445005045408678,0.9814484742804108,1.0,112/471,22.14%,NEDD4L;PDZRN3;UBE2L6;ZNRF2;FBXL15;DTX1;PELI2;UBE2E2;SH3RF2;IRF2BP1;UBE3C;LZTR1;RNF122;LMO7;SPSB4;PSME3;LRSAM1;LEO1;TMEM129;KEAP1;TRIM21;SELENOS;UBR5;CHFR;PEX2;PAF1;UBE2V2;SIAH1;FBXO31;ZNRF3;CUL3;AMFR;PSMB5;BLMH;RNF220;LNPEP;ANAPC7;DTX4;UBE3D;OBI1;RCHY1;KLHL7;TRPC4AP;ANAPC11;FBXL19;LONRF1;NEDD4;KLHL21;FBXL5;FBXL17;FBXO11;NFE2L2;RFWD3;RNF185;FBXO21;PSMB2;CBFB;UBE2J2;UBA1;UBE2D3;UBE2D1;PSMA2;KLHL22;PSMA6;WWP2;PSMD13;FBXW8;PSMA7;TRIM5;FBXO41;DDB2;FANCL;UBE2R2;FBXL12;FBXW7;FBXL3;RTF1;ITCH;CUL4B;RNF7;VPS11;PSME4;ANAPC16;PINK1;KLHL18;PSMC4;CDC23;PSMB6;PSMD12;PSMD14;USP9X;ATG3;DDA1;PEX13;HECTD2;UBE2W;CDC73;PRKN;MKRN1;RNF146;RNF14;MUL1;CUL7;TRAF7;ZNRF1;PSMB3;AKTIP;DERL1;RNF157;CUL5;MIB2;FBXW11
prerank,DNA recombination (GO:0006310),-0.22699437464186073,-0.7644340815051913,0.8626198083067093,0.9597222821197791,1.0,4/37,5.83%,RAD51B;TSN;WRN;BLM
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.316447038911718,-0.7638036547464353,0.7857142857142857,0.9598258574964175,1.0,5/11,19.71%,BLM;ZRANB3;LIG3;TIPIN;TIMELESS
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.2817582999773354,0.7637148485926619,0.7812061711079944,0.98347762090502,1.0,4/37,8.91%,OGT;FHIT;N4BP1;DDRGK1
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.29987211089394067,-0.7634669326832564,0.764018691588785,0.9595031868833427,1.0,2/12,3.65%,NKD1;PROM1
prerank,negative regulation of telomere maintenance (GO:0032205),0.33086670601319373,0.7626097762416655,0.75,0.9847286895017647,1.0,8/15,28.07%,NBN;ERCC1;TERF2;SLX4;SMG6;TNKS;RAD50;TERF2IP
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.2992856324167573,-0.7624339512150271,0.7619047619047619,0.9602760151108957,1.0,7/14,28.88%,PAXIP1;SNW1;DNMT3B;SMAD4;BRCA1;KMT2E;WDR5
prerank,endochondral bone morphogenesis (GO:0060350),0.35243299285461893,0.7623781807225409,0.7396551724137931,0.9845822995016484,1.0,2/11,4.10%,TRPV4;BMPR1B
prerank,peroxisome organization (GO:0007031),0.3032063621141744,0.762376098570201,0.7414050822122571,0.9840643883135186,1.0,5/25,12.75%,FIS1;TMEM135;PEX2;ACOT8;ABCD1
prerank,glycoprotein metabolic process (GO:0009100),-0.2067077212712209,-0.7623515479503914,0.8846153846153846,0.959581811835964,1.0,14/53,19.86%,ST8SIA4;MGAT4A;ST6GALNAC3;HIF1A;GANC;STT3B;B4GALT7;FBXO17;ST8SIA2;GCNT1;FUT8;FBXO44;GAL3ST2;ST8SIA1
prerank,positive regulation of histone deacetylation (GO:0031065),-0.29683650759644853,-0.7622038058926356,0.7720588235294118,0.9590103480916489,1.0,4/12,29.95%,AKAP8L;APLNR;PRKD1;CTBP1
prerank,male gonad development (GO:0008584),0.28489583148085973,0.7621176795295302,0.7756315007429421,0.9839413184040219,1.0,7/34,15.35%,WNT2B;SOX9;WNT5A;MSH2;CSDE1;NR5A1;KITLG
prerank,regulation of presynapse organization (GO:0099174),-0.2747745891050059,-0.76200285429316,0.7877094972067039,0.9576792163008027,1.0,12/18,37.46%,LRRC4B;MDGA1;PTPRD;EIF4G1;IL1RAPL2;SLITRK2;SLITRK3;VPS35;LRFN4;LRFN5;SNCA;WNT7A
prerank,regulation of presynapse assembly (GO:1905606),-0.2747745891050059,-0.76200285429316,0.7877094972067039,0.9576792163008027,1.0,12/18,37.46%,LRRC4B;MDGA1;PTPRD;EIF4G1;IL1RAPL2;SLITRK2;SLITRK3;VPS35;LRFN4;LRFN5;SNCA;WNT7A
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.3035694410149391,-0.7619887690007937,0.7733990147783252,0.9568864510343437,1.0,5/12,15.94%,STMN2;EML2;CLIP3;STMN1;TUBB4A
prerank,mitochondrial translation (GO:0032543),0.2372419714166373,0.7617421967151985,0.850835322195704,0.984041941655323,1.0,28/104,21.17%,MRPL37;MRPL43;MRPL33;FASTKD2;MRPS28;MRPS35;RARS2;PTCD3;MRPL41;MRPS22;MRPS15;MRPS33;MRPL3;CHCHD1;MRPL16;NDUFA7;MTRF1L;MRPL40;MRPL22;MRRF;GADD45GIP1;MRPL4;MRPL2;MRPL34;GFM1;GATB;TSFM;MRPS7
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.307524274815588,-0.7615747102638061,0.7945544554455446,0.9566893276812264,1.0,5/12,21.74%,SGTA;SEC61B;SEC62;SGTB;GET3
prerank,regulation of steroid biosynthetic process (GO:0050810),0.3549404883642453,0.76147645522886,0.7512953367875648,0.9839531991136405,1.0,5/11,18.69%,BMP5;EGR1;NR5A1;ASAH1;STAR
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.3113428585959737,-0.7614689943484623,0.7673860911270983,0.9560417084954633,1.0,4/11,25.91%,FAS;LGALS9;PLAUR;CAAP1
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.2080947431873446,-0.7608446842034239,0.8734693877551021,0.9561484699946973,1.0,14/52,20.87%,DNAJC3;PREB;GOSR2;SSR1;WIPI1;TPP1;SYVN1;LMNA;GSK3A;TLN1;DNAJB11;SEC31A;XBP1;TATDN2
prerank,neutrophil activation (GO:0042119),0.34821559219747,0.7608241193017378,0.7231833910034602,0.984446389800722,1.0,4/12,24.11%,IL15;SYK;PREX1;PRKCD
prerank,protein localization to organelle (GO:0033365),0.2354837890696498,0.7604741854703282,0.8520642201834863,0.9844847224720779,1.0,45/133,25.31%,ZNF423;STX1A;SCG3;CSRP3;PACSIN2;PAF1;SNX10;RIPOR1;ARF6;OBSCN;DDRGK1;TRAM1;LAMP1;GCC2;COL1A1;TTC21B;EMD;OTOF;TMEM30A;UBE2J2;SEC61G;YWHAE;RAB33B;STX5;EHD1;COG3;BBS1;CEP250;DHX9;LAMP2;TIA1;TULP2;VAMP2;IFT140;ZBTB7A;PRNP;ARL3;VAPA;SIX1;BMP7;SERP1;MDM2;CD68;CSNK1D;CNTLN
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.2967487443055729,0.7604445059817423,0.7703125,0.9840090621173232,1.0,6/24,18.75%,PSME3;TMF1;PKD1;RHBDF1;PINK1;PSMD14
prerank,transcription by RNA polymerase I (GO:0006360),-0.22396195077005654,-0.7587426393961239,0.8596491228070176,0.958362664545681,1.0,12/34,23.84%,MNAT1;TAF1D;ERCC2;TCOF1;CCNH;POLR2F;TAF1C;GTF2H4;POLR2K;POLR1C;POLR1F;RRN3
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.30313274302714943,0.7582108717237397,0.7555886736214605,0.9869591085190497,1.0,3/23,5.26%,SPI1;PPM1A;UACA
prerank,protein targeting to peroxisome (GO:0006625),0.2942206670632342,0.7581701280540302,0.7799401197604791,0.9865019180173648,1.0,5/29,12.75%,RAB8B;FIS1;PEX2;PXMP2;ABCD1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.29531545895075745,0.7579994959987362,0.7942073170731707,0.9862447361274996,1.0,7/27,18.23%,PISD;SLC27A1;PLAAT5;ETNK2;PNPLA8;SELENOI;LPIN1
prerank,negative regulation of secretion (GO:0051048),-0.31786260371247804,-0.7571157084229994,0.7720090293453724,0.9599057225077302,1.0,8/10,42.87%,NR1H3;EGF;ERBB3;SPX;NRG1;VAMP3;TIFAB;CD74
prerank,apoptotic DNA fragmentation (GO:0006309),0.3264987330095291,0.7570343409337879,0.7475728155339806,0.9872633402071951,1.0,4/16,14.63%,DFFB;HMGB1;EXOG;DICER1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.3405782649347907,0.7570190020593093,0.7620689655172413,0.9867692151285797,1.0,6/14,24.09%,SRSF4;SFSWAP;SAP18;SRSF12;SRSF10;RBMX
prerank,glutathione biosynthetic process (GO:0006750),-0.30170967794002734,-0.7567780548267055,0.7959641255605381,0.9596023952142573,1.0,4/11,18.02%,GCLM;CNDP2;GGCT;GCLC
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.27498412880291395,0.7567628296996598,0.7945205479452054,0.9866661459161918,1.0,8/39,16.83%,ASS1;JAG1;RDX;MAPK7;NF2;PLG;CDH1;RGCC
prerank,GTP metabolic process (GO:0046039),-0.27837416539222093,-0.7565010433182372,0.8081841432225064,0.9592027687848041,1.0,3/15,15.53%,LRRK2;IMPDH1;OPA1
prerank,vacuolar acidification (GO:0007035),0.3045863066986353,0.7562595559319277,0.75,0.9869702734031077,1.0,4/21,11.50%,ATP6V0D2;DMXL1;ATP6V0A1;DMXL2
prerank,peptidyl-lysine dimethylation (GO:0018027),0.32016590840635883,0.7560937533585677,0.7731788079470199,0.9867115501117818,1.0,5/18,17.48%,KMT2A;SUV39H1;KMT2D;SETD2;SUV39H2
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.29943197921949616,0.7556415835862271,0.7653374233128835,0.9869099769956841,1.0,8/24,20.34%,NF1;FOXO3;MCL1;SRPK2;BACE1;FBXW7;BAX;DDIT3
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.3240844362832202,0.7551601834040229,0.7793880837359098,0.9871539582366368,1.0,2/16,9.55%,CRTAM;LAMP1
prerank,protein targeting (GO:0006605),-0.1759790353157667,-0.7546533608809152,0.9637681159420289,0.9610484816615597,1.0,27/118,20.47%,PARD3;KIF13B;ZFAND6;AKAP6;RASSF9;AQP11;RABGEF1;TIMM44;GABARAP;AP4E1;ZFAND2A;TIMM17B;TAOK2;SPCS1;MICALL1;ZDHHC2;HACL1;PEX6;AIP;VPS37C;PEX1;ZDHHC14;TIMM10B;TIMM8B;CDC37;KATNB1;ZDHHC24
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.24877106862289528,-0.75444542213626,0.8174157303370787,0.9605402943470105,1.0,7/21,19.84%,CMKLR1;IL34;THBS1;PTK2;CSF1;RARRES2;MIF
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.25527880772188466,-0.7541527900734959,0.8162162162162162,0.9601361534202263,1.0,4/21,12.40%,NES;PROX1;KDM1A;TOX
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.3414824823348648,0.7537120844711939,0.738255033557047,0.988896722377868,1.0,4/12,14.77%,DPYS;DPYSL2;CTPS2;DPYSL5
prerank,interstrand cross-link repair (GO:0036297),0.262030324522884,0.7536797085797483,0.7997382198952879,0.9884271476010107,1.0,13/53,21.53%,FAAP24;MSH6;FANCC;FANCF;ERCC1;RFWD3;NUCKS1;RAD51AP2;FANCL;ERCC6L2;ATR;SLX4;RPA3
prerank,myelination in peripheral nervous system (GO:0022011),0.3349549220511163,0.7536092892527149,0.7394366197183099,0.9880307760495519,1.0,8/13,23.99%,NF1;CNTNAP1;NCMAP;DICER1;ARHGEF10;PRX;SIRT2;SKI
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.32655087620857914,0.7532849435814378,0.7593220338983051,0.988041399293844,1.0,6/15,26.20%,CNTNAP4;ZDHHC3;ZDHHC12;NLGN2;USP46;ADRA1A
prerank,neuron fate commitment (GO:0048663),-0.28212643201880383,-0.753081610002286,0.7935034802784223,0.960768484607806,1.0,6/14,28.17%,TGFBR1;MYT1L;ID2;POU3F2;DLL4;DLL1
prerank,purine nucleotide catabolic process (GO:0006195),-0.29842596867092086,-0.7526231018189633,0.8088235294117647,0.9605784310509751,1.0,5/13,24.17%,XDH;NT5C;HINT1;NT5C1A;GDA
prerank,mitochondrial translational termination (GO:0070126),0.23911491807179996,0.7522957101655375,0.8378378378378378,0.9891174995464798,1.0,20/88,18.17%,MRPL37;MRPL43;MRPL33;MRPS28;MRPS35;PTCD3;MRPL41;MRPS22;MRPS15;MRPS33;MRPL3;CHCHD1;MRPL16;MTRF1L;MRPL40;MRPL22;MRRF;GADD45GIP1;MRPL4;MRPL2
prerank,positive regulation of locomotion (GO:0040017),0.288217351564627,0.7519530884002147,0.7796101949025487,0.9891147902442211,1.0,2/27,4.97%,NTN1;CAVIN1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.3484655305604968,0.751887007620974,0.7441860465116279,0.9887100626875119,1.0,4/11,17.92%,PRKCA;RDX;SYK;JAK1
prerank,mitotic cytokinesis (GO:0000281),0.2644994970292116,0.7513926451019518,0.8125,0.9889329751801405,1.0,12/47,17.60%,RACGAP1;SON;USP8;SPAST;PDCD6IP;CNTROB;CHMP4B;APC;CIT;STAMBP;RTKN;SPTBN1
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.3038929675926174,-0.7510882317812392,0.7585421412300684,0.9609880909099485,1.0,2/11,11.03%,CCT7;CCT8
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.3038929675926174,-0.7510882317812392,0.7585421412300684,0.9609880909099485,1.0,2/11,11.03%,CCT7;CCT8
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.2857660363344136,0.7510296152787845,0.7692307692307693,0.9889764036377177,1.0,3/30,8.36%,ACKR3;FBXO5;DYRK1A
prerank,epithelial cell differentiation (GO:0030855),0.24289159403980404,0.7509499077602153,0.8384332925336597,0.9886007724393898,1.0,16/88,17.72%,GLI1;CDHR2;JAG1;ANXA4;ZDHHC7;HDAC2;GSTK1;KDM6B;FZD7;ERBB4;UPK1A;PGK1;PPARG;SCRIB;CTSB;FSTL1
prerank,positive regulation of mRNA processing (GO:0050685),0.3111034070861776,0.7504570575406796,0.7633711507293355,0.9888728074178375,1.0,7/21,20.09%,LEO1;PAF1;CELF4;RBMXL1;TRA2B;PRDX6;CDC73
prerank,T cell differentiation (GO:0030217),0.2714760378734281,0.7499799068444083,0.7905027932960894,0.9890809899533045,1.0,4/40,4.99%,LEPR;SPI1;PTPN22;PTPRC
prerank,ether lipid biosynthetic process (GO:0008611),-0.31621948816666073,-0.7498007781466757,0.8090692124105012,0.961956991064172,1.0,1/10,3.61%,CHPT1
prerank,sarcomere organization (GO:0045214),-0.24131390875261796,-0.7491402315270539,0.8598130841121495,0.9620369277793144,1.0,2/27,1.91%,ACTN2;TPM1
prerank,piRNA metabolic process (GO:0034587),0.3064877103395225,0.7485762148217188,0.7718446601941747,0.9907356211710112,1.0,2/19,12.29%,PIWIL2;TEX15
prerank,maintenance of protein location in nucleus (GO:0051457),0.3081308491659067,0.7484339153419606,0.7656500802568218,0.9904512029318988,1.0,3/20,9.77%,BCL3;MORC3;SUN1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.29426880864419974,0.7483291629757115,0.7856071964017991,0.9901011694480399,1.0,10/25,21.88%,CUL3;LONP1;HDAC6;ZYG11B;FBXL17;RNF185;KLHL15;UBE2W;YME1L1;DERL1
prerank,regulation of macroautophagy (GO:0016241),0.23762068932294256,0.7480238909591337,0.8598574821852731,0.9900403817665191,1.0,25/105,22.03%,DCN;PRKAG1;ATP6V0D2;SCOC;SESN1;NRBP2;ATP6V0A1;PAFAH1B2;HDAC6;NEDD4;ERN1;RRAGB;SNX5;TBK1;UBQLN1;BNIP3;PINK1;ATP6V1G1;LAMTOR5;RB1CC1;RPTOR;CAPN1;MAPK8;TSC2;GNAI3
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.3183815747064225,0.7472377932788827,0.7641196013289037,0.9907361152410217,1.0,6/15,24.70%,FGF1;ITGA5;JAK1;PDPK1;PKM;FGF2
prerank,regulation of stem cell population maintenance (GO:2000036),0.31436374669741335,0.7462949122375249,0.7581903276131046,0.9916826605276041,1.0,8/18,27.17%,NCOA3;CNOT1;ZC3H13;LOXL2;ELAVL1;CNOT2;REST;TAF6L
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.2687884288191964,0.7462223973278166,0.8085991678224688,0.9912742485896167,1.0,12/39,22.12%,TFR2;ISL1;RASL10B;GCK;SOX4;AIMP1;GPER1;BAD;IRS2;GLUD1;TCF7L2;NLGN2
prerank,cellular response to drug (GO:0035690),-0.2408865901422174,-0.7460195012418627,0.8649425287356322,0.9655464385837931,1.0,2/25,3.02%,ACER2;TFRC
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.23464956000732445,-0.7459502355047632,0.859375,0.964836126690759,1.0,8/30,26.38%,CD34;PLCG2;PRKCZ;LGALS9;ISG15;NOD2;PYCARD;STAT3
prerank,positive regulation of hormone secretion (GO:0046887),0.3175514339338609,0.7455879335165706,0.7748344370860927,0.9917535084589021,1.0,3/17,11.35%,TFR2;RASL10B;VAMP8
prerank,positive regulation of protein kinase activity (GO:0045860),0.22590670073294467,0.7453388705652706,0.8832035595105673,0.9915990598825114,1.0,21/148,11.42%,RAP1A;AXIN1;MINK1;PRKAG1;MMD2;SRC;SLC27A1;PTPRC;TOM1L1;LCP2;SRCIN1;SYAP1;IRGM;STK3;RASSF2;DLG3;LAT;ADRA2A;RELN;TAB2;EGR1
prerank,positive regulation of protein polymerization (GO:0032273),0.24912582079324194,0.7452927225461947,0.8258642765685019,0.991156787492868,1.0,15/65,21.98%,PRKCE;CDC42EP4;FER;NCK2;ARF6;OCLN;CTTN;CDC42EP3;SLAIN2;PINK1;BAIAP2;PFN2;NCK1;TENM1;HCK
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.20474916105183444,-0.7452752975634506,0.925,0.9649247397773787,1.0,17/49,28.88%,EP300;SETD1A;HDAC1;MYL9;AGO3;THBS1;MOV10;AGO4;TNRC6C;KAT2B;RAB7B;NR4A3;KMT2B;CIB1;L3MBTL1;KMT2E;WDR5
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.3580512917602168,0.7451981090618912,0.7629382303839732,0.990785959446227,1.0,1/10,2.99%,PDE4D
prerank,response to prostaglandin E (GO:0034695),-0.3163892892762474,-0.7451939102509297,0.7866666666666666,0.9642217614550066,1.0,4/10,28.88%,TGFBR3;CCL19;ADCY6;SFRP1
prerank,protein deacylation (GO:0035601),0.30026042905587624,0.7451781259883495,0.7618296529968455,0.9902930544562413,1.0,10/23,23.98%,HDAC4;SIRT3;SIRT7;HDAC6;ABHD10;HDAC3;LYPLA2;ABHD17C;SIRT2;SIN3A
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.3003813210487187,0.7450007381686002,0.7689922480620155,0.9900469115098078,1.0,7/21,16.76%,FKBP1B;BOD1L1;GSK3B;MASTL;ENSA;PTPA;YWHAE
prerank,regulation of chromosome segregation (GO:0051983),0.3233074994801657,0.7447858084309702,0.7648026315789473,0.9898636465572458,1.0,5/16,21.51%,SMC5;CDC6;PUM2;CSNK2A2;PUM1
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.23372804750465542,-0.7447727673892557,0.8666666666666667,0.9640227534978437,1.0,12/28,36.21%,SIRPA;SH3KBP1;CYRIB;NCKAP1L;NOD2;PYCARD;TNIP2;CCR2;HSPD1;CCL2;PRKCQ;THY1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.2705150952581521,0.7445762856130349,0.8121546961325967,0.989650003285431,1.0,1/42,0.78%,ACKR3
prerank,microtubule-based transport (GO:0099111),0.3318009453884285,0.7445362927822063,0.7694859038142621,0.9891931350125298,1.0,5/13,24.33%,SPAG17;HTT;CCDC40;DYNC1I1;DYNC1I2
prerank,regulation of apoptotic process (GO:0042981),0.2092712977102491,0.7440399229445556,0.9779338014042126,0.9894109578994639,1.0,101/676,15.34%,NGF;ITGA6;PLK2;DKKL1;TIAM2;EGFR;PPP1R13B;BCL3;SH3RF2;ANO6;TNFAIP8;GPLD1;TFPT;NF1;AKAP13;PHLDA3;RNF122;APH1B;STIL;FOXO3;CIDEB;SOX9;VAV2;SRC;NUP62;WNT5A;ACVR1C;TRIO;EGLN3;DDAH2;SON;ANXA4;TRADD;ARHGEF5;NCSTN;ADAM10;PHLDA1;MCL1;NLRC4;ARHGEF1;PERP;SIAH1;BAG3;MAP3K5;PHLPP1;NAA35;RBM5;KALRN;AATF;OBSCN;DDRGK1;STK3;GSK3B;RPS6KA3;HMGB1;NLRP2B;RASSF2;SLC27A4;USP47;AXL;HDAC2;TAX1BP1;HYPK;RARG;APC;PROC;IL6ST;PRLR;HTATIP2;SGK1;ARHGEF6;SEMA4D;FAF1;LANCL1;FBXO11;TMBIM4;NF2;DHCR24;MGMT;PTPA;AQP1;ADAMTSL4;DIABLO;CREBBP;IL7;ATG7;SOX4;LCMT1;HTRA2;HTT;DNAJA3;DDX42;RTN4;UNC13B;CHM;COPS5;FZD9;GPER1;PTPN6;BAD;PDCD2
prerank,selective autophagy (GO:0061912),0.2586087392100632,0.7438588685033239,0.8274044795783926,0.9891683274106412,1.0,15/56,21.47%,DYNLL1;WDR81;ATG5;DDRGK1;DYNLL2;HDAC6;LGALS8;UBQLN1;ATG2B;MAP1LC3B;DYNC1LI2;RB1CC1;PRKN;DYNC1I1;ATG14
prerank,establishment of spindle orientation (GO:0051294),0.29110538675810615,0.743828885555267,0.8023598820058997,0.9886954673686694,1.0,9/28,22.14%,SAPCD2;PAFAH1B1;MAP4;NDE1;HTT;ZW10;ITGB1;GPSM2;FBXW11
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.332345774008995,0.7436674961362011,0.7724770642201835,0.9884336138039262,1.0,2/12,4.99%,PTPN22;PTPRC
prerank,response to UV-B (GO:0010224),0.3346536243608117,0.7434969578574733,0.7666098807495741,0.9881821878021314,1.0,2/12,10.88%,MSH2;MME
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.1846988635628274,-0.7424774445342393,0.9530516431924883,0.9662478856020533,1.0,19/72,22.71%,ENPP1;EDC3;RBX1;EDC4;ZC3H12A;PNRC2;ERCC2;XPA;POLK;SPO11;MUS81;RFC2;PDE12;GTF2H4;DDX1;PARP1;ERCC4;ERCC5;POLD2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.33727875421060527,0.7424424935752727,0.756140350877193,0.9893277173242818,1.0,3/12,7.68%,GLI2;EPHB2;PAFAH1B1
prerank,DNA metabolic process (GO:0006259),0.21564887720057066,0.7416721422668003,0.9327731092436975,0.9899893464322389,1.0,59/270,19.61%,TDG;MSH6;POLI;KMT5C;NTHL1;SMARCAD1;FANCC;PDS5B;RFC3;STN1;KPNA2;ORC5;NBN;UBE2V2;TOP3B;MSH2;NT5E;DFFB;HMGB1;SIRT7;ORC3;TRRAP;AXIN2;LONP1;SRPK2;ERCC1;TDP1;TOP1;MEN1;INO80;MGMT;CDC6;GEN1;ADPRS;GTF2H1;ALKBH1;POLB;REXO4;RECQL5;RAN;POLE;DDB2;FANCL;INTS3;CHD1L;USP45;GMNN;PSME4;TERF2;BACH1;NOC3L;ORC1;RFC1;ORC6;GTF2H3;MRE11;XRCC6;RPAIN;SUMO1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.2994429181955519,-0.7416358314405976,0.8157248157248157,0.9665991255076486,1.0,4/12,26.36%,IL18;CD80;PAEP;IL17D
prerank,cellular response to interferon-beta (GO:0035458),0.3216545258011864,0.741081762388446,0.7920792079207921,0.9903610042546349,1.0,3/14,13.78%,ACOD1;IRGM;HTRA2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.28624124698199743,-0.7410529851519028,0.8144578313253013,0.9665773636710178,1.0,3/13,20.58%,TMSB4X;PER2;MAD2L2
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.2839665748515089,-0.7405996612794039,0.7974358974358975,0.9663415344504944,1.0,6/14,35.01%,IL18;CD80;PAEP;IL17D;CD84;RASGRP1
prerank,dendritic spine morphogenesis (GO:0060997),-0.2799945900721414,-0.7405339343864812,0.8206388206388207,0.9656184566187366,1.0,5/15,18.50%,SHANK3;CDC42;EPHB3;CTNND2;EPHB1
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.2685963599832054,-0.7404910532618916,0.8529411764705882,0.9648928423287682,1.0,5/17,15.31%,NR1H3;HDAC9;NR1H2;FURIN;SORT1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.304053793381706,-0.7399130546501251,0.7962529274004684,0.9648417870295873,1.0,6/11,42.87%,KDM1A;MIF;TAF9;TRIAP1;MUC1;CD74
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.2920299448081063,0.739839626307217,0.7585139318885449,0.99174741402489,1.0,5/23,19.23%,ALOXE3;LTA4H;ELOVL6;HPGD;FADS1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.21321242241517044,0.7397938396127429,0.94129763130793,0.9913226930880427,1.0,61/336,17.71%,NFATC2;BCL3;UBE2E2;SMC5;MSH6;POLI;CIDEB;WDR76;PAXX;KMT5C;FANCC;PDS5B;BRSK1;RFC3;FANCF;NBN;UBR5;HIC1;MCL1;MSH2;SUV39H1;FBXO31;AATF;BOD1L1;SFN;MASTL;SIRT7;USP47;TRRAP;APC;ERCC1;TDP1;MEN1;INO80;OARD1;MGMT;RFWD3;ADPRS;GTF2H1;CHCHD6;ETAA1;HTRA2;ALKBH1;POLB;UBA1;REXO4;NEK4;RECQL5;FAM111A;YAP1;DDB2;FANCL;INTS3;BATF;CHD1L;USP45;E2F1;CUL4B;DYRK2;PSME4;BACH1
prerank,protein mono-ADP-ribosylation (GO:0140289),0.3368665014543699,0.7397792784499854,0.7693661971830986,0.9908371675390967,1.0,4/11,22.08%,PARP11;PARP6;PARP8;TIPARP
prerank,ribosomal large subunit assembly (GO:0000027),-0.242362992740877,-0.7397358679514012,0.8664495114006515,0.9642941353139997,1.0,11/24,33.54%,RPLP0;RPL3;MRPL20;NLE1;PPAN;RPL5;RPF2;RPL11;RPL24;DDX28;NOP53
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.28518085743168115,-0.7394871803461268,0.8366834170854272,0.9637985979788235,1.0,1/13,1.43%,GLI3
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.26863428998214794,0.7393921533022472,0.826950354609929,0.990918930405994,1.0,14/38,25.91%,NDUFA6;NDUFB10;NDUFS3;NDUFS6;NDUFA3;NDUFV2;NDUFV1;NDUFA7;NDUFS2;NDUFA11;NDUFA12;NDUFS4;NDUFS1;NDUFA9
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.3136511562983132,0.7392065992165568,0.7993579454253612,0.990677859022094,1.0,2/17,9.55%,CRTAM;LAMP1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.32713368876519316,0.7391557115734775,0.7688356164383562,0.9902478172187756,1.0,3/14,11.03%,TSEN54;RTRAF;TSEN34
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.2773726845310809,0.7387641848571409,0.801178203240059,0.990313394850978,1.0,6/30,15.93%,TNIP3;TICAM1;UBE2D3;UBE2D1;TICAM2;TBK1
prerank,protein modification by small protein conjugation (GO:0032446),0.21439176783797356,0.7384923713435709,0.9496919917864476,0.9902240308296237,1.0,87/361,22.14%,NEDD4L;PDZRN3;FBXL15;DTX1;STX1A;EYA1;LZTR1;LMO7;UBE2I;SPSB4;LEO1;TMEM129;NUP62;KEAP1;TRIM21;SELENOS;CHFR;PEX2;PAF1;UBE2V2;PIAS2;ZNRF3;CUL3;AMFR;NUP160;RNF220;DDRGK1;ANAPC7;DTX4;NUP37;TPR;RCHY1;KLHL7;TRPC4AP;ANAPC11;NUP50;NEDD4;RANBP2;KLHL21;FBXL5;FBXL17;FBXO11;NFE2L2;NUP210;NUP153;RFWD3;ATG7;UBE2J2;UBA1;UBE2D3;UBE2D1;WWP2;FBXW8;NUP93;TRIM5;UBE2R2;FBXW7;FBXL3;RTF1;URM1;ITCH;CUL4B;RNF7;VPS11;ANAPC16;PINK1;KLHL18;CDC23;USP9X;ATG3;SUMO1;PEX13;UBE2W;CDC73;TRPM4;PRKN;MKRN1;RNF14;MUL1;CUL7;NUP43;TRAF7;DERL1;RNF157;CUL5;MIB2;FBXW11
prerank,DNA strand elongation (GO:0022616),0.307405579901413,0.7384903350908534,0.7980456026058632,0.9897222917096046,1.0,3/18,8.17%,RFC3;NBN;GINS4
prerank,atrioventricular valve development (GO:0003171),-0.27733253596918805,-0.7374001409354316,0.8175182481751825,0.965700385775358,1.0,5/14,25.08%,BMPR2;BMP2;TGFB2;APLNR;NOTCH1
prerank,V(D)J recombination (GO:0033151),-0.29732806421183344,-0.7372948741280994,0.7949308755760369,0.965024172645376,1.0,4/11,24.88%,DCAF1;LIG3;XRCC4;LIG4
prerank,positive regulation of interferon-alpha production (GO:0032727),0.30320924050165377,0.736593680993439,0.773015873015873,0.9921015694877175,1.0,6/19,24.18%,TLR7;TBK1;SETD2;DHX9;IFIH1;RIPK2
prerank,chromatin assembly or disassembly (GO:0006333),0.3388154079950468,0.7364858467560453,0.7373913043478261,0.9917381722110556,1.0,3/11,20.24%,CDAN1;SUV39H2;RBBP4
prerank,mitotic sister chromatid segregation (GO:0000070),0.23710470700008335,0.7364427784270743,0.8736462093862816,0.9912892277588811,1.0,28/98,22.26%,NUP62;PDS5B;TUBG1;DSN1;CUL3;DIS3L2;TEX14;CHMP5;PDCD6IP;CHMP4A;CHMP4B;CHMP4C;INO80;TUBG2;KLHL22;ZW10;RAN;REC8;PIBF1;CENPK;CSNK2A2;CDC23;DCTN2;RRS1;KMT5A;CHMP2A;PRC1;MIS12
prerank,negative regulation of JUN kinase activity (GO:0043508),0.3495368168893572,0.7362246594605638,0.7530864197530864,0.9911012451341691,1.0,2/10,10.68%,PTPN22;MAPK8IP1
prerank,sister chromatid segregation (GO:0000819),0.2783962100558469,0.7362236006871943,0.8055964653902798,0.9905969827338188,1.0,8/31,17.27%,TUBG1;DSN1;INO80;TUBG2;KLHL22;ZW10;RAN;CENPK
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.34776699239142905,0.736165866703607,0.7693631669535284,0.9901718334523946,1.0,8/11,31.20%,NAGK;GNPDA2;GFPT1;GFPT2;AMDHD2;RENBP;GNPNAT1;GNPDA1
prerank,RNA interference (GO:0016246),0.31097943205631334,0.735858032669376,0.7959527824620574,0.9901298497229531,1.0,6/17,19.32%,CELF1;AGO1;DICER1;TSNAX;PRKRA;DHX9
prerank,mitochondrial fission (GO:0000266),0.31312733988915536,0.7351498727389837,0.7618270799347472,0.9906193425737408,1.0,3/16,8.63%,DNM1;FIS1;MIEF1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.29977363326878376,0.7344769089401378,0.7897196261682243,0.991122692205191,1.0,4/20,7.97%,SCD5;ACACA;GCDH;HSD17B4
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.27960583086361557,0.7336990962170187,0.8040123456790124,0.9916987060477873,1.0,6/31,13.19%,WEE1;DACT1;KANK2;APC;PTEN;FHL1
prerank,neuron cell-cell adhesion (GO:0007158),0.3262978589957947,0.7328792451887839,0.7870216306156406,0.9923601801289187,1.0,1/14,1.67%,CEL
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.23765916152697802,0.7327042261857686,0.8562577447335812,0.9920997930406938,1.0,13/86,15.09%,PRKCE;CDC42EP4;TRPV4;FER;NCK2;ARF6;OCLN;PLEK;EFEMP2;CTTN;CFL2;CDC42EP3;SLAIN2
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.23234225804403685,-0.7325758623175621,0.8825396825396825,0.9701688625724503,1.0,10/29,22.18%,EDC3;NT5C3B;HBS1L;EDC4;EXOSC3;LSM7;DIS3;EXOSC1;DCP2;LSM5
prerank,protein localization to condensed chromosome (GO:1903083),0.34008801093373175,0.7322907536648681,0.7440677966101695,0.9921968793886776,1.0,4/12,22.26%,BUB3;ZWILCH;ZW10;MIS12
prerank,negative regulation of viral genome replication (GO:0045071),0.26981415380945906,0.7317673792051532,0.8242857142857143,0.9924714258766636,1.0,7/40,11.00%,N4BP1;SRPK1;TNIP1;PLSCR1;RESF1;SRPK2;ILF3
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.34378291418887885,0.7315599119304923,0.7897727272727273,0.9922686271385214,1.0,2/10,7.86%,CHFR;DIS3L2
prerank,regulation of protein binding (GO:0043393),0.22736650931720695,0.7315237624539317,0.8900462962962963,0.9918033044082711,1.0,35/114,24.53%,CAV1;EFHB;ADD1;HDAC4;DACT1;STYX;TRIM21;AMFR;STK3;GSK3B;MEN1;PKD1;CTNNBIP1;CAPRIN2;RAN;GNL3L;BAG2;PPP1CA;SYMPK;PPP2CA;BAX;PIN1;PRKN;MAPK8;DDX11;AKTIP;TCF7L2;DERL1;NMD3;DTX3L;PRMT8;PRKCD;RIPK2;HIPK2;ROCK1
prerank,proteasomal protein catabolic process (GO:0010498),0.21756330944110952,0.7307805880387648,0.9372246696035242,0.9923907468873893,1.0,49/201,22.14%,NEDD4L;RNF122;PCBP2;SPSB4;PSME3;SOCS6;SIAH1;CUL3;PSMB5;SIAH3;UBE3D;SHARPIN;FBXL19;NEDD4;SPOPL;FBXL17;FAF1;NFE2L2;RNF185;PSMB2;UBE2D3;PSMA2;KLHL22;FEM1C;PSMA6;WWP2;PSMD13;PSMA7;PLAA;FBXW7;ITCH;CUL4B;PSME4;PSMC4;PSMB6;PSMD12;PSMD14;KBTBD7;GID4;SEL1L;UBE2W;DDIT3;PRKN;PPP2R5C;ZNRF1;PSMB3;DERL1;GID8;FBXW11
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.24210878199120334,-0.7306784025612303,0.8512396694214877,0.971755391647856,1.0,6/22,18.58%,PHF8;DHX33;NCL;HEATR1;PWP1;ATF4
prerank,dendritic cell chemotaxis (GO:0002407),0.32247457241934674,0.7301682635109871,0.7526132404181185,0.9927880099260445,1.0,4/14,20.27%,HMGB1;GPR183;CCR5;TRPM4
prerank,regulation of transport (GO:0051049),0.2719288306146458,0.7300285449635383,0.8227146814404432,0.9924869096079377,1.0,10/36,21.39%,CLDN19;LEPR;CLDN10;WWC1;MBTPS1;PINK1;ICA1L;PRKN;MUL1;VAMP2
prerank,neuron remodeling (GO:0016322),-0.3041947770889819,-0.729988223312326,0.8290398126463701,0.9717954218457946,1.0,5/10,31.39%,EPHA8;C1QA;C3;SCARF1;RND1
prerank,regulation of histone methylation (GO:0031060),0.326857194104748,0.7297517016695191,0.7770034843205574,0.9923750298303873,1.0,2/13,9.16%,PAF1;TET1
prerank,cell proliferation in forebrain (GO:0021846),-0.30716499858931523,-0.729357886818036,0.7985948477751756,0.9717696048289679,1.0,1/10,0.77%,NUMB
prerank,membrane depolarization during action potential (GO:0086010),0.29214971797433625,0.7290872255368221,0.8181818181818182,0.9927921485830035,1.0,3/26,5.19%,SCN10A;CACNA1H;ATP1A2
prerank,monocarboxylic acid metabolic process (GO:0032787),0.22776166598545347,0.7290638332645127,0.8885017421602788,0.9923227452884518,1.0,22/117,17.73%,ALDH1A3;PCCB;CYP2S1;HOGA1;CKMT2;DLAT;SCPEP1;ABAT;SLC27A4;ACSF2;GAMT;SLC16A1;ACOT2;MSMO1;PNPLA8;AASDH;GGT1;PANK2;ME2;LDHB;PPARG;LPL
prerank,cellular response to oxygen levels (GO:0071453),-0.30744514017767877,-0.7286178159357432,0.8131868131868132,0.9718725078335655,1.0,3/10,22.77%,CPEB4;PICK1;CCDC115
prerank,regulation of trophoblast cell migration (GO:1901163),-0.27755609920254626,-0.7284856956077189,0.803763440860215,0.9712287840232321,1.0,7/14,31.97%,GJA1;SMURF2;C1QBP;YTHDF3;ACVR1B;CALR;TIMP1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.3345888945159231,0.728432258253635,0.7656529516994633,0.9927565731677231,1.0,3/11,21.15%,HMGB1;CBFB;RUNX1
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.22956929157597286,-0.7284162019582429,0.8856304985337243,0.9697247152809894,1.0,14/29,31.96%,NPM1;RUVBL1;SMARCA5;CENPT;CENPP;CENPC;CENPQ;MIS18BP1;CENPO;CENPX;CENPI;MIS18A;CENPN;CENPA
prerank,CENP-A containing chromatin organization (GO:0061641),-0.22956929157597286,-0.7284162019582429,0.8856304985337243,0.9697247152809894,1.0,14/29,31.96%,NPM1;RUVBL1;SMARCA5;CENPT;CENPP;CENPC;CENPQ;MIS18BP1;CENPO;CENPX;CENPI;MIS18A;CENPN;CENPA
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.24806206709900036,0.7283856097713238,0.8367875647668394,0.9923228049207665,1.0,12/57,15.99%,BRCC3;BRSK1;NBN;RINT1;FBXO31;UIMC1;MDC1;DONSON;RFWD3;EME2;FZR1;NEK11
prerank,tRNA processing (GO:0008033),0.24310012967388667,0.7278490944094698,0.8528252299605782,0.9925710789188,1.0,18/61,23.14%,TSEN54;PUS3;WDR4;CDKAL1;KARS1;POP7;RTRAF;TSEN34;FTSJ1;ADAT1;ANKRD16;URM1;TYW5;PTCD1;RPP21;THG1L;TRMT1;RPP30
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.3066488878579103,0.7278139250937966,0.7909238249594813,0.9921245591680565,1.0,6/17,17.11%,APLN;TAFA5;EFEMP2;PTEN;GPER1;PPARG
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.2833581195491872,0.7276665745906706,0.8242424242424242,0.9918458741888551,1.0,5/29,17.96%,TEX11;SIRT7;MEI4;REC8;SYCP2
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.26760976796931046,-0.7275075967224753,0.8422391857506362,0.9700734724924707,1.0,1/14,1.35%,PPP2R2B
prerank,leukocyte tethering or rolling (GO:0050901),0.30971012754847854,0.7275067723427746,0.8052373158756138,0.9915831104404742,1.0,6/17,24.53%,ITGB7;PODXL2;ITGB1;CX3CR1;GOLPH3;ROCK1
prerank,gas transport (GO:0015669),0.34794397902479945,0.7273146802569308,0.752542372881356,0.9913618234310666,1.0,2/10,12.99%,IPCEF1;AQP1
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.3053033432927939,-0.7270524089262521,0.8111888111888111,0.9682408469143575,1.0,2/10,5.83%,WRN;BLM
prerank,t-circle formation (GO:0090656),-0.3053033432927939,-0.7270524089262521,0.8111888111888111,0.9682408469143575,1.0,2/10,5.83%,WRN;BLM
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.3053033432927939,-0.7270524089262521,0.8111888111888111,0.9682408469143575,1.0,2/10,5.83%,WRN;BLM
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.28684425768948574,-0.7268050712160643,0.8282352941176471,0.9677481532565282,1.0,6/12,30.04%,WAC;PLK5;RPS27L;CDK2;CCND1;PLK3
prerank,protein K63-linked ubiquitination (GO:0070534),-0.21368457657806433,-0.7267662442468511,0.8909090909090909,0.967010903547715,1.0,7/41,9.85%,RNF115;TRAF3IP2;TRAF6;UBE2N;UBE2S;RNF152;UBE2O
prerank,necroptotic process (GO:0070266),-0.2656664810428915,-0.7267363041726165,0.8341968911917098,0.9662537359770315,1.0,6/16,25.91%,PGAM5;IPMK;TRPM7;TLR3;RIPK1;LY96
prerank,negative regulation of reproductive process (GO:2000242),0.30975601337046976,0.7259767768995906,0.7708978328173375,0.992797387556235,1.0,2/17,5.04%,SULF1;ACVR1C
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.3017946944455231,0.725611000870517,0.7876923076923077,0.9928090085048622,1.0,5/20,23.89%,ANO6;GPER1;RGCC;IL6;PDCD4
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.3354390981851199,0.7255820540559306,0.7619047619047619,0.9923509480984477,1.0,2/11,8.10%,PCBP2;IGF2BP2
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.3040640405240881,-0.7252103543559968,0.8211009174311926,0.9672978426559213,1.0,2/10,4.89%,HOXB4;ACE
prerank,inflammatory response (GO:0006954),0.21634287206210467,0.7247304046117047,0.9234972677595629,0.9930548769415335,1.0,8/195,4.50%,HRH1;F11R;PTGFR;FOLR2;IL1A;HDAC4;HNRNPA0;REL
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.33029278911110055,0.7246550582828153,0.7945670628183361,0.9926647219880623,1.0,2/13,9.18%,NRARP;COL4A1
prerank,ncRNA export from nucleus (GO:0097064),0.2635545964585363,0.7245175162385608,0.8002936857562408,0.9923486331586283,1.0,10/36,15.45%,NUP62;NUP160;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153;RAN;NUP93
prerank,regulation of neurogenesis (GO:0050767),0.2478052532976799,0.7240336926180447,0.8565941101152369,0.9925237726560853,1.0,13/55,21.67%,RGS14;HEYL;BHLHE40;MME;DOCK7;HOOK3;PCM1;GPER1;YAP1;NAP1L1;IL6;CX3CR1;CX3CL1
prerank,recombinational repair (GO:0000725),0.23580324438987357,0.7232679259033816,0.8730964467005076,0.9930723954902982,1.0,18/77,19.01%,SMC5;NBN;PALB2;SWI5;ZSWIM7;ZFYVE26;INO80;GEN1;RFWD3;NUCKS1;SFPQ;RAD51AP2;REV3L;RECQL5;RHNO1;SFR1;PSMD14;MRE11
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.2804992718075823,-0.7231526474868933,0.8636363636363636,0.9689461947583109,1.0,4/14,23.24%,ENTPD1;ENTPD5;ENTPD3;NUDT16
prerank,mitotic sister chromatid cohesion (GO:0007064),0.3123109989656499,0.7230029593076268,0.7971014492753623,0.9929527451233439,1.0,3/16,17.28%,PDS5B;REC8;DSCC1
prerank,tRNA modification (GO:0006400),0.24118129414724254,0.7223452417455604,0.8649350649350649,0.9934044528241267,1.0,19/62,22.36%,TARBP1;PUS7;PUS3;WDR4;CDKAL1;THADA;FTSJ1;TRMT5;ALKBH1;ANKRD16;URM1;TYW5;THUMPD3;METTL2A;METTL2B;OSGEP;TRMO;THG1L;TRMT1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.2591849093152572,-0.7219686414294463,0.8668341708542714,0.9695238570291433,1.0,7/16,28.56%,SLC39A14;GSK3A;MRAP2;PDE6H;C3;ACP3;GRP
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.21156664515533286,-0.7217876975916022,0.9166666666666666,0.968952897432298,1.0,7/40,14.30%,PID1;ARL6IP5;AKT1;VCP;LRRK2;SLC25A33;MAPT
prerank,establishment of mitotic spindle orientation (GO:0000132),0.29151039101936643,0.7217048602471952,0.7876506024096386,0.9938312109696522,1.0,8/23,22.14%,SAPCD2;PAFAH1B1;NDE1;HTT;ZW10;ITGB1;GPSM2;FBXW11
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.2162805852251558,-0.7215906646353898,0.8964285714285715,0.9683782915846143,1.0,6/34,11.96%,GRIN2B;GABRA2;AKT1;GRIN1;LRRK2;GSK3A
prerank,regulation of mRNA stability (GO:0043488),0.2197111069508253,0.7211315701449358,0.922384701912261,0.9941266459702232,1.0,35/145,22.21%,FXR2;DND1;GIGYF2;CELF1;PRKCA;PSME3;SAMD4B;EXOSC5;IGF2BP2;PSMB5;TENT5C;AXIN2;TENT5D;TAF15;ZFP36L2;PSMB2;FXR1;PSMA2;PUM2;FASTKD1;PSMA6;PSMD13;PSMA7;E2F1;PSME4;PSMC4;PSMB6;PSMD12;PSMD14;HNRNPD;EXOSC7;PUM1;PSMB3;ELAVL1;YWHAB
prerank,phagosome acidification (GO:0090383),-0.2310553885401526,-0.720579281648035,0.9101796407185628,0.9687713489186438,1.0,8/26,24.02%,ATP6V0A4;ATP6V0C;ATP6V1C1;ATP6V1D;ATP6V1F;RAB7A;ATP6V1E1;RAB38
prerank,neurotransmitter biosynthetic process (GO:0042136),0.31260742910012185,0.7204730528120422,0.7891373801916933,0.9945690856252646,1.0,1/14,1.67%,ALDH9A1
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.23607377118026968,-0.7203856456767789,0.8651026392961877,0.968206037568019,1.0,4/22,14.99%,B2M;TRAF6;CYRIB;ZBTB1
prerank,O-glycan processing (GO:0016266),0.2491482176332699,0.7200501756041517,0.8357615894039735,0.9946822905952211,1.0,5/54,9.50%,ST3GAL4;C1GALT1C1;GCNT4;POFUT1;ST6GAL1
prerank,regulation of secretion (GO:0051046),-0.27218827839676246,-0.7199392683037404,0.8528678304239401,0.9678843012459372,1.0,2/13,2.67%,ACSL3;MYO6
prerank,negative regulation of cellular component organization (GO:0051129),0.24019422525346934,0.7186401271033025,0.8611111111111112,0.9960835613063211,1.0,11/74,13.63%,FAP;RAPGEF3;SRC;LRSAM1;IRAK3;RDX;ISL1;GSK3B;HDAC6;SACS;LCMT1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.2729701485585268,0.71844874834431,0.8273894436519258,0.9958547453412598,1.0,7/34,16.88%,DOCK5;DOCK1;RREB1;FERMT2;P4HB;MDK;ARHGEF7
prerank,telomere capping (GO:0016233),0.30405426829688414,0.7181760886922032,0.7873462214411248,0.9957219705765924,1.0,4/16,19.01%,STN1;NBN;TERF2;MRE11
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.26990253287981264,-0.7178858296200481,0.8609112709832134,0.9694882137391657,1.0,6/15,22.10%,SPHK1;SMPD3;ORMDL1;ORMDL2;RACK1;ORMDL3
prerank,translational termination (GO:0006415),0.22607058776185163,0.7177934807141553,0.8895631067961165,0.9957423637955529,1.0,21/95,18.17%,MRPL37;MRPL43;MRPL33;MRPS28;MRPS35;PTCD3;MRPL41;MRPS22;MRPS15;MRPS33;MRPL3;ETF1;CHCHD1;MRPL16;MTRF1L;MRPL40;MRPL22;MRRF;GADD45GIP1;MRPL4;MRPL2
prerank,response to UV (GO:0009411),0.22995806456072077,0.7177133994720566,0.8827751196172249,0.9953559414827888,1.0,14/95,13.11%,EGFR;SCARA3;BCL3;MSH6;BRSK1;N4BP1;MSH2;USP47;ERCC6;NEDD4;MEN1;INO80;AQP1;CREBBP
prerank,DNA replication initiation (GO:0006270),-0.21018480414632215,-0.7176242570630139,0.9120521172638436,0.9689938235234178,1.0,17/37,32.04%,PRIM2;POLE4;MCM6;ORC2;POLA1;LRWD1;CDC7;TOPBP1;CDC45;POLA2;CDK2;MCM3;MCM7;POLE3;MCM5;MCM10;MCM2
prerank,urogenital system development (GO:0001655),0.32983406633357853,0.7175908479588489,0.7966666666666666,0.9950393119066923,1.0,2/11,6.38%,SOX9;EPHB2
prerank,mesenchymal cell development (GO:0014031),0.3040652850957242,0.7173026342159766,0.7938808373590982,0.994951738755673,1.0,2/18,7.85%,HEYL;CDH2
prerank,positive regulation of insulin secretion (GO:0032024),0.26377212415732404,0.7170472703364593,0.8377997179125529,0.9948220883482757,1.0,13/36,22.12%,GPLD1;ISL1;GCK;SOX4;GPER1;BAD;ADCY8;STX4;IRS2;GLUD1;TRPM4;TCF7L2;NLGN2
prerank,histone mRNA metabolic process (GO:0008334),-0.2294675244109915,-0.7169944802424653,0.9021406727828746,0.9689497949964201,1.0,10/27,27.27%,SSB;TENT2;SNRPE;TUT7;MTPAP;NCBP1;LSM11;DCP2;SLBP;ATM
prerank,negative regulation of cilium assembly (GO:1902018),0.32988888573929137,0.7162509974259141,0.7909407665505227,0.9954150963051177,1.0,4/12,15.72%,LIMK2;CCP110;MAP4;YAP1
prerank,fluid transport (GO:0042044),0.3230830474358558,0.7161894041147061,0.7759472817133443,0.9950045267332329,1.0,3/12,21.69%,SLC4A11;AQP1;SLC26A6
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.2373658474611354,0.7161608702659018,0.8706786171574904,0.9945471189160205,1.0,17/65,18.75%,PSME3;CHFR;PSMB5;USP47;CHMP4C;FHL1;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;INTS3;PSME4;PSMC4;PSMB6;PSMD12;PSMD14
prerank,protein oxidation (GO:0018158),-0.2865238282633825,-0.716129537673031,0.8271028037383178,0.9691904527488706,1.0,2/11,12.25%,LOXL1;LOXL3
prerank,dendritic cell migration (GO:0036336),-0.2609743597363559,-0.715511995966402,0.8385542168674699,0.969109084904159,1.0,1/16,0.58%,EPS8
prerank,histone modification (GO:0016570),0.2226606850950546,0.7150027108810344,0.8920863309352518,0.995606005620364,1.0,19/109,15.99%,EYA1;KAT6B;HDAC4;TAF10;RCOR3;SIN3B;MSL3;SIRT7;HDAC2;TRRAP;HDAC6;PHF20L1;CREBBP;BAZ2A;KAT8;BRD8;PRMT6;MORF4L2;NEK11
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.3154125349214504,0.7149351053775096,0.8031358885017421,0.9951964214470417,1.0,2/14,7.45%,SOCS5;RARA
prerank,receptor recycling (GO:0001881),-0.305854902988172,-0.714247585686207,0.8169642857142857,0.9697822711658649,1.0,4/10,18.43%,ARFGEF2;NSG1;PLEKHJ1;RAB11B
prerank,pre-miRNA processing (GO:0031054),-0.2794870966369361,-0.7141637934075798,0.8381642512077294,0.9690982309037146,1.0,4/14,14.64%,ADAR;AGO3;AGO4;TUT7
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.3366586621349701,0.7137827312877552,0.7832167832167832,0.9963202593655,1.0,5/10,22.92%,BAG3;NCK1;JUN;IMPACT;SIRT2
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.2984207593059272,0.7136359141571389,0.7743506493506493,0.9960377147503469,1.0,7/19,20.40%,HDAC6;HTRA2;HTT;FBXW7;CSNK2A2;PINK1;PRKN
prerank,positive regulation of histone modification (GO:0031058),0.2666909709107099,0.7135565249839069,0.8477951635846372,0.995656058089848,1.0,3/33,9.16%,PPARGC1A;PAF1;TET1
prerank,nuclear export (GO:0051168),0.22919276986223827,0.7132128765722271,0.907292954264524,0.9956264473869266,1.0,21/80,21.76%,RBM8A;SRSF4;NUP62;EIF4E;TPR;UPF3B;CSE1L;NUP153;PKD1;THOC3;LSG1;RAN;THOC5;CHP1;XPO5;SLU7;SRSF3;DHX38;SRSF11;STRADB;XPO4
prerank,regulation of cell growth (GO:0001558),0.21158410486590817,0.713202543794872,0.9492988133764833,0.9951456135615355,1.0,47/204,21.74%,PTCH2;VGLL4;PLCE1;CEACAM1;CAMK2D;EGFR;DCBLD2;ADAM10;NDUFS3;LTBP4;PTPRJ;EBAG9;RPS6KA3;USP47;S100A9;SGK1;INO80;KIF26A;CRLF3;FHL1;NAIF1;RTN4;CAPRIN2;KLHL22;SIPA1;NDRG3;EI24;ERBB2;ARHGEF11;RAB33B;MMP14;MINAR1;ITCH;SOCS2;PPP2CA;EIF4G2;RPTOR;MUL1;CISH;CEP43;FRZB;CCAR2;SERTAD2;OSGIN1;ENO1;TAF9B;RBBP7
prerank,mitochondrial translational elongation (GO:0070125),0.22764803949906395,0.713143169957233,0.8945409429280397,0.9947165102383658,1.0,34/88,27.92%,MRPL37;MRPL43;MRPL33;MRPS28;MRPS35;PTCD3;MRPL41;MRPS22;MRPS15;MRPS33;MRPL3;CHCHD1;MRPL16;MRPL40;MRPL22;GADD45GIP1;MRPL4;MRPL2;MRPL34;GFM1;TSFM;MRPS7;MRPL11;MRPL19;MRPL39;MRPS18A;MRPL1;MRPL13;MRPL47;MRPL21;DAP3;MRPL57;MRPL46;GFM2
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.25031194999200485,0.7125126881906145,0.8571428571428571,0.9950758096962605,1.0,14/45,23.65%,FOXO3;GCNT2;EIF4E;ATXN2;EIF2B4;PUM2;SPOUT1;LARP4;NUDT21;ATG14;PUM1;DDX25;YTHDC1;ZC3H7B
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.3083351103119414,0.7124329937124046,0.8072289156626506,0.9947016272303149,1.0,1/15,1.39%,AK5
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.3352531081972027,0.711883328897901,0.8024263431542461,0.9949447317290387,1.0,2/10,11.14%,RACGAP1;APC
prerank,glutathione metabolic process (GO:0006749),-0.20439985974386785,-0.7117607117535842,0.9037800687285223,0.970967684931262,1.0,12/38,25.82%,GCLM;CTNS;ETHE1;GLRX2;CNDP2;GGCT;GSTT2;HPGDS;GCLC;GSTT1;GSR;GGT5
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.28700939835108974,0.711720330558322,0.819935691318328,0.994665382994764,1.0,3/21,6.59%,EIF2AK3;CREB3L1;SELENOS
prerank,negative regulation of binding (GO:0051100),0.23298857376170187,0.7115575690492862,0.8978829389788294,0.9943974656906667,1.0,20/81,21.85%,CAV1;EFHB;DACT1;STYX;GSK3B;SMO;CTNNBIP1;GNL3L;BAG2;E2F1;PPP1CA;SYMPK;SUMO1;BAX;PIN1;HABP4;MAPK8;RSF1;DDX11;JUN
prerank,regulation of cytokine production (GO:0001817),0.22181994098795146,0.7109388779157706,0.9165687426556992,0.9947188696722105,1.0,15/126,10.36%,GLMN;ITK;TXK;IL1A;PTPRC;TRIM21;N4BP1;PLD3;CRTAM;PTGER4;IGF2BP2;DTX4;NLRP4;HILPDA;ADRA2A
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.23023058787563647,0.7108607622646334,0.8863361547762999,0.9943313949197565,1.0,14/88,14.11%,FXR2;GIGYF2;EIF2AK3;CNOT10;SAMD4B;CLN8;PUS7;IGF2BP2;CNOT7;RIC1;ILF3;HDAC6;DDX6;FXR1
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.2744042149924589,-0.710683938035394,0.8674698795180723,0.9713914161189422,1.0,4/13,17.73%,ZC3HAV1;ZC3H12A;MOV10;RC3H1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.21321843007091248,0.7106026406516552,0.9411764705882353,0.9941921305282202,1.0,35/175,22.10%,EDA;TNFSF8;ADAMTS12;FOXO3;PSME3;TRADD;ACOD1;PSMB5;NFE2L2;CDIP1;TNFRSF11B;ZFP36L2;TXNDC17;PSMB2;PSMA2;PSMA6;GPER1;TNFRSF14;PSMD13;PSMA7;PSME4;ASAH1;PSMC4;PSMB6;PSMD12;PSMD14;DHX9;YBX3;CCL14;ST18;TRAF3;TRAF5;PSMB3;CX3CL1;LTBR
prerank,sodium ion import across plasma membrane (GO:0098719),0.3001737376752996,0.7105716533056392,0.7929373996789727,0.9937491710252185,1.0,3/17,11.17%,SLC12A2;SLC9A7;SLC9A6
prerank,release of cytochrome c from mitochondria (GO:0001836),0.30222840660373146,0.7099490593643689,0.8194888178913738,0.9940679420917892,1.0,8/17,27.21%,FIS1;SFN;FZD9;BAD;BAX;DNM1L;MFF;BCL2L1
prerank,histone H3 acetylation (GO:0043966),-0.2044027756643691,-0.709871141831955,0.9246575342465754,0.9715375569801622,1.0,10/40,18.34%,LEF1;JADE1;TRIM16;KAT14;PHF14;SGF29;DR1;KAT2B;KAT2A;JADE2
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.31154880503464033,0.7096699995970718,0.8101472995090017,0.9939545014382416,1.0,3/15,9.57%,TMEM129;SELENOS;NPLOC4
prerank,neutrophil activation involved in immune response (GO:0002283),0.2034625087392301,0.70927665653095,0.9735234215885947,0.9940194971001577,1.0,79/428,19.50%,DYNLL1;NAPRT;CEACAM1;ARG1;RAP1A;ARHGAP9;ANO6;CD55;ITGAX;PTPRC;NIT2;CD53;DOCK2;CDK13;NCSTN;ADAM10;PPIE;NRAS;NEU1;ACTR10;RAB3A;DSN1;ILF2;YPEL5;FRMPD3;PGM1;PTPRJ;ATP6V0A1;HMGB1;LAMP1;IST1;CANT1;S100A9;MME;MANBA;PAFAH1B2;PLD1;VAMP8;LAIR1;CEP290;CCT2;PGRMC1;TSPAN14;LTA4H;MVP;DERA;ATG7;MLEC;TMEM30A;GSDMD;HEXB;PSMA2;TMEM63A;PTPN6;PSMD13;TICAM2;ATP8B4;AP2A2;HGSNAT;SYK;GLIPR1;CTSB;CREG1;CRACR2A;ASAH1;CYBB;ERP44;PSMD12;ATP6AP2;SNAP23;RHOA;PRDX6;PSMD14;SNAP29;RNASE3;PTGES2;XRCC6;AP1M1;LAMP2
prerank,TOR signaling (GO:0031929),0.27746466036914097,0.7086590126670735,0.8269794721407625,0.9943376633150149,1.0,3/26,10.01%,PRR5;SYAP1;MAPKAP1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.2899458226529007,-0.7085183144359205,0.8242280285035629,0.9722187555006903,1.0,2/11,12.14%,SLC30A10;ABCD2
prerank,cellular lipid catabolic process (GO:0044242),0.2773812251628681,0.7077744357571624,0.82642089093702,0.9950224557758168,1.0,4/27,10.28%,CEL;MGST2;ABHD12;ACOT8
prerank,metal ion transport (GO:0030001),0.23266438399593065,0.7074470540850618,0.8888888888888888,0.9949860052321422,1.0,4/86,4.37%,CAV1;SLC24A1;TRPV4;SLC30A9
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.3167011944754875,0.7069757678301317,0.810671256454389,0.9951358845874541,1.0,2/13,7.59%,BMS1;NOP14
prerank,pentose-phosphate shunt (GO:0006098),-0.2845970374424798,-0.7067030403369009,0.8495370370370371,0.9734373394242795,1.0,4/11,19.23%,RPIA;PGLS;PGD;RBKS
prerank,entry into host (GO:0044409),0.3126525161824079,0.7063566814492289,0.7892156862745098,0.9954658122217949,1.0,3/13,15.38%,SRC;CCR5;CDH1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.23939603261626022,0.7061886261240461,0.8930412371134021,0.9951945962618219,1.0,9/63,11.08%,LEPR;GPLD1;FOXK1;PTPN22;MCL1;FOXK2;EIF4E;RIC1;TAB2
prerank,oligodendrocyte differentiation (GO:0048709),0.29016023432969756,0.7061411931039893,0.8222565687789799,0.9947583991279101,1.0,4/19,13.09%,EIF2B3;SOX9;EIF2B4;NSUN5
prerank,autophagy of peroxisome (GO:0030242),-0.2862183649278527,-0.7060184249320525,0.8501228501228502,0.973392814033595,1.0,4/12,15.58%,SQSTM1;NBR1;ACBD5;USP30
prerank,spindle assembly (GO:0051225),0.2377121992891662,0.7057410525541046,0.8742138364779874,0.9947973694777145,1.0,21/67,26.16%,KIF2A;SMC3;NEK7;NCOR1;TUBGCP5;MAP9;INO80;MAPRE2;ARHGEF10;PIBF1;OFD1;RHOA;HDAC3;TUBGCP6;HAUS8;HAUS3;HAUS7;NEK6;CSNK1D;TNKS;CLASP2
prerank,innate immune response in mucosa (GO:0002227),0.33232247688034855,0.7056525649413086,0.8067978533094812,0.994424048853222,1.0,2/10,18.92%,DEFA6;RNASE3
prerank,regulation of necroptotic process (GO:0060544),0.2864276639777127,0.7054275736076797,0.8265625,0.994240527293776,1.0,3/23,9.03%,OGT;FLOT2;PDCD6IP
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.23046303753421826,0.7048277968226551,0.901985111662531,0.9945409000771986,1.0,5/77,6.97%,ITGA6;SRC;PSME3;NDUFS3;MCL1
prerank,protein localization to mitochondrion (GO:0070585),0.32863327599806286,0.7048208766912661,0.8123924268502581,0.9940641918336538,1.0,1/11,1.86%,HK2
prerank,regulation of mast cell activation (GO:0033003),-0.2972630274257393,-0.7048031836879785,0.8764568764568764,0.9739193508467288,1.0,7/10,42.19%,LYN;CRLF2;MILR1;CD300LF;CD84;TSLP;CD226
prerank,negative regulation of cell cycle process (GO:0010948),0.23525719873996903,0.7046518189236967,0.8860435339308579,0.99380747998586,1.0,18/61,24.75%,FBXO43;TOM1L1;FBXO5;CCP110;TOM1L2;CHMP4C;GPER1;E2F1;TERF2;FOXO4;RBBP4;CHMP2A;RBBP7;TFDP1;NME6;BMP7;APAF1;CBX3
prerank,positive regulation of JNK cascade (GO:0046330),0.23291676732465041,0.7045021496131886,0.890840652446675,0.993501339359034,1.0,10/70,12.04%,AXIN1;SH3RF2;MINK1;WNT16;SEMA3A;MAP3K5;HMGB1;RASSF2;MAPK8IP1;MTURN
prerank,serine family amino acid metabolic process (GO:0009069),-0.2599656457347379,-0.7044851641013737,0.8625954198473282,0.97347612861415,1.0,9/16,34.19%,PSPH;CBS;GCLC;SEPHS2;CTH;THNSL2;SHMT2;CDO1;SHMT1
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.24014296078537425,0.7043120939948287,0.8702983138780804,0.9932525110260115,1.0,21/59,25.70%,CAMK2D;PRKCA;HIPK1;DYRK1A;CAD;GSK3B;CIT;TBK1;LMTK2;DYRK2;CSNK2A2;PDPK1;CDC42BPG;ACVR1;MAPK8;MAPK1;PRKCD;HIPK2;ROCK1;TNKS;TAF1
prerank,neutrophil degranulation (GO:0043312),0.20197742527897275,0.7040083090079373,0.9765545361875637,0.9931284650851722,1.0,78/425,19.50%,DYNLL1;NAPRT;CEACAM1;ARG1;RAP1A;ARHGAP9;ANO6;CD55;ITGAX;PTPRC;NIT2;CD53;DOCK2;CDK13;NCSTN;ADAM10;PPIE;NRAS;NEU1;ACTR10;RAB3A;DSN1;ILF2;YPEL5;FRMPD3;PGM1;PTPRJ;ATP6V0A1;HMGB1;LAMP1;IST1;CANT1;S100A9;MME;MANBA;PAFAH1B2;PLD1;VAMP8;LAIR1;CEP290;CCT2;PGRMC1;TSPAN14;LTA4H;MVP;DERA;ATG7;MLEC;TMEM30A;GSDMD;HEXB;PSMA2;TMEM63A;PTPN6;PSMD13;TICAM2;ATP8B4;AP2A2;HGSNAT;GLIPR1;CTSB;CREG1;CRACR2A;ASAH1;CYBB;ERP44;PSMD12;ATP6AP2;SNAP23;RHOA;PRDX6;PSMD14;SNAP29;RNASE3;PTGES2;XRCC6;AP1M1;LAMP2
prerank,osteoclast differentiation (GO:0030316),0.2824610776057423,0.7034703798919637,0.8343949044585988,0.9933366346215788,1.0,4/22,11.77%,SRC;SNX10;GAB2;GPR183
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.22835521322221802,-0.7033906388636704,0.9217877094972067,0.9738684691941154,1.0,10/24,27.21%,RBPJ;HIF1A;KLF2;HSF1;CEBPB;ATF4;ATF6;NOTCH1;ATF3;ATF6B
prerank,positive regulation of translation (GO:0045727),0.2255123212596134,0.7033829419893955,0.9035294117647059,0.9929725578186791,1.0,26/94,23.74%,BCL3;FXR2;PIWIL2;RMND1;FASTKD2;METTL5;PLD1;UPF3B;NSUN5;MPV17L2;SOX4;FXR1;PYM1;CPEB3;ERBB2;RPUSD4;DHX9;YBX3;HNRNPD;LARP4;IL6;HABP4;ELAVL1;PKM;NIBAN1;MTOR
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.29767272592119826,0.7033552643216817,0.8100840336134454,0.9925262386978118,1.0,7/18,18.46%,SRC;RDX;EZR;RAB21;VPS11;SNX12;DENND10
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.2979040355703314,0.703166487302373,0.8184873949579832,0.9922784945085734,1.0,9/18,29.29%,NAIF1;BAD;BNIP3;MUL1;BCL2L1;SLC25A5;SPG7;PPIF;BCL2
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.27924741385967145,0.7031644517191251,0.8313253012048193,0.9917962756790089,1.0,5/23,14.65%,DFFB;HMGB1;EXOG;DICER1;REXO4
prerank,coenzyme A metabolic process (GO:0015936),-0.2684647292377869,-0.7031395609921874,0.8734177215189873,0.9733558044085246,1.0,6/14,24.11%,ACOT7;PANK1;ACLY;PPCDC;PANK3;DCAKD
prerank,cardiac muscle cell action potential (GO:0086001),0.2729432213676198,0.7026336097285795,0.8481203007518797,0.9919986307106168,1.0,3/30,5.19%,SCN10A;SLC4A3;ATP1A2
prerank,neurogenesis (GO:0022008),0.2518171214759873,0.7024750082457252,0.8763888888888889,0.991728149281691,1.0,6/43,13.54%,LPAR1;NTN5;BTBD2;ERCC6;WDR62;CIT
prerank,cGMP biosynthetic process (GO:0006182),-0.2989952555319672,-0.7023237368081418,0.8558558558558559,0.9734733707524033,1.0,1/10,4.51%,NPR1
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.2495987541109168,-0.7021275016324509,0.8656330749354005,0.9728989465862027,1.0,1/18,0.68%,SMAD3
prerank,protein import into peroxisome matrix (GO:0016558),-0.2844063272794005,-0.7015535898427389,0.8581907090464548,0.9726531086788838,1.0,4/12,19.50%,PEX26;PEX6;PEX1;PEX10
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.28801147280995126,0.7014730665864498,0.8319604612850082,0.9925240552752962,1.0,4/18,14.35%,SEC14L1;NPLOC4;USP15;PUM2
prerank,regulation of autophagosome assembly (GO:2000785),0.26695631950796433,0.7014226879701085,0.8540145985401459,0.9921080845925025,1.0,6/33,10.70%,LRSAM1;PIP4K2B;RAB3GAP2;MTMR3;CHMP4A;CHMP4B
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.26130366075095857,0.7012152906559662,0.8404558404558404,0.9918868777304515,1.0,10/31,22.61%,DCP1B;EXOSC5;DIS3L2;CNOT7;DDX6;CNOT8;LSM3;EXOSC7;DCPS;LSM2
prerank,peptidyl-arginine modification (GO:0018195),-0.26300962887207374,-0.7011015144567715,0.8463476070528967,0.9723565320014584,1.0,11/15,50.67%,ART3;PRMT7;KRTCAP2;PRMT1;PADI2;PARK7;ART1;PADI1;PADI4;ART4;ART5
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.288330689802627,-0.7009908374162502,0.8325358851674641,0.9716821869223592,1.0,5/11,32.17%,SMARCD1;SERTAD1;ZMIZ2;CDCA4;ZMIZ1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.2967598980864069,0.700261165773537,0.7996768982229402,0.9926175511388006,1.0,6/17,21.88%,TMEM129;SELENOS;NPLOC4;HM13;SEL1L;DERL1
prerank,mitochondrial transport (GO:0006839),0.24305708319676728,0.6999830926907129,0.8590604026845637,0.9924662126431344,1.0,9/53,16.94%,TOMM34;MFN2;FIS1;SLC25A13;TOMM40;STARD3;BAD;BCS1L;BNIP3
prerank,neural crest cell migration (GO:0001755),0.2618435369288232,0.6999560578894108,0.8478581979320532,0.9920191140826755,1.0,9/36,18.70%,FOLR1;SEMA4B;FN1;SEMA3A;SEMA4D;SEMA6C;ERBB4;SEMA4C;SEMA4A
prerank,natural killer cell mediated immunity (GO:0002228),-0.2614357965051619,-0.6998795932189448,0.8606356968215159,0.972051381215785,1.0,4/15,21.88%,CEBPG;TUBB4B;PLEKHM2;RAET1E
prerank,positive regulation of lipid storage (GO:0010884),-0.233625675092336,-0.6997016425838539,0.8873994638069705,0.9714535186618904,1.0,6/21,25.18%,OSBPL11;ZC3H12A;PLIN3;FITM2;C3;SCARB1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.3035696925821064,0.699401516117888,0.8422818791946308,0.992246590019062,1.0,1/15,1.84%,KCNA5
prerank,negative regulation of myotube differentiation (GO:0010832),-0.27979197972585756,-0.6993076384585935,0.8447058823529412,0.9710953479295508,1.0,5/12,25.08%,CCN3;HDAC1;BDNF;XBP1;NOTCH1
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.2560335130109117,-0.6987163998569449,0.8537234042553191,0.9709092895634414,1.0,5/15,25.78%,FKBP1A;LEMD3;CSNK2B;FSTL3;ACVR1B
prerank,cellular response to glucose stimulus (GO:0071333),0.26502134673370503,0.6983729911368434,0.8490566037735849,0.9930039530801928,1.0,8/30,15.57%,ZBTB20;RAB11FIP5;ERN1;SOX4;UNC13B;TRA2B;GPER1;ADCY8
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.33734118990553336,0.6982848750004979,0.8149466192170819,0.9926343056911666,1.0,2/10,8.00%,DPP4;PIEZO1
prerank,JNK cascade (GO:0007254),0.2534061428773804,0.6981964749825593,0.8806179775280899,0.9922586365382615,1.0,6/40,12.00%,MINK1;MAPK10;MAP3K5;PTGER4;TAB2;ARHGEF6
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.21889545437638325,0.6977860371372118,0.9238095238095239,0.991784314236339,1.0,23/104,18.93%,SRC;PSME3;NRAS;KRAS;PSMB5;TAB2;CREBBP;PRKACB;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;RELB;SYK;PAK3;PSME4;PSMC4;PSMB6;PSMD12;PDPK1;PSMD14;RAF1
prerank,cellular response to lectin (GO:1990858),0.21889545437638325,0.6977860371372118,0.9238095238095239,0.991784314236339,1.0,23/104,18.93%,SRC;PSME3;NRAS;KRAS;PSMB5;TAB2;CREBBP;PRKACB;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;RELB;SYK;PAK3;PSME4;PSMC4;PSMB6;PSMD12;PDPK1;PSMD14;RAF1
prerank,vitamin D metabolic process (GO:0042359),0.3150246952654966,0.6977072577169824,0.8055555555555556,0.9914032320298929,1.0,2/13,10.14%,CUBN;GC
prerank,I-kappaB phosphorylation (GO:0007252),0.3272406746353097,0.6959070037273157,0.8245315161839863,0.9931413365705001,1.0,1/10,5.70%,TLR7
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.2518834341410144,-0.6957337128301041,0.8781725888324873,0.9731232506928031,1.0,4/17,22.82%,WASF3;FCHSD2;PICK1;CORO1B
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.21772906549714566,0.6953164690171137,0.9176610978520287,0.9933878473514695,1.0,10/104,8.83%,TRIB2;CCND3;SRC;SLC27A1;TSG101;CCNG1;CDK7;SYAP1;CCNJ;IRGM
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.30312227888044074,0.694958681386129,0.8166383701188455,0.9933619118872902,1.0,4/13,18.10%,TYK2;IL6ST;JAK1;OAS2
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.2612573228742703,-0.6945384312110171,0.8588807785888077,0.9734639750773648,1.0,6/15,21.79%,ATF2;TIPIN;MUS81;RAD17;RAD9B;FANCD2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.22657078308981077,-0.6944612913963252,0.888283378746594,0.9720053841904267,1.0,9/21,27.84%,RBX1;ERCC2;XPA;GTF2H4;PARP1;ERCC4;ERCC5;GTF2H5;DDB1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.22657078308981077,-0.6944612913963252,0.888283378746594,0.9720053841904267,1.0,9/21,27.84%,RBX1;ERCC2;XPA;GTF2H4;PARP1;ERCC4;ERCC5;GTF2H5;DDB1
prerank,positive regulation of viral life cycle (GO:1903902),0.27593192816538203,0.6944101186940661,0.8298816568047337,0.9935308605637958,1.0,4/22,14.08%,TSG101;KPNA2;AXL;P4HB
prerank,regulation of telomere maintenance (GO:0032204),0.2743092911769137,0.6939185876656797,0.8633540372670807,0.993633816245814,1.0,12/26,28.07%,NBN;ERCC1;TERF2;MRE11;HNRNPD;SMG6;ATRX;PML;YLPM1;RAD50;SMG5;TERF2IP
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.2178074950767252,0.6933159400854737,0.9270334928229665,0.9938714444185591,1.0,23/105,18.93%,SRC;PSME3;NRAS;KRAS;PSMB5;TAB2;CREBBP;PRKACB;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;RELB;SYK;PAK3;PSME4;PSMC4;PSMB6;PSMD12;PDPK1;PSMD14;RAF1
prerank,histone exchange (GO:0043486),-0.20693756166287358,-0.6932764514902622,0.9457627118644067,0.972408479643676,1.0,16/37,31.96%,NPM1;RUVBL1;SMARCA5;ANP32E;CENPT;RNF8;CENPP;CENPC;CENPQ;MIS18BP1;CENPO;CENPX;CENPI;MIS18A;CENPN;CENPA
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.23868303932506868,0.6931817092513071,0.8702185792349727,0.9935523265907125,1.0,17/53,24.49%,PSME3;BCKDK;PSMB5;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;PSME4;PSMC4;PSMB6;PSMD12;PSMD14;PSMB3;OAZ2;AZIN1;PSMD2
prerank,negative regulation of lipid catabolic process (GO:0050995),0.2930586904959306,0.6931263715272892,0.8144654088050315,0.9931365022659455,1.0,2/17,10.36%,GPLD1;ADRA2A
prerank,negative regulation of immune system process (GO:0002683),0.29512239229487935,0.6929233686920838,0.8265139116202946,0.992920452471077,1.0,2/16,6.65%,SOX9;COL3A1
prerank,"transcription, DNA-templated (GO:0006351)",0.2044379172937535,0.6927493439500279,0.9575163398692811,0.992677889886618,1.0,38/207,18.15%,DTX1;BCL3;MLLT3;FOXO3;TAF10;LEO1;GTF3C6;TAF4B;CDK7;PAF1;RREB1;SMN1;POLR3G;ELL;NELFB;SUPT4H1;TFB2M;ERCC6;NAT14;NFKBIB;GTF2F2;TAF15;BRF2;GTF2H1;TRIP11;GTF3C5;MBD1;BAZ2A;CBFB;TEFM;TAF5;CRCP;ELOA;E2F1;RTF1;TCEA1;TSC22D1;GTF2H3
prerank,positive regulation of protein transport (GO:0051222),0.22972836066074706,0.6926010009294257,0.8957528957528957,0.9923780703607602,1.0,12/67,14.27%,RAB29;KIF20B;IL1A;FRMD4A;CEP131;ARHGEF5;RIPOR1;ARF6;TPR;CEP290;PCM1;UNC13B
prerank,translational elongation (GO:0006414),0.21803327978460282,0.6924958999232865,0.9287469287469288,0.9920210766746239,1.0,28/101,22.51%,MRPL37;MRPL43;MRPL33;MRPS28;MRPS35;EEFSEC;PTCD3;MRPL41;MRPS22;MRPS15;MRPS33;MRPL3;CHCHD1;MRPL16;LTN1;MRPL40;MRPL22;GADD45GIP1;MRPL4;GTPBP1;MRPL2;MRPL34;EEF1G;GFM1;TSFM;MRPS7;MRPL11;GTPBP2
prerank,sulfur amino acid metabolic process (GO:0000096),-0.23512068731466407,-0.6923275611557955,0.9011299435028248,0.9726277570009002,1.0,11/24,31.64%,NOX4;MTHFR;MTR;MTRR;CBS;GCLC;ADI1;CTH;MSRA;MPST;CDO1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.30267909919740865,0.6919504298147899,0.8408710217755444,0.9922116466806585,1.0,2/14,12.38%,RAB29;CD81
prerank,regulation of intracellular transport (GO:0032386),0.25705894954973973,0.6912331283556558,0.8743169398907104,0.9925995702920625,1.0,10/38,21.27%,RINT1;INPP5F;ATP9A;LAMP1;WWC1;TTC21B;ATPSCKMT;LCP1;DNAJC30;GRIPAP1
prerank,inositol phosphate catabolic process (GO:0071545),-0.274445075542583,-0.690632973742968,0.8604651162790697,0.9734544458343595,1.0,6/12,29.35%,NUDT3;IMPA1;INPP5A;INPP5B;SYNJ1;INPP5J
prerank,protein targeting to lysosome (GO:0006622),0.2803866499184984,0.6906279726000414,0.8462783171521036,0.9928547394873679,1.0,7/20,19.50%,ZFYVE16;M6PR;GCC2;NEDD4;AP3M1;SCARB2;LAMP2
prerank,axon extension (GO:0048675),0.2808988291123959,0.6906271119329235,0.857566765578635,0.9923776274752586,1.0,7/23,21.71%,NRP2;SEMA3A;SLC9A6;AUTS2;USP9X;SPG11;NLGN3
prerank,cellular response to UV-A (GO:0071492),-0.2821557743930041,-0.6902701003924204,0.8642857142857143,0.9730342015661496,1.0,2/11,11.42%,MMP2;MMP1
prerank,positive regulation of RNA splicing (GO:0033120),0.2677690770302076,0.6899592423699692,0.8413173652694611,0.9927333153205701,1.0,7/29,14.85%,SLC38A2;RBM22;DYRK1A;CELF4;RBMXL1;ERN1;TRA2B
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.2672000083085931,-0.689680776975097,0.8611111111111112,0.9728337410622997,1.0,5/13,22.42%,FLNA;SUFU;DBN1;GOPC;GET4
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.30715852531453663,0.6896455903317292,0.8387096774193549,0.9926532908319966,1.0,2/15,7.89%,FAP;DPP4
prerank,centromere complex assembly (GO:0034508),-0.20793953757378403,-0.6892126374652018,0.95,0.9725263367347576,1.0,16/36,31.96%,NPM1;RUVBL1;SMARCA5;CENPT;CENPP;CENPC;CENPQ;MIS18BP1;CENPO;CENPE;CENPX;CENPI;MIS18A;CENPN;CENPF;CENPA
prerank,positive regulation of TOR signaling (GO:0032008),-0.19554197383834165,-0.6887258611627397,0.9490909090909091,0.972226501301967,1.0,15/40,28.17%,FNIP1;LAMTOR3;SEH1L;RRAGC;GPR137B;RICTOR;RRAGD;LAMTOR2;NCKAP1L;PIP4P1;SLC38A9;FLCN;MLST8;RHEB;LAMTOR4
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.319330245651128,0.6886887354379019,0.7753623188405797,0.9933210090880671,1.0,2/10,9.57%,SEC14L1;NPLOC4
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.2071169790011559,-0.6875100110210208,0.9491525423728814,0.9726387139887767,1.0,11/32,23.84%,MNAT1;TAF1D;ERCC2;CCNH;POLR2F;TAF1C;GTF2H4;POLR2K;POLR1C;POLR1F;RRN3
prerank,cellular response to misfolded protein (GO:0071218),0.2800844273324108,0.6872684387335768,0.8387096774193549,0.9945474396133335,1.0,10/20,30.00%,CUL3;RNF185;KLHL15;UBE2W;DERL1;STUB1;UGGT1;UGGT2;DNAJB12;DNAJC18
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.20872677358840752,-0.6870716330866387,0.9248366013071896,0.9722941587752376,1.0,5/32,12.85%,RPS19;RPL30;PGLYRP1;GAPDH;CCL13
prerank,purine ribonucleotide catabolic process (GO:0009154),0.2837449058683588,0.6869813978927922,0.8407643312101911,0.9944058407471437,1.0,5/21,12.50%,PDE4D;ACAT1;NT5E;NT5C2;NUDT18
prerank,microtubule bundle formation (GO:0001578),0.2454017375004314,0.6869682341167502,0.8680272108843538,0.9939455684271428,1.0,5/42,9.40%,NCKAP5L;SPEF1;CAPN6;SPAST;FOXJ1
prerank,positive regulation of T cell migration (GO:2000406),0.2829648256724543,0.6867135865798888,0.8322784810126582,0.9937809897051008,1.0,5/20,18.89%,WNT5A;ADAM10;TNFRSF14;RHOA;DOCK8
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.22011723960597993,0.6858449182689538,0.9141475211608222,0.994372340337002,1.0,22/88,18.75%,FBXL15;PSME3;FBXO31;PSMB5;FBXL5;FBXL17;FBXO38;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;FBXL12;DMAC2;FBXW7;FBXL3;CUL4B;PSME4;PSMC4;PSMB6;PSMD12;PSMD14
prerank,lipid biosynthetic process (GO:0008610),0.22618289609688202,0.6849947798934608,0.9055415617128464,0.9948785906011213,1.0,15/77,20.41%,HSD17B3;AGPAT4;CLN8;SCD5;ACACA;AGPAT5;PRLR;LSS;SCD;LPL;STAR;AGPS;FADS1;GGPS1;DOLPP1
prerank,positive regulation of chromosome organization (GO:2001252),0.29749581672412123,0.6848770887523554,0.8350340136054422,0.9945484101132388,1.0,7/15,26.70%,NBN;SHCBP1L;MRE11;DDX11;ATRX;PML;RAD50
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.2911785861123978,0.6846222371848881,0.8523274478330658,0.9943618462351737,1.0,3/18,9.58%,EIF2AK3;UTP15;SIRT7
prerank,neutrophil mediated immunity (GO:0002446),0.19561817569945597,0.6838963257927136,0.9848024316109423,0.9947250410819766,1.0,78/432,19.50%,DYNLL1;NAPRT;CEACAM1;ARG1;RAP1A;ARHGAP9;ANO6;CD55;ITGAX;PTPRC;NIT2;CD53;DOCK2;CDK13;NCSTN;ADAM10;PPIE;NRAS;NEU1;ACTR10;RAB3A;DSN1;ILF2;YPEL5;FRMPD3;PGM1;PTPRJ;ATP6V0A1;HMGB1;LAMP1;IST1;CANT1;S100A9;MME;MANBA;PAFAH1B2;PLD1;VAMP8;LAIR1;CEP290;CCT2;PGRMC1;TSPAN14;LTA4H;MVP;DERA;ATG7;MLEC;TMEM30A;GSDMD;HEXB;PSMA2;TMEM63A;PTPN6;PSMD13;TICAM2;ATP8B4;AP2A2;HGSNAT;GLIPR1;CTSB;CREG1;CRACR2A;ASAH1;CYBB;ERP44;PSMD12;ATP6AP2;SNAP23;RHOA;PRDX6;PSMD14;SNAP29;RNASE3;PTGES2;XRCC6;AP1M1;LAMP2
prerank,tRNA 5'-leader removal (GO:0001682),0.30142093692494387,0.6835049044791595,0.8403361344537815,0.9946969936020659,1.0,6/13,24.92%,POP4;POP7;RPP14;RPP21;RPP30;PRORP
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.21488371924587418,-0.683017260058311,0.9105431309904153,0.9752391236149303,1.0,10/28,29.85%,ITPR1;TMEM117;CEBPB;CASP4;ATF4;BBC3;AIFM1;TRIB3;TRAF2;PPP1R15A
prerank,long-term memory (GO:0007616),0.28686105686135593,0.6829863403504738,0.8700475435816165,0.9948286654255704,1.0,4/19,15.60%,RGS14;SGK1;NFATC4;CPEB3
prerank,retrograde axonal transport (GO:0008090),0.29570819298796613,0.6829096341023604,0.8246445497630331,0.9944437005083285,1.0,6/16,22.14%,ACTR10;PAFAH1B1;KIF5A;KIF5B;DLG2;FBXW11
prerank,regulation of immunoglobulin production (GO:0002637),0.2728925218460679,0.6825993782822204,0.853035143769968,0.9943418833585018,1.0,2/23,6.38%,PTPRC;EPHB2
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.2867117361742012,-0.6822740336606795,0.8806682577565632,0.9751456003507151,1.0,6/10,34.14%,COMT;SARDH;CHDH;SLC44A1;DMGDH;HNMT
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.31475738321278157,0.6822587569142562,0.8308550185873605,0.9942728624277013,1.0,3/10,23.11%,CRTAM;SCRIB;PRNP
prerank,membrane repolarization (GO:0086009),-0.26030143314271914,-0.6821117546366905,0.8990147783251231,0.9745413853842223,1.0,7/15,30.78%,KCNJ2;ATP1B1;ATP1B2;KCNE4;KCNH2;ATP1A1;KCNQ1
prerank,lysosome localization (GO:0032418),0.2523326529965538,0.681928166182624,0.8742937853107344,0.9942043550439555,1.0,8/37,14.20%,RAB3A;TFEB;BORCS6;HDAC6;SPAG9;ARL8B;KIF5B;RAB34
prerank,positive regulation of type I interferon production (GO:0032481),-0.17661771061290188,-0.6813238045420476,0.9658536585365853,0.974481172603736,1.0,17/73,21.44%,EP300;POLR3E;POLR3B;IRF1;GAPDH;POLR3A;DHX33;POLR3H;ISG15;DHX36;POLR2F;FLOT1;POLR2K;CGAS;TLR3;POLR1C;RIOK3
prerank,negative regulation by host of viral transcription (GO:0043922),-0.2677055538959313,-0.6808968575214255,0.8833746898263027,0.9741233104199013,1.0,7/12,44.42%,HDAC1;POU2F3;HMGA2;TFAP4;CCL5;CCL4;TARDBP
prerank,DNA-dependent DNA replication (GO:0006261),0.2096926509677487,0.679604883155887,0.9556592765460911,0.9963989477339845,1.0,32/128,18.75%,PSME3;RFC3;ORC5;GINS4;PSMB5;SIRT7;ORC3;SRPK2;CDK2AP1;CDC6;PSMB2;TEFM;POLG2;POLB;PSMA2;PSMA6;REV3L;RECQL5;PSMD13;POLE;PSMA7;GMNN;PSME4;GINS3;NOC3L;ORC1;RFC1;ORC6;PSMC4;PSMB6;PSMD12;PSMD14
prerank,transcription by RNA polymerase III (GO:0006383),-0.21407502684438023,-0.6783862995348581,0.9142011834319527,0.9755994848533155,1.0,8/27,19.33%,BRF1;SNAPC1;ZC3H8;GTF3C4;IVNS1ABP;POLR3H;SNAPC5;POLR2K
prerank,purine-containing compound biosynthetic process (GO:0072522),0.2694561596753402,0.6780347549157912,0.8407738095238095,0.9977075999676145,1.0,8/25,20.45%,MTHFD1;PPAT;PRPSAP2;PRPS1L1;PRPS1;DCK;GART;ADSL
prerank,protein localization to chromosome (GO:0034502),-0.20078864771514343,-0.6776256806940684,0.9580645161290322,0.975512201916831,1.0,13/34,31.96%,SLF2;TPP1;SLF1;ESR1;PINX1;XRCC4;ACD;TNKS2;PARP3;CHMP7;MCM9;TINF2;CENPA
prerank,positive regulation of transporter activity (GO:0032411),0.30087316604130565,0.6771787729082588,0.8333333333333334,0.9982116045501911,1.0,2/13,11.95%,KMT2A;SGK1
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.2819386847772368,0.6759238960719998,0.8527918781725888,0.9991445679698503,1.0,3/17,8.58%,SRC;ATP1A2;ACOD1
prerank,heme catabolic process (GO:0042167),-0.2569188038381595,-0.6758297383559109,0.885286783042394,0.9755751453954025,1.0,1/14,2.64%,ABCG2
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.2569188038381595,-0.6758297383559109,0.885286783042394,0.9755751453954025,1.0,1/14,2.64%,ABCG2
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.22842644706211776,0.6750959775125975,0.9248704663212435,0.9991033138925245,1.0,13/56,18.16%,NDUFA6;NDUFB10;NDUFS3;NDUFS6;NDUFA3;NDUFV2;NDUFV1;NDUFAF5;BCS1L;NDUFA7;DMAC2;NDUFAF6;NDUFS2
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.22842644706211776,0.6750959775125975,0.9248704663212435,0.9991033138925245,1.0,13/56,18.16%,NDUFA6;NDUFB10;NDUFS3;NDUFS6;NDUFA3;NDUFV2;NDUFV1;NDUFAF5;BCS1L;NDUFA7;DMAC2;NDUFAF6;NDUFS2
prerank,chromatin remodeling at centromere (GO:0031055),-0.20986272867090727,-0.6749466695878563,0.9420731707317073,0.9755565278544891,1.0,14/31,31.96%,NPM1;RUVBL1;SMARCA5;CENPT;CENPP;CENPC;CENPQ;MIS18BP1;CENPO;CENPX;CENPI;MIS18A;CENPN;CENPA
prerank,regulation of microtubule nucleation (GO:0010968),0.31748858387921264,0.6747115874772635,0.8197573656845754,0.9990787002019166,1.0,3/10,16.88%,CKAP5;MECP2;ARHGEF7
prerank,cardiac muscle cell contraction (GO:0086003),0.2836010268292708,0.6745340731306423,0.8423493044822257,0.998806124306028,1.0,1/19,1.42%,CAMK2D
prerank,nucleosome assembly (GO:0006334),0.25240042346249963,0.6738712687135164,0.8926380368098159,0.9990897266831268,1.0,3/31,4.44%,SOX9;HAT1;KAT6B
prerank,pinocytosis (GO:0006907),0.32648199251296245,0.6725941269086327,0.8362369337979094,0.9999879794189672,1.0,3/10,15.48%,DOCK2;RAB34;SNX5
prerank,ruffle organization (GO:0031529),-0.24501836618539724,-0.6718191668440509,0.9097744360902256,0.9775124657166342,1.0,5/16,22.82%,TPM1;AIF1L;PIP5K1A;CARMIL1;CORO1B
prerank,negative regulation of leukocyte migration (GO:0002686),0.31431208999756893,0.6714920691646381,0.8454706927175843,1.0,1.0,2/10,9.00%,BMP5;CD200R1
prerank,heterochromatin assembly (GO:0031507),0.2755224789781593,0.6714873907530192,0.8408360128617364,1.0,1.0,7/20,24.46%,BEND3;SUV39H1;BAZ2A;ZNFX1;SIRT2;EZH1;CENPV
prerank,polarized epithelial cell differentiation (GO:0030859),0.2974906123287897,0.6710250040711907,0.8529411764705882,1.0,1.0,5/13,18.51%,OPHN1;ZDHHC7;EZR;SCRIB;RHOA
prerank,positive regulation of defense response to virus by host (GO:0002230),0.26380722303616216,0.6704049140291445,0.8768768768768769,1.0,1.0,2/24,6.12%,PTPN22;ZDHHC1
prerank,telomere organization (GO:0032200),-0.18979434159198527,-0.6697420035566106,0.9713261648745519,0.9784850006749082,1.0,13/43,29.82%,SP100;WRN;BLM;DCLRE1B;PARP1;ERCC4;POLD2;ACD;PARP3;ATM;CTC1;PTGES3;TINF2
prerank,protein catabolic process (GO:0030163),0.22895631808878888,0.6696094024969913,0.9290407358738502,1.0,1.0,5/59,7.41%,CEACAM1;LRSAM1;CLN8;SOCS6;SIAH1
prerank,central nervous system myelination (GO:0022010),0.3062848119268593,0.6695352594942926,0.8534031413612565,1.0,1.0,2/11,12.80%,CNTNAP1;PTEN
prerank,amino sugar biosynthetic process (GO:0046349),0.3072098667664817,0.6693337803483812,0.8537414965986394,1.0,1.0,8/12,31.20%,NAGK;GNPDA2;GFPT1;GFPT2;AMDHD2;RENBP;GNPNAT1;GNPDA1
prerank,NIK/NF-kappaB signaling (GO:0038061),0.22225888408606975,0.6693004101534451,0.9258777633289987,0.9997732109624916,1.0,16/72,18.75%,REL;PSME3;CARD10;PSMB5;PSMB2;PSMA2;PSMA6;DICER1;PSMD13;PSMA7;RELB;PSME4;PSMC4;PSMB6;PSMD12;PSMD14
prerank,tRNA methylation (GO:0030488),0.24322861858705877,0.6692284523449382,0.8977272727272727,0.9993828125961238,1.0,13/34,25.34%,TARBP1;THADA;FTSJ1;TRMT5;THUMPD3;METTL2A;METTL2B;TRMT1L;TRMO;TRMT1;THUMPD2;PRORP;MTO1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.24992792805357275,0.6691550538825651,0.886535552193646,0.998998991898675,1.0,6/33,13.19%,WEE1;DACT1;KANK2;APC;PTEN;FHL1
prerank,regulation of cytoplasmic transport (GO:1903649),0.31316459219627835,0.6690197046172266,0.8422876949740035,0.9986744898324335,1.0,2/11,9.27%,SRC;ATP9A
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.2809974119056676,0.6681014278550572,0.8557536466774717,0.9992337765488015,1.0,5/18,20.40%,MAPK7;NFE2L2;HTRA2;PINK1;PRKN
prerank,phosphate ion transmembrane transport (GO:0035435),-0.26824358527685405,-0.667841721307273,0.8776978417266187,0.9793203343826353,1.0,5/12,29.54%,SLC25A30;SLC25A11;SLC37A1;SLC37A2;SLC37A3
prerank,positive regulation of T cell differentiation (GO:0045582),-0.1964006809364792,-0.6664851089487216,0.9634551495016611,0.9796400205704917,1.0,3/36,5.06%,LEF1;GLI3;DUSP10
prerank,magnesium ion transport (GO:0015693),0.3042903652959926,0.6663596889949865,0.864957264957265,1.0,1.0,3/12,12.89%,NIPA2;MRS2;TUSC3
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.2457352704054757,0.6660161412431651,0.8794642857142857,1.0,1.0,6/34,9.65%,IRAK3;TNFAIP3;ACOD1;SARM1;NLRP2B;TICAM1
prerank,global genome nucleotide-excision repair (GO:0070911),0.2614505969350661,0.6659686509710913,0.8795731707317073,1.0,1.0,8/26,18.15%,ERCC1;CETN2;GTF2H1;DDB2;CHD1L;USP45;CUL4B;GTF2H3
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.19341723636093103,0.6656120931056183,0.99375,0.9999828384031515,1.0,77/314,22.14%,NEDD4L;FBXL15;RNF122;PCBP2;SPSB4;PSME3;TMEM129;SELENOS;SIAH1;FBXO31;FBXO5;CUL3;CDC20;AMFR;PSMB5;ANAPC5;ANAPC7;SIAH3;NPLOC4;UBE3D;SHARPIN;ANAPC11;FBXL19;NEDD4;SPOPL;BUB3;FBXL5;FBXL17;FAF1;NFE2L2;RNF185;FBXO38;ANAPC2;PSMB2;UBE2J2;UBE2D3;UBE2D1;PSMA2;KLHL22;KLHL15;FEM1C;PSMA6;ANAPC4;WWP2;FZR1;PSMD13;PSMA7;PLAA;FBXL12;LTN1;DMAC2;FBXW7;UBQLN1;FBXL3;ITCH;CUL4B;PSME4;ANAPC16;WFS1;PSMC4;CDC23;PSMB6;PSMD12;PSMD14;KBTBD7;GID4;SEL1L;UBE2W;DDIT3;PRKN;PPP2R5C;ZNRF1;PSMB3;DERL1;GID8;CUL5;FBXW11
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.29132973752080005,0.6654828194516635,0.8521008403361344,0.9996468550635896,1.0,8/15,28.93%,RAB3GAP2;SEC61G;RAB3GAP1;SRPRA;SEC61A1;ZFAND2B;SRPRB;SPCS3
prerank,cellular response to virus (GO:0098586),-0.2067990966288798,-0.664617605169043,0.948051948051948,0.9803481719243012,1.0,10/30,32.36%,GSDME;HIF1A;ZC3H12A;LGALS9;RIOK3;CCL19;DDX3X;VWCE;EIF5A;CXCL10
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.25831551167756595,0.6646099875823176,0.8703703703703703,1.0,1.0,7/25,21.37%,ZNF326;ELL;SUPT4H1;ERCC6;THOC5;TSFM;CCAR2
prerank,axonemal dynein complex assembly (GO:0070286),0.2574498832004566,0.6643351339640416,0.886535552193646,0.9999407579949341,1.0,7/28,22.53%,CFAP73;CCDC39;DNAH5;CCDC40;ODAD1;DNAI4;CFAP100
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.3050946559136499,0.6642861123421929,0.8461538461538461,0.9995156633103238,1.0,1/12,2.29%,JAG1
prerank,lipid homeostasis (GO:0055088),0.22268383587856805,0.6640241891265608,0.9287598944591029,0.9993318614808571,1.0,11/57,17.63%,ZBTB20;CLN8;USF2;TLCD3A;ABCA1;THADA;ABCD1;PNPLA8;FBXW7;PPARG;IRS2
prerank,regulation of synapse maturation (GO:0090128),0.3161485700109915,0.6637164451090608,0.8625678119349005,0.9991711637621867,1.0,3/10,13.84%,CDC20;RELN;ANAPC2
prerank,lipoxygenase pathway (GO:0019372),0.2861275137462324,0.6634352365522883,0.8448566610455311,0.9989881370357805,1.0,3/14,21.54%,ALOXE3;HPGD;PON3
prerank,negative regulation of mRNA processing (GO:0050686),0.29414581049106936,0.6625736233587018,0.8612521150592216,0.9994304586670679,1.0,6/15,24.09%,SRSF4;SFSWAP;SAP18;SRSF12;SRSF10;RBMX
prerank,glycerophospholipid metabolic process (GO:0006650),0.21861574095886746,0.6624495673262932,0.9185750636132316,0.9990867473978156,1.0,8/75,9.37%,PLCB3;GPLD1;ACP6;PAFAH1B1;PIGB;ABHD12;PLEK;PIGA
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.22404599227613656,0.6623011721706203,0.9340369393139841,0.9987803320464018,1.0,17/60,21.69%,RUNX2;SOX9;MED7;AGO1;MED13;MECP2;MED23;PTEN;CBFB;MED8;MED12;MED31;BAX;MED15;IL6;MED16;TCF7L2
prerank,N-terminal protein amino acid modification (GO:0031365),0.2981925673918401,0.6620529764771119,0.8518518518518519,0.9985635149574287,1.0,4/14,19.21%,NAA35;NAA10;NAA40;NAA60
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.21097321261042096,0.6612524811987438,0.9407496977025392,0.998947159765467,1.0,24/86,21.94%,PSME3;EGLN3;ANKRD2;MAPK7;BAG3;PSMB5;INO80;NFE2L2;CREBBP;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;PSME4;BACH1;PSMC4;PSMB6;PSMD12;PSMD14;GCN1;DDIT3;PSMB3;IMPACT
prerank,regulation of sensory perception of pain (GO:0051930),-0.2714494719151805,-0.6611439050377631,0.8886255924170616,0.9823469732434058,1.0,4/11,31.41%,CCN3;ACP3;SPX;F2R
prerank,positive regulation of telomere capping (GO:1904355),0.2756149721343257,0.6607609284964938,0.8610223642172524,0.9989862822832678,1.0,4/17,25.69%,NEK7;HNRNPD;MAPK1;TNKS
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.25028135042857935,-0.660510601796548,0.8813953488372093,0.9820710002447264,1.0,5/14,29.82%,TPP1;PINX1;ACD;TNKS2;TINF2
prerank,cellular biogenic amine metabolic process (GO:0006576),0.3045408584480227,0.6602483817381055,0.8551959114139693,0.9990561218795933,1.0,2/12,4.89%,SLC29A4;SLC22A3
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.30317662518061006,0.659779054458832,0.8358974358974359,0.9990582696652326,1.0,2/11,9.88%,SELENOS;AXL
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.19764134766116612,-0.6592033449479759,0.9828767123287672,0.982295133736584,1.0,16/38,29.94%,NPM1;HIRA;RUVBL1;SMARCA5;CENPT;CENPP;UBN1;CENPC;CENPQ;MIS18BP1;CENPO;IPO4;CENPX;CENPI;MIS18A;CENPN
prerank,peptidyl-methionine modification (GO:0018206),-0.2579236813955891,-0.6591594360219971,0.9015544041450777,0.9815612881383073,1.0,1/12,5.92%,NAA15
prerank,defense response to Gram-positive bacterium (GO:0050830),0.23387320227382616,0.658233509617876,0.9033149171270718,1.0,1.0,1/40,0.73%,LBP
prerank,protein-DNA complex assembly (GO:0065004),0.20451321560540722,0.658041258976842,0.9639423076923077,0.999853137296133,1.0,34/116,21.62%,SOX9;KAT6B;PSME3;ORC5;CDK7;PSMB5;ORC3;CETN2;CDC6;GTF2H1;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;DDB2;CHD1L;GMNN;CUL4B;PSME4;ORC1;ORC6;NAP1L1;GTF2H3;PSMC4;PSMB6;PSMD12;PSMD14;SPTY2D1;NAA60;DAXX;RSF1;RPA3;PSMB3
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.21996870563004478,-0.6575888232041203,0.9211267605633803,0.981951771715528,1.0,7/22,20.51%,WDR12;NOP9;RPS21;EXOSC3;NOL9;KRI1;ERI3
prerank,negative regulation of interferon-gamma production (GO:0032689),0.25452965086614826,0.6574793035799337,0.8796875,0.9999443674119373,1.0,3/23,9.88%,RARA;HMGB1;AXL
prerank,organelle fission (GO:0048285),0.2667042726880654,0.6572319750403811,0.8830963665086888,0.9997300082281493,1.0,4/24,10.28%,DNM1;FIS1;MIEF1;ACOT8
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.20575930575063678,-0.6563534127410279,0.9369085173501577,0.9821467676312323,1.0,16/29,37.90%,IKBKB;CASP8;CD40;TLR3;IKBKG;RIPK1;BIRC3;LY96;UBB;TANK;CD300LF;IKBKE;TLR6;RPS27A;UBC;CD14
prerank,carbohydrate transport (GO:0008643),0.3091269808962615,0.6562294721505233,0.8447098976109215,1.0,1.0,2/11,12.99%,SLC2A2;AQP1
prerank,anterograde axonal transport (GO:0008089),0.24355448080666992,0.6562113003313906,0.9093484419263456,0.99979146648929,1.0,12/37,24.60%,SPAST;KIF5A;KIF5B;AP3M1;AP3B1;RAB21;AP3S2;RAB27B;DLG2;BLOC1S2;MAPK8IP3;BLOC1S4
prerank,protein localization to cell junction (GO:1902414),0.2626522463600194,0.6561990459026843,0.8741935483870967,0.9993419958381798,1.0,6/22,22.12%,TJP2;CGNL1;FERMT2;JAK1;ARHGEF18;NLGN2
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.29670336551234155,0.6557730445845765,0.8387096774193549,0.9993203776233092,1.0,1/12,4.05%,SOX9
prerank,regulation of microtubule depolymerization (GO:0031114),0.25069744980626385,0.6551828748603108,0.8736349453978159,0.9994452724270527,1.0,2/25,3.32%,SPEF1;TRPV4
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.26413263219752664,0.6538103412107599,0.8894154818325435,1.0,1.0,9/20,25.77%,AGO1;PUM2;DICER1;SPOUT1;TSNAX;PRKRA;PUM1;ZC3H7B;AGO2
prerank,protein localization to vacuole (GO:0072665),-0.25466709139433436,-0.6535745945145588,0.8954869358669834,0.9834490170631387,1.0,3/13,13.93%,SH3GLB1;GLMP;LMBRD1
prerank,mitochondrial protein processing (GO:0034982),-0.26597410492623874,-0.6532825523140781,0.9048723897911833,0.9828894116873984,1.0,1/11,1.45%,OMA1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.27489232896970006,-0.6531397470126549,0.8834080717488789,0.9822377904811295,1.0,2/10,17.73%,ZC3H12A;RC3H1
prerank,positive regulation of protein sumoylation (GO:0033235),-0.27231350495418827,-0.6530986691829621,0.8989010989010989,0.9815082433183456,1.0,4/10,18.89%,UBA2;PIAS3;RWDD3;GNL3
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.22317623331783987,-0.6529766262761776,0.9206798866855525,0.9808344184460583,1.0,7/22,21.74%,RNF115;VPS4A;MVB12A;VPS37C;UBAP1;VPS28;RNF126
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.27738880420362766,0.6528906809120284,0.8637931034482759,1.0,1.0,2/16,8.76%,KMT5C;WRAP53
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.23367857760808175,0.6528391675847859,0.9135285913528591,1.0,1.0,9/40,15.66%,BOD1L1;DONSON;GEN1;RFWD3;NUCKS1;ETAA1;EME2;FAM111A;POLE
prerank,regulation of protein targeting to membrane (GO:0090313),-0.20545784767779435,-0.6526720192511849,0.9216300940438872,0.9802984587338469,1.0,10/28,26.51%,KCNB1;C2CD5;ANK3;MTCL1;MIEF2;TCAF2;HRAS;ITGB2;CIB1;ITGAM
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.24553821599255657,0.6521034203277561,0.8957703927492447,1.0,1.0,4/28,10.73%,KMT5C;WRAP53;SIRT7;ERCC6
prerank,integrated stress response signaling (GO:0140467),0.288239700539736,0.6513045208661019,0.8679245283018868,1.0,1.0,6/14,24.32%,EIF2AK3;NFE2L2;QRICH1;DDIT3;IMPACT;HSPA5
prerank,B cell proliferation (GO:0042100),-0.2320981962362264,-0.6506766459361722,0.9251336898395722,0.981050095124238,1.0,1/17,1.74%,CTPS1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.27463432093650475,0.6502335827012596,0.8810344827586207,1.0,1.0,2/17,7.80%,EMC9;EMC7
prerank,heart looping (GO:0001947),0.24170486768368007,0.65015973225669,0.9044222539229672,1.0,1.0,4/40,7.30%,FOLR1;STIL;TBX2;CCDC39
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.24385379580806166,-0.6499735363815755,0.9079903147699758,0.9807759269227307,1.0,8/14,32.62%,WDR12;NOL9;RPF2;RPL7;ZNHIT3;RPL7L1;DDX18;FTSJ3
prerank,programmed necrotic cell death (GO:0097300),-0.22994143012262674,-0.6497638153421832,0.9230769230769231,0.9801885387535385,1.0,6/18,25.91%,PGAM5;IPMK;TRPM7;TLR3;RIPK1;LY96
prerank,positive regulation of bone resorption (GO:0045780),0.29949191403867437,0.649510542537594,0.8632326820603907,1.0,1.0,2/11,16.49%,PRKCA;SYK
prerank,positive regulation of chemokine production (GO:0032722),0.22803392498593233,0.6490075478108621,0.920911528150134,1.0,1.0,10/44,21.61%,WNT5A;IL17RA;TLR7;HMGB1;EGR1;IL7;SYK;LPL;IL6;TWIST1
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.2963961239154102,0.6489513978131147,0.8671328671328671,1.0,1.0,4/11,24.21%,ATL2;RTN4;VCPIP1;VAPB
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.25092458751641866,0.6488577233322927,0.8925373134328358,1.0,1.0,7/28,20.40%,AXIN1;DDRGK1;PTEN;FBXW7;BAG2;TMTC3;PRKN
prerank,outer dynein arm assembly (GO:0036158),-0.24148508372571942,-0.6487234496251493,0.9064935064935065,0.9801925889414638,1.0,8/15,40.56%,LRRC49;DNAL1;ODAD2;ODAD3;ODAD4;DNAH17;DNAAF4;CCDC63
prerank,negative regulation of translation (GO:0017148),0.21292566249385037,0.6481264915329558,0.956575682382134,1.0,1.0,11/87,11.00%,FXR2;GIGYF2;EIF2AK3;CNOT10;CELF1;SAMD4B;PUS7;IGF2BP2;CNOT7;TPR;ILF3
prerank,mitotic metaphase plate congression (GO:0007080),0.22853241698265048,0.6477573742781033,0.9155495978552279,1.0,1.0,15/51,22.26%,NUP62;CUL3;CHMP5;PDCD6IP;CHMP4A;CHMP4B;CHMP4C;ZW10;PIBF1;MAD1L1;CDC23;DCTN2;RRS1;CHMP2A;MIS12
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.2739801706511469,-0.6474434430894188,0.9046511627906977,0.9795946560942275,1.0,1/10,4.40%,AP2A1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.2739801706511469,-0.6474434430894188,0.9046511627906977,0.9795946560942275,1.0,1/10,4.40%,AP2A1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.24424930658087898,-0.6455771391065571,0.8936170212765957,0.9801917816429885,1.0,3/15,11.03%,CCT7;RUVBL1;CCT8
prerank,regulation of endocytic recycling (GO:2001135),0.3015539828332795,0.6454350700991751,0.8821490467937608,1.0,1.0,3/11,9.27%,EHD2;INPP5F;ATP9A
prerank,positive regulation of heart contraction (GO:0045823),0.27211337866167623,0.645287719941122,0.8778877887788779,1.0,1.0,2/19,5.61%,ATP1A2;APLN
prerank,aromatic amino acid family metabolic process (GO:0009072),0.302605072612925,0.6448170670410343,0.8697247706422019,1.0,1.0,1/10,3.06%,IL4I1
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.2470916624629436,-0.6443574309216169,0.9036144578313253,0.980256928438801,1.0,3/13,17.04%,RBPJ;GSK3A;SMAD4
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.2211302449312504,0.6434692112622947,0.9231770833333334,1.0,1.0,13/56,18.51%,RACGAP1;SON;USP8;SPAST;PDCD6IP;IST1;CHMP4B;APC;CIT;STAMBP;RTKN;SPTBN1;RHOA
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.26243498793166664,0.6433469953446156,0.8763358778625954,1.0,1.0,2/21,8.37%,KCNA5;NOS1AP
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.29284136909323977,0.6430502806948118,0.8695652173913043,1.0,1.0,1/11,4.96%,WNT5A
prerank,establishment of mitotic spindle localization (GO:0040001),0.24628843303378542,0.6430266551960618,0.8856729377713459,1.0,1.0,8/28,22.14%,SAPCD2;PAFAH1B1;NDE1;HTT;ZW10;ITGB1;GPSM2;FBXW11
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.22375941366197805,0.6420870334426465,0.9308996088657105,1.0,1.0,6/55,8.66%,COQ7;MPV17;RAC2;DHRS4;ACOD1;AATF
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.2004838253393318,-0.6420552880017475,0.9603658536585366,0.981085716333567,1.0,11/29,27.84%,RBX1;MNAT1;ERCC2;XPA;CCNH;GTF2H4;PARP1;ERCC5;UBB;GTF2H5;DDB1
prerank,macrophage activation (GO:0042116),0.24035965004042817,0.6418525078148402,0.9,1.0,1.0,1/34,0.73%,LBP
prerank,regulation of lipid catabolic process (GO:0050994),0.2620277985224542,0.6416843772273588,0.8774193548387097,1.0,1.0,4/19,20.89%,ADRA2A;ABCD1;TYSND1;ALK
prerank,ESCRT III complex disassembly (GO:1904903),0.3038458974866006,0.6412742616121426,0.8648648648648649,1.0,1.0,2/10,9.92%,CHMP5;IST1
prerank,ESCRT complex disassembly (GO:1904896),0.3038458974866006,0.6412742616121426,0.8648648648648649,1.0,1.0,2/10,9.92%,CHMP5;IST1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.2800959739487075,0.6411450469431624,0.8834459459459459,1.0,1.0,2/14,6.59%,CREB3L1;SELENOS
prerank,telomere maintenance (GO:0000723),-0.17561599146744883,-0.6408499341566914,0.985663082437276,0.9811466448172884,1.0,18/50,30.41%,SP100;WRN;BLM;DCLRE1B;SMC6;TPRKB;PARP1;ERCC4;POLD2;ACD;RAD51;PARP3;ATM;CTC1;PTGES3;TINF2;XRCC3;TEN1
prerank,pyroptosis (GO:0070269),-0.24508160231690096,-0.6406551496083938,0.9116883116883117,0.9805221915837968,1.0,6/15,32.87%,GSDME;CASP8;CASP4;ZBP1;CASP1;TREM2
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.2515307922362576,0.640441617335312,0.8987538940809969,1.0,1.0,8/25,22.31%,B3GALT1;B4GAT1;NDST1;EXT1;EXT2;B3GNT8;NDST4;HS2ST1
prerank,regulation of cellular amine metabolic process (GO:0033238),0.2232119012117399,0.6402616404815766,0.9274755927475593,1.0,1.0,16/50,24.49%,PSME3;PSMB5;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;PSME4;PSMC4;PSMB6;PSMD12;PSMD14;PSMB3;OAZ2;AZIN1;PSMD2
prerank,nuclear migration (GO:0007097),0.2910463890835209,0.6402529258918364,0.8624338624338624,1.0,1.0,5/13,14.23%,PAFAH1B1;DOCK7;HOOK3;PCM1;CLMN
prerank,DNA geometric change (GO:0032392),-0.2121949666367228,-0.6400937167932124,0.9235127478753541,0.9801535458443709,1.0,6/24,18.89%,WRN;BLM;ANXA1;ZRANB3;DHX36;DDX1
prerank,pancreas development (GO:0031016),0.2916422016807392,0.6392998840875003,0.8758389261744967,1.0,1.0,4/12,15.14%,CCDC39;ISL1;FOXF1;CCDC40
prerank,mitochondrial membrane organization (GO:0007006),0.23861896600039578,0.6389777136678595,0.9302325581395349,1.0,1.0,15/32,29.89%,MFN2;MICOS10;MTX1;CHCHD6;BAD;BNIP3;CHCHD3;HSPA9;APOOL;BCL2L1;SLC25A5;SPG7;PPIF;BCL2;APOO
prerank,negative regulation of calcium ion transport (GO:0051926),0.2763266687603938,0.6382622972169519,0.8821656050955414,1.0,1.0,4/15,21.04%,ATP1A2;ADRA2A;PACSIN3;CBARP
prerank,DNA methylation (GO:0006306),0.250999896250914,0.6382138643729927,0.8988580750407831,1.0,1.0,4/23,13.94%,BEND3;TEX15;ZFP57;BAZ2A
prerank,regulation of interleukin-1 beta production (GO:0032651),0.2109883066184982,0.6381655332721475,0.9470365699873896,0.9998633500174394,1.0,7/66,11.42%,USP50;WNT5A;TNFAIP3;NLRC4;ISL1;NLRP2B;EGR1
prerank,water transport (GO:0006833),-0.2493830035749044,-0.6378841888449219,0.9209876543209876,0.98089328868376,1.0,3/12,31.14%,AQP11;AQP4;PDPN
prerank,glycosphingolipid metabolic process (GO:0006687),0.2291277993214763,0.6375238216370458,0.9353932584269663,0.9999692117887838,1.0,8/42,14.23%,A4GALT;SUMF1;CERK;NEU1;HEXA;ST8SIA5;ST8SIA3;HEXB
prerank,snRNA metabolic process (GO:0016073),0.27366837344671785,0.637366492216937,0.8876404494382022,0.9996539275028516,1.0,2/17,5.85%,INTS10;TUT1
prerank,cell cycle G1/S phase transition (GO:0044843),0.21582941035048211,0.6371928305165587,0.9509043927648578,0.9993406514741633,1.0,9/61,17.29%,PLK2;CDK7;CUL3;EIF4E;CRLF3;POLE;E2F1;USP37;CUL4B
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.23626590046133472,0.6370053553245029,0.9188034188034188,0.9990431309325644,1.0,9/37,18.15%,NTHL1;RFC3;ERCC1;GTF2H1;DDB2;CHD1L;CUL4B;RFC1;GTF2H3
prerank,autophagy of nucleus (GO:0044804),-0.23282525280462896,-0.6359470627249341,0.9118457300275482,0.9814297024050683,1.0,7/16,24.50%,WIPI1;ULK2;ATG13;WIPI2;ATG12;WDR45B;WDR45
prerank,sphingoid biosynthetic process (GO:0046520),0.29609027987087816,0.6357363856879968,0.8618181818181818,0.9992611306292657,1.0,1/11,2.60%,ACER3
prerank,sphingosine biosynthetic process (GO:0046512),0.29609027987087816,0.6357363856879968,0.8618181818181818,0.9992611306292657,1.0,1/11,2.60%,ACER3
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.23888339875147765,-0.6350597040216146,0.9116945107398569,0.9812666832846965,1.0,3/14,18.15%,SCAP;SEC23A;SEC31A
prerank,regulation of cell cycle (GO:0051726),0.1846792448517617,0.6346074949590351,0.9926778242677824,0.9998042281504885,1.0,50/271,18.31%,FAP;MYBBP1A;PPP1R13B;KIF20B;SOX9;MFN2;PTPRC;SON;RPRD1B;NEK7;NBN;ADAM10;TRIM21;CDK7;LIN54;RARA;FBXO5;BRINP1;E4F1;PES1;NLRP2B;MASTL;POU4F1;TRNP1;SRPK2;APC;ZBTB49;FBXL17;MEN1;NF2;DHCR24;CRLF3;PKD1;ERN1;HTRA2;TTC28;SIPA1;FZD9;GPER1;FBXL12;HPGD;CDC14A;FBXL3;RGCC;GMNN;LIN37;GADD45GIP1;CSNK2A2;FGF10;FOXO4
prerank,negative regulation of ion transport (GO:0043271),-0.203654443810859,-0.6345188291387709,0.9505813953488372,0.9808652269752675,1.0,14/24,43.08%,ACTN2;PXK;NOS1;GPM6B;PLN;WNK1;WNK2;STC1;LILRB1;SNCA;HTR1B;CD33;HRH3;VIP
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.28875894720381395,0.6338377539886585,0.8859060402684564,1.0,1.0,6/11,24.99%,FXR1;PUM2;XPO5;DHX9;PUM1;FMR1
prerank,rRNA catabolic process (GO:0016075),0.26884483554082567,0.6306577784296894,0.8962585034013606,1.0,1.0,2/16,9.56%,EXOSC5;EXOSC10
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.28158648251706936,0.6302096551196097,0.8772893772893773,1.0,1.0,3/12,18.69%,CACNA1H;STARD3;STAR
prerank,regulation of myelination (GO:0031641),0.2487373151479348,0.629616688100236,0.9081163859111792,1.0,1.0,5/25,14.63%,ITGAX;EIF2AK3;NCMAP;NSUN5;DICER1
prerank,regulation of mRNA catabolic process (GO:0061013),0.19558557582298225,0.6293474585696168,0.9811542991755006,1.0,1.0,30/121,22.21%,FXR2;PRKCA;PSME3;SAMD4B;EXOSC5;IGF2BP2;PSMB5;CNOT7;ZFP36L2;PSMB2;FXR1;PSMA2;PUM2;PSMA6;PSMD13;PSMA7;PSME4;CNOT8;GTPBP1;PSMC4;PSMB6;PSMD12;PSMD14;CNOT1;HNRNPD;EXOSC7;PUM1;PSMB3;ELAVL1;YWHAB
prerank,regulation of oxidoreductase activity (GO:0051341),0.27440837805027296,0.6293415878403986,0.8887015177065767,1.0,1.0,2/13,11.27%,ABL2;HDAC6
prerank,negative regulation of translational initiation (GO:0045947),-0.2391010541092382,-0.6284397444749816,0.9194805194805195,0.9838897698616731,1.0,2/13,10.26%,PAIP2;EIF2AK4
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.23439383115079515,-0.6277141911492551,0.9570707070707071,0.9835740634417692,1.0,5/15,29.80%,ARMC10;KDM1A;MIF;TAF9;TRIAP1
prerank,sensory perception (GO:0007600),0.2228501456022948,0.627526694847953,0.9375,1.0,1.0,7/45,13.89%,SCN10A;ALOXE3;GNAL;MME;TMEM150C;TRPV2;KCNK4
prerank,B cell mediated immunity (GO:0019724),0.29686729217927865,0.6270434547374492,0.8933092224231465,1.0,1.0,1/10,7.44%,MSH2
prerank,endoderm formation (GO:0001706),0.23682269675069806,0.6266203232865862,0.9194915254237288,1.0,1.0,3/35,5.16%,MMP15;ITGA7;FN1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.25088870303136784,0.6265400315526115,0.9015625,1.0,1.0,7/24,18.70%,SEMA4B;DSCAM;SEMA3A;SEMA4D;SEMA6C;SEMA4C;SEMA4A
prerank,phagosome maturation (GO:0090382),-0.1836851399124749,-0.6258130769706354,0.9647435897435898,0.9839382666751447,1.0,9/35,24.02%,ATP6V0A4;ATP6V0C;ATP6V1C1;ATP6V1D;RAB32;ATP6V1F;RAB7A;ATP6V1E1;RAB38
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.2853494667905873,0.6256779643124085,0.8873949579831932,1.0,1.0,4/12,20.63%,WRAP53;CCT2;GNL3L;CCT3
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.2962291922515,0.6248726466098375,0.8723404255319149,1.0,1.0,3/10,20.75%,HDAC6;PRKN;ETFBKMT
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.2672360772609653,0.6245364947983171,0.8922829581993569,1.0,1.0,3/16,15.60%,DND1;ZFP36L2;CPEB3
prerank,phosphate ion transport (GO:0006817),-0.22924438091561644,-0.6244163907437389,0.9244791666666666,0.984032398816376,1.0,5/16,29.54%,SLC25A30;SLC25A11;SLC37A1;SLC37A2;SLC37A3
prerank,regulation of neuroblast proliferation (GO:1902692),0.267794919949756,0.6239375422636402,0.8856682769726248,1.0,1.0,4/15,21.67%,NF1;FZD3;CX3CR1;CX3CL1
prerank,regulation of microglial cell activation (GO:1903978),-0.23701729679713918,-0.623912430687811,0.9267015706806283,0.9835894604206553,1.0,3/15,13.41%,LDLR;TTBK1;SPHK1
prerank,B cell activation (GO:0042113),0.20708774439181307,0.6238239800488818,0.95703125,1.0,1.0,7/68,8.21%,TPD52;HDAC4;PTPRC;BANK1;EPHB2;MSH2;PTPRJ
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.28544484631987876,0.6229147613374799,0.8827708703374778,1.0,1.0,2/10,18.26%,HMGB1;PSMC4
prerank,regulation of protein modification process (GO:0031399),0.21632229336765146,0.6220127689578937,0.9455511288180611,1.0,1.0,14/50,21.47%,CDH5;SPRED1;FN1;FER;STAT2;ATG7;SPRED2;SOCS1;WARS1;RABL3;PPP2CA;PIN1;CCAR2;ATG14
prerank,positive regulation of interleukin-8 production (GO:0032757),0.2167249988054945,0.6217006994885769,0.9411764705882353,1.0,1.0,3/49,9.48%,LBP;TLR7;HMGB1
prerank,mRNA destabilization (GO:0061157),0.22920058831406215,0.6215546476371666,0.9338129496402877,1.0,1.0,4/38,7.86%,DND1;GIGYF2;CELF1;DIS3L2
prerank,gene silencing by miRNA (GO:0035195),0.2262349248056312,0.621507054256253,0.9438990182328191,1.0,1.0,10/32,18.94%,AGO1;CNOT7;PUM2;DICER1;RAN;SPOUT1;PRKRA;XPO5;CNOT8;CNOT1
prerank,DNA alkylation (GO:0006305),0.2521521433997926,0.6214235132268512,0.9115191986644408,1.0,1.0,3/19,13.94%,BEND3;TEX15;BAZ2A
prerank,DNA methylation or demethylation (GO:0044728),0.2521521433997926,0.6214235132268512,0.9115191986644408,1.0,1.0,3/19,13.94%,BEND3;TEX15;BAZ2A
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.29054462436366935,0.6211107695200029,0.8759124087591241,1.0,1.0,3/10,18.34%,FN1;LAPTM4B;CDH3
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.2540662277510851,-0.6207755652890303,0.919047619047619,0.9846860744823274,1.0,7/12,28.39%,PARP2;PARP10;PARP1;TNKS2;PARP3;PARP12;PARP16
prerank,protein export from nucleus (GO:0006611),0.23721327617881457,0.6206915498759674,0.9196969696969697,1.0,1.0,9/27,21.76%,STYX;TPR;CSE1L;PKD1;RAN;CHP1;XPO5;STRADB;XPO4
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.2456357054061467,0.6205024931103692,0.9080824088748018,1.0,1.0,3/24,12.76%,SLC27A1;CDS2;PNPLA8
prerank,positive regulation of response to external stimulus (GO:0032103),0.1907855449765408,0.6191998020043877,0.9841628959276018,1.0,1.0,23/128,17.73%,PRKCA;MGST2;LRSAM1;WNT5A;ABCC1;IL17RA;TLR7;TRADD;POLR3G;PTGER4;TNIP1;ACOD1;PLSCR1;S100A9;POLR3D;USP15;PUM2;PLG;IL15;NFKBIZ;MDK;STX4;LPL
prerank,synaptic vesicle localization (GO:0097479),0.27908160283984235,0.6184373179626582,0.9006410256410257,1.0,1.0,4/13,19.70%,KIF5A;KIF5B;TMEM230;SPG11
prerank,cholesterol efflux (GO:0033344),-0.21367559974539235,-0.6183522716412159,0.948509485094851,0.9853351194429311,1.0,8/20,32.70%,APOE;STX12;ABCG1;TSKU;ABCG4;SCARB1;SOAT2;APOC1
prerank,regulation of viral genome replication (GO:0045069),0.21102559259069373,0.6173123401332731,0.9642384105960264,1.0,1.0,8/56,11.00%,PPIE;N4BP1;SRPK1;TNIP1;PLSCR1;CNOT7;SRPK2;ILF3
prerank,regulation of cellular pH (GO:0030641),0.23912786524137436,0.6169262508353369,0.9290030211480362,1.0,1.0,4/29,11.17%,SLC4A3;SLC4A4;SLC9A7;SLC9A6
prerank,regulation of interferon-beta production (GO:0032648),0.2169662434062468,0.6169105911609073,0.9336043360433605,1.0,1.0,14/46,24.66%,REL;TLR7;POLR3G;POLR3D;TBK1;RELB;OAS2;DHX9;TRAF3;IFIH1;DHX58;POLR3C;RIPK2;YY1
prerank,histone ubiquitination (GO:0016574),0.25241010759622673,0.6163252591219718,0.9086614173228347,1.0,1.0,2/21,6.81%,LEO1;PAF1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.22598616071493213,0.6161284481810515,0.9390934844192634,1.0,1.0,9/39,18.15%,NTHL1;RFC3;ERCC1;GTF2H1;DDB2;CHD1L;CUL4B;RFC1;GTF2H3
prerank,nucleoside salvage (GO:0043174),0.2887203977319779,0.6159205661264153,0.8737024221453287,1.0,1.0,1/10,4.03%,UPP2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.2678729708846691,0.6154644127425181,0.893030794165316,1.0,1.0,2/15,10.36%,GPLD1;ADRA2A
prerank,negative regulation of dephosphorylation (GO:0035305),0.26129104045229457,0.6150198742275265,0.9228295819935691,0.9998955787220929,1.0,4/18,17.13%,SH3RF2;ENSA;PTPA;CHP1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.20898044858475415,0.6146430706076033,0.9460526315789474,0.9997300937622386,1.0,14/55,18.75%,PSME3;PSMB5;USP47;FHL1;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;PSME4;PSMC4;PSMB6;PSMD12;PSMD14
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.24440221820112307,-0.6142507488348709,0.9197080291970803,0.986888796311291,1.0,2/12,13.12%,ACSL3;MFSD2A
prerank,positive regulation of TORC1 signaling (GO:1904263),0.26091381409606196,0.614185426038503,0.8990228013029316,0.9996377570459366,1.0,7/16,24.89%,SIK3;RRAGB;KLHL22;GPR137C;LAMTOR5;RRAGA;CLEC16A
prerank,negative regulation of cation channel activity (GO:2001258),0.24199151953984321,0.6140588216012987,0.9221556886227545,0.9992696638630375,1.0,4/26,10.76%,FKBP1B;EPHB2;CASQ2;KCNAB1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.27345485428777594,0.6139444042445306,0.8834459459459459,0.9989094897551195,1.0,4/13,18.76%,GCC2;CD81;TMEM30A;TM9SF4
prerank,male meiosis I (GO:0007141),-0.2285819297692056,-0.6134625810788106,0.9359605911330049,0.9865945874047031,1.0,2/16,8.93%,FOXJ3;MYBL1
prerank,regulation of response to stress (GO:0080134),0.28939735023598245,0.6129165600079903,0.8825622775800712,0.9992167060063499,1.0,1/10,3.16%,SLC38A2
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.25816268124178965,0.6126059903735187,0.897822445561139,0.9989899796600644,1.0,2/16,9.37%,PIGB;PIGA
prerank,protein acetylation (GO:0006473),0.23359788019780175,0.6118655833102788,0.9375886524822695,0.999126793708392,1.0,8/30,19.21%,HAT1;NAA35;CREBBP;NAT9;NAA10;DSCC1;NAA40;NAA60
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.21468399777590802,-0.6117497508950868,0.967391304347826,0.9867728979454482,1.0,3/19,9.06%,NPHP3;RFX3;SPEF2
prerank,exit from mitosis (GO:0010458),0.2772892037611714,0.611585247119133,0.8936535162950258,0.9988868444320324,1.0,3/12,10.70%,SPAST;SIRT7;CHMP4B
prerank,regulation of response to oxidative stress (GO:1902882),0.2848266090093138,0.6115478365550188,0.8940972222222222,0.9984637115474745,1.0,4/11,20.40%,ABCD1;AIFM2;PINK1;PRKN
prerank,AMP metabolic process (GO:0046033),-0.23805678357699245,-0.611399052962295,0.9311224489795918,0.9862246931980458,1.0,3/13,18.92%,XDH;NUDT2;NT5C1A
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.2697449418830385,0.6110057911757154,0.8994800693240901,0.9983958179970567,1.0,5/14,23.43%,USP15;PUM2;PUM1;ZDHHC5;DHX58
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.2733359618253148,0.6108164835153044,0.9,0.9980804506459702,1.0,6/13,27.68%,DYRK1A;YJU2;TWIST1;PTTG1IP;MDM2;SNAI1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.22410001780069497,0.6108121126628687,0.93974175035868,0.9976389231046273,1.0,6/36,15.63%,TXK;WNT5A;IRGM;AXL;IL7;TICAM2
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.21923307467335515,-0.610689062814654,0.9481481481481482,0.9858477168851331,1.0,2/15,7.39%,BCL2L11;ANXA1
prerank,regulation of T cell mediated immunity (GO:0002709),-0.25927762536418314,-0.6099964643731682,0.9354066985645934,0.98549502707327,1.0,4/10,29.78%,TNFRSF1B;ZBTB1;AGER;CCR2
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.2846430035006109,0.6090405749717842,0.8902229845626072,0.9984889416118629,1.0,3/10,14.45%,ST6GAL1;NAGK;GNPDA2
prerank,regulation of hemopoiesis (GO:1903706),0.28464216902047557,0.6087060029409432,0.9057971014492754,0.9982977667241163,1.0,4/10,26.72%,CREBBP;CBFB;RUNX1;MYSM1
prerank,T cell differentiation in thymus (GO:0033077),-0.23087811716347414,-0.6078830987769994,0.9303482587064676,0.9859081104916394,1.0,1/14,1.43%,GLI3
prerank,ribonucleoprotein complex assembly (GO:0022618),0.1858910601766555,0.6069102022135752,0.9942922374429224,0.9991530238882091,1.0,13/132,11.35%,RPSA;SF3B1;CELF1;ZRSR2;SNRPF;SMN1;SRPK1;RBM5;NAF1;CELF2;CELF4;SRPK2;LUC7L2
prerank,regulation of chromatin binding (GO:0035561),-0.2497605942903401,-0.6066042071611523,0.9117647058823529,0.9858062830784688,1.0,3/10,26.40%,MED25;KDM4D;BTAF1
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.19791571050530615,-0.6061289874334148,0.9647058823529412,0.9853267863397962,1.0,3/24,12.16%,RAPGEF2;PDE2A;PRKAR2B
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.1961001551635337,0.6057742287791505,0.972972972972973,0.9995282298200573,1.0,17/84,18.94%,FXR2;GIGYF2;EIF2AK3;CNOT10;SAMD4B;PUS7;IGF2BP2;CNOT7;ILF3;DDX6;FXR1;RTN4;CPEB3;SYNCRIP;CNOT8;CHRNA7;CNOT1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.24789606708307943,0.6053473133026392,0.922514619883041,0.9993837903177591,1.0,4/23,13.61%,HOOK2;HOOK3;KIF5A;KIF5B
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.2228141759178793,-0.6043958830198514,0.9553349875930521,0.9854713273340721,1.0,4/16,16.55%,TRA2A;SNW1;NCL;NCBP1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.2000127456660391,0.6034189634309709,0.9667093469910372,1.0,1.0,17/70,18.75%,PSME3;TAPBP;PSMB5;LNPEP;VAMP8;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;PSME4;CYBB;PSMC4;PSMB6;PSMD12;SNAP23;PSMD14
prerank,double-strand break repair via homologous recombination (GO:0000724),0.19082787410748192,0.60269150217954,0.9889434889434889,1.0,1.0,19/95,19.01%,SMC5;NBN;PALB2;SWI5;GINS4;ZSWIM7;ZFYVE26;INO80;GEN1;RFWD3;NUCKS1;SFPQ;RAD51AP2;REV3L;RECQL5;REC8;SFR1;PSMD14;MRE11
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.24472307828224243,0.6023061766289425,0.9354304635761589,1.0,1.0,5/20,18.94%,CELF1;AGO1;CNOT7;CNOT8;CNOT1
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.28148451327282903,0.6005442317856595,0.9175627240143369,1.0,1.0,1/11,4.21%,HAT1
prerank,rRNA 3'-end processing (GO:0031125),-0.25488213690977557,-0.6001250763796158,0.9480812641083521,0.986787087894241,1.0,3/10,20.51%,RPS21;EXOSC3;ERI3
prerank,establishment of vesicle localization (GO:0051650),0.25196476780387167,0.5988973481077816,0.9070121951219512,1.0,1.0,5/18,19.70%,LIMK2;KIF5A;KIF5B;TMEM230;SPG11
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.2528950725631838,-0.5983480152090296,0.9263392857142857,0.9868873099673435,1.0,5/10,35.92%,SMYD2;SETD6;EHMT1;SETD7;METTL18
prerank,error-free translesion synthesis (GO:0070987),0.238527376094621,0.5972491083984202,0.9289099526066351,1.0,1.0,8/22,27.69%,RFC3;NPLOC4;RCHY1;RFC1;RPA3;REV1;RPA2;RPA1
prerank,P-body assembly (GO:0033962),-0.2357824356232231,-0.5968045543978279,0.9528301886792453,0.986882043171932,1.0,7/12,36.14%,EDC3;RC3H1;LIMD1;LSM4;DYNC1H1;EIF4ENIF1;PATL2
prerank,protein methylation (GO:0006479),0.21525026088062785,0.596317403607039,0.9465317919075145,1.0,1.0,12/40,25.76%,ETF1;ATPSCKMT;LCMT1;METTL22;PRMT6;CAMKMT;ICMT;ETFBKMT;VCPKMT;EEF2KMT;PRMT8;PRMT3
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.2795365444793111,0.5960878172380445,0.921875,1.0,1.0,3/10,20.63%,WRAP53;CCT2;CCT3
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.2650642987134705,0.5954056610442772,0.9229480737018425,1.0,1.0,5/15,24.60%,AP3M1;AP3B1;AP3S2;BLOC1S2;BLOC1S4
prerank,anterograde synaptic vesicle transport (GO:0048490),0.2650642987134705,0.5954056610442772,0.9229480737018425,1.0,1.0,5/15,24.60%,AP3M1;AP3B1;AP3S2;BLOC1S2;BLOC1S4
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.24740341366675175,0.5948842474625796,0.9332220367278798,1.0,1.0,1/18,2.89%,GPLD1
prerank,stress granule assembly (GO:0034063),0.24303063937507915,0.5942223496587471,0.9356357927786499,1.0,1.0,5/20,19.08%,ATXN2;CSDE1;UBAP2L;DDX6;G3BP1
prerank,regulation of interferon-alpha production (GO:0032647),0.2363214934536941,0.5935528657005077,0.9129082426127527,1.0,1.0,8/23,28.83%,TLR7;TBK1;SETD2;DHX9;IFIH1;RIPK2;HAVCR2;MAVS
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.24598455243698975,-0.5927473998369962,0.9230769230769231,0.9880523322764279,1.0,4/10,29.08%,SSBP1;CDC7;WIZ;E2F7
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.2713248307495211,0.5919296010115987,0.935042735042735,1.0,1.0,3/11,20.63%,WRAP53;CCT2;CCT3
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.2232503760101383,-0.5916788865317206,0.9603960396039604,0.9877861944205699,1.0,2/14,15.72%,TRAF6;CSF1
prerank,microtubule anchoring at centrosome (GO:0034454),0.27953467638053486,0.5900861591410705,0.9015817223198594,1.0,1.0,3/10,15.04%,HOOK3;PCM1;CCDC120
prerank,cellular response to nutrient levels (GO:0031669),0.20047291096203837,0.5895009487264619,0.9872773536895675,1.0,1.0,8/62,13.75%,INHBB;KLF10;PDK4;RIPOR1;STK24;TFEB;ATG7;RRAGB
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.2576984326384423,0.589149878987138,0.9131147540983606,1.0,1.0,2/15,9.65%,IL17RA;TICAM1
prerank,renal absorption (GO:0070293),0.2718831939306459,0.588433615482989,0.9193548387096774,1.0,1.0,2/10,11.95%,MAGED2;SGK1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.26771781266905614,0.5872766161261628,0.9343185550082101,1.0,1.0,4/14,22.72%,TUT1;ERN1;NUDT21;CPSF2
prerank,protein ADP-ribosylation (GO:0006471),-0.1856371819732896,-0.5856072078959054,0.9709302325581395,0.9897545313996129,1.0,10/28,29.26%,ART3;ZC3HAV1;PARP2;PARP10;PARP1;TNKS2;PARP3;PARP12;PARP16;SIRT6
prerank,positive regulation of interferon-beta production (GO:0032728),0.22086230687517625,0.5841866537571117,0.9453471196454948,1.0,1.0,10/33,24.18%,TLR7;POLR3G;POLR3D;TBK1;OAS2;DHX9;IFIH1;DHX58;POLR3C;RIPK2
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.21532045250536913,-0.5841136289447518,0.9631449631449631,0.989699252335879,1.0,5/15,24.84%,HECW2;ANAPC1;PTTG1;CENPE;TACC3
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.24279365966517263,0.5834866455714012,0.9548387096774194,1.0,1.0,4/18,17.64%,RFC3;GINS4;POLE;GINS3
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.19561033736558964,-0.5822755804149873,0.9666666666666667,0.9897338901245172,1.0,11/25,32.45%,HSPA8;DNAJB5;SDF2;BAG1;HSPA1A;HSPA14;DNAJB1;PTGES3;HSPA1B;HSPA2;SDF2L1
prerank,intracellular sterol transport (GO:0032366),0.2599032884463052,0.5821132133500836,0.9052453468697124,1.0,1.0,7/13,26.12%,ABCA1;OSBPL2;STAR;NPC1;RELCH;STARD4;NPC2
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.2270168992056108,-0.5820091063581603,0.9439024390243902,0.9890947992228375,1.0,3/13,12.41%,SEC16A;SEC16B;SAR1B
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.26636646704513023,0.5807212224967768,0.9220338983050848,1.0,1.0,8/13,31.20%,NAGK;GNPDA2;GFPT1;GFPT2;AMDHD2;RENBP;GNPNAT1;GNPDA1
prerank,cellular response to topologically incorrect protein (GO:0035967),0.21784484264579043,0.5801308778321957,0.9689807976366323,1.0,1.0,13/31,30.00%,BAG3;HDAC6;ERN1;BAX;UBE2W;PRKN;DAXX;HSPA9;HSPA5;STUB1;RHBDD1;DNAJB12;DNAJC18
prerank,positive regulation of chromatin organization (GO:1905269),-0.2316127266719164,-0.579353282561757,0.9610983981693364,0.9894676805383038,1.0,4/12,29.82%,UBE2N;TAL1;ACD;TINF2
prerank,regulation of response to cytokine stimulus (GO:0060759),0.23591270186536928,0.5786105590177121,0.9290322580645162,1.0,1.0,6/19,22.88%,WNT5A;MAPK7;CBFB;DHX9;RUNX1;IFIH1
prerank,tRNA 5'-end processing (GO:0099116),0.25114287450797657,0.5785841455904137,0.9320066334991708,1.0,1.0,6/15,24.92%,POP4;POP7;RPP14;RPP21;RPP30;PRORP
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.2642106479266745,0.5785189005025411,0.9385665529010239,1.0,1.0,4/13,21.52%,SPI1;ARID1B;SERTAD2;ARID1A
prerank,protein targeting to mitochondrion (GO:0006626),0.19945256910813314,0.5779026671105995,0.978319783197832,1.0,1.0,9/52,19.35%,TOMM34;MFN2;FIS1;IMMP2L;TOMM40;MIPEP;HSPA4;DNAJC19;GRPEL2
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.27247752439695494,0.5772676733357798,0.9428571428571428,1.0,1.0,3/11,15.33%,COASY;ACAT1;PANK2
prerank,coenzyme A biosynthetic process (GO:0015937),0.27247752439695494,0.5772676733357798,0.9428571428571428,1.0,1.0,3/11,15.33%,COASY;ACAT1;PANK2
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.27247752439695494,0.5772676733357798,0.9428571428571428,1.0,1.0,3/11,15.33%,COASY;ACAT1;PANK2
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.2708624605827081,0.5765051138718484,0.9178321678321678,1.0,1.0,1/10,4.33%,DIP2A
prerank,cellular response to unfolded protein (GO:0034620),-0.18176696275686663,-0.5750713343735147,0.984472049689441,0.9904548823739753,1.0,12/26,36.75%,HSPA8;HSF1;OPTN;ABCB10;TMBIM6;HSPA1A;HSPA14;HSPA1B;HSPD1;HSPA2;PACRG;DAB2IP
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.19371265571761975,-0.5747364611370609,0.9663865546218487,0.989848488691064,1.0,10/23,36.82%,RBX1;XPA;COPS6;PARP1;GPS1;UBB;DDB1;COPS8;RPS27A;UBC
prerank,replication fork processing (GO:0031297),0.2094681759248595,0.5736897490746191,0.972463768115942,1.0,1.0,15/38,27.58%,BOD1L1;GEN1;RFWD3;NUCKS1;ETAA1;EME2;FAM111A;MRE11;ATR;DDX11;PRIMPOL;ATRX;FBH1;FANCM;BRCA2
prerank,homologous chromosome segregation (GO:0045143),-0.19895335620845173,-0.5729035540067311,0.9722991689750693,0.9898368819422054,1.0,15/20,50.59%,TERB1;PTTG1;CENPC;FANCD2;ZCWPW1;SGO1;MAJIN;MEIOB;IHO1;PRDM9;FMN2;RNF212B;MEIKIN;ANKRD31;TERB2
prerank,cranial nerve development (GO:0021545),-0.23890875839417633,-0.5728928494675719,0.9382422802850356,0.9891064692774459,1.0,3/11,16.64%,CHD7;SALL1;TMEM126A
prerank,nucleotide-excision repair (GO:0006289),0.18229093888633088,0.5723282266584084,0.986857825567503,1.0,1.0,20/101,18.15%,SLC30A9;FANCC;RFC3;PPIE;CDK7;ERCC6;ERCC1;CETN2;GTF2H1;POLB;COPS5;POLE;DDB2;CHD1L;USP45;TCEA1;CUL4B;BRIP1;RFC1;GTF2H3
prerank,modulation by symbiont of host process (GO:0044003),-0.2422305089678561,-0.5720973139255225,0.965034965034965,0.9886577731968239,1.0,1/10,4.54%,B2M
prerank,peptidyl-lysine methylation (GO:0018022),0.2227608272919983,0.5719038119051164,0.9484848484848485,1.0,1.0,8/26,22.64%,SUV39H1;ATPSCKMT;SETD2;SUV39H2;ETFBKMT;KMT5A;VCPKMT;EEF2KMT
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.25907046691917224,0.5699711763976848,0.9162210338680927,1.0,1.0,1/12,4.28%,PRKCA
prerank,positive regulation of lipid catabolic process (GO:0050996),0.2315607230896109,0.5688519435966348,0.9431438127090301,1.0,1.0,6/19,24.58%,ABCD1;IRS2;AKT2;TWIST1;PRKCD;DAGLB
prerank,DNA replication (GO:0006260),0.1792475864865941,0.5686877634495332,0.9929660023446659,1.0,1.0,29/105,22.78%,RFC3;ORC5;NBN;PTMS;ORC3;TOP1;CDK2AP1;DONSON;CDC6;POLG2;POLB;REV3L;RECQL5;FAM111A;POLE;RHNO1;BRIP1;ORC1;RFC1;ORC6;NAP1L1;MRE11;RPAIN;ATR;RAD9A;RPA3;HELB;POLE2;MCM4
prerank,hyaluronan metabolic process (GO:0030212),0.23073576985532276,0.5683151400703951,0.9521604938271605,1.0,1.0,7/23,24.70%,HEXA;CEMIP2;HEXB;CHP1;CEMIP;GUSB;FGF2
prerank,histone monoubiquitination (GO:0010390),0.22219813743360983,0.5679794367486752,0.9606656580937972,1.0,1.0,8/24,23.22%,LEO1;PAF1;DDB2;CUL4B;CDC73;PCGF1;RNF20;DTX3L
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.18874212958899003,0.5664632685895377,0.9833119383825417,1.0,1.0,16/67,18.75%,PSME3;TAPBP;PSMB5;VAMP8;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;PSME4;CYBB;PSMC4;PSMB6;PSMD12;SNAP23;PSMD14
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.22085567873575823,0.5664181716075102,0.9554531490015361,1.0,1.0,1/27,1.39%,AK5
prerank,histone lysine methylation (GO:0034968),0.2130921790745398,0.5659455049653069,0.9553695955369595,1.0,1.0,8/33,21.35%,KMT2A;SUV39H1;MEN1;DYDC2;KMT2D;SUV39H2;ASH2L;SETDB1
prerank,production of siRNA involved in RNA interference (GO:0030422),0.2639236532435706,0.5651107631185576,0.9562043795620438,1.0,1.0,3/10,16.65%,DICER1;TSNAX;PRKRA
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.22058942133177786,0.5650247965717382,0.9548872180451128,1.0,1.0,7/27,21.51%,EGFR;DDX6;FXR1;PUM2;DHX9;IL6;PUM1
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.26031288442794076,0.56410396505808,0.9204152249134948,1.0,1.0,4/10,27.78%,FZD3;CX3CR1;CX3CL1;SMARCD3
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.2524328461170595,0.5639044583110574,0.9234608985024958,1.0,1.0,3/13,13.63%,TPR;GEN1;LCMT1
prerank,regulation of leukocyte migration (GO:0002685),0.24176303222356627,0.5633929895684875,0.9444444444444444,1.0,1.0,2/16,12.38%,RAC2;CD81
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.2194860695101023,0.563385378002953,0.9638364779874213,1.0,1.0,5/22,21.08%,PPM1A;DUSP8;PPP1CA;PPP2CA;PPM1E
prerank,insulin secretion (GO:0030073),0.2379159990686771,0.5631562956018549,0.9396411092985318,1.0,1.0,4/19,18.74%,RIMS2;RAB11FIP5;CAMK2G;RAB11FIP2
prerank,ATP transport (GO:0015867),-0.23830665763874403,-0.561867373513214,0.9478260869565217,0.9915948930557451,1.0,3/10,27.26%,ABCC6;SLC25A24;SLC25A42
prerank,central nervous system neuron axonogenesis (GO:0021955),0.25137190669112197,0.5604345680689675,0.9309734513274336,1.0,1.0,2/12,12.80%,EPHB2;PTEN
prerank,DNA biosynthetic process (GO:0071897),-0.2026024372307548,-0.5589909589907779,0.9716981132075472,0.9918147110672776,1.0,6/16,35.08%,WRN;POLA1;POLD2;CDKN2D;POLL;TYMS
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.20760184622622738,0.5589539255713777,0.967551622418879,1.0,1.0,7/33,19.01%,STN1;WRAP53;TNKS1BP1;PPP6R3;TERF2;RFC1;MRE11
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.203966005306923,-0.5588633816514975,0.9651741293532339,0.9911224976189461,1.0,6/16,26.75%,MUS81;ERCC4;TOP2B;TOP2A;CENPX;RMI1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.24328423306980265,0.5581217574758278,0.9465408805031447,1.0,1.0,5/16,19.21%,NAA35;CREBBP;NAA10;NAA40;NAA60
prerank,skeletal muscle contraction (GO:0003009),0.22701420671495776,0.5576312081020526,0.9536321483771252,1.0,1.0,3/19,16.68%,TNNI1;TNNI3;RCSD1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.2128864725801465,0.5565412183494205,0.9732142857142857,1.0,1.0,7/31,19.94%,AXIN1;CDC20;PTEN;FZR1;FBXW7;PINK1;PIN1
prerank,sulfur amino acid catabolic process (GO:0000098),0.2619827208791866,0.5562540234727176,0.9253187613843351,1.0,1.0,2/10,15.15%,BLMH;TXN2
prerank,regulation of protein sumoylation (GO:0033233),0.23772899312131035,0.5549368282849343,0.9329896907216495,1.0,1.0,6/17,25.05%,HDAC4;EGR1;GNL3L;MUL1;SAE1;PIAS1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.21434105236297596,0.5541731928276076,0.966275659824047,1.0,1.0,3/30,6.71%,CAVIN1;CDK7;POLR1E
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.2491759642283074,0.5534572859019375,0.9524617996604414,1.0,1.0,4/13,24.32%,DDRGK1;WFS1;NCK1;HSPA5
prerank,detection of calcium ion (GO:0005513),-0.21285785960354098,-0.5524194492526621,0.9696969696969697,0.9925090285715981,1.0,8/13,46.95%,CALM1;CALM3;SYT1;RYR2;KCNMB2;KCNMB1;CASR;KCNIP2
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.26054753945213477,0.549425716168726,0.9358108108108109,1.0,1.0,2/10,11.18%,GABRG2;GABRG1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.23310901412665147,0.5490479585803357,0.953125,1.0,1.0,5/18,20.63%,NAF1;EXOSC10;CCT2;RUVBL2;CCT3
prerank,lipid droplet formation (GO:0140042),-0.23006942737508063,-0.5472008122917764,0.9749430523917996,0.9932585903919261,1.0,5/10,35.91%,FITM2;AUP1;BSCL2;SQLE;CDS1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.18008175712287552,-0.5447337047184254,0.9911242603550295,0.9932420427171117,1.0,7/24,21.22%,JARID2;BMI1;SUZ12;DNMT3B;EED;TASOR;DNMT3A
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.23452177347889805,0.5446552883806353,0.9448946515397083,1.0,1.0,8/15,30.78%,CNOT7;CPEB3;CNOT1;TENT4B;AGO2;TENT4A;POLR2G;TOB1
prerank,organelle transport along microtubule (GO:0072384),0.2068154014520211,0.5441548087633253,0.9710144927536232,1.0,1.0,8/31,22.77%,PAFAH1B1;NDE1;COPG1;KIF5B;HTT;DYNC1I1;FBXW11;RHOT2
prerank,protein localization to chromatin (GO:0071168),0.22897693758607474,0.5440253690644875,0.9589257503949447,1.0,1.0,4/18,18.67%,MSH2;PPHLN1;LEMD2;RUVBL2
prerank,regulation of intracellular pH (GO:0051453),0.20622536779831235,0.5436929584714605,0.9731258840169731,1.0,1.0,4/34,11.17%,SLC4A3;SLC4A4;SLC9A7;SLC9A6
prerank,cytoplasmic translational initiation (GO:0002183),0.2280156578225924,0.5427458483056307,0.9682804674457429,1.0,1.0,1/17,3.60%,EIF2B3
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.2477567171831404,0.5423628231656265,0.9576988155668359,1.0,1.0,3/12,15.38%,CDC20;PTEN;FZR1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.1976601562723894,-0.5419423979138582,0.9782608695652174,0.9932969779713718,1.0,9/16,34.30%,CACTIN;SRSF1;WBP4;WBP11;DDX23;SNRPC;SART1;NCBP2;CWC15
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.20576389802554013,0.5407235055514847,0.9775112443778111,1.0,1.0,2/29,7.62%,AXIN1;FBXO5
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.25102257624941887,0.5403045962542812,0.9449378330373002,1.0,1.0,4/11,24.32%,CREB3L1;DDIT3;MBTPS2;HSPA5
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.2441536989720779,0.5400835687894098,0.9501718213058419,1.0,1.0,4/13,25.21%,ALG9;DPAGT1;ALG12;ALG14
prerank,RNA biosynthetic process (GO:0032774),0.20498571283661748,0.5397964808762652,0.9711399711399712,1.0,1.0,5/31,15.64%,TAF10;SMN1;NAT14;BRF2;TAF5
prerank,protein localization to kinetochore (GO:0034501),0.249491137609925,0.5393724876912249,0.9486301369863014,1.0,1.0,3/14,14.74%,BUB3;ZWILCH;ZW10
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.2346193631621185,0.5386817181474072,0.9632224168126094,1.0,1.0,5/14,21.61%,ABCD1;TYSND1;IRS2;AKT2;TWIST1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.20482767625920462,0.5365641184838402,0.9747774480712166,1.0,1.0,11/29,28.07%,WRAP53;TNKS1BP1;PPP6R3;TERF2;RFC1;MRE11;PPP6C;RAD50;RPA1;SHQ1;TERF2IP
prerank,positive regulation of viral genome replication (GO:0045070),0.20281472365974004,0.5364829019322113,0.9834834834834835,1.0,1.0,4/29,10.89%,PPIE;SRPK1;CNOT7;SRPK2
prerank,regulation of RNA export from nucleus (GO:0046831),0.25028636446770786,0.536363874784013,0.9576719576719577,1.0,1.0,5/11,24.03%,TPR;NUP153;SETD2;DHX9;IWS1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.24451577357572776,0.5355756298279962,0.9522184300341296,1.0,1.0,3/12,15.04%,HOOK3;PCM1;CCDC120
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.2253455618231928,0.5346372946971832,0.9630818619582665,1.0,1.0,6/18,24.53%,ITGB7;PODXL2;ITGB1;CX3CR1;GOLPH3;ROCK1
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.2480225988700564,0.5344520062137091,0.9512195121951219,1.0,1.0,11/11,75.21%,RTP3;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;LPO;RTP4;PKD1L3;PKD2L1
prerank,protein deneddylation (GO:0000338),-0.22407268343896644,-0.5343003992311102,0.9699074074074074,0.9947268114308471,1.0,4/10,32.49%,COPS6;GPS1;COPS8;TOR1A
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.2085581349460222,-0.5342270924615536,0.9774436090225563,0.9940089611928713,1.0,4/13,22.43%,NCBP1;CPSF1;CPSF7;CPSF6
prerank,telomere maintenance via telomerase (GO:0007004),0.20558207979344606,0.5336601058200694,0.9819819819819819,1.0,1.0,11/28,28.07%,WRAP53;TNKS1BP1;PPP6R3;TERF2;RFC1;MRE11;PPP6C;RAD50;RPA1;SHQ1;TERF2IP
prerank,regulation of nervous system development (GO:0051960),0.19455443254855165,0.5336516977786908,0.9766483516483516,1.0,1.0,9/37,22.92%,HEYL;BHLHE40;DOCK7;NSUN5;YAP1;GBX1;CX3CR1;CX3CL1;SIRT2
prerank,antibacterial humoral response (GO:0019731),0.22712076145905039,0.5334278010878041,0.9599358974358975,1.0,1.0,15/16,65.36%,DEFA6;RNASE3;ANG;DMBT1;PLA2G1B;WFDC2;LTF;DEFB1;RNASE7;WFDC3;RNASE6;CAMP;JCHAIN;SLPI;PLA2G6
prerank,sensory perception of pain (GO:0019233),0.2184098881299374,0.5324574992510261,0.9472868217054263,1.0,1.0,3/21,13.89%,ALOXE3;MME;KCNK4
prerank,acylglycerol catabolic process (GO:0046464),0.1977541821658061,0.5321680948320878,0.9823008849557522,1.0,1.0,5/30,20.01%,ABHD12;LIPE;LPL;FAAH;LYPLA2
prerank,regulation of macrophage migration (GO:1905521),0.2545049985494333,0.5312485608182101,0.9476439790575916,1.0,1.0,2/10,12.38%,CD200R1;CD81
prerank,positive regulation of type 2 immune response (GO:0002830),-0.20533085269384999,-0.530639715215914,0.980246913580247,0.9941958642140626,1.0,4/14,23.42%,IL18;PRKCZ;RSAD2;NOD2
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.22937222663529616,0.5300607435813434,0.9710884353741497,1.0,1.0,4/15,18.94%,CNOT7;ZFP36L2;CPEB3;CNOT1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.22937222663529616,0.5300607435813434,0.9710884353741497,1.0,1.0,4/15,18.94%,CNOT7;ZFP36L2;CPEB3;CNOT1
prerank,intracellular pH reduction (GO:0051452),0.19661473163949256,0.5295168765321558,0.9784791965566715,1.0,1.0,4/33,11.50%,ATP6V0D2;DMXL1;ATP6V0A1;DMXL2
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.1665003161753898,-0.5286566160059961,0.9837662337662337,0.9939740562810462,1.0,12/30,32.45%,HSPA8;ENTPD5;DNAJB5;SDF2;BAG1;HSPA1A;HSPA14;DNAJB1;PTGES3;HSPA1B;HSPA2;SDF2L1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.20253296293283296,-0.5248965226408926,0.9735576923076923,0.9941441532177745,1.0,2/13,15.53%,LRRK2;OPA1
prerank,peptide hormone secretion (GO:0030072),0.20229953407118484,0.5238155212106232,0.9878234398782344,1.0,1.0,2/26,6.96%,RIMS2;LTBP4
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.21344269106878788,0.5237799055731399,0.9891472868217054,1.0,1.0,6/22,18.15%,CETN2;GTF2H1;DDB2;CHD1L;CUL4B;GTF2H3
prerank,inorganic ion transmembrane transport (GO:0098660),0.24055024833618668,0.5229547070957036,0.9581881533101045,1.0,1.0,1/12,4.79%,CACNA1H
prerank,regulation of tau-protein kinase activity (GO:1902947),0.24527304719502335,0.5209357901960067,0.9649737302977233,1.0,1.0,1/10,11.42%,EGR1
prerank,histone methylation (GO:0016571),0.20125704030897104,0.519136861807729,0.9788838612368024,1.0,1.0,5/26,17.48%,SUV39H1;SIRT7;CREBBP;PRMT6;SUV39H2
prerank,inositol phosphate dephosphorylation (GO:0046855),0.2360037160745078,0.5159975080634158,0.967409948542024,1.0,1.0,2/11,12.80%,OCRL;PTEN
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.2360037160745078,0.5159975080634158,0.967409948542024,1.0,1.0,2/11,12.80%,OCRL;PTEN
prerank,immunoglobulin mediated immune response (GO:0016064),0.23871696691984187,0.5149393375045815,0.9715808170515098,1.0,1.0,10/10,76.14%,CD81;ZP3;GAPT;CD19;CARD9;CD74;TLR8;FCER1G;FCGR2B;CD27
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.19451508904316156,-0.5130083429303707,0.9848101265822785,0.9960016018557151,1.0,7/16,29.82%,PINX1;DHX36;PARP1;ERCC4;TNKS2;ATM;TINF2
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.24726457369634217,0.5127142053672238,0.9646643109540636,1.0,1.0,1/10,6.35%,SIRT3
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.24726457369634217,0.5127142053672238,0.9646643109540636,1.0,1.0,1/10,6.35%,SIRT3
prerank,steroid catabolic process (GO:0006706),0.24486849538635372,0.5127017869636505,0.9632352941176471,1.0,1.0,10/10,75.53%,HSD17B11;HSD11B1;SPP1;HSD17B6;CYP19A1;FGF23;CYP24A1;CYP27B1;HSD17B14;YWHAH
prerank,negative regulation of interleukin-12 production (GO:0032695),0.22185731287264793,0.5116496487563685,0.9710884353741497,1.0,1.0,2/14,15.86%,IRAK3;PIBF1
prerank,phagosome-lysosome fusion (GO:0090385),0.24061688664078218,0.5114740972459954,0.9698581560283688,1.0,1.0,3/10,18.86%,ARL8B;RAB34;RAB39A
prerank,response to peptide (GO:1901652),0.1917345168813682,0.5114393405593719,0.9844413012729845,0.9997819788172201,1.0,4/33,12.28%,EIF2B3;MMP12;EIF2B4;STAT2
prerank,negative regulation of interferon-beta production (GO:0032688),0.23909261146082195,0.5101079520371788,0.9490909090909091,0.9997239229180586,1.0,1/10,4.50%,REL
prerank,regulation of double-strand break repair (GO:2000779),0.18291137359215917,0.5100672007995091,0.9929178470254958,0.999311438446217,1.0,10/39,22.69%,OTUB2;UBR5;WRAP53;SIRT7;MGMT;PPP4C;SETD2;DDX11;TWIST1;SPIDR
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.23235989181365974,0.5093249032512897,0.9612676056338029,0.9990950864244964,1.0,2/11,15.10%,EFNB2;GPER1
prerank,cell differentiation in hindbrain (GO:0021533),0.2407830308720879,0.5087409630569293,0.9719298245614035,0.99882449181352,1.0,1/11,3.66%,OPHN1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.1909043920886217,0.5067593257475171,0.9800285306704708,0.998942955253046,1.0,6/32,23.04%,NEK7;NAF1;CCT2;ATR;CCT3;MAPK1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.20937205907531906,0.5031939342503994,0.9819967266775778,0.9994683731128373,1.0,8/18,28.36%,AMFR;RNF185;EDEM2;SEL1L;RNF103;MAN1B1;UGGT1;UGGT2
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.2045484448210997,-0.5006092247372794,0.9814814814814815,0.9975901459699047,1.0,3/11,28.12%,JAK2;XBP1;CIITA
prerank,striated muscle contraction (GO:0006941),0.17172293638905778,0.49947571558464077,0.9922178988326849,0.999977356111751,1.0,8/53,16.68%,CSRP3;ATP1A2;CASQ2;SCN2B;TNNI1;TNNI3;ARHGEF11;RCSD1
prerank,negative regulation of cellular metabolic process (GO:0031324),0.18205764186323417,0.4990968175501935,0.994277539341917,0.9996553088856693,1.0,8/37,22.92%,NCOR1;AATF;ATXN2;ANKRD13B;PINK1;PRKN;PAX2;SIRT2
prerank,positive regulation of immune response (GO:0050778),0.16747183171738916,0.4985667744230588,0.9974160206718347,0.9993586945273507,1.0,9/64,17.17%,PTPRC;POLR3G;PLSCR1;KARS1;IL6ST;CD81;POLR3D;IL15;STX4
prerank,T cell activation involved in immune response (GO:0002286),-0.1952909394795581,-0.4950900191705873,0.9868421052631579,0.9977927397851702,1.0,10/12,52.70%,EIF2AK4;ICAM1;SLC11A1;LILRB1;FCER1G;CD74;ITGAL;F2RL1;IFNK;TNFSF18
prerank,sensory perception of smell (GO:0007608),0.22403075467730602,0.4933718227095098,0.9807355516637478,1.0,1.0,10/11,48.40%,ADCY3;UBR3;SLC24A4;OBP2B;GFY;DRD2;OMP;BEST2;SYT10;BBS4
prerank,cellular response to radiation (GO:0071478),0.17745525634589943,0.49030960802409645,0.9886201991465149,1.0,1.0,9/40,22.69%,OPN1MW;OPN1MW3;SWI5;INO80;TNKS1BP1;RHNO1;GPR52;RAD9A;SPIDR
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.21754695456034676,0.4896412138931342,0.9723127035830619,1.0,1.0,1/14,5.17%,CARD10
prerank,regulation of mast cell degranulation (GO:0043304),0.21350321454570786,0.48935384699970774,0.9847972972972973,0.9998539514012947,1.0,3/14,16.49%,FER;GAB2;SYK
prerank,serine family amino acid catabolic process (GO:0009071),-0.19988168133379497,-0.48800696617031525,0.9836448598130841,0.9980916133075602,1.0,5/10,34.19%,CBS;GCSH;THNSL2;SHMT2;SHMT1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.20410640972732436,-0.4851771441587337,0.9857142857142858,0.9977755475672425,1.0,5/10,35.96%,AKT1;MYD88;TREM2;CD36;TLR6
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.21073428350633097,0.4848214492229007,0.9690189328743546,1.0,1.0,4/14,24.32%,DDRGK1;COPS5;BAX;HSPA5
prerank,positive regulation of T cell activation (GO:0050870),0.16195304207946776,0.4838214302629233,1.0,1.0,1.0,13/62,21.78%,FLOT2;PTPRC;NCK2;IL6ST;CD276;CD81;IL7;IL15;MDK;DOCK8;IL6;NCK1;CCDC88B
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.1976163066533248,0.4801768210986007,0.9790322580645161,1.0,1.0,3/18,13.31%,ISL1;AQP1;ZFP36L2
prerank,nuclear membrane disassembly (GO:0051081),0.2135380774547981,0.4797603618342067,0.9844827586206897,1.0,1.0,1/14,4.28%,PRKCA
prerank,lipid droplet organization (GO:0034389),0.19165776744770419,0.4785634338439348,0.9877300613496932,0.9999359852211738,1.0,22/22,80.86%,HILPDA;CDS2;RAB18;RAB3GAP1;PLA2G4C;FAF2;ZFYVE1;PPIA;FITM1;CIDEC;TSPO2;HSD17B13;SMIM22;CIDEA;PLIN5;CDS1;SQLE;BSCL2;PPID;AUP1;FITM2;PNPLA3
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.21014258804591937,0.4784631071552235,0.9833610648918469,0.9995271762708665,1.0,3/13,18.94%,CNOT7;CPEB3;CNOT1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.20535241623659814,0.47565764335270383,0.9879101899827288,0.999645782370378,1.0,4/15,23.66%,POP7;DICER1;RPP30;RNASEH1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.1891141943277572,0.47439277569997296,0.989247311827957,0.9994742447458136,1.0,5/24,21.53%,RFC3;POLB;POLE;RFC1;RPA3
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.1870840994122074,0.47373045129126945,0.9869753979739508,0.999179735259369,1.0,6/25,19.71%,CIDEB;GPER1;BAD;BNIP3;PINK1;BAX
prerank,phospholipid homeostasis (GO:0055091),-0.1936739875914866,-0.46834977521492854,0.9824945295404814,0.9991825886682087,1.0,4/11,34.57%,ABCG1;RCN3;FABP3;TLCD2
prerank,negative regulation of interleukin-17 production (GO:0032700),0.2217061075889775,0.4654060729654968,0.9804964539007093,1.0,1.0,10/10,77.84%,DDIT3;PRNP;VSIR;IFNG;TNFSF4;IL12B;FOXP3;TLR4;IL12A;NCKAP1L
prerank,glycine metabolic process (GO:0006544),0.21564442212317161,0.46540362620219383,0.9746192893401016,0.9997731807557054,1.0,12/12,78.45%,GLDC;DLD;SDSL;SDS;BAAT;AMT;GLYAT;SHMT1;GCAT;SHMT2;GCSH;RIDA
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.1885282374650174,0.46416647672003686,0.9924698795180723,0.9995451584963673,1.0,2/23,9.55%,CRTAM;LAMP1
prerank,neural crest cell differentiation (GO:0014033),0.1934587791036283,0.46382911820464967,0.9938461538461538,0.9991809394604981,1.0,2/18,11.86%,CDH2;FBXL17
prerank,regulation of response to interferon-gamma (GO:0060330),0.2048533090946995,0.46365276753904927,0.9875444839857651,0.9987873044114035,1.0,5/14,26.56%,SOCS1;JAK1;SUMO1;PIAS1;PTPN2
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.20739556909948498,0.46239270527189125,0.9828178694158075,0.9985786056372081,1.0,1/12,8.27%,GCNT2
prerank,protein trimerization (GO:0070206),-0.17448843816706833,-0.4603918969290029,0.9973821989528796,0.998516504576339,1.0,1/14,3.29%,SCARA5
prerank,protein homotrimerization (GO:0070207),-0.17448843816706833,-0.4603918969290029,0.9973821989528796,0.998516504576339,1.0,1/14,3.29%,SCARA5
prerank,regulation of AMPA receptor activity (GO:2000311),0.17811747101371178,0.4579874677489263,0.9923896499238964,0.9988298145752998,1.0,2/25,10.51%,MINK1;RELN
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.18111816183725332,-0.4518835873269907,0.9900497512437811,0.9985629195520463,1.0,5/11,37.95%,VCP;AUP1;TOR1A;POMT2;UFD1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.18610218990757896,0.4506785298873465,0.995334370139969,0.9994552499523957,1.0,7/19,26.08%,NAGK;GNPDA2;PMM1;GFPT1;GFPT2;PMM2;AMDHD2
prerank,spermatid development (GO:0007286),0.1681521375899172,0.4429192717918361,0.9984984984984985,0.9999875772014797,1.0,6/32,23.54%,TDRD5;IQCG;CEP57;CDYL;DDX25;SYCP3
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.1866148377840119,0.4427538990408216,0.9853181076672104,0.9995896856830336,1.0,7/17,27.68%,DYRK1A;YJU2;PRKN;TWIST1;PTTG1IP;MDM2;SNAI1
prerank,spliceosomal snRNP assembly (GO:0000387),0.1625551879888697,0.44118883402027026,0.9970544918998527,0.9993601368869691,1.0,3/38,7.36%,SNRPF;PRPF3;SMN1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.17598375156922505,0.44048899269041725,0.9968944099378882,0.999011052150266,1.0,9/22,28.36%,AMFR;RNF185;EDEM2;SEL1L;RNF103;MAN1B1;UGGT1;MAN1C1;UGGT2
prerank,negative regulation of receptor internalization (GO:0002091),0.20094802786698474,0.4381895426467269,0.9914529914529915,0.9988455316282292,1.0,2/12,15.17%,ATXN2;ANKRD13B
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.1955841356615129,0.43632986342867436,0.9896551724137931,0.9986426430411799,1.0,2/13,21.30%,NEDD4;EPN2
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.16492968357609245,-0.4311817927481111,0.9975669099756691,0.9994023317873124,1.0,13/13,83.53%,MAPT;ITGB2;ITGAM;TGFB1;CRP;GSTP1;F2RL1;CD177;FPR2;TYROBP;SOD1;PRKCD;SYK
prerank,phagolysosome assembly (GO:0001845),0.19685719520082953,0.43078867855009934,0.980701754385965,0.9987994488582695,1.0,3/12,18.86%,ARL8B;RAB34;RAB39A
prerank,regulation of superoxide anion generation (GO:0032928),0.1890167969601817,0.42854834350682613,0.993322203672788,0.9985857046423154,1.0,2/14,16.49%,AATF;SYK
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.1587519488860583,0.4259132231537353,0.9971870604781997,0.9984060511408797,1.0,3/35,12.07%,NEK7;NAF1;CCT2
prerank,cell-cell junction maintenance (GO:0045217),-0.17147613815213833,-0.4214204515785646,0.9976190476190476,0.9992016648651438,1.0,1/11,6.24%,MYADM
prerank,regulation of lipid storage (GO:0010883),0.16928804130501396,0.4162718685670886,0.9968152866242038,0.9987874245366068,1.0,4/22,20.68%,HILPDA;FBXW7;LPL;IL6
prerank,regulation of chromosome organization (GO:0033044),0.16391028743760822,0.41026015644414005,0.998468606431853,0.9988229529879553,1.0,10/22,31.15%,SHCBP1L;TERF2;HNRNPD;SMG6;CENPV;YLPM1;SMG5;TERF2IP;XRCC5;WAPL
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.18736139752656422,0.40672845152794246,0.9929328621908127,0.9986493333400595,1.0,3/11,23.74%,SIRT7;DDX11;MTOR
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.17283766276993162,0.4040449770905809,0.9896373056994818,0.9983876806462088,1.0,2/14,19.89%,NLRP2B;CCDC3
prerank,positive regulation of lymphocyte migration (GO:2000403),0.18379520606466215,0.39571875567872994,0.9982788296041308,0.9984622874393128,1.0,3/12,18.89%,TNFRSF14;RHOA;DOCK8
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.15551486266250492,-0.386238195608387,0.9976798143851509,0.999528136211894,1.0,6/11,42.67%,JAK2;STAT3;IL12RB2;STAT4;IL27RA;IL12A
prerank,secretory granule organization (GO:0033363),0.1727280869744977,0.3751276578167904,0.9948630136986302,0.9989415629469153,1.0,1/10,9.72%,ABCA1
